Citrus Sinensis ID: 006906
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 626 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGE0 | 1014 | Probable LRR receptor-lik | yes | no | 0.985 | 0.608 | 0.671 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.972 | 0.586 | 0.598 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.971 | 0.587 | 0.597 | 0.0 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.974 | 0.598 | 0.548 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.940 | 0.618 | 0.535 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.953 | 0.584 | 0.517 | 1e-171 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.955 | 0.586 | 0.525 | 1e-171 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.972 | 0.590 | 0.456 | 1e-150 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.969 | 0.587 | 0.453 | 1e-145 | |
| O23081 | 665 | Cysteine-rich receptor-li | no | no | 0.431 | 0.406 | 0.463 | 6e-69 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 827 bits (2136), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/624 (67%), Positives = 489/624 (78%), Gaps = 7/624 (1%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++KTLIL KC I G IP YIGD+ KLK +DLSFN L+G IP++FE + K +F+YLTGNKL
Sbjct: 282 SIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFNLLSGEIPSSFENMKKADFIYLTGNKL 341
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPI-ECPRGSVNLVESYSSPRNKLDKVHPCLRQ 120
TG VP Y NKNVD+S NNFT ESS P +C R + NLVES++ NK K C Q
Sbjct: 342 TGGVPNYFVERNKNVDVSFNNFTDESSIPSHDCNRVTSNLVESFAL-GNKSHKGSTCFLQ 400
Query: 121 NFPCSAPADQYHYTLHINCGGAKINTG-HTKYEADMEARGASMF-YSSGQYWAFSSTGKF 178
PC P + Y L+INCGG ++ Y+AD E +GASM+ + + WA SSTG F
Sbjct: 401 RMPCVHPKRYHLYKLYINCGGGEVKVDKEITYQADDEPKGASMYVLGANKRWALSSTGNF 460
Query: 179 MDDDTDLDNYIRTNTSTLS-KVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAE 237
MD+D D D Y NTS LS S+ LYRTARVSPLSLTYYG+CLGNGNYTV LHFAE
Sbjct: 461 MDNDDDADEYTVQNTSRLSVNASSPSFGLYRTARVSPLSLTYYGICLGNGNYTVNLHFAE 520
Query: 238 IIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHL 297
IIF +D+T SLGKR+FDIY+Q++LV K+FNI++ A G+G PI+K+F VT HTLKI L
Sbjct: 521 IIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARGSGKPIIKSFLVNVTDHTLKIGL 580
Query: 298 YWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILF 357
WAG+GTTGIP+RG YGP+ISAISV+ NFKPPV + K+ ++ + V A+ LL+ +I+
Sbjct: 581 RWAGKGTTGIPIRGVYGPMISAISVEPNFKPPVYYDTKDIILKVGVPVAAATLLLFIIVG 640
Query: 358 IMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS 417
+ WK K DKELRGLDLQTG +TLRQIKAAT+NFD K+GEGGFGSVYKG LS
Sbjct: 641 VF-WKK-RRDKNDIDKELRGLDLQTGTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELS 698
Query: 418 DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 477
+G +IAVKQLS+KSRQGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL+LVYEY++NNC
Sbjct: 699 EGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLILVYEYLENNC 758
Query: 478 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537
LSRA+FGKD RLKLDW TRKKI +GIA+GL +LHE+SRIKIVHRDIK SNVLLDKDLN
Sbjct: 759 LSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLN 818
Query: 538 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
AKISDFGLAKL ++ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGK
Sbjct: 819 AKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGK 878
Query: 598 SNTNYRPNEDFVYLLDWAYVLQEE 621
SNTN+RP EDFVYLLDWAYVLQE
Sbjct: 879 SNTNFRPTEDFVYLLDWAYVLQER 902
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 746 bits (1927), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/623 (59%), Positives = 458/623 (73%), Gaps = 14/623 (2%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
M +K L+L CLI G IP+YIG M++LK +DLS N LTG IP TF L NFM+L N
Sbjct: 282 MKMKRLVLRNCLIRGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFRNLDAFNFMFLNNNS 341
Query: 61 LTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQ 120
LTGPVP++I NS +N+D+S NNFT + + C + VNL+ SY S + + V CLR+
Sbjct: 342 LTGPVPQFIINSKENLDLSDNNFTQPPT--LSCNQLDVNLISSYPSVTD--NSVQWCLRE 397
Query: 121 NFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
PC P D +L INCGG+++ G Y D+ +RG S F S + W +SS+G ++
Sbjct: 398 GLPC--PEDAKQSSLFINCGGSRLKIGKDTYTDDLNSRGQSTFSSVSERWGYSSSGVWLG 455
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
+ Y+ T+ L ++ E Y+TAR+SP SL YYGLCL G+Y ++LHFAEI+F
Sbjct: 456 KEDA--GYLATDRFNL--INGSTPEYYKTARLSPQSLKYYGLCLRRGSYKLQLHFAEIMF 511
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPA-EVTSHTLKIHLYW 299
ND TFNSLG+RIFDIY+Q L+++DFNI + AGG G P ++ +V TL+IHL W
Sbjct: 512 SNDQTFNSLGRRIFDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNGSTLEIHLQW 571
Query: 300 AGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIM 359
G+GT IP RG YGPLISAI++ NFK N + ++ A + LL+L I+
Sbjct: 572 TGKGTNVIPTRGVYGPLISAITITPNFKVDTGKPLSNGA-VAGIVIAACAVFGLLVLVIL 630
Query: 360 RWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD 418
R G LGGK V ++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VYKG+L+D
Sbjct: 631 RLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLAD 690
Query: 419 GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478
G IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY++NN L
Sbjct: 691 GMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSL 750
Query: 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538
+RA+FG + + RL LDW TR KICIGIA+GLAYLHE+SR+KIVHRDIK +NVLLD LNA
Sbjct: 751 ARALFGTEKQ-RLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNA 809
Query: 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
KISDFGLAKL +++ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGKS
Sbjct: 810 KISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKS 869
Query: 599 NTNYRPNEDFVYLLDWAYVLQEE 621
NTNYRP E+FVYLLDWAYVLQE+
Sbjct: 870 NTNYRPKEEFVYLLDWAYVLQEQ 892
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/623 (59%), Positives = 458/623 (73%), Gaps = 15/623 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
N++ L+L CLI IP+YIG MT LK +DLS N L G IP TF L NFMYL N
Sbjct: 280 NMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMYLNNNS 339
Query: 61 LTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQ 120
LTGPVP++I +S +N+D+S NNFT + + C + VNL+ SY S N + V CLR+
Sbjct: 340 LTGPVPQFILDSKQNIDLSYNNFTQPPT--LSCNQLDVNLISSYPSVTN--NSVQWCLRK 395
Query: 121 NFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
+ PC P D +H +L INCGG ++ +Y D+ RGAS F S + W +SS+G ++
Sbjct: 396 DLPC--PGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTFSSVSERWGYSSSGAWLG 453
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
+D Y+ T+T L ++ E Y+TAR++ SL YYGLC+ G+Y V+L+FAEI+F
Sbjct: 454 NDGA--TYLATDTFNL--INESTPEYYKTARLASQSLKYYGLCMRRGSYKVQLYFAEIMF 509
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYW 299
ND T++SLG+R+FDIY+Q L+++DFNI AGG G P ++ +V TL+IHL W
Sbjct: 510 SNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEIHLKW 569
Query: 300 AGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIM 359
G+GT IP RG YGPLISAI+V NFK N V + ++ A V LL+L I+
Sbjct: 570 TGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGV-VAGIVIAACVAFGLLVLVIL 628
Query: 360 RWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD 418
R G LGGK V ++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VYKG+L+D
Sbjct: 629 RLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLAD 688
Query: 419 GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478
G IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY++NN L
Sbjct: 689 GMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSL 748
Query: 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538
+RA+FG + + RL LDW TR K+CIGIA+GLAYLHE+SR+KIVHRDIK +NVLLD LNA
Sbjct: 749 ARALFGTEKQ-RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNA 807
Query: 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
KISDFGLAKL EE+ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGKS
Sbjct: 808 KISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKS 867
Query: 599 NTNYRPNEDFVYLLDWAYVLQEE 621
NTNYRP E+F+YLLDWAYVLQE+
Sbjct: 868 NTNYRPKEEFIYLLDWAYVLQEQ 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 678 bits (1749), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/627 (54%), Positives = 443/627 (70%), Gaps = 17/627 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++K LIL C + G++P Y+G KLKN+DLSFN L+G IP T+ L+ +F+Y T N L
Sbjct: 279 SMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATYSGLSDVDFIYFTSNML 338
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
G VP ++ + +DI+ NNF+ + ++ EC + SVN S S CL +
Sbjct: 339 NGQVPSWMVDQGDTIDITYNNFSKDKTE--ECQQKSVNTFSSTSPLVANNSSNVSCLSK- 395
Query: 122 FPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDD 181
+ C + Y LHINCGG +I + TKY+AD +Y S W S+TG F+DD
Sbjct: 396 YTCP----KTFYGLHINCGGNEITSNETKYDAD--TWDTPGYYDSKNGWVSSNTGNFLDD 449
Query: 182 DTDLDNYIRTNTSTLSKV--SAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEII 239
D + + + S+ K+ S++D LY AR+S +SLTY LCLG GNYTV LHFAEI+
Sbjct: 450 DRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGNYTVNLHFAEIM 509
Query: 240 FKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYW 299
F + +++LG+R FDIY+Q K KDFNI DEA G G +VK FP VT+ L+I L W
Sbjct: 510 FNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVGKAVVKKFPVMVTNGKLEIRLQW 569
Query: 300 AGRGTTGIPLRGTYGPLISAISVKSNFKPP-----VVHSKKNHVMIMAAIVGASVLLVLL 354
AG+GT IP+RG YGPLISA+SV +F PP + ++ +++ ++V LVLL
Sbjct: 570 AGKGTQAIPVRGVYGPLISAVSVDPDFIPPKEPGTGTGGGSSVGTVVGSVIASTVFLVLL 629
Query: 355 ILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKG 414
I I+ W+GCL K +K+ + LD Q ++LRQIK AT+NFDPANK+GEGGFG V+KG
Sbjct: 630 IGGILWWRGCLRPKSQMEKDFKNLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPVHKG 689
Query: 415 ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474
I++DGTVIAVKQLS+KS+QGNREF+NEI MISA QHP+LVKLYGCCVEG+QLLLVYEY++
Sbjct: 690 IMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYLE 749
Query: 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 534
NN L+RA+FG E ++ L+WP R+KIC+GIARGLAYLHE+SR+KIVHRDIK +NVLLDK
Sbjct: 750 NNSLARALFGPQ-ETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 808
Query: 535 DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 594
+LN KISDFGLAKL EE+ THISTR+AGT GYMAPEYAMRG+LT KADVYSFGVV LEIV
Sbjct: 809 ELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIV 868
Query: 595 SGKSNTNYRPNEDFVYLLDWAYVLQEE 621
GKSNT+ R D YLLDW +VL+E+
Sbjct: 869 HGKSNTSSRSKADTFYLLDWVHVLREQ 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 635 bits (1637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/622 (53%), Positives = 421/622 (67%), Gaps = 33/622 (5%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
++TLIL C + G++PDY+G +T K +DLSFN L+G IP T+ L ++Y TGN L
Sbjct: 256 METLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTGNMLN 315
Query: 63 GPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNF 122
G VP ++ N +D+S NNF+ + ++ + C K + V C+R N+
Sbjct: 316 GSVPDWMVNKGYKIDLSYNNFSVDPTNAV-C----------------KYNNVLSCMR-NY 357
Query: 123 PCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDD 182
C + LHINCGG +++ T YE+D R S +Y S W ++ G F+DD
Sbjct: 358 QCPKTFN----ALHINCGGDEMSINGTIYESDKYDRLES-WYESRNGWFSNNVGVFVDDK 412
Query: 183 TDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKN 242
+ T S S+++ VD LY AR+S +SLTYY LCL NGNY V LHFAEI+F
Sbjct: 413 HVPERV--TIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNG 470
Query: 243 DSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGR 302
++ + SLG+R FDIYIQ KL KDFNI EA G ++K FP E+ L+I LYWAGR
Sbjct: 471 NNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGR 530
Query: 303 GTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHV---MIMAAIVGASVLLVLLILFIM 359
GTT IP YGPLISAISV S+ P S +N + + +V S+ +V L+ +
Sbjct: 531 GTTVIPKERVYGPLISAISVDSSVNP----SPRNGMSTGTLHTLVVILSIFIVFLVFGTL 586
Query: 360 RWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDG 419
KG L K +K+ + L+L ++LRQIK ATNNFD AN++GEGGFG VYKG L DG
Sbjct: 587 WKKGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDG 646
Query: 420 TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 479
T+IAVKQLS+ S+QGNREF+NEIGMISA HPNLVKLYGCCVEG QLLLVYE+++NN L+
Sbjct: 647 TIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLA 706
Query: 480 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 539
RA+FG E +L+LDWPTR+KICIG+ARGLAYLHE+SR+KIVHRDIK +NVLLDK LN K
Sbjct: 707 RALFGPQ-ETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPK 765
Query: 540 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599
ISDFGLAKL EED THISTRIAGT GYMAPEYAMRG+LT KADVYSFG+V LEIV G+SN
Sbjct: 766 ISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSN 825
Query: 600 TNYRPNEDFVYLLDWAYVLQEE 621
R + YL+DW VL+E+
Sbjct: 826 KIERSKNNTFYLIDWVEVLREK 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1553), Expect = e-171, Method: Compositional matrix adjust.
Identities = 323/624 (51%), Positives = 415/624 (66%), Gaps = 27/624 (4%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
L +IL C I G+IP Y+ + +L+ +DLSFN L GGIP+ F + F+ L GN L
Sbjct: 291 LTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPS-FAQAENLRFIILAGNMLE 349
Query: 63 GPVPKYIFNSNKNVDISLNNFTWESSDPIEC-PRGSVNLVESYSSPRNKLDKVHPCLRQN 121
G P + VD+S NN W+S + C P ++NL S+ K K PC++ +
Sbjct: 350 GDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLPCIK-D 408
Query: 122 FPCSAPADQYHYTLHINCGGAKINTGHTK----YEAD--MEARGASMFYSSGQYWAFSST 175
F C +Y LH+NCGG+ + K YE D +E A F W FSST
Sbjct: 409 FKCP----RYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGFSST 464
Query: 176 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 235
G FMDD N + T+ ++ +LY++AR++P+SLTY+ CL NGNYT+ L F
Sbjct: 465 GDFMDD-----NNFQNTRFTMFVPASNQSDLYKSARIAPVSLTYFHACLENGNYTINLDF 519
Query: 236 AEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKI 295
AEI F ND +N LG+R+FDIYIQEKLV KDFNI DEA G PI+K A VT+H L I
Sbjct: 520 AEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTNHFLTI 579
Query: 296 HLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAI---VGASVLLV 352
L WAG+GTT IP RG YGP+ISAIS+ S+ KP K + A I +GA L++
Sbjct: 580 RLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP--CERPKTGMSPGAYIAIGIGAPCLII 637
Query: 353 LLILFIMRW-KGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSV 411
++ F+ W GCL K+ +L +G +TLRQIK AT++F+P NK+GEGGFG+V
Sbjct: 638 FILGFL--WICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEGGFGAV 695
Query: 412 YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471
+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG IS QHPNLVKL+G CVE QLLL YE
Sbjct: 696 FKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYE 755
Query: 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 531
YM+NN LS A+F + ++ +DWPTR KIC GIA+GLA+LHE+S +K VHRDIK +N+L
Sbjct: 756 YMENNSLSSALFSPKHK-QIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNIL 814
Query: 532 LDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTL 591
LDKDL KISDFGLA+L EE+KTHIST++AGTIGYMAPEYA+ GYLT KADVYSFGV+ L
Sbjct: 815 LDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVL 874
Query: 592 EIVSGKSNTNYRPNEDFVYLLDWA 615
EIV+G +N+N+ D V LL++A
Sbjct: 875 EIVAGITNSNFMGAGDSVCLLEFA 898
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 601 bits (1549), Expect = e-171, Method: Compositional matrix adjust.
Identities = 330/628 (52%), Positives = 416/628 (66%), Gaps = 30/628 (4%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
LK LIL + G IP YI ++T LK +DLSFN L G I + K +YLTGN L+
Sbjct: 286 LKRLILRNVGLSGPIPSYIWNLTDLKILDLSFNKLNG-IVQGVQNPPKN--IYLTGNLLS 342
Query: 63 GPVPKY-IFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
G + + NS +D+S NNF+W SS C +GS S +N L + PC
Sbjct: 343 GNIESGGLLNSQSYIDLSYNNFSWSSS----CQKGSTINTYQSSYSKNNLTGLPPC---- 394
Query: 122 FPCSAPAD--QYHYTLHINCGGAKINT----GHTKYEADMEARGASMFYSSGQYWAFSST 175
+ PA+ +Y LHINCGG +++ G Y+ D + + YW S+T
Sbjct: 395 ---AVPANCKKYQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQFDYWGVSNT 451
Query: 176 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 235
G F DD++D D Y + TLS +LY+TAR S LSL YY CL NGNY V+LHF
Sbjct: 452 GDFTDDNSDHDEYYTSTNLTLSGDYP---DLYKTARRSALSLVYYAFCLENGNYNVKLHF 508
Query: 236 AEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKI 295
EI F + ++ LG+RIFD+Y+Q KL +DFNI EA G P++K A VT+H L+I
Sbjct: 509 MEIQFSDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEINATVTNHMLEI 568
Query: 296 HLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGAS---VLLV 352
LYWAG+GTT IP RG YGPLISAIS+ + +P K H + I+GAS V +V
Sbjct: 569 RLYWAGKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLILGASGALVTIV 628
Query: 353 LLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY 412
LL + I +++LR LQT ++ RQ++ ATNNFD ANK+GEGGFGSV+
Sbjct: 629 LLAVGIYARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQANKLGEGGFGSVF 688
Query: 413 KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472
KG LSDGT+IAVKQLSSKS QGNREFVNEIGMIS HPNLVKLYGCCVE +QLLLVYEY
Sbjct: 689 KGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCCVERDQLLLVYEY 748
Query: 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532
M+NN L+ A+FG+++ LKLDW R+KIC+GIARGL +LH+ S +++VHRDIKT+NVLL
Sbjct: 749 MENNSLALALFGQNS---LKLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNVLL 805
Query: 533 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLE 592
D DLNAKISDFGLA+L+E + THIST++AGTIGYMAPEYA+ G LT KADVYSFGVV +E
Sbjct: 806 DTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFGVVAME 865
Query: 593 IVSGKSNTNYRPNEDFVYLLDWAYVLQE 620
IVSGKSNT + N D V L++WA LQ+
Sbjct: 866 IVSGKSNTKQQGNADSVSLINWALTLQQ 893
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 532 bits (1370), Expect = e-150, Method: Compositional matrix adjust.
Identities = 290/635 (45%), Positives = 405/635 (63%), Gaps = 26/635 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L L+L + G IP IG+ + L+ +DLSFN L G IP + L++ ++L N L
Sbjct: 292 SLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTL 351
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP---CL 118
G P S +NVD+S N+ + + P +NLV + + ++V P CL
Sbjct: 352 NGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVANNFTLEGLDNRVLPGLNCL 411
Query: 119 RQNFPCSAPADQYHYTLHINCGGAKIN--TGHTKYEADMEARGASMFYSSGQYWAFSSTG 176
++NFPC+ Y INCGG + TG D + AS F S+GQ WA SS G
Sbjct: 412 QKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAASSVG 470
Query: 177 KFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFA 236
F ++ YI T+ S V+ +D EL+++AR+S S+ YYGL L NG YTV L FA
Sbjct: 471 LFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFA 526
Query: 237 EI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN-FPAEVTSHTL 293
EI + +T+ LG+R FDIY+Q +LV+KDF++ AG + + V+ + A V+ + L
Sbjct: 527 EIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHL 586
Query: 294 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKP-----PVVHSKKNHVMIMAAIVGAS 348
++HL+WAG+GT IP++G YGPLISA+S +F P P K I+ IVG
Sbjct: 587 EVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVG 646
Query: 349 VLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEG 406
+L +L +++F +R + + + D+EL G+D++ ++T ++K+AT +FDP+NK+GEG
Sbjct: 647 LLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEG 703
Query: 407 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466
GFG VYKG L+DG V+AVK LS SRQG +FV EI IS+ H NLVKLYGCC EG
Sbjct: 704 GFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHR 763
Query: 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 526
+LVYEY+ N L +A+FG T L LDW TR +IC+G+ARGL YLHE++ ++IVHRD+K
Sbjct: 764 MLVYEYLPNGSLDQALFGDKT---LHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVK 820
Query: 527 TSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 586
SN+LLD L +ISDFGLAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DVY+F
Sbjct: 821 ASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAF 880
Query: 587 GVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 621
GVV LE+VSG+ N++ E+ YLL+WA+ L E+
Sbjct: 881 GVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-145, Method: Compositional matrix adjust.
Identities = 289/637 (45%), Positives = 403/637 (63%), Gaps = 30/637 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L L+L + G IP IG+ + L+ +DLSFN L G IP + L + ++L N L
Sbjct: 291 SLSILVLRNNNLTGTIPSNIGEYSSLRQLDLSFNKLHGTIPASLFNLRQLTHLFLGNNTL 350
Query: 62 TGPVPKYIFNSNKNVDISLNNFT-----WESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116
G +P S NVD+S N+ + W S + + N + N++
Sbjct: 351 NGSLPTQKGQSLSNVDVSYNDLSGSLPSWVSLPNLNLNLVANNF--TLEGLDNRVLSGLN 408
Query: 117 CLRQNFPCSAPADQYHYTLHINCGGAKINT-GHTKYEADMEARG-ASMFYSSGQYWAFSS 174
CL++NFPC+ Y INCGG +I + +E + E G AS S+GQ WA SS
Sbjct: 409 CLQKNFPCNRGKGIYS-DFSINCGGPEIRSVTEAVFEREDEDLGPASFVVSAGQRWAASS 467
Query: 175 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 234
G F ++ YI T+ S V+ +D EL+++AR+S SL YYGL L NG YTV L
Sbjct: 468 VGLFAGSSNNI--YISTSQSQF--VNTLDSELFQSARLSASSLRYYGLGLENGGYTVTLQ 523
Query: 235 FAEI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIV-KNFPAEVTSH 291
FAEI + +T+ LG+R FDIY+Q +LV+KDF++ AG + + V + + A V+ +
Sbjct: 524 FAEIQILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQREYKANVSQN 583
Query: 292 TLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKP-----PVVHSKKNHVMIMAAIVG 346
L+IHL+WAG+GT IP++G YGPLISA+ +F P P K I+ IVG
Sbjct: 584 HLEIHLFWAGKGTCCIPIQGAYGPLISAVGATPDFTPTVGNRPPSKGKSMTGTIVGVIVG 643
Query: 347 ASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVG 404
+L ++ +++FI+R + + + D+E+ +D++ +T ++K+AT +FDP+NK+G
Sbjct: 644 VGLLSIISGVVIFIIRKRR---KRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLG 700
Query: 405 EGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 464
EGGFG VYKG L+DG +AVK LS SRQG +FV EI ISA QH NLVKLYGCC EG
Sbjct: 701 EGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGE 760
Query: 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 524
LLVYEY+ N L +A+FG+ T L LDW TR +IC+G+ARGL YLHE++R++IVHRD
Sbjct: 761 HRLLVYEYLPNGSLDQALFGEKT---LHLDWSTRYEICLGVARGLVYLHEEARLRIVHRD 817
Query: 525 IKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVY 584
+K SN+LLD L K+SDFGLAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DVY
Sbjct: 818 VKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVY 877
Query: 585 SFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 621
+FGVV LE+VSG+ N++ ++ YLL+WA+ L E+
Sbjct: 878 AFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEK 914
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O23081|CRK41_ARATH Cysteine-rich receptor-like protein kinase 41 OS=Arabidopsis thaliana GN=CRK41 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 135/291 (46%), Positives = 193/291 (66%), Gaps = 21/291 (7%)
Query: 338 VMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQ-------- 389
+ + +++G +++ V L F+ R + +A + G DL+ + Q
Sbjct: 283 IATVCSVIGFAIIAVFLYFFMTR------NRRTAKQRHEGKDLEELMIKDAQLLQLDFDT 336
Query: 390 IKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ 449
I+ ATN+F N++GEGGFG+VYKG+L G IAVK+LS KS QG+ EF+NE+ +++ Q
Sbjct: 337 IRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVAKLQ 396
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
H NLV+L G C++G + +L+YE+ KN L IF D+ R+ LDW TR +I G+ARGL
Sbjct: 397 HRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIF--DSNRRMILDWETRYRIISGVARGL 454
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED---KTHISTRIAGTIGY 566
YLHEDSR KIVHRD+K SNVLLD +N KI+DFG+AKL++ D +T ++++AGT GY
Sbjct: 455 LYLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYGY 514
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED-FVYLLDWAY 616
MAPEYAM G + K DV+SFGV+ LEI+ GK N N+ P ED ++LL + +
Sbjct: 515 MAPEYAMSGEFSVKTDVFSFGVLVLEIIKGKKN-NWSPEEDSSLFLLSYVW 564
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 626 | ||||||
| 255584521 | 941 | conserved hypothetical protein [Ricinus | 0.984 | 0.654 | 0.782 | 0.0 | |
| 317106662 | 927 | JHL10I11.12 [Jatropha curcas] | 0.984 | 0.664 | 0.763 | 0.0 | |
| 224080095 | 977 | predicted protein [Populus trichocarpa] | 0.988 | 0.633 | 0.737 | 0.0 | |
| 302143484 | 1011 | unnamed protein product [Vitis vinifera] | 0.985 | 0.610 | 0.756 | 0.0 | |
| 449444971 | 1028 | PREDICTED: probable LRR receptor-like se | 0.985 | 0.600 | 0.735 | 0.0 | |
| 147795288 | 961 | hypothetical protein VITISV_022626 [Viti | 0.985 | 0.642 | 0.717 | 0.0 | |
| 359485473 | 999 | PREDICTED: probable LRR receptor-like se | 0.956 | 0.599 | 0.741 | 0.0 | |
| 356501491 | 1025 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.602 | 0.693 | 0.0 | |
| 357494365 | 1039 | BED finger-nbs resistance protein [Medic | 0.988 | 0.595 | 0.672 | 0.0 | |
| 345651730 | 1027 | rfls6 protein [Glycine max] | 0.987 | 0.601 | 0.683 | 0.0 |
| >gi|255584521|ref|XP_002532988.1| conserved hypothetical protein [Ricinus communis] gi|223527234|gb|EEF29396.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2593), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/621 (78%), Positives = 543/621 (87%), Gaps = 5/621 (0%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++KTLIL KCL+ G+IP+YIG M KLKN+DLSFNNLTG IP TF LAK +FMYLTGNKL
Sbjct: 192 SMKTLILRKCLLSGKIPEYIGHMKKLKNLDLSFNNLTGEIPATFSHLAKVDFMYLTGNKL 251
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
TGP+P+++ NKNVDIS NNFTW+SS IECPRGSVNLVESYSS NKL KVH CL+QN
Sbjct: 252 TGPIPEWVLERNKNVDISDNNFTWDSSSQIECPRGSVNLVESYSSSTNKLSKVHSCLKQN 311
Query: 122 FPCSAPADQYHYTLHINCGGAKINTG-HTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
FPCS+ + +Y LHINCGG +I G + Y AD+EARGASM+YSS Q WAFSSTG FMD
Sbjct: 312 FPCSSKPN--NYALHINCGGKEIIAGSNITYNADLEARGASMYYSS-QNWAFSSTGNFMD 368
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
+D D D YI+ NTS +S VSA+D +LY+TARVSPLSL+YYGLCL NGNYTV+LHFAEI+F
Sbjct: 369 NDIDADPYIQINTSAISNVSALDAQLYKTARVSPLSLSYYGLCLINGNYTVKLHFAEIVF 428
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWA 300
+D+TFNSLGKRIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLKIH YWA
Sbjct: 429 TDDNTFNSLGKRIFDVYIQEKLVLKDFNIAEEAGGTGRPIVKMFTVAVTSHTLKIHFYWA 488
Query: 301 GRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMR 360
GRGTTGIP+RG YGPLISAISV NFKPP + KKN V+I+A V A+V LVLLIL IM
Sbjct: 489 GRGTTGIPVRGIYGPLISAISVDPNFKPPSDNDKKN-VIIVATTVSAAVFLVLLILGIMW 547
Query: 361 WKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT 420
KGCLG VSADKELRGLDLQTG++TLRQIKAAT NFDPANK+GEGGFGSVYKG+LSDGT
Sbjct: 548 RKGCLGDNVSADKELRGLDLQTGIFTLRQIKAATKNFDPANKLGEGGFGSVYKGLLSDGT 607
Query: 421 VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 480
+IAVKQLSSKS+QGNREFVNEIGMIS QHPNLVKLYGCCVEGNQLLL+YEYM+NNCLSR
Sbjct: 608 IIAVKQLSSKSKQGNREFVNEIGMISGLQHPNLVKLYGCCVEGNQLLLIYEYMENNCLSR 667
Query: 481 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540
A+FGK++ RLKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVLLDKDLNAKI
Sbjct: 668 ALFGKNSTSRLKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLLDKDLNAKI 727
Query: 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600
SDFGLAKL E++ THISTRIAGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIVSGKSNT
Sbjct: 728 SDFGLAKLNEDENTHISTRIAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIVSGKSNT 787
Query: 601 NYRPNEDFVYLLDWAYVLQEE 621
NYRP E+FVYLLDWAYVLQE
Sbjct: 788 NYRPKEEFVYLLDWAYVLQER 808
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106662|dbj|BAJ53166.1| JHL10I11.12 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2536), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/621 (76%), Positives = 537/621 (86%), Gaps = 5/621 (0%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++K LIL CL+ EIP+YIG M KLKN+DLSFNNLTG IPT+F L K +FMYLTGNKL
Sbjct: 171 SIKALILRNCLLSDEIPEYIGHMKKLKNLDLSFNNLTGEIPTSFSYLGKADFMYLTGNKL 230
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
TG VP+++ NKNVDIS NNF+WESS PIECPRGSVNLVESYSS KL KVH CL+QN
Sbjct: 231 TGSVPEWVLERNKNVDISDNNFSWESSSPIECPRGSVNLVESYSSSTEKLSKVHSCLKQN 290
Query: 122 FPCSAPADQYHYTLHINCGGAK-INTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
FPCS+ ++ +Y+L+INCGG + I G+T Y+AD+E RGASMFY+S Q WAFSSTG FMD
Sbjct: 291 FPCSS--NKKYYSLYINCGGEEMIAGGNTTYQADLEPRGASMFYTS-QSWAFSSTGNFMD 347
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
++ D D YI+ NTS +S VS+ D +LY TARVSP+SLTYYGLCL NGNYTV LHFAEI+F
Sbjct: 348 NNIDSDPYIQINTSAISNVSSPDAQLYTTARVSPISLTYYGLCLINGNYTVNLHFAEIVF 407
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWA 300
NDS+FNSLG+RIFD+YIQEKLV KDFNI +EAGGTG PIVK F VTSHTLKIH YWA
Sbjct: 408 INDSSFNSLGRRIFDVYIQEKLVLKDFNIVEEAGGTGRPIVKKFTVTVTSHTLKIHFYWA 467
Query: 301 GRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMR 360
G+GTTGIP+RGTYGPLISAISV NFKPP + +K +++ + + GA V LVLL+L IM
Sbjct: 468 GKGTTGIPVRGTYGPLISAISVDPNFKPPSDNDEKEKIIVSSTVAGA-VFLVLLVLCIMW 526
Query: 361 WKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT 420
KGCLGGKV ADKELRGLDLQTG++TL+QIKAAT NFD ANKVGEGGFGSVYKG LSDGT
Sbjct: 527 RKGCLGGKVYADKELRGLDLQTGIFTLKQIKAATKNFDAANKVGEGGFGSVYKGQLSDGT 586
Query: 421 VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 480
+IAVKQLSSKS+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQLLL+YEYM+NNCLSR
Sbjct: 587 IIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLLLIYEYMENNCLSR 646
Query: 481 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540
A+FGK+ RLKLDWPTR+KIC+G+ARGLAYLHE+S IKIVHRDIKTSNVL+DKDLNAKI
Sbjct: 647 ALFGKNPTSRLKLDWPTRQKICLGVARGLAYLHEESIIKIVHRDIKTSNVLIDKDLNAKI 706
Query: 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600
SDFGLAKL E+D THISTR+AGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIVSGKSNT
Sbjct: 707 SDFGLAKLNEDDNTHISTRVAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIVSGKSNT 766
Query: 601 NYRPNEDFVYLLDWAYVLQEE 621
NYRP E+FVYLLDWAYVLQE
Sbjct: 767 NYRPKEEFVYLLDWAYVLQER 787
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224080095|ref|XP_002306015.1| predicted protein [Populus trichocarpa] gi|222848979|gb|EEE86526.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/622 (73%), Positives = 523/622 (84%), Gaps = 3/622 (0%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++KTLIL CLI+GEIP+Y+G M KLK++D+SFNNL G IP+TF +LA+ +F+YLTGNKL
Sbjct: 246 SMKTLILRNCLIYGEIPEYVGQMEKLKHLDVSFNNLRGEIPSTFIQLARIDFLYLTGNKL 305
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
TG VP ++ NKNVD+S NNFTW+SS P EC RGSVN+VES+S P K H CL+QN
Sbjct: 306 TGSVPPWLLERNKNVDLSYNNFTWQSSSPDECARGSVNIVESFS-PSTIKSKAHSCLKQN 364
Query: 122 FPCSAPADQYHYTLHINCGGAKINT-GHTKYEADMEARGASMFYS-SGQYWAFSSTGKFM 179
FPCSA +Q HYTLHINCGG +I G+T Y+ D E RGASMFYS Q WAFSSTG FM
Sbjct: 365 FPCSASRNQQHYTLHINCGGNEITVDGNTTYQDDKEPRGASMFYSHPSQEWAFSSTGNFM 424
Query: 180 DDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEII 239
DDD++ D Y +TN S +S VSA +LY TARVSPLSLTYYGLCL NGNYTV+LHFAEII
Sbjct: 425 DDDSEADAYTKTNKSAISNVSATIAQLYTTARVSPLSLTYYGLCLMNGNYTVKLHFAEII 484
Query: 240 FKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYW 299
F NDS+ SLGKRIFD+YIQ KLV KDFNIEDEAGG IP+VK F A VT +TLKI LYW
Sbjct: 485 FTNDSSLTSLGKRIFDVYIQGKLVLKDFNIEDEAGGVAIPLVKTFIAAVTHNTLKIRLYW 544
Query: 300 AGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIM 359
AGRGTTGIPLRG YGPLISAISV NFKPP SK+N V+I+ V ++ L L+L +M
Sbjct: 545 AGRGTTGIPLRGIYGPLISAISVDPNFKPPSNGSKRNVVIIVTGAVAGAIFLAFLVLGVM 604
Query: 360 RWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDG 419
G L GK +ADKEL+GLDLQTGL+TLRQ+KAATNNFD NKVGEGGFGSVYKG LSDG
Sbjct: 605 WRNGWLCGKAAADKELKGLDLQTGLFTLRQMKAATNNFDAENKVGEGGFGSVYKGSLSDG 664
Query: 420 TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 479
TVIAVK LSSKS+QGNREFVNEIGMISA QHPNLVKLYGCCVEGNQL++VYEYM+NNCLS
Sbjct: 665 TVIAVKLLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLMIVYEYMENNCLS 724
Query: 480 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 539
RA+ GK++++R+KLDWPTR+KIC+G+A+GL YLHE+S IKIVHRDIKTSNVLLDK+LNAK
Sbjct: 725 RALLGKESKFRMKLDWPTRQKICLGVAKGLMYLHEESIIKIVHRDIKTSNVLLDKELNAK 784
Query: 540 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599
ISDFGLAKL E+D THISTRIAGTIGYMAPEYAMRGYLT+KADVYSFGVV LEIVSGKSN
Sbjct: 785 ISDFGLAKLNEDDDTHISTRIAGTIGYMAPEYAMRGYLTNKADVYSFGVVALEIVSGKSN 844
Query: 600 TNYRPNEDFVYLLDWAYVLQEE 621
TNYRP E+FVYLLDWAYVLQE
Sbjct: 845 TNYRPKEEFVYLLDWAYVLQER 866
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143484|emb|CBI22045.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2441), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/620 (75%), Positives = 528/620 (85%), Gaps = 3/620 (0%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+LKTL+L KCLIHGEIP+YIGDM KLK++DLSFN L G IPT+F++LAKT+FMYLTGN L
Sbjct: 275 SLKTLVLRKCLIHGEIPEYIGDMKKLKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNML 334
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
TG +P +I +NKN D+S NNFTW+SS P+ECPRGSVNLVESYSS + CL+QN
Sbjct: 335 TGHIPDWILGTNKNFDLSYNNFTWDSSSPVECPRGSVNLVESYSSSSVRRSIHS-CLKQN 393
Query: 122 FPCSAPADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
FPCSA ++QYHY+LHINCGG + + G TKYEAD+E GASMFY GQ WAFSSTG FMD
Sbjct: 394 FPCSASSNQYHYSLHINCGGKETSINGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMD 452
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
+D D D YI NTS+LS VS +D+ELY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF
Sbjct: 453 NDVDGDAYIEANTSSLSNVSVLDVELYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIF 512
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWA 300
ND +FNSLG+RIFD+YIQ KLV KDFNIE EAGGTG PI+KNF AEVTSHTLK+ YWA
Sbjct: 513 INDKSFNSLGERIFDVYIQGKLVLKDFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWA 572
Query: 301 GRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMR 360
GRGTTGIPLRG YGPLISAISV NF+PP K + I+ +V+LVLL L I+
Sbjct: 573 GRGTTGIPLRGFYGPLISAISVDPNFEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILW 632
Query: 361 WKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT 420
KG LGGK S DKELRGLDLQTGL+TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGT
Sbjct: 633 RKGWLGGKTSEDKELRGLDLQTGLFTLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGT 692
Query: 421 VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 480
VIAVKQLSSKS+QGNREFVNE+GMISA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSR
Sbjct: 693 VIAVKQLSSKSKQGNREFVNEVGMISALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSR 752
Query: 481 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540
A+FG+D Y+LKL+W TR+ IC+GIARGLAYLHE+S +KIVHRDIKTSNVLLDKD+NAKI
Sbjct: 753 ALFGRDATYKLKLNWSTRQNICVGIARGLAYLHEESTLKIVHRDIKTSNVLLDKDMNAKI 812
Query: 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600
SDFGLAKL E+D THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGKSNT
Sbjct: 813 SDFGLAKLDEDDNTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGKSNT 872
Query: 601 NYRPNEDFVYLLDWAYVLQE 620
NYRP E+FVYLLDWAYVLQE
Sbjct: 873 NYRPKEEFVYLLDWAYVLQE 892
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444971|ref|XP_004140247.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] gi|449481221|ref|XP_004156118.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 933 bits (2411), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/620 (73%), Positives = 523/620 (84%), Gaps = 3/620 (0%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++KTLIL KC I GEIP YIGDM KLKN+DLS+N+LTG +P TFE+L K ++++LT NKL
Sbjct: 288 SMKTLILRKCFIFGEIPKYIGDMKKLKNLDLSYNDLTGEVPATFERLDKIDYIFLTANKL 347
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
G +P +I SNKNVD+S NNFTWE+S P ECPRGSVNLVE+YS KL ++HPCL++N
Sbjct: 348 NGIIPGWILGSNKNVDLSNNNFTWENSSPAECPRGSVNLVETYSPSAEKLTRIHPCLKRN 407
Query: 122 FPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDD 181
FPCSA +++HY+L INCGG + + +YEAD E GASMFY+ GQ WAFSSTG FMD+
Sbjct: 408 FPCSASREEHHYSLRINCGGKETSIRGERYEADRE--GASMFYT-GQNWAFSSTGSFMDN 464
Query: 182 DTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFK 241
D D DNYI TNTS LS VSA ELY AR SP SLTYYGLCL NGNYTV+LHFAEI+F
Sbjct: 465 DVDADNYIVTNTSALSNVSATYSELYTKARNSPQSLTYYGLCLINGNYTVKLHFAEIVFI 524
Query: 242 NDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAG 301
NDS+FNSLG+R+FD+YIQEKLV KDF+IE EAGGTG PI+K VTSHTLKIH YWAG
Sbjct: 525 NDSSFNSLGRRVFDVYIQEKLVLKDFDIEHEAGGTGKPIIKKITVAVTSHTLKIHFYWAG 584
Query: 302 RGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRW 361
RGTTGIPLRG YGPLISAISV NF PP H KK+ +I+ A+ +L+LL+L IMR
Sbjct: 585 RGTTGIPLRGNYGPLISAISVDPNFTPPKNHGKKDFTIIIIGTAAAAFVLLLLVLCIMRR 644
Query: 362 KGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV 421
KG LGGK S KELRG+DLQTGL+T+RQIKAAT NFD ANKVGEGGFG+VYKG+LSDGT+
Sbjct: 645 KGWLGGKASVYKELRGIDLQTGLFTIRQIKAATKNFDAANKVGEGGFGAVYKGLLSDGTI 704
Query: 422 IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 481
IAVKQLSSKS+QGNREFVNEIGMISA QHPNLVKLYGCC++GNQL+L+YEYM+NNCLSRA
Sbjct: 705 IAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIDGNQLMLIYEYMENNCLSRA 764
Query: 482 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541
+F D +LKLDWPTR+KIC+GIARGLAYLHE+SR+KIVHRDIKTSNVLLDKD +AKIS
Sbjct: 765 LFRNDPGSKLKLDWPTRQKICLGIARGLAYLHEESRLKIVHRDIKTSNVLLDKDFSAKIS 824
Query: 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601
DFGLAKL+E+D THISTR+AGTIGYMAPEYAMRG LTSKADVYSFGVV LEIVSGKSNTN
Sbjct: 825 DFGLAKLHEDDNTHISTRVAGTIGYMAPEYAMRGCLTSKADVYSFGVVALEIVSGKSNTN 884
Query: 602 YRPNEDFVYLLDWAYVLQEE 621
Y P EDFVYLLDWA VLQE+
Sbjct: 885 YMPKEDFVYLLDWASVLQEK 904
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147795288|emb|CAN60698.1| hypothetical protein VITISV_022626 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 927 bits (2396), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/654 (71%), Positives = 528/654 (80%), Gaps = 37/654 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+LKTL+L KCLIHGEIP+YIGDM KLK++DLSFN L G IPT+F++LAKT+FMYLTGN L
Sbjct: 204 SLKTLVLRKCLIHGEIPEYIGDMKKLKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNML 263
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
TG +P +I +NKN D+S NNFTW+SS P+ECPRGSVNLVESYSS + CL+QN
Sbjct: 264 TGHIPDWILGTNKNFDLSYNNFTWDSSSPVECPRGSVNLVESYSSSSVRRSIHS-CLKQN 322
Query: 122 FPCSAPADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
FPCSA ++QYHY+LHINCGG + + G TKYEAD+E GASMFY GQ WAFSSTG FMD
Sbjct: 323 FPCSASSNQYHYSLHINCGGKETSINGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMD 381
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
+D D D YI NTS+LS VS +D+ELY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF
Sbjct: 382 NDVDGDAYIEANTSSLSNVSVLDVELYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIF 441
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWA 300
ND +FNSLG+RIFD+YIQ KLV KDFNIE EAGGTG PI+KNF AEVTSHTLK+ YWA
Sbjct: 442 INDKSFNSLGERIFDVYIQGKLVLKDFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWA 501
Query: 301 GRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMR 360
GRGTTGIPLRG YGPLISAISV NF+PP K + I+ +V+LVLL L I+
Sbjct: 502 GRGTTGIPLRGFYGPLISAISVDPNFEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILW 561
Query: 361 WKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYK------- 413
KG LGGK S DKELRGLDLQTGL+TLRQIKAAT NFD NK+GEGGFG+V+K
Sbjct: 562 RKGWLGGKTSEDKELRGLDLQTGLFTLRQIKAATKNFDAENKLGEGGFGAVFKKLQQNLR 621
Query: 414 ---------------------------GILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 446
G LSDGTVIAVKQLSSKS+QGNREFVNE+GMIS
Sbjct: 622 KRFDGLVIKMKTSEKLNKIGLGRWGFEGTLSDGTVIAVKQLSSKSKQGNREFVNEVGMIS 681
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
A QHPNLVKLYGCC+EGNQL LVYEYM+NN LSRA+FG+D Y+LKL+W TR+ IC+GIA
Sbjct: 682 ALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSRALFGRDATYKLKLNWSTRQNICVGIA 741
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
RGLAYLHE+S +KIVHRDIKTSNVLLDKD+NAKISDFGLAKL E+D THISTRIAGTIGY
Sbjct: 742 RGLAYLHEESTLKIVHRDIKTSNVLLDKDMNAKISDFGLAKLDEDDNTHISTRIAGTIGY 801
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 620
MAPEYAMRGYLT KADVYSFGVV LEIVSGKSNTNYRP E+FVYLLDWAYVLQE
Sbjct: 802 MAPEYAMRGYLTDKADVYSFGVVALEIVSGKSNTNYRPKEEFVYLLDWAYVLQE 855
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485473|ref|XP_002278131.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2383), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/620 (74%), Positives = 517/620 (83%), Gaps = 21/620 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+LKTL+L KCLIHGEIP+YIGDM KLK++DLSFN L G IPT+F++LAKT+FMYLTGN L
Sbjct: 281 SLKTLVLRKCLIHGEIPEYIGDMKKLKHLDLSFNELAGEIPTSFQELAKTDFMYLTGNML 340
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
TG +P +I +NKN D+S NNFTW+SS P+ECPRGSVNLVESYSS +R+N
Sbjct: 341 TGHIPDWILGTNKNFDLSYNNFTWDSSSPVECPRGSVNLVESYSSS---------SVRRN 391
Query: 122 FPCSAPADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
HY+LHINCGG + + G TKYEAD+E GASMFY GQ WAFSSTG FMD
Sbjct: 392 ----------HYSLHINCGGKETSINGSTKYEADLEPTGASMFYL-GQNWAFSSTGNFMD 440
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
+D D D YI NTS+LS VS +D+ELY+ ARVSPLSLTYYGLCLGNGNYTV+LHFAEIIF
Sbjct: 441 NDVDGDAYIEANTSSLSNVSVLDVELYKKARVSPLSLTYYGLCLGNGNYTVKLHFAEIIF 500
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWA 300
ND +FNSLG+RIFD+YIQ KLV KDFNIE EAGGTG PI+KNF AEVTSHTLK+ YWA
Sbjct: 501 INDKSFNSLGERIFDVYIQGKLVLKDFNIEKEAGGTGKPIIKNFTAEVTSHTLKVQFYWA 560
Query: 301 GRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMR 360
GRGTTGIPLRG YGPLISAISV NF+PP K + I+ +V+LVLL L I+
Sbjct: 561 GRGTTGIPLRGFYGPLISAISVDPNFEPPSPPGKNWDIKIVVGAAAVAVVLVLLTLGILW 620
Query: 361 WKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGT 420
KG LGGK S DKELRGLDLQTGL+TLRQIKAAT NFD NK+GEGGFG+V+KG LSDGT
Sbjct: 621 RKGWLGGKTSEDKELRGLDLQTGLFTLRQIKAATKNFDAENKLGEGGFGAVFKGTLSDGT 680
Query: 421 VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 480
VIAVKQLSSKS+QGNREFVNE+GMISA QHPNLVKLYGCC+EGNQL LVYEYM+NN LSR
Sbjct: 681 VIAVKQLSSKSKQGNREFVNEVGMISALQHPNLVKLYGCCIEGNQLSLVYEYMENNSLSR 740
Query: 481 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540
A+FG+D Y+LKL+W TR+ IC+GIARGLAYLHE+S +KIVHRDIKTSNVLLDKD+NAKI
Sbjct: 741 ALFGRDATYKLKLNWSTRQNICVGIARGLAYLHEESTLKIVHRDIKTSNVLLDKDMNAKI 800
Query: 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600
SDFGLAKL E+D THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGKSNT
Sbjct: 801 SDFGLAKLDEDDNTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGKSNT 860
Query: 601 NYRPNEDFVYLLDWAYVLQE 620
NYRP E+FVYLLDWAYVLQE
Sbjct: 861 NYRPKEEFVYLLDWAYVLQE 880
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501491|ref|XP_003519558.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g07650-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/620 (69%), Positives = 511/620 (82%), Gaps = 2/620 (0%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++KTL+L KC+I GEIP YIG M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL
Sbjct: 287 SMKTLVLRKCMIKGEIPAYIGRMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKL 346
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
+G +P ++ +NKN+DIS NNF+W+SS P ECPRGS+NLVESYSS N +K+H CL++N
Sbjct: 347 SGIIPGWVLANNKNIDISDNNFSWDSSSPTECPRGSINLVESYSSSVNTQNKIHSCLKRN 406
Query: 122 FPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDD 181
FPC++ ++YHY+++INCGG + N YEAD E +GA+M Y +GQ WA SSTG FMD+
Sbjct: 407 FPCTSSVNKYHYSMNINCGGNEANISGQIYEADREQKGAAMLYYTGQDWALSSTGNFMDN 466
Query: 182 DTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFK 241
D D D Y+ NTS L+ VSA++ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF
Sbjct: 467 DIDSDPYVVANTSRLN-VSALNSQLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFI 525
Query: 242 NDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAG 301
ND + SLG+R+FD+YIQ LV KDF+I+ EAGGTG PIVK A VT HTL+IH YWAG
Sbjct: 526 NDRSLYSLGRRVFDVYIQGNLVLKDFDIQREAGGTGKPIVKTLNASVTQHTLEIHFYWAG 585
Query: 302 RGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRW 361
+GTTGIP RG YGPLISAISV NFKPP K+ + M+ IV +++VLL+L +MR
Sbjct: 586 KGTTGIPTRGVYGPLISAISVNPNFKPPSGDGKRTYFMLAIGIVAGVLVVVLLVLVLMRR 645
Query: 362 KGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV 421
G LGGK KELRG+DLQTGL+TLRQIKAAT NFD NK+GEGGFG V+KG+LSDGT+
Sbjct: 646 MGWLGGKDPVYKELRGIDLQTGLFTLRQIKAATKNFDAENKIGEGGFGCVFKGLLSDGTI 705
Query: 422 IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 481
IAVKQLSSKS+QGNREFVNE+G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR
Sbjct: 706 IAVKQLSSKSKQGNREFVNEMGLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRI 765
Query: 482 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541
+FG+D + KLDWPTRKKIC+GIA+ LAYLHE+SRIKI+HRDIK SNVLLDKD NAK+S
Sbjct: 766 LFGRDPN-KTKLDWPTRKKICLGIAKALAYLHEESRIKIIHRDIKASNVLLDKDFNAKVS 824
Query: 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601
DFGLAKL E+DKTHISTR+AGTIGYMAPEYAMRGYLT KADVYSFGVV LE VSGKSNTN
Sbjct: 825 DFGLAKLIEDDKTHISTRVAGTIGYMAPEYAMRGYLTDKADVYSFGVVALETVSGKSNTN 884
Query: 602 YRPNEDFVYLLDWAYVLQEE 621
+RPNEDF YLLDWAYVLQE
Sbjct: 885 FRPNEDFFYLLDWAYVLQER 904
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357494365|ref|XP_003617471.1| BED finger-nbs resistance protein [Medicago truncatula] gi|355518806|gb|AET00430.1| BED finger-nbs resistance protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/638 (67%), Positives = 505/638 (79%), Gaps = 19/638 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++KTL+L KCLI GEIP+YIG+M KLK +DLSFN+L+G IP +F L K +FMYLT N L
Sbjct: 282 SMKTLVLRKCLIKGEIPEYIGEMAKLKVLDLSFNSLSGKIPESFRDLDKVDFMYLTRNNL 341
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
+G +P ++ +NKN+D+S NNF WESS P EC RGSVNLVESYS K +H CL++N
Sbjct: 342 SGTIPDWVLKNNKNIDVSYNNFEWESSSPTECQRGSVNLVESYSLSATKKSNIHSCLKRN 401
Query: 122 FPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDD 181
FPC++ + HY+L INCGG + N Y AD+E +GASM Y S + WA SSTG FMD+
Sbjct: 402 FPCTS-KNPRHYSLRINCGGNEANVSGNIYTADIERKGASMLYISAEDWALSSTGSFMDN 460
Query: 182 DTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFK 241
D D D YI TNTS+L VS ++ +LY TARVSPLSLTYYGLC+ NGNYTV+LHFAEIIF
Sbjct: 461 DIDSDPYIVTNTSSLQNVSVINSKLYTTARVSPLSLTYYGLCMINGNYTVQLHFAEIIFI 520
Query: 242 NDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAG 301
ND + NSLG+RIFD+YIQ KLV +DF+IE EAGG PIVK F A VT +TLKI YWAG
Sbjct: 521 NDRSLNSLGRRIFDVYIQGKLVLRDFDIEREAGGAEKPIVKKFNATVTENTLKIQFYWAG 580
Query: 302 RGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMA-AIVGASVLLVLLILFIMR 360
+GTTGIP RG YGPL+SAISV NFKPP H + V+++A IV + +VL+++ +MR
Sbjct: 581 KGTTGIPTRGVYGPLVSAISVDPNFKPPSEHGNRTRVILLAVGIVCGFLAVVLIMVAVMR 640
Query: 361 WKGCLGGKVSADK-----------------ELRGLDLQTGLYTLRQIKAATNNFDPANKV 403
KG LGGK K ELRG+DLQTGL+TLRQIK AT NFD ANK+
Sbjct: 641 RKGLLGGKDPVYKGKVINFVIESKFPFFFSELRGIDLQTGLFTLRQIKVATKNFDAANKL 700
Query: 404 GEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463
GEGGFGSVYKG LSDGTVIAVKQLSSKS+QGNREFVNEIGMIS QHPNLVKL+GCCVEG
Sbjct: 701 GEGGFGSVYKGQLSDGTVIAVKQLSSKSKQGNREFVNEIGMISGLQHPNLVKLHGCCVEG 760
Query: 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 523
NQL+L+YEYM+NNCLSR +FGK +E + KLDW TRKKIC+GIA+ LAYLHE+SRIKI+HR
Sbjct: 761 NQLILIYEYMENNCLSRILFGKGSESKKKLDWLTRKKICLGIAKALAYLHEESRIKIIHR 820
Query: 524 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADV 583
DIK SNVLLDKD NAK+SDFGLAKL E+DKTH+STRIAGT+GYMAPEYAMRGYLT KADV
Sbjct: 821 DIKASNVLLDKDFNAKVSDFGLAKLIEDDKTHVSTRIAGTVGYMAPEYAMRGYLTDKADV 880
Query: 584 YSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 621
YSFGVV LEI+SGKSNTNYRP+++F YLLDWAYVLQE
Sbjct: 881 YSFGVVALEIISGKSNTNYRPDDEFFYLLDWAYVLQER 918
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|345651730|gb|AEO14875.1| rfls6 protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/620 (68%), Positives = 505/620 (81%), Gaps = 2/620 (0%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++KTL+L KC+I GEIP+YIG M KLK +DLS+N L+G IP +F +L K +FMYLTGNKL
Sbjct: 287 SMKTLVLRKCMIKGEIPEYIGRMEKLKILDLSYNGLSGEIPESFAQLDKVDFMYLTGNKL 346
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
+G +P+++ +N+N+DIS NNF+W+SS P EC RGSVNLVESYSS N K++ CL++N
Sbjct: 347 SGIIPRWVLANNENIDISDNNFSWDSSSPTECQRGSVNLVESYSSSVNTQTKINSCLKKN 406
Query: 122 FPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDD 181
F C+A QY Y+L+INCGG + N YEAD E +GA+M Y + Q WA SSTG F D+
Sbjct: 407 FLCTASPSQYRYSLNINCGGNEANVSGNIYEADREQKGAAMLYYTSQDWALSSTGNFTDN 466
Query: 182 DTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFK 241
D D D YI NTS L+ VSA++ +LY TARVSPL+LTYYGLCL NGNYTV+LHFAEIIF
Sbjct: 467 DIDSDPYIVANTSRLN-VSALNSKLYTTARVSPLALTYYGLCLINGNYTVKLHFAEIIFI 525
Query: 242 NDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAG 301
ND + NSLG+R+FD+YIQ LV KDF+I EAGGTG I K F A VT HTLKIH YWAG
Sbjct: 526 NDRSLNSLGRRVFDVYIQGNLVLKDFDIRREAGGTGKSIEKTFNASVTQHTLKIHFYWAG 585
Query: 302 RGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRW 361
+GTTGIP RG YGPL+SAISV NFKPP K+ ++++ IV +++VLL+L ++R
Sbjct: 586 KGTTGIPTRGVYGPLVSAISVNPNFKPPSGEGKRTYLILAIIIVAGVLVVVLLVLVLLRR 645
Query: 362 KGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV 421
G LGGK KELRG+DLQTGL+TLRQIKAAT NFD NK+GEGGFG VYKG SDGT+
Sbjct: 646 MGWLGGKDPVYKELRGIDLQTGLFTLRQIKAATKNFDALNKIGEGGFGCVYKGQQSDGTM 705
Query: 422 IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 481
IAVKQLSSKS+QGNREFVNE+G+IS QHPNLVKLYGCCVEGNQL+L+YEYM+NNCLSR
Sbjct: 706 IAVKQLSSKSKQGNREFVNEMGLISGLQHPNLVKLYGCCVEGNQLILIYEYMENNCLSRI 765
Query: 482 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541
+FG+D + KLDWPTRKKIC+GIA+ LAYLHE+SRIKI+HRD+K SNVLLDKD NAK+S
Sbjct: 766 LFGRDPN-KTKLDWPTRKKICLGIAKALAYLHEESRIKIIHRDVKASNVLLDKDFNAKVS 824
Query: 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601
DFGLAKL E++KTHISTR+AGTIGYMAPEYAMRGYLT KADVYSFGVV LE VSGKSNT+
Sbjct: 825 DFGLAKLIEDEKTHISTRVAGTIGYMAPEYAMRGYLTDKADVYSFGVVALETVSGKSNTD 884
Query: 602 YRPNEDFVYLLDWAYVLQEE 621
+RPNEDFVYLLDWAYVLQE
Sbjct: 885 FRPNEDFVYLLDWAYVLQER 904
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 626 | ||||||
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.971 | 0.587 | 0.598 | 2e-197 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.940 | 0.618 | 0.519 | 1.2e-162 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.944 | 0.548 | 0.525 | 8.6e-159 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.404 | 0.261 | 0.713 | 8.8e-158 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.953 | 0.584 | 0.522 | 1.3e-157 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.972 | 0.590 | 0.462 | 4.1e-147 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.953 | 0.570 | 0.421 | 3.4e-128 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.413 | 0.664 | 0.545 | 8.4e-74 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.378 | 0.603 | 0.525 | 5.3e-73 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.448 | 0.349 | 0.474 | 1.6e-67 |
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1878 (666.1 bits), Expect = 2.0e-197, Sum P(2) = 2.0e-197
Identities = 373/623 (59%), Positives = 457/623 (73%)
Query: 2 NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
N++ L+L CLI IP+YIG MT LK +DLS N L G IP TF L NFMYL N
Sbjct: 280 NMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFRSLNAFNFMYLNNNS 339
Query: 61 LTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQ 120
LTGPVP++I +S +N+D+S NNFT + + C + VNL+ SY S N + V CLR+
Sbjct: 340 LTGPVPQFILDSKQNIDLSYNNFTQPPT--LSCNQLDVNLISSYPSVTN--NSVQWCLRK 395
Query: 121 NFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMD 180
+ PC P D +H +L INCGG ++ +Y D+ RGAS F S + W +SS+G ++
Sbjct: 396 DLPC--PGDAHHSSLFINCGGNRLKVDKDEYADDLNKRGASTFSSVSERWGYSSSGAWLG 453
Query: 181 DDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIF 240
+D Y+ T+T L S E Y+TAR++ SL YYGLC+ G+Y V+L+FAEI+F
Sbjct: 454 NDGA--TYLATDTFNLINESTP--EYYKTARLASQSLKYYGLCMRRGSYKVQLYFAEIMF 509
Query: 241 KNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFP-AEVTSHTLKIHLYW 299
ND T++SLG+R+FDIY+Q L+++DFNI AGG G P ++ +V TL+IHL W
Sbjct: 510 SNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEIHLKW 569
Query: 300 AGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIM 359
G+GT IP RG YGPLISAI+V NFK N V + ++ A V LL+L I+
Sbjct: 570 TGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGV-VAGIVIAACVAFGLLVLVIL 628
Query: 360 RWKGCLGGK-VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSD 418
R G LGGK V ++ELRGLDLQTG +TL+QIK ATNNFDP NK+GEGGFG VYKG+L+D
Sbjct: 629 RLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLAD 688
Query: 419 GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478
G IAVKQLSSKS+QGNREFV EIGMISA QHPNLVKLYGCC+EG +LLLVYEY++NN L
Sbjct: 689 GMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSL 748
Query: 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538
+RA+FG + + RL LDW TR K+CIGIA+GLAYLHE+SR+KIVHRDIK +NVLLD LNA
Sbjct: 749 ARALFGTEKQ-RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNA 807
Query: 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
KISDFGLAKL EE+ THISTRIAGTIGYMAPEYAMRGYLT KADVYSFGVV LEIVSGKS
Sbjct: 808 KISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKS 867
Query: 599 NTNYRPNEDFVYLLDWAYVLQEE 621
NTNYRP E+F+YLLDWAYVLQE+
Sbjct: 868 NTNYRPKEEFIYLLDWAYVLQEQ 890
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1491 (529.9 bits), Expect = 1.2e-162, Sum P(2) = 1.2e-162
Identities = 315/606 (51%), Positives = 396/606 (65%)
Query: 23 DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 82
++ K++ + L NLTG +P K+ F+ L+ NKL+G +P N I
Sbjct: 252 NIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYINLRDGGYIYFTG 311
Query: 83 FTWESSDPIECPRGSVNLVESYSS----PRN---KLDKVHPCLRQNFPCSAPADQYHYTL 135
S P + SY++ P N K + V C+R N+ C + L
Sbjct: 312 NMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYNNVLSCMR-NYQCPKTFN----AL 366
Query: 136 HINCGGAKINTGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTST 195
HINCGG +++ T YE+D R S +Y S W ++ G F+DD + T S
Sbjct: 367 HINCGGDEMSINGTIYESDKYDRLES-WYESRNGWFSNNVGVFVDDKHVPERV--TIESN 423
Query: 196 LSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFD 255
S+++ VD LY AR+S +SLTYY LCL NGNY V LHFAEI+F ++ + SLG+R FD
Sbjct: 424 SSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLHFAEIMFNGNNNYQSLGRRFFD 483
Query: 256 IYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGP 315
IYIQ KL KDFNI EA G ++K FP E+ L+I LYWAGRGTT IP YGP
Sbjct: 484 IYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRGTTVIPKERVYGP 543
Query: 316 LISAISVKSNFKPPVVHSKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKEL 375
LISAISV S+ P + + ++ S+ +V L+ + KG L K +K+
Sbjct: 544 LISAISVDSSVNPSPRNGMSTGTLHTLVVI-LSIFIVFLVFGTLWKKGYLRSKSQMEKDF 602
Query: 376 RGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN 435
+ L+L ++LRQIK ATNNFD AN++GEGGFG VYKG L DGT+IAVKQLS+ S+QGN
Sbjct: 603 KSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGN 662
Query: 436 REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 495
REF+NEIGMISA HPNLVKLYGCCVEG QLLLVYE+++NN L+RA+FG E +L+LDW
Sbjct: 663 REFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQ-ETQLRLDW 721
Query: 496 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555
PTR+KICIG+ARGLAYLHE+SR+KIVHRDIK +NVLLDK LN KISDFGLAKL EED TH
Sbjct: 722 PTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTH 781
Query: 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 615
ISTRIAGT GYMAPEYAMRG+LT KADVYSFG+V LEIV G+SN R + YL+DW
Sbjct: 782 ISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWV 841
Query: 616 YVLQEE 621
VL+E+
Sbjct: 842 EVLREK 847
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1547 (549.6 bits), Expect = 8.6e-159, P = 8.6e-159
Identities = 336/639 (52%), Positives = 432/639 (67%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+LK L+L + G IP + D+ L +DLSFN LTG +P + + YL GN L
Sbjct: 290 SLKFLVLRNMNLTGPIPTSLWDLPNLMTLDLSFNRLTGEVPAD---ASAPKYTYLAGNML 346
Query: 62 TGPVPKYIF-NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPR--NKLDKVHPCL 118
+G V F ++ N+D+S NNFTW S C N + +Y+S R N L ++ PC
Sbjct: 347 SGKVESGPFLTASTNIDLSYNNFTWSQS----CKER--NNINTYASSRSTNSLTRLLPCS 400
Query: 119 RQNFPCSAPADQYHYTLHINCGGAKI---NT-GHTKYEADMEARGASMFYSSGQYWAFSS 174
N C Y+ +LHINCGG + N+ G YE D S G+ W FS+
Sbjct: 401 AINL-CQ----NYNRSLHINCGGPDVTIENSRGRFLYEGDNYGLTGSATNYYGKNWGFSN 455
Query: 175 TGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLH 234
TG FMDD D Y S+ S VSA +LY+ AR SPLSL Y+ +C NG+Y V+LH
Sbjct: 456 TGDFMDDAITEDTY---TVSSESAVSAKYPDLYQNARRSPLSLAYFAICFENGSYNVKLH 512
Query: 235 FAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLK 294
FAEI F ++ F+ L KR+F+IY+Q KL+ +DF+I +EA GT ++K VT +TL+
Sbjct: 513 FAEIQFSDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANGTHKEVIKEVNTTVTDNTLE 572
Query: 295 IHLYWAGRGTTGIPLRGTYGPLISAISV----KSNFKPPV-VH--SKKNHVMIMA-AIVG 346
I LYWAG+GTT IP RG YG LISAISV +S PV +H +K+ H I+G
Sbjct: 573 IRLYWAGKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQIHPVTKQQHKQRKYHLILG 632
Query: 347 ASVLLV---LLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV 403
+ L+V LIL + W+ C+ +AD E RG ++LRQ+K AT++F+P NK+
Sbjct: 633 IAALIVSLSFLILGALYWRICVS---NADGEKRGS------FSLRQLKVATDDFNPLNKI 683
Query: 404 GEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463
GEGGFGSVYKG L +GT+IAVK+LSSKS QGN+EF+NEIG+I+ QHPNLVKLYGCCVE
Sbjct: 684 GEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVEK 743
Query: 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 523
QLLLVYEY++NNCL+ A+FG+ LKLDW TR KIC+GIARGLA+LHEDS +KI+HR
Sbjct: 744 TQLLLVYEYLENNCLADALFGRSG---LKLDWRTRHKICLGIARGLAFLHEDSAVKIIHR 800
Query: 524 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADV 583
DIK +N+LLDKDLN+KISDFGLA+L+E+D++HI+TR+AGTIGYMAPEYAMRG+LT KADV
Sbjct: 801 DIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMRGHLTEKADV 860
Query: 584 YSFGVVTLEIVSGKSNTNYRP-NEDFVYLLDWAYVLQEE 621
YSFGVV +EIVSGKSN NY P NE V LLDWA+VLQ++
Sbjct: 861 YSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKK 899
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 965 (344.8 bits), Expect = 8.8e-158, Sum P(2) = 8.8e-158
Identities = 184/258 (71%), Positives = 223/258 (86%)
Query: 366 GGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVK 425
GG +L+G DL+TG ++LRQ+K ATN+FDP NK+GEGGFGSVYKG L DGT+IAVK
Sbjct: 609 GGMKKKISKLKGPDLRTGSFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVK 668
Query: 426 QLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF-G 484
+LSSKS QGN+EFVNEIGMI+ QHPNLVKLYGCCVE NQLLLVYEY++NNCLS A+F G
Sbjct: 669 KLSSKSHQGNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAG 728
Query: 485 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544
+ LKL+W TR KIC+GIARGLA+LHEDS +KI+HRDIK +NVLLDKDLN+KISDFG
Sbjct: 729 RSC---LKLEWGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFG 785
Query: 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604
LA+L+E++++HI+TR+AGTIGYMAPEYAMRG+LT KADVYSFGVV +EIVSGKSN Y P
Sbjct: 786 LARLHEDNQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTP 845
Query: 605 NEDF-VYLLDWAYVLQEE 621
+++ V LLDWA+VLQ++
Sbjct: 846 DDECCVGLLDWAFVLQKK 863
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1536 (545.8 bits), Expect = 1.3e-157, P = 1.3e-157
Identities = 326/624 (52%), Positives = 419/624 (67%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
L +IL C I G+IP Y+ + +L+ +DLSFN L GGIP+ F + F+ L GN L
Sbjct: 291 LTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPS-FAQAENLRFIILAGNMLE 349
Query: 63 GPVPKYIFNSNKNVDISLNNFTWESSDPIEC-PRGSVNLVESYSSPRNKLDKVHPCLRQN 121
G P + VD+S NN W+S + C P ++NL S+ K K PC++ +
Sbjct: 350 GDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMNLNLNLFQSTSTKKSSKFLPCIK-D 408
Query: 122 FPCSAPADQYHYTLHINCGGAK--INTGHTK--YEAD--MEARGASMFYSSGQYWAFSST 175
F C P +Y LH+NCGG+ + TK YE D +E A F W FSST
Sbjct: 409 FKC--P--RYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFLKPDANWGFSST 464
Query: 176 GKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHF 235
G FMDD+ N+ T T+ ++ +LY++AR++P+SLTY+ CL NGNYT+ L F
Sbjct: 465 GDFMDDN----NFQNTRF-TMFVPASNQSDLYKSARIAPVSLTYFHACLENGNYTINLDF 519
Query: 236 AEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKI 295
AEI F ND +N LG+R+FDIYIQEKLV KDFNI DEA G PI+K A VT+H L I
Sbjct: 520 AEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTNHFLTI 579
Query: 296 HLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAI---VGASVLLV 352
L WAG+GTT IP RG YGP+ISAIS+ S+ KP K + A I +GA L++
Sbjct: 580 RLSWAGKGTTRIPTRGVYGPIISAISIVSDSKP--CERPKTGMSPGAYIAIGIGAPCLII 637
Query: 353 LLILFIMRWK-GCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSV 411
++ F+ W GCL K+ +L +G +TLRQIK AT++F+P NK+GEGGFG+V
Sbjct: 638 FILGFL--WICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEGGFGAV 695
Query: 412 YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471
+KG+L+DG V+AVKQLSSKSRQGNREF+NEIG IS QHPNLVKL+G CVE QLLL YE
Sbjct: 696 FKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYE 755
Query: 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 531
YM+NN LS A+F + ++ +DWPTR KIC GIA+GLA+LHE+S +K VHRDIK +N+L
Sbjct: 756 YMENNSLSSALFSPKHK-QIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNIL 814
Query: 532 LDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTL 591
LDKDL KISDFGLA+L EE+KTHIST++AGTIGYMAPEYA+ GYLT KADVYSFGV+ L
Sbjct: 815 LDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVL 874
Query: 592 EIVSGKSNTNYRPNEDFVYLLDWA 615
EIV+G +N+N+ D V LL++A
Sbjct: 875 EIVAGITNSNFMGAGDSVCLLEFA 898
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1366 (485.9 bits), Expect = 4.1e-147, Sum P(2) = 4.1e-147
Identities = 294/635 (46%), Positives = 411/635 (64%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L L+L + G IP IG+ + L+ +DLSFN L G IP + L++ ++L N L
Sbjct: 292 SLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTL 351
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP---CL 118
G P S +NVD+S N+ + + P +NLV + + ++V P CL
Sbjct: 352 NGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVANNFTLEGLDNRVLPGLNCL 411
Query: 119 RQNFPCSAPADQYHYTLHINCGGA-KINTGHTKYEADMEARG-ASMFYSSGQYWAFSSTG 176
++NFPC+ Y INCGG K + +E + E G AS F S+GQ WA SS G
Sbjct: 412 QKNFPCNRGKGIYS-DFSINCGGPEKRSVTGALFEREDEDFGPASFFVSAGQRWAASSVG 470
Query: 177 KFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFA 236
F ++ YI T+ S V+ +D EL+++AR+S S+ YYGL L NG YTV L FA
Sbjct: 471 LFAGSSNNI--YIATSQSQF--VNTLDSELFQSARLSASSVRYYGLGLENGGYTVTLQFA 526
Query: 237 EI--IFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKN-FPAEVTSHTL 293
EI + +T+ LG+R FDIY+Q +LV+KDF++ AG + + V+ + A V+ + L
Sbjct: 527 EIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHL 586
Query: 294 KIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH---SK-KNHV-MIMAAIVGAS 348
++HL+WAG+GT IP++G YGPLISA+S +F P V + SK KN I+ IVG
Sbjct: 587 EVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVG 646
Query: 349 VLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEG 406
+L +L +++F +R + + + D+EL G+D++ ++T ++K+AT +FDP+NK+GEG
Sbjct: 647 LLSILAGVVMFTIRKRR---KRYTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEG 703
Query: 407 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466
GFG VYKG L+DG V+AVK LS SRQG +FV EI IS+ H NLVKLYGCC EG
Sbjct: 704 GFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHR 763
Query: 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 526
+LVYEY+ N L +A+FG T L LDW TR +IC+G+ARGL YLHE++ ++IVHRD+K
Sbjct: 764 MLVYEYLPNGSLDQALFGDKT---LHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVK 820
Query: 527 TSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 586
SN+LLD L +ISDFGLAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DVY+F
Sbjct: 821 ASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAF 880
Query: 587 GVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 621
GVV LE+VSG+ N++ E+ YLL+WA+ L E+
Sbjct: 881 GVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 3.4e-128, Sum P(2) = 3.4e-128
Identities = 269/638 (42%), Positives = 391/638 (61%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE------KLAKTNFMY- 55
L L L ++G +P G L N+D+S+N+L+G +P+ L NF
Sbjct: 316 LTHLFLGNNTLNGSLPTLKGQ--SLSNLDVSYNDLSGSLPSWVSLPDLKLNLVANNFTLE 373
Query: 56 -LTGNKLTG-PVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113
L L+G + F N+ I N P + +N V++Y N L +
Sbjct: 374 GLDNRVLSGLHCLQKNFPCNRGEGICKCN----KKIPSQIMFSMLN-VQTYGQGSNVLLE 428
Query: 114 VHPCLRQNFPCSAPADQYHYTLHINCGGAKINT--GHTKYEADMEARGASMFYSSGQYWA 171
+ C + F D Y INCGG +I + G + D + AS S+ + WA
Sbjct: 429 KN-CFK-TFAIDWCLD---YNFSINCGGPEIRSVSGALFEKEDADLGPASFVVSAAKRWA 483
Query: 172 FSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTV 231
SS G F ++ YI T+ + ++ +D EL+++AR+S SL YYGL L NG YTV
Sbjct: 484 ASSVGNFAGSSNNI--YIATSLAQF--INTMDSELFQSARLSASSLRYYGLGLENGGYTV 539
Query: 232 RLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIV-KNFPAEVTS 290
L FAE+ + +++ +G+R F+IY+Q +LV+KDF+I AGG+ + V + + V+
Sbjct: 540 TLQFAEVQIEGSNSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSVRAVQREYKTNVSE 599
Query: 291 HTLKIHLYWAGRGTTGIPLRGTYGPLISAISVKSNFKPPVVH---SK-KNHV-MIMAAIV 345
+ L++HL+WAG+GT IP++G YGPLI+A+S +F P V + SK K+ I+ IV
Sbjct: 600 NHLEVHLFWAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSKGKSRTGTIVGVIV 659
Query: 346 GASVLLVL--LILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV 403
G +L + +++ ++R + + D+E+ +D++ +T ++K AT +FD +NK+
Sbjct: 660 GVGLLSIFAGVVILVIRKRR---KPYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKL 716
Query: 404 GEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463
GEGGFG+VYKG L+DG +AVKQLS SRQG +FV EI IS+ H NLVKLYGCC EG
Sbjct: 717 GEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEG 776
Query: 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 523
+ LLVYEY+ N L +A+FG + L LDW TR +IC+G+ARGL YLHE++ ++I+HR
Sbjct: 777 DHRLLVYEYLPNGSLDQALFGDKS---LHLDWSTRYEICLGVARGLVYLHEEASVRIIHR 833
Query: 524 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADV 583
D+K SN+LLD +L K+SDFGLAKLY++ KTHISTR+AGTIGY+APEYAMRG+LT K DV
Sbjct: 834 DVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDV 893
Query: 584 YSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 621
Y+FGVV LE+VSG+ N++ E YLL+WA+ L E+
Sbjct: 894 YAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEK 931
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 745 (267.3 bits), Expect = 8.4e-74, P = 8.4e-74
Identities = 143/262 (54%), Positives = 191/262 (72%)
Query: 361 WKGCLGGKVS-ADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDG 419
W C + + D E+ +D +Y R+I+ AT++F NK+GEGGFGSVYKG L DG
Sbjct: 5 WLSCHRREATEVDGEIAAID-NVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDG 63
Query: 420 TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 479
+ A+K LS++SRQG +EF+ EI +IS QH NLVKLYGCCVEGN +LVY +++NN L
Sbjct: 64 KLAAIKVLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLD 123
Query: 480 RAIF-GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538
+ + G T ++ DW +R IC+G+A+GLA+LHE+ R I+HRDIK SN+LLDK L+
Sbjct: 124 KTLLAGGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSP 183
Query: 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
KISDFGLA+L + TH+STR+AGTIGY+APEYA+RG LT KAD+YSFGV+ +EIVSG+S
Sbjct: 184 KISDFGLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRS 243
Query: 599 NTNYRPNEDFVYLLDWAYVLQE 620
N N R ++ YLL+ A+ L E
Sbjct: 244 NKNTRLPTEYQYLLERAWELYE 265
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 717 (257.5 bits), Expect = 5.3e-73, Sum P(2) = 5.3e-73
Identities = 125/238 (52%), Positives = 180/238 (75%)
Query: 384 LYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG 443
+++ +++AT++F P N++G GG+G V+KG+L DGT +AVK LS++S+QG REF+ EI
Sbjct: 33 VFSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEIN 92
Query: 444 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 503
+IS HPNLVKL GCC+EGN +LVYEY++NN L+ + G + Y + LDW R IC+
Sbjct: 93 LISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRY-VPLDWSKRAAICV 151
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
G A GLA+LHE+ +VHRDIK SN+LLD + + KI DFGLAKL+ ++ TH+STR+AGT
Sbjct: 152 GTASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGT 211
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 621
+GY+APEYA+ G LT KADVYSFG++ LE++SG S+T ++++ L++W + L+EE
Sbjct: 212 VGYLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREE 269
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 1.6e-67, Sum P(2) = 1.6e-67
Identities = 138/291 (47%), Positives = 193/291 (66%)
Query: 333 SKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSADKELRGLDLQT----GL--YT 386
+K+N + I+A+ V S+ ++L W+ + K K+ DL++ GL +
Sbjct: 421 NKRNKI-IVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEFFE 479
Query: 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 446
+ I+ ATNNF +NK+G+GGFGSVYKG L DG IAVKQLSS S QG EF+NEI +IS
Sbjct: 480 MNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVLIS 539
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
QH NLV++ GCC+EG + LL+YE+M N L +F D +L++DWP R I GIA
Sbjct: 540 KLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVF--DARKKLEVDWPKRFDIVQGIA 597
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 565
RGL YLH DSR+K++HRD+K SN+LLD+ +N KISDFGLA++YE + TR + GT+G
Sbjct: 598 RGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTLG 657
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 616
YM+PEYA G + K+D+YSFGV+ LEI+ G+ + + E+ LL +A+
Sbjct: 658 YMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAW 708
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGE0 | Y1765_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6714 | 0.9856 | 0.6084 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 626 | |||
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 6e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-33 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-30 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-27 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-22 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 9e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.001 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 6e-58
Identities = 86/192 (44%), Positives = 101/192 (52%), Gaps = 32/192 (16%)
Query: 133 YTLHINCGGAKINTGH-TKYEAD-MEARGASMFYSSGQYWAFSSTGKFMDDDTDLDNYIR 190
L INCGG + YEAD G++ +Y S + S G D
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG--TTDP-------- 50
Query: 191 TNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLG 250
ELY+T R SP S +YY CL NGNYTV LHFAEI F D LG
Sbjct: 51 --------------ELYQTERYSPSSFSYYIPCLENGNYTVILHFAEIYFGED----GLG 92
Query: 251 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTSHTLKIHLYWAGRGTTGIPL 309
+R+FD+Y+Q KLV KDF+I EAGG G K + P VT TL+IH YWAG+GT IP
Sbjct: 93 RRVFDVYVQGKLVLKDFDIVAEAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPF 152
Query: 310 RGTYG-PLISAI 320
RG YG P ISAI
Sbjct: 153 RGVYGNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 74/195 (37%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 460
+GEGGFG+VY G +A+K + + E + EI ++ HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ N L LV EY + L + E KL +I + I GL YLH I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHS---NGI 113
Query: 521 VHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYLT 578
+HRD+K N+LLD D K++DFGL+KL DK + I GT YMAPE +GY +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 579 SKADVYSFGVVTLEI 593
K+D++S GV+ E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 79/207 (38%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 401 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
K+GEG FG VYKG L T +AVK L S + ++F+ E ++ HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 456 LYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
L G C E L LV EYM+ L SR +F + L L I IA+G+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKD--LLSFAIQIAKGM 118
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMA 568
YL K VHRD+ N L+ +DL KISDFGL++ +D + I +MA
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVS 595
PE G TSK+DV+SFGV+ EI +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-51
Identities = 75/200 (37%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 402 KVGEGGFGSVYKGILSD-----GTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
L G C E L +V EYM+ L + + R KL + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
+HRD+ N L+ ++L KISDFGL++ +D + I +MAPE G
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 576 YLTSKADVYSFGVVTLEIVS 595
TSK+DV+SFGV+ EI +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-50
Identities = 74/206 (35%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 402 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 455
K+GEG FG VYKG L T +AVK L + + R EF+ E ++ HPN+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAY 511
L G C +G L +V EYM L ++ KL ++ + IA+G+ Y
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLL--------DFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPE 570
L VHRD+ N L+ ++L KISDFGL++ ED + I +MAPE
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSG 596
G TSK+DV+SFGV+ EI +
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-50
Identities = 73/200 (36%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 402 KVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
K+GEG FG VYKG L +AVK L S Q EF+ E ++ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
L G C E L++V EYM L + + + +L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPK-ELSLSDLLSFALQIARGMEYLE-- 120
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
+HRD+ N L+ ++L KISDFGL++ +D + I +MAPE G
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 576 YLTSKADVYSFGVVTLEIVS 595
TSK+DV+SFGV+ EI +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 7e-48
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 16/206 (7%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 454
++ K+GEG FG VY G ++A+K + K + +RE + EI ++ +HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+LY + ++L LV EY + L + G+ +E + I L YL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H IVHRD+K N+LLD+D + K++DFGLA+ + + T GT YMAPE
Sbjct: 114 HS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVL 168
Query: 573 MRGYLTSKADVYSFGVVTLEIVSGKS 598
+ D++S GV+ E+++GK
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYG 458
K+G G FG+VYK G ++AVK L +S + ++ EI ++ HPN+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ + L LV EY + L + L KKI + I RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 577
I+HRD+K N+LLD++ KI+DFGLAK + + ++T GT YMAPE
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY 176
Query: 578 TSKADVYSFGVVTLEIVSGK 597
K DV+S GV+ E+++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 77/205 (37%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 401 NKVGEGGFGSVYKGILSD-GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
+G G FGSVY + D G ++AVK LS S + EI ++S+ QHPN+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 458 GCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
G E N L + EY+ LS + FGK E P +K I GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYLH 118
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPEYA 572
+ IVHRDIK +N+L+D D K++DFG AK + +T T + GT +MAPE
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 573 MRGYLTSKADVYSFGVVTLEIVSGK 597
AD++S G +E+ +GK
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
F+ K+G+GGFG VYK G +A+K + +S++ + +NEI ++ +HPN+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
YG ++ ++L +V E+ L + K T L +C + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIA--YVCKELLKGLEYLHS- 116
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
I+HRDIK +N+LL D K+ DFGL+ T + GT +MAPE
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAPEVINGK 172
Query: 576 YLTSKADVYSFGVVTLEIVSGK 597
KAD++S G+ +E+ GK
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 401 NKVGEGGFGSVYKG-ILSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQHPNLVKLY 457
++G+G FG VY SDG + +K++ S + RE NE+ ++ HPN++K Y
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-------LDWPTRKKICIGIARGLA 510
E +L +V EY LS+ I K + K LDW + + L
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDW------FVQLCLALK 117
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH KI+HRDIK N+ L + K+ DFG++K+ T + GT Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 571 -YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ Y K+D++S G V E+ + K
Sbjct: 174 LCQNKPY-NYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 14/206 (6%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQH 450
+ K+GEG G VYK + G +A+K+ L ++++ +NEI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
PN+V Y + G++L +V EYM L+ I T+ ++++ P +C + +GL
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLE 130
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH + I HRDIK+ N+LL KD + K++DFG A ++K+ ++ + GT +MAPE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPE 186
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSG 596
R K D++S G++ +E+ G
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 73/213 (34%), Positives = 112/213 (52%), Gaps = 21/213 (9%)
Query: 403 VGEGGFGSVYKGILS------DGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 455
+GEG FG V+ G D ++AVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRK-------KICIGIA 506
YG C EG+ ++V+EYM++ L++ + G D + D P + +I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIG 565
G+ YL + VHRD+ T N L+ DL KI DFG+++ +Y D + I
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GK 597
+M PE M T+++DV+SFGVV EI + GK
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 69/200 (34%), Positives = 99/200 (49%), Gaps = 26/200 (13%)
Query: 403 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462
+G+G FG V G V AVK L S F+ E +++ +HPNLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYRGQKV-AVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 463 GNQLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
GN L +V EYM L RA+ + LD + G+ YL E
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD----------VCEGMEYLEEK 121
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
VHRD+ NVL+ +DL AK+SDFGLAK E + S ++ + + APE
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREK 174
Query: 576 YLTSKADVYSFGVVTLEIVS 595
++K+DV+SFG++ EI S
Sbjct: 175 KFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGN-REFVNEIGMISAQQHPNLVKLY 457
NK+G G FG VY + L G ++AVK++ + +E +E+ ++ +HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G V ++ + EY L + E+ LD + + + GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG---YMAPEYAMR 574
IVHRDIK +N+ LD + K+ DFG A + + T + + G YMAPE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 575 GYLTSK---ADVYSFGVVTLEIVSGK 597
G AD++S G V LE+ +GK
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 70/212 (33%), Positives = 112/212 (52%), Gaps = 26/212 (12%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPN 452
N+ + +G G FG VYKG+ L G +A+KQ+S + + + EI ++ +HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA---R 507
+VK G + L ++ EY +N L + I FG E L + + + +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-SL---------VAVYVYQVLQ 110
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGY 566
GLAYLHE ++HRDIK +N+L KD K++DFG+A KL + K + GT +
Sbjct: 111 GLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYW 165
Query: 567 MAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK 597
MAPE M G ++ +D++S G +E+++G
Sbjct: 166 MAPEVIEMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 401 NKVGEGGFGSVYKG---ILSDGT--VIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 454
++GEG FG V L D T +AVK L+ S Q +F EI ++ H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 455 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
K G C + G L L+ EY+ + L + +R +++ I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 570
+ +HRD+ N+L++ + KISDFGLAK+ EDK + + G I + APE
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVS 595
+S +DV+SFGV E+ +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 5e-33
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
FD K+GEG +GSVYK I G V+A+K + + +E + EI ++ P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYL 512
YG + L +V EY +S + K T L T ++I +GL YL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTL-----TEEEIAAILYQTLKGLEYL 115
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H K +HRDIK N+LL+++ AK++DFG++ + +T I GT +MAPE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVI 171
Query: 573 MR-GYLTSKADVYSFGVVTLEIVSGK 597
GY +KAD++S G+ +E+ GK
Sbjct: 172 QEIGY-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 8e-33
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 403 VGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVK 455
+G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGK--DTEYRLKLDWPTRKKI---CIGIARGLA 510
L G G L+V E M L + + + E L PT +K IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 569
YL K VHRD+ N ++ +DL KI DFG+ + +YE D + + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVS-------GKSN 599
E G T+K+DV+SFGVV E+ + G SN
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 6e-32
Identities = 71/199 (35%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLYG 458
K+G G FG V+ G + T +AVK L + G F+ E ++ +H LV+LY
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
C E + +V EYM L F K E + KL P + IA G+AYL
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLD--FLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SR 122
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK--THISTRIAGTIGYMAPEYAMRGY 576
+HRD+ N+L+ ++L KI+DFGLA+L E+D+ + I + APE A G
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGR 180
Query: 577 LTSKADVYSFGVVTLEIVS 595
T K+DV+SFG++ EIV+
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 70/204 (34%), Positives = 109/204 (53%), Gaps = 21/204 (10%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLS-----SKSRQGNREFVNEIGMISAQQHPNLVKL 456
+G G FGSVY+G+ L DG AVK++S ++ ++ EI ++S QHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
G E + L + E + L++ + +G E ++L TR+ I GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQ-----ILLGLEYLHD 120
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
VHRDIK +N+L+D + K++DFG+AK E S + G+ +MAPE +
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIAQ 175
Query: 575 -GYLTSKADVYSFGVVTLEIVSGK 597
G AD++S G LE+ +GK
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 396 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 452
+F+ NK+G+G FG V+K + +D V A+KQ LS +R+ E ++E +++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD--WPTRKKICIGIARGLA 510
+++ Y ++ +L +V EY +N L + L D W + I I GLA
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDL-HKLLKMQRGRPLPEDQVW----RFFIQILLGLA 115
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
+LH KI+HRDIK+ N+ LD N KI D G+AKL D T+ + I GT Y++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPE 171
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
K+DV++ GVV E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 402 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 459
+G+G G VYK G + A+K++ + R + + E+ + + + P +VK YG
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519
+ ++ +V EYM L+ + + K+ P I I +GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGYMAPEYAM 573
I+HRDIK SN+L++ KI+DFG++K + + GT+ YM+PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 574 RGYLTSKADVYSFGVVTLEIVSGK 597
+ AD++S G+ LE GK
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 397 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 456
F K+G G FG V++G+ + +A+K L S ++F E+ + +H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
+ C G + ++ E M+ L F + E ++ L + + +A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ- 123
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEYAMRG 575
+HRD+ N+L+ +DL K++DFGLA+L +ED +I + APE A G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHG 179
Query: 576 YLTSKADVYSFGVVTLEIVS 595
++K+DV+SFG++ E+ +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 402 KVGEGGFGSVY----KGIL--SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
++GEG FG V+ +L D ++AVK L S ++F E +++ QH ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----------KLDWPTRKKICIGI 505
YG C EG LL+V+EYM++ L+R + + ++ +L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTI 564
A G+ YL + + VHRD+ T N L+ + L KI DFG+++ +Y D + R I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+M PE + T+++D++SFGVV EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 19/201 (9%)
Query: 404 GEGGFGSVYKGI---LSDGTVI--AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
G G FG+VYKG+ + I A+K L S + N+E ++E ++++ HP++V+L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLAYLHED 515
G C+ +Q+ L+ + M CL + + L+W C+ IA+G++YL E+
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL-EE 127
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAMR 574
R+ VHRD+ NVL+ + KI+DFGLAKL + D+ I +MA E +
Sbjct: 128 KRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 575 GYLTSKADVYSFGVVTLEIVS 595
T K+DV+S+GV E+++
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 6e-30
Identities = 66/212 (31%), Positives = 113/212 (53%), Gaps = 15/212 (7%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 458
++G G FG V+ G + +A+K + R+G +F+ E ++ HP LV+LYG
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
C E + + LV+E+M++ CLS + + R K T +C+ + G+AYL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLESSN-- 120
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
++HRD+ N L+ ++ K+SDFG+ + +D+ ST + + +PE +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 579 SKADVYSFGVVTLEIVS-GKSNTNYRPNEDFV 609
SK+DV+SFGV+ E+ S GK+ R N + V
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 395 NNFDPANKVGEGGFGSVYK----GILS--DGTVIAVKQLSSK-SRQGNREFVNEIGMISA 447
NN + +G+G FG V++ G+L T++AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCL-------------SRAIFGKDTEYR 490
HPN+VKL G C G + L++EYM N L S + K
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 491 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLY 549
L L + I +A G+AYL E K VHRD+ T N L+ +++ KI+DFGL+ +Y
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
D S A I +M PE T+++DV+++GVV EI S
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISA-QQHPNLVKLY 457
K+GEG FG VY D ++A+K L+ K + F+ EI ++++ PN+VKLY
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+ L LV EY+ L + K + L I I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHS--- 119
Query: 518 IKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTR-----IAGTIGYMAPEY 571
I+HRDIK N+LLD+D K+ DFGLAKL + + S GT GYMAPE
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 572 AM---RGYLTSKADVYSFGVVTLEIVSGKS 598
+ Y +S +D++S G+ E+++G
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 403 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 457
+G G FG V +G L +A+K L + S R +F+ E ++ HPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARGLAYLHE 514
G + ++++ EYM+N L D E K + GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEYMENGSL-------DKFLRENDGKFTVGQLVGMLRGIASGMKYL-- 122
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYA 572
S + VHRD+ N+L++ +L K+SDFGL++ E+ + +T+ G I + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAI 180
Query: 573 MRGYLTSKADVYSFGVVTLEIVS 595
TS +DV+SFG+V E++S
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
K+G G FG V++G+ ++ T +AVK L + +F+ E ++ +HP L++LY C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
+ +V E MK L + LKL P + +A G+AYL + I
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKL--PQLIDMAAQVASGMAYLEAQNYI--- 125
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 581
HRD+ NVL+ ++ K++DFGLA++ +ED I + APE A+ + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 582 DVYSFGVVTLEIVS 595
DV+SFG++ EIV+
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 76/221 (34%), Positives = 121/221 (54%), Gaps = 16/221 (7%)
Query: 396 NFDPANKVGEGGFGSVYK-GILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 452
+F K+G+G +GSVYK LSD A+K+ L S S++ + VNEI ++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGIARGL 509
++ ++GN+L +V EY LS+AI + + +L + W +I I + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
LHE KI+HRD+K++N+LL + KI D G++K+ + K T+I GT YMAP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAP 170
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
E + K+D++S G + E+ + R +D Y
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 70/212 (33%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 403 VGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVK 455
+GEG FG VYKG L T +A+K L + +EF E ++S QHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIF-----------GKDTEYRLKLDWPTRKKICIG 504
L G C + +++EY+ + L + D + LD I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGT 563
IA G+ YL S VHRD+ N L+ + L KISDFGL++ Y D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +M PE + G T+++D++SFGVV EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS-RQG-NREFVNEIGMISAQQHPNL 453
++ ++GEG +G VYK G ++A+K++ ++ ++G + EI ++ +HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 454 VKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
V+L + +V+EYM ++ L+ + +K K + GL Y
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHD-LTGLL----DSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 570
LH I+HRDIK SN+L++ D K++DFGLA+ Y + + T T+ Y PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 571 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y + D++S G + E+ GK
Sbjct: 173 LLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 69/223 (30%), Positives = 114/223 (51%), Gaps = 20/223 (8%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYG 458
+G G VY I L + +A+K++ + Q + + + E+ +S HPN+VK Y
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 459 CCVEGNQLLLVYEYMK-NNCLS--RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
V G++L LV Y+ + L ++ + + LD + + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-----LDEAIIATVLKEVLKGLEYLHSN 121
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEE-DKTHIS-TRIAGTIGYMAPE-- 570
+I HRDIK N+LL +D + KI+DFG+ A L + D+T GT +MAPE
Sbjct: 122 GQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGKSN-TNYRPNEDFVYLL 612
+ GY KAD++SFG+ +E+ +G + + Y P + + L
Sbjct: 179 EQVHGY-DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 403 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462
+G G FG V+ G +A+K + + +F+ E ++ HPNLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 522
+ +V EYM N CL + ++ + +L +W +C + + YL + I H
Sbjct: 71 QRPIFIVTEYMANGCLLN--YLRERKGKLGTEWLL--DMCSDVCEAMEYLESNGFI---H 123
Query: 523 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKAD 582
RD+ N L+ +D K+SDFGLA+ +D+ S + + PE +SK+D
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 583 VYSFGVVTLEIVSG 596
V+SFGV+ E+ S
Sbjct: 184 VWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGC 459
+G+G FG VYK I V+A+K + + + E + EI +S + P + K YG
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 460 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICI---GIARGLAYLHED 515
++G++L ++ EY +CL GK E I + GL YLHE+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDE----------TYIAFILREVLLGLEYLHEE 117
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
+I HRDIK +N+LL ++ + K++DFG++ + +T GT +MAPE +
Sbjct: 118 GKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQS 173
Query: 576 YLTSKADVYSFGVVTLEIVSGK 597
KAD++S G+ +E+ G+
Sbjct: 174 GYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF----VNEIGMISAQQHPNLVKL 456
K+GEG +G VYK G ++A+K++ + + EI ++ +HPN+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
+L LV+EY + L + + D L K I + RGLAY H
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-LKKYL---DK-RPGPLSPNLIKSIMYQLLRGLAYCH--- 115
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMR 574
+I+HRD+K N+L+++D K++DFGLA+ + + + T+ Y APE +
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
Y T+ D++S G + E+++GK
Sbjct: 175 HYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 14/200 (7%)
Query: 402 KVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 458
++GEG G V+K G +A+K+++ + +G + + EI + A QHP +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
G+ +LV EYM ++ LS + + L K + +G+AY+H +
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVL----RDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAMRGY 576
I+HRD+K +N+L+ D KI+DFGLA+L+ E++ + + T Y APE Y R Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 577 LTSKADVYSFGVVTLEIVSG 596
D+++ G + E+++G
Sbjct: 179 -DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 30/220 (13%)
Query: 403 VGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 455
+GEG FG V K + T +AVK L + R+ ++E ++ HP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 456 LYGCCVEGNQLLLVYEYMKNNCL------SRAI----FGKD-TEYRLKLDWPTRKKICIG 504
LYG C + LLL+ EY K L SR + G D LD P + + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 505 --------IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTH 555
I+RG+ YL E +K+VHRD+ NVL+ + KISDFGL++ +YEED
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
++ + +MA E T+++DV+SFGV+ EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 13/204 (6%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
D K+GEG G V S G +AVK++ + +Q NE+ ++ QHPN+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
++Y + G++L +V E+++ L+ D +++ +C+ + + L++LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAM 573
++HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVIS 188
Query: 574 RGYLTSKADVYSFGVVTLEIVSGK 597
R ++ D++S G++ +E+V G+
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 77/244 (31%), Positives = 120/244 (49%), Gaps = 24/244 (9%)
Query: 402 KVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
++GEG FG V+ D ++AVK L S ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK------ICIGIAR 507
YG CVEG+ L++V+EYMK+ L++ + G D + + P I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 566
G+ YL VHRD+ T N L+ ++L KI DFG+++ +Y D + I +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE----- 620
M PE M T+++DV+S GVV EI + GK N + + + VLQ
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCP 248
Query: 621 EEIY 624
+E+Y
Sbjct: 249 KEVY 252
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYG 458
K+G G FG V+ G + T +A+K L +QG+ F+ E ++ QHP LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
V + ++ EYM+N L + T +KL + IA G+A++ + I
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
HRD++ +N+L+ + L KI+DFGLA+L E+++ I + APE G T
Sbjct: 125 ---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 579 SKADVYSFGVVTLEIVS 595
K+DV+SFG++ EIV+
Sbjct: 182 IKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 402 KVGEGGFGSVYKG------ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
++GEG FG V+ D ++AVK L + ++F E +++ QH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-----------ICIG 504
YG C +G+ L++V+EYMK+ L++ + + + +D R+ I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 563
IA G+ YL VHRD+ T N L+ +L KI DFG+++ +Y D +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
I +M PE M T+++DV+SFGV+ EI +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 25/236 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKG-ILSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHP 451
++ + ++G G G V K G ++AVK +L ++ + E+ ++ P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSP 59
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW-PTR--KKICIGIARG 508
+V YG + + EYM L D + P R KI + + +G
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSL-------DKILKEVQGRIPERILGKIAVAVLKG 112
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
L YLHE KI+HRD+K SN+L++ K+ DFG++ ++ GT YMA
Sbjct: 113 LTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMA 167
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVYLLDWAYVLQEE 621
PE + K+D++S G+ +E+ +G+ N P+ F LL Y++ E
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQ--YIVNEP 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 10/195 (5%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
K+G G FG V+ G + T +AVK L + F+ E ++ +H LV+LY
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
E + +V EYM L F KD E R LKL P + +A G+AY+ R+
Sbjct: 72 E-EPIYIVTEYMSKGSL--LDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
+HRD++++N+L+ L KI+DFGLA+L E+++ I + APE A+ G T K
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 581 ADVYSFGVVTLEIVS 595
+DV+SFG++ E+V+
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 403 VGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 457
+G G FG V++GIL +A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 516
G + +++ EYM+N L + + D E+ +L R GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 574
+ VHRD+ N+L++ +L K+SDFGL+++ E+D T G I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 575 GYLTSKADVYSFGVVTLEIVS 595
TS +DV+SFG+V E++S
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 402 KVGEGGFGSVY----KGILS-----------DGTVIAVKQLSSKSRQGNR-EFVNEIGMI 445
K+GEG FG V+ +G+ ++AVK L + + R +F+ EI ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 446 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKL--DWPTRKK--- 500
S ++PN+++L G CV + L ++ EYM+N L++ + ++ E + P+
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 501 --ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIS 557
+ + IA G+ YL + + VHRD+ T N L+ KI+DFG+++ LY D I
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
R I +MA E + G T+ +DV++FGV E+ +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGCC 460
K+G+G FG VYKG+L T +AVK S + F+ E ++ HPN+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
V+ + +V E + L + K +K ++ + A G+ YL + I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK----KLLQMSLDAAAGMEYLESKNCI-- 115
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI--GYMAPEYAMRGYLT 578
HRD+ N L+ ++ KISDFG+++ EE + + I + APE G T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 579 SKADVYSFGVVTLEIVSGKS 598
S++DV+S+G++ E S
Sbjct: 174 SESDVWSYGILLWETFSLGD 193
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
E + +V EYM L + G+ +Y L P + IA G+AY+ R+ V
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 581
HRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+ G T K+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 582 DVYSFGVVTLEIVS 595
DV+SFG++ E+ +
Sbjct: 185 DVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 401 NKVGEGGFGSVYKGI--LSDGTVI--AVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVK 455
++G G FGSV KG+ + G + AVK L G +EF+ E +++ HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
L G C +G L+LV E L + + + L K++ +A G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESK 114
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 573
VHRD+ NVLL AKISDFG+++ + AG + + APE
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
G +SK+DV+S+GV E S
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMIS 446
NF K+G+G F VYK I L DG V+A+K+ + +K+RQ + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
HPN++K +E N+L +V E LSR I + RL + T K + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
L ++H +I+HRDIK +NV + K+ D GL + + KT + + GT Y
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
M+PE K+D++S G + E+ + +S
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVN---EIGMISAQ 448
++F +GEG F +V A+K L + ++ ++V E+ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
HP ++KLY + L V EY N L + I LD + I
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYAAEILLA 114
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------- 561
L YLH I+HRD+K N+LLDKD++ KI+DFG AK+ + + + S +
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 562 ------------GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
GT Y++PE +D+++ G + ++++GK
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 23/210 (10%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQL-----SSKSRQGNREFVN----EIGMISAQQHPN 452
+G G FGSVY G+ S G ++AVKQ+ S+ S+ R ++ EI ++ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+V+ G ++ + L + EY+ ++ + Y + + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL----NNYG-AFEETLVRNFVRQILKGLNYL 122
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-----GTIGYM 567
H +R I+HRDIK +N+L+D KISDFG++K E + T A G++ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
APE + T KAD++S G + +E+++GK
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
++ ++G G +G VYK ++ G ++A+K + + EI M+ +HPN+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+G + ++L +V EY L + G +E ++ +C +GLAYL
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-------VCRETLKGLAYL 117
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGY 566
HE +I HRDIK +N+LL +D + K++DFG++ ++ IA GT +
Sbjct: 118 HETGKI---HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYW 167
Query: 567 MAPEYA---MRGYLTSKADVYSFGVVTLEIVSGK 597
MAPE A +G K D+++ G+ +E+ +
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQQ 449
++ K+GEG + VYK G ++A+K++ R+ ++ +N EI ++ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
HPN++ L + + LV+E+M+ + L + I KD L K + RGL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD-LEKVI--KDKSIVLTP--ADIKSYMLMTLRGL 115
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
YLH + I+HRD+K +N+L+ D K++DFGLA+ + ++ ++ T Y AP
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171
Query: 570 E--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
E + R Y D++S G + E++
Sbjct: 172 ELLFGARHY-GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 72/222 (32%), Positives = 110/222 (49%), Gaps = 8/222 (3%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
K+G G FG V+ G ++ T +AVK L + + F+ E ++ QH LV+LY
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
+ + ++ EYM L F K E K+ P IA G+AY+ + I
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKNYI--- 125
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 581
HRD++ +NVL+ + L KI+DFGLA++ E+++ I + APE G T K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 582 DVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 622
DV+SFG++ EIV+ GK N D + L Y + E
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 73/216 (33%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 403 VGEGGFGSVYK---GILSDGT--VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
+G+G FGSV L D T V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 458 GCCVEG--NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
G C L LV EY+ L R K E +LD I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSL-RDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK 127
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 573
+ VHRD+ T N+L++ + KI DFGL K+ +DK + R G I + APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 574 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 609
+ +DV+SFGVV E+ + S+ + P +F+
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFM 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYG 458
K+GEG +G VYK G ++A+K++ + + + EI ++ HPN++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
L LV+E+M + KD + L K + +GLA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYK---LIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK---TH-ISTRIAGTIGYMAPE--YA 572
I+HRD+K N+L++ + K++DFGLA+ + TH + TR Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLG 172
Query: 573 MRGYLTSKADVYSFGVVTLEIVSGK 597
+GY ++ D++S G + E++S +
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 72/225 (32%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 401 NKVGEGGFGSVYKGILS--DGTV----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 453
+G G FG VY+G+ DG +AVK L S S Q +F+ E ++S H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK------KICIGIAR 507
V+L G E ++ E M L + E R + + P+ +A+
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL----RENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK-LYEEDKTHISTRIAGT 563
G YL E+ +HRDI N LL AKI+DFG+A+ +Y R
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 607
I +M PE + G TSK DV+SFGV+ EI S G R N++
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 403 VGEGGFGSVYKG----ILSDGT---VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLV 454
+G G FG VY+G IL G+ +AVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYL 512
KL G C+ ++ E M+ L + + L IC+ +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 513 HEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 566
++ +HRD+ N L+ D D KI DFGLA+ +Y+ D + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
MAPE + G T+++DV+SFGV+ EI++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHPNLVKLY 457
+G+G FG+V K SDG ++ K++ + + + ++ V+E+ ++ +HPN+V+ Y
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 458 GCCV-EGNQLL-LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-- 513
+ NQ L +V EY + L++ I K + R ++ +I + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
D ++HRD+K +N+ LD + N K+ DFGLAK+ D + T GT YM+PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMSPEQLN 183
Query: 574 RGYLTSKADVYSFGVVTLEIVSGK 597
K+D++S G + E+ +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 403 VGEGGFGSVYK-GILSDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+G FG V G + A+K L K R+ + E ++S HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+L LV EY L + + + I L YLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFSEERARFYAAEIVLALEYLH---SL 112
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
I++RD+K N+LLD D + K++DFGLAK + + +T GT Y+APE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 579 SKADVYSFGVVTLEIVSGKS 598
D +S GV+ E+++GK
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 37/212 (17%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--------VNEIGMISA-QQHP 451
++G+G FGSVY G ++A+K++ ++F + E+ + +HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGL 509
N+VKL E ++L V+EYM+ N ++ KD + + + I I +GL
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKP-FSESVIRSIIYQILQGL 112
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH---ISTRIAGTIGY 566
A++H + HRD+K N+L+ KI+DFGLA+ + +STR Y
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WY 164
Query: 567 MAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 597
APE +R +S D+++ G + E+ + +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
E + +V E+M L + D +Y LKL P + IA G+AY+ R+ +
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKY-LKL--PQLVDMAAQIADGMAYIE---RMNYI 124
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 581
HRD++ +N+L+ +L KI+DFGLA+L E+++ I + APE A+ G T K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 582 DVYSFGVVTLEIVS 595
DV+SFG++ E+V+
Sbjct: 185 DVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+G FG V D + A+K ++ + + R +NE ++ HP LV L+
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAYLHE 514
+ + LV + + G D Y L K K I L YLH
Sbjct: 68 SFQDEENMYLVVDLL---------LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
I+HRDIK N+LLD+ + I+DF +A D ++T +GT GYMAPE R
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCR 173
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
+ D +S GV E + GK
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 402 KVGEGGFGSVY----KGIL-------------SDGTVIAVKQLSSKSRQGNR-EFVNEIG 443
K+GEG FG V+ +G+ + ++AVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 444 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLK--LDWPT 497
++S + PN+++L C+ + L ++ EYM+ N LSR + E + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHI 556
+ IA G+ YL S + VHRD+ T N L+ K+ KI+DFG+++ LY D I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
R I +M+ E + G T+ +DV++FGV EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 18/203 (8%)
Query: 403 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 457
+G G FG V +G L +A+K L S + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 516
G + ++++ E+M+N L + D ++ ++L R GIA G+ YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSE-- 124
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG--YMAPEYA 572
+ VHRD+ N+L++ +L K+SDFGL++ E+D + ++ + G I + APE
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 573 MRGYLTSKADVYSFGVVTLEIVS 595
TS +DV+S+G+V E++S
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ +HPN+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 86 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
+HRDIK+ N+LL D + K++DFG +++ ST + GT +MAPE R K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 581 ADVYSFGVVTLEIVSGK 597
D++S G++ +E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFV----NEIGMISAQQHP 451
+G+G +G VY + ++ G ++AVKQ+ + + ++ V +EI + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGL 509
N+V+ G L + EY+ + + +G+ E + + GL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-------QLVRFFTEQVLEGL 121
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK----LYEEDKTHISTRIAGTIG 565
AYLH I+HRD+K N+L+D D KISDFG++K +Y+ D+ + G++
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVF 175
Query: 566 YMAPEY---AMRGYLTSKADVYSFGVVTLEIVSGK 597
+MAPE +GY ++K D++S G V LE+ +G+
Sbjct: 176 WMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 4e-23
Identities = 58/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+G+G G+VY I ++ G +A+KQ++ + + +NEI ++ ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 86 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALDFLHSN---QV 136
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
+HRDIK+ N+LL D + K++DFG +++ ST + GT +MAPE R K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 581 ADVYSFGVVTLEIVSGK 597
D++S G++ +E+V G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 4e-23
Identities = 67/202 (33%), Positives = 112/202 (55%), Gaps = 19/202 (9%)
Query: 403 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 456
+G G FG+VYKGI + +G + A+K L+ + + N EF++E ++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
G C+ + LV + M + CL + + +L L+W C+ IA+G+ YL E
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 573
++VHRD+ NVL+ + KI+DFGLA+L E D+ + I +MA E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
T ++DV+S+GV E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 69/217 (31%), Positives = 120/217 (55%), Gaps = 14/217 (6%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNL 453
NF K+GEG + +VYKG + G ++A+K++ + +G + EI ++ +H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYL 512
V+L+ N+L+LV+EYM + L + + DT R LD T K + +G+A+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
HE+ +++HRD+K N+L++K K++DFGLA+ + S + T+ Y AP+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172
Query: 573 M--RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607
+ R Y TS D++S G + E+++G+ NED
Sbjct: 173 LGSRTYSTS-IDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 398 DPANK------VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISA-QQ 449
DP +GEG +G VYK G ++A+K + + E E ++
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 450 HPNLVKLYGC------CVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKIC 502
HPN+ YG +QL LV E ++ + G + RLK +W I
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--IL 119
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKL-YEEDKTHISTRI 560
RGLAYLHE+ K++HRDIK N+LL K+ K+ DFG+ A+L + +
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-- 174
Query: 561 AGTIGYMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
GT +MAPE +++DV+S G+ +E+ GK
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 402 KVGEGGFGSVY----------------KGILSDGTV-IAVKQL----SSKSRQGNREFVN 440
K+GEG FG V+ + +D V +AVK L S +R+ +F+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLK 68
Query: 441 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDT--EYRLKLD 494
E+ ++S PN+ +L G C L ++ EYM+ N L + + L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 495 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDK 553
+ T + IA G+ YL + VHRD+ T N L+ K+ KI+DFG+++ LY D
Sbjct: 129 FSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ R I +MA E + G T+K+DV++FGV EI++
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 403 VGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHPNLV 454
+GEG FG V K + +AVK L + + + V+E+ M+ +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKI--------CI 503
L G C + L +V EY + L RA P + +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 562
+ARG+ +L S+ K +HRD+ NVL+ +D KI+DFGLA+ ++ D +T
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +MAPE T ++DV+SFGV+ EI +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
+G+G +G VY LS IA+K++ + + + EI + S +H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 462 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
E + E + LS R+ +G LK + T I GL YLH++
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGP-----LKDNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 519 KIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMR 574
+IVHRDIK NVL++ KISDFG +K T GT+ YMAPE R
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPR 186
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
GY + AD++S G +E+ +GK
Sbjct: 187 GY-GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 403 VGEGGFGSVYKGI-LSDGTVI----AVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 456
+G G FG+V+KGI + +G I A+K + +S RQ +E + + + + H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 457 YGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
G C G L LV + L R RL L+W C+ IA+G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL-LNW------CVQIAKGMYYLE 126
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYA 572
E ++VHR++ N+LL D +I+DFG+A LY +DK + + I +MA E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 573 MRGYLTSKADVYSFGVVTLEIVS 595
+ G T ++DV+S+GV E++S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 58/198 (29%), Positives = 107/198 (54%), Gaps = 13/198 (6%)
Query: 402 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+GEG G V + S G ++AVK++ + +Q NE+ ++ QH N+V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ G++L +V E+++ L+ D +++ +C+ + + L+ LH +
Sbjct: 87 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---V 137
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 579
+HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGP 195
Query: 580 KADVYSFGVVTLEIVSGK 597
+ D++S G++ +E+V G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 31/212 (14%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGN--REFVNEIGMISAQQHPNLVK 455
+G G F S Y+ + GT++AVKQ++ + S Q EI +++ HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ G E + L E+M +S + +G E + + RGL+YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-------INYTEQLLRGLSYLH 120
Query: 514 EDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKT---HISTRIAGTIGYM 567
E+ +I+HRD+K +N+L+D + L +I+DFG A T ++ GTI +M
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 568 APEYAMRG--YLTSKADVYSFGVVTLEIVSGK 597
APE +RG Y S DV+S G V +E+ + K
Sbjct: 176 APE-VLRGEQYGRS-CDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 69/225 (30%), Positives = 116/225 (51%), Gaps = 17/225 (7%)
Query: 403 VGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLY 457
+G G FG V G L +A+K L + + + R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIARGLAYLHEDS 516
G + +++V EYM+N L + D ++ ++L R GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL---S 123
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG--YMAPEYAMR 574
+ VHRD+ N+L++ +L K+SDFGL+++ E+D T G I + APE
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 575 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 618
TS +DV+S+G+V E++S G+ N+D + ++ Y L
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 61/220 (27%), Positives = 113/220 (51%), Gaps = 11/220 (5%)
Query: 379 DLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE 437
++ L T+ I + K+G+G G+V+ I ++ G +A+KQ++ + +
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62
Query: 438 FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
+NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQ 116
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
+C + L +LH + +++HRDIK+ NVLL D + K++DFG +++ S
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
T + GT +MAPE R K D++S G++ +E+V G+
Sbjct: 174 TMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQL---SSKSRQGNREFVN---EIGMISAQQHPNLV 454
+G+G +G+VY G+ + G +IAVKQ+ +S +E+ E+ ++ + +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+ G C++ N + + E++ +S + FG E P K I G+AYL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-------PVFCKYTKQILDGVAYL 118
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-----EEDKTHISTRIAGTIGYM 567
H + +VHRDIK +NV+L + K+ DFG A+ +++ + GT +M
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
APE K+D++S G E+ +GK
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 452
+++GEG GSV K L + G + A+K +++ ++ + E+ + + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 453 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
+VK YG ++ + + + EY + L +I+ K + ++ KI + +GL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH KI+HRDIK SN+LL + K+ DFG++ E ++ GT YMAPE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPE 173
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ +DV+S G+ LE+ +
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 403 VGEGGFGSVYKGILS--DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+GEG FGSV +G LS DG+ +AVK +L + EF++E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 457 YGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIARG 508
G C E + L +++ +MK+ L + L P + K + IA G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALG 125
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED---KTHISTRIAGTI 564
+ YL S +HRD+ N +L +D+ ++DFGL+ K+Y D + I+ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PV 179
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
++A E TSK+DV++FGV EI +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 396 NFDPANKVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQG-NREFVNEIGMISAQ 448
N +G G FG V+ KGI +G T++ VK L + EF E+ M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLK-LDWPTRKKICIG 504
H N+V+L G C E ++ EY L RA KD + + L + +C
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 563
IA G+ +L S + VHRD+ N L+ K+S L+K +Y + + +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ ++APE ++K+DV+SFGV+ E+ +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 65/204 (31%), Positives = 113/204 (55%), Gaps = 23/204 (11%)
Query: 403 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+G G FG+VYKGI + DG + A+K L + S + N+E ++E +++ P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 512
G C+ + + LV + M CL + ++ + R+ L+W C+ IA+G++YL
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEY 571
E +++VHRD+ NVL+ + KI+DFGLA+L + D+T I +MA E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 572 AMRGYLTSKADVYSFGVVTLEIVS 595
+ T ++DV+S+GV E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 79/253 (31%), Positives = 118/253 (46%), Gaps = 44/253 (17%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSVYKG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 444
++ A N+ + ++G G G VYK G V+AVKQ+ R GN+E I M
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDL 64
Query: 445 -ISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTEYRLKLDWPTRK 499
+ + H P +VK YG + + + + E M L + I G E L
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG------- 117
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
K+ + I + L YL E ++HRD+K SN+LLD N K+ DFG++ + K TR
Sbjct: 118 KMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 560 IAGTIGYMAPE----------YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE-DF 608
AG YMAPE Y +R ADV+S G+ +E+ +G+ Y+ + +F
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQF--PYKNCKTEF 225
Query: 609 VYLLDWAYVLQEE 621
L +LQEE
Sbjct: 226 EVL---TKILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 54/197 (27%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+G+G G+VY + ++ G +A++Q++ + + +NEI ++ ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ G++L +V EY+ L+ D +D +C + L +LH + ++
Sbjct: 87 LVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
+HRDIK+ N+LL D + K++DFG +++ S + GT +MAPE R K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPK 196
Query: 581 ADVYSFGVVTLEIVSGK 597
D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 23/216 (10%)
Query: 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 454
F ++G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 455 KLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
K YG ++G +L ++ EY+ L RA G E+++ + I +GL Y
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIA-------TMLKEILKGLDY 116
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
LH + +I HRDIK +NVLL + + K++DFG+A + + +T + GT +MAPE
Sbjct: 117 LHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 172
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607
+ SKAD++S G+ +E+ G+ PN D
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEP-----PNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 9e-22
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
++G G FG V G +A+K + S + EF+ E ++ H LV+LYG C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
+ + +V EYM N CL + E+ + ++C + G+AYL + +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 581
HRD+ N L+D K+SDFGL++ +D+ S + + PE + +SK+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 582 DVYSFGVVTLEIVS-GK 597
DV++FGV+ E+ S GK
Sbjct: 183 DVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF-VNEIGM---ISAQQH 450
++ ++GEG +G+VYK L+ G +A+K++ S +G + EI + + + +H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 451 PNLVKLYGCCV-----EGNQLLLVYEYMK-------NNCLSRAIFGKDTEYRLKLDWPTR 498
PN+V+L C +L LV+E++ + C L T
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-----------LPPETI 109
Query: 499 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS- 557
K + + RG+ +LH +IVHRD+K N+L+ D KI+DFGLA++Y ++
Sbjct: 110 KDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMAL 163
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 593
T + T+ Y APE ++ + D++S G + E+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 396 NFDPANKVGEGGFGS--VYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 451
++ P +G+G FG +Y+ D +++ K+ L+ S + R+ +NEI ++S QHP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT---EYRLKLDWPTRKKICIGIARG 508
N++ Y ++ N LL+ EY L I + E + L + I
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSA 113
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
++Y+H+ I+HRDIKT N+ L K K+ DFG++K+ + + T + GT YM+
Sbjct: 114 VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMS 169
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
PE K+D+++ G V E+++ K
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 30/207 (14%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQH---PNLVKLY 457
+G G +G+VY+G + G V+A+K ++ + + + E+ ++S + PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 458 GCCVEGNQLLLVYEYMKNN---CLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 510
G ++G +L ++ EY + L +A P +K I R L
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALK 115
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
Y+H+ ++HRDIK +N+L+ N K+ DFG+A L ++ + ST GT +MAPE
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPE 171
Query: 571 YAMRG-YLTSKADVYSFGVVTLEIVSG 596
G Y +KAD++S G+ E+ +G
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 14/194 (7%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
+GEG FG+V +G + G +AVK + K + F+ E +++ H NLV+L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
N L +V E M L + T R + + + +A G+ YL K+V
Sbjct: 70 H-NGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 581
HRD+ N+L+ +D AK+SDFGLA++ ++++ + + APE +SK+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 582 DVYSFGVVTLEIVS 595
DV+S+GV+ E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 402 KVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKL 456
+GEG FG VY+G+ ++ +AVK + + RE F+ E ++ HP++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
G E N + +V E L + + LD + ++ LAYL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 576
+ VHRDI NVL+ K+ DFGL++ E++ + +++ I +MAPE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 577 LTSKADVYSFGVVTLEIVS-GKSNTNYRPNED 607
TS +DV+ FGV EI+ G N D
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 402 KVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+GEG G V G +AVK + + +Q NE+ ++ QH N+V++Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ G +L ++ E+++ L+ D + +L+ +C + + L YLH +
Sbjct: 88 LVGEELWVLMEFLQGGALT------DIVSQTRLNEEQIATVCESVLQALCYLHSQG---V 138
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAMRGYLT 578
+HRDIK+ ++LL D K+SDFG +D + R + GT +MAPE R
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 579 SKADVYSFGVVTLEIVSGK 597
++ D++S G++ +E+V G+
Sbjct: 196 TEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 42/230 (18%)
Query: 402 KVGEGGFGSVY--------------------KGILSDGTVIAVKQLSSKSRQGNR-EFVN 440
K+GEG FG V+ KG ++AVK L + + R +F+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG---RPLLVAVKILRPDANKNARNDFLK 68
Query: 441 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR---------- 490
E+ ++S + PN+++L G CV+ + L ++ EYM+N L++ + + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 491 ----LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546
+ + + + + IA G+ YL S + VHRD+ T N L+ ++L KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 547 K-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ LY D I R I +MA E + G T+ +DV++FGV EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 40/214 (18%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISAQQHPNL 453
N++G G G+VYK I G + A+K + GN R+ EI ++ HPN+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
VK + ++ ++ E+M L + L R+ I G+AYLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF----LADVARQ-----ILSGIAYLH 185
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE--DKTHISTRIAGTIGYMAPEY 571
R IVHRDIK SN+L++ N KI+DFG++++ + D + S GTI YM+PE
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPER 239
Query: 572 --------AMRGYLTSKADVYSFGVVTLEIVSGK 597
A GY D++S GV LE G+
Sbjct: 240 INTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 57/198 (28%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 402 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+GEG G V G +AVK++ + +Q NE+ ++ H N+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ G++L +V E+++ L+ D +++ +C+ + R L+YLH +
Sbjct: 89 LVGDELWVVMEFLEGGALT------DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 139
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 579
+HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGT 197
Query: 580 KADVYSFGVVTLEIVSGK 597
+ D++S G++ +E++ G+
Sbjct: 198 EVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 9/222 (4%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
K+G G FG V+ + T +AVK + S F+ E ++ QH LVKL+ V
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
+ ++ E+M L F K E K P IA G+A++ + + I
Sbjct: 71 TKEPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKA 581
HRD++ +N+L+ L KI+DFGLA++ E+++ I + APE G T K+
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 582 DVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 622
DV+SFG++ +EIV+ G+ N + + L+ Y + E
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 402 KVGEGGFGSVYKG--ILSDGTVI--AVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKL 456
K+G+G FG V +G S G VI AVK L S +F+ E ++ + H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 457 YGCCVEGNQLLLV---------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
YG V + L++V + ++ + L + +Y + IA
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------------AVQIAN 108
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHIST---RIAGT 563
G+ YL + +HRD+ N+LL D KI DFGL + L + + ++ ++
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP-- 163
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ APE + +DV+ FGV E+ +
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 403 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462
+G+G FG V G G +AVK + K+ + F+ E +++ +H NLV+L G VE
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 463 GN-QLLLVYEYMKNNCL-------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
L +V EYM L R++ G D + LD + + YL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD----------VCEAMEYLEA 120
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
++ VHRD+ NVL+ +D AK+SDFGL K E T + ++ + + APE
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALRE 173
Query: 575 GYLTSKADVYSFGVVTLEIVS 595
++K+DV+SFG++ EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 402 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKLY 457
++G G FG+VY V+A+K++S +Q N ++ + E+ + +HPN ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
GC + + LV EY CL A + ++ L IC G +GLAYLH R
Sbjct: 82 GCYLREHTAWLVMEY----CLGSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--YAM-R 574
I HRDIK N+LL + K++DFG A L + + GT +MAPE AM
Sbjct: 137 I---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDE 188
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
G K DV+S G+ +E+ K
Sbjct: 189 GQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 402 KVGEGGFGSVYKGIL-----SDGTVIAVKQLSS-KSRQGNREFVNEIGMISAQQHPNLVK 455
++GE FG +YKG L ++A+K L + Q EF E +++ HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIF------------GKDTEYRLKLDWPTRKKICI 503
L G + + +++EY+ L + +D + LD I I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 562
IA G+ YL S VH+D+ N+L+ + L+ KISD GL++ +Y D + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
I +M PE M G +S +D++SFGVV EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQ 448
N+ +G+G FG VY D G +AVKQ S ++++ EI ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIA 506
QH +V+ YGC + L + EYM + + +G TE +K I
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE-------TVTRKYTRQIL 114
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTI 564
G+ YLH + IVHRDIK +N+L D N K+ DFG +K + + + + GT
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 565 GYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 597
+M+PE GY KADV+S G +E+++ K
Sbjct: 172 YWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 403 VGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCCV 461
+G+G FG V+KG L D T +AVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
+ + +V E + + K E + K K + A G+AYL + +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTK----QLVKFALDAAAGMAYLESKN---CI 115
Query: 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAMRGYLTSK 580
HRD+ N L+ ++ KISDFG+++ E+D + S+ + I + APE G +S+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 581 ADVYSFGVVTLEIVS 595
+DV+S+G++ E S
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 396 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLS-SKSRQG-NREFVNEIGMISAQQHPN 452
F+ N++GEG +G VY+ + G ++A+K++ R G + EI ++ +HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 453 LVKLYGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
+V+L V G L LV EY + + L+ + T + K + + + RGL
Sbjct: 68 IVELKEV-VVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSE----SQVKCLMLQLLRGL 121
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
YLHE+ I+HRD+K SN+LL KI+DFGLA+ Y ++ ++ T+ Y AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 570 E--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
E Y T+ D+++ G + E+++ K
Sbjct: 178 ELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 402 KVGEGGFGSVY----KGILSDG--TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLV 454
++G+G FG VY KG++ D T +A+K ++ + R EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICI---GIARGL 509
+L G +G L++ E M L + + E P+ KK+ IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 568
AYL+ + K VHRD+ N ++ +D KI DFG+ + +YE D + + +M+
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVS 595
PE G T+ +DV+SFGVV EI +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 458
++G G FG V+ G +A+K + +G +F+ E ++ HP LV+LYG
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 459 CCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
C + L +V E+M+N CL + KD +C + G+ YL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL----------SMCQDVCEGMEYL 116
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
+S I HRD+ N L+ K+SDFG+ + +D+ S+ + + PE
Sbjct: 117 ERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 573 MRGYLTSKADVYSFGVVTLEIVS-GK----SNTNY 602
+SK+DV+SFGV+ E+ + GK +NY
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 402 KVGEGGFGSVYKGILSD------GTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLV 454
++G+G FG VY+G D T +AVK ++ S S + EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKI---CIGIARGL 509
+L G +G L+V E M + L + + E PT +++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMA 568
AYL+ K VHRD+ N ++ D KI DFG+ + +YE D + + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVS 595
PE G T+ +D++SFGVV EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAV-KQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
++G+G FG VYK + V+A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
N L ++ E+ C A+ E L P + +C L YLHE+ KI
Sbjct: 72 YYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAM----- 573
+HRD+K N+L D + K++DFG++ ++ I R GT +MAPE M
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 574 -RGYLTSKADVYSFGVVTLEI 593
R Y KADV+S G+ +E+
Sbjct: 182 DRPY-DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 401 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 460 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
C ++ E+M N L + ++ R +++ + I+ + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLD---YLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 575
HRD+ N L+ ++ K++DFGL++L D T AG I + APE
Sbjct: 127 ---HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYN 180
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+ K+DV++FGV+ EI +
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 448
NF K+G G F VY+ L DG +A+K+ + +K+R + + EI ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL---KLDWPTRKKICIGI 505
HPN++K Y +E N+L +V E LSR I + RL K W ++C
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC--- 116
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
L ++H SR +++HRDIK +NV + K+ D GL + + KT + + GT
Sbjct: 117 -SALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPY 171
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
YM+PE K+D++S G + E+ + +S
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 30/212 (14%)
Query: 403 VGEGGFGSVYKGILSDG--TVIAVKQLS---------SKSRQGN-REFVNEIGMISAQ-Q 449
+G G FG VYK + ++A+K+++ + R + + V+E+ +I Q +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF------GKDTEYRLKLDWPTRKKICI 503
HPN+V+ Y +E ++L +V + ++ L + TE R+ W I +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---W----NIFV 120
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
+ L YLH++ RI VHRD+ +N++L +D I+DFGLAK + + T + GT
Sbjct: 121 QMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
I Y PE KADV++FG + ++ +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 403 VGEGGFGSVYKGIL------SDGT--VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNL 453
+GEG FG V L +DGT ++AVK L + Q N + EI ++ H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 454 VKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG------- 504
VK GCC E L L+ EY+ L D+ + K+ +
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSL--------------RDYLPKHKLNLAQLLLFAQ 114
Query: 505 -IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
I G+AYLH I HRD+ NVLLD D KI DFGLAK E + R G
Sbjct: 115 QICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 564 --IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 612
+ + A E + +DV+SFGV E+++ ++ P + F ++
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 61/204 (29%), Positives = 115/204 (56%), Gaps = 23/204 (11%)
Query: 403 VGEGGFGSVYKGI-LSDGTVI----AVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+G G FG+VYKG+ + +G + A+K+L + S + N+E ++E ++++ +P++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAYL 512
G C+ + + L+ + M CL + ++ + + L+W C+ IA+G+ YL
Sbjct: 75 LGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIGYMAPEY 571
E ++VHRD+ NVL+ + KI+DFGLAKL ++K + + I +MA E
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 572 AMRGYLTSKADVYSFGVVTLEIVS 595
+ T ++DV+S+GV E+++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 393 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ-LSSKSRQGNREF----VNEIGMIS 446
+++ K+GEG FG VYK + G V+A+K+ L + G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLD 494
+HPN+V L + + E + R T Y +KL
Sbjct: 63 KLKHPNVVPL---------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 495 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK- 553
K + + G+ YLHE+ I+HRDIK +N+L+D KI+DFGLA+ Y+
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 554 ---------THISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
T T + T Y PE + R Y T+ D++ G V E+ + +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 81/235 (34%), Positives = 117/235 (49%), Gaps = 28/235 (11%)
Query: 403 VGEGGFGSVYKGIL--SDGTVI--AVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 457
+G+G FG VY G L SDG I AVK L+ + E F+ E ++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 458 GCCVEGNQL-LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG----IARGLAYL 512
G C+ L+V YMK+ L I R + PT K + IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDL-IGFGLQVAKGMEYL 114
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LY--EEDKTHISTRIAGTIGYMAP 569
K VHRD+ N +LD+ K++DFGLA+ +Y E H T + +MA
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF---VYLLDWAYVLQEE 621
E T+K+DV+SFGV+ E+++ + Y + F VYLL +LQ E
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPE 225
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 397 FDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 454
F ++G+G FG VYKGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 510
+ YG ++G +L ++ EY+ G + L P + I R GL
Sbjct: 66 RYYGSYLKGTKLWIIMEYL----------GGGSALDLLKPGPLEETYIATILREILKGLD 115
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH + +I HRDIK +NVLL + + K++DFG+A + + +T + GT +MAPE
Sbjct: 116 YLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 171
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 608
+ KAD++S G+ +E+ G+ PN D
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEP-----PNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 61/201 (30%), Positives = 87/201 (43%), Gaps = 14/201 (6%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+GGFG V + G + A K+L K R+G + +NE ++ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ L LV M L I+ I GL +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 577
+IV+RD+K NVLLD N +ISD GLA +L K AGT GYMAPE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVY 171
Query: 578 TSKADVYSFGVVTLEIVSGKS 598
D ++ G E+++G+S
Sbjct: 172 DFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462
G+G FG VYK G A K + +S + +F+ EI ++S +HPN+V LY
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 522
N+L ++ E+ C A+ E L P + +C + L +LH K++H
Sbjct: 74 ENKLWILIEF----CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 523 RDIKTSNVLLDKDLNAKISDFGL-AKLYEEDKTHISTRIAGTIGYMAPEYAM------RG 575
RD+K N+LL D + K++DFG+ AK + T I GT +MAPE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNP 184
Query: 576 YLTSKADVYSFGVVTLEI 593
Y KAD++S G+ +E+
Sbjct: 185 Y-DYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 449
N ++ VGEG +G V K G ++A+K+ K + + + + E+ ++ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
H N+V L +L LV+EY++ L L + + + +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL-----EASPGGLPPDAVRSYIWQLLQAI 113
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
AY H I+HRDIK N+L+ + K+ DFG A+ T T Y AP
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 570 E----YAMRGYLTSKADVYSFGVVTLEIVSG 596
E G DV++ G + E++ G
Sbjct: 171 ELLVGDTNYG---KPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 402 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
++G+G FG VYK + G + A K + +KS + +++ EI +++ HP +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+L ++ E+ C A+ E L P + IC + L YLH +KI
Sbjct: 79 YWDGKLWIMIEF----CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKI 131
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLA----KLYEEDKTHISTRIAGTIGYMAPEYAMRGY 576
+HRD+K NVLL D + K++DFG++ K + + I GT +MAPE M
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 577 LTS-----KADVYSFGVVTLEI 593
+ KAD++S G+ +E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLV 454
F K+G+G FG V+KGI + V+A+K + + + E + EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
K YG ++ +L ++ EY+ D LD I I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS------ALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
+ +I HRDIK +NVLL + K++DFG+A + + GT +MAPE +
Sbjct: 120 EKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
SKAD++S G+ +E+ G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 28/208 (13%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR-QGNREFV-----NEIGMISAQQHPNLV 454
K+GEG +G VYK G ++A+K K R + E V EI ++ HPN+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALK----KIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+L N+L LV+E++ + L + + D+ LD P K + +G+AY H
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLD-LKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYCH- 116
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKTHISTRIAGTIGYMAPEY 571
S +++HRD+K N+L+D++ K++DFGLA+ + TH T+ Y APE
Sbjct: 117 -SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEI 170
Query: 572 AM--RGYLTSKADVYSFGVVTLEIVSGK 597
+ R Y T D++S G + E+V+ +
Sbjct: 171 LLGSRQYSTP-VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-19
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 396 NFDPANKVGEGGFGSVY--KG-ILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
++ K+GEG FG +Y K S+ VI L+ + E+ +++ +HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 453 LVKLYGCCVEGNQLLLVYEY------MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
+V + E +L +V EY MK R + + + L W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSW------FVQIS 111
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
GL ++H+ KI+HRDIK+ N+ L K+ + AK+ DFG+A+ D ++ GT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPY 167
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y++PE +K D++S G V E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 396 NFDPANKVGEGGFGSVY--KGILSDGTVI----AVKQLSSKSRQGNREFVNEIGMISAQQ 449
++ VG G FG V+ + VI V+Q++ R + NE ++
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLS 57
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
HPN+++ Y +E L++V EY L+ I + LD T + I L
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL---LDEDTILHFFVQILLAL 114
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
++H I+HRD+KT N+LLDK KI DFG++K+ K+ T + GT Y++
Sbjct: 115 HHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYIS 169
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
PE K+D+++ G V E+ S K
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 402 KVGEGGFGSVYKGILSDGT------VIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 454
++GE FG VYKG L +A+K L K+ RE F +E M S QHPN+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-----------DTEYRLKLDWPTRKKICI 503
L G + L +++ Y ++ L + + D + L+ I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 562
IA G+ +L S +VH+D+ T NVL+ LN KISD GL + +Y D +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
I +M+PE M G + +D++S+GVV E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+++G G FG V G G A VK+L +S + F+ E+ HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
G C+E LLV E+ L + +++ +A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYA--- 572
+ +H D+ N L DL+ KI D+GLA + Y ED A + ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 573 ----MRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 623
+ T K++++S GV E+ +P D V++E++I
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL----FTAADQPYPDLSDEQVLKQVVREQDI 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 43/217 (19%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGN-REFVNEIGMI-SAQQHPNLVKLYG- 458
+G G FG+V K + GT++AVK++ S + + + ++ ++ + P +VK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 459 ------C--CVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 504
C C+E VYE + + + I GK I +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK---------------IAVA 115
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
+ L YL E+ +KI+HRD+K SN+LLD++ N K+ DFG++ + + TR AG
Sbjct: 116 TVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAGCR 171
Query: 565 GYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
YMAPE A GY ++DV+S G+ E+ +GK
Sbjct: 172 PYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREF----VNEIGMISAQQ 449
++ N++ EG +G VY+ G ++A+K+L K ++G F + EI ++ Q
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 450 HPNLVKLYGCCVEGN--QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
HPN+V + V N ++ +V EY++++ L + + K + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHD-LKSLMETMKQPFLQ----SEVKCLMLQLLS 117
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
G+A+LH++ I+HRD+KTSN+LL+ KI DFGLA+ Y T++ T+ Y
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYR 173
Query: 568 APEYAM-RGYLTSKADVYSFGVVTLEIVSGK 597
APE + ++ D++S G + E+++ K
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPNLVKL 456
+++G G FG+VY S V+AVK++S +Q N ++ + E+ + +HPN ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
GC ++ + LV EY CL A + ++ L I G +GLAYLH +
Sbjct: 87 KGCYLKEHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM--- 573
I HRDIK N+LL + K++DFG A K+ + GT +MAPE +
Sbjct: 142 MI---HRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMD 193
Query: 574 RGYLTSKADVYSFGVVTLEIVSGK 597
G K DV+S G+ +E+ K
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 397 FDPANKVGEGGFGSVY-KGILSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 452
F ++G G FG+VY + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
++ GC + + LV EY CL A + ++ L I G +GLAYL
Sbjct: 87 SIEYKGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYL 141
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H + ++HRDIK N+LL + K++DFG A + + + GT +MAPE
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 573 M---RGYLTSKADVYSFGVVTLEIVSGK 597
+ G K DV+S G+ +E+ K
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 452
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
++ GC + + LV EY CL A + ++ L + G +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEY----CLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H + ++HRD+K N+LL + K+ DFG A + + GT +MAPE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 573 M---RGYLTSKADVYSFGVVTLEIVSGK 597
+ G K DV+S G+ +E+ K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 403 VGEGGFGSVYKGILS-DGTV--IAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
+GEG FGSV +G L+ D ++ +AVK +++ +R +F++E + HPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 458 GCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
G C++ + +++ +MK+ L S ++ + + L K IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAP 569
YL S +HRD+ N +L++++N ++DFGL+K + RIA + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVS 595
E T+K+DV+SFGV EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ------LSSKSRQGNREFVNEIGMISAQ 448
NF K+G G F VY+ L D +A+K+ + +K+RQ + V EI ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK--KICIGIA 506
HPN++K +E N+L +V E LS+ I + RL P R K + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL---IPERTVWKYFVQLC 116
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
+ ++H SR +++HRDIK +NV + K+ D GL + + KT + + GT Y
Sbjct: 117 SAVEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYY 172
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
M+PE K+D++S G + E+ + +S
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 45/217 (20%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNE--IGMISAQQHPNLVKLYGC 459
G G +G V K + GT++AVK++ ++ + Q + + + I M S P V YG
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVTFYGA 68
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR------KKICIGIARGLAYLH 513
+ + E M L D Y+ D KI + I + L YLH
Sbjct: 69 LFREGDVWICMEVMDT-SL-------DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFG--------LAKLYEEDKTHISTRIAGTIG 565
++ ++HRD+K SNVL++++ K+ DFG +AK T AG
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------TIDAGCKP 168
Query: 566 YMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
YMAPE +GY K+DV+S G+ +E+ +G+
Sbjct: 169 YMAPERINPELNQKGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 41/223 (18%)
Query: 395 NNFDPANKVGEGGFGSVYK----GILSDGTVI--AVKQLSSKSRQGNRE-FVNEIGMIS- 446
NN +G G FG V + G+ V+ AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK------ 500
H N+V L G C G +L++ EY C Y L++ RK+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEY----CC----------YGDLLNFLRRKRESFLTL 140
Query: 501 ---ICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555
+ +A+G+A+L + +HRD+ NVLL KI DFGLA+ D +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 556 I---STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ + R+ + +MAPE T ++DV+S+G++ EI S
Sbjct: 198 VVKGNARLP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 57/228 (25%), Positives = 110/228 (48%), Gaps = 33/228 (14%)
Query: 397 FDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQ 449
++ ++GEG +G V+K + + G +A+K++ ++ + + E+ ++ +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 450 HPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWP-----TRK 499
HPN+V+L+ C +L LV+E++ + T Y K+ P T K
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL---------TTYLDKVPEPGVPTETIK 113
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
+ + RGL +LH ++VHRD+K N+L+ K++DFGLA++Y T
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTS 168
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607
+ T+ Y APE ++ + D++S G + E+ + +R + D
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 403 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 457
+GEG FG V + ++ DG + A+K L S +R+F E+ ++ HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 458 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 506
G C L + EY L SR + F K+ L + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
G+ YL E + +HRD+ NVL+ ++L +KI+DFGL++ E R+ + +
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP--VRW 184
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
MA E T+K+DV+SFGV+ EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 402 KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 457
++G G FG V KG+ +A+K L +++ + R E + E ++ +P +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G C E L+LV E L++ + GK E + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKYLEGKN- 115
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 575
VHRD+ NVLL AKISDFGL+K D ++ R AG + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+S++DV+S+G+ E S
Sbjct: 174 KFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPN 452
NF K+GEG +G VYK G V+A+K+ L +++ + EI ++ HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+VKL N+L LV+E++ + L + + D + P K + +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKTHISTRIAGTIGYMAP 569
H +++HRD+K N+L++ + K++DFGLA+ + TH T+ Y AP
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 169
Query: 570 EYAM-RGYLTSKADVYSFGVVTLEIVSGKS 598
E + Y ++ D++S G + E+V+ ++
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGCC 460
+G G GSV K + GTV+A K + ++ R + + E+ ++ + P +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ N + + E+M L R I+ K +++ KI + + GL YL+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVHRI-- 125
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
+HRDIK SN+L++ K+ DFG++ E I+ GT YM+PE G T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 581 ADVYSFGVVTLEIVSGK 597
+DV+S G+ +E+ GK
Sbjct: 183 SDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 19/234 (8%)
Query: 402 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
++G G FG V G ++ G + VK+L S S Q +F+ E + QH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G C E LLV E+ L + + D T +++ IA GL +LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGTIGYMAPEYA--MR 574
+H D+ N LL DL KI D+GL+ Y+ED ++ + ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 575 GYL-----TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 623
G L T +++V+S GV E+ + YR D L Y ++E+++
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFE-LGSQPYRHLSDEQVL---TYTVREQQL 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 454
F+ VG G +G VYKG + G + A+K + + E EI M+ H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 455 KLYGCCVEGN------QLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIAR 507
YG ++ N QL LV E+ ++ I K+T+ LK +W IC I R
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY--ICREILR 122
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
GL++LH+ K++HRDIK NVLL ++ K+ DFG++ + +T I GT +M
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 178
Query: 568 APEYAM-----RGYLTSKADVYSFGVVTLEIVSG 596
APE K+D++S G+ +E+ G
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 403 VGEGGFGSVYKGILS----DGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
+G G FG + +G L +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G GN +++V EYM N L F + E +L + G+A G+ YL E
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAG--QLMGMLPGLASGMKYLSE--- 125
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYAMRG 575
+ VH+ + VL++ DL KIS F +L E+ I T ++G + + APE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+ +S +DV+SFG+V E++S
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 403 VGEGGFGSVY--KGILSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKL 456
+ +G FGSVY K + G A+K L + N M+ + P + KL
Sbjct: 4 ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK------LDWPTRKKICIGIARGLA 510
Y + L LV EY+ G D +K DW K+ + G+
Sbjct: 63 YYSFQSKDYLYLVMEYLN---------GGDCASLIKTLGGLPEDWA--KQYIAEVVLGVE 111
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
LH+ I+HRDIK N+L+D+ + K++DFGL++ E+K + GT Y+APE
Sbjct: 112 DLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPE 163
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604
+ +D +S G V E + G Y P
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFG-----YPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 402 KVGEGGFGSVYKGIL-SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
++G G FG V+ G L +D T +AVK + +F+ E ++ HPN+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK-----KICIGIARGLAYLHE 514
C + + +V E ++ G D L+ + P K ++ A G+ YL
Sbjct: 62 CTQKQPIYIVMELVQ---------GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT----IGYMAPE 570
I HRD+ N L+ + KISDFG+++ EED + ST G + + APE
Sbjct: 113 KHCI---HRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPE 166
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVS 595
G +S++DV+SFG++ E S
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 50/223 (22%)
Query: 395 NNFDPANKVGEGGFGSV----YKG--------ILSDGTVIAVKQLSSKSRQGNREFVNEI 442
++F+ +G G FG V +KG ILS ++ +KQ+ +NE
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE--------HVLNEK 52
Query: 443 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 502
++ + +HP LV LYG + + L LV EY + G + L+ +
Sbjct: 53 RILQSIRHPFLVNLYGSFQDDSNLYLVMEY---------VPGGELFSHLR----KSGRFP 99
Query: 503 IGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554
+AR L YLH + IV+RD+K N+LLD D KI+DFG AK + +T
Sbjct: 100 EPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRT 155
Query: 555 HISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSG 596
+ + GT Y+APE + +GY D ++ G++ E+++G
Sbjct: 156 YT---LCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF--VNEIGMI---SAQQH 450
++P ++G G +G+VYK G +A+K + ++ + V E+ ++ A H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 451 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 505
PN+V+L C ++ LV+E++ + R K L + T K +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE--TIKDLMRQF 117
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-TRIAGTI 564
RGL +LH + IVHRD+K N+L+ K++DFGLA++Y ++ T + T+
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTL 171
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y APE ++ + D++S G + E+ K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
+G G G+VYK L ++AVK + + + ++ ++E+ ++ P ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
N++ + E+M L ++ K E+ L +I + + +GL YL +KI
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKI 116
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
+HRD+K SN+L++ K+ DFG++ + I+ GT YMAPE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 581 ADVYSFGVVTLEIVSGK 597
+DV+S G+ +E+ G+
Sbjct: 174 SDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 397 FDPANKVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQH 450
++ +G G +G VYK DG A+K+ Q ++ EI ++ +H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 451 PNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
N+V L +E + L+++Y +++ F + + R+ + K + I G
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNG 120
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAK--------LYEEDKTHI 556
+ YLH + ++HRD+K +N+L+ + KI D GLA+ L + D +
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 557 STRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVS 595
TI Y APE + R Y T D+++ G + E+++
Sbjct: 178 ------TIWYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 406 GGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVKLYGCCV 461
G +G V+ S G + A+K + + + E ++S Q P +VKLY
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 462 EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519
L LV EY+ L+ + G LD + I L YLH
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGS-------LDEDVARIYIAEIVLALEYLH---SNG 113
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHIST-----RIAGTIGYMAPEYA 572
I+HRD+K N+L+D + + K++DFGL+K L RI GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 573 MRGYLTSKADVYSFGVVTLEIVSG 596
+ + D +S G + E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPN 452
++ K+GEG +G+V+K ++A+K +L + EI ++ +H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 453 LVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
+V+LY +L LV+EY +K S +D K + +G
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDS---------CNGDIDPEIVKSFMFQLLKG 111
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
LA+ H ++HRD+K N+L++K+ K++DFGLA+ + S + T+ Y
Sbjct: 112 LAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRP 167
Query: 569 PEYAM--RGYLTSKADVYSFGVVTLEIVSG 596
P+ + Y TS D++S G + E+ +
Sbjct: 168 PDVLFGAKLYSTS-IDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 403 VGEGGFGSVY------KGILSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVK 455
+GEG FG V +G + G +AVK L +S + + EI ++ H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 456 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
G C E GN + L+ E++ + L + + LK + K + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK----QQLKYAVQICKGMDYL- 125
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEY 571
SR + VHRD+ NVL++ + KI DFGL K E DK + + + + + + APE
Sbjct: 126 -GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLL 612
++ +DV+SFGV E+++ ++ P F+ ++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 403 VGEGGFGSVYKGILS-DGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 457
+GEG FG V K + DG + A+K++ S+ +R+F E+ ++ HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 458 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 506
G C L L EY + L SR + F L +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
RG+ YL + + +HRD+ N+L+ ++ AKI+DFGL++ E R+ + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
MA E T+ +DV+S+GV+ EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV 454
F+ VG G +G VYKG + G + A+K + + E EI M+ H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 455 KLYGCCVE------GNQLLLVYEYMKNNCLSRAIFGKDTEYR-LKLDWPTRKKICIGIAR 507
YG ++ +QL LV E+ ++ + K+T+ LK DW IC I R
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAY--ICREILR 132
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
GLA+LH K++HRDIK NVLL ++ K+ DFG++ + +T I GT +M
Sbjct: 133 GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 188
Query: 568 APEY--------AMRGYLTSKADVYSFGVVTLEIVSG 596
APE A Y ++D++S G+ +E+ G
Sbjct: 189 APEVIACDENPDATYDY---RSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 36/212 (16%)
Query: 402 KVGEGGFGSVYKGIL----SDGTVIAVKQ-----LSSKSRQGNREFVNEIGMISAQQHPN 452
K+GEG FG K IL DG +K+ +S K R+ +R+ E+ ++S +HPN
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN 60
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-------FGKDTEYRLKLDWPTRKKICIGI 505
+V+ E L +V +Y + L + I F +D LDW +IC+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ----ILDWFV--QICLA- 113
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
L ++H+ KI+HRDIK+ N+ L KD K+ DFG+A++ T I GT
Sbjct: 114 ---LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPY 166
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y++PE +K+D+++ G V E+ + K
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 403 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHPNLVKLYG 458
+G GGFG V + S A+K + + G +E + +E ++ HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ + ++ EY L + +D R D T + + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL--RD---RGLFDEYTARFYIACVVLAFEYLHNRG-- 113
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAM-RGY 576
I++RD+K N+LLD + K+ DFG AK L KT GT Y+APE + +GY
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169
Query: 577 LTSKADVYSFGVVTLEIVSGK 597
S D +S G++ E+++G+
Sbjct: 170 DFS-VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 21/158 (13%)
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 502
A +HP L +L+ C ++L V EY+ G D + + + D P +
Sbjct: 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVN---------GGDLMFHIQRSGRFDEPRARFYA 102
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRI 560
I GL +LHE I++RD+K NVLLD + + KI+DFG+ K + T +
Sbjct: 103 AEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STF 156
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
GT Y+APE D ++ GV+ E+++G+S
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
K+GEG +G VYKG G ++A+K+ L S+ + EI ++ QHPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIGIARGLAYLHEDSR 517
++ ++L L++E++ + L + + D+ + + +D K I +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCH---S 119
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI----AGTIGYMAPEYAM 573
+++HRD+K N+L+D K++DFGLA+ + I R+ T+ Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHEVVTLWYRAPEVLL 174
Query: 574 RGYLTS-KADVYSFGVVTLEIVSGK 597
S D++S G + E+ + K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 31/208 (14%)
Query: 403 VGEGGFGSVY---KGILSD-GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 455
+G+G FG V+ K D G + A+K L + K R R E +++ HP +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 456 L-YGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
L Y EG +L L+ ++++ LS+ + + + + L +A L
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALD 112
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMA 568
+LH + I++RD+K N+LLD++ + K++DFGL+K + E K + GT+ YMA
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMA 166
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSG 596
PE R T AD +SFGV+ E+++G
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 445
L + T+ ++ +G+G +G VYK DG++ AVK L + E E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNIL 72
Query: 446 -SAQQHPNLVKLYGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
S HPN+VK YG + G QL LV E ++ + G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-LICGQRLDEAMIS 131
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
I G GL +LH + +I+HRD+K +N+LL + K+ DFG++ + +T
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 560 IAGTIGYMAPEYAM--RGYLTS---KADVYSFGVVTLEIVSG 596
+ GT +MAPE + Y S + DV+S G+ +E+ G
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 41/235 (17%)
Query: 394 TNNFDPANK-VGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGM--- 444
+ + +GEG +G V K G ++A+K++ S +R+ V G+
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 445 -------ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
++ +H N++ L VEG+ + LV + M ++ L + + + +++L
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV-----DRKIRLTESQ 120
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-------- 549
K I + I GL LH+ +HRD+ +N+ ++ KI+DFGLA+ Y
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 550 -EEDKTHISTRIAG----TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
+D+T T+ Y APE M Y D++S G + E+++GK
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 402 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKL 456
++G G FG+V KG+ +AVK L + + E + E ++ +P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI---CIGIARGLAYLH 513
G C E +LV E A G ++ K T K I ++ G+ YL
Sbjct: 62 IGIC-EAESWMLVMEL--------AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 571
E + VHRD+ NVLL AKISDFGL+K D+ + + G + + APE
Sbjct: 113 ETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 572 AMRGYLTSKADVYSFGVVTLEIVS 595
+SK+DV+SFGV+ E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 397 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 451
++ K+GEG +G VYK D IA+K+ L + + EI ++ QH
Sbjct: 4 YEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 452 NLVKLYGCCVEGNQLLLVYEY----MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
N+V+L +L LV+EY +K + S F K+ RL K I R
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN--PRLI------KTYLYQILR 113
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGY 566
G+AY H +++HRD+K N+L+D+ NA K++DFGLA+ + + + T+ Y
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWY 169
Query: 567 MAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
APE + R Y T D++S G + E+V+ K
Sbjct: 170 RAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 72/233 (30%), Positives = 110/233 (47%), Gaps = 26/233 (11%)
Query: 403 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 452
+GEG FG V GI D +AVK L + + + V+E+ M+ +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEY---RLKLDWPTRKKI--- 501
++ L G C + L ++ EY L +R G D + +L + T K +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 502 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 560
+ARG+ YL K +HRD+ NVL+ +D KI+DFGLA+ ++ D +T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 612
+ +MAPE T ++DV+SFGV+ EI + G S P E+ LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
N + G G+ YKG + V + + + ++G + QHPN+VKL G C
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL---QHPNIVKLIGLC 752
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
L++EY++ LS + L W R+KI IGIA+ L +LH +
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 521 VHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 579
V ++ +++D KD L L D + Y+APE +T
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR--LSLPGLLCTDTKCFISS-----AYVAPETRETKDITE 857
Query: 580 KADVYSFGVVTLEIVSGKSNTN 601
K+D+Y FG++ +E+++GKS +
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 402 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
VGEG +G V K + G ++A+K+ S + + + EI M+ +H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+L LV+E++ + L D E Y LD +K I RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE---EDKT-HISTRIAGTIGYMAPEYAM 573
I+HRDIK N+L+ + K+ DFG A+ E T +++TR Y APE +
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLV 173
Query: 574 RGYLTSKA-DVYSFGVVTLEIVSG 596
+A D+++ G + E+++G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 403 VGEGGFGSVYKG-ILSDGTVI--AVKQLSS-KSRQGNREFVNEIGMISA-QQHPNLVKLY 457
+GEG FG V K I DG + A+K++ S+ +R+F E+ ++ HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 458 GCCVEGNQLLLVYEYMKNNCL------SRAI-----FGKDTEYRLKLDWPTRKKICIGIA 506
G C L L EY + L SR + F L +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
RG+ YL S+ + +HRD+ N+L+ ++ AKI+DFGL++ E R+ + +
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 189
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
MA E T+ +DV+S+GV+ EIVS
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 71/233 (30%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 403 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 452
+GEG FG V GI D +AVK L + + + + V+E+ M+ +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKL----DWPTRKKICIG- 504
++ L G C + L ++ EY L RA EY + D K +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 505 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 560
+ARG+ YL K +HRD+ NVL+ ++ KI+DFGLA+ + D +T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 612
+ +MAPE T ++DV+SFGV+ EI + G S P E+ LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 26/233 (11%)
Query: 403 VGEGGFGSVYK----GILSDG----TVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 452
+GEG FG V G+ + T +AVK L S + + + + ++E+ M+ +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG----- 504
++ L G C + L ++ EY L RA EY +++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 505 ---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 560
+ARG+ YL + K +HRD+ NVL+ +D KI+DFGLA+ ++ D +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 612
+ +MAPE T ++DV+SFGV+ EI + G S P E+ LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 403 VGEGGFGSV----YKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 456
VG+G +G V ++ +DG +K+L+ + SR+ + E ++S +HPN+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-A 63
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI--CIGIARGLAYLHE 514
Y EG LL Y M C ++ K E + KL P + + + IA L YLHE
Sbjct: 64 YRESWEGEDGLL-YIVM-GFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHE 120
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
I+HRD+KT NV L + K+ D G+A++ E ST I GT YM+PE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 575 GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
K+DV++ G E+ + K N + VY
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 455
+G G FG VY +D G +AVKQ+ S++ ++E VN EI ++ +H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 456 LYGCCV--EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 511
YGC E +L + EYM + + +G TE ++ I +G++Y
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-------NVTRRYTRQILQGVSY 121
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMA 568
LH + IVHRDIK +N+L D N K+ DFG +K + T I + + GT +M+
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMS 177
Query: 569 PEY-AMRGYLTSKADVYSFGVVTLEIVSGK 597
PE + GY KADV+S +E+++ K
Sbjct: 178 PEVISGEGY-GRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLS--SKSRQGNREFVN---EIGMISAQQHPNLVKL 456
+G+G FG VY D G +A KQ+ +S + ++E EI ++ QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 457 YGCCVE-GNQLLLVY-EYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
YGC + + L ++ EYM + + +G TE +K I G++YL
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-------SVTRKYTRQILEGMSYL 122
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMAP 569
H + IVHRDIK +N+L D N K+ DFG +K + T I + + GT +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSP 178
Query: 570 EY-AMRGYLTSKADVYSFGVVTLEIVSGK 597
E + GY KADV+S G +E+++ K
Sbjct: 179 EVISGEGY-GRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 403 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGK-DTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+ L LV M L I+ + + +IC G L LH++
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 577
+IV+RD+K N+LLD + +ISD GLA E +T I R+ GT+GYMAPE
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 178
Query: 578 TSKADVYSFGVVTLEIVSGKS 598
T D ++ G + E+++G+S
Sbjct: 179 TFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 455
+G GGFG VY +D G + A+K L K +QG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK----LDWPTRKKICIGIARGLAY 511
+ ++L + + M G D Y L + I GL +
Sbjct: 62 MSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
+H +V+RD+K +N+LLD+ + +ISD GLA + + K H S GT GYMAPE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 572 AMRGY-LTSKADVYSFGVVTLEIVSGKS 598
+G S AD +S G + +++ G S
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA----QQHPNLVK 455
K+GEG F V K G A+K + K + E VN + I A HPN+++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 456 LYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
L + +L LV+E M N L I G+ + L K + + L ++H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMN-LYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL------YEEDKTHISTRIAGTIGYM 567
R I HRDIK N+L+ D+ K++DFG + Y E +ISTR Y
Sbjct: 118 ---RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTE---YISTR-----WYR 165
Query: 568 APEYAMR-GYLTSKADVYSFGVVTLEIVS 595
APE + GY K D+++ G V EI+S
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 39/95 (41%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
I RGL YLH I+HRDIK N+L++ + KI DFGLA++ E D++ T+ T
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 565 GYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
Y APE M R Y TS D++S G + E++ +
Sbjct: 169 YYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 26/205 (12%)
Query: 402 KVGEGGFGSVYKGILSDGTVIA------VKQLSSKSRQGNREFVN---EIGMISAQQHPN 452
++G+G FG+VY ++ D +A +K++ N E V E ++S HP
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPA 63
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IGIARGL 509
+VK + +E + ++ EY C R + K E + + ++C I + G+
Sbjct: 64 IVKFHASFLERDAFCIITEY----CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
Y+H+ +I+HRD+K N+ L +L KI DFG+++L ++T GT YM+P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSP 174
Query: 570 E-YAMRGYLTSKADVYSFGVVTLEI 593
E +GY SK+D++S G + E+
Sbjct: 175 EALKHQGY-DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNE---IGMISAQQHPNLVK 455
+G GGFG VY +D G + A+K L K +QG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAY 511
+ ++L + + M G D Y L +K I GL +
Sbjct: 62 MTYAFHTPDKLCFILDLMN---------GGDLHYHLSQHGVFSEKEMRFYATEIILGLEH 112
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
+H +R +V+RD+K +N+LLD+ + +ISD GLA + + K H S GT GYMAPE
Sbjct: 113 MH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 572 AMRGY-LTSKADVYSFGVVTLEIVSGKS 598
+G S AD +S G + +++ G S
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 52/206 (25%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 395 NNFDPANKVGEGGFGSVYK-GILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 452
++F+ +++G G G V K G ++A K + + + R + + E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+V YG ++ + E+M L + + E + ++ K+ I + RGLAYL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL----KEAK-RIPEEILGKVSIAVLRGLAYL 119
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEY 571
E + +I+HRD+K SN+L++ K+ DFG++ +L + ++ GT YM+PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPER 173
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGK 597
+ + ++D++S G+ +E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 26/233 (11%)
Query: 403 VGEGGFGSVYK----GILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISA-QQHPN 452
+GEG FG V + GI +AVK L + + + ++E+ ++ +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRL------KLDWPTRKKI 501
++ L G C + L ++ EY L +R G D + + +L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 502 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRI 560
+ARG+ YL +SR + +HRD+ NVL+ +D KI+DFGLA+ +++ D ++
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLL 612
+ +MAPE T ++DV+SFG++ EI + G S P E+ LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 403 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+GGFG V + + G + A K+L K + G + + E ++ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
L LV M L I+ L+ I G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEMERVIHYSAQITCGILHLHS---M 114
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
IV+RD+K NVLLD N ++SD GLA ++ KT T+ AGT GYMAPE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172
Query: 579 SKADVYSFGVVTLEIVSGKS 598
D ++ G E+V+G++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 54/223 (24%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 452
+G G +G V + G +A+K++ + F + EI ++ +H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 453 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC---IG 504
++ L + N + +V E M+ + L + I + L T I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVI-----KSPQPL---TDDHIQYFLYQ 111
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS------- 557
I RGL YLH ++HRD+K SN+L++ + + KI DFGLA+ + D+
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 558 TRIAGTIGYMAPE--YAMRGYLTSKA-DVYSFGVVTLEIVSGK 597
TR Y APE + Y +KA D++S G + E+++ K
Sbjct: 169 TRW-----YRAPELLLSSSRY--TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 405 EGGFGSVYKGILSDGT--------VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 456
EG FG ++ GIL D V VK +S+ Q + E ++ H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73
Query: 457 YGCCVEGNQLLLV-YEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIG--IARGLA 510
C+E + V Y YM L +F + E T++ + + IA G++
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGTIGYMAP 569
YLH + ++H+DI N ++D++L KI+D L++ L+ D + + +MA
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVS 595
E + +S +DV+SFGV+ E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 43/215 (20%)
Query: 404 GEGGFGSV----YKG--------ILSDGTVIA---VKQLSSKSRQGNREFVNEIGMISAQ 448
G G FG V YK L G +IA V+ L + R + E +++
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKR------IFET--ANSE 59
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 507
+HP LV L+ C + + V EY G D + D + + A
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAA---------GGDLMMHIHTDVFSEPRAVFYAACV 110
Query: 508 --GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGT 563
GL YLHE+ KIV+RD+K N+LLD + KI+DFGL K + D+T ST GT
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGT 164
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
++APE T D + GV+ E++ G+S
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 403 VGEGGFGSVYKGIL--SDGTV--IAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKL 456
+G+G FGSV + L DG+ +AVK L + S EF+ E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 457 YGCCVEGNQL------LLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
G + +++ +MK+ L + + + E L T + I IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMA 568
YL S +HRD+ N +L++++ ++DFGL+ K+Y D + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVS 595
E T+ +DV++FGV EI++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 33/209 (15%)
Query: 402 KVGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
K+GEG +G V+K + G ++A+K+ S + + EI M+ +HPNLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+L LV+EY + L+ + + KKI + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL-----EKNPRGVPEHLIKKIIWQTLQAVNFCHKH--- 119
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL---YEEDKT-HISTRIAGTIGYMAPE---- 570
+HRD+K N+L+ K K+ DFG A++ +D T +++TR Y APE
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVG 174
Query: 571 ---YAMRGYLTSKADVYSFGVVTLEIVSG 596
Y DV++ G V E+++G
Sbjct: 175 DTQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
+F+ ++G G +G VYK ++ G + A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+G + ++L + E+ L ++ + +R+ + +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIGYMA 568
++ HRDIK +N+LL + + K++DFG++ I+ IA GT +MA
Sbjct: 125 KGKM---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMA 174
Query: 569 PEYAM---RGYLTSKADVYSFGVVTLEI 593
PE A +G D+++ G+ +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
++++ +VG G +G VYK L G + AVK + + EI M+ +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRA--IFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
V +G + +L + EY L + G +E ++ +C +GLAY
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-------VCRETLQGLAY 121
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA------GTIG 565
LH ++ HRDIK +N+LL + + K++DFG+A I+ IA GT
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPY 171
Query: 566 YMAPEYAM---RGYLTSKADVYSFGVVTLEI 593
+MAPE A G D+++ G+ +E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 396 NFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--- 448
NF+ +G G +G V+ G G + A+K L K+ + E Q
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-KATIVQKAKTAEHTRTERQVLE 59
Query: 449 ---QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG- 504
+ P LV L+ +L L+ +Y+ L ++ ++ ++ I
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTES---EVRVYIAE 113
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
I L +LH+ + I++RDIK N+LLD + + ++DFGL+K + ++ + GTI
Sbjct: 114 IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 565 GYMAPEYAMRGYLT-SKA-DVYSFGVVTLEIVSGKS 598
YMAPE G KA D +S GV+T E+++G S
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 54/158 (34%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 444 MISAQQHPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKK 500
+ A +HP L L+ C + + L V EY+ L I G+ E R R
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR------ARFY 101
Query: 501 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 560
I GL +LH+ I++RD+K NVLLDKD + KI+DFG+ K + ST
Sbjct: 102 AA-EIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-F 156
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
GT Y+APE D +SFGV+ E++ G+S
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS------AQQHPNLVK 455
+G+G FG V+ L A+K L + + E M+ A +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLAY 511
LY L V EY+ G D + + K D P I GL +
Sbjct: 61 LYCTFQTKENLFFVMEYLN---------GGDLMFHIQSCHKFDLPRATFYAAEIICGLQF 111
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAP 569
LH IV+RD+K N+LLD D + KI+DFG+ K + + KT GT Y+AP
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAP 165
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
E + + D +SFGV+ E++ G+S
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 54/210 (25%), Positives = 106/210 (50%), Gaps = 22/210 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 452
++F+ +++G G G V+K G ++A K + + + R + + E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 453 LVKLYGCCVEGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
+V YG ++ + E+M + L +A G+ E L K+ I + +G
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG-------KVSIAVIKG 115
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYM 567
L YL E + KI+HRD+K SN+L++ K+ DFG++ +L + ++ GT YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 169
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+PE + + ++D++S G+ +E+ G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 35/87 (40%), Positives = 55/87 (63%), Gaps = 2/87 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+LK + L + GEIP IG +T L ++DL +NNLTG IP++ L +++L NKL
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 62 TGPVPKYIFNSNK--NVDISLNNFTWE 86
+GP+P IF+ K ++D+S N+ + E
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGE 299
|
Length = 968 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 403 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+GGFG V + + G + A K+L+ K R+G + E I A+ H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVE-KRILAKVHSRFIVSLA 59
Query: 459 CCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+ L LV M L I+ D E P I GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 577
+I++RD+K NVLLD D N +ISD GLA ++ ++ + AGT G+MAPE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 578 TSKADVYSFGVVTLEIVSGK 597
D ++ GV E+++ +
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 402 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGC 459
K+GEG + +VYKGI +G ++A+K +S K+ +G + E ++ +H N+V L+
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
L V+EYM + I G Y ++L + RGLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIH---G 121
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY- 576
I+HRD+K N+L+ K++DFGLA+ S+ + T+ Y P+ +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180
Query: 577 LTSKADVYSFGVVTLEIVSGK 597
+S D++ G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN------REFVNEIGMISA 447
+ ++ K+GEG +G VYK + G ++A+K+ + + RE ++ + M+S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE-ISLLQMLS- 58
Query: 448 QQHPNLVKLYGCCVEGN-------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 500
+ +V+L VE L LV+EY+ ++ L + + L T K
Sbjct: 59 -ESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKS 114
Query: 501 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTR 559
+ +G+A+ H + ++HRD+K N+L+DK KI+D GL + + +
Sbjct: 115 FMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 560 IAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSG 596
I T+ Y APE + + ++ D++S G + E+
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE--F----VNEIGMISA 447
+ ++ K+G+G FG V+K ++A+K K N + F + EI ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEKEGFPITALREIKILQL 67
Query: 448 QQHPNLVKLYGCC----VEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
+H N+V L C N LV+E+ +++ L+ + K+ ++ L K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTL----SEIK 122
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY----EEDKTH 555
K+ + GL Y+H R KI+HRD+K +N+L+ KD K++DFGLA+ +
Sbjct: 123 KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 556 ISTRIAGTIGYMAPE 570
+ R+ T+ Y PE
Sbjct: 180 YTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQL--SSKSRQGNREFVN----EIGMISAQQHPNLVK 455
+G+G FG VY +D G +AVKQ+ +S + ++E VN EI ++ H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 456 LYGCCVEGNQ--LLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 511
YGC + + L + E+M + + +G TE +K I G++Y
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-------NVTRKYTRQILEGVSY 121
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE---DKTHISTRIAGTIGYMA 568
LH + IVHRDIK +N+L D N K+ DFG +K + T + + + GT +M+
Sbjct: 122 LHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMS 177
Query: 569 PEY-AMRGYLTSKADVYSFGVVTLEIVSGK 597
PE + GY KAD++S G +E+++ K
Sbjct: 178 PEVISGEGY-GRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 402 KVGEGGFGSVYKGILSDGTVIA---VKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
++G G FG V + T +A VK+L ++ S + EF+ + QHPN+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G CVE LLV+EY + L ++ ++ +R +++ IA G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDL-KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAMR-- 574
+H D+ N L DL K+ D+G+ Y+ED + ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 575 -GYLTSK----ADVYSFGVVTLEI 593
G +T++ ++V++ GV E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 39/221 (17%)
Query: 397 FDPANKVGEGGFGSVYKGILSD---GTVIAVK------QLSSKSRQGNRE--FVNEIGMI 445
++ K+G+G +G V+K I D V+A+K + ++ +++ RE F+ E+G
Sbjct: 9 YEILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-- 64
Query: 446 SAQQHPNLVKLYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK-IC 502
HPN+VKL N + LV+EYM+ + L I R + K+ I
Sbjct: 65 ---DHPNIVKLLNVIKAENDKDIYLVFEYMETD-LHAVI-------RANILEDVHKRYIM 113
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK----LYEEDKTHIST 558
+ + L Y+H S ++HRD+K SN+LL+ D K++DFGLA+ L E + + T
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 559 RIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
T Y APE Y T D++S G + E++ GK
Sbjct: 171 DYVATRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 401 NKVGEGGFGSVYKGILS-DGTVIAVKQL-----SSKSRQGNREFVNEIGMISAQQHPNLV 454
+++G+G +GSVYK + G +A+K++ SK Q + E+ ++ P +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ----IIMELDILHKAVSPYIV 62
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
YG + + EYM L + G + ++I + +GL +L E
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGI--PEDVLRRITYAVVKGLKFLKE 120
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEY- 571
+ I+HRD+K +NVL++ + K+ DFG++ KT+I G YMAPE
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERI 173
Query: 572 -----AMRGYLTSKADVYSFGVVTLEIVSGK 597
T ++DV+S G+ LE+ G+
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 397 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGN-RE-----FVNEIGMISAQQ 449
FD ++GEG +G VYK D G ++A+K K R N +E + EI ++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK----KVRLDNEKEGFPITAIREIKILRQLN 64
Query: 450 HPNLVKLYGCCVEGNQLL----------LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
H N+V L + L LV+EYM ++ + G + K
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIK 119
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
+ GL Y H+ + +HRDIK SN+LL+ K++DFGLA+LY +++ T
Sbjct: 120 SFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 560 IAGTIGYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 597
T+ Y PE + A DV+S G + E+ + K
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 397 FDPANKVGEGGFGSVYKGILSD---GTVIAVKQ----LSSKSRQGNREFVNEIGMISAQQ 449
+D +G+GG G VY D +A+K+ LS R F+ E + +
Sbjct: 4 YDIIRLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLI 60
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDT---EYRLKLDWPTRKKICI 503
HP +V +Y C +G+ + Y++ L ++++ K++ E K I
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---LYEEDKTHIST-- 558
I + Y+H S+ ++HRD+K N+LL I D+G A L EED I
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 559 ------------RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+I GT YMAPE + + D+Y+ GV+ ++++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 403 VGEGGFGSVYKGILSDGT----VIAVKQLSS----KSRQGNREFVNEIGMISAQQHPNLV 454
+G+GG+G V++ G + A+K L ++++ E ++ A +HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICI---GIA 506
L G +L L+ EY+ L IF +DT C I+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA-------------CFYLSEIS 110
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 564
L +LH+ I++RD+K N+LLD + K++DFGL K ++E TH GTI
Sbjct: 111 LALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTI 164
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596
YMAPE MR D +S G + ++++G
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 401 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 457
K+GEG + +V+KG L++ ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 512
L LV+EY+ KD + + + K I RGLAY
Sbjct: 71 DIVHTDKSLTLVFEYLD----------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H R K++HRD+K N+L+++ K++DFGLA+ S + T+ Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVL 176
Query: 573 M-RGYLTSKADVYSFGVVTLEIVSGK 597
+ +++ D++ G + E+ SG+
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 21/228 (9%)
Query: 403 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREF---VNEIGMIS-AQQHPNLVKLY 457
+G+G FG V L G + AVK L + + + E ++S A+ HP L +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
C ++L V E++ L I + + D + I L +LH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPEYAMRGY 576
I++RD+K NVLLD + + K++DFG+ K E +T GT Y+APE
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 577 LTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIY 624
D ++ GV+ E++ G + NED ++ +L +E +Y
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDLF----EAILNDEVVY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 30/162 (18%)
Query: 444 MISAQQHPNLVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDW 495
++ HP+++++ V G +V Y Y+ SR +
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKR--SRPL------------- 154
Query: 496 PTRKKICI--GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553
P + + I I GL YLH +I+HRD+KT N+ ++ I D G A+
Sbjct: 155 PIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211
Query: 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +AGT+ APE R SKAD++S G+V E+++
Sbjct: 212 AFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 23/233 (9%)
Query: 403 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHE 514
+ L LV M L I+ E R +I G L LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEILCG----LEDLHR 120
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYMAPEYAM 573
++ V+RD+K N+LLD + +ISD GLA K+ E + I R+ GT+GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLN 174
Query: 574 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS 626
T D + G + E++ G+S R + +D VL+ EE+Y +
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-RRVLETEEVYSA 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 65/204 (31%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 403 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIF----GKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+ L LV M L I+ E R +I G L LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF---YAAEITCG----LEDLH- 119
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
R +IV+RD+K N+LLD + +ISD GLA E +T I R+ GT+GYMAPE
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKN 175
Query: 575 GYLTSKADVYSFGVVTLEIVSGKS 598
T D + G + E++ GKS
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-12
Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 23/193 (11%)
Query: 419 GTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLL-VYEYMK 474
G +A+K L + + + + F E + + HPN+V L LL V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-- 532
L R + D L ++ + + LA H IVHRD+K N+++
Sbjct: 63 GRTL-REVLAADG----ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 533 -DKDLNAKISDFGLAKL----YEEDKTHIS--TRIAGTIGYMAPEYAMRGY-LTSKADVY 584
+AK+ DFG+ L + D ++ T + GT Y APE +RG +T +D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 585 SFGVVTLEIVSGK 597
++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 396 NFDPANKVGEGGFGSVY---------------KGILSDGTVIAVKQLSSKSRQGNREFVN 440
NF+ +G G +G V+ +L T++ + + +R R+ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT-ERQVLE 59
Query: 441 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTR 498
I +Q P LV L+ +L L+ +Y+ L + ++ E ++
Sbjct: 60 HI-----RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ------ 108
Query: 499 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
I G I L +LH ++ I++RDIK N+LLD + + ++DFGL+K + ED+ +
Sbjct: 109 --IYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163
Query: 558 TRIAGTIGYMAPEYAMRGYL--TSKADVYSFGVVTLEIVSGKS 598
GTI YMAP+ G D +S GV+ E+++G S
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLY---- 457
+G G G V+ + SD +AVK++ Q + + EI +I H N+VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 458 ----------GCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIA 506
G E N + +V EYM+ + L+ + G +E +L +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARL-------FMYQLL 124
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
RGL Y+H + ++HRD+K +NV ++ +DL KI DFGLA++ + +H G +
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 566 --YMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
Y +P + Y T D+++ G + E+++GK
Sbjct: 182 KWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 401 NKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLY 457
+K+GEG + +VYKG L+D ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-----LDWPTRKKICIGIARGLAYL 512
L LV+EY+ KD + L ++ K + RGL Y
Sbjct: 71 DIIHTEKSLTLVFEYLD----------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H R K++HRD+K N+L+++ K++DFGLA+ S + T+ Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDIL 176
Query: 573 MRGY-LTSKADVYSFGVVTLEIVSGK 597
+ +++ D++ G + E+ +G+
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 403 VGEGGFGSVYK-GILSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYG 458
+G+GGFG V + + G + A K+L K R+G +NE ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIF-----GKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ L LV M L I+ G D + + ++C G L
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCG-------LE 116
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
+ R +IV+RD+K N+LLD + +ISD GLA E +T + R+ GT+GYMAPE
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVIN 174
Query: 574 RGYLTSKADVYSFGVVTLEIVSGKS 598
T D + G + E++ G+S
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 55/249 (22%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 450
+F +VG+GG+G V+ D G ++A+K++ R + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
LVKL + L L EY+ G D +R L G+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVP---------GGD--FRTLL-----------NNLGV- 97
Query: 511 YLHEDS----------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554
L ED + +HRD+K N L+D + K++DFGL+K
Sbjct: 98 -LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIV 152
Query: 555 HISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK---SNTNYRPNEDFVY 610
+ + G+ YMAPE +GY D +S G + E + G S + PNE +
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWEN 209
Query: 611 LLDWAYVLQ 619
L W LQ
Sbjct: 210 LKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 54/223 (24%)
Query: 404 GEGGFGSVYKGIL---SDG--------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
G+G F ++YKG+L SD + +K L S R + F ++S H +
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKH 62
Query: 453 LVKLYGCCV-EGNQLLLVYEYMK----NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
LVKLYG CV + N +V EY+K + L R ++L + +A
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-------LNAKISDFG-----LAKLYEEDKTH 555
L YL + K+VH ++ N+L+ + K+SD G L++ ++
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER-- 167
Query: 556 ISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSG 596
I ++APE G LT AD +SFG LEI S
Sbjct: 168 --------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 403 VGEGGFGS--VYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
VGEG FG + + + SD A+K++ SS + + +R+ E +++ +HPN+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAY 511
L +V EY L + I K +L L W ++C+G+ +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQWFV--QMCLGVQ----H 115
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
+HE +++HRDIK+ N+ L ++ K+ DFG A+L + T + GT Y+ PE
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEI 171
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGK 597
+K+D++S G + E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 403 VGEGGFGSVYKGILS--DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 459
+G+G +G V+K +L+ +G+ AVK L + E E ++ A HPN+VK YG
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 460 -----CVEGNQLLLVYEYMKNNCLSRAIFG--KDTEYRLKLDWPTRKKICIGIARGLAYL 512
G+QL LV E ++ + G K E +++ P I GL +L
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE---RMEEPIIAYILHEALMGLQHL 140
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 571
H + K +HRD+K +N+LL + K+ DFG++ + +T + GT +MAPE
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196
Query: 572 AMRGYLTS----KADVYSFGVVTLEIVSG 596
A L S + DV+S G+ +E+ G
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 16/150 (10%)
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARG 508
P +V YG ++ + E+M L + + G+ E L KI I + RG
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-------KISIAVLRG 111
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGYM 567
L YL E + KI+HRD+K SN+L++ K+ DFG++ +L + ++ GT YM
Sbjct: 112 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 165
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+PE + T ++D++S G+ +E+ G+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 51/205 (24%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPN 452
++++ K+GEG + +VYKG +G ++A+K + + +G + E ++ +H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+V L+ L LV+EY+ + ++ L K + RGL+Y+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYM-----DKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H+ I+HRD+K N+L+ K++DFGLA+ + +H + T+ Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYRPPDVL 175
Query: 573 MRGYLTSKA-DVYSFGVVTLEIVSG 596
+ S D++ G + +E++ G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPN 452
+ + +GEG +G V G +A+K++S Q R + EI ++ +H N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64
Query: 453 LVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---G 504
++ + N + +V E M+ + L + I + I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSN---------DHIQYFLYQ 114
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY--EEDKTHISTRIAG 562
I RGL Y+H + ++HRD+K SN+LL+ + + KI DFGLA++ E D T T
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 563 TIGYMAPEYAM--RGYLTSKA-DVYSFGVVTLEIVSGK 597
T Y APE + +GY +KA D++S G + E++S +
Sbjct: 172 TRWYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 46/216 (21%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPN 452
VG G +G V + G +A+K+LS R F + E+ ++ H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 453 LVKLYGCCVEG------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI--- 503
++ L + LV M G D +K + I
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLM----------GADLNNIVKCQKLSDDHIQFLVY 125
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAG 562
I RGL Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T +++TR
Sbjct: 126 QILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR--- 179
Query: 563 TIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 597
Y APE + + D++S G + E+++GK
Sbjct: 180 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNRE----FVNEIGMISAQQHPNLVKLY 457
+G+G FG V L G AVK L + + V + + A ++P L LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
L V E++ L I K + + + +C GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHSKG- 116
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYAMRG 575
I++RD+K NV+LD+D + KI+DFG+ K ++ +++ ++ GT Y+APE
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIAPEILQGL 171
Query: 576 YLTSKADVYSFGVVTLEIVSGKS 598
T D +SFGV+ E++ G+S
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGNRE----FVNEIGMISA 447
+FD + VG G FG V ++ + G + A+K + KS +E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICI 503
P + +L + + L LV EY + L+R Y + D +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR--------YEDQFDEDMAQFYLA 109
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
+ + +H+ + VHRDIK NVL+D+ + K++DFG A +K S GT
Sbjct: 110 ELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
Query: 564 IGYMAPEY--AMRGYLTSKADV----YSFGVVTLEIVSGKS 598
Y+APE M G V +S GV+ E++ G+S
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 394 TNNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQ 449
TN + VG G FG V + L+ G +A+K++ + + E+ ++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 450 HPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
H N++ L + + + V E + + L R + + E + + I RG
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTD-LHRLLTSRPLEKQFI------QYFLYQILRG 120
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYM 567
L Y+H +VHRD+K SN+L++++ + KI DFGLA++ + T ++STR Y
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172
Query: 568 APEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
APE + + Y + D++S G + E++ GK
Sbjct: 173 APEIMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEI 442
T+ ++ N P VG G +GSV G +AVK+LS +S + E+
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67
Query: 443 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI- 501
++ +H N++ L L E + L + G D +K T +
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123
Query: 502 --CIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HIST 558
I RGL Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T +++T
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180
Query: 559 RIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKS 598
R Y APE + + D++S G + E+++G++
Sbjct: 181 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIG------MISAQQHPNLVK 455
+G+G FG VY+ D + A+K LS K +E + IG + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG-IARGLAYLHE 514
L + L LV +YM + E R D R K I + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYM---SGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLHK 114
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYA 572
IV+RD+K N+LLD + + DFGL+K L + T+ GT Y+APE
Sbjct: 115 YD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPEVL 168
Query: 573 M--RGYLTSKADVYSFGVVTLEIVSGKS 598
+ +GY T D +S GV+ E+ G S
Sbjct: 169 LDEKGY-TKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREF----VNEIGMISAQQ 449
N F+ VGEG +G V K + ++A+K+ K + N E + E+ M+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT---RKKICIGIA 506
N+V+L +L LV+EY++ N L L + P +K+ I
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML-----------ELLEEMPNGVPPEKVRSYIY 107
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
+ + +H + IVHRDIK N+L+ + K+ DFG A+ E T T Y
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+PE + D++S G + E+ G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 63/238 (26%), Positives = 92/238 (38%), Gaps = 48/238 (20%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS---RQGNREFVNEIGMISA 447
++F+ +G G FG V+ L G V A+K L KS ++ V I A
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILA 56
Query: 448 QQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
P +VKLY + L LV EYM L + KD + R IA
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEET-AR----FYIA 108
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT------------ 554
+ L ++ +HRDIK N+L+D D + K++DFGL K + K
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 555 ----------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596
+ GT Y+APE + D +S GV+ E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPN 452
+ P +G G +G V I G +A+K++ + + E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 453 LVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI---GI 505
++ + + + +V + M+++ L I L + I +
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQP---LTEE-----HIRYFLYQL 116
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY----EEDKTHISTRIA 561
RGL Y+H ++HRD+K SN+L+++D +I DFG+A+ E K ++ +A
Sbjct: 117 LRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 562 GTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIV 594
T Y APE ++ Y T+ D++S G + E++
Sbjct: 174 -TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
A HP LV L+ C ++L V EY+ L +F + +L + I +A
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA 108
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 564
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T + GT
Sbjct: 109 --LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTP 160
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
Y+APE D ++ GV+ E+++G+S
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYG 458
+K+GEG + +V+KG ++A+K++ + +G + E+ ++ +H N+V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLD-------WPTRKKICIGIARGLAY 511
L LV+EY+ D++ + LD K + RGL+Y
Sbjct: 71 IIHTERCLTLVFEYL------------DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
H+ KI+HRD+K N+L+++ K++DFGLA+ S + T+ Y P+
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 174
Query: 572 AMRGY-LTSKADVYSFGVVTLEIVSGK 597
+ ++ D++ G + E+ +G+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIG 504
A +P LV L+ C ++L LV EY+ L +F + +L + +ICI
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIA 108
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAG 562
L +LHE I++RD+K NVLLD D + K++D+G+ K L D T + G
Sbjct: 109 ----LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCG 158
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
T Y+APE D ++ GV+ E+++G+S
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 42/109 (38%), Positives = 64/109 (58%), Gaps = 10/109 (9%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 561
+ARG+ +L SR K +HRD+ N+LL ++ KI DFGLA+ +D ++ S R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSN-TNYRPNEDF 608
+ +MAPE T+++DV+SFGV+ EI S G S + NE+F
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 21/153 (13%)
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 506
P L +L+ C ++L V EY+ G D Y + K P IA
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPHAVFYAAEIA 111
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 564
GL +LH I++RD+K NV+LD + + KI+DFG+ K ++ T GT
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTP 165
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y+APE D ++FGV+ E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKL--- 456
VG G +GSV I G +A+K+LS +S + E+ ++ QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 457 YGCCVEGNQL---LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ V G++ LV YM+ + L + + +E K+ + + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD-LQKIMGHPLSED--KVQYLVYQMLC-----GLKYIH 134
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYA 572
I+HRD+K N+ +++D KI DFGLA+ + + T ++ TR Y APE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 186
Query: 573 MRG-YLTSKADVYSFGVVTLEIVSGKS 598
+ + D++S G + E+++GK+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKS--RQGNREFV-NEIGMISAQQHP 451
+ + VG G FG V+ A+K ++ R + V NE ++ HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKICIGIA 506
+++L+ + L ++ EY+ L + F T + + +C
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL-----FYASEIVC---- 112
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
L YLH IV+RD+K N+LLDK+ + K++DFG AK D+T + GT Y
Sbjct: 113 -ALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEY 164
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+APE D ++ G++ E++ G
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 403 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLVKLY 457
+G+G FG V SDG+ AVK L K+ +E + + ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+L V +Y+ L F E P + +A + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFL--EPRARFYAAEVASAIGYLHS--- 114
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 577
+ I++RD+K N+LLD + ++DFGL K E + ST GT Y+APE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPY 173
Query: 578 TSKADVYSFGVVTLEIVSG 596
D + G V E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 403 VGEGGFGSV---YKGILSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLY 457
VG G +GSV Y L +AVK+LS +S R E+ ++ +H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 458 GCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
N++ LV M + + K ++ ++ + + RGL Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKY 133
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPE 570
+H I+HRD+K SNV +++D +I DFGLA+ +++ T +++TR Y APE
Sbjct: 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE 185
Query: 571 YAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 609
+ + D++S G + E++ GK+ P D++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA---LFPGNDYI 222
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 446 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 505
+A HP LV L+ C ++L V E++ L +F + +L + I +
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISL 107
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
A L +LHE I++RD+K NVLLD + + K++D+G+ K ST GT
Sbjct: 108 A--LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPN 161
Query: 566 YMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKS 598
Y+APE +RG Y S D ++ GV+ E+++G+S
Sbjct: 162 YIAPE-ILRGEDYGFS-VDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 4/95 (4%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
I L +LH ++ IV+RDIK N+LLD + + ++DFGL+K + ++ + GTI
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 565 GYMAPEYAMRGYLTSKA-DVYSFGVVTLEIVSGKS 598
YMAPE KA D +S G++ E+++G S
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
+E+ ++A H +VK + ++LLL+ EY L++ I + RLK P ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168
Query: 500 K----ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT- 554
+ I L +H SR K++HRD+K++N+ L K+ DFG +K Y + +
Sbjct: 169 YEVGLLFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604
+++ GT Y+APE R + KAD++S GV+ E++ T +RP
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL-----TLHRP 270
|
Length = 478 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 506
P L +L+ C ++L V EY+ G D Y + K P I+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVN---------GGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 565
GL +LH I++RD+K NV+LD + + KI+DFG+ K E ++TR GT
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPD 166
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y+APE D +++GV+ E+++G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--------QHPNL 453
+G+G FG V +DG AVK L K+ E I A+ +HP L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNVLLKNVKHPFL 58
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
V L+ ++L V +Y+ L F E P + IA L YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFP--EPRARFYAAEIASALGYLH 113
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
+ I++RD+K N+LLD + ++DFGL K E ST GT Y+APE
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLR 169
Query: 574 RGYLTSKADVYSFGVVTLEIVSG 596
+ D + G V E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 25/224 (11%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 439
+R+++ ++D +G G FG V +K S V A+K LS R + F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
E +++ P +V+L+ + L +V EYM L + + Y + W K
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--K 145
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 558
+ L +H + ++HRD+K N+LLDK + K++DFG K+ E T
Sbjct: 146 FYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 559 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 598
+ GT Y++PE GY + D +S GV E++ G +
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 561
+ARG+ +L SR K +HRD+ N+LL ++ KI DFGLA+ +D ++ R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +MAPE T+++DV+SFGV+ EI S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIG-MISAQQHPNLVKLY 457
+G+G FG V DG AVK L K +R+ + + E ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+L V +++ L F E P + IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRER--SFPEPRARFYAAEIASALGYLHS--- 114
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMAPEYAMRG 575
I IV+RD+K N+LLD + ++DFGL K + + D T T GT Y+APE +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 576 YLTSKADVYSFGVVTLEIVSG 596
+ D + G V E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLY 457
+G+G FG V ++ AVK L K+ ++ + ++E ++ +HP LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW----PTRKKICIGIARGLAYLH 513
++L V +Y I G + Y L+ + P + IA L YLH
Sbjct: 63 FSFQTADKLYFVLDY---------INGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
+ IV+RD+K N+LLD + ++DFGL K E ST GT Y+APE
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLH 169
Query: 574 RGYLTSKADVYSFGVVTLEIVSG 596
+ D + G V E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 19/156 (12%)
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 502
A +HP L L+ C ++L V EY+ G D +++ K D P +
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVN---------GGDLMFQIQRSRKFDEPRSRFYA 102
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIA 561
+ L +LH R +++RD+K N+LLD + + K++DFG+ K T +T
Sbjct: 103 AEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFC 157
Query: 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
GT Y+APE D ++ GV+ E+++G+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 44/212 (20%), Positives = 81/212 (38%), Gaps = 39/212 (18%)
Query: 406 GGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463
+ K T++AVK+ L S S++ + EI QHPN++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 464 NQLLLVYEYM---------KNNCLSRAIFG-KDTEYRLKLDWPTRKKICIGIARGLAYLH 513
++L +V M K + G + I + L Y+H
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF---------ILKDVLNALDYIH 118
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDK----THISTR-IAGTIGYM 567
+HR +K S++LL D +S + + + K H + + ++
Sbjct: 119 ---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 568 APEY---AMRGYLTSKADVYSFGVVTLEIVSG 596
+PE ++GY K+D+YS G+ E+ +G
Sbjct: 176 SPEVLQQNLQGY-NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTV--IAVKQLSS----KSRQGNREFV 439
R+ K +F+ +G G FG V + +A+K+ K +Q + F
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF- 79
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
+E +++ HP V LYG + + L LV E++ + F T R +P
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFV----IGGEFF---TFLRRNKRFPNDV 132
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
C A+ + + IV+RD+K N+LLDKD K++DFG AK+ + +T+
Sbjct: 133 G-CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT--- 187
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596
+ GT Y+APE + AD ++ G+ EI+ G
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
I L YLH +V+RD+K N++LDKD + KI+DFGL K D + T GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y+APE D + GVV E++ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 2/90 (2%)
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYM 567
LA H S+ ++HRDIK++N+LL + K+ DFG +K+Y + + GT Y+
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
APE R + KAD++S GV+ E+++ K
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 403 VGEGGFGSVYKGI---LSDG-----TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
+G+G F ++KGI + D T + +K L R + F M+S H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY-LH 513
YG CV G++ ++V EY+K L + K + + + W + +A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWK------LEVAKQLAWALH 114
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE--DKTHISTRI-AGTIGYMAPE 570
+ H ++ NVLL ++ + K + KL + T + I I ++ PE
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 571 YAMRG-YLTSKADVYSFGVVTLEIVSG 596
L+ AD +SFG EI SG
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIA 506
P L +L+ C ++L V EY+ G D Y++ + P IA
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYQIQQVGRFKEPHAVFYAAEIA 111
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIG 565
GL +LH I++RD+K NV+LD + + KI+DFG+ K E ++T+ GT
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPD 166
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
Y+APE D ++FGV+ E+++G++
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 403 VGEGGFGSVYKGIL----SDGTVIAVKQLSSKSRQGNREF---VNEIGMISAQQHPNLVK 455
+G+G FG V IL + G A+K L + E + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 456 LYGCCVEGNQLLLVYEYMKNN----CLSRA-IFGKDTEYRLKLDWPTRKKICIGIARGLA 510
L ++L V EY+ LSR +F +D + I L
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE----------IVSALD 109
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH KIV+RD+K N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPE 165
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
D + GVV E++ G+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
I L YLH + +V+RD+K N++LDKD + KI+DFGL K +D + T GT
Sbjct: 104 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTP 160
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y+APE D + GVV E++ G+
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
I L YLH +V+RDIK N++LDKD + KI+DFGL K D + T GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y+APE D + GVV E++ G+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 24/155 (15%)
Query: 402 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNLVKLYGC 459
K+GEG + +VYKG G ++A+K++ + +G + E ++ +H N+V L+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW------PTRKKICI-GIARGLAYL 512
L LV+EY+ DT+ + +D ++ + + RGLAY
Sbjct: 72 IHTKKTLTLVFEYL------------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547
H + +++HRD+K N+L+ + K++DFGLA+
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
+ RGL Y+H + ++HRD+K SN+LL+ + + KI DFGLA+ +K T T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTR 172
Query: 565 GYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 597
Y APE + Y T+ DV+S G + E++ K
Sbjct: 173 WYRAPELLLNCSEY-TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG-T 563
+A+G+ +L SR K +HRD+ N+LL ++ KI DFGLA+ +D ++ A
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +MAPE T ++DV+SFGV+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 396 NFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKS--RQGNREFVN-EIGMISAQ 448
+F+ +G G FG V +KG G A+K L + + + V E ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT--RKKICIGIA 506
HP +V + + N++ + E++ + +F T R +P K +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFV----VGGELF---THLRKAGRFPNDVAKFYHAELV 128
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
YLH I++RD+K N+LLD + K++DFG AK D+T + GT Y
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEY 181
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596
+APE D ++ GV+ E ++G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 11/99 (11%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT----HISTRI 560
I GL Y+H + ++HRD+K N+L++ D KI DFGLA+ + E+ ++ +
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 561 AGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
A T Y APE + + Y T DV+S G + E++ K
Sbjct: 171 A-TRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 561
+A+G+ +L + I HRD+ NVLL AKI DFGLA+ D ++ + R+
Sbjct: 221 VAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKS 598
+ +MAPE T ++DV+S+G++ EI S GKS
Sbjct: 278 --VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 503 IGIARGL----AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIS 557
I I R L AYLH I+HRD+KT N+ LD+ NA + DFG A KL T
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 558 TRIAGTIGYMAPEY-AMRGYLTSKADVYSFGVVTLEI 593
+GT+ +PE A+ Y K D++S G+V E+
Sbjct: 245 YGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 43/177 (24%), Positives = 60/177 (33%), Gaps = 47/177 (26%)
Query: 170 WAFSSTGKFM--DDDT-------DLDNYIRTNTSTLSKVSAVD--------LELYRTARV 212
F + + DD + + ST V + +TA
Sbjct: 175 LNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVT 234
Query: 213 -----SPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDF 267
+PL+ T+ L N Y V LHFAEI SL R FDIYI K V D
Sbjct: 235 PTNASAPLNFTW-DLVDPNFEYYVYLHFAEI--------QSLETREFDIYINGKTVYGDV 285
Query: 268 NIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLR----GTYGPLISAI 320
+ G + +FP + +G G I L T PL++A+
Sbjct: 286 SP-KYLGTDTGALYLDFP-----------VNVSGGGLLNISLVPTSGSTLPPLLNAL 330
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 24/64 (37%), Positives = 38/64 (59%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
L+++ L+ I G IP +G +T L+ +DLS+N+ G IP + +L + L GN L+
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 63 GPVP 66
G VP
Sbjct: 504 GRVP 507
|
Length = 623 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYG 458
KVG G +G VYK DG K+ + K +G + EI ++ +HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 459 CCVEGN--QLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ + ++ L+++Y +++ F K + ++L K + I G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 514 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYM 567
+ ++HRD+K +N+L+ + KI+D G A+L+ ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 568 APEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 597
APE + +KA D+++ G + E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
VG G +G+V + G +A+K+L +S + E+ ++ +H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 460 CV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ LV +M + K +E R++ + + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIH 135
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYA 572
I+HRD+K N+ +++D KI DFGLA+ + + T ++ TR Y APE
Sbjct: 136 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVI 187
Query: 573 MRG-YLTSKADVYSFGVVTLEIVSGK 597
+ + T D++S G + E+++GK
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 28/176 (15%)
Query: 432 RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 491
R G E ++ A HP++++L G + Y K CL + D L
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKG----------TFTYNKFTCLILPRYKTDLYCYL 173
Query: 492 KLDWPTRKKICI--------GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543
++ I I + R + YLHE+ I+HRDIK N+ ++ + + DF
Sbjct: 174 A----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDF 226
Query: 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599
G A + + AGTI APE R D++S G+V E+ + +
Sbjct: 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 29/190 (15%)
Query: 419 GTVIAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQL 466
G +AVK+LS + +++ RE V ++ H N++ L E +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDV 101
Query: 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 526
LV E M N L + I ++LD + + G+ +LH I+HRD+K
Sbjct: 102 YLVMELMDAN-LCQVI-------HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 527 TSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSF 586
SN+++ D KI DFGLA+ + T T Y APE + D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 208
Query: 587 GVVTLEIVSG 596
G + E+V G
Sbjct: 209 GCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 36/237 (15%)
Query: 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 449
N P +G + Y +L +A+K+LS + +++ RE V ++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 74
Query: 450 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 503
H N++ L E + LV E M N L + I +++LD +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI-------QMELDHERMSYLLY 126
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
+ G+ +LH I+HRD+K SN+++ D KI DFGLA+ + + T T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 181
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQE 620
Y APE + D++S G + E+V K P D Y+ W V+++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRD--YIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 43/121 (35%), Positives = 60/121 (49%), Gaps = 19/121 (15%)
Query: 206 LYRTARVS----PLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEK 261
LY++A VS P L+Y N NY+V LHFAEI D++ + GKR+FD+ I
Sbjct: 254 LYQSALVSTDTQP-DLSYTMDVDPNRNYSVWLHFAEI----DNSITAEGKRVFDVLINGD 308
Query: 262 LVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGRGTTGIPLRGTYGPLISAIS 321
KD +I +G +V N V+ TL I L P +GT+ +I+AI
Sbjct: 309 TAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQ---------PKKGTHA-IINAIE 358
Query: 322 V 322
V
Sbjct: 359 V 359
|
Length = 623 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 402 KVGEGGFGSVYKGILSDG---TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
KVG G +G VYK DG A+KQ+ + EI ++ +HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 459 CCVE--GNQLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ ++ L+++Y +++ F K + ++L K + I G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 514 EDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYM 567
+ ++HRD+K +N+L+ + KI+D G A+L+ ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 568 APEYAMRGYLTSKA-DVYSFGVVTLEIVSGK 597
APE + +KA D+++ G + E+++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQ-------LSSKSRQGNREFVNEIGMISAQQHPNLV 454
+G+G +G V I G +A+K+ +S +R + EI ++ +HP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-----ILREIKLLRLLRHPDIV 62
Query: 455 KLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
++ + E + +V+E M+++ L + I D L + + R L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESD-LHQVIKAND-----DLTPEHHQFFLYQLLRAL 116
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYM 567
Y+H + + HRD+K N+L + D KI DFGLA++ D T T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 568 APEY--AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 613
APE + T D++S G + E+++GK P ++ V+ LD
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP---LFPGKNVVHQLD 218
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT- 563
+ARG+ +L + VHRD+ NVLL + KI DFGLA+ D ++S G+
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK---GST 299
Query: 564 ---IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +MAPE T+ +DV+S+G++ EI S
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 56/247 (22%)
Query: 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS------SKSRQGNREFVNEIGMISAQQ 449
N P +G + Y IL +A+K+LS + +++ RE V ++
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVN 81
Query: 450 HPNLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 503
H N++ L E + +V E M N L + I +++LD +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHERMSYLLY 133
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
+ G+ +LH I+HRD+K SN+++ D KI DFGLA R AGT
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGT 178
Query: 564 IGYMAPEYAMRGY----------LTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLD 613
M P R Y D++S G + E++ G P D ++
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV---LFPGTD--HIDQ 233
Query: 614 WAYVLQE 620
W V+++
Sbjct: 234 WNKVIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 439
+ +++ +FD +G G FG V +K S V A+K LS R + F
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFW 91
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
E +++ +V+L+ + L +V EYM L + + Y + W
Sbjct: 92 EERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFY 147
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 558
+ +A L +H + +HRD+K N+LLDK + K++DFG K+ T
Sbjct: 148 TAEVVLA--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202
Query: 559 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSG 596
+ GT Y++PE GY + D +S GV E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-08
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 440 NEIGMISAQQHPNLVKLYGCC-VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPT 497
NEI + H N++K+ E N ++ +Y + L ++ + +++ + L T
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFDWKDRPLLKQT 269
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
R I + + Y+H+ K++HRDIK N+ L+ D + DFG A +E+++
Sbjct: 270 RA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
GT+ +PE D++S G++ L+++S
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+LK L L ++ G+IP+ + ++T L+ + L+ N L G IP ++ ++YL N L
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 62 TGPVPKYI--FNSNKNVDISLNNFT 84
+G +P I S ++D+ NN T
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLT 249
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 27/66 (40%), Positives = 39/66 (59%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL+TL L+ ++ GEIP+ IG + LK +DL N L G IP + L F+ L N+L
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL 200
Query: 62 TGPVPK 67
G +P+
Sbjct: 201 VGQIPR 206
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 31/83 (37%), Positives = 50/83 (60%), Gaps = 2/83 (2%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
L L L++ + GEIPD + KL ++DLS N L+G IP +F ++ + + L+ N+L+
Sbjct: 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
Query: 63 GPVPKYIFN--SNKNVDISLNNF 83
G +PK + N S V+IS N+
Sbjct: 561 GEIPKNLGNVESLVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 26/86 (30%), Positives = 47/86 (54%), Gaps = 3/86 (3%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
L+ L L + G +PD G +L+N+DLS N +G +P L++ + L+ NKL+
Sbjct: 454 LQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLS 512
Query: 63 GPVPKYIFNSNK--NVDISLNNFTWE 86
G +P + + K ++D+S N + +
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQ 538
|
Length = 968 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 52/232 (22%)
Query: 391 KAATNNFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSKSRQGNREFVNEIGMISAQQ 449
++ ++ N +G G FG VY+ I D + +A+K++ + NRE + ++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 450 HPNLVKL----YGCCVEGNQ--LLL----------VYEYMK----NNCLSRAIFGKDTEY 489
H N++ L Y C + N+ + L V++YMK NN K Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 490 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKL 548
+L R LAY+H I HRD+K N+L+D + + K+ DFG AK
Sbjct: 178 QL--------------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 549 Y---EEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSG 596
+ ++I +R Y APE + T+ D++S G + E++ G
Sbjct: 221 LLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 25/224 (11%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSS---KSRQGNREFV 439
+R ++ +++ +G G FG V +K S V A+K LS R + F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
E +++ P +V+L+ + L +V EYM L + + Y + W +
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWA--R 145
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 558
+ L +H + +HRD+K N+LLDK + K++DFG K+ +E T
Sbjct: 146 FYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 559 RIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKS 598
+ GT Y++PE GY + D +S GV E++ G +
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/266 (22%), Positives = 107/266 (40%), Gaps = 55/266 (20%)
Query: 396 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL- 453
+F+ +G G FG V D G V A+K L R+ + ++G I A++ +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL----RKADMLEKEQVGHIRAERDILVE 57
Query: 454 ------VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
VK++ + L L+ E++ + + KDT T ++ IA
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL--------TEEETQFYIAE 109
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL---------------------- 545
+ + ++ +HRDIK N+LLD + K+SDFGL
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 546 ------------AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 593
A+ ++ ++ ++ GT Y+APE M+ D +S GV+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 594 VSGKSN-TNYRPNEDFVYLLDWAYVL 618
+ G + P E + +++W L
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 49/198 (24%)
Query: 422 IAVKQLS------SKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV------EGNQLLLV 469
+A+K+LS + +++ RE V ++ H N++ L E + LV
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 529
E M N L + I ++ LD + + G+ +LH I+HRD+K SN
Sbjct: 100 MELMDAN-LCQVI-------QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 148
Query: 530 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY----------LTS 579
+++ D KI DFGLA R AGT M P R Y
Sbjct: 149 IVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 196
Query: 580 KADVYSFGVVTLEIVSGK 597
D++S G + E++ G
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 55/246 (22%)
Query: 395 NNFDPANKVGEGGFGSV--YKGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQ 448
++F+ +G G FG V + + G + A+K+L KS +E V E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDT-GHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEA 58
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
+P +VKLY + N L L+ EY+ + + KDT T ++ IA
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF--------TEEETRFYIAET 110
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--------LYEEDKTHI---- 556
+ + ++ +HRDIK N+LLD + K+SDFGL + +H
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 557 ----------STRIA---------------GTIGYMAPEYAMR-GYLTSKADVYSFGVVT 590
S R A GT Y+APE ++ GY + D +S GV+
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIM 229
Query: 591 LEIVSG 596
E++ G
Sbjct: 230 YEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY--AM- 573
++ VHRDIK NVLLDK+ + +++DFG D T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 574 --RGYLTSKADVYSFGVVTLEIVSGKS 598
+G + D +S GV E++ G++
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 46/230 (20%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKS----RQGNREFVNEIGMISAQQ 449
+F+ + G +G+VY + A+K+++ ++ Q + FV E +++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59
Query: 450 HPNLVKLYGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR- 507
+P +V ++ C E + L +V EY++ G D LK + + +AR
Sbjct: 60 NPFVVSMF-CSFETKRHLCMVMEYVE---------GGDCATLLKNIGA----LPVDMARM 105
Query: 508 -------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---------LYE- 550
L YLH IVHRD+K N+L+ + K++DFGL+K LYE
Sbjct: 106 YFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 551 ----EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596
+ + + ++ GT Y+APE +R D ++ G++ E + G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 27/64 (42%), Positives = 35/64 (54%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
L+ L L + G+IP +G M LK I L +NNL+G IP L N + L N LT
Sbjct: 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 63 GPVP 66
GP+P
Sbjct: 250 GPIP 253
|
Length = 968 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARG 508
+PN +KLY +L+ +Y+K+ L F D + KL KKI +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----F--DLLKKEGKLSEAEVKKIIRQLVEA 121
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
L LH + I+H DIK NVL D+ + + D+GL K+ + GT+ Y
Sbjct: 122 LNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173
Query: 568 APE-YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+PE Y S D ++ GV+T E+++GK
Sbjct: 174 SPEKIKGHNYDVS-FDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 17/131 (12%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT- 563
+A G+ +L + VHRD+ NVL+ + KI DFGLA+ D +IS G+
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301
Query: 564 ---IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNYRPNEDFVYLLDWAYVL 618
+ +MAPE T+ +DV+SFG++ EI + G NE F + Y +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361
Query: 619 QE-----EEIY 624
+ +EIY
Sbjct: 362 AKPAHASDEIY 372
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 31/94 (32%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIA 561
+A+G+++L + I HRD+ N+LL KI DFGLA+ D ++ + R+
Sbjct: 223 VAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +MAPE T ++DV+S+G++ EI S
Sbjct: 280 --VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 403 VGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQHPNLVKLY 457
+ G FG VY G ++ + AVK + K+ N+ V+++ ++ + P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 458 GCCVEGNQLLLVYEYMKNNCLSR--AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
N + LV EY+ + I+G D K +A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLH-- 121
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548
R I+HRD+K N+L+ + + K++DFGL+K+
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 30/88 (34%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
L LH+ +++RD+K N+LLD + + DFGL KL +D +T GT Y+A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSG 596
PE + T D ++ GV+ E+++G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 55/263 (20%), Positives = 103/263 (39%), Gaps = 47/263 (17%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI----GMISAQQH 450
++F+ +G G FG V D I ++ K+ +E V I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
+VK++ + L L+ E++ + + KDT + + IA +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL--------SEEATQFYIAETVL 112
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL------------------------- 545
+ ++ +HRDIK N+LLD + K+SDFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 546 ---------AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596
A+ +++++ ++ GT Y+APE M+ D +S GV+ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 597 KSN-TNYRPNEDFVYLLDWAYVL 618
+ P E + +++W L
Sbjct: 233 YPPFCSETPQETYRKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 45/192 (23%), Positives = 88/192 (45%), Gaps = 22/192 (11%)
Query: 419 GTVIAVK--QLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476
GT++ V+ L + + + + NE+ + +HPN++ + G+ L ++ +M
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536
+ + T + + I G RGL YLH++ I HR+IK S++L+ D
Sbjct: 85 SANSLL---KTYFPEGMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILISGDG 138
Query: 537 NAKISDFGLAKLYEEDKTHISTRIA--------GTIGYMAPEYA---MRGYLTSKADVYS 585
+S GL+ LY + ++ + +++PE + GY K+D+YS
Sbjct: 139 LVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYS 195
Query: 586 FGVVTLEIVSGK 597
G+ E+ +G+
Sbjct: 196 VGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
IA + +H ++ VHRDIK NVLLD + + +++DFG +D T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 565 GYMAPEY--AMR---GYLTSKADVYSFGVVTLEIVSGKS 598
Y++PE AM G + D +S GV E++ G++
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NLK+L L+ + + LK +DLS NNLT P F L + L+GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 34/124 (27%), Positives = 54/124 (43%), Gaps = 7/124 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL LIL + GEIP +G L+ + L N+ +G +P+ F KL F+ ++ N L
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
Query: 62 TGPV--PKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLR 119
G + K+ S + + ++ N F D GS L E+ RN+ P
Sbjct: 441 QGRINSRKWDMPSLQMLSLARNKFFGGLPDSF----GSKRL-ENLDLSRNQFSGAVPRKL 495
Query: 120 QNFP 123
+
Sbjct: 496 GSLS 499
|
Length = 968 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 19/196 (9%)
Query: 410 SVYKGILSDGTVI--AVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG----CCVEG 463
S+YKGI ++ VI K+ + NEI + N++K+YG +
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHR 523
+L L+ EY L + + L + T+ + I +GL L+ ++
Sbjct: 95 PRLSLILEYCTRGYLREVL-----DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYK 147
Query: 524 DIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY--LTSKA 581
++ + + L+ ++ KI GL K+ + + Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 582 DVYSFGVVTLEIVSGK 597
D+YS GVV EI +GK
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY--AM- 573
++ VHRDIK N+L+D + + +++DFG ED T S+ GT Y++PE AM
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 574 --RGYLTSKADVYSFGVVTLEIVSGKS 598
+G + D +S GV E++ G++
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 2/87 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L +L L+ + GEIP+ + + L+ + L NN TG IP L + + L NK
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 62 TGPVPKYIFNSNK--NVDISLNNFTWE 86
+G +PK + N +D+S NN T E
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGE 371
|
Length = 968 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAP 569
Y+H + I+HRDIKT NVL++ + + DFG A T IAGT+ AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 570 EYAMRGYLTSKADVYSFGVVTLE 592
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 42/123 (34%)
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYEEDKTH------------ 555
++ +HRDIK N+L+D+D + K++DFGL +K Y++ H
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 556 ---------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 594
++ + GT Y+APE +R T D +S GV+ E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 595 SGK 597
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 24/65 (36%), Positives = 36/65 (55%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL+ L L + + G IP I + KL ++DLS N+L+G IP +L ++L N
Sbjct: 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
Query: 62 TGPVP 66
TG +P
Sbjct: 321 TGKIP 325
|
Length = 968 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 58/242 (23%)
Query: 397 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHP 451
F +G+G G V+ L G + A+K L K R V E +++ HP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHP 61
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 507
L LY L LV +Y L R L K + +AR
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRL-----------LQRQPGKCLSEEVARFYAA 110
Query: 508 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK---------------- 547
L YLH + IV+RD+K N+LL + + +SDF L+K
Sbjct: 111 EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 548 ------------LYEEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIV 594
+ E+ + S GT Y+APE + G S D ++ G++ E++
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEML 226
Query: 595 SG 596
G
Sbjct: 227 YG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 49/241 (20%)
Query: 395 NNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH 450
N ++ K+G G FG V+ K A+ K R+ + + V E+ ++ +H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-QLVIEVNVMRELKH 71
Query: 451 PNLVKLYGCCV-EGNQ-LLLVYEYMKNNCLSRAI------FGKDTEYRLKLDWPTRKKIC 502
N+V+ + + NQ L ++ E+ LSR I FGK E+ + I
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV-------DIT 124
Query: 503 IGIARGLAYLHE----DSRIKIVHRDIKTSNVLLD-------------KDLN----AKIS 541
+ LAY H + +++HRD+K N+ L +LN AKI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 542 DFGLAK-LYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGK 597
DFGL+K + E H GT Y +PE + + Y K+D+++ G + E+ SGK
Sbjct: 185 DFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGK 240
Query: 598 S 598
+
Sbjct: 241 T 241
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 28/184 (15%)
Query: 422 IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 481
+ +K L R F ++S H +L ++G CV G++ ++V E++++ L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-- 104
Query: 482 IFGKDTEYRLKLDWPTRKKICIG--IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA- 538
+ + + R+ + W KI + +A L+YL + + +VH ++ N+LL + A
Sbjct: 105 VCLRKEKGRVPVAW----KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157
Query: 539 ------KISDFG--LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVV 589
K+SD G L E++ I ++APE G L++ AD +SFG
Sbjct: 158 GTSPFIKLSDPGVSFTALSREERVE-------RIPWIAPECVPGGNSLSTAADKWSFGTT 210
Query: 590 TLEI 593
LEI
Sbjct: 211 LLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 32/127 (25%), Positives = 52/127 (40%), Gaps = 46/127 (36%)
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYE------EDKTHISTR-- 559
++ +HRDIK N+L+D+D + K++DFGL +K Y+ +D S
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 560 -----------------------------IAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590
+ GT Y+APE +R T D +S GV+
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 591 LEIVSGK 597
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 47/150 (31%)
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGL---------AKLYEE---------------- 551
++ +HRDIK N+L+D D + K++DFGL +K Y++
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 552 ------------------DKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590
K H ++ + GT Y+APE +R T D +S GV+
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 591 LEIVSGKSN-TNYRPNEDFVYLLDWAYVLQ 619
E++ G+ P E + +++W L
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 25 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNV---DISLN 81
+++ +IDLS N++G I + +L + L+ N+L+GP+P IF ++ ++ ++S N
Sbjct: 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNN 128
Query: 82 NFTWESSDPIECPRGSVNLVESYSSPRNKL 111
NFT I PRGS+ +E+ N L
Sbjct: 129 NFT----GSI--PRGSIPNLETLDLSNNML 152
|
Length = 968 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 30/175 (17%)
Query: 395 NNFDPANKVGEGGFGSV-YKGILSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQ 449
+F +G+G FG V G + A+K L KS ++ + E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESD 59
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCL-----SRAIFGKDTEYRLKLDWPTRKKI--C 502
P +V LY + L L+ E++ L F +D TR + C
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------TRFYMAEC 110
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
+ + +H ++ +HRDIK N+L+D+ + K+SDFGL+ + K H S
Sbjct: 111 V---LAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH--KQHDS 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 403 VGEGGFGSVYKGIL-------SDGTV------IAVKQLSSKSRQGNREFVNEIGMISAQQ 449
+G G +Y GIL DG + +K L R + F M+
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
H ++V LYG CV + ++V E+++ L + K L P + K+ +A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASAL 118
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKD-LNA------KISDFG--LAKLYEEDKTHISTRI 560
+YL ED +VH ++ T N+LL ++ ++ K+SD G + L ++
Sbjct: 119 SYL-EDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE----- 170
Query: 561 AGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEI 593
I ++APE L+ AD +SFG EI
Sbjct: 171 --RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 20/65 (30%), Positives = 35/65 (53%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L L++ G +P +G +++L + LS N L+G IP K + L+ N+L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 62 TGPVP 66
+G +P
Sbjct: 536 SGQIP 540
|
Length = 968 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 27/150 (18%), Positives = 55/150 (36%), Gaps = 17/150 (11%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLV-KLYGC 459
+ G VY + + +K S+ + +RE E+ ++ + V K+
Sbjct: 5 LLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519
L+ E+++ G+ + + + I +A LA LH+ +
Sbjct: 62 GESDGWSYLLMEWIE---------GETLDEVSEEEKE---DIAEQLAELLAKLHQLPLLV 109
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549
+ H D+ N+L+D I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 68/223 (30%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSVYKGI---LSDGTVIAVKQLSSKS------------- 431
+ ++++F +K+G G FG ++G+ D V +L+++
Sbjct: 138 ANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD 197
Query: 432 RQGNR-EFVNEIGMISAQQHPNLVKLYGC------------CVE---------------- 462
RQG R +F+ + +V+ Y C C E
Sbjct: 198 RQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTK 257
Query: 463 GNQLLLVYEYMKNNCLSRAIFGKDTEY------------RLKLDWPTRKK---ICIGIAR 507
G+Q L V+++ + L A+ GK + ++ + P K+ + G+ R
Sbjct: 258 GSQWL-VWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR 316
Query: 508 ----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546
GL LH RI IVHRDIK N+L+ D KI DFG A
Sbjct: 317 QVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 22/75 (29%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 13 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLTGPVPKYIFN 71
I G+I I + ++ I+LS N L+G IP F + ++ L+ N TG +P+
Sbjct: 81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIP 140
Query: 72 SNKNVDISLNNFTWE 86
+ + +D+S N + E
Sbjct: 141 NLETLDLSNNMLSGE 155
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 16/52 (30%), Positives = 28/52 (53%)
Query: 15 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 66
G IP+ I + L++I+LS N++ G IP + + + L+ N G +P
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
|
Length = 623 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 4/58 (6%)
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555
++ + +A LH+ IVH D+ TSN ++ D I DFGL K + +
Sbjct: 430 NPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGKYSDLIEDK 483
|
Length = 535 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 18/95 (18%)
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
V+ + L+V EY++ L A+ R + + R + LH + I
Sbjct: 69 VDPDNGLIVMEYIEGELLKDAL------------EEARPDLLREVGRLVGKLH---KAGI 113
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKL--YEEDK 553
VH D+ TSN++L DFGL + EDK
Sbjct: 114 VHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 626 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.98 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.98 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.98 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.98 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.98 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.42 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.1 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.06 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.05 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.89 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.78 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.76 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.72 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.71 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.63 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.63 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.61 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.47 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.41 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.41 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.4 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.32 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.23 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.22 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.2 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.16 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.15 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.05 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.98 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.98 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=424.28 Aligned_cols=239 Identities=56% Similarity=0.916 Sum_probs=212.9
Q ss_pred CCCcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006906 381 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460 (626)
Q Consensus 381 ~~~~~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 460 (626)
....|++++++.||++|+..+.||+|+||.||+|.+++++.||||++.....+..++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988775433166799999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEE
Q 006906 461 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 539 (626)
Q Consensus 461 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 539 (626)
.+.+ +.+||||||++|+|.++|+..... .++|.+|.+||.++|+||+|||+.+.++||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999987532 789999999999999999999999988999999999999999999999
Q ss_pred EeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHh
Q 006906 540 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ 619 (626)
Q Consensus 540 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~~~~ 619 (626)
|+|||+|+..............||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.....++..+++|++...
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999997665411111111179999999999999999999999999999999999999998766566777999998887
Q ss_pred hcc
Q 006906 620 EEE 622 (626)
Q Consensus 620 ~~~ 622 (626)
+++
T Consensus 298 ~~~ 300 (361)
T KOG1187|consen 298 EEG 300 (361)
T ss_pred HCc
Confidence 765
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=475.01 Aligned_cols=503 Identities=23% Similarity=0.334 Sum_probs=301.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..|.++++|+.|+|++|+++|.+|..+ +++|+.|+++
T Consensus 381 ~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 460 (968)
T PLN00113 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460 (968)
T ss_pred CCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECc
Confidence 56778888888888888888888888888888888888888888888888888888888887777655 4577777777
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCCcccccCCcccccccccCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAKINTGHTKYEADMEARG 159 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~ 159 (626)
+|++.+.+|..+ ..++|+.|++++|++++.+|..+..++....+.+..+.+.....
T Consensus 461 ~n~~~~~~p~~~-----~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p------------------- 516 (968)
T PLN00113 461 RNKFFGGLPDSF-----GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP------------------- 516 (968)
T ss_pred CceeeeecCccc-----ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCC-------------------
Confidence 777777666543 34667777777777777777766666655544333322211100
Q ss_pred ccccccCCcceeEeeecccccCCCCCCCceEecceeecccccCcHHhhhhhcccCCcceeeeeccCCceeeEEEEEeeee
Q 006906 160 ASMFYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEII 239 (626)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~p~~l~~~~~~~~~g~~~~~l~~~~~~ 239 (626)
..+....+ ...+.-+.|.+.+.++.....+..+...+..-+...+..|..+... ..--.++++.+...
T Consensus 517 -~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-----~~L~~l~ls~N~l~ 584 (968)
T PLN00113 517 -DELSSCKK------LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV-----ESLVQVNISHNHLH 584 (968)
T ss_pred -hHHcCccC------CCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcC-----cccCEEeccCCcce
Confidence 00000000 0001111122222222222233333344444444444444333210 00001111111110
Q ss_pred ecCCccccccCceEEEEEecCccccccCCcccccCCcCcceeeeeeeeeecCeeEEEEEecCC-ceeeecCCCCCCCccc
Q 006906 240 FKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHLYWAGR-GTTGIPLRGTYGPLIS 318 (626)
Q Consensus 240 ~~~~~~~~~l~~~~~~i~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~ 318 (626)
. .+. ..+.... .... ...|+ +.|+.+..
T Consensus 585 ~-----------~~p------------------~~~~~~~--------~~~~------~~~~n~~lc~~~~~-------- 613 (968)
T PLN00113 585 G-----------SLP------------------STGAFLA--------INAS------AVAGNIDLCGGDTT-------- 613 (968)
T ss_pred e-----------eCC------------------Ccchhcc--------cChh------hhcCCccccCCccc--------
Confidence 0 000 0000000 0000 00111 12211100
Q ss_pred cccccCCCCCCccC--CCCcceeeeehhHHHHHHHHHHHHHHhhhcccCCCCcCc-ccccccCCC------CCCcccHHH
Q 006906 319 AISVKSNFKPPVVH--SKKNHVMIMAAIVGASVLLVLLILFIMRWKGCLGGKVSA-DKELRGLDL------QTGLYTLRQ 389 (626)
Q Consensus 319 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~ 389 (626)
. ..++... +......+++++++++++++++++++++++++++.+... +.+...... ....+++++
T Consensus 614 -----~-~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 687 (968)
T PLN00113 614 -----S-GLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND 687 (968)
T ss_pred -----c-CCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH
Confidence 0 0011111 111122233333333333333333333333322111111 100000000 011223333
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
+ ...|+..+.||+|+||.||+|+.. ++..||||++...... ..+|++.+++++|||||+++++|.+.+..++
T Consensus 688 ~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 688 I---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred H---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 3 456788899999999999999974 7899999998754322 2346888999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||....
T Consensus 761 v~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 761 IHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999999984 37899999999999999999997766679999999999999999988876 666543
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHh
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ 619 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~~~~ 619 (626)
.... ....+|..|+|||++....++.|+|||||||++|||+||+.|++.... ....+++|++..+
T Consensus 832 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~ 896 (968)
T PLN00113 832 LCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCY 896 (968)
T ss_pred cccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhc
Confidence 3221 123578999999999999999999999999999999999999964332 3456788887554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=363.63 Aligned_cols=200 Identities=31% Similarity=0.565 Sum_probs=181.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
-.+|...+.||+|+||+||+|+++ ++..||||.+.++ .....+.+..|+.+|+.++|||||++++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888889999999999999986 5899999999877 4555667889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC------CCEEEeecC
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFG 544 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------~~~kl~DfG 544 (626)
|||.+|+|.++++..+ .+++...+.++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999998764 6999999999999999999999998 9999999999999764 458999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+|+.+... ......+|++.|||||++..++|+.|+|+||+|+|+|+|++|+.||+..
T Consensus 161 fAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 161 FARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99988643 3446689999999999999999999999999999999999999999843
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=340.05 Aligned_cols=200 Identities=29% Similarity=0.447 Sum_probs=180.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.++||+|+||+||.++.+ +++.+|+|++.++. ....+...+|..+|.+++||.||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999976 58899999998763 33456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
+||+.||.|..+|..++ .+++..++-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999997663 6899999999999999999999998 999999999999999999999999999965
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... .....+||+.|||||++.+..|+..+|.||+||++|||++|.+||..
T Consensus 176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 43322 34457999999999999999999999999999999999999999964
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.33 Aligned_cols=200 Identities=38% Similarity=0.620 Sum_probs=175.1
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhc--HHHHHHHHHHHhcCCCCceeeEEEEEEeCC-eEEEEEEecCC
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEYMKN 475 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e~~~~ 475 (626)
..+.||+|+||+||+|.+++...||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 446699999999999999766669999998753222 569999999999999999999999999887 79999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcccccCCCc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~~~ 554 (626)
|+|.++++... ...+++..+.+++.|||+||+|||++.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999998741 2479999999999999999999999863 99999999999999997 99999999998765432
Q ss_pred ceecccccCCcccchhhhc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 2233367999999999999 6699999999999999999999999997653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=334.15 Aligned_cols=214 Identities=29% Similarity=0.487 Sum_probs=184.2
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 462 (626)
.++.|++. .+.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++.+.+||+||.+||.|.+
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45555554 488999999999999987 6889999999554 34556889999999999999999999999999
Q ss_pred CC-eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 463 GN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 463 ~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
+. ++.++||||++|+|++.+...+ .+++...-+|+.++++||.|||+.. +||||||||+|||++..|++|||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEec
Confidence 88 5999999999999999986552 5899999999999999999999742 59999999999999999999999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC--CCCChhhHHHHH
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNEDFVYLLDWA 615 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~--~~~~~~~l~~w~ 615 (626)
|||.+..+... .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+... ...+-..|..++
T Consensus 222 DFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I 294 (364)
T KOG0581|consen 222 DFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI 294 (364)
T ss_pred cccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH
Confidence 99999977654 445678999999999999999999999999999999999999999764 122334444444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=350.11 Aligned_cols=200 Identities=30% Similarity=0.516 Sum_probs=181.8
Q ss_pred cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+|+++.+.++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588889999999999999997 78999999999874 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|+|++++|.++++.. ..+++..++.++.||+.||.|||+++ |+|||||..|+|+++++++||+|||||....
T Consensus 98 ELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999998633 37999999999999999999999997 9999999999999999999999999999887
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+.. ...+.+||+.|+|||++.+...+-.+||||+||+||.|++|++||+-.
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 5433 334579999999999999999999999999999999999999999753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.58 Aligned_cols=205 Identities=28% Similarity=0.450 Sum_probs=177.3
Q ss_pred CCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEE-EEEeCCe-EEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYG-CCVEGNQ-LLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lV~ 470 (626)
+|.+.++||+|.||+|||+.. .+|..||.|.+.-. .....+....|+.+|++++|||||++++ .+.++++ +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 466779999999999999984 58999999988643 3445577889999999999999999999 4555555 89999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK--IVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||+..|+|..+++... .....+++..+++++.|+++||.++|+.- ++ |+||||||.||+++.+|.+||+|||+++.
T Consensus 100 E~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999986542 23357999999999999999999999842 33 99999999999999999999999999998
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+..... .....+|||.||+||.+....|+.|+||||+||++|||..-++||.+.
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 875433 445688999999999999999999999999999999999999999764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=340.57 Aligned_cols=200 Identities=34% Similarity=0.543 Sum_probs=177.4
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
..+.||+|-||.||.|.++....||+|.++.. ....+.|.+|+++|++++|+|||+++++|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 45889999999999999988889999999875 34567899999999999999999999999998899999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
.++|..... ..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++......
T Consensus 289 l~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 289 LDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred HHHhhhcCC---CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999986322 47899999999999999999999997 999999999999999999999999999965555444444
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 605 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~~ 605 (626)
...-...|.|||.+..+.++.|+|||||||+||||+| |+.|+..+..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 3334568999999999999999999999999999998 8999876644
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.70 Aligned_cols=204 Identities=30% Similarity=0.484 Sum_probs=179.4
Q ss_pred cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 469 (626)
+.|+..++||+|.||.||||+. .+|+.||+|++..+. ........+||.+|++++||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566778999999999999995 479999999987654 44456778999999999999999999998876 689999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
+|||+. +|..++.... ..|++.++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 197 FeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999986 6777765543 57999999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 606 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~ 606 (626)
........+..+-|..|.|||++.+. .|+..+|+||.||||.||++|++.+.+..+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv 326 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV 326 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence 87666556666789999999999875 6999999999999999999999999876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=326.11 Aligned_cols=202 Identities=28% Similarity=0.436 Sum_probs=174.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
.+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+... .......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 355778899999999999999865 799999999976421 122345799999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CCEEEee
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISD 542 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~D 542 (626)
.|+|||||+||.|.+.+-.+. .+.+..-+.++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999886653 5777888999999999999999998 9999999999999765 7799999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
||+|+... ....+.+.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.....
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 99999876 344567789999999999997653 34588999999999999999999976533
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=306.69 Aligned_cols=197 Identities=29% Similarity=0.434 Sum_probs=178.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|+..+.||.|+||+|..++.+ +|..+|+|++++..- ...+...+|..+|+.+.||.++++++.|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45778899999999999999976 688999999987632 23445678999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|.|..+++..+ .++++.++-+|.||+.|++|||+.+ |++|||||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999998764 6999999999999999999999998 9999999999999999999999999999775
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .-..+||+.|+|||++....+...+|.|||||++|||+.|.+||...
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 43 34578999999999999999999999999999999999999999643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.69 Aligned_cols=197 Identities=30% Similarity=0.486 Sum_probs=180.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+.. ....+.+.+|+++++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999976 68899999997753 3445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+.+ +|.++|.... .++++.++.|+.++..||.|||+.. |+|||+||.|||++..+.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9987 9999996653 6999999999999999999999996 99999999999999999999999999998765
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
...+.+.+.||+-|||||+..+..|+..+|.||+|||+|||++|++||-
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 4456677889999999999999999999999999999999999999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=310.02 Aligned_cols=208 Identities=26% Similarity=0.397 Sum_probs=178.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
+.|+...++|+|+||.|||++.+ +|+.||||++..... ...+-.++|+++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778899999999999999987 599999999976532 334567899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||+..-|+++-+.. ..++.+.+.+++.|++.|+.|+|+++ +|||||||+|||++.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99876665543222 35889999999999999999999997 99999999999999999999999999998874
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhH
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 611 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l 611 (626)
. ....+.++.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+..+-|...+
T Consensus 154 p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~ 213 (396)
T KOG0593|consen 154 P-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL 213 (396)
T ss_pred C-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH
Confidence 2 334456778999999999987 6899999999999999999999999987665544433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.48 Aligned_cols=219 Identities=24% Similarity=0.388 Sum_probs=188.3
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
..++|+.+..||+|+||.||.++-+ +|+.+|+|++++.. ....+....|-.+|...++++||+++..|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3478999999999999999999966 69999999998864 3445667889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||++||++..+|...+ .|++..++.++.+++.|++-+|+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 219 iMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 999999999999997764 6999999999999999999999998 99999999999999999999999999864
Q ss_pred ccC-----------------------CCc----ce-------------------ecccccCCcccchhhhccCCCCChhh
Q 006906 549 YEE-----------------------DKT----HI-------------------STRIAGTIGYMAPEYAMRGYLTSKAD 582 (626)
Q Consensus 549 ~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~k~D 582 (626)
+.. +.. .. ....+|||-|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 321 000 00 01256999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCC-CChhhHHHHHHHHh
Q 006906 583 VYSFGVVTLEIVSGKSNTNYRPN-EDFVYLLDWAYVLQ 619 (626)
Q Consensus 583 v~s~Gvil~elltG~~p~~~~~~-~~~~~l~~w~~~~~ 619 (626)
.||+|||||||+.|-+||..... +--..++.|...+.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~ 408 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK 408 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc
Confidence 99999999999999999986543 23467888875543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.95 Aligned_cols=204 Identities=28% Similarity=0.438 Sum_probs=179.8
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 466 (626)
+-.++|...+.||+|+|++|++|+.. .++.||||++.+.. +...+-...|-++|.++ .||.|++|+..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567889999999999999999965 68999999997652 23334566788888888 899999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
|+|+||+++|+|.++|+..+ .|++...+.++.+|+.||+|||++| ||||||||+|||||.||++||+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999998764 6999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCcc----------ee--cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTH----------IS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+.+...... .. ..++||..|.+||++.....+..+|+|+||||+|.|+.|++||...
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 987542211 11 4478999999999999999999999999999999999999999753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.33 Aligned_cols=211 Identities=34% Similarity=0.539 Sum_probs=180.5
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
.+.+....+.||+|+||+||+|... +...||||.++..... ..++|.+|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455667789999999999999853 3567999999887655 77899999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCccc---------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEY---------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
+++|+|||..|+|.++|....... ..+|+..+.+.||.|||.||+||-+++ +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999996433221 234899999999999999999999886 99999999999999999
Q ss_pred CEEEeecCCcccccCCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 006906 537 NAKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNE 606 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~~~ 606 (626)
.|||+|||+++..-..+ .+......-..+|||||.+..++++.++|||||||+|||++| |+.|+.....+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 99999999999554333 322223344679999999999999999999999999999996 99999776543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=328.23 Aligned_cols=206 Identities=29% Similarity=0.543 Sum_probs=176.8
Q ss_pred cHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 006906 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463 (626)
Q Consensus 386 ~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 463 (626)
+.++.+...+.+.+.+.||+|.||+||+|.|. | .||||++... ..+..+.|..|+.++++.||.||+-+.|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34566666677778899999999999999985 3 4899998765 345668899999999999999999999999988
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
.. .+|+.+|++.+|+.++|-.+ .+|+..+.+.||+|||+||.|||.++ |||||||+.|||++++++|||+||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred ce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 77 99999999999999998875 36899999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCC-cceecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 544 GLAKLYEEDK-THISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 544 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
|++..-..-. ........|...|||||+++. .+|+..+||||||+|+|||+||.-||.
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 9987533211 111112347889999999975 469999999999999999999999997
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.51 Aligned_cols=198 Identities=30% Similarity=0.544 Sum_probs=180.7
Q ss_pred cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
..|..-++||+|+.|.||.+.- .+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999984 478899999999877666777899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+.+... .+++.++..|+.++++||+|||.++ |+|||||+.|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999988554 5899999999999999999999998 9999999999999999999999999999887655
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. .....+||+.|||||++....|++|.||||||++++||+-|++||-.
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 4 33457899999999999999999999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=291.26 Aligned_cols=202 Identities=29% Similarity=0.445 Sum_probs=174.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.+|...+.+|+|.||.||+|+.. .|+.||||+++.... .-.....+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35667889999999999999954 799999999976532 235678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||+ .+|+..++.+. ..++..++..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 997 47888887654 47999999999999999999999997 99999999999999999999999999998875
Q ss_pred CCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
..... +..+-|..|.|||.+.+. .|+...||||.|||+.||+-|++-+.+..+
T Consensus 154 p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 154 PNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred CCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 44322 223578999999999875 689999999999999999999876765443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.37 Aligned_cols=203 Identities=28% Similarity=0.446 Sum_probs=177.9
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 467 (626)
.-++|...++||+|.||+|+++..+ +++.+|||.+++.. ..+.+..+.|.+++... +||.+++++.+|+..++++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467999999999999999999987 57899999998863 34456677788877666 5999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+.||++..+.+.. .+++..++-++..|+.||+|||+++ ||+||||.+|||||.+|.+||+|||+++
T Consensus 446 fvmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 999999999965554432 6999999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
..-.. .....+.+||+.|||||++....|+..+|.|||||+||||+.|+.||.+.++
T Consensus 517 e~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 517 EGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred ccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 54322 2245668999999999999999999999999999999999999999987544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=299.34 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=174.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh--cHHHHHHHHHHHhcCCCCceeeEEEEEE--eCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ--GNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~lV 469 (626)
++|+..+.|++|.||.||+|+.+ +++.||+|+++.+... -.-.-++|+.+|.+.+|||||.+..+.. +-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777899999999999999976 6899999999765321 1235679999999999999999988876 44679999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
||||+. +|..++..-. ..+...+.+.++.|+++|++|||++. |+|||||++|+|+...|.+||+|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999985 6878776553 36889999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 606 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~ 606 (626)
..... ..+..+-|..|.|||++.+. .|++..|+||+|||+.||+++++-|.+..+-
T Consensus 228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 76543 34456679999999999875 6999999999999999999999999876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.06 Aligned_cols=201 Identities=27% Similarity=0.447 Sum_probs=176.6
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC----Ch-hcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK----SR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 465 (626)
...+|...+.||+|+||+|+.|... +++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4567889999999999999999865 6899999977653 11 23456668999999999 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeecC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFG 544 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfG 544 (626)
.++||||+.+|.|.+++... ..+.+..+++++.|++.|++|||+++ |+||||||+|||+|.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999763 26888999999999999999999998 9999999999999999 999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCC-CC-ChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY-LT-SKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 999874 2223445678999999999998866 64 789999999999999999999975
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.31 Aligned_cols=193 Identities=34% Similarity=0.534 Sum_probs=162.9
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhc--CCCCceeeEEEEEEeCC----eEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVEGN----QLLLV 469 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lV 469 (626)
.....++||+|.||.||||++. ++.||||++.. +..+.|.+|-++.+. ++|+||++++++-.... +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445689999999999999995 68999999975 445678888887765 68999999999877655 89999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
+||.+.|+|.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||++|||+..|+++.|+||
T Consensus 287 t~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999765 689999999999999999999975 4567999999999999999999999999
Q ss_pred CCcccccCCCcc-eecccccCCcccchhhhccCC------CCChhhHHHHHHHHHHHHhCCC
Q 006906 544 GLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVSGKS 598 (626)
Q Consensus 544 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~s~Gvil~elltG~~ 598 (626)
|+|..+...... .....+||.+|||||++.+.. .-.+.||||+|.|||||++.-.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 999988643221 222368999999999997642 2247899999999999998643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=307.96 Aligned_cols=201 Identities=34% Similarity=0.551 Sum_probs=172.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC--eEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e 471 (626)
.++...+.||+|+||+||++...+ |+..|||..........+.+.+|+.+|++++|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 345567899999999999999764 8999999987764333677899999999999999999999855444 6899999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~ 550 (626)
|+++|+|.+++...+. .+++..+++.+.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 97 y~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999976532 5999999999999999999999997 999999999999999 7999999999998766
Q ss_pred C--CCcceecccccCCcccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 E--DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ..........||+.|||||++..+. ...++|||||||++.||+||++||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 3 2222234477999999999999643 34599999999999999999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=303.55 Aligned_cols=205 Identities=26% Similarity=0.405 Sum_probs=178.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|+..+.||.|..++||+|+. +.++.||||++..+... ..+.+.+|+..++.++||||++++..|..+.++|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35688899999999999999995 46899999999876433 35889999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||.+|++.++++..-. ..+++..+..|..++++||.|||++| .||||||+.||||+.+|.+||+|||....+..
T Consensus 105 fMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999975533 36999999999999999999999998 99999999999999999999999998776554
Q ss_pred CCccee---cccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHIS---TRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
...+.. ...+||++|||||+++. ..|+.|+|||||||...||.+|..||...+
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 332211 44689999999999764 368999999999999999999999997654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.78 Aligned_cols=201 Identities=24% Similarity=0.366 Sum_probs=174.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||++... +++.||+|++.... ......+.+|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999875 58899999997542 223456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999986542 5899999999999999999999987 9999999999999999999999999987543
Q ss_pred CCCc----------------------------------ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhC
Q 006906 551 EDKT----------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596 (626)
Q Consensus 551 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG 596 (626)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001235699999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 006906 597 KSNTNYR 603 (626)
Q Consensus 597 ~~p~~~~ 603 (626)
+.||...
T Consensus 233 ~~Pf~~~ 239 (363)
T cd05628 233 YPPFCSE 239 (363)
T ss_pred CCCCCCC
Confidence 9999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.76 Aligned_cols=205 Identities=27% Similarity=0.426 Sum_probs=176.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHH-HHHHHHHHHhcCC-CCceeeEEEEEEeCC-eEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR-EFVNEIGMISAQQ-HPNLVKLYGCCVEGN-QLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~-~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lV 469 (626)
.++|...++||.|.||.||+|+-. .++.||||+++.+.....+ --++|+..|++++ |||||++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 456778899999999999999954 6899999999876433222 2368999999999 999999999999888 99999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
||||+. +|++++++.+ ..|++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||..
T Consensus 89 fE~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred HHhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999974 7999987653 47999999999999999999999998 999999999999998889999999999977
Q ss_pred cCCCcceecccccCCcccchhhhc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCh
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 608 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~ 608 (626)
.... ..+.++.|..|.|||++. .+.|+.+.||||+|||++|+.+-|+-|.+..+-|+
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq 218 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ 218 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence 6433 345678899999999976 46799999999999999999999998877654444
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.11 Aligned_cols=201 Identities=30% Similarity=0.537 Sum_probs=176.9
Q ss_pred CCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
...+.++||.|.||.||+|+++ ....||||.++... ....++|+.|+.+|.+.+||||++|.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3456789999999999999986 24579999998764 445678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|||++|+|+.+|+.++. ++.+.+..-++.+||.||+||.+.+ +|||||..+|||++.+..+||+|||+++.++
T Consensus 710 EyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999988764 6899999999999999999999887 9999999999999999999999999999887
Q ss_pred CCCcceeccccc--CCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 551 EDKTHISTRIAG--TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
++.....+..-| ..+|.|||.+...+++..+|||||||+|||.++ |.+|+=.+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 665333333333 369999999999999999999999999999875 98887443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.15 Aligned_cols=200 Identities=30% Similarity=0.406 Sum_probs=173.6
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|++++.+++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 677899999999999999974 78999999987542 22334678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 82 MNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred cCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999888754321 25899999999999999999999987 999999999999999999999999999875432
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 21 233568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=317.24 Aligned_cols=205 Identities=25% Similarity=0.369 Sum_probs=175.9
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
+....++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344577999999999999999999986 5789999998643 22334567889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999988543 4788899999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+...............||+.|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 987654332223345799999999998754 3788999999999999999999999643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.11 Aligned_cols=201 Identities=25% Similarity=0.408 Sum_probs=174.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999976 68999999997532 233456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999986542 5899999999999999999999997 9999999999999999999999999987543
Q ss_pred CCCcc-------------------------------------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHH
Q 006906 551 EDKTH-------------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEI 593 (626)
Q Consensus 551 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~el 593 (626)
..... ......||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 01124689999999999999999999999999999999
Q ss_pred HhCCCCCCCC
Q 006906 594 VSGKSNTNYR 603 (626)
Q Consensus 594 ltG~~p~~~~ 603 (626)
++|+.||...
T Consensus 233 ~~G~~Pf~~~ 242 (364)
T cd05599 233 LVGYPPFCSD 242 (364)
T ss_pred hcCCCCCCCC
Confidence 9999999653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.67 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=172.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 67899999997542 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 999999999986542 5889999999999999999999987 99999999999999999999999999764311
Q ss_pred CCc----------------------------------------------ceecccccCCcccchhhhccCCCCChhhHHH
Q 006906 552 DKT----------------------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYS 585 (626)
Q Consensus 552 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s 585 (626)
... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0012346999999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 006906 586 FGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 586 ~Gvil~elltG~~p~~~~ 603 (626)
|||++|||+||+.||...
T Consensus 234 lG~il~elltG~~Pf~~~ 251 (381)
T cd05626 234 VGVILFEMLVGQPPFLAP 251 (381)
T ss_pred hhhHHHHHHhCCCCCcCC
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.22 Aligned_cols=197 Identities=25% Similarity=0.362 Sum_probs=174.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 68899999986532 223456888999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 9999999999986542 5889999999999999999999997 9999999999999999999999999998664
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 2346899999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.34 Aligned_cols=201 Identities=22% Similarity=0.364 Sum_probs=172.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+++.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999875 68899999986532 233456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999998654 25889999999999999999999997 9999999999999999999999999996432
Q ss_pred CCCcc----------------------------------------------eecccccCCcccchhhhccCCCCChhhHH
Q 006906 551 EDKTH----------------------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVY 584 (626)
Q Consensus 551 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~ 584 (626)
..... ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 00124699999999999998999999999
Q ss_pred HHHHHHHHHHhCCCCCCCC
Q 006906 585 SFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 585 s~Gvil~elltG~~p~~~~ 603 (626)
||||++|||+||+.||...
T Consensus 233 SlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred ecchhhhhhhcCCCCCCCC
Confidence 9999999999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=297.76 Aligned_cols=199 Identities=27% Similarity=0.477 Sum_probs=179.5
Q ss_pred cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.+|++.+.||+|.||+|-+|+. ..|+.||||.+++.. .++.-.+.+|+++|+.++||||++++.+|++.+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3467788999999999999985 579999999997753 444556789999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||..+|.|++++...+ .|++..++.++.||..|+.|+|.+. ++|||||.+|||+|+++++||+|||++..+.
T Consensus 133 EYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999997653 6999999999999999999999986 9999999999999999999999999999886
Q ss_pred CCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ..+.++|++-|.+||++.+.+| ++.+|-||+||+||.|+.|..||++.
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 533 4566899999999999988766 78999999999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.54 Aligned_cols=207 Identities=24% Similarity=0.364 Sum_probs=178.2
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 462 (626)
.+++....++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566689999999999999999999976 5789999998643 12334567889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
++..++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999988543 4788889999999999999999997 99999999999999999999999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccC----CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 999987654333233446799999999998753 378999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.29 Aligned_cols=197 Identities=26% Similarity=0.375 Sum_probs=173.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC--CcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~--g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||.||+|++.+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998653 3689999986532 23345788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999986542 5889999999999999999999997 999999999999999999999999999865
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 4321 2356899999999999888999999999999999999999999753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.09 Aligned_cols=197 Identities=24% Similarity=0.371 Sum_probs=175.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999986 58899999987542 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 9999999999986542 5889999999999999999999997 9999999999999999999999999998654
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 3 223356899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.88 Aligned_cols=205 Identities=26% Similarity=0.414 Sum_probs=172.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCc-eeeEEEEEEeCC------
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPN-LVKLYGCCVEGN------ 464 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------ 464 (626)
..|+..++||+|+||+||+|+.+ +|+.||+|++..... .......+|+.+++.++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556688999999999999965 789999999976643 23456789999999999999 999999999877
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.+++|+||++. +|..++....... ..++...++.++.||++||+|||+++ |+||||||.|||++++|.+||+|||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999964 7888875543211 24666889999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
+|+.+.-.... .+..++|..|.|||++.+. .|+...||||+|||+.||+++++-|.+..+
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 99976533322 3445689999999999876 799999999999999999999988876544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.82 Aligned_cols=196 Identities=23% Similarity=0.381 Sum_probs=174.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999986 58899999987532 233457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999886542 5788999999999999999999997 9999999999999999999999999998664
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ....||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 322 234689999999999998899999999999999999999999964
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.55 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=172.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999975 68899999987542 2334578889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 999999999886542 5788999999999999999999997 99999999999999999999999999753311
Q ss_pred CC----------------------------------------------cceecccccCCcccchhhhccCCCCChhhHHH
Q 006906 552 DK----------------------------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYS 585 (626)
Q Consensus 552 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s 585 (626)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00012246899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 006906 586 FGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 586 ~Gvil~elltG~~p~~~~ 603 (626)
|||++|||++|+.||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred chHHHHHHHhCCCCCCCC
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.99 Aligned_cols=193 Identities=27% Similarity=0.347 Sum_probs=168.9
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999987542 233456788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 151 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence 999888654 26899999999999999999999997 99999999999999999999999999875432211 2
Q ss_pred ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 557 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 2335699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.01 Aligned_cols=201 Identities=23% Similarity=0.371 Sum_probs=172.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999975 58899999986532 223456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 81 E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 9999999999986542 5788899999999999999999987 9999999999999999999999999975331
Q ss_pred CCC------------------------------------------cceecccccCCcccchhhhccCCCCChhhHHHHHH
Q 006906 551 EDK------------------------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGV 588 (626)
Q Consensus 551 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gv 588 (626)
... ........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 00011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 006906 589 VTLEIVSGKSNTNYR 603 (626)
Q Consensus 589 il~elltG~~p~~~~ 603 (626)
++|||++|+.||...
T Consensus 233 ilyell~G~~Pf~~~ 247 (376)
T cd05598 233 ILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeehhhCCCCCCCC
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.79 Aligned_cols=202 Identities=25% Similarity=0.338 Sum_probs=173.7
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467889999999999999999976 6889999998643 12334557789999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999988543 4788889999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCcceecccccCCcccchhhhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.............||+.|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 654332222345699999999998653 4789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.17 Aligned_cols=207 Identities=28% Similarity=0.443 Sum_probs=171.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC-C
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 464 (626)
.++|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999974 235689999987543 23346789999999999 899999999998764 4
Q ss_pred eEEEEEEecCCCchhhhhcCCCcc--------------------------------------------------------
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 488 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 488 (626)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 589999999999999988643210
Q ss_pred -cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce-ecccccCCcc
Q 006906 489 -YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGY 566 (626)
Q Consensus 489 -~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y 566 (626)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0135888999999999999999999987 9999999999999999999999999998654322211 1223456789
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 567 ~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+|||++....++.++|||||||++|||++ |+.||...
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999899999999999999999997 99998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.68 Aligned_cols=194 Identities=28% Similarity=0.359 Sum_probs=168.7
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999987542 233456778999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 9998886542 5899999999999999999999997 99999999999999999999999999875432221 1
Q ss_pred ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 557 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 22356899999999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=305.88 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=173.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999976 5889999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999986432 25889999999999999999999997 9999999999999999999999999997665
Q ss_pred CCCcceecccccCCcccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 433322333468999999999863 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=298.42 Aligned_cols=202 Identities=24% Similarity=0.363 Sum_probs=174.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||.||+++.+ +++.||||++.... ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999986 57899999987542 2334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|++++.+..+.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99998776554322 25889999999999999999999987 99999999999999999999999999987654
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..........|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 33222334568999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=296.12 Aligned_cols=207 Identities=30% Similarity=0.427 Sum_probs=168.3
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eEEEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLLLVY 470 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~ 470 (626)
|...+++|+|+||.||+|++. +++.||||+...+.+. -.+|+++|++++|||||++..+|.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 556789999999999999976 4689999998765332 236899999999999999999887432 345899
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeecCCcccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLY 549 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~ 549 (626)
|||+. +|.+.++.. ......++...++-++.||.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 102 eymP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HhchH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99985 788887642 122346778888999999999999999986 9999999999999987 89999999999988
Q ss_pred cCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHH
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 616 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~ 616 (626)
...... .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... ...|+..+.
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik 240 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIK 240 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHH
Confidence 765544 334578899999999875 699999999999999999999998877433 344554443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.51 Aligned_cols=201 Identities=25% Similarity=0.328 Sum_probs=173.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+++.. +++.||+|++... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999976 5788999998653 1223445788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999996532 25889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 433322333569999999999875 4678899999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=278.86 Aligned_cols=202 Identities=26% Similarity=0.430 Sum_probs=180.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
-++|++.+.||+|-||.||.|+.+ ++-.||+|++.+. ..+..+++.+|+++-+.++||||++++++|.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357899999999999999999975 5778999998764 234467889999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
+||..+|++...|..... .++++.....++.|+|.|+.|+|..+ ||||||||+|+|++.++..||+|||.+..-
T Consensus 101 lEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999985543 36889999999999999999999886 999999999999999999999999998754
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+. ......+||.-|.+||...+..++..+|+|++|++.||++.|.+||....
T Consensus 175 p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 175 PS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred CC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 42 23345789999999999999999999999999999999999999997643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=304.49 Aligned_cols=194 Identities=28% Similarity=0.361 Sum_probs=169.5
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999997542 234467888999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 999888654 25899999999999999999999987 99999999999999999999999999875432221 2
Q ss_pred ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 557 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 23356899999999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.30 Aligned_cols=186 Identities=30% Similarity=0.500 Sum_probs=165.6
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
.++-||+|+.|.||+|+++ ++.||||+++.-. ..+++-|++++|+||+.+.|+|.....+++|||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4578999999999999995 6779999875432 2578889999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
...|+... .+.......+..+||.||.|||.+. |||||||+-||||..+..+||+|||-++...+... .-
T Consensus 200 ~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--kM 269 (904)
T KOG4721|consen 200 YEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--KM 269 (904)
T ss_pred HHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh--hh
Confidence 99997653 5777888899999999999999884 99999999999999999999999999997765422 23
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.++||..|||||++++.+.++|+||||||||||||+||..||..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 47899999999999999999999999999999999999999964
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.64 Aligned_cols=191 Identities=25% Similarity=0.371 Sum_probs=167.9
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
||+|+||.||+++.. +++.||+|++... .......+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 5789999998653 233456778899999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 99986542 5899999999999999999999987 9999999999999999999999999998543222 1223
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 45689999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=304.80 Aligned_cols=201 Identities=25% Similarity=0.340 Sum_probs=172.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+++.+ +++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999976 47889999986431 223345788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999996532 25899999999999999999999987 9999999999999999999999999997654
Q ss_pred CCCcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 33332333456999999999986 34678999999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.53 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=171.5
Q ss_pred CCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCC----hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 466 (626)
+|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|++++..+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998853 57899999986531 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999988654 25889999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+.+............||+.|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 86544333333345799999999998765 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=309.58 Aligned_cols=201 Identities=24% Similarity=0.378 Sum_probs=174.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 58899999987532 233456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999986542 5899999999999999999999997 9999999999999999999999999987543
Q ss_pred CCCc----------------------------------ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhC
Q 006906 551 EDKT----------------------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596 (626)
Q Consensus 551 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG 596 (626)
.... .......||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2100 001234699999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 006906 597 KSNTNYR 603 (626)
Q Consensus 597 ~~p~~~~ 603 (626)
+.||...
T Consensus 233 ~~Pf~~~ 239 (360)
T cd05627 233 YPPFCSE 239 (360)
T ss_pred CCCCCCC
Confidence 9999654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.67 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=176.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999976 58889999987643 2335678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999986542 5889999999999999999999864 499999999999999999999999999986543
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .....|+..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 157 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 23356899999999999889999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=294.59 Aligned_cols=201 Identities=30% Similarity=0.457 Sum_probs=168.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--------------hcHHHHHHHHHHHhcCCCCceeeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------------QGNREFVNEIGMISAQQHPNLVKLYG 458 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l~~ 458 (626)
-++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|+|||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 478999999999999999999965 789999999976421 11247889999999999999999999
Q ss_pred EEEe--CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 459 CCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 459 ~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
+..+ .+.+|||+|||..|.+...=-. ...+++.++++++.++..||+|||.++ ||||||||+|+||+++|
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 9864 5689999999999887543211 123999999999999999999999998 99999999999999999
Q ss_pred CEEEeecCCcccccCC----CcceecccccCCcccchhhhccC----CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 537 NAKISDFGLAKLYEED----KTHISTRIAGTIGYMAPEYAMRG----YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++||+|||.+...... ........+||+.|+|||....+ ..+.+.||||+||+||-|+.|+.||..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 9999999999876322 11122347899999999998763 246689999999999999999999964
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=300.37 Aligned_cols=193 Identities=25% Similarity=0.376 Sum_probs=167.5
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999976 68899999997642 23345678899999888 799999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 9998887544 26899999999999999999999997 99999999999999999999999999874322111
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 22345789999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.84 Aligned_cols=199 Identities=27% Similarity=0.384 Sum_probs=170.5
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCC-ceeeEEEEEEeCCeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 470 (626)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999976 47889999987532 23445678899999988765 5888999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999998886542 5889999999999999999999987 9999999999999999999999999987532
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 2111 223356899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.39 Aligned_cols=201 Identities=23% Similarity=0.400 Sum_probs=170.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999976 68899999987543 23345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LDS-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCc-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 985 8888875442 25789999999999999999999987 999999999999999999999999999765432
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.. ......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223457899999999865 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.23 Aligned_cols=199 Identities=27% Similarity=0.394 Sum_probs=170.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999976 57899999987542 22334566777877776 5899999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+.+.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998886542 5889999999999999999999987 9999999999999999999999999997543
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||++....++.++|||||||++|||+||+.||...
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 2221 223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.18 Aligned_cols=195 Identities=26% Similarity=0.372 Sum_probs=168.1
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 57899999997642 23345677899988887 699999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 9998887543 25899999999999999999999997 99999999999999999999999999875322211
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 2234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.28 Aligned_cols=201 Identities=27% Similarity=0.370 Sum_probs=175.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999976 68899999997642 234456888999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999986542 26899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhc------cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 44333333456899999999986 45678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.96 Aligned_cols=201 Identities=28% Similarity=0.397 Sum_probs=176.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 68999999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999998654 26899999999999999999999987 9999999999999999999999999998665
Q ss_pred CCC----------------------------cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDK----------------------------THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 432 1112335689999999999999999999999999999999999999975
Q ss_pred C
Q 006906 603 R 603 (626)
Q Consensus 603 ~ 603 (626)
.
T Consensus 233 ~ 233 (350)
T cd05573 233 D 233 (350)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.69 Aligned_cols=194 Identities=27% Similarity=0.354 Sum_probs=168.0
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.||+|+||.||+++.. +++.||+|++.... .....++.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68899999987542 233456778999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 999888554 258999999999999999999997 55 99999999999999999999999999875432222
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 223356899999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=299.82 Aligned_cols=197 Identities=29% Similarity=0.433 Sum_probs=168.0
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHH---hcCCCCceeeEEEEEEeCCeEEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999975 68999999997542 22234566665554 567899999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|...++.. .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 9999999998887542 5899999999999999999999987 999999999999999999999999998754
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 32221 223456899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.24 Aligned_cols=194 Identities=28% Similarity=0.436 Sum_probs=167.6
Q ss_pred CeeeccCceEEEEEEE----cCCcEEEEEEeccCC----hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 401 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+.||+|+||.||+++. .+++.||||++.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999987532 22335677899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... .+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999886542 5788899999999999999999997 999999999999999999999999998754322
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 21 223356899999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=298.06 Aligned_cols=194 Identities=29% Similarity=0.434 Sum_probs=165.3
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57889999987542 2233455666666664 5899999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 99998886542 5889999999999999999999987 9999999999999999999999999998543322 2
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 233456899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.03 Aligned_cols=193 Identities=26% Similarity=0.385 Sum_probs=166.5
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 57899999997642 23345677888888766 899999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 9998887544 26899999999999999999999997 99999999999999999999999999875432211
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 22335689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=300.27 Aligned_cols=206 Identities=31% Similarity=0.520 Sum_probs=178.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcH-HHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~-~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.....+.++||+|-||.|..+....+..||||.++....... ++|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 344567899999999999999998889999999998755544 8999999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc-cC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~-~~ 551 (626)
|++|+|..++.....+ .++-....+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++-+ ..
T Consensus 617 mEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999776433 2456677889999999999999886 999999999999999999999999999944 44
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHH--hCCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV--SGKSNTNYRPN 605 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ell--tG~~p~~~~~~ 605 (626)
+..+...+.+-..+|||||.+..++++.++|||+||+++||++ +...|+....+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 4444555556678999999999999999999999999999986 56778865443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=290.24 Aligned_cols=202 Identities=27% Similarity=0.402 Sum_probs=171.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||.||+|++. .+..||+|.++... ....+.+.+|+..+.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999864 35689999988653 23346789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999986542 26899999999999999999999987 999999999999999999999999987654
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
............++..|+|||.+....++.++|||||||++||+++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 3222111112235678999999999999999999999999999875 99998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.90 Aligned_cols=205 Identities=29% Similarity=0.499 Sum_probs=170.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-----------------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 456 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 456 (626)
++|.+.+.||+|+||.||++.+++ +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999998642 3369999987653 3345679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhcCCCc--------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 006906 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDT--------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVH 522 (626)
Q Consensus 457 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 522 (626)
++++.+.+..++||||+++|+|.+++..... .....++|..+.+++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998854321 11135788999999999999999999987 999
Q ss_pred eCCCCCCEEEcCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCC
Q 006906 523 RDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSN 599 (626)
Q Consensus 523 ~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt--G~~p 599 (626)
|||||+|||++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322 12223445788999999988899999999999999999987 4556
Q ss_pred CCC
Q 006906 600 TNY 602 (626)
Q Consensus 600 ~~~ 602 (626)
+..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=313.28 Aligned_cols=203 Identities=23% Similarity=0.317 Sum_probs=175.4
Q ss_pred CCCCCeeeccCceEEEEEEEc-C-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999864 3 67788888766555555678889999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+|+|.++++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 149 GGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999998875431 12246889999999999999999999987 99999999999999999999999999987654321
Q ss_pred -ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 -HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.......||++|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2233456999999999999999999999999999999999999998643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=308.16 Aligned_cols=202 Identities=34% Similarity=0.528 Sum_probs=173.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC--C--cE-EEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD--G--TV-IAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~--g--~~-vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
.++....++||+|+||.||+|++.. + .. ||||..+.+ .....++|++|+++++.++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3444556899999999999999763 2 23 899998863 46677899999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
+++|||+|.||+|.++|..... .++..++.+++.+.|+||+|||+.. +|||||.++|+|++.++.+||+|||+
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999987643 5899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
++......... ....-..+|+|||.+....++.++|||||||++||+++ |..|+...
T Consensus 309 s~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 309 SRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred ccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 88543111111 01123568999999999999999999999999999998 88898754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=293.90 Aligned_cols=201 Identities=24% Similarity=0.408 Sum_probs=170.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999976 688999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 996 56766665432 25889999999999999999999997 99999999999999999999999999875432
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 156 PSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 2233457899999999865 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.18 Aligned_cols=199 Identities=28% Similarity=0.490 Sum_probs=177.6
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.|...+.||+|.||.||||... .++.||+|++..+.. ....++.+|+.+|..++|+||.++|+.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666789999999999999965 688999999987643 33567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
.+|++.+.|.... .+++..+..|+.++..|+.|||.+. .+|||||+.|||+..+|.+||+|||.+.......
T Consensus 94 ~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred cCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999987653 3577888889999999999999997 9999999999999999999999999999877655
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ..++||+.|||||++....|+.|+||||||++.+||++|.+|+...
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 443 5678999999999999889999999999999999999999998643
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.08 Aligned_cols=200 Identities=24% Similarity=0.443 Sum_probs=175.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|++++++++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999986 68889999887642 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999986542 5789999999999999999999853 499999999999999999999999999976533
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 22346899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.77 Aligned_cols=207 Identities=34% Similarity=0.538 Sum_probs=175.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC--Cc----EEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD--GT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~--g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
.+.+..+.||+|+||.||+|...+ +. .||||.+... +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567899999999999999753 43 4899998775 4566789999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 468 LVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
+++|||++|+|..+|+..+.. ....++..+.+.++.|||+|++||++++ +|||||..+|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999765211 1346899999999999999999999997 99999999999999999999999999
Q ss_pred cccccC-CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 546 AKLYEE-DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 546 a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
|+.+.. +.........-..+|||||.+..+.++.|+|||||||++||++| |..||....
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 994433 32222222223468999999999999999999999999999998 888886543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.62 Aligned_cols=194 Identities=28% Similarity=0.445 Sum_probs=167.2
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|+.+ +++.||||++.... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 58899999987532 23345677888888766 699999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 99998886542 5899999999999999999999987 99999999999999999999999999875432221
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 223356899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.78 Aligned_cols=204 Identities=26% Similarity=0.335 Sum_probs=176.4
Q ss_pred CCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
+|+..+.||+|.-|+||.+.+++ +..+|+|++.+.. +....+...|-++|+.++||.+..||+.++.++..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 35556889999999999999875 5889999998764 3344567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||+||+|..+++.+.. ..+++..++-++.+++.||+|||..| ||.|||||+||||.++|++.|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999987755 37999999999999999999999998 99999999999999999999999998653210
Q ss_pred ---------------------------------CCc----------------------ceecccccCCcccchhhhccCC
Q 006906 552 ---------------------------------DKT----------------------HISTRIAGTIGYMAPEYAMRGY 576 (626)
Q Consensus 552 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 576 (626)
... ..+...+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0112357999999999999999
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 577 LTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 577 ~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
.+..+|.|+|||++|||+.|+.||.+...
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 99999999999999999999999987543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=298.32 Aligned_cols=194 Identities=27% Similarity=0.418 Sum_probs=167.2
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 57899999987542 23345677888888765 899999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|...+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 9999888644 25889999999999999999999997 99999999999999999999999999875432221
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 223356899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.02 Aligned_cols=208 Identities=26% Similarity=0.419 Sum_probs=176.9
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEecc--CChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe-----CC
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSS--KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-----GN 464 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~ 464 (626)
....|...+.||+|+||.|+.+... +|+.||||++.. ......++..+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999976 689999999973 355667888999999999999999999998864 35
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.+|+|+|+| +.+|...++.+. .|+......++.|+++||+|+|+.+ |+||||||+|+|++.+..+||+|||
T Consensus 100 DvYiV~elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 789999999 468888887652 4899999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCC-CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChh
Q 006906 545 LAKLYEED-KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 609 (626)
Q Consensus 545 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~ 609 (626)
+|+..... .....+..+-|..|.|||++.. ..|+...||||.|||+.||++|++-|.+.+.-+..
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql 237 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL 237 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH
Confidence 99987542 1223355678999999999864 67999999999999999999999999876544333
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.31 Aligned_cols=199 Identities=27% Similarity=0.396 Sum_probs=170.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|.+++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999975 68899999987542 233456778888888775 577888999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999886542 5899999999999999999999987 9999999999999999999999999987543
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 2221 223356899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=290.28 Aligned_cols=193 Identities=22% Similarity=0.328 Sum_probs=166.3
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhc---HHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeEEEEEE
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVYE 471 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~e 471 (626)
....||+|++|.||+|.+ +|+.||||++....... .+.|.+|++++.+++||||+++++++.+ ....++|||
T Consensus 24 ~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 24 TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 346899999999999998 68899999997653332 4678899999999999999999999876 346899999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.+++... ..+++....+++.|++.||+|||+.. .++||||||+|||+++++.+||+|||+++....
T Consensus 103 y~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 103 YCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred eCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999999754 25889999999999999999999852 277999999999999999999999999986543
Q ss_pred CCcceecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 176 ~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 176 PP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred cc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 22 12357889999999976 67899999999999999999999999754
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.81 Aligned_cols=194 Identities=31% Similarity=0.452 Sum_probs=166.0
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999987642 2234556677777775 5999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 9999988653 25889999999999999999999987 99999999999999999999999999875322211
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 223356899999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.82 Aligned_cols=195 Identities=29% Similarity=0.438 Sum_probs=175.0
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|+..+.||.|+-|.|-.|++. +|+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 556788999999999999964 79999999997762 23346688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++|.|.+++..++ .+.+.++.+++.||+.|+.|+|..+ |+|||+||+|+|||..+.+||+|||+|..-..+
T Consensus 94 v~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred cCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999997764 6899999999999999999999987 999999999999999999999999999865443
Q ss_pred CcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
. .-.+.+|++.|.|||++++..| +.++||||.|||||.|+||+-||+
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 2 3455789999999999998776 678999999999999999999997
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.77 Aligned_cols=196 Identities=30% Similarity=0.415 Sum_probs=168.2
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999975 688999999865422 2235677899999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
..++.... .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 88875432 12246899999999999999999999987 99999999999999999999999999986543322 123
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 356899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=301.38 Aligned_cols=202 Identities=28% Similarity=0.465 Sum_probs=180.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-EEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ-LLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV~ 470 (626)
++|...+.+|+|+||.++..+.+ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999998876 67889999887653 3334567899999999999999999999999888 99999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
+|++||++.+.+.... ...++++++.+++.|++.|+.|||++. |+|||||+.|||++.+..+||+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997664 257999999999999999999999876 9999999999999999999999999999887
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ....++||+.||+||++.+.+|..|+|||||||++|||++-+++|+..
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 6542 345578999999999999999999999999999999999999999754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.22 Aligned_cols=201 Identities=28% Similarity=0.509 Sum_probs=173.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||.||++.++++..+|+|.+... .....++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999988889999988644 3345678999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+|+|.++++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999986542 25899999999999999999999987 99999999999999999999999999986543322
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22222335668999999988889999999999999999999 89998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.47 Aligned_cols=194 Identities=29% Similarity=0.417 Sum_probs=165.4
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+++.. +++.||+|++.... ....+++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 68999999987542 223345555654 46789999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 9998887643 26899999999999999999999987 99999999999999999999999999875332211
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 223456899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.52 Aligned_cols=192 Identities=31% Similarity=0.470 Sum_probs=160.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHh--cCCCCceeeEEEEEEeCC----eEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMIS--AQQHPNLVKLYGCCVEGN----QLL 467 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~--~l~H~nIv~l~~~~~~~~----~~~ 467 (626)
..+....+.||+|.||.||+|.|+ |+.||||++... +++.+.+|.++.. .+||+||+.+++.-..++ +++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 356777899999999999999996 788999999754 3456777777765 469999999998865433 689
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-----DSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
||++|.+.|||+++|... .++-...++++..+|.||+|||. +++|.|.|||||++|||+..++.+.|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 999999999999999664 68999999999999999999995 4788999999999999999999999999
Q ss_pred cCCcccccCCCcc---eecccccCCcccchhhhccCC------CCChhhHHHHHHHHHHHHh
Q 006906 543 FGLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVS 595 (626)
Q Consensus 543 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~s~Gvil~ellt 595 (626)
+|||.....+... .....+||.+|||||++...- --..+||||||.|+||+..
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999877654322 123467999999999986431 2246999999999999874
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.14 Aligned_cols=201 Identities=26% Similarity=0.467 Sum_probs=166.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcC---CCCceeeEEEEEE-----e
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCV-----E 462 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~-----~ 462 (626)
++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 468899999875422 2234566777766655 7999999999986 2
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
....++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999997 588888865422 25899999999999999999999997 99999999999999999999999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
||+++..... .......||+.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 9999866433 12234568999999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.81 Aligned_cols=194 Identities=31% Similarity=0.492 Sum_probs=164.1
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445688999999999999976 68999999986543 2335678899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 156 ~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 156 GGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 99986432 3466788899999999999999997 99999999999999999999999999987643221
Q ss_pred ceecccccCCcccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||..|+|||++.. ...+.++|||||||++|||++|+.||...
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1233568999999998743 23456899999999999999999999743
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=296.60 Aligned_cols=194 Identities=28% Similarity=0.427 Sum_probs=165.1
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||+||+|+.. +++.||+|++.... ....+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 68999999987532 222344555554 56789999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 9999888654 25889999999999999999999997 9999999999999999999999999987543222 1
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 223456899999999999989999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.40 Aligned_cols=194 Identities=30% Similarity=0.413 Sum_probs=166.0
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|+.. +++.||+|.++... ......+..|.+++.. .+|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 58899999987542 2234556677777765 5899999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 9999888654 25889999999999999999999997 9999999999999999999999999987432211 1
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.24 Aligned_cols=199 Identities=26% Similarity=0.430 Sum_probs=167.5
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CeEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLL 467 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~ 467 (626)
+|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999975 6899999998753 223345788999999999999999999988643 3579
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999996 6888887543 25899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCc--ceecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKT--HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....... .......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 6532211 11233568999999999875 67899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=288.63 Aligned_cols=200 Identities=32% Similarity=0.419 Sum_probs=173.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.|+..+.||+|+||.||++... +++.||+|++.... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999975 68899999987542 2223457789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988754321 35899999999999999999999997 99999999999999999999999999987543
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....|+..|+|||.+....++.++||||+||++|||++|+.||...
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 222 12346899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.13 Aligned_cols=193 Identities=23% Similarity=0.298 Sum_probs=167.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||.||++... +++.||+|... .+.+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56899999999999999999975 68899999753 235678999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 ~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 166 K-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 6 6787777543 25889999999999999999999987 9999999999999999999999999997543322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
........||+.|+|||++.+..++.++|||||||++|||+||+.|+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 2223345799999999999999999999999999999999999988643
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.48 Aligned_cols=194 Identities=27% Similarity=0.410 Sum_probs=164.4
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|+.. +++.||+|++.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 68899999987542 122344555554 67889999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 9998887543 25788899999999999999999987 9999999999999999999999999987532222 1
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 223456899999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.91 Aligned_cols=201 Identities=31% Similarity=0.524 Sum_probs=175.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688899999999999999998888899999987543 345788999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.++++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 85 KGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999865422 36889999999999999999999987 99999999999999999999999999987654332
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
.......++..|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 22222345678999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.10 Aligned_cols=193 Identities=27% Similarity=0.404 Sum_probs=163.6
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||+||+++.. +++.||+|++.... ....+++..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 57889999987532 122334444444 56789999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|.+++.... .+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 99999886542 5788899999999999999999997 99999999999999999999999999975432221
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 22345699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.56 Aligned_cols=207 Identities=28% Similarity=0.433 Sum_probs=171.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
.++|++.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999974 235689999987543 23346788999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcc---------------------------------------------------------
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------- 488 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 488 (626)
.++||||+++|+|.++++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999988643210
Q ss_pred -------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 489 -------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 489 -------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
....++|..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0125889999999999999999999987 999999999999999999999999999866433221
Q ss_pred -eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 556 -ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 556 -~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 1122334668999999999999999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.96 Aligned_cols=200 Identities=29% Similarity=0.430 Sum_probs=170.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 467 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 467 (626)
+|++.+.||+|+||.||++... +++.||||++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999975 7899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+. ++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 5677766443 26899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..............++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 6654333233334678999999998764 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.63 Aligned_cols=207 Identities=30% Similarity=0.456 Sum_probs=171.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
.++|++.+.||+|+||.||+|+.. ++..||||++.... ......+.+|+++++.+ +|+|||+++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999999842 24579999997643 23345688999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCc----------------------------------------------------------
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDT---------------------------------------------------------- 487 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 487 (626)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred -------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc-eecc
Q 006906 488 -------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTR 559 (626)
Q Consensus 488 -------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~ 559 (626)
.....+++..+.+++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01124788999999999999999999987 999999999999999999999999999865433221 1112
Q ss_pred cccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 560 ~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
..++..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 335678999999998899999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=296.37 Aligned_cols=194 Identities=28% Similarity=0.404 Sum_probs=168.6
Q ss_pred CeeeccCceEEEEEEE----cCCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 401 NKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~----~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
+.||+|+||.||+++. .+++.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 3578999999975421 233457789999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999988543 25899999999999999999999987 99999999999999999999999999986543322
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......|++.|+|||.+....++.++|||||||++|||++|+.||...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 223356899999999999888899999999999999999999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=282.44 Aligned_cols=193 Identities=31% Similarity=0.430 Sum_probs=166.9
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
||+|+||.||++..+ +++.||+|++.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999975 58999999986532 12234566799999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 988754422 35889999999999999999999987 9999999999999999999999999998664332 222
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...|+..|+|||++....++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 346899999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=291.63 Aligned_cols=194 Identities=29% Similarity=0.437 Sum_probs=167.0
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||+||+++.. +++.||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57899999997542 23345667888888877 799999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 99998886542 5899999999999999999999987 99999999999999999999999999875322221
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 223346899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=282.08 Aligned_cols=203 Identities=31% Similarity=0.529 Sum_probs=175.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999998888889999987643 34577899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999986543 236899999999999999999999987 9999999999999999999999999998765322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.........+..|+|||++....++.++||||||+++|||+| |+.|+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 111111223457999999998899999999999999999999 99988643
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=281.32 Aligned_cols=201 Identities=29% Similarity=0.502 Sum_probs=173.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ....++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577889999999999999998877789999987543 345679999999999999999999999999889999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++.... ..+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999986542 25899999999999999999999987 99999999999999999999999999886544322
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.......++..|+|||......++.++|||||||++|||++ |+.|+...
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 22222335678999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=315.26 Aligned_cols=205 Identities=24% Similarity=0.395 Sum_probs=174.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.++||+|+||.||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999976 58899999987542 233467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCC------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 471 EYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
||+++++|.+++.... ......+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 111235678889999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCc-----------------ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 545 LAKLYEEDKT-----------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986621110 011224699999999999999999999999999999999999999965
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=280.41 Aligned_cols=200 Identities=30% Similarity=0.508 Sum_probs=171.9
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+|++.+.||+|+||.||++.++++..+|+|.+.... ....++.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998877889999986542 3346788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999986543 25899999999999999999999997 999999999999999999999999999865432221
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 1112224457999999998899999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.84 Aligned_cols=201 Identities=30% Similarity=0.545 Sum_probs=170.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.+|+..+.||+|+||.||+|++. +++ .||+|.+.... ....+++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 333 38999987543 34467889999999999999999999999765 5679
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|+||+++|+|.+++.... ..+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999987643 25889999999999999999999987 99999999999999999999999999997
Q ss_pred ccCCCccee-cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 549 YEEDKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......... ....++..|+|||++.+..++.++|||||||++|||++ |+.|++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 654332221 12234678999999999999999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=308.02 Aligned_cols=208 Identities=24% Similarity=0.335 Sum_probs=175.5
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC---
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--- 464 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 464 (626)
+...++|.+.+.||+|+||+||+++.. +++.||||++... .......+.+|+.++..++|+|+++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 334578999999999999999999864 6899999998654 2344567889999999999999999988765432
Q ss_pred -----eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEE
Q 006906 465 -----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 539 (626)
Q Consensus 465 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 539 (626)
.+++||||+++|+|.++++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 3689999999999999886532 12246899999999999999999999987 99999999999999999999
Q ss_pred EeecCCcccccCCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 540 ISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 540 l~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999998764322 1223346799999999999999999999999999999999999999964
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=288.72 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=170.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|.+.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999976 67889999987543 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 985 7777765432 25789999999999999999999987 999999999999999999999999999764332
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.. ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 1223457899999998865 468999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=286.56 Aligned_cols=202 Identities=32% Similarity=0.438 Sum_probs=181.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+.|..-++||+|+||.||-++.+ +|+.+|.|++.++ .+....-.+.|-.+|.+++.+.||.+-..|+..+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45788899999999999999876 6999999998765 2344566788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
..|.||+|.-+|...+. ..+++..++-++.+|+.||++||.+. ||.||+||+|||+|+.|+++|+|+|+|..+.
T Consensus 265 tlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999977654 47999999999999999999999996 9999999999999999999999999999887
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
...... ..+||.+|||||++.+..|+...|.||+||++|||+.|+.||....
T Consensus 339 ~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 339 EGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 654432 2379999999999999999999999999999999999999997643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=283.83 Aligned_cols=206 Identities=33% Similarity=0.539 Sum_probs=173.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....+|.+|++++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367888999999999999998643 2579999987543 233467899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEY-----------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
++|||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999986532111 136889999999999999999999997 99999999999999999
Q ss_pred CEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 537 NAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999986533221 12223446788999999998899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=282.01 Aligned_cols=204 Identities=29% Similarity=0.515 Sum_probs=179.2
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
...+|++.+.||+|+||.||+|...+++.+|+|.+.........++.+|+++++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44568889999999999999999988999999999877665677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.+......
T Consensus 84 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 84 MEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred cccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999976432 36899999999999999999999987 999999999999999999999999999866433
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
... .....++..|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 221 122335678999999988889999999999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=284.26 Aligned_cols=206 Identities=32% Similarity=0.528 Sum_probs=175.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|.+.+.||+|+||.||+|+..+ ++.||||.+...... ..+.+.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998643 478999999765443 4578999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCc---------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 468 LVYEYMKNNCLSRAIFGKDT---------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
+||||+++++|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999865421 12245889999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 539 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999986533221 11223345788999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=281.66 Aligned_cols=199 Identities=31% Similarity=0.424 Sum_probs=172.4
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|+..+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++.+++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999976 68899999986542 22234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999988854322 35899999999999999999999987 999999999999999999999999998765432
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 22 12346899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.56 Aligned_cols=199 Identities=29% Similarity=0.391 Sum_probs=172.2
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|...+.||+|+||+||++... +++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999975 688999999865422 2234578899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999988864322 26899999999999999999999987 999999999999999999999999999765432
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 21 12346899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=291.63 Aligned_cols=201 Identities=27% Similarity=0.402 Sum_probs=179.4
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChh---cHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 467 (626)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.+++.+++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999999874 999999999876443 3458899999999998 999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC----CCEEEeec
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDF 543 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~Df 543 (626)
+|||++.+|.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999988654 2899999999999999999999987 9999999999999543 57999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
|++..... .......+||+.|+|||++....|+.++||||+||++|.|++|.+||....
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 99998776 334566789999999999999999999999999999999999999997654
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=280.15 Aligned_cols=201 Identities=27% Similarity=0.462 Sum_probs=173.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.+|++.+.||+|+||.||+|... .++.||+|++... .....++.+|++++.+++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999976 5888999998754 334567899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999865422 35899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
........++..|+|||.+....++.++|||||||++|||++ |+.|+..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 222222234668999999998899999999999999999998 8988864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=295.85 Aligned_cols=207 Identities=27% Similarity=0.399 Sum_probs=172.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCCh-hcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 465 (626)
.++|.+.++||+|+||.||+|+... +..||||++..... ...+.+.+|++++++++ ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678889999999999999998631 34699999975433 33467899999999996 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcc---------------------------------------------------------
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------- 488 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 488 (626)
.++||||+++|+|.++++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999888643110
Q ss_pred ----------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 006906 489 ----------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 534 (626)
Q Consensus 489 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 534 (626)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124788999999999999999999987 999999999999999
Q ss_pred CCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 535 DLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 535 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999865432221 1122346788999999998889999999999999999997 98888653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=316.74 Aligned_cols=207 Identities=28% Similarity=0.354 Sum_probs=186.4
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 462 (626)
.+++....++|++.++||+|+||.|..++.+ .+++||+|++.+. .+....-|.+|-.+|...+.+-||+++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4555566789999999999999999999986 5899999999874 23455678999999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
++++|+|||||+||+|-.++...+ .++++.++-++..|..||+-||+.| +|||||||.|||||..|++||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 999999999999999999986553 5899999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhc----c-CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAM----R-GYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
||.+..+..+..-.+...+|||-|++||++. + +.|++.+|.||+||++|||+.|..||-
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 9999988877766677788999999999985 2 679999999999999999999999994
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=281.25 Aligned_cols=196 Identities=31% Similarity=0.507 Sum_probs=177.5
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
|++.++||+|+||.|||+.++ .|+++|||.+.-. .+.+++..|+.++.+.+.+++|++||.|.....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 677899999999999999976 6999999998764 5678999999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|++.+.++... ..|++..+..++...+.||+|||... -||||||..|||++.+|.+||+|||.|..+.+....
T Consensus 113 GSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 113 GSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999986653 47999999999999999999999874 789999999999999999999999999877654332
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...+.||+.|||||++..-.|..++||||+|+...||..||+|+..
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 3447899999999999999999999999999999999999999853
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=268.08 Aligned_cols=208 Identities=26% Similarity=0.314 Sum_probs=176.8
Q ss_pred hcCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 467 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 467 (626)
.++|.+.+.+|+|||..||.++ ..+++.+|+|++...+.++.+..++|++..++++|||++++++++..+. +.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3568889999999999999998 5688999999998888788889999999999999999999999876433 489
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
++++|...|+|.+.+..... ....+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.+++.|||.++
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999998865422 2347999999999999999999999986 579999999999999999999999999988
Q ss_pred cccCCCccee--------cccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTHIS--------TRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.....-.... .....|..|.|||.+. ....++++|||||||+||+|+.|..||+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 6542211100 1123688999999985 457899999999999999999999999754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=278.62 Aligned_cols=202 Identities=30% Similarity=0.492 Sum_probs=173.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|++.+.||+|+||.||+|++.. ...||||.++... .....+|.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999999752 4579999987643 3345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++.... ..+++..+.+++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999986543 26899999999999999999999987 99999999999999999999999999997
Q ss_pred ccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 549 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
....... ......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 7522221 1122334678999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=282.09 Aligned_cols=199 Identities=38% Similarity=0.623 Sum_probs=166.4
Q ss_pred CCCeeeccCceEEEEEEEc-----CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 399 PANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
..+.||+|.||.||+|.+. .+..|+||.+.... ....++|.+|++.+++++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999987 25789999996543 33478899999999999999999999999988889999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++|+|.++++.... ..+++..+.+|+.||++||+|||+++ ++|+||+++||+++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999977521 36899999999999999999999986 999999999999999999999999999876322
Q ss_pred -CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 553 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 553 -~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.............|+|||.+....++.++||||||+++|||++ |+.|+...
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1222233446778999999999889999999999999999999 77887543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=282.34 Aligned_cols=206 Identities=33% Similarity=0.539 Sum_probs=175.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888999999999999999852 345689999987666666789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc--------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 469 VYEYMKNNCLSRAIFGKDT--------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
||||+++++|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 9999999999999864321 11235899999999999999999999987 999999999999999999999
Q ss_pred eecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 541 SDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 541 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+|||+++....... .......++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986543221 11222345778999999998889999999999999999998 89888643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=277.83 Aligned_cols=199 Identities=27% Similarity=0.421 Sum_probs=172.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++|+||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46889999999999999999974 68899999997665555567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.++++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999988643 25889999999999999999999987 9999999999999999999999999998664322
Q ss_pred cceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......++..|+|||.+. ...++.++|||||||++|||++|+.|+..
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 112345888999999874 34578899999999999999999999843
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=281.17 Aligned_cols=205 Identities=30% Similarity=0.505 Sum_probs=171.8
Q ss_pred cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|++.+.||+|+||.||+|++ .++..||+|.+.... .....++.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999985 246789999997543 3344678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 469 VYEYMKNNCLSRAIFGKDT------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
||||+++++|.+++..... .....+++.+...++.|++.||+|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853211 11235889999999999999999999987 99999999999999999
Q ss_pred CEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 537 NAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999986543221 11222345678999999988889999999999999999998 9888854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=277.33 Aligned_cols=200 Identities=31% Similarity=0.530 Sum_probs=171.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788999999999999999988888899999876433 4567899999999999999999999875 456899999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.++++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 84 KGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999875432 35899999999999999999999987 99999999999999999999999999987654332
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
.......++..|+|||+.....++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 22222335668999999988889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.84 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=171.8
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-C-----CceeeEEEEEEeCC
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-H-----PNLVKLYGCCVEGN 464 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~ 464 (626)
...-+|++.+.||+|+||.|-||... +++.||||+++... .-.++...|+.+|..++ | -|+|++++||...+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 33447899999999999999999965 68999999998763 33456677999998887 4 38999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC--CCEEEee
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISD 542 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~D 542 (626)
+++||+|.+. -+|+++++.+.. ..++...++.|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|
T Consensus 262 HlciVfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEe
Confidence 9999999985 589999987654 36999999999999999999999987 9999999999999653 4799999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||.++....... ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.
T Consensus 335 FGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 335 FGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 999997654322 345678899999999999999999999999999999998777654
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.05 Aligned_cols=208 Identities=27% Similarity=0.438 Sum_probs=173.0
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
.+++|++.+.||+|+||.||+|.+. .+..||||++.... .....++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999853 24679999986532 2345678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
.++||||+++++|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 1234688899999999999999999987 999999999999999999999
Q ss_pred eecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 541 SDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 541 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+|||+++......... .....++..|+|||++....++.++|||||||++|||++ |+.|+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999988654322211 112345778999999998889999999999999999999 68888643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=276.51 Aligned_cols=200 Identities=30% Similarity=0.447 Sum_probs=172.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|+..+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999865 68999999986432 1223568889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++... ..+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999988654 25789999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCccee--cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 549 YEEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 543221111 234578899999999998899999999999999999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=280.35 Aligned_cols=201 Identities=31% Similarity=0.487 Sum_probs=167.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|++.+.||+|+||.||+|++. +++ .+++|.+.... ....+++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999974 344 47788876442 223467788888999999999999999875 455788
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
++||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999996543 26899999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 549 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
....... ......++..|+|||.+....++.++|||||||++|||++ |+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 5433221 2223456778999999998899999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.80 Aligned_cols=202 Identities=31% Similarity=0.534 Sum_probs=173.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.++||+|+||.||+|..++++.||+|.+.... ....++.+|++++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45688899999999999999999889999999987643 34568899999999999999999999864 56789999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 83 ENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999998865432 36899999999999999999999987 9999999999999999999999999998765332
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 222222345678999999998889999999999999999999 99998643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=274.96 Aligned_cols=201 Identities=32% Similarity=0.496 Sum_probs=175.6
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|++|.||+++.. +++.|++|.+... .....+++.+|+++++.++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999976 6889999998643 334567888999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.++++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999875421 36899999999999999999999987 999999999999999999999999999866543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......|+..|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 22 123345788999999999988999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.03 Aligned_cols=202 Identities=30% Similarity=0.509 Sum_probs=171.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|.+.+.||+|+||.||+|++.+...||+|++.... ...+++.+|++++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688899999999999999998777789999997543 34567899999999999999999999875 45689999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 83 SKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999865321 35799999999999999999999987 9999999999999999999999999998665433
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........++..|+|||+..+..++.++||||||+++|||+| |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 222223346678999999988899999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=273.06 Aligned_cols=196 Identities=30% Similarity=0.454 Sum_probs=168.2
Q ss_pred CeeeccCceEEEEEEEcCCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCchh
Q 006906 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 479 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 479 (626)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988899999999876532 33457889999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecc
Q 006906 480 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559 (626)
Q Consensus 480 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 559 (626)
+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 9886542 25889999999999999999999987 9999999999999999999999999987544322211122
Q ss_pred cccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 560 ~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
..++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 234568999999998889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.06 Aligned_cols=205 Identities=31% Similarity=0.531 Sum_probs=174.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999853 355799999887666666789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 469 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
||||+++++|.+++..... .....+++..++.++.||+.|++|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865421 11235899999999999999999999997 999999999999999999
Q ss_pred EEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
++|+|||++........ .......++..|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999986543221 11223446788999999998899999999999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=281.33 Aligned_cols=198 Identities=26% Similarity=0.525 Sum_probs=174.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|+|++++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46788899999999999999864 68899999998765556678889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999988542 4789999999999999999999997 9999999999999999999999999988654322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 1 12234588899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=281.96 Aligned_cols=198 Identities=26% Similarity=0.441 Sum_probs=172.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999976 57889999887542 33346688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.++++.. ..+++..+..++.|++.||+|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 9999999998654 25889999999999999999999842 3999999999999999999999999998755332
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 154 M---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred c---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 1 2234688999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=277.67 Aligned_cols=193 Identities=25% Similarity=0.431 Sum_probs=169.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|+..+.||+|+||.||+|+.. +++.||+|.+... .....+++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36778899999999999999864 6889999998654 334456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999986542 4678889999999999999999987 999999999999999999999999999865432
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. .....++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 149 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 I---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred c---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 1 2234689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.86 Aligned_cols=201 Identities=29% Similarity=0.474 Sum_probs=173.1
Q ss_pred CCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------CeEEEEE
Q 006906 399 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLLVY 470 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~lV~ 470 (626)
..+.||+|+||.||+|+++ .|+.||||.+..... ...+...+|++++++++|+|||++++.-++. ....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 4578999999999999965 699999999987543 3345677899999999999999999986543 3568999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCCC--EEEeecCCc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLN--AKISDFGLA 546 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~--~kl~DfGla 546 (626)
|||.+|+|...|...+ ....|++...+.+..+++.||.|||+++ |+||||||.||++- .+|+ -||+|||.|
T Consensus 97 EyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred eecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999997654 3457999999999999999999999987 99999999999994 3343 599999999
Q ss_pred ccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 606 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~ 606 (626)
+...++. ....++||..|.+||++.+ ..|+..+|.|||||++||.+||..||.+....
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9887654 5567889999999999985 88999999999999999999999999876544
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=267.50 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=172.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC----hhcH----HHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS----RQGN----REFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~----~~~~----~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
-++|+..+.||+|..+.|-++..+ +|+.+|+|++.... .+.. +.-.+|+.+|+++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356788899999999999998865 68889999986432 1112 2345689999887 799999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
..+++|+|.|+.|.|.++|... ..++++..++|+.|+..|++|||.+. |+||||||+|||+|++.++||+||
T Consensus 96 sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999655 47999999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|+++.++... .-...+||++|+|||.+.. ..|+.+.|+||.|||||.|+.|-+||=+
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9999876543 3355789999999999864 3588899999999999999999999843
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=275.14 Aligned_cols=203 Identities=33% Similarity=0.547 Sum_probs=175.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|.+.+.||+|+||.||+|..++++.||||.+.... ...+++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788999999999999999998888899999987643 34578999999999999999999999999889999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++..... ..+++..+..++.|++.|++|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 84 SKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999876432 36899999999999999999999997 9999999999999999999999999998765322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211122234568999999998889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.68 Aligned_cols=203 Identities=23% Similarity=0.308 Sum_probs=164.8
Q ss_pred HHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCC------CceeeEEEEEE
Q 006906 389 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH------PNLVKLYGCCV 461 (626)
Q Consensus 389 ~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~~ 461 (626)
++...+++|++.++||+|+||+||+|... .++.||||+++... ...+++..|++++..++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999975 57889999986532 223455667777666654 45899999887
Q ss_pred eC-CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEcCCC---
Q 006906 462 EG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDL--- 536 (626)
Q Consensus 462 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~--- 536 (626)
.. ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 54 5788999988 67788877543 2689999999999999999999974 5 99999999999998765
Q ss_pred -------------CEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 537 -------------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 537 -------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864322 123467999999999999999999999999999999999999999765
Q ss_pred CC
Q 006906 604 PN 605 (626)
Q Consensus 604 ~~ 605 (626)
..
T Consensus 349 ~~ 350 (467)
T PTZ00284 349 DN 350 (467)
T ss_pred Ch
Confidence 43
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.18 Aligned_cols=199 Identities=25% Similarity=0.354 Sum_probs=162.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--------C
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--------N 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~ 464 (626)
..+|.+.+.||+|+||.||+|+.. +++.||||++.... ....+|+.+++.++|+||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457889999999999999999975 58899999886432 2345799999999999999999886432 2
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeec
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDF 543 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~Df 543 (626)
.+++||||+++ +|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 46799999985 5666553221 11236899999999999999999999997 99999999999999664 7999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99986643322 223568999999999865 46899999999999999999999999754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=291.14 Aligned_cols=192 Identities=28% Similarity=0.378 Sum_probs=161.0
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcC---CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 589999999865321 2223455566666554 799999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 9999888654 25899999999999999999999997 99999999999999999999999999875432221
Q ss_pred eecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 22345699999999998754 4789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=275.82 Aligned_cols=200 Identities=27% Similarity=0.393 Sum_probs=164.9
Q ss_pred CeeeccCceEEEEEEEcC---CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 401 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.||+|+||.||+|++.+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 4579999887653 233457889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+|.++++..........++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986543222235678888999999999999999987 9999999999999999999999999997543322211
Q ss_pred -ecccccCCcccchhhhccC-------CCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 557 -STRIAGTIGYMAPEYAMRG-------YLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 557 -~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.....++..|+|||++... .++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 1234567889999998642 35789999999999999996 99999654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.22 Aligned_cols=198 Identities=26% Similarity=0.368 Sum_probs=167.8
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----- 464 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 464 (626)
..++|.+.+.||+|+||.||++... +++.||||++... ......++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999875 5889999998653 2334567889999999999999999999986443
Q ss_pred -eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 465 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 465 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 57999999976 45554422 4788899999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9998543321 223356899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=277.61 Aligned_cols=203 Identities=30% Similarity=0.483 Sum_probs=171.8
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC------
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG------ 463 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------ 463 (626)
.+++.|++.+.||+|+||.||+|... +++.||+|++.... ....++..|++++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888999999999999999976 58889999987543 3456788999999988 799999999998753
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
...++||||+++++|.+++..... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 468999999999999999865321 36899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.|+..
T Consensus 156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99986543221 223356889999999986 34578899999999999999999999853
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=302.12 Aligned_cols=204 Identities=24% Similarity=0.302 Sum_probs=172.0
Q ss_pred CCCCCCeeeccCceEEEEEEEcCC-cEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEE-EEe------CCeE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGC-CVE------GNQL 466 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~-~~~------~~~~ 466 (626)
+..+.+.|.+|||+.||.|+...+ ..||+|++-...+...+...+|+++|++++ |+|||.+++. ... .-++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 345678999999999999998766 999999998888888899999999999997 9999999993 221 2368
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
+|.||||++|.|-+++..... ..|++.++++|+.++++|+++||.. .++|||||||-+||||+.++..||||||.|
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 999999999999999964322 3599999999999999999999998 478999999999999999999999999998
Q ss_pred ccccCCCccee--------cccccCCcccchhhh---ccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTHIS--------TRIAGTIGYMAPEYA---MRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.-......... -....|+.|.|||++ .+..+++|+|||||||+||-|+....||+..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 74322111000 013468999999987 4678999999999999999999999999754
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=273.49 Aligned_cols=201 Identities=30% Similarity=0.501 Sum_probs=170.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|.+.+.||+|++|.||++.+.++..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577889999999999999998877789999886543 34567889999999999999999999875 456899999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.++++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999865422 35899999999999999999999987 99999999999999999999999999986643322
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.......++..|+|||...+..++.++||||||+++|||+| |+.|+...
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22222345678999999988889999999999999999999 89888643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=279.04 Aligned_cols=198 Identities=28% Similarity=0.527 Sum_probs=175.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.+|.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56888999999999999999964 78999999997765555677889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999988543 4788999999999999999999987 9999999999999999999999999988654332
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 12234578899999999998899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=274.56 Aligned_cols=207 Identities=29% Similarity=0.381 Sum_probs=175.5
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556778888889999999999999965 578899999887766667789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCEEEeecCCcc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAK 547 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~ 547 (626)
|+||+++++|.+++...... ...++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999998654211 12278889999999999999999987 999999999999976 6789999999987
Q ss_pred cccCCCcceecccccCCcccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....... ......++..|+|||++... .++.++||||||+++|||++|+.|+..
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 6543222 12234578899999998664 378899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=275.05 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=162.5
Q ss_pred CeeeccCceEEEEEEEcC---CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 401 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|++.++.++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 3568888876543 334567889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+|.+++...........++.....++.||+.|++|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999987653322234578889999999999999999987 9999999999999999999999999987543322111
Q ss_pred -ecccccCCcccchhhhcc-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 557 -STRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 557 -~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.....++..|+|||+... ..++.++|||||||++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 122345678999998743 356889999999999999999 77787543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=279.41 Aligned_cols=199 Identities=28% Similarity=0.529 Sum_probs=175.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.+|+..+.||.|++|.||+|... +++.||+|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 35888899999999999999864 68999999997765555678889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++... .+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999988542 5899999999999999999999997 9999999999999999999999999988654332
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......++..|+|||.+....++.++|||||||++|||++|+.||...
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 122345888999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=271.26 Aligned_cols=200 Identities=32% Similarity=0.521 Sum_probs=176.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|+..+.||+|+||.||+|+..+ ++.+|+|.+..... .+++.+|++++++++|+||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578899999999999999999875 78999999876532 67899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999986432 36899999999999999999999987 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.|+...
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 21 222345788999999999889999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=272.09 Aligned_cols=196 Identities=27% Similarity=0.447 Sum_probs=166.0
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 68899999876543 34456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCccee-
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS- 557 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~- 557 (626)
.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99986542 25889999999999999999999987 99999999999999999999999999885443211110
Q ss_pred cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 558 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.....+..|+|||.+....++.++||||||+++|||++ |..|+...
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 11123457999999998889999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=281.84 Aligned_cols=198 Identities=26% Similarity=0.422 Sum_probs=160.8
Q ss_pred CCeeeccCceEEEEEEEc---CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEEEEEEecC
Q 006906 400 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVYEYMK 474 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~e~~~ 474 (626)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999987542 23567889999999999999999998854 456899999986
Q ss_pred CCchhhhhcCCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCCEEEeecCCc
Q 006906 475 NNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 546 (626)
Q Consensus 475 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 546 (626)
+ +|.+++..... .....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 67666542211 11235899999999999999999999997 9999999999999 45678999999999
Q ss_pred ccccCCCcc--eecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876533211 1234568999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=276.02 Aligned_cols=198 Identities=29% Similarity=0.505 Sum_probs=171.3
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|+|++++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999976 4778899998776666667889999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|..++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 99988876432 26899999999999999999999987 99999999999999999999999999876543221
Q ss_pred eecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......++..|+|||++. ...++.++|||||||++|||++|+.|+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 223346889999999984 34578899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=275.43 Aligned_cols=199 Identities=25% Similarity=0.416 Sum_probs=172.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 45777789999999999999875 68899999987665555567888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.... .+++.+++.++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999886542 5899999999999999999999997 9999999999999999999999999987654322
Q ss_pred cceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......|+..|+|||.+. ...++.++|||||||++|||++|+.|+..
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 1 123346899999999874 45688999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=273.71 Aligned_cols=198 Identities=33% Similarity=0.518 Sum_probs=171.9
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHH--HHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNR--EFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
|++.+.||+|+||+||+++.. +++.||+|++......... ...+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999987 4678999999887543332 3456999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-N 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-T
T ss_pred ccccccccccc-----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-c
Confidence 99999999872 136899999999999999999999997 99999999999999999999999999986422 2
Q ss_pred cceecccccCCcccchhhhc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
........++..|+|||.+. ...++.++||||+|+++|+|++|+.|+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22334456899999999998 788999999999999999999999999754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=271.27 Aligned_cols=194 Identities=29% Similarity=0.478 Sum_probs=162.9
Q ss_pred eeeccCceEEEEEEEc---CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCc
Q 006906 402 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 477 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 477 (626)
.||+|+||.||+|++. ++..||+|++..... ...+++.+|++++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 355799999876533 33467899999999999999999999885 457899999999999
Q ss_pred hhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCccee
Q 006906 478 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557 (626)
Q Consensus 478 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 557 (626)
|.+++.... ..+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999986532 26899999999999999999999987 99999999999999999999999999986544322211
Q ss_pred cc--cccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 558 TR--IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 558 ~~--~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.. ..++..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 11 223578999999988889999999999999999996 99998643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=274.01 Aligned_cols=203 Identities=26% Similarity=0.408 Sum_probs=173.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999975 6899999987642 2333457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++..... ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988753211 1235789999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 3322 11234578899999999888899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=275.95 Aligned_cols=208 Identities=31% Similarity=0.431 Sum_probs=172.4
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999999753 5678999886543 3345678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---CEEE
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKI 540 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 540 (626)
.++||||+++++|.+++..... .....++|..+.+++.||+.|++|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865431 11235899999999999999999999987 99999999999998754 5999
Q ss_pred eecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 541 SDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 541 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999998663322111 112223568999999998899999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=273.16 Aligned_cols=200 Identities=29% Similarity=0.410 Sum_probs=169.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 466 (626)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57888999999999999999975 58899999875321 12345788899999999999999999998763 467
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+++++|.+++.... .+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccc
Confidence 89999999999999886432 4788899999999999999999987 999999999999999999999999998
Q ss_pred ccccCCCc--ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 86542111 111234588899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=277.29 Aligned_cols=205 Identities=32% Similarity=0.481 Sum_probs=170.6
Q ss_pred CCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
+|.+.+.||+|+||.||+|+.. ....+|+|.+.... ....+++.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4678899999999999999853 23578999887543 2335678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc-------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 006906 469 VYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 529 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 529 (626)
||||+.+++|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998754211 11235889999999999999999999987 9999999999
Q ss_pred EEEcCCCCEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 530 VLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 530 ILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+++++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999998654322211 122345678999999988889999999999999999998 99988643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=275.54 Aligned_cols=200 Identities=32% Similarity=0.486 Sum_probs=170.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-----CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 467 (626)
.+|.+.+.||+|+||.||++..+ +++.||+|++........+++.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788999999999999999853 578999999987766667789999999999999999999998754 34689
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999986542 25899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCccee--cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 548 LYEEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 548 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
.......... ....++..|+|||.+....++.++|||||||++|||++|..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 7654322111 11223456999999988889999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=289.93 Aligned_cols=197 Identities=22% Similarity=0.273 Sum_probs=169.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc---CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..+|.+.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 356889999999999999999754 3578999987643 24568999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|++. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||+++...
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9996 5777777332 36899999999999999999999987 9999999999999999999999999998665
Q ss_pred CCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 551 EDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 551 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 43221 2233569999999999999999999999999999999999999996543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=285.62 Aligned_cols=207 Identities=29% Similarity=0.460 Sum_probs=170.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEe-CC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE-GN 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-~~ 464 (626)
.++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+..|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888999999999999999742 24789999987543 23345678899999999 89999999998874 45
Q ss_pred eEEEEEEecCCCchhhhhcCCCcc--------------------------------------------------------
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 488 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 488 (626)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999888543210
Q ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce-ecccccCCccc
Q 006906 489 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYM 567 (626)
Q Consensus 489 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 567 (626)
....++|..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0136899999999999999999999987 9999999999999999999999999998764332221 12234567899
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 568 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 568 aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=288.22 Aligned_cols=198 Identities=24% Similarity=0.337 Sum_probs=167.9
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 463 (626)
..++|.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3467999999999999999999965 5888999998754 233456788999999999999999999987543
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999975 56555532 4788899999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 9998654321 223356899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=276.88 Aligned_cols=200 Identities=29% Similarity=0.483 Sum_probs=173.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|+|++++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56788899999999999999976 48899999998776666788999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|..++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999988775432 25899999999999999999999987 9999999999999999999999999987543221
Q ss_pred cceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......++..|+|||++. ...++.++|||||||++|||++|+.|+..
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 1 122345788999999984 34578899999999999999999999854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=275.61 Aligned_cols=205 Identities=32% Similarity=0.532 Sum_probs=173.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|...++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999742 356899999887766667789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 469 VYEYMKNNCLSRAIFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
||||+++++|.+++...... ....+++..++.++.|++.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 99999999999998654210 1135899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 539 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 539 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999976543221 11122335678999999998899999999999999999998 8998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=277.53 Aligned_cols=199 Identities=28% Similarity=0.474 Sum_probs=164.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcC---CCCceeeEEEEEEe-----CC
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVE-----GN 464 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~ 464 (626)
+|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999976 688999999875422 2234556677766654 79999999998864 34
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence 57999999985 78777754322 25899999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++...... ......+|..|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 998664322 123346889999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=276.54 Aligned_cols=202 Identities=27% Similarity=0.486 Sum_probs=175.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999975 6889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999886542 25899999999999999999999997 999999999999999999999999998765432
Q ss_pred CcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......++..|+|||.+. ...++.++||||||+++|||++|+.|+...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 22 122345889999999975 345778999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-32 Score=275.15 Aligned_cols=202 Identities=31% Similarity=0.541 Sum_probs=169.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
.++|+..+.||+|+||+||+|++. +++ .||+|.+... .....+++.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356888899999999999999864 444 4899998754 334456788999999999999999999998754 578
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+++||+++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 9999999999999986542 25899999999999999999999987 9999999999999999999999999998
Q ss_pred cccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 548 LYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......... .....++..|+|||...+..++.++|||||||++|||++ |+.|++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 765332211 111234678999999998899999999999999999998 89998643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=271.63 Aligned_cols=199 Identities=29% Similarity=0.493 Sum_probs=172.3
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC------hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
+|...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467889999999999999998889999999886532 12235688899999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999986532 5789999999999999999999987 999999999999999999999999998865
Q ss_pred cCCC-----cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDK-----THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 3211 1112234588999999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-34 Score=267.41 Aligned_cols=199 Identities=27% Similarity=0.416 Sum_probs=172.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++.|++-+.||+|.|+.||+.... .|+.+|+|++... +..+.+++.+|+.+-..++|||||++.+...+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456777889999999999998864 6899999987543 3346688999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEeecCCcc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK 547 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~ 547 (626)
|+|.|+.|..-+-.. ..+++..+-..++||+++|.|+|.++ |||||+||+|+++.. ..-+||+|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999997655332 25788889999999999999999997 999999999999943 3458999999999
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.+.. .......+||++|||||++++.+|+..+|||+-|||||-|+.|..||-.
T Consensus 162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 8773 2334456899999999999999999999999999999999999999964
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=277.82 Aligned_cols=205 Identities=29% Similarity=0.480 Sum_probs=169.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC---------------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD---------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYG 458 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~---------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~ 458 (626)
++|++.+.||+|+||.||+++..+ ...||+|.+.... ......+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 568889999999999999987642 2358999987642 333457899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhcCCCcc-------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEE
Q 006906 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 531 (626)
Q Consensus 459 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL 531 (626)
++...+..++||||+++++|.+++...... ....+++..+++++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 999999999999999999999988543211 1124789999999999999999999987 999999999999
Q ss_pred EcCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 006906 532 LDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNY 602 (626)
Q Consensus 532 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt--G~~p~~~ 602 (626)
+++++.+||+|||++......... ......++..|+|||.+....++.++|||||||++|||++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999865432211 1122345678999999988889999999999999999998 5566654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=275.79 Aligned_cols=206 Identities=28% Similarity=0.443 Sum_probs=173.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... .....++.+|++++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999998642 3689999987543 34456788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
++||||+++++|.+++...... ....++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998653221 1235789999999999999999999987 9999999999999999999999
Q ss_pred ecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 542 DFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 542 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
|||+++....... .......++..|+|||.+....++.++|||||||++|||+| |+.|+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 224 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence 9999986543321 11223346789999999988889999999999999999998 8988864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=276.27 Aligned_cols=197 Identities=29% Similarity=0.439 Sum_probs=173.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999976 58999999986532 233466889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998654 26889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .....+++.|+|||.+.....+.++||||||+++|||++|+.||...
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 43 22345889999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=293.22 Aligned_cols=194 Identities=24% Similarity=0.287 Sum_probs=166.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
...|.+.+.||+|+||.||+++.. .++.||||.... ..+.+|++++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457889999999999999999986 478899996432 3456899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+. ++|.+++.... ..++|.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 242 ~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 67887775432 26899999999999999999999997 999999999999999999999999999865432
Q ss_pred Cc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 553 KT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 553 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
.. .......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 21 12223569999999999999999999999999999999999887653
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=274.56 Aligned_cols=197 Identities=31% Similarity=0.483 Sum_probs=166.8
Q ss_pred CCCCCeeeccCceEEEEEEE-----cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEE
Q 006906 397 FDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 468 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 468 (626)
|...+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 357889999987653 23456788999999999999999999998753 46899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++... .+++.++..++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999998543 5899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 549 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....... ......++..|+|||.+....++.++||||||+++|||+||+.|+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 6543221 11122356679999999888899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=273.67 Aligned_cols=201 Identities=26% Similarity=0.410 Sum_probs=172.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 58999999986542 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|..++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99999888876443 25899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1223457889999999875 557899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=285.09 Aligned_cols=197 Identities=28% Similarity=0.415 Sum_probs=167.9
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----- 463 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 463 (626)
...++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999865 67899999987542 22345678899999999999999999987533
Q ss_pred -CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 464 -NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 464 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
...++++|++ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 4578999988 67888777432 5899999999999999999999997 99999999999999999999999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 162 fg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 162 FGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99998654322 23468999999999876 5689999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=272.07 Aligned_cols=202 Identities=29% Similarity=0.480 Sum_probs=172.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45688899999999999999998788889999887542 345678899999999999999999999887 7789999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999865432 36889999999999999999999987 9999999999999999999999999998664332
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........++..|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 222222335678999999998889999999999999999999 89998643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=272.61 Aligned_cols=202 Identities=30% Similarity=0.491 Sum_probs=171.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.+|++.+.||+|+||.||+|++. .+..+|+|.++... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788999999999999999864 23479999987543 33356789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999986543 25899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCcceec--ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 550 EEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......... ...++..|+|||.+....++.++||||||+++||+++ |+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 543322211 1223568999999998889999999999999999886 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=272.25 Aligned_cols=202 Identities=30% Similarity=0.522 Sum_probs=171.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CC---cEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
+++|+..+.||+|+||.||+|+.. ++ ..+|+|.++... ....+++..|++++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456888899999999999999975 23 379999987653 3345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999986542 26899999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCcceec--ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 549 YEEDKTHIST--RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
.......... ....+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 6432221111 1123457999999988889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=270.62 Aligned_cols=201 Identities=27% Similarity=0.459 Sum_probs=176.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999975 57889999998765556788999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999886542 26889999999999999999999987 9999999999999999999999999988654322
Q ss_pred cceecccccCCcccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......++..|+|||.+... .++.++||||||+++|||+||+.|+...
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1 12234578899999999776 7899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=286.32 Aligned_cols=198 Identities=26% Similarity=0.337 Sum_probs=167.7
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 463 (626)
..++|...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 58899999987542 33346778899999999999999999988643
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 357999999975 45555422 4788999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9998654321 223356899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=288.09 Aligned_cols=207 Identities=27% Similarity=0.433 Sum_probs=172.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 465 (626)
.++|.+.+.||+|+||.||+|++. .++.||+|++..... ...+.+.+|++++.++. |||||+++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345778899999999999999864 246799999976532 23457889999999997 9999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcc---------------------------------------------------------
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTE--------------------------------------------------------- 488 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 488 (626)
.++||||+++|+|.++++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999999999998654210
Q ss_pred ------------------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 489 ------------------------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 489 ------------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
....+++..+.+++.||+.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1124788889999999999999999886 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.|+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999986543221 11122356788999999998889999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=269.93 Aligned_cols=200 Identities=30% Similarity=0.578 Sum_probs=172.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
.+|++.+.||+|+||.||++.+.+++.+|+|.+.... ....++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778899999987542 335678999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++.... ..++++.+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999986543 25789999999999999999999987 99999999999999999999999999886543222
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
.......++.+|+|||.+....++.++||||||+++|||++ |+.|+..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 11222335678999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=268.79 Aligned_cols=201 Identities=28% Similarity=0.354 Sum_probs=177.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhc---HHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG---NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|+..++||+|.||+|-.++-+ .++.+|+|++++...-. ...-+.|-++|...+||.+..+-..|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367889999999999999999865 68999999998764333 33456788999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||..||.|.-+|.... .+++...+-+...|..||.|||+++ ||.||||.+|.|+|.||++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999886653 6899999999999999999999987 999999999999999999999999999854
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
-.. .......+||+.|+|||++....|+..+|.|.+||+||||++||.||-..
T Consensus 319 I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 319 IKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 322 23455689999999999999999999999999999999999999999654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=270.71 Aligned_cols=203 Identities=29% Similarity=0.453 Sum_probs=175.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 7899999988642 2233567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... .....+++.++..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999885431 11236899999999999999999999987 9999999999999999999999999988654
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... .....++..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus 158 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 32211 2234578899999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=278.19 Aligned_cols=200 Identities=23% Similarity=0.408 Sum_probs=169.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999976 57899999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 58888775432 25789999999999999999999987 999999999999999999999999999765432
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 1122356889999998865 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=272.07 Aligned_cols=203 Identities=28% Similarity=0.455 Sum_probs=165.9
Q ss_pred CCCCCeeeccCceEEEEEEEcCC-c--EEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------Ce
Q 006906 397 FDPANKVGEGGFGSVYKGILSDG-T--VIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQ 465 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~~g-~--~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 465 (626)
|.+.+.||+|+||.||+|++.+. . .||+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678999999999999997643 2 5899988654 334457788999999999999999999987532 24
Q ss_pred EEEEEEecCCCchhhhhcCCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988743211 11235899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 545 LAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+++.+....... .....+++.|+|||......++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 998765432211 122345678999999999899999999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=279.07 Aligned_cols=198 Identities=26% Similarity=0.427 Sum_probs=160.3
Q ss_pred CCeeeccCceEEEEEEEc---CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEE--eCCeEEEEEEecC
Q 006906 400 ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQLLLVYEYMK 474 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~lV~e~~~ 474 (626)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999975 35789999987542 2356788999999999999999999985 3567899999987
Q ss_pred CCchhhhhcCCC----cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCCEEEeecCCc
Q 006906 475 NNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 546 (626)
Q Consensus 475 ~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 546 (626)
+ +|.+++.... ......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 6666653221 111235889999999999999999999987 9999999999999 56678999999999
Q ss_pred ccccCCCcc--eecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1233568999999999876 45799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=269.82 Aligned_cols=200 Identities=24% Similarity=0.345 Sum_probs=173.5
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 6889999998643 2334567888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++++|||++.......
T Consensus 81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999988754322 25789999999999999999999987 9999999999999999999999999998664322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 2 22335688899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=272.50 Aligned_cols=198 Identities=29% Similarity=0.488 Sum_probs=174.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778899999999999999976 68899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998643 5899999999999999999999987 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ......++..|+|||++.+..++.++||||||+++|||+||+.|+..
T Consensus 152 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 152 MS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred cc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 22 22234578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=279.66 Aligned_cols=205 Identities=30% Similarity=0.461 Sum_probs=169.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCc--EEEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|++.+.||+|+||.||+|.++ ++. .+|+|.+... .....+++.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999975 343 4678877653 234456788999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 469 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
||||+++++|.++++.... .....+++.+++.++.|++.|++|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999865421 11235889999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+||+|||++........ .....++..|+|||++....++.++|||||||++|||+| |..||...
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 99999999864321111 111224567999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=277.29 Aligned_cols=204 Identities=30% Similarity=0.454 Sum_probs=168.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-Cc--EEEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||.||+|+..+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999753 33 4788888743 334456789999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 470 YEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
|||+++++|.++++..... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999998653210 1125889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+|||++........ ......+..|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999874322111 111123457999999988889999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=270.79 Aligned_cols=190 Identities=27% Similarity=0.414 Sum_probs=161.2
Q ss_pred CeeeccCceEEEEEEEcC-------------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 401 NKVGEGGFGSVYKGILSD-------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
+.||+|+||.||+|++.+ ...||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998642 2358999887765555668889999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC-------EEE
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-------AKI 540 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------~kl 540 (626)
+||||+++++|..+++... ..+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998886542 25899999999999999999999987 999999999999987664 899
Q ss_pred eecCCcccccCCCcceecccccCCcccchhhhc-cCCCCChhhHHHHHHHHHHHH-hCCCCCCC
Q 006906 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIV-SGKSNTNY 602 (626)
Q Consensus 541 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~s~Gvil~ell-tG~~p~~~ 602 (626)
+|||++....... ...++..|+|||.+. ...++.++|||||||++|||+ +|+.|+..
T Consensus 154 ~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 154 SDPGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999987553221 234788899999886 467899999999999999998 58888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=269.25 Aligned_cols=192 Identities=30% Similarity=0.463 Sum_probs=162.9
Q ss_pred eeeccCceEEEEEEEc---CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 402 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
.||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999986543 234567899999999999999999999875 45678999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999998543 25899999999999999999999987 9999999999999999999999999998765433221
Q ss_pred e--cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 557 S--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 557 ~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
. ....++..|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 11234578999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=275.81 Aligned_cols=207 Identities=29% Similarity=0.439 Sum_probs=171.0
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
.+++|++.+.||+|+||.||+|..++ +..||+|.+.... .....++.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45778999999999999999997542 4579999886543 2334568889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
.++||||+++|+|.+++...... .....++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999998643211 1234677889999999999999999987 999999999999999999999
Q ss_pred eecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 541 SDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 541 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |+.|+..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999865432211 1112235678999999998889999999999999999998 7888854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=290.48 Aligned_cols=194 Identities=30% Similarity=0.493 Sum_probs=168.5
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|...+.||+|+||.||.|+.. +.++||||++.-. +.+..++++.|+..|.+++|||+|.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 555688999999999999964 7889999998654 334457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
|- |+-.+++.-.. .++.+..+..|+.+.+.||+|||+.+ .||||||..|||+.+.|.|||+|||.|.+....
T Consensus 108 Cl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred Hh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 96 46666663322 36889999999999999999999997 899999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..++||+.|||||++. .+.|+-|+||||+||+..||.-.++|...+
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 3468999999999985 468999999999999999999999997543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=272.88 Aligned_cols=203 Identities=28% Similarity=0.442 Sum_probs=174.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+++.. +++.+|||.+.... .....++.+|+++++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778899999999999999964 78999999876532 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++..... ....+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999998864211 1236899999999999999999999987 9999999999999999999999999988664
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... ......++..|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3322 12234588899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=269.73 Aligned_cols=201 Identities=29% Similarity=0.429 Sum_probs=170.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 466 (626)
.+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+ ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999875 58899999886432 2234568889999999999999999998875 3678
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
+++|||+++++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 89999999999999986542 5789999999999999999999887 999999999999999999999999998
Q ss_pred ccccCCCc--ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 86542111 1112245788999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=271.40 Aligned_cols=203 Identities=30% Similarity=0.452 Sum_probs=168.1
Q ss_pred CCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-----
Q 006906 397 FDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 465 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 465 (626)
|.+.+.||+|+||.||+|++.. +..||+|++.... .....++.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998752 3679999987542 3334678999999999999999999999876554
Q ss_pred -EEEEEEecCCCchhhhhcCCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 466 -LLLVYEYMKNNCLSRAIFGKDTE-YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 466 -~~lV~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
.++||||+++++|..++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999888543211 1236899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 544 GLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
|+++......... .....++..|+|||++....++.++|||||||++|||++ |..|+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9998665432211 112234678999999988889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=272.49 Aligned_cols=201 Identities=27% Similarity=0.447 Sum_probs=169.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999976 68899999986542 22346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
++ ++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 678877754322 136899999999999999999999987 999999999999999999999999999765432
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.|+...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 1222356889999998865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=273.88 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=173.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777899999999999999975 58899999876543 33457889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++... ..+++..+..++.+++.||.|||+.. .++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999888653 25899999999999999999999742 3999999999999999999999999998754322
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
. .....|+..|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 1 123468999999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=276.89 Aligned_cols=204 Identities=28% Similarity=0.430 Sum_probs=172.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
.++|.+.+.||+|+||.||+++.. .+..||||.++... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356889999999999999999742 34579999987653 23346788999999999 79999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++|+|.++++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+|||++.++.++++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999865432 24899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 546 AKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
++........ ......++..|+|||.+....++.++|||||||++|||++ |+.|+...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 9865433221 1122345678999999998889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=306.67 Aligned_cols=210 Identities=25% Similarity=0.393 Sum_probs=172.0
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CC
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GN 464 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~ 464 (626)
.....++|.+.+.||+|+||+||++... .++.||+|.+... .......+..|+.++..++|||||++++++.. .+
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445578999999999999999999976 5778999988653 23345678899999999999999999998864 45
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEeCCCCCCEEEcCC-----
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR----IKIVHRDIKTSNVLLDKD----- 535 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiH~Dlkp~NILl~~~----- 535 (626)
.+++||||+++++|.++|.... .....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 6899999999999999886431 112368999999999999999999998542 249999999999999643
Q ss_pred ------------CCEEEeecCCcccccCCCcceecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 536 ------------LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 536 ------------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
..+||+|||++....... ......||+.|+|||++.. ..++.++|||||||+||||+||+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999998664322 2233568999999999854 458899999999999999999999996
Q ss_pred C
Q 006906 602 Y 602 (626)
Q Consensus 602 ~ 602 (626)
.
T Consensus 245 ~ 245 (1021)
T PTZ00266 245 K 245 (1021)
T ss_pred c
Confidence 4
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=278.28 Aligned_cols=194 Identities=28% Similarity=0.499 Sum_probs=170.3
Q ss_pred CCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCc
Q 006906 399 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 477 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 477 (626)
....||+|+||.||++... +++.||+|++........+.+.+|+.++..++|||++++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 689999999876555556778899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCccee
Q 006906 478 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557 (626)
Q Consensus 478 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 557 (626)
|.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 105 L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 105 LTDIVSQT------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 99877432 5889999999999999999999987 99999999999999999999999999876543221 12
Q ss_pred cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 558 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 235688999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=277.50 Aligned_cols=203 Identities=26% Similarity=0.362 Sum_probs=174.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999976 489999999976532 24467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 99999999999864322 36899999999999999999999987 9999999999999999999999999987553
Q ss_pred CCCcc----------------------------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTH----------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 21110 11124578899999999988899999999999999999999999864
Q ss_pred C
Q 006906 603 R 603 (626)
Q Consensus 603 ~ 603 (626)
.
T Consensus 235 ~ 235 (316)
T cd05574 235 S 235 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=275.56 Aligned_cols=204 Identities=31% Similarity=0.448 Sum_probs=169.5
Q ss_pred CCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
+|.+.+.||+|+||.||+|...+ ++.||+|++...... ....+.+|+++++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35667889999999999998642 578999999765432 34568899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 469 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
++||+++++|.+++..... .....+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 9999999999988753210 11235889999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..|+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999886543221 11222345778999999988889999999999999999998 8888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=272.15 Aligned_cols=200 Identities=31% Similarity=0.537 Sum_probs=169.5
Q ss_pred CCCCCCeeeccCceEEEEEEEcC-C---cEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~-g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+|++.+.||+|+||.||+|.+.. + ..||||.+... .....++|..|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46788999999999999999753 3 36999998765 3344578999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... ..+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999986543 25899999999999999999999987 9999999999999999999999999988654
Q ss_pred CCCcce--ecccc--cCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 551 EDKTHI--STRIA--GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 551 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
...... ..... .+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 322111 11111 1357999999998899999999999999999986 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=269.54 Aligned_cols=199 Identities=31% Similarity=0.519 Sum_probs=170.8
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh---------cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ---------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999875 5789999988654221 12467889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999998654 25889999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcc-----eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 546 AKLYEEDKTH-----ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 546 a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 9876532111 11224578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=274.31 Aligned_cols=205 Identities=28% Similarity=0.484 Sum_probs=170.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-----------------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-----------------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKL 456 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-----------------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 456 (626)
++|++.+.||+|+||.||++... +...||+|.+.... .....++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998643 23468999987643 3345688999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhcCCCcc------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 006906 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 530 (626)
Q Consensus 457 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 530 (626)
++++...+..++||||+++++|.+++...... ....+++.++..++.|++.|++|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998654211 1135888999999999999999999997 99999999999
Q ss_pred EEcCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 006906 531 LLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNY 602 (626)
Q Consensus 531 Ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt--G~~p~~~ 602 (626)
|++.++.++|+|||+++.+...... ......++..|+|||....+.++.++|||||||++|||++ |..|+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999865432211 1122334678999999888889999999999999999998 6677754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=279.01 Aligned_cols=198 Identities=19% Similarity=0.276 Sum_probs=165.0
Q ss_pred CCCeeecc--CceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 399 PANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 399 ~~~~IG~G--~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+.++||+| +|++||++..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999875 68999999997642 233456778999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999854322 25899999999999999999999987 9999999999999999999999998755432111
Q ss_pred cc------eecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 TH------ISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~------~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 10 0111346778999999876 4589999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=268.28 Aligned_cols=198 Identities=32% Similarity=0.544 Sum_probs=173.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888999999999999999875 78899999987644 5678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999865432 25899999999999999999999997 9999999999999999999999999998663322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
. ....+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 1 2234568999999988889999999999999999997 99888543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=277.67 Aligned_cols=207 Identities=29% Similarity=0.429 Sum_probs=171.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
.++|.+.+.||+|+||.||++... +...+|+|.+.... .....++.+|++++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356889999999999999999853 23569999997642 33456788899999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.+++...... ....+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999654211 1135899999999999999999999987 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.|+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999988654321111 111224568999999998889999999999999999998 88887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=289.67 Aligned_cols=195 Identities=28% Similarity=0.483 Sum_probs=165.3
Q ss_pred CCCeeeccCceEEEEEEEc-CCcEEE---EEEecc-CChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe--EEEEEE
Q 006906 399 PANKVGEGGFGSVYKGILS-DGTVIA---VKQLSS-KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ--LLLVYE 471 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~-~g~~vA---vK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lV~e 471 (626)
..++||+|+|-+||||... +|-.|| ||.-+. .+....+.|..|+++|+.++|+|||+++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999875 455665 222111 133445789999999999999999999999987655 789999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~ 550 (626)
.|..|+|..+++..+ .++...+++++.||++||.|||++. |||||||||-.||||+. -|.+||+|+|||....
T Consensus 124 L~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999987653 5788899999999999999999985 78999999999999975 5899999999999876
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ..+.|||.|||||++. ..|++.+||||||++|+||+|+..||...
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence 4332 2378999999999987 78899999999999999999999998644
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=274.81 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=172.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-----------------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceee
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-----------------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVK 455 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 455 (626)
..+|++.+.||+|+||.||+++..+ +..||+|.+.... ....+++.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998642 2468999987653 334567889999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhcCCCccc------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 006906 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 529 (626)
Q Consensus 456 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 529 (626)
+++++..++..++||||+++++|.+++....... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543211 126899999999999999999999987 9999999999
Q ss_pred EEEcCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCCCCC
Q 006906 530 VLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS--GKSNTNY 602 (626)
Q Consensus 530 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt--G~~p~~~ 602 (626)
|+++.++.++|+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |..|+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999986543221 12223446778999999988889999999999999999998 6667654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=277.54 Aligned_cols=196 Identities=28% Similarity=0.525 Sum_probs=171.4
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
|+....||+|+||.||++... +++.||||.+........+.+.+|+..++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 444577999999999999875 6889999998766555567789999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 104 ~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 104 GALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 9999987432 4789999999999999999999987 99999999999999999999999999876543221
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......|+..|+|||+.....++.++||||||+++|||++|+.||..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12234588999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=277.02 Aligned_cols=209 Identities=28% Similarity=0.428 Sum_probs=173.6
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
...++|+..+.||+|+||.||++...+ ...+|+|.+... ......++.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344678889999999999999998642 367999998764 233446788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.++++.... .....+++..+++++.|++.|++|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 999999999999999999864310 12246899999999999999999999987 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+.++.+||+|||+++.+....... .....++..|+|||.+....++.++|||||||++|||++ |..|+...
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999998765432211 112234578999999988899999999999999999997 88887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=274.34 Aligned_cols=203 Identities=27% Similarity=0.414 Sum_probs=169.0
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578899999999999999999875 688999999875432 22346788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+. +++.+++.... ..+.+..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 56666654332 25788889999999999999999987 9999999999999999999999999997543
Q ss_pred CCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||+...
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 3221 1122346889999999875 357889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=285.40 Aligned_cols=206 Identities=26% Similarity=0.451 Sum_probs=178.9
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.+-...+....++||-|.||.||.|+|+. .-.||||.++.+. ....+|+.|+.+|+.++|||+|+|+|+|..+..+|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33344456677899999999999999974 5679999998763 457899999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|+|||..|+|.++|+..... .++--..+.++.||+.||+||..++ +|||||..+|.|+.++..+||+|||++++
T Consensus 341 iTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999877543 5677778899999999999999987 99999999999999999999999999999
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+..+.........-...|.|||-+....++.|+|||+|||+|||+.| |-.|+.+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 87655433222233568999999999999999999999999999987 8888854
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=276.69 Aligned_cols=206 Identities=27% Similarity=0.440 Sum_probs=171.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
.++|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888999999999999999742 24579999987542 34457789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
...++||||+++++|.+++...... ....+++.++..++.||+.||+|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 9999999999999999998653211 1235889999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999998765332211 122335678999999988889999999999999999998 7888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=267.27 Aligned_cols=201 Identities=27% Similarity=0.396 Sum_probs=171.9
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e 471 (626)
+|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999976 57889999986542 3345678899999999999999999998764 446799999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++..... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999998865321 35899999999999999999999997 99999999999999999999999999986643
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......+++.|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 322 223345789999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=266.97 Aligned_cols=200 Identities=28% Similarity=0.456 Sum_probs=174.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998864 6889999988654 234456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999986542 136899999999999999999999987 999999999999999999999999999866443
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ......+++.|+|||...+..++.++||||||+++|||++|+.|+..
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 32 22335688999999999888889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=266.86 Aligned_cols=201 Identities=29% Similarity=0.481 Sum_probs=177.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|++|.||+++.. +++.||+|++..... ...+++.+|++.+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999987 489999999877643 4467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999998654 368999999999999999999999 86 99999999999999999999999999987654
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.... .....++..|+|||.+....++.++||||||+++|||+||+.|+....
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3322 123457889999999998899999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=274.98 Aligned_cols=213 Identities=26% Similarity=0.428 Sum_probs=175.7
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEE-
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV- 461 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~- 461 (626)
+.+..+..++++|++.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566678899999999999999999999875 57899999886532 2345678899999998 6999999999884
Q ss_pred ----eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 462 ----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 462 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
.++..++||||+++++|.++++... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 3457899999999999998875321 11236889999999999999999999986 999999999999999999
Q ss_pred EEEeecCCcccccCCCcceecccccCCcccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999986543221 1223468999999998753 45788999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=267.37 Aligned_cols=198 Identities=32% Similarity=0.498 Sum_probs=172.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+++++.++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999987 78999999886543 23456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998654 25889999999999999999999987 999999999999999999999999998865
Q ss_pred cCCCcceecccccCCcccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||...
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 4332 223355888999999987766 899999999999999999999998643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=274.82 Aligned_cols=200 Identities=23% Similarity=0.376 Sum_probs=171.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|+..+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+++++.++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999976 57889999987653 233457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... .+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999986542 5899999999999999999999987 9999999999999999999999999987421
Q ss_pred CCCc--------------ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKT--------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... .......++..|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1100 011123578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=271.02 Aligned_cols=201 Identities=29% Similarity=0.424 Sum_probs=169.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|++++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998653 2468999887654 4455689999999999999999999998875 557899
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999986542 25899999999999999999999987 999999999999999999999999999866
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
............++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 5433222222334568999999988889999999999999999986 99998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=271.18 Aligned_cols=206 Identities=25% Similarity=0.415 Sum_probs=173.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-----CcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-----g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 466 (626)
.++|.+.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999865 688999998754 23445678899999999999999999998876 4678
Q ss_pred EEEEEecCCCchhhhhcCCCcc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTE---YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
++++||+++++|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998653211 1136899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 544 GLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
|+++.+...... ......++..|+|||++....++.++||||||+++||+++ |+.||..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 999866433222 1222345678999999998889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=266.43 Aligned_cols=206 Identities=26% Similarity=0.420 Sum_probs=173.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-----CcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEe-CCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-----g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 465 (626)
-..|+....||+|.||.||||+-.+ .+.+|+|+++.+.. .-.....+|+.+++.++|+|++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999996432 33799999987533 224677899999999999999999999877 888
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC----CCEEEe
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKIS 541 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~ 541 (626)
+++++||.+. +|...++.........++....+.|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999986 5777776554444468999999999999999999999998 9999999999999877 899999
Q ss_pred ecCCcccccCCCcce--ecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 542 DFGLAKLYEEDKTHI--STRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 542 DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|||+++.+...-... ...++-|..|.|||++.+. .|++..||||.|||+.||+|-++-|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999987643322 3446779999999999875 6899999999999999999999877664
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=268.30 Aligned_cols=195 Identities=29% Similarity=0.475 Sum_probs=168.6
Q ss_pred CeeeccCceEEEEEEEcC--C--cEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILSD--G--TVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~--g--~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+++.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999753 3 3689999987655 556789999999999999999999999988 889999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|.+++..... ..++|..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999876532 36899999999999999999999987 999999999999999999999999999876542221
Q ss_pred --eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 556 --ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 556 --~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
......++..|+|||++....++.++|||||||++|||++ |+.|+..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1112446789999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=271.57 Aligned_cols=190 Identities=25% Similarity=0.382 Sum_probs=159.6
Q ss_pred eeeccCceEEEEEEEcC-------------------------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeE
Q 006906 402 KVGEGGFGSVYKGILSD-------------------------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKL 456 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 456 (626)
.||+|+||.||+|++.. ...||+|++.........+|.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999998521 13589999876655556788899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 457 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
+++|.+....++||||+++|+|..++.... ..+++..+.+++.||++||+|||+++ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 999999999999999999999999886532 25889999999999999999999987 99999999999997643
Q ss_pred -------CEEEeecCCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHH-hCCCCCCCC
Q 006906 537 -------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIV-SGKSNTNYR 603 (626)
Q Consensus 537 -------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~ell-tG~~p~~~~ 603 (626)
.+|++|||++....... ...++..|+|||.+.. ..++.++|||||||++|||+ +|+.|+...
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 37999999986443221 1346788999998865 56899999999999999994 799998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=270.18 Aligned_cols=197 Identities=29% Similarity=0.522 Sum_probs=172.5
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999976 58899999987543 344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++... .+++.+...++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999988542 4788999999999999999999987 9999999999999999999999999997654322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......++..|+|||++.+..++.++|+|||||++|||+||+.|+..
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 12234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=274.14 Aligned_cols=214 Identities=29% Similarity=0.452 Sum_probs=177.3
Q ss_pred cccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEE
Q 006906 384 LYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV 461 (626)
Q Consensus 384 ~~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 461 (626)
.+++.++..++++|++.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++.++ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3566777778899999999999999999999975 68899999986542 2345677899999888 8999999999987
Q ss_pred eC-----CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 462 EG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 462 ~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
.. +..++||||+++++|.++++... .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~ 165 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEG 165 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCC
Confidence 54 35899999999999999875421 11236899999999999999999999987 99999999999999999
Q ss_pred CEEEeecCCcccccCCCcceecccccCCcccchhhhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 537 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.|+...
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999999886543221 11234578899999998643 3688999999999999999999998643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=274.30 Aligned_cols=196 Identities=30% Similarity=0.527 Sum_probs=170.4
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555678999999999999875 57889999987543 3345678899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++... .+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 86 GGSALDLLKPG------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988542 5889999999999999999999987 99999999999999999999999999986543221
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......++..|+|||++.+..++.++|||||||++|||+||+.|+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 11224578899999999988899999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=272.58 Aligned_cols=200 Identities=24% Similarity=0.414 Sum_probs=169.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|+..+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999976 688999999875432 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 985 8988876543 26889999999999999999999987 999999999999999999999999998754322
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1122346788999999865 45789999999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=270.62 Aligned_cols=205 Identities=25% Similarity=0.395 Sum_probs=172.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|++.+.||+|+||.||+|+.+ +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999964 3467999998765433 4568999999999999999999999999989999
Q ss_pred EEEEecCCCchhhhhcCCCccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
+||||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986543111 125899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9987543322222223346778999999988888999999999999999998 7778753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=270.64 Aligned_cols=201 Identities=31% Similarity=0.560 Sum_probs=170.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-Cc----EEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-GT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.+|.+.+.||+|+||.||+|.+++ ++ .+|+|.+.... .....++.+|++++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999999753 33 58999887653 3345678899999999999999999999987 78899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.+++.... ..+++..+..++.||+.|++|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999986543 25899999999999999999999986 99999999999999999999999999987
Q ss_pred ccCCCccee-cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 549 YEEDKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......... ....++..|+|||.+....++.++||||||+++||+++ |+.||+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 653322211 11223568999999988889999999999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.56 Aligned_cols=192 Identities=24% Similarity=0.319 Sum_probs=164.2
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
...+|.+.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999976 4678999975432 23468999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+. ++|.+++.... ..+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 138 HYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred ccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 995 57877775432 36899999999999999999999997 99999999999999999999999999975432
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
.. ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 122356899999999999999999999999999999999866554
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=266.41 Aligned_cols=200 Identities=38% Similarity=0.569 Sum_probs=172.1
Q ss_pred CeeeccCceEEEEEEEcC----CcEEEEEEeccCChhc-HHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|...+ +..||+|.+....... .+.+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 7889999998764433 67889999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 476 NCLSRAIFGKDTE----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 476 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
++|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764211 0246899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 552 DKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 552 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 12233457889999999988889999999999999999999 69998654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=288.38 Aligned_cols=193 Identities=33% Similarity=0.462 Sum_probs=170.3
Q ss_pred eeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCchhh
Q 006906 402 KVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 480 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 480 (626)
+||+|.||+||-|+..+ ...+|||.+........+.+.+|+...+.++|.|||+++|+|.+++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999765 45699999988877778889999999999999999999999999999999999999999999
Q ss_pred hhcCCCcccccCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCcccccCCCccee
Q 006906 481 AIFGKDTEYRLKL--DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHIS 557 (626)
Q Consensus 481 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~ 557 (626)
+|+.+=+ ++ ++.++-.+..||++||.|||++. |||||||-.|||++ -.|.+||+|||-++.+..- ....
T Consensus 662 LLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T 733 (1226)
T KOG4279|consen 662 LLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT 733 (1226)
T ss_pred HHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence 9976522 34 77788889999999999999996 99999999999996 5789999999999876532 2344
Q ss_pred cccccCCcccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 558 TRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 558 ~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..+.||..|||||++..+ .|+..+|||||||.+.||.|||+||-.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 557799999999999865 489999999999999999999999954
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=275.60 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=175.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.-|+..+.||+|-|..|-.|++- .|..||||++++... .....+.+|++.|+.++|||||++|.+......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34667788999999999999854 799999999987633 334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~ 550 (626)
.=++|+|++++-..+. .+.+..+.+++.||+.|+.|+|+.+ +|||||||+||++- .-|-+||+|||++..+.
T Consensus 98 LGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999976643 6899999999999999999999997 99999999999885 46889999999998876
Q ss_pred CCCcceecccccCCcccchhhhccCCCC-ChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLT-SKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... -+..+|+..|-|||++.+..|+ +.+||||+|||||.|++|+.||...
T Consensus 171 PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 171 PGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred Ccch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 5432 3456899999999999988764 6799999999999999999999754
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=272.40 Aligned_cols=198 Identities=29% Similarity=0.485 Sum_probs=168.4
Q ss_pred CCCCCCeeeccCceEEEEEEEc-----CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 467 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 467 (626)
.|.+.+.||+|+||.||++... ++..||+|.++... ......+.+|++++++++|+|++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4678899999999999999842 57889999987553 33446789999999999999999999998875 5689
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++
T Consensus 85 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999985442 25899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 548 LYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 548 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
........ ......++..|+|||.+.+..++.++||||||+++|||+|++.|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 66533221 112344677899999998888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=272.53 Aligned_cols=201 Identities=26% Similarity=0.484 Sum_probs=170.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||.||++... +++.||+|.+... ......++.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999986 6899999988754 233346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++..... ...+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999988865311 236899999999999999999999742 3999999999999999999999999999765332
Q ss_pred CcceecccccCCcccchhhhccC------CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. .....++..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 1 1224578899999998544 358899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=267.28 Aligned_cols=189 Identities=30% Similarity=0.477 Sum_probs=161.2
Q ss_pred CeeeccCceEEEEEEEcCCc-----------EEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 401 NKVGEGGFGSVYKGILSDGT-----------VIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986433 5788887655333 6788999999999999999999999988 778999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-------CEEEee
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-------NAKISD 542 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~~kl~D 542 (626)
|||+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999865432 6899999999999999999999987 99999999999999887 799999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccC--CCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||++...... ....++..|+|||++... .++.++||||||+++|||++ |..|+...
T Consensus 152 fg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9999865431 123466789999998876 78999999999999999999 57777544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=295.32 Aligned_cols=204 Identities=19% Similarity=0.317 Sum_probs=161.8
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEcC--CcEEEEEE--------------ecc---CChhcHHHHHHHHHHHhcCCCCc
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQ--------------LSS---KSRQGNREFVNEIGMISAQQHPN 452 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~~--g~~vAvK~--------------l~~---~~~~~~~~~~~E~~~l~~l~H~n 452 (626)
...++|++.+.||+|+||+||++.++. +..+++|. +.+ ........+.+|++++.+++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987642 22222221 100 11223456889999999999999
Q ss_pred eeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 453 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
||++++++...+..++|+|++. ++|.+++...............++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999986 46666665432222223445677889999999999999987 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p 599 (626)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999987754433333346799999999999999999999999999999999998754
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=272.06 Aligned_cols=201 Identities=25% Similarity=0.390 Sum_probs=173.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 57899999987542 3334678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|++++.+..+.... ..+++..+..++.||+.|++|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99987776655432 25899999999999999999999987 99999999999999999999999999987665
Q ss_pred CCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..........++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 433233345678899999999887 8899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=272.91 Aligned_cols=199 Identities=28% Similarity=0.535 Sum_probs=174.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999864 67899999987655555677899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999988543 4788999999999999999999997 9999999999999999999999999987654332
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......+++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 122345888999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=267.32 Aligned_cols=200 Identities=29% Similarity=0.424 Sum_probs=170.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-----ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 466 (626)
.+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57889999999999999999975 5889999987532 123345788999999999999999999998764 468
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++|+||+++++|.+++.... .+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence 89999999999999886432 4789999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCc--ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDKT--HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 86532111 111234588999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=266.78 Aligned_cols=200 Identities=34% Similarity=0.559 Sum_probs=174.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999975 688999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999986542 4788999999999999999999987 999999999999999999999999999876543
Q ss_pred Ccceec---ccccCCcccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHIST---RIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... ...++..|+|||++.... .+.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 322211 245788999999998765 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=265.77 Aligned_cols=195 Identities=30% Similarity=0.478 Sum_probs=167.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEE-eCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~e~~ 473 (626)
++|.+.+.||+|+||.||++... ++.||+|.+... ...+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999874 778999998654 23567899999999999999999999765 456789999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999865432 25889999999999999999999987 9999999999999999999999999988543322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
....++..|+|||++....++.++|||||||++|||++ |+.|+..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12234568999999998889999999999999999997 9988854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=271.34 Aligned_cols=199 Identities=29% Similarity=0.469 Sum_probs=171.9
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 68999999987653 23356789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+ +++|.+++.... ..+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999886543 36899999999999999999999987 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.........++..|+|||.+... .++.++||||+|++++||+||++|+..
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 32222334688999999998654 468999999999999999999877754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=267.89 Aligned_cols=198 Identities=30% Similarity=0.470 Sum_probs=163.2
Q ss_pred CeeeccCceEEEEEEEcC-Cc--EEEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~-g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|++.+ +. .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999864 33 4688888753 234456788999999999 899999999999999999999999999
Q ss_pred CchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 476 NCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 476 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
++|.+++..... .....+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 11135889999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
++........ ......+..|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9863321111 111123567999999988889999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=274.10 Aligned_cols=199 Identities=27% Similarity=0.418 Sum_probs=170.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|+..+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999986 588999999865422 234578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.++.... ..+++..+..++.||+.||+|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99999998876543 24899999999999999999999987 99999999999999999999999999886544
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. .......++..|+|||++.+ ..++.++||||||+++|||++|+.|+..
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 153 PG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred Cc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 32 22233457889999999875 4578899999999999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=263.91 Aligned_cols=196 Identities=32% Similarity=0.505 Sum_probs=167.8
Q ss_pred CeeeccCceEEEEEEEcCCcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCchh
Q 006906 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 479 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 479 (626)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765433 4568899999999999999999999999999999999999999999
Q ss_pred hhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCccee-c
Q 006906 480 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-T 558 (626)
Q Consensus 480 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~ 558 (626)
+++.... ..+++..+..++.+++.|++|||+++ ++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9986543 25789999999999999999999987 99999999999999999999999999986542221111 1
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
....+..|+|||.+.+..++.++|||||||++|||+| |..|+...
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 1223567999999988889999999999999999999 88887543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=272.12 Aligned_cols=206 Identities=32% Similarity=0.509 Sum_probs=172.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|++.+.||+|+||.||++... ++..||+|.+.... ....+++.+|++++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999864 46789999987653 33456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCc-----------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 006906 467 LLVYEYMKNNCLSRAIFGKDT-----------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 529 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 529 (626)
++||||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999864211 11135789999999999999999999987 9999999999
Q ss_pred EEEcCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 530 VLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 530 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
|+++.++.++|+|||++........ ........+..|+|||.+....++.++|||||||++|||++ |..|+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999886533221 11122234667999999988899999999999999999997 8888753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=266.89 Aligned_cols=199 Identities=29% Similarity=0.467 Sum_probs=171.4
Q ss_pred CCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCC------hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
+|+..+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 468899999987532 1134678899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK 547 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~ 547 (626)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999998653 25889999999999999999999997 99999999999998776 58999999998
Q ss_pred cccCCCcc---eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 548 LYEEDKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 548 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
........ ......++..|+|||.+.+..++.++||||+|++++||++|+.|+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 76543211 11234578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=265.79 Aligned_cols=204 Identities=29% Similarity=0.487 Sum_probs=176.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999965 67889999987542 33567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999865422 136899999999999999999999987 999999999999999999999999999876543
Q ss_pred Ccc---eecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......|+..|+|||++... .++.++|+|||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 222 12334688999999998877 7899999999999999999999998643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=268.21 Aligned_cols=192 Identities=30% Similarity=0.408 Sum_probs=159.4
Q ss_pred eeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHH---hcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 402 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMI---SAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..++ ...+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998865421 2223344454433 44579999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999888654 25899999999999999999999997 99999999999999999999999999875543221
Q ss_pred ceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 22458999999999864 567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=274.92 Aligned_cols=206 Identities=26% Similarity=0.434 Sum_probs=170.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
.++|.+.+.||+|+||.||+++.. ....+|+|.+.... .....++.+|+++++++ +|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356788999999999999999752 24578999987542 33456788999999999 699999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.+++..... .....+++.++.+++.|++.||+|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999865321 01235899999999999999999999987 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+.++.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999998654322111 111223467999999998889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=279.41 Aligned_cols=207 Identities=29% Similarity=0.440 Sum_probs=168.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC-C
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG-N 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 464 (626)
.++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35688999999999999999974 346889999997643 23346788999999999 689999999988654 4
Q ss_pred eEEEEEEecCCCchhhhhcCCCcc--------------------------------------------------------
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTE-------------------------------------------------------- 488 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 488 (626)
..++||||+++|+|.++++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999988643210
Q ss_pred ------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc-eecccc
Q 006906 489 ------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIA 561 (626)
Q Consensus 489 ------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 561 (626)
....+++.++.+++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124788999999999999999999987 999999999999999999999999999865432211 111233
Q ss_pred cCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 562 gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
++..|+|||.+....++.++||||||+++|||++ |..|+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 5678999999988889999999999999999997 89898643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=264.56 Aligned_cols=194 Identities=32% Similarity=0.511 Sum_probs=164.1
Q ss_pred CeeeccCceEEEEEEEcC----CcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+++++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998642 26899999886543 34567899999999999999999999876 4568999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|.+++.... .+++..+..++.|++.|++|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999996542 5899999999999999999999987 999999999999999999999999999866443322
Q ss_pred eecc--cccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 556 ISTR--IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 556 ~~~~--~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.... ..++..|+|||.+....++.++||||||+++|||++ |+.||+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 1111 123467999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=291.62 Aligned_cols=203 Identities=34% Similarity=0.539 Sum_probs=174.6
Q ss_pred CCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 398 DPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
...++||+|+||+||||.|- +|+ +||+|++... ..+..+++++|+-+|.+++|||+++++++|..+. +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 35689999999999999863 443 6899998765 4455789999999999999999999999998776 889999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||+.|+|.++++.++. .+.-...+.+..|||+||.|||++. ++||||..+|||+..-..+||.|||+++....
T Consensus 778 ~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999977543 6788899999999999999999886 99999999999999999999999999998876
Q ss_pred CCcceecc-cccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCCh
Q 006906 552 DKTHISTR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDF 608 (626)
Q Consensus 552 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~~~~~ 608 (626)
+....... ..-.+.|||=|.+....++.++|||||||.+||++| |..|++..+.++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 55444332 223468999999999999999999999999999998 9999988765443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.03 Aligned_cols=200 Identities=26% Similarity=0.436 Sum_probs=178.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
...|.+...||+|.|++|..|++. .+..||||.+++.. ....+.+.+|++++..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888999999999999999975 68999999998763 233356889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+.+|.+++++...+ ...+..++.++.|+.+|++|||+++ |+|||||++||||+.++.+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999998765 3455888999999999999999997 9999999999999999999999999999886
Q ss_pred CCCcceecccccCCcccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. .......+|++.|.|||++.+.. .++++|+||+|+++|-|+.|.-||++.
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 3 33456678999999999998765 478999999999999999999999854
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=270.29 Aligned_cols=202 Identities=26% Similarity=0.452 Sum_probs=165.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHH-HhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.. ++..+|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 68999999987643 2334556666664 667799999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|++ ++|.+++..... ....+++..+..++.||+.||+|||++. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 678777644211 1246899999999999999999999862 399999999999999999999999999986543
Q ss_pred CCcceecccccCCcccchhhhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ......++..|+|||.+.. ..++.++|+||||+++|||++|+.|+..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 22 1122457889999998864 4568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=263.18 Aligned_cols=213 Identities=25% Similarity=0.336 Sum_probs=171.2
Q ss_pred HHHHHHHhcCCCCCCee--eccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHh-cCCCCceeeEEEEEEe
Q 006906 387 LRQIKAATNNFDPANKV--GEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPNLVKLYGCCVE 462 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~I--G~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~ 462 (626)
..+.....++|++.+.+ |+|+||.||+++.+ +++.+|+|.+....... . |+.... ..+|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEec
Confidence 34445555778887777 99999999999975 67889999986542111 1 222222 1279999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEe
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKIS 541 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~ 541 (626)
.+..++||||+++++|.+++.... .+++..+..++.|+++|++|||+.+ ++||||||+||+++.++ .++|+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 999999999999999999986542 6899999999999999999999997 99999999999999998 99999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHH
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVL 618 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~~~ 618 (626)
|||++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||....+ .......|....
T Consensus 153 dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~ 223 (267)
T PHA03390 153 DYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ 223 (267)
T ss_pred cCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh
Confidence 999987654322 23578999999999988899999999999999999999999974432 233444554433
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=271.51 Aligned_cols=198 Identities=24% Similarity=0.424 Sum_probs=166.9
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999976 68899999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++ +|.+++.... ..+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CDQ-DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 974 6777665432 25899999999999999999999987 999999999999999999999999999865432
Q ss_pred CcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... .....++..|+|||.+.+. .++.++|||||||++|||+||+.|+..
T Consensus 153 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 153 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 221 1224578899999998764 478999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=263.29 Aligned_cols=200 Identities=37% Similarity=0.574 Sum_probs=171.9
Q ss_pred CCCCCeeeccCceEEEEEEEcC-----CcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~~-----g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
|.+.+.||+|+||.||+++..+ +..||+|.+...... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999764 378999999765433 5678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++..... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999865432 12899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
...........++..|+|||.+....++.++||||+|++++||++ |+.|+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 442222212236789999999988889999999999999999998 7888764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=273.09 Aligned_cols=201 Identities=32% Similarity=0.567 Sum_probs=167.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|+..+.||+|+||.||+|++. +++ .||+|.+..... ....++.+|+.+++.++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999864 343 478898875432 3345788999999999999999999998754 4678
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 999999999999986542 25889999999999999999999987 99999999999999999999999999986
Q ss_pred ccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 549 YEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........ .....++..|+|||.+....++.++|||||||++|||++ |+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65332211 122345678999999998889999999999999999997 88898643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=269.16 Aligned_cols=209 Identities=29% Similarity=0.480 Sum_probs=174.4
Q ss_pred cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEe-
Q 006906 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE- 462 (626)
Q Consensus 386 ~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 462 (626)
++.++..+.+.|++.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667788999999999999999999975 68899999986543 3345688899999888 79999999999853
Q ss_pred -----CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 463 -----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 463 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 4678999999999999998865322 25788899999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccCCCcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 99999999876542221 122345889999999876 34678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=266.03 Aligned_cols=196 Identities=31% Similarity=0.522 Sum_probs=171.2
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667889999999999999875 68899999986542 3334678899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 86 GGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999988542 5789999999999999999999987 99999999999999999999999999876543221
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......++..|+|||++....++.++|||||||++|||++|+.|+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 12234578899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=273.01 Aligned_cols=206 Identities=25% Similarity=0.393 Sum_probs=169.8
Q ss_pred CCCCCCeeeccCceEEEEEEEcC---CcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSD---GTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLL 467 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~---g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 467 (626)
+|++.+.||+|+||.||+|+... ++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999998732 33346778899999999999999999999988 8899
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC----CCCEEEeec
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKISDF 543 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~Df 543 (626)
+||||+++ ++.+.+..........+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999985 5655553322222236889999999999999999999987 999999999999999 899999999
Q ss_pred CCcccccCCCc--ceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 544 GLAKLYEEDKT--HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 544 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
|++........ .......++..|+|||.+.+. .++.++|||||||+++||++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987643322 112234678899999988764 578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=264.14 Aligned_cols=200 Identities=26% Similarity=0.425 Sum_probs=173.2
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 6889999998653 233456889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++..... ..+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998864321 25789999999999999999999987 999999999999999999999999999866442
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ......|+..|+|||+..+..++.++|||||||+++||++|+.|+..
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 21 12234578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=267.82 Aligned_cols=199 Identities=30% Similarity=0.442 Sum_probs=175.4
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999986 58899999987542 2345788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999988654 26889999999999999999999987 99999999999999999999999999886644
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.. ......|+..|+|||.+....++.++|+||||+++|+|++|+.|+....
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 32 1233457889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=266.34 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=168.8
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh----------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR----------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 464 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~----------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 464 (626)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+++++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999865 688999998864211 11245778999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998654 26899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCcc-eecccccCCcccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 545 LAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+++........ ......++..|+|||.+.... ++.++|+||||+++|||++|+.|+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 99865432111 122345788999999987654 78999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.41 Aligned_cols=198 Identities=27% Similarity=0.534 Sum_probs=171.2
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.|+..+.||+|+||.||+|... +++.||+|.+.... .....++.+|++++++++ |+|++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777899999999999999974 68999999987542 334567888999998886 999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999987542 5889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... .....|+..|+|||.+..+ .++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 43321 2334688999999998654 5689999999999999999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=270.26 Aligned_cols=198 Identities=29% Similarity=0.440 Sum_probs=169.4
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh-----cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
+|+..+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 6899999999765322 245677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+ +++|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999986543 25899999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|.+|+..
T Consensus 153 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 153 GSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred cCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 543221 122346788999998854 4678999999999999999999877754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=269.73 Aligned_cols=199 Identities=28% Similarity=0.399 Sum_probs=169.8
Q ss_pred CCCCCCeeeccCceEEEEEEE----cCCcEEEEEEeccCCh----hcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeE
Q 006906 396 NFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAvK~l~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 466 (626)
+|++.+.||+|+||.||++.. .+|+.||+|++..... ...+++.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3688999999875322 2346678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999998654 25789999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...............|+..|+|||.+... .++.++||||||+++|||++|+.|+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 86644332222335688999999998753 467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=258.82 Aligned_cols=205 Identities=23% Similarity=0.374 Sum_probs=173.8
Q ss_pred cHHHHHHHhcCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 386 ~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
+++++-..| .+.||+|+|+.|--++ +.+|..+|||++++.......+..+|++++... .|+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356665554 4789999999999887 568999999999998777778899999999887 699999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---CEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKI 540 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl 540 (626)
...|||||-|.||+|..+++.. ..+++..+.++..+||.||+|||.++ |.|||+||+|||-..-. -+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence 9999999999999999998765 36999999999999999999999998 99999999999996543 3799
Q ss_pred eecCCcccccCC--Ccce----ecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 541 SDFGLAKLYEED--KTHI----STRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 541 ~DfGla~~~~~~--~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+||.+..-+... -... -...+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||.+.
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 999987644321 1111 12356889999999863 346899999999999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=263.93 Aligned_cols=194 Identities=29% Similarity=0.455 Sum_probs=159.6
Q ss_pred CeeeccCceEEEEEEEc----CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEE-eCCeEEEEEEecC
Q 006906 401 NKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLLVYEYMK 474 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~e~~~ 474 (626)
+.||+|+||.||+|++. +...||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2457999998643 3344568889999999999999999999876 4556899999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999986542 24678888999999999999999986 99999999999999999999999999986543211
Q ss_pred c---eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCC
Q 006906 555 H---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTN 601 (626)
Q Consensus 555 ~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG-~~p~~ 601 (626)
. ......++..|+|||++....++.++|||||||++|||++| ..|+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1 11123456789999999888899999999999999999995 45554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=276.25 Aligned_cols=206 Identities=28% Similarity=0.426 Sum_probs=170.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 464 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 464 (626)
.+|.+.+.||+|+||.||+++.. ....||+|.+.... ....+++.+|++++.++ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999752 12368999887542 33456889999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 533 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 533 (626)
..+++|||+++|+|.+++..... .....++|.++..++.|++.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999864321 11235899999999999999999999987 99999999999999
Q ss_pred CCCCEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 534 KDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 534 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999998654322111 111224567999999999999999999999999999998 88887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=266.70 Aligned_cols=202 Identities=27% Similarity=0.422 Sum_probs=171.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 470 (626)
++|+..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999985 578899999875432 3456789999999999999999999998653 4689999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999887643211 2235889999999999999999999987 9999999999999999999999999987554
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ....++..|+|||.+.+..++.++||||||+++|||++|+.|++..
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 3221 2345788999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=266.38 Aligned_cols=198 Identities=23% Similarity=0.401 Sum_probs=158.9
Q ss_pred CeeeccCceEEEEEEEcCC---cEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 401 NKVGEGGFGSVYKGILSDG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986443 346677765442 344578999999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC-cc
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-TH 555 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~ 555 (626)
+|.++++..... ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999998754221 234677788899999999999999987 9999999999999999999999999986432211 11
Q ss_pred eecccccCCcccchhhhcc-------CCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
......++..|+|||++.. ..++.++|||||||++|||++ |+.|+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 1223457889999998743 245789999999999999997 4667753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=266.32 Aligned_cols=196 Identities=28% Similarity=0.533 Sum_probs=171.8
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
|+..+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 445679999999999999964 6889999998766555566788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|.+++... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 101 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 101 GALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999988652 5889999999999999999999987 99999999999999999999999998875543222
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 12234588999999999888899999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=266.33 Aligned_cols=193 Identities=32% Similarity=0.415 Sum_probs=166.8
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
||+|+||+||++... +++.||+|.+.... ....+.+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999986532 22345667899999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 998865432 36899999999999999999999987 9999999999999999999999999988654321 122
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 345788999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=267.57 Aligned_cols=189 Identities=27% Similarity=0.444 Sum_probs=160.6
Q ss_pred CeeeccCceEEEEEEEcC--------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 401 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888888766555567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC--------EEEeecC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFG 544 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~kl~DfG 544 (626)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999976532 5899999999999999999999987 999999999999987765 5999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCC-CCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK-SNTN 601 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~-~p~~ 601 (626)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|. .|+.
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 98754322 22457889999999976 45789999999999999999995 4543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=268.36 Aligned_cols=200 Identities=29% Similarity=0.481 Sum_probs=169.1
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999975 68899999987543 22335788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 578888755422 36899999999999999999999987 999999999999999999999999998865432
Q ss_pred CcceecccccCCcccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 122234678999999886644 688999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=258.12 Aligned_cols=199 Identities=33% Similarity=0.588 Sum_probs=177.1
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
+|+..+.||+|++|.||++... +++.+++|++........+++.+|++++++++|+|++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999986 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++.... ..+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999886542 36899999999999999999999986 99999999999999999999999999987654332
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.....++..|+|||++....++.++||||||++++||++|+.|+...
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23356888999999998888999999999999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=264.45 Aligned_cols=202 Identities=27% Similarity=0.486 Sum_probs=169.2
Q ss_pred CCCCCCeeeccCceEEEEEEEcC--CcEEEEEEeccCC----------hhcHHHHHHHHHHHhc-CCCCceeeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS----------RQGNREFVNEIGMISA-QQHPNLVKLYGCCVE 462 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~--g~~vAvK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 462 (626)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 6889999875321 2233557788888765 799999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
++..++||||+++++|.+++.... .....+++..+++++.|++.||.|||+.. .++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998874321 11236899999999999999999999632 399999999999999999999999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
||++....... ......++..|+|||.+....++.++||||||+++|||++|+.|+..
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99998655432 22335688999999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=265.80 Aligned_cols=199 Identities=26% Similarity=0.478 Sum_probs=174.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|+..+.||+|++|.||++... +++.||+|++.... ....+++.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999986 68899999987653 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
+++++|.+++.... ..+++..+.+++.|++.|++|||+ .+ ++|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999986542 368899999999999999999999 66 99999999999999999999999999876543
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ...++..|+|||++.+..++.++||||||+++|||++|+.|+...
T Consensus 154 ~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 154 SLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2211 156888999999999889999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=265.48 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=170.6
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+|+..+.||+|++|.||+|+.. +++.||||++..... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999986 688999999876533 23466788999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++ +|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 85 78877754322 236899999999999999999999987 9999999999999999999999999997654322
Q ss_pred cceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
. ......++..|++||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1122456889999998865 457889999999999999999999987543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=239.95 Aligned_cols=219 Identities=23% Similarity=0.380 Sum_probs=174.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|+..++||+|.||+||||+.. .++.||+|+++.. .+.......+|+-+++.++|+|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999966 5788999998654 334456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
|.. +|..+..... ..++.+..+.++.|+++|+.++|+++ +.|||+||.|.|++.+|+.|++|||+++-+.-.
T Consensus 83 cdq-dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hhH-HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 964 5655543332 25888999999999999999999997 999999999999999999999999999987654
Q ss_pred CcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCChhhHHHHHHHHhhccc
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEI 623 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~~~~~~~l~~w~~~~~~~~~ 623 (626)
....+ ..+-|..|.+|+++.+. -|+...|+||.|||+.|+.. |++.|.+.+-++...-.-|.-....|+.
T Consensus 155 vrcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 155 VRCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred eEeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 33332 33468999999998875 47899999999999999985 5655655443344333344433334443
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=265.61 Aligned_cols=202 Identities=29% Similarity=0.463 Sum_probs=172.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-----CCcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-----~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 466 (626)
++|...+.||+|+||.||++++. +++.||||.+...... ..++|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677899999999999999864 3678999999865443 46789999999999999999999999887 5678
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999997653 25899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCcce--ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.......... .....++..|+|||......++.++||||||+++|||+||+.|+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 8765322211 11223456799999998888999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=267.40 Aligned_cols=203 Identities=25% Similarity=0.356 Sum_probs=167.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCe-----
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQ----- 465 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 465 (626)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999976 689999998865432 23467888999999995 6999999999987665
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCEEEeecC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFG 544 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfG 544 (626)
.++||||+++ +|.+++..........+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888775443222346899999999999999999999987 999999999999998 8899999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+++.+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 99865432211 122346788999998865 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=284.97 Aligned_cols=199 Identities=26% Similarity=0.479 Sum_probs=173.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcE-EEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTV-IAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~-vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+.+++...||.|+||+||||+.++... .|.|++..++.+...+|+-|+++|...+||+||++++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345667889999999999999876444 5678888888888899999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
.||-++..+-.-+ ..|.+.++..++.|++.||.|||++. |||||||..|||++-+|.++|+|||.+......
T Consensus 112 ~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred CCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 9999988875443 37999999999999999999999996 999999999999999999999999997654321
Q ss_pred cceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
......+.||++|||||+.+ ..+|+.++|||||||.|.||..+.+|-.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 11234478999999999875 4579999999999999999999998864
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=265.81 Aligned_cols=202 Identities=31% Similarity=0.575 Sum_probs=177.1
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..++.|+..+.||+|++|.||+|..+ +++.||+|++..... ..+.+.+|+++++.++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999987 688999999976544 5677889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999986543 36899999999999999999999987 9999999999999999999999999987654
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus 168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 3221 11224578899999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=261.01 Aligned_cols=200 Identities=29% Similarity=0.447 Sum_probs=172.4
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|+..+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 68889999987542 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeecCCcccccC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~~~~ 551 (626)
+++++|.+++..... ..+++..+.+++.+++.|++|||+++ ++|+||+|+||+++++ +.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999865422 35899999999999999999999987 9999999999999865 4579999999987653
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....++..|+|||.+....++.++||||||+++|||++|+.|+...
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 321 22345788999999999888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=262.03 Aligned_cols=195 Identities=29% Similarity=0.481 Sum_probs=166.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|.+.+.||+|+||.||++.. .++.||+|.+.... ....+.+|+.++++++|+|++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67789999986542 346788999999999999999999998754 4799999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 82 KGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999865432 35889999999999999999999987 9999999999999999999999999987643221
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 11234567999999988899999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=267.72 Aligned_cols=193 Identities=27% Similarity=0.521 Sum_probs=169.4
Q ss_pred CCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 400 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
...||+|+||.||++... +++.||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999875 6899999998765555567789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
.+++... .+++..+..++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++........ ...
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~ 174 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 174 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence 9887432 4789999999999999999999987 99999999999999999999999999876543221 122
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...++..|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 34588999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=265.98 Aligned_cols=199 Identities=32% Similarity=0.519 Sum_probs=165.6
Q ss_pred CeeeccCceEEEEEEEcC-------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 401 NKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~-------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998653 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-----CEEEeecCC
Q 006906 473 MKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-----NAKISDFGL 545 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~~kl~DfGl 545 (626)
+++++|.+++...... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998643211 1235889999999999999999999987 99999999999999877 899999999
Q ss_pred cccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 546 AKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 546 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 976543211 11122345678999999999999999999999999999998 9999854
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=263.04 Aligned_cols=191 Identities=30% Similarity=0.422 Sum_probs=159.2
Q ss_pred eeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHH---HHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 402 KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIG---MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
.||+|+||.||++... +++.||+|.+..... .....+..|.. .++..+|++|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999875421 11223344433 4455689999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999888543 25899999999999999999999987 99999999999999999999999999876543221
Q ss_pred ceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 234689999999998754 6899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=260.65 Aligned_cols=192 Identities=25% Similarity=0.396 Sum_probs=168.8
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
||+|++|.||+++.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 48899999987542 23446789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 99986542 4889999999999999999999987 9999999999999999999999999998765432 122
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
...++..|+|||.+....++.++|+||||+++|||++|+.|+....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 3467889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=267.88 Aligned_cols=195 Identities=31% Similarity=0.511 Sum_probs=166.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+.|+..+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|+++++.++||||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999975 68899999986432 233457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+. |++.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9997 56666654322 25899999999999999999999987 9999999999999999999999999987654
Q ss_pred CCCcceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ...++..|+|||.+. ...++.++||||||+++|||+||+.|+..
T Consensus 167 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 167 PAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CCC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 321 245788999999874 45688899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=261.35 Aligned_cols=206 Identities=27% Similarity=0.458 Sum_probs=172.4
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 470 (626)
+|++.+.||+|+||.||++... +++.||+|++... .....+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 6789999998653 23445678899999999999999999998764 45679999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||+++++|.+++.... .....+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999985431 12246899999999999999999999332 23499999999999999999999999999987
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... ......++..|+|||.+....++.++||||||+++|+|++|+.|+...
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 654332 122346889999999999888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=265.03 Aligned_cols=199 Identities=29% Similarity=0.473 Sum_probs=169.8
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEEEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVYE 471 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 471 (626)
|++.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 48899999998763 33456788999999999999999999999988 88999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++ +|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9985 8888775542 36899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..........++..|+|||.+.+ ..++.++||||||+++|||+||+.|+...
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43222233456788999997764 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=266.21 Aligned_cols=200 Identities=28% Similarity=0.435 Sum_probs=169.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 469 (626)
++|++.+.||+|+||.||+|+.. +++.+|+|.++.... .....+.+|++++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999986 588999999875432 2234567899999999999999999999877 889999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||++ ++|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 48888876542 25899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 54321 12234578899999998754 4689999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=265.49 Aligned_cols=201 Identities=28% Similarity=0.435 Sum_probs=166.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999976 688999999865422 234678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~ 550 (626)
|++ ++|.+++..... ..+++..+..++.||+.||+|||+++ ++||||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 477777644321 24678889999999999999999987 999999999999985 5678999999997654
Q ss_pred CCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......+++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 1123456889999998866 45789999999999999999999999754
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=266.84 Aligned_cols=204 Identities=28% Similarity=0.439 Sum_probs=169.7
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC---
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--- 464 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 464 (626)
+...++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999986 58899999987543 223456778999999999999999999987654
Q ss_pred -------eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 465 -------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 465 -------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
..++|+||+++ ++...+.... ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence 78999999986 5666654432 36899999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765433222222346778999998864 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=264.26 Aligned_cols=204 Identities=30% Similarity=0.498 Sum_probs=171.7
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCC------
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN------ 464 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------ 464 (626)
++++|++.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999986 578899999876543 356789999999998 7999999999997644
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999998875432 11246899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++........ ......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 9886543222 1223458899999998753 3467899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=259.44 Aligned_cols=200 Identities=26% Similarity=0.451 Sum_probs=171.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 58889999986542 23345778999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC-EEEeecCCcccccC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~~~~ 551 (626)
+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++. +||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999998865422 35799999999999999999999987 999999999999998854 69999999986653
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ......|++.|+|||......++.++||||||+++|||++|+.|+..
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 22234588899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=272.24 Aligned_cols=199 Identities=27% Similarity=0.430 Sum_probs=166.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 466 (626)
+++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999865 68999999986432 23346688899999999999999999987644 357
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++|+||+.+ +|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 999999975 777766432 5899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCcc--eecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
......... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 865432211 1123467899999998754 5689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=273.59 Aligned_cols=204 Identities=32% Similarity=0.512 Sum_probs=175.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC---Cc--EEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD---GT--VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~---g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
.+.....++||+|-||.||+|+..+ |+ .||||.-+.. .....+.|++|..+++.++|||||+++|+|.+ ...|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 3445567899999999999999532 33 5888887764 44556789999999999999999999999975 5689
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+|||.++-|.|..+|..+. ..|+......++.||+.||.|||+.. +|||||..+|||+.....+||+|||+++
T Consensus 467 ivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred EEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 9999999999999997664 26888899999999999999999985 9999999999999999999999999999
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 605 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~~ 605 (626)
.+.++.....+...-...|||||.+.-.+++..+|||.|||+|||+++ |..||.+-..
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 888776655555455679999999999999999999999999999874 9999976533
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=267.07 Aligned_cols=201 Identities=28% Similarity=0.383 Sum_probs=170.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhc---HHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG---NREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 469 (626)
.+|....+||+|+||+|..|.-+ ..+.+|||++++...-+ .+--+.|-++|... +-|.+++++.+++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 57889999999999999999876 46779999998763221 22234566666655 568899999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+.+|+|--++..-+ .+.+..+.-+|.+||-||-+||+++ ||.||||..|||+|.+|++||+|||+++.-
T Consensus 429 MEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999988776543 5788899999999999999999998 999999999999999999999999999843
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
--+ .......+||+-|+|||++...+|+..+|.|||||+||||+.|++||++.+
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 222 223445889999999999999999999999999999999999999998743
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=263.09 Aligned_cols=199 Identities=28% Similarity=0.481 Sum_probs=168.4
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
|++.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+++++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999975 78999999987543 223457889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
+ ++|.+++..... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 689888865432 36899999999999999999999986 9999999999999999999999999997654322
Q ss_pred cceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 154 RT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1223468899999987654 5789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=260.82 Aligned_cols=204 Identities=27% Similarity=0.435 Sum_probs=165.9
Q ss_pred CCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 006906 397 FDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 464 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 464 (626)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999864 3678999998764 2334567889999999999999999999886532
Q ss_pred eEEEEEEecCCCchhhhhcCCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
..++++||+.+|+|.+++..... .....+++.....++.|++.|++|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 24789999999999887743211 11235789999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 544 GLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
|+++........ ......++..|++||.+....++.++||||||+++|||++ |+.|+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 999866432211 1122335678999999988889999999999999999999 88887643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=266.90 Aligned_cols=201 Identities=30% Similarity=0.466 Sum_probs=167.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 468 (626)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999975 589999999875432 2234567899999999999999999998754 56899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 86 v~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999975 7877775432 36899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6543211 122345788999999865 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=305.06 Aligned_cols=202 Identities=31% Similarity=0.471 Sum_probs=172.5
Q ss_pred cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
-++.-...||.|.||.||-|.. .+|+..|||.+.... ....+...+|+.++..++|||+|+++|+-.++++.+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3556678999999999999995 468889999886543 3334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||++|+|.+.+...+ ..++.....+..|++.|+.|||+.| ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1315 yC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999986543 4677777888999999999999998 99999999999999999999999999998765
Q ss_pred CCcce---ecccccCCcccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHI---STRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..... .....||+-|||||++.+. ....++||||+|||..||+||++||...+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 42111 2346799999999999754 34668999999999999999999997654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=266.38 Aligned_cols=201 Identities=26% Similarity=0.432 Sum_probs=165.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-------
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------- 464 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------- 464 (626)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999976 68899999886542 222345678999999999999999999987654
Q ss_pred -eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 465 -QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 465 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
..++||||+.+ +|.+.+.... ..+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 45999999975 7777765432 25899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcc---eecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||+||+.|+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999866432211 11224567889999988664 4688999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=255.25 Aligned_cols=198 Identities=30% Similarity=0.522 Sum_probs=174.6
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|++|.||+++.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 578999999977643 4456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999988654 26899999999999999999999987 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... .....++..|+|||......++.++||||+|+++|||++|+.|+..
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 321 2334578899999999887889999999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=260.06 Aligned_cols=193 Identities=28% Similarity=0.447 Sum_probs=167.7
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999876533 3456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc----
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT---- 554 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~---- 554 (626)
.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99986542 5899999999999999999999987 99999999999999999999999999886543211
Q ss_pred ---ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 ---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 ---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.......++..|+|||.......+.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1122345788999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=271.17 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=168.1
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 463 (626)
..++|+..+.||+|+||.||+|... +++.||+|++... .....+++.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4577999999999999999999975 6899999998653 233445778899999999999999999988643
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999996 477776632 2788899999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 163 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 163 GLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred ccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 99986543221 22345788999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=265.11 Aligned_cols=193 Identities=30% Similarity=0.501 Sum_probs=164.9
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|+..+.||+|+||.||+++.. +++.||+|++.... ....+++.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999975 68899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+.+ ++.+.+.... ..+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CLG-SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 974 7777664332 35899999999999999999999987 999999999999999999999999998754432
Q ss_pred CcceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....++..|+|||++. ...++.++|||||||++|||++|+.|+..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2245788999999974 45688999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=269.51 Aligned_cols=205 Identities=27% Similarity=0.407 Sum_probs=172.4
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCV 461 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 461 (626)
...+++..++++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 455677778899999999999999999999864 68899999987542 233466888999999999999999999886
Q ss_pred eC------CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 006906 462 EG------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 535 (626)
Q Consensus 462 ~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 535 (626)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 43 3467888876 67888877532 5889999999999999999999997 9999999999999999
Q ss_pred CCEEEeecCCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 536 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 536 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999998865332 123457889999998866 56889999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=258.88 Aligned_cols=196 Identities=28% Similarity=0.382 Sum_probs=163.0
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeC--CeEEEEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLVYE 471 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~e 471 (626)
|++.+.||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999975 68899999987642 222344567888888885 99999999999987 88999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|++ ++|.+.+.... ..++|..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 57777775432 26899999999999999999999987 999999999999999 9999999999986643
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 322 122457889999997654 56788999999999999999999999653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=262.81 Aligned_cols=201 Identities=21% Similarity=0.241 Sum_probs=153.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCChhcH-----------HHHHHHHHHHhcCCCCceeeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-----------REFVNEIGMISAQQHPNLVKLYG 458 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~~ 458 (626)
.++|.+.++||+|+||+||+|.+.+ +..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578899999999999999999764 34566665433221111 11223344566789999999999
Q ss_pred EEEeCC----eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 006906 459 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 534 (626)
Q Consensus 459 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 534 (626)
++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 876543 34677777643 444444322 13578889999999999999999987 999999999999999
Q ss_pred CCCEEEeecCCcccccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 535 DLNAKISDFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 535 ~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++.++|+|||+++.+...... ......||+.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999876432211 112246999999999999999999999999999999999999999765
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=264.31 Aligned_cols=202 Identities=29% Similarity=0.465 Sum_probs=163.6
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|...+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556688999999999999975 58999999987543 334567889999999996 99999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+.. ++.++...........+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 4443321100011136899999999999999999999752 3999999999999999999999999999865432
Q ss_pred CcceecccccCCcccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRG---YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. .....|+..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 21 1223578899999998766 689999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=256.87 Aligned_cols=190 Identities=28% Similarity=0.390 Sum_probs=160.9
Q ss_pred CeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHH-HhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|... +++.||+|++..... .....+..|..+ ....+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999975 588999999875422 222334445444 4556899999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 99999986542 5889999999999999999999987 99999999999999999999999999875433
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 12245788999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=269.79 Aligned_cols=195 Identities=28% Similarity=0.434 Sum_probs=170.1
Q ss_pred CCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 400 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
.+.||+|.||+||-|+++ +|+.||||++++. .......+.+|+++|..++||.||.+..-|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 579999999999999976 7999999999875 2344567889999999999999999999999999999999999776
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CCEEEeecCCcccccCCC
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~~~~~~ 553 (626)
-|+-.|.... ..|++....-++.||+.||.|||.++ |+|+||||+|||+.+. -.+||+|||.|+++.+..
T Consensus 649 MLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSSEK----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 6655554432 36888888899999999999999997 9999999999999643 469999999999887543
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....++||+.|+|||+++...|...-|+||.|||+|.-++|..||+..
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 345578999999999999999999999999999999999999999754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=254.46 Aligned_cols=201 Identities=34% Similarity=0.507 Sum_probs=176.2
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 470 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 470 (626)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++++... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999987 688999999876542 4567889999999999999999999999988 8999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999986542 6899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 551 EDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 551 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..... ......++..|+|||.......+.++||||||++++||++|+.|+....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43321 1223457889999999988889999999999999999999999987543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=270.13 Aligned_cols=201 Identities=29% Similarity=0.469 Sum_probs=168.2
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC--CeE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG--NQL 466 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~ 466 (626)
..++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999976 5889999988643 223345677899999999 999999999998653 468
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||++ ++|..++... .++|..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 5888877543 5789999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCc----ceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKT----HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
........ .......|+..|+|||.+.. ..++.++||||||+++|||+||+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 86643321 12233568899999998754 56788999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=258.08 Aligned_cols=201 Identities=32% Similarity=0.490 Sum_probs=174.5
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|+||.||+++.. +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 67899999987542 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999885531 12246899999999999999999999987 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. .....++..|+|||...+..++.++|+||||+++|||++|+.|+...
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 22245788999999999888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=260.51 Aligned_cols=198 Identities=28% Similarity=0.442 Sum_probs=162.3
Q ss_pred CCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHh-cCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 400 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
...||.|+||+|+|-.++ .|+.+|||+++.... ..+++++.|.+... .-+.||||+++|.+..++..|+.||.|. .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 478999999999999976 699999999987644 55677888888654 4579999999999999999999999996 4
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
|++.+-+.-.......+++.-.-.|+.....||.||.... +|||||+||+|||+|..|.+||||||++-.+.+.- .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 5544322111122346888888899999999999998875 79999999999999999999999999998665432 2
Q ss_pred ecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 557 STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 557 ~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.+.-+|...|||||.+.. ..|+.++||||+|++|+|+.||+.|++.
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 344568899999999864 3589999999999999999999999864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=254.98 Aligned_cols=203 Identities=26% Similarity=0.450 Sum_probs=177.0
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+|++.+.||+|+||.||++... +++.||+|++..... ...+++.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999976 588999999876533 4567788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++..... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999998865421 1246899999999999999999999987 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. .......|++.|+|||......++.++||||+|+++++|++|+.|+...
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 3 2233356888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.20 Aligned_cols=200 Identities=28% Similarity=0.445 Sum_probs=169.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
...|++.++||+||.++||++...+.+.||+|++... ..+...-|.+|++.|.++ .|.+||++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4568889999999999999999988899999876543 455567899999999998 5999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||= ..+|..+|..... ...+| .++.+..|++.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 440 E~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 974 4689999976543 23445 78899999999999999998 99999999999996 4589999999999887
Q ss_pred CCCcce-ecccccCCcccchhhhccC-----------CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHI-STRIAGTIGYMAPEYAMRG-----------YLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.+.... ....+||+.||+||.+... +.+.++||||+|||||+|+.|++||..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 665443 3457899999999998532 267789999999999999999999853
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=278.19 Aligned_cols=198 Identities=27% Similarity=0.426 Sum_probs=170.2
Q ss_pred CCCeeeccCceEEEEEEEc--CCc--EEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 399 PANKVGEGGFGSVYKGILS--DGT--VIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~--~g~--~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
..|+||+|.||.|++|.|. .|+ .||||.+...... ...+|++|+.+|.+++|+|+++|||+..+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3588999999999999986 344 5899999876544 56899999999999999999999999887 7789999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
+.|+|.+.|+.... ..|-......++.|||.||.||..++ +|||||..+|+|+-..-.+||+||||.+-+....
T Consensus 193 plGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999987322 36778889999999999999999987 9999999999999999899999999999776543
Q ss_pred cc-eec-ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 TH-IST-RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~-~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.+ .+. ...-.+-|+|||.+....++.++|||+|||.+|||+| |..||.+.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 32 222 2223567999999999999999999999999999997 78899764
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=262.86 Aligned_cols=199 Identities=28% Similarity=0.412 Sum_probs=169.0
Q ss_pred CCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCC----hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 466 (626)
+|++.+.||+|++|.||+++.. +++.||||.+.... ....+.+.+|++++.++ +|+||+++++++..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677899999999999999853 56889999987532 22345688899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999988643 25889999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCCcceecccccCCcccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+..............|+..|+|||...+.. .+.++||||||+++|||++|+.|+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 865443322223345889999999987654 78899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=272.31 Aligned_cols=213 Identities=23% Similarity=0.389 Sum_probs=177.4
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
-|..++.||-|+||+|.++.-- +...+|+|.+++.. +........|..+|...+.+-||+|+..|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3777889999999999999744 46779999998763 3344567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc-
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE- 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~- 550 (626)
|++||++-.+|-..+ .|.+..++-++.++..|+++.|..| +|||||||.|||||.||++||+||||+.-+.
T Consensus 710 YIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 999999988886553 5888888999999999999999998 9999999999999999999999999987431
Q ss_pred -CC------Ccc---------------------------------eecccccCCcccchhhhccCCCCChhhHHHHHHHH
Q 006906 551 -ED------KTH---------------------------------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590 (626)
Q Consensus 551 -~~------~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil 590 (626)
.+ ..+ .....+||..|+|||++.+..++.-+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 000 00125699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCC-CChhhHHHHHH
Q 006906 591 LEIVSGKSNTNYRPN-EDFVYLLDWAY 616 (626)
Q Consensus 591 ~elltG~~p~~~~~~-~~~~~l~~w~~ 616 (626)
|||+.|+.||..... +-...+..|-.
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhh
Confidence 999999999976543 33445555643
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=250.11 Aligned_cols=198 Identities=28% Similarity=0.492 Sum_probs=166.8
Q ss_pred CCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEecC
Q 006906 398 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
+....||+|..|.|++++.+ .|..+|||.+... ..+..++++..+.++.+-+ +|.||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34578999999999999976 5899999999765 4455677788888776654 8999999999999999999999985
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
.+++.++..-. .++++.-+-++...+..||.||.+++ .|+|||+||+|||+|+.|.+|++|||++-.+.+...
T Consensus 175 -~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 175 -TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred -HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 35666664332 36888888899999999999999887 699999999999999999999999999988765443
Q ss_pred ceecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.++.+|.+.|||||.+.. ..|+.++|||||||.++||.||+.||....
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 345679999999999863 478999999999999999999999998743
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=261.23 Aligned_cols=201 Identities=28% Similarity=0.448 Sum_probs=174.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 469 (626)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999976 6899999998753 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999986542 6899999999999999999999987 999999999999999999999999998866
Q ss_pred cCCCc-------------------ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKT-------------------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... .......++..|+|||......++.++||||||++++|+++|+.|+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 43221 1112245788999999998888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=268.73 Aligned_cols=201 Identities=23% Similarity=0.409 Sum_probs=169.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 466 (626)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467889999999999999999975 68999999987642 2335677889999999999999999998753 3568
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 58888876542 5899999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCc---ceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKT---HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 86543221 11123468889999999865 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=266.33 Aligned_cols=195 Identities=27% Similarity=0.433 Sum_probs=163.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 464 (626)
.++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999975 68999999987532 22345688999999999999999999998754 3
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 46999999964 5655431 25889999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 163 LARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 988653321 22457889999999876 46889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=265.21 Aligned_cols=199 Identities=25% Similarity=0.409 Sum_probs=168.2
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC---
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--- 464 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 464 (626)
....++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999865 68999999986432 223456889999999999999999999987553
Q ss_pred ---eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 465 ---QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 465 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
..++||||+ +++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 458999998 67888877532 5889999999999999999999987 9999999999999999999999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|||++....... ....+++.|+|||.+.. ..++.++|+||||+++|+|++|+.||...
T Consensus 161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998654322 22357889999999876 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=289.21 Aligned_cols=198 Identities=32% Similarity=0.503 Sum_probs=162.0
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe------
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------ 462 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------ 462 (626)
.+-.++|++.++||+||||.|||++.+ ||+.||||++.... ......+.+|+..+++++|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678999999999999999999987 99999999997653 3445678899999999999999999865421
Q ss_pred -------------------------------------------------C------------------------------
Q 006906 463 -------------------------------------------------G------------------------------ 463 (626)
Q Consensus 463 -------------------------------------------------~------------------------------ 463 (626)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHH
Q 006906 464 ----------------------------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509 (626)
Q Consensus 464 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L 509 (626)
..+|+-||||+..++.++++.+... -.....++++.+|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHHH
Confidence 1257889999888888877655321 14667889999999999
Q ss_pred HHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc------C-----------CCcceecccccCCcccchhhh
Q 006906 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE------E-----------DKTHISTRIAGTIGYMAPEYA 572 (626)
Q Consensus 510 ~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~ 572 (626)
.|+|+++ ||||||||.||++|++..+||+|||+|.... . ......+..+||.-|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999998 9999999999999999999999999998721 0 011123457899999999999
Q ss_pred ccC---CCCChhhHHHHHHHHHHHHh
Q 006906 573 MRG---YLTSKADVYSFGVVTLEIVS 595 (626)
Q Consensus 573 ~~~---~~~~k~Dv~s~Gvil~ellt 595 (626)
.+. .|+.|+|+||+|||++||+.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc
Confidence 754 59999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=239.02 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=163.8
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+....+.||+|++|.|=+-++. +|+..|+|++... ..+..++.+.|+.+..+ ..+|.+|+++|........++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3344678999999999888764 7999999999765 34445677788887654 5799999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
|. .||+.+-..- -.....+++..+-+|+..+..||.|||++- .+||||+||+|||++.+|++|+||||++-.+.+.
T Consensus 127 M~-tSldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 127 MD-TSLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred hh-hhHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 96 4565443211 122246889999999999999999999975 6999999999999999999999999999877543
Q ss_pred CcceecccccCCcccchhhhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
-. .+...|...|||||.+.. ..|+.|+||||+|+.+.||.+++.|++.-
T Consensus 203 iA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 22 122457889999999853 36899999999999999999999999753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=260.18 Aligned_cols=199 Identities=30% Similarity=0.537 Sum_probs=164.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||.||+|+..+ ++.||||.+.... .....++.+|++++.+.. |+||+++++++.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999874 8999999997543 233456777887776664 9999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+.+ ++.+++.... ..+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++..+..
T Consensus 95 ~~~~-~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMST-CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccCc-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9864 6666654322 26899999999999999999999742 399999999999999999999999999986543
Q ss_pred CCcceecccccCCcccchhhhccCC----CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGY----LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2221 2234778999999987553 78899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=264.16 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=169.3
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe-CCe
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQ 465 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 465 (626)
+..++++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999865 78999999886432 2334678899999999999999999999875 567
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++|+||+ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||+
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 89999998 46888877543 4788889999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+....... ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 155 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 155 ARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred ccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 88543221 22356889999998766 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=266.48 Aligned_cols=200 Identities=28% Similarity=0.434 Sum_probs=168.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Ce
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 465 (626)
.++|.+.+.||+|+||+||+++.. +++.||||.+... .......+.+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999965 6899999998753 233345677899999999999999999987644 35
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999996 6788877543 25899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 98664332 12233457889999998865 46889999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=257.22 Aligned_cols=197 Identities=29% Similarity=0.469 Sum_probs=164.8
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcC---CCCceeeEEEEEEeCCe-----
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCVEGNQ----- 465 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 465 (626)
|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|++++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999987 489999999975422 2234566777766555 69999999999988776
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.+++|||+.+ +|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999974 78887755322 25899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+........ .....++..|+|||.+.+..++.++|||||||++|||++|+.|+..
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 987643322 1223478899999999988899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=263.31 Aligned_cols=202 Identities=31% Similarity=0.473 Sum_probs=165.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-------
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEG------- 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 463 (626)
.++|++.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468889999999999999999976 688999999865432 2234677899999999999999999987543
Q ss_pred -CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 464 -NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 464 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
...++||||+.. ++...+.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 346999999975 5666554432 36899999999999999999999997 99999999999999999999999
Q ss_pred cCCcccccCCCcc----------eecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTH----------ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 9999865432211 11223568889999987654 5789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=248.47 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=174.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 468 (626)
-++|+..++||+|+|.+|..++++ +.+.+|+|+++++ ..++.+....|-.+..+. +||.+|-++.+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 367999999999999999999976 5788999998765 233344555666666554 79999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|.||+++|+|--++..+ .+++++.++-+...|+.||.|||+++ ||.||||..|||+|.+|++||+|+|+++.
T Consensus 329 vieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999997776554 37999999999999999999999998 99999999999999999999999999985
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
--.+ .......+||+.|+|||++++..|+-..|.|++||+|+||+.|+.||+.
T Consensus 401 ~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 4332 2344568999999999999999999999999999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=266.13 Aligned_cols=199 Identities=27% Similarity=0.428 Sum_probs=171.8
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-----eEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-----QLL 467 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 467 (626)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999976 48999999987653 344568899999999999999999999988775 789
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999998 47888876542 6899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCc--ceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKT--HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 7654321 112334578899999999877 7899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=257.63 Aligned_cols=193 Identities=31% Similarity=0.507 Sum_probs=163.8
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|...+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 688999999865422 2335688899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+. +++.+.+.... ..+++..+..++.||+.|++|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 96 56766664432 25899999999999999999999987 999999999999999999999999998643221
Q ss_pred CcceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....|+..|+|||++. ...++.++|||||||++|||++|+.|+..
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2345888999999984 45688899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=257.06 Aligned_cols=198 Identities=28% Similarity=0.449 Sum_probs=169.9
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
|+..+.||+|++|.||++... +++.+|+|++..... .....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999975 688999999876532 24567888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++ ++.+.+.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 7777775532 36899999999999999999999987 9999999999999999999999999998765433
Q ss_pred cceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...
T Consensus 153 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 153 R-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred c-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 12234578899999998776 7899999999999999999999998643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=261.29 Aligned_cols=197 Identities=19% Similarity=0.235 Sum_probs=162.9
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCc
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 477 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 477 (626)
.+.+|.|+++.||+++. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44455666666666655 6899999998754 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc---
Q 006906 478 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT--- 554 (626)
Q Consensus 478 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~--- 554 (626)
|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999865322 25889999999999999999999997 99999999999999999999999999875532211
Q ss_pred ---ceecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 ---HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 ---~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 01122346788999999876 35789999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=262.23 Aligned_cols=200 Identities=27% Similarity=0.400 Sum_probs=165.2
Q ss_pred cCCC-CCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhc--------------HHHHHHHHHHHhcCCCCceeeEEE
Q 006906 395 NNFD-PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG--------------NREFVNEIGMISAQQHPNLVKLYG 458 (626)
Q Consensus 395 ~~f~-~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~ 458 (626)
++|. +.+.||+|+||.||+|... +++.||||++....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3577999999999999975 68999999986542221 125778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 459 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
++...+..++||||+. ++|.+++... ..+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 9999999999999997 5888887543 25889999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccCCC-------------cceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 539 KISDFGLAKLYEEDK-------------THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998654110 0111123467889999998764 4689999999999999999999998654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=259.60 Aligned_cols=194 Identities=29% Similarity=0.498 Sum_probs=164.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3667788999999999999975 5788999988642 22334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+. |++.+.+.... ..+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 997 57777664332 25889999999999999999999987 99999999999999999999999999876543
Q ss_pred CCcceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ....++..|+|||.+. ...++.++|||||||++|||++|+.|+..
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2 2245788999999975 34678899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=261.53 Aligned_cols=197 Identities=21% Similarity=0.342 Sum_probs=161.9
Q ss_pred Ceeecc--CceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G--~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+| +||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999975 78999999987542 23346788899999999999999999999999999999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
+++.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998865422 25889999999999999999999987 999999999999999999999999865433221110
Q ss_pred e------ecccccCCcccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 I------STRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~------~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0 0112245679999999764 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=264.76 Aligned_cols=199 Identities=27% Similarity=0.418 Sum_probs=165.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC----------
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG---------- 463 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------- 463 (626)
.+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999975 5889999998776666667889999999999999999999776543
Q ss_pred ----CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCE
Q 006906 464 ----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNA 538 (626)
Q Consensus 464 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~ 538 (626)
...++||||++ ++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 5887777432 5889999999999999999999987 999999999999974 5678
Q ss_pred EEeecCCcccccCCCcc--eecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 539 KISDFGLAKLYEEDKTH--ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999865432111 1122357889999998754 56788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=256.32 Aligned_cols=198 Identities=28% Similarity=0.426 Sum_probs=167.5
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEec
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
|++.+.||+|++|+||+|+.. +++.||||++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999986 478899999876532 22334567899999999 999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
+++|.+++..... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 7889888865431 36899999999999999999999987 9999999999999999999999999998664322
Q ss_pred cceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. .....++..|+|||.+.+ ..++.++|+||||++++||++|+.||...
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 2 123457889999998754 45789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=247.60 Aligned_cols=192 Identities=30% Similarity=0.416 Sum_probs=167.9
Q ss_pred eeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 403 VGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
||+|+||.||++... +++.+|+|.+..... .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 588999999876432 2345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceec
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 558 (626)
.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 99986542 5899999999999999999999987 99999999999999999999999999987644321 223
Q ss_pred ccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 559 ~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...++..|+|||...+...+.++|+||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 355788999999998888899999999999999999999999644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=253.97 Aligned_cols=198 Identities=30% Similarity=0.474 Sum_probs=169.9
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999976 48999999988653 333467888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
+ ++|.+++.... ..+++..+.+++.|++.||+|||+++ |+||||+|+||++++++.+||+|||++.......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 8 58999886542 26899999999999999999999997 9999999999999999999999999998664432
Q ss_pred cceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......++..|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2 12223457789999998766 7899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=258.85 Aligned_cols=199 Identities=26% Similarity=0.395 Sum_probs=163.5
Q ss_pred CCCCCCeeeccCceEEEEEEEc-C--CcEEEEEEeccCC--hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC----Ce
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-D--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG----NQ 465 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~--g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 465 (626)
+|++.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|++++.++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999975 3 6789999987532 22346788899999998 599999999875432 45
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999886 6888887543 26899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcc---eecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTH---ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 9865432211 1123468899999998765 46899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=269.33 Aligned_cols=206 Identities=23% Similarity=0.302 Sum_probs=156.0
Q ss_pred HhcCCCCCCeeeccCceEEEEEEE-----------------cCCcEEEEEEeccCChhcHHHH--------------HHH
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGIL-----------------SDGTVIAVKQLSSKSRQGNREF--------------VNE 441 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~-----------------~~g~~vAvK~l~~~~~~~~~~~--------------~~E 441 (626)
..++|++.++||+|+||.||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356799999876443333333 346
Q ss_pred HHHHhcCCCCce-----eeEEEEEEe--------CCeEEEEEEecCCCchhhhhcCCCcc-------------------c
Q 006906 442 IGMISAQQHPNL-----VKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTE-------------------Y 489 (626)
Q Consensus 442 ~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~ 489 (626)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777776654 667777753 35689999999999999998753211 1
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccch
Q 006906 490 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569 (626)
Q Consensus 490 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 569 (626)
...++|..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 124678889999999999999999987 99999999999999999999999999976543222111112347899999
Q ss_pred hhhccCC----------------------CCChhhHHHHHHHHHHHHhCCC-CCC
Q 006906 570 EYAMRGY----------------------LTSKADVYSFGVVTLEIVSGKS-NTN 601 (626)
Q Consensus 570 E~~~~~~----------------------~~~k~Dv~s~Gvil~elltG~~-p~~ 601 (626)
|.+.... ...+.||||+||+++||++|.. |+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9875432 1234799999999999999975 554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=258.64 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=168.8
Q ss_pred cCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccC--Ch-----hcHHHHHHHHHHHhcCCCCceeeEEEEEE-eCCe
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SR-----QGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQ 465 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~--~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~ 465 (626)
++|-.+.+||+|||+.||||.. ...+-||||+-... .+ .-.+...+|.++-+.++||-||++++|+. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4566678999999999999984 45778899986432 11 11245678999999999999999999987 5667
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEee
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISD 542 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~D 542 (626)
++-|+|||+|.+|+-+|+... .+++..++.|+.||+.||.||.+. .+||||-||||.|||+-. -|.+||+|
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 899999999999999997653 589999999999999999999988 478999999999999954 47899999
Q ss_pred cCCcccccCCCcc------eecccccCCcccchhhhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+++++..+... .....+||.+|++||.+.- .+++.|+||||.|||+|..+.|+.||...
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 9999998764332 2334679999999998753 35789999999999999999999999654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=264.84 Aligned_cols=199 Identities=23% Similarity=0.348 Sum_probs=175.2
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCc-EEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGT-VIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~-~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
+++....||-|+||.|=.+...... .+|+|++++. ..........|-.+|...+.|.||++|..|.++..+|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455678999999999998876443 4888888765 33445567789999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
-|-||.|...|+..+ .++..+.+-++..+.+|++|||.++ ||.|||||+|.++|.+|.+||.|||+|+.+..
T Consensus 501 aClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999997764 6889999999999999999999998 99999999999999999999999999998875
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
... .-.++||+.|.|||++.....+..+|.||+|+++|||++|++||...+
T Consensus 573 g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 573 GRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred CCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 443 345789999999999999999999999999999999999999998754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=278.31 Aligned_cols=145 Identities=28% Similarity=0.439 Sum_probs=130.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999986 68899999987542 223467888999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
||+.+++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986542 5788999999999999999999986 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=245.92 Aligned_cols=197 Identities=24% Similarity=0.302 Sum_probs=165.4
Q ss_pred HhcCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEE----eCCe
Q 006906 393 ATNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV----EGNQ 465 (626)
Q Consensus 393 ~t~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~----~~~~ 465 (626)
.|++|.+. ++||-|-.|+|-.+..+ .++.+|+|++... ....+|++..-.. .|||||+++++|. ....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 68999999999999876 6889999998654 3456788865444 6999999999876 3567
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEee
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISD 542 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~D 542 (626)
+.+|||.|+||.|...+...+. ..+++.++..|+.||+.|+.|||+.. |.||||||+|+|... |..+||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecc
Confidence 8999999999999999876643 47999999999999999999999987 999999999999954 55789999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
||+|+.-.... .....+-|+.|.|||++...+|+..+|+||+||+||-|++|-+||-.
T Consensus 208 fGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 208 FGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred cccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 99999655322 22335679999999999999999999999999999999999999843
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=262.76 Aligned_cols=197 Identities=27% Similarity=0.441 Sum_probs=167.9
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe----
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ---- 465 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 465 (626)
..++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999986 5789999998653 22334667789999999999999999998776554
Q ss_pred --EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 466 --LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 466 --~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
.++|+||+ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 56898887542 5899999999999999999999987 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|++...... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999865432 223457889999999865 46789999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=249.70 Aligned_cols=201 Identities=24% Similarity=0.352 Sum_probs=164.9
Q ss_pred CCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccC-----ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998753 444555555432 122344677899999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.... .....+++..++.++.|++.|++|||+.+ ++|+||+|+||++++ +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999998885421 12246899999999999999999999987 999999999999975 56999999998866
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... ......|+..|+|||......++.++|+||||+++|+|++|+.|+..
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43222 22234578899999999888889999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=275.76 Aligned_cols=223 Identities=30% Similarity=0.450 Sum_probs=179.8
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc----C----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEE
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS----D----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGC 459 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~----~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~ 459 (626)
.+...++..+.+.+|+|.||.|++|... . ...||||.++... ..+.+.+..|+++++.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555667779999999999999853 1 4569999998653 34567899999999887 69999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhcCCC---------cccc--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 006906 460 CVEGNQLLLVYEYMKNNCLSRAIFGKD---------TEYR--LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 528 (626)
Q Consensus 460 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~ 528 (626)
|..++..++|+||+..|+|.++++..+ .... ..++..+.+.++.|||.||+||++.. ++||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998765 1111 13889999999999999999999985 999999999
Q ss_pred CEEEcCCCCEEEeecCCcccccCCCcceeccccc--CCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 006906 529 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG--TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 605 (626)
Q Consensus 529 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~~ 605 (626)
|||+..+..+||+|||+|+..............+ ...|||||.+....|+.|+|||||||+||||+| |..|+....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~- 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP- 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-
Confidence 9999999999999999999765544433222222 346999999999999999999999999999998 778886522
Q ss_pred CChhhHHHHHHH
Q 006906 606 EDFVYLLDWAYV 617 (626)
Q Consensus 606 ~~~~~l~~w~~~ 617 (626)
...++.+|.+.
T Consensus 527 -~~~~l~~~l~~ 537 (609)
T KOG0200|consen 527 -PTEELLEFLKE 537 (609)
T ss_pred -cHHHHHHHHhc
Confidence 12334445544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=244.08 Aligned_cols=180 Identities=24% Similarity=0.245 Sum_probs=153.6
Q ss_pred cCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcC
Q 006906 406 GGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 484 (626)
Q Consensus 406 G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 484 (626)
|.+|.||+++.. +++.||+|++.... ++.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999975 68899999997643 233455555566799999999999999999999999999999998854
Q ss_pred CCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCC
Q 006906 485 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564 (626)
Q Consensus 485 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 564 (626)
.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+....... ....++.
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 146 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVEN 146 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCc
Confidence 32 5899999999999999999999987 9999999999999999999999999887554321 2234567
Q ss_pred cccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 565 ~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.|+|||.+....++.++||||+|+++|||++|+.|+..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 89999999888889999999999999999999987653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=266.25 Aligned_cols=204 Identities=28% Similarity=0.482 Sum_probs=175.6
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEE-----eCC
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCV-----EGN 464 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~-----~~~ 464 (626)
..++.|++.+.||.|.+|.||+++.. +++.+|+|++.... ....++..|.++++.. +|||++.++|++. .++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34567889999999999999999954 78899999987753 3456777888888876 7999999999986 367
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.+|||||||.+||..+++++.. ...+.|+.+..|+..+++|+.+||.+. ++|||||=.|||++.++.+|+.|||
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 8999999999999999998765 357999999999999999999999986 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+......... .....||+.|||||++... .|+.++|+||+|++..||.-|.+|+..+
T Consensus 169 vSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 169 VSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 99877644332 2345799999999999643 5788999999999999999999998653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=235.20 Aligned_cols=199 Identities=34% Similarity=0.513 Sum_probs=173.1
Q ss_pred CCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 397 FDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 889999999876544 56788999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++..... .+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999865421 2789999999999999999999986 99999999999999999999999999987754421
Q ss_pred ceecccccCCcccchhhh-ccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122334577889999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=257.84 Aligned_cols=196 Identities=28% Similarity=0.418 Sum_probs=164.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++.|.....+|.|+|+.|-++... +++..+||++.+.. .+-.+|+.++.. -+|+||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556777788999999999998865 68889999998762 223356655544 479999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE-cCCCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~~kl~DfGla~~~~ 550 (626)
.+.++-+.+.+.... ... ..+..|+.+|+.|++|||++| |+||||||+|||+ ++.++++|+|||.++..+
T Consensus 397 ~l~g~ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hccccHHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999998877776553 222 677789999999999999987 9999999999999 589999999999999776
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 606 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~ 606 (626)
.+ ....+-|..|.|||++....|++.+|+||||++||||++|+.|+...+.+
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 54 11224578899999999999999999999999999999999999876554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=265.83 Aligned_cols=202 Identities=24% Similarity=0.331 Sum_probs=144.5
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-C----CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEE------EE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-D----GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC------CV 461 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~----g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 461 (626)
..++|++.+.||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999976 4 68999998764321 1111111 1112222222222111 24
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCccc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 006906 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEY---------------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 526 (626)
Q Consensus 462 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 526 (626)
.+...++||||+.+++|.++++...... .....+..+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 5678999999999999999886542110 011223456689999999999999987 9999999
Q ss_pred CCCEEEcC-CCCEEEeecCCcccccCCCcceecccccCCcccchhhhccC----------------------CCCChhhH
Q 006906 527 TSNVLLDK-DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG----------------------YLTSKADV 583 (626)
Q Consensus 527 p~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~Dv 583 (626)
|+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654433344456789999999965322 23456799
Q ss_pred HHHHHHHHHHHhCCCCCC
Q 006906 584 YSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 584 ~s~Gvil~elltG~~p~~ 601 (626)
|||||++|||+++..+.+
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999776543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=238.57 Aligned_cols=208 Identities=25% Similarity=0.448 Sum_probs=166.3
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--------CC
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------GN 464 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~~ 464 (626)
.|+...+||+|.||.||+|+.+ +|+.||+|++-.+ ...-.....+|+.+|..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445678999999999999976 5778898865432 22334567899999999999999999988753 23
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.+|+||++|+. +|..+|... ...++..++.+++.++..||.|+|... |+|||+|+.|+|++.++.+||+|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 58999999985 677776443 246899999999999999999999885 9999999999999999999999999
Q ss_pred CcccccCCCcc---eecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhH
Q 006906 545 LAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 611 (626)
Q Consensus 545 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l 611 (626)
+++.+...... ..+..+-|..|.+||.+.+. .|+++.|||+.||||.||+||.+-+....+.....+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 99876533221 12334568999999998864 689999999999999999999988876654433333
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=239.34 Aligned_cols=198 Identities=29% Similarity=0.429 Sum_probs=165.9
Q ss_pred CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CeEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQLLL 468 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~l 468 (626)
.+..+.||-|+||.||.++.. +|+.||.|++... +-...+.+.+|+++|+-.+|.|++..++..+.. +++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345688999999999999875 7999999998654 233457889999999999999999998876643 25678
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
++|.|. .+|...+-.. ..++-+.++-+..||++||+|||+.+ |.||||||.|.|++.+..+||+|||+++.
T Consensus 135 ~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 888885 4677776543 36888899999999999999999997 99999999999999999999999999998
Q ss_pred ccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+.+....++..+-|..|.|||++++. .|+...||||.|||+.|++..|..|...
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 776554444445568899999999875 6899999999999999999888877643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=251.12 Aligned_cols=195 Identities=26% Similarity=0.366 Sum_probs=166.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--------hcHHHHHHHHHHHhcCC---CCceeeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQ---HPNLVKLYGCCVE 462 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 462 (626)
.+|...+.+|+|+||.|+.+.++ +...|+||.+.+..- ......-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999987 466788998765421 11123456999999987 9999999999999
Q ss_pred CCeEEEEEEecC-CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 463 GNQLLLVYEYMK-NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 463 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
++..||+||-.. +.+|.+++..+. .+++..+.-|+.||+.|+++||+++ |||||||-+||.++.+|.+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 999999999864 458888886653 6899999999999999999999998 9999999999999999999999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCC
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
|||.+....... ....+||..|.|||++.+..| +..-|||++||+||.++....||
T Consensus 713 dfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 713 DFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred eccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999998654432 344679999999999998766 66789999999999999888886
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-28 Score=241.55 Aligned_cols=214 Identities=20% Similarity=0.315 Sum_probs=174.9
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCC--C----ceeeEEEE
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--P----NLVKLYGC 459 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~----nIv~l~~~ 459 (626)
++.....+++|.+...+|+|.||.|-++... .+..||||+++..... .+..+-|+++|.++.+ | -+|++.+|
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3334445889999999999999999999865 4688999999765322 2344568899988832 2 27888999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----
Q 006906 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK----- 534 (626)
Q Consensus 460 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----- 534 (626)
+.-.++.++|+|.+ |-|+.++|..+.. .+++...++.|+.|++++++|||+.. ++|.||||+|||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence 99999999999987 4588999976532 47899999999999999999999986 999999999999931
Q ss_pred ---------------CCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC
Q 006906 535 ---------------DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599 (626)
Q Consensus 535 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p 599 (626)
+..+||+|||.|+.-.... ..++.|..|.|||++.+..++..+||||+||||.|+.||..-
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 2358999999999765544 345679999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHH
Q 006906 600 TNYRPNEDFVYLL 612 (626)
Q Consensus 600 ~~~~~~~~~~~l~ 612 (626)
|...++.+++.+.
T Consensus 309 FqtHen~EHLaMM 321 (415)
T KOG0671|consen 309 FQTHENLEHLAMM 321 (415)
T ss_pred cccCCcHHHHHHH
Confidence 9877655544333
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=228.64 Aligned_cols=186 Identities=32% Similarity=0.532 Sum_probs=165.3
Q ss_pred CceEEEEEEEc-CCcEEEEEEeccCChhc-HHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcC
Q 006906 407 GFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG 484 (626)
Q Consensus 407 ~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 484 (626)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999998765544 68899999999999999999999999999999999999999999998865
Q ss_pred CCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCC
Q 006906 485 KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564 (626)
Q Consensus 485 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~ 564 (626)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 42 3889999999999999999999987 9999999999999999999999999998765432 223355788
Q ss_pred cccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 565 ~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.|++||......++.++||||||++++||++|+.|+..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999888889999999999999999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=229.89 Aligned_cols=214 Identities=21% Similarity=0.341 Sum_probs=174.0
Q ss_pred HHHHHHhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006906 388 RQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCC 460 (626)
Q Consensus 388 ~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 460 (626)
+++.....++....++-+|.||.||+|.|.+ .+.|-||.++.. +.-....++.|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3445555678888899999999999997653 345677877654 344556788999999999999999999998
Q ss_pred EeC-CeEEEEEEecCCCchhhhhcC---CCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 461 VEG-NQLLLVYEYMKNNCLSRAIFG---KDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 461 ~~~-~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
.++ +..+++|.++.-|+|..+|.- .+......+.-.+...++.|++.||+|||.++ |||.||..+|.++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 754 456889999999999999862 22233346777888999999999999999997 99999999999999999
Q ss_pred CEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 537 NAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
++||+|=.+++.+...+.+. .........||+||.+....|+..+|||||||+||||+| |+.|+...+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 99999999999765443332 222334568999999999999999999999999999997 899987543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=220.26 Aligned_cols=212 Identities=23% Similarity=0.397 Sum_probs=175.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeC--CeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG--NQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV 469 (626)
.++|++.+++|+|-++.||.|.. .+.+.++||+++.. ..+.+.+|+.+|..++ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 35788899999999999999984 47888999999764 3568889999999997 99999999998764 456899
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeecCCccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKL 548 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla~~ 548 (626)
+||+.+.+...+- ..++...++..+.+++.||.|+|+.| |+|||+||+|+++|.. -.++|+|+|+|.+
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 9999987764432 25777889999999999999999998 9999999999999864 5689999999999
Q ss_pred ccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHhhcc
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEE 622 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~~~~~~~ 622 (626)
+...... ...+.+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||....+ ...+|++.|.-+-.++
T Consensus 183 YHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 183 YHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDE 254 (338)
T ss_pred cCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHH
Confidence 8765432 22335677899999865 5688899999999999999999999976543 4678888887765554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=249.32 Aligned_cols=198 Identities=31% Similarity=0.439 Sum_probs=160.3
Q ss_pred CCCCCeeeccCce-EEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 397 FDPANKVGEGGFG-SVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 397 f~~~~~IG~G~fG-~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
|...+++|.|+-| .||+|.. +|+.||||++-.. ...-..+|+..|+.- +|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4455788999887 4699998 6889999998653 234556899988776 69999999999999999999999996
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---C--CCEEEeecCCcccc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---D--LNAKISDFGLAKLY 549 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~~kl~DfGla~~~ 549 (626)
.+|.+++.....+ .....-...+.+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++.+
T Consensus 587 -~sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 587 -CSLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5899999764111 111222456788999999999999976 999999999999975 3 46899999999988
Q ss_pred cCCCccee--cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCCCC
Q 006906 550 EEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG-~~p~~~~ 603 (626)
..+..... ....||.||+|||.+....-+..+||||+||++|+.++| +.||...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 76554433 346799999999999998888899999999999999987 8888643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-26 Score=220.88 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=167.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------Ce
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQ 465 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 465 (626)
.+|.-...+|.|.- .|.-+... .++.||+|++... .....+...+|..++..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 44556778888887 66666543 5889999987654 344567788999999999999999999998643 35
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.|+|||+|. .+|...++ ..++-.++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 799999996 57777665 24788899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHH
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 616 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~ 616 (626)
|+.-..+ ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+ ...+.+|-.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-----~d~idQ~~k 228 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-----KDHIDQWNK 228 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-----chHHHHHHH
Confidence 9864433 455677889999999999988899999999999999999999998863 345556653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-26 Score=217.10 Aligned_cols=208 Identities=20% Similarity=0.354 Sum_probs=163.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEE-EEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGC-CVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lV~ 470 (626)
.+.|++.+.+|+|.||.+-.+.++. .+.+++|-+... ....++|.+|...--.+ .|.||+.-++. |+..+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3568889999999999999999874 677889988764 45578899998765444 68999987664 67778889999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE-cC-CCCEEEeecCCccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-DK-DLNAKISDFGLAKL 548 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~-~~~~kl~DfGla~~ 548 (626)
||++.|+|.+-+... .+.+....+++.|+++|++|+|+.. +||||||.+|||+ +. ..++||||||+.+.
T Consensus 102 E~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred ccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999998877543 4778889999999999999999997 9999999999999 33 35799999999986
Q ss_pred ccCCCcceecccccCCcccchhhhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHH
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 616 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~ 616 (626)
....-. ...-+..|.+||..... ...+.+|||.|||+++.++||+.||... .-+....++|..
T Consensus 173 ~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 173 VGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQ 240 (378)
T ss_pred cCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHH
Confidence 543221 12235579999987532 3577899999999999999999999833 333345555553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-26 Score=233.83 Aligned_cols=224 Identities=21% Similarity=0.289 Sum_probs=186.7
Q ss_pred CCCCCCcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC------C
Q 006906 378 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ------H 450 (626)
Q Consensus 378 ~~~~~~~~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~------H 450 (626)
++...+.|.+...+.....|.+....|+|-|++|.+|... .|..||||++.... .-.+.=+.|+++|+++. .
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhh
Confidence 3445667888888888899999999999999999999965 47899999998652 23344567999999885 3
Q ss_pred CceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 006906 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 530 (626)
Q Consensus 451 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 530 (626)
-|+++++..|...++++||+|-+. -+|.++|+..+.. ..|....++.++.|+.-||..|...+ |+|.||||.||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNi 567 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNI 567 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccce
Confidence 489999999999999999999875 5788998765433 56888899999999999999999876 99999999999
Q ss_pred EEcCC-CCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChh
Q 006906 531 LLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFV 609 (626)
Q Consensus 531 Ll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~ 609 (626)
|+++. ..+||||||.|.....+.. +.+.-+..|.|||++.+..|+...|+||.||+||||.||+..|.+.....++
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred EeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 99876 4579999999987765432 2334566899999999999999999999999999999999999888766554
Q ss_pred hH
Q 006906 610 YL 611 (626)
Q Consensus 610 ~l 611 (626)
.|
T Consensus 645 rl 646 (752)
T KOG0670|consen 645 RL 646 (752)
T ss_pred HH
Confidence 44
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-24 Score=204.38 Aligned_cols=183 Identities=39% Similarity=0.668 Sum_probs=159.3
Q ss_pred eeccCceEEEEEEEcC-CcEEEEEEeccCChh-cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCchhh
Q 006906 403 VGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ-GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSR 480 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 480 (626)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999876432 35678999999999999999999999999999999999999999999
Q ss_pred hhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCEEEeecCCcccccCCCcceecc
Q 006906 481 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYEEDKTHISTR 559 (626)
Q Consensus 481 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~ 559 (626)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 986542 25889999999999999999999997 999999999999999 89999999999987654321 1223
Q ss_pred cccCCcccchhhhccC-CCCChhhHHHHHHHHHHH
Q 006906 560 IAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEI 593 (626)
Q Consensus 560 ~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~el 593 (626)
..+...|++||..... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4577899999999877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-26 Score=238.26 Aligned_cols=198 Identities=27% Similarity=0.482 Sum_probs=174.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|+....+|+|.||.|||++.. .++..|+|+++.....+..-..+|+-+++..+|+|||.++|.+..++.++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888999999999999999965 6889999999987777777788899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
|.+|+|.+.-|... .+++.++..++....+|++|||+.+ -+|||||=.||++++.|.+|++|||.+..+...
T Consensus 94 cgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999877764 7999999999999999999999998 689999999999999999999999998866543
Q ss_pred CcceecccccCCcccchhhh---ccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYA---MRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
-. ....+.||+.|||||+. +++.|.+++|||+.|+...|+---++|.
T Consensus 166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 22 23446799999999987 4677999999999999999987666664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=217.92 Aligned_cols=166 Identities=21% Similarity=0.195 Sum_probs=129.4
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEeccC-----ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 463 (626)
....++|.+.+.||+|+||+||+|++. +++.||||++... .....+.|.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999875 5788899987533 12234568999999999999999853322 2
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCEEEcCCCCEEEee
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAKISD 542 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~D 542 (626)
+..++||||+++++|... . . .. ...++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~-~-------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R-P-------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C-c-------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999999632 1 1 01 1467889999999999987 999999 99999999999999999
Q ss_pred cCCcccccCCCcc-------eecccccCCcccchhhhcc
Q 006906 543 FGLAKLYEEDKTH-------ISTRIAGTIGYMAPEYAMR 574 (626)
Q Consensus 543 fGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 574 (626)
||+++.+...... ......+++.|+|||++..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999976543211 1134568889999999854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=210.82 Aligned_cols=132 Identities=26% Similarity=0.423 Sum_probs=109.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-----C---CceeeEEEEEEe---
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----H---PNLVKLYGCCVE--- 462 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~--- 462 (626)
.+|.+.++||-|-|++||++... +.+-||+|+.+.. ..-.+..+.|+++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57888999999999999999864 5778999998765 223345678999998773 3 469999999974
Q ss_pred -CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 006906 463 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 533 (626)
Q Consensus 463 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 533 (626)
+.++++|+|++ |.+|..++....- ..++...+++|++||+.||.|||..+ .|||.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 56899999998 4567777755432 36889999999999999999999997 799999999999995
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.9e-24 Score=213.57 Aligned_cols=212 Identities=31% Similarity=0.454 Sum_probs=170.9
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 464 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 464 (626)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+ ....+..|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344567889999999999999999864 36789999997753 345688999999887 5999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeec
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDF 543 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~Df 543 (626)
...+|+||++.....++.. .++...+...+..+..||+++|++| ||||||||+|+|.+.. +.-.|.||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred eeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence 9999999999888777653 4678899999999999999999998 9999999999999754 56789999
Q ss_pred CCcccccCCC------c-------------------------------------ceecccccCCcccchhhhcc-CCCCC
Q 006906 544 GLAKLYEEDK------T-------------------------------------HISTRIAGTIGYMAPEYAMR-GYLTS 579 (626)
Q Consensus 544 Gla~~~~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~ 579 (626)
|+|...+... . ......+||+||.|||++.+ ...++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9998321100 0 00112569999999999876 45788
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHH
Q 006906 580 KADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 615 (626)
Q Consensus 580 k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~ 615 (626)
++||||.|||++-+++++.||....+ +-..+++-+
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~d-d~~al~ei~ 292 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKD-DADALAEIA 292 (418)
T ss_pred ccceeeccceeehhhccccccccCcc-ccchHHHHH
Confidence 99999999999999999999976543 334444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=201.07 Aligned_cols=202 Identities=22% Similarity=0.252 Sum_probs=164.7
Q ss_pred CCCCCCeeeccCceEEEEEEEcCC--cEEEEEEeccCChhcHHHHHHHHHHHhcCCC----CceeeEEEEE-EeCCeEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDG--TVIAVKQLSSKSRQGNREFVNEIGMISAQQH----PNLVKLYGCC-VEGNQLLL 468 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g--~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 468 (626)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999997653 4788888766533333367778888887763 6888899888 47778899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-----CCEEEeec
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-----LNAKISDF 543 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~~kl~Df 543 (626)
||+.+ +.+|.++..... ...++..+..+|+.|++.+|++||+.| ++||||||.|+++... ..+.|.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99977 678988775443 247999999999999999999999998 9999999999999764 46899999
Q ss_pred CCcc--cccCCCcc-----e--ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 544 GLAK--LYEEDKTH-----I--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 544 Gla~--~~~~~~~~-----~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
|+++ .+...... . .....||.+|++++...+...+.+.|+||++.++.|++.|..||....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 9999 43222111 1 123459999999999999999999999999999999999999997654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-20 Score=192.06 Aligned_cols=200 Identities=35% Similarity=0.555 Sum_probs=169.7
Q ss_pred CCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChh---cHHHHHHHHHHHhcCCCC-ceeeEEEEEEeCCeEEEEEEe
Q 006906 397 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ---GNREFVNEIGMISAQQHP-NLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~e~ 472 (626)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+..+..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 78899998765433 367899999999999988 799999999877778999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcccccC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~ 551 (626)
+.++++.+++...... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++... .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666543211 25888999999999999999999997 99999999999999988 799999999986554
Q ss_pred CCcc-----eecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTH-----ISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......|+..|+|||.+.. ..+....|+||+|++++++++|+.|+...
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 3321 2345679999999999987 57899999999999999999999996543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-22 Score=232.86 Aligned_cols=146 Identities=18% Similarity=0.200 Sum_probs=113.2
Q ss_pred CCC-CceeeEEEEE-------EeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 006906 448 QQH-PNLVKLYGCC-------VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519 (626)
Q Consensus 448 l~H-~nIv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 519 (626)
.+| +||++++++| .+.+.++.++||+ +++|.+++.... ..+++.+++.++.||++||+|||+++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 455 5788888877 2334677889987 569999996432 35899999999999999999999987
Q ss_pred eEEeCCCCCCEEEcC-------------------CCCEEEeecCCcccccCCCc---------------ceecccccCCc
Q 006906 520 IVHRDIKTSNVLLDK-------------------DLNAKISDFGLAKLYEEDKT---------------HISTRIAGTIG 565 (626)
Q Consensus 520 iiH~Dlkp~NILl~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~ 565 (626)
|+||||||+||||+. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566667776654211000 00111357889
Q ss_pred ccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 566 y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
|||||++.+..++.++|||||||+||||++|..|+.
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 999999999999999999999999999999988864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-21 Score=180.23 Aligned_cols=203 Identities=23% Similarity=0.318 Sum_probs=167.5
Q ss_pred hcCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCC-CceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 471 (626)
..+|...++||+|+||.+|.|. ..+|+.||||.-..... ..++..|..+...++| ..|..+..+..+.+.-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3678899999999999999998 45799999998765433 3456678888888876 567777778888888999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CCEEEeecCCccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLAKL 548 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla~~ 548 (626)
.+ +.+|+++..-.. ..++.++.+-.+.|++.-++|+|.++ +|||||||+|+|+.-+ ..+.++|||+++.
T Consensus 92 LL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 87 678988875553 26888999999999999999999998 9999999999999654 4578999999998
Q ss_pred ccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 006906 549 YEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 606 (626)
Q Consensus 549 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~ 606 (626)
+.+.... ......||.+|.+-....+-+.+.+.|+-|+|.+|.+.--|+-||.+....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 7653322 123467999999988888888899999999999999999999999876443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=181.34 Aligned_cols=140 Identities=14% Similarity=0.165 Sum_probs=107.7
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChh--c-------H-----------------HHHHHHHHHHhcCCCCce
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--G-------N-----------------REFVNEIGMISAQQHPNL 453 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~H~nI 453 (626)
...||+|+||.||+|...+|+.||||+++..... . . .....|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998754211 1 0 122348899999988776
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeCCCCCCEEE
Q 006906 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 454 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlkp~NILl 532 (626)
.....+... ..++||||++++++....... ..+++....+++.|++.+|+|+ |+.+ |+||||||+|||+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 443332222 238999999988775443221 2588999999999999999999 6776 9999999999999
Q ss_pred cCCCCEEEeecCCccccc
Q 006906 533 DKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~ 550 (626)
+ ++.++|+|||++....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-21 Score=185.38 Aligned_cols=172 Identities=15% Similarity=0.138 Sum_probs=134.4
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHH---------HHHHHHHHhcCCCCceeeEEEEEEe
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNRE---------FVNEIGMISAQQHPNLVKLYGCCVE 462 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~~~~~~ 462 (626)
...++|...+++|.|+||.||.... ++..+|+|.+........+. +.+|++.+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3568899999999999999999765 57789999997654333322 6789999999999999999988664
Q ss_pred C--------CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 006906 463 G--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 534 (626)
Q Consensus 463 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 534 (626)
. ...++||||++|.+|.++. .++. ....+++.++..+|+.+ ++|||+||+||+++.
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 3 3578999999999997763 1222 24568999999999997 999999999999999
Q ss_pred CCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHH
Q 006906 535 DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 594 (626)
Q Consensus 535 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ell 594 (626)
++ ++|+|||.......+... ..+.....+..++|+|+||+.+....
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 98 999999988765332211 11334445667999999999877653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=181.60 Aligned_cols=199 Identities=24% Similarity=0.345 Sum_probs=165.8
Q ss_pred cCCCCCCeeeccCceEEEEEE-EcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
-+|.+.++||+|.||.++.|+ +-+++.||||.-..+++ .-++..|.+..+.+ ..+.|...+.+..++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999998 45899999998765543 33455566666655 568899988888888888999998
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----CCCEEEeecCCcc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAK 547 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~ 547 (626)
+ |-+|+++..-++. .++.++...||.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|+
T Consensus 106 L-GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred h-CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 7 6788887755543 6999999999999999999999997 999999999999953 3358999999999
Q ss_pred cccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+.+.... ......||.+||+-....+.+.+.+.|.-|+|-++++.+-|..||.+-
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 88754332 223467999999999999999999999999999999999999999864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.2e-20 Score=175.22 Aligned_cols=141 Identities=16% Similarity=0.171 Sum_probs=110.8
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhc--------------------------HHHHHHHHHHHhcCCCCce
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG--------------------------NREFVNEIGMISAQQHPNL 453 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~H~nI 453 (626)
...||+|++|.||+|+..+|+.||||++....... ...+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999998889999999987642110 1123578899999999987
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEE
Q 006906 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 454 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl 532 (626)
.....+... ..++||||++++++....... ..++.....+++.|++.++.++|+ .+ |+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 554444333 248999999988654332111 246788899999999999999999 76 9999999999999
Q ss_pred cCCCCEEEeecCCcccccC
Q 006906 533 DKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~ 551 (626)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999986653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=171.75 Aligned_cols=107 Identities=25% Similarity=0.270 Sum_probs=93.5
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.++++... ..++|.++..++.||+.||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 67888886532 26999999999999999999999874 999999999999999 99998664322
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..||+.|+|||++.+..++.++|||||||++|||+||+.|+...
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25889999999999999999999999999999999999998643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-19 Score=166.64 Aligned_cols=185 Identities=14% Similarity=0.054 Sum_probs=139.5
Q ss_pred CCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChh----cHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEe
Q 006906 398 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ----GNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~----~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.+...|++|+||+||.+.- ++..++.+.+.....- ....+.+|+++|+++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4678899999999997765 6788888887765331 1225789999999995 4789999886 346999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCEEEcCCCCEEEeecCCcccccC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI-KTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
+.+.+|...+.. ....++.|++++++++|+++ |+|||| ||.|||++.++.++|+|||++.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999888654311 11357789999999999998 999999 79999999999999999999986543
Q ss_pred CCcc----e--------ecccccCCcccchhhhccC-CCC-ChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTH----I--------STRIAGTIGYMAPEYAMRG-YLT-SKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... . ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 3210 0 0112357778888765432 233 567889999999999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=167.69 Aligned_cols=138 Identities=14% Similarity=0.265 Sum_probs=107.7
Q ss_pred CCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-----CCCceeeEEEEEEeCC---e-EEE
Q 006906 398 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----QHPNLVKLYGCCVEGN---Q-LLL 468 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~-~~l 468 (626)
+..+.||+|+||.||. +++....+||++........+++.+|+.+++.+ .||||+++++++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4568999999999996 443333479988765455567899999999999 6799999999998864 3 337
Q ss_pred EEEe--cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEeCCCCCCEEEcC----CCCEEEe
Q 006906 469 VYEY--MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL-AYLHEDSRIKIVHRDIKTSNVLLDK----DLNAKIS 541 (626)
Q Consensus 469 V~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~~kl~ 541 (626)
|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+
T Consensus 83 I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 8999 5689999999543 24444 35677888777 9999997 999999999999974 3479999
Q ss_pred e-cCCccc
Q 006906 542 D-FGLAKL 548 (626)
Q Consensus 542 D-fGla~~ 548 (626)
| ||....
T Consensus 152 Dg~G~~~~ 159 (210)
T PRK10345 152 DNIGESTF 159 (210)
T ss_pred ECCCCcce
Confidence 9 555444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=173.18 Aligned_cols=193 Identities=24% Similarity=0.387 Sum_probs=152.8
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
...+|.+...|..|+|+|+.+ .+++|++.-. .....++|.+|.-.|+...||||+.+++.|.....+.++..||+-|
T Consensus 194 l~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345688889999999999644 4566665432 3344578999999999999999999999999999999999999999
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+|+..||+... ...+-.++.+++.+||+|++|||+.. +-|.---|.++.|++|++.+++|+ .+-+++......
T Consensus 273 slynvlhe~t~---vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfqe~g-- 345 (448)
T KOG0195|consen 273 SLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG-- 345 (448)
T ss_pred HHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeeeccc--
Confidence 99999998643 46788899999999999999999986 224445799999999999999875 222222111111
Q ss_pred ecccccCCcccchhhhccCCCC---ChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 557 STRIAGTIGYMAPEYAMRGYLT---SKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 557 ~~~~~gt~~y~aPE~~~~~~~~---~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..-.+.||+||.+.+.+.+ ..+|+|||++++||+.|...||..
T Consensus 346 ---r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 346 ---RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred ---cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 1225779999999876533 468999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=192.46 Aligned_cols=186 Identities=28% Similarity=0.333 Sum_probs=156.6
Q ss_pred eeeccCceEEEEEE----EcCCcEEEEEEeccCChhc--HHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEecC
Q 006906 402 KVGEGGFGSVYKGI----LSDGTVIAVKQLSSKSRQG--NREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~----~~~g~~vAvK~l~~~~~~~--~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
.+|+|+||.|+.+. .+.|+.+|+|.+++..... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999764 3357889999887653211 124456777888887 9999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+|.|...+.... .+++.........++-+++++|+.+ ++|||+|++||+++.+|++++.|||+.+..-+...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999988876543 5677777888889999999999998 99999999999999999999999999997654433
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. +||..|||||++. .....+|.||||++++||+||-.||..
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2 7999999999998 557789999999999999999999976
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-19 Score=195.84 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=157.6
Q ss_pred CCCCeeeccCceEEEEEEEc-CCcEEEEEEec----cC-Ch-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 398 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLS----SK-SR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~----~~-~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
...+++|.|++|.|+..+.. ..+..+.|.+. .. .. .....+..|..+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988777643 34434444332 11 11 11122556777778899999988877777766666679
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||++. +|...+.... .+....+..++.|+..|++|+|+.| |.|||+|++|+++..++.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 9998886542 5778899999999999999999998 9999999999999999999999999998765
Q ss_pred CCCc---ceecccccCCcccchhhhccCCCCCh-hhHHHHHHHHHHHHhCCCCCCCCCCC
Q 006906 551 EDKT---HISTRIAGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSGKSNTNYRPNE 606 (626)
Q Consensus 551 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~s~Gvil~elltG~~p~~~~~~~ 606 (626)
.... ......+|+..|+|||.+....|.+. .||||.||++..|++|+.||......
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 4322 34556789999999999999888775 79999999999999999999876443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.8e-17 Score=160.63 Aligned_cols=135 Identities=22% Similarity=0.305 Sum_probs=113.7
Q ss_pred CeeeccCceEEEEEEEcCCcEEEEEEeccCChh--------cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+.||+|++|.||+|.. ++..+++|+....... ....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 6777889986543211 124577899999999999988887777777888999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
+++++|.+++... .+ .+..++.+++.+|.++|+.+ ++|||++|.|||++ ++.++|+|||.+...
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999887432 12 78899999999999999987 99999999999999 789999999998853
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.7e-18 Score=190.59 Aligned_cols=200 Identities=22% Similarity=0.229 Sum_probs=157.5
Q ss_pred HHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC---CCceeeEEEEEEeCCe
Q 006906 389 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 389 ~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~ 465 (626)
+.+.-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+....- +|.--.+++.+++ -+.|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 334445678889999999999999999988999999997665321 1222223333333 2344555555556677
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-------CCCCE
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-------KDLNA 538 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-------~~~~~ 538 (626)
-+||+||.+.|+|.+++... ...+|.-.+.+..|+++.+++||..+ |||+||||.|.||. +..-+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 89999999999999999743 36899999999999999999999987 99999999999993 23458
Q ss_pred EEeecCCcccccCC-CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC
Q 006906 539 KISDFGLAKLYEED-KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599 (626)
Q Consensus 539 kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p 599 (626)
+|+|||-+..+.-- ........++|-.+-++|+..+..++.++|.|.++-+++-|+.|+..
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999998765422 22244557789999999999999999999999999999999999853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=163.38 Aligned_cols=143 Identities=16% Similarity=0.161 Sum_probs=110.3
Q ss_pred CCCCCCeeeccCceEEEEEE--EcCCcEEEEEEeccCChh------------------------cHHHHHHHHHHHhcCC
Q 006906 396 NFDPANKVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQ 449 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 449 (626)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999998 568999999998754210 0123567999999987
Q ss_pred CCc--eeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 006906 450 HPN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 527 (626)
Q Consensus 450 H~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp 527 (626)
+.. +.+++++ ...++||||+++++|....... ..+.......++.|++.++++||+.+ .++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence 633 3344432 2358999999998887654222 13455667899999999999999985 499999999
Q ss_pred CCEEEcCCCCEEEeecCCccccc
Q 006906 528 SNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 528 ~NILl~~~~~~kl~DfGla~~~~ 550 (626)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999988544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-17 Score=181.86 Aligned_cols=141 Identities=21% Similarity=0.284 Sum_probs=113.6
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh-------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
....|...+.||+|+||+||+|.+.+...++.++...... .....+.+|++++..++|++++....++...+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3445567899999999999999986554433333322111 123568899999999999999988888887778
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ .++.++|+|||+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 899999999999988763 35678999999999999987 9999999999999 577999999999
Q ss_pred ccccc
Q 006906 546 AKLYE 550 (626)
Q Consensus 546 a~~~~ 550 (626)
++...
T Consensus 474 a~~~~ 478 (535)
T PRK09605 474 GKYSD 478 (535)
T ss_pred cccCC
Confidence 98643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-17 Score=157.63 Aligned_cols=145 Identities=19% Similarity=0.182 Sum_probs=111.9
Q ss_pred HHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh----------------------hcHHHHHHHHHHHh
Q 006906 389 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------------------QGNREFVNEIGMIS 446 (626)
Q Consensus 389 ~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~----------------------~~~~~~~~E~~~l~ 446 (626)
++......|.+.+.||+|+||.||++..++|+.||||++..... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444444778899999999999999988899999998764320 01123567888888
Q ss_pred cCCCCc--eeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 006906 447 AQQHPN--LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 524 (626)
Q Consensus 447 ~l~H~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D 524 (626)
.+.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 888774 444443 2345899999999998765321 245678899999999999987 99999
Q ss_pred CCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 525 IKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 525 lkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-17 Score=156.14 Aligned_cols=132 Identities=25% Similarity=0.330 Sum_probs=107.5
Q ss_pred eeeccCceEEEEEEEcCCcEEEEEEeccCCh--------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.||+|+||.||+|.+ ++..|++|....... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 577899998654321 11256778999999999987666666666677789999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
++++|.+.+.... ..++.+++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++....
T Consensus 80 ~g~~l~~~~~~~~------------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN------------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH------------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999988764321 078999999999999987 99999999999999 8899999999988643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.1e-18 Score=189.03 Aligned_cols=197 Identities=22% Similarity=0.269 Sum_probs=152.7
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC-hhcHHHHHHHHHH--HhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS-RQGNREFVNEIGM--ISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++...+.||++.|=+|.+|+.++|. |+||++-+.. ....+.|.++++- ...++|||.+++.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4667789999999999999998887 8889886553 4445555554443 4556999999998887777788999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc--c
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY--E 550 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~--~ 550 (626)
+.+ +|++.+.... -+...+.+.|+.|++.|+..+|..+ |+|||||.+|||++.-..+.|+||..-+.. +
T Consensus 103 vkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 865 7888775542 5777888999999999999999998 999999999999999999999999877642 2
Q ss_pred CCCccee----cccccCCcccchhhhccC----------C-CCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 551 EDKTHIS----TRIAGTIGYMAPEYAMRG----------Y-LTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
++..... .+...-.+|+|||.+... . .+++-||||+||++.||++ |++||..
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 2222211 111233579999987431 2 6778999999999999987 6888753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.8e-16 Score=155.66 Aligned_cols=197 Identities=19% Similarity=0.242 Sum_probs=126.8
Q ss_pred CCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCC----------CceeeEEEEEE---
Q 006906 399 PANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH----------PNLVKLYGCCV--- 461 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~~--- 461 (626)
..+.||.|+++.||.++.. +++.+|||++.... ....+++.+|.-....+.+ -.++..++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4678999999999999987 48999999886543 2234566666655444322 12222222211
Q ss_pred ------eC---C-----eEEEEEEecCCCchhhhhc---CCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 006906 462 ------EG---N-----QLLLVYEYMKNNCLSRAIF---GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRD 524 (626)
Q Consensus 462 ------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D 524 (626)
.. . ..+++|+-+ .++|.+++. ..... ...+....++.+..|+++.+++||+.+ ++|+|
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 235677766 457776642 11111 123444556777899999999999998 99999
Q ss_pred CCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhcc--------CCCCChhhHHHHHHHHHHHHhC
Q 006906 525 IKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--------GYLTSKADVYSFGVVTLEIVSG 596 (626)
Q Consensus 525 lkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~s~Gvil~elltG 596 (626)
|+|+|++++.+|.+.|+||+......... .. ...+..|.+||.... -.++.+.|.|++|+++|.|++|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999998776544321 11 234578999997744 2478899999999999999999
Q ss_pred CCCCCCCC
Q 006906 597 KSNTNYRP 604 (626)
Q Consensus 597 ~~p~~~~~ 604 (626)
+.|+....
T Consensus 247 ~lPf~~~~ 254 (288)
T PF14531_consen 247 RLPFGLSS 254 (288)
T ss_dssp S-STCCCG
T ss_pred cCCCCCCC
Confidence 99998653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.3e-15 Score=136.83 Aligned_cols=135 Identities=19% Similarity=0.208 Sum_probs=114.3
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCC--CceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|++.+..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899999866533 5678899999999977 58899998888878899999999987
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
.+..+ +......++.+++++++++|......++|+|++|+||+++.++.++++|||.+..
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76533 4567788899999999999986545699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.4e-16 Score=172.36 Aligned_cols=167 Identities=23% Similarity=0.361 Sum_probs=120.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
..+|+.+++|..|+||.||..+++. .+.+|+|+-+.. -+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence 3678899999999999999999874 567788442221 01100 22223333333
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
|+-...++.-+ .+.. +++.+++|||+.+ |+|||+||.|.+|..-|++|++|||+.+..-..
T Consensus 136 ---gDc~tllk~~g-----~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG-----PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ---chhhhhcccCC-----CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 33333333221 2221 2378999999997 999999999999999999999999998764211
Q ss_pred Cc------------c--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 553 KT------------H--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 553 ~~------------~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
.. + ....++||+.|+|||++....|+..+|.|++|+|+||.+.|..||.....
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 10 0 11236899999999999999999999999999999999999999987644
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-15 Score=142.87 Aligned_cols=138 Identities=20% Similarity=0.266 Sum_probs=97.9
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChh--cHHHH----------------------HHHHHHHhcCCCCc--e
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--GNREF----------------------VNEIGMISAQQHPN--L 453 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~--~~~~~----------------------~~E~~~l~~l~H~n--I 453 (626)
.+.||+|+||+||+|...+++.||||++...... ....+ ..|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653211 11111 24555555554432 3
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEE
Q 006906 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 454 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl 532 (626)
.+.+++ ...++||||++++.+........ ... .....++.+++.++.++|. .+ |+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 334432 24589999999965432111110 011 5678899999999999998 65 9999999999999
Q ss_pred cCCCCEEEeecCCcccccC
Q 006906 533 DKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~ 551 (626)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-15 Score=159.99 Aligned_cols=166 Identities=32% Similarity=0.481 Sum_probs=133.1
Q ss_pred hcCCCCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC
Q 006906 446 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 525 (626)
Q Consensus 446 ~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 525 (626)
+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.... ..++|.....++.+|+.||+|||+-. . ..|+.+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGAL 75 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeee
Confidence 56799999999999999999999999999999999997643 47999999999999999999999863 2 289999
Q ss_pred CCCCEEEcCCCCEEEeecCCcccccCC-CcceecccccCCcccchhhhccC-------CCCChhhHHHHHHHHHHHHhCC
Q 006906 526 KTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEYAMRG-------YLTSKADVYSFGVVTLEIVSGK 597 (626)
Q Consensus 526 kp~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~s~Gvil~elltG~ 597 (626)
+++|.++|....+||+|||+....... .........-..-|.|||.++.. ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998876431 11111112234579999998753 2577899999999999999999
Q ss_pred CCCCCCCC-CChhhHHHHHHH
Q 006906 598 SNTNYRPN-EDFVYLLDWAYV 617 (626)
Q Consensus 598 ~p~~~~~~-~~~~~l~~w~~~ 617 (626)
.||+.... .+...++.++.+
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred CccccccccCChHHHHHHHHh
Confidence 99986422 222345555544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4e-16 Score=162.75 Aligned_cols=123 Identities=27% Similarity=0.429 Sum_probs=107.2
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.+++.|++|...+|.+|+.+... ....++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 57899999999999999975432 2467888999999999999999 54 8999999999999999999999999
Q ss_pred CcccccCCC-----cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh
Q 006906 545 LAKLYEEDK-----THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595 (626)
Q Consensus 545 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt 595 (626)
+........ ....+...||..||+||.+.+..|+.|+||||+|+||+|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 998765544 223344679999999999999999999999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-14 Score=142.11 Aligned_cols=137 Identities=18% Similarity=0.214 Sum_probs=105.8
Q ss_pred CCeee-ccCceEEEEEEEcCCcEEEEEEeccCC-------------hhcHHHHHHHHHHHhcCCCCce--eeEEEEEEeC
Q 006906 400 ANKVG-EGGFGSVYKGILSDGTVIAVKQLSSKS-------------RQGNREFVNEIGMISAQQHPNL--VKLYGCCVEG 463 (626)
Q Consensus 400 ~~~IG-~G~fG~Vyk~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~ 463 (626)
...|| .|+.|+||++... +..++||++.... ......+.+|++++..++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999885 6778998875321 1223567889999999998885 6677765432
Q ss_pred C----eEEEEEEecCC-CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 464 N----QLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 464 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
. ..++||||+++ .+|.+++... .++.. .+.+|+.++.+||+.+ |+||||||.|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 6888887432 23333 3578999999999998 9999999999999999999
Q ss_pred EEeecCCccccc
Q 006906 539 KISDFGLAKLYE 550 (626)
Q Consensus 539 kl~DfGla~~~~ 550 (626)
+|+|||.+....
T Consensus 182 ~LIDfg~~~~~~ 193 (239)
T PRK01723 182 WLIDFDRGELRT 193 (239)
T ss_pred EEEECCCcccCC
Confidence 999999988643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.5e-14 Score=141.14 Aligned_cols=145 Identities=25% Similarity=0.405 Sum_probs=108.6
Q ss_pred CCCCceeeEEEEEEe---------------------------CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHH
Q 006906 448 QQHPNLVKLYGCCVE---------------------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 500 (626)
Q Consensus 448 l~H~nIv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~ 500 (626)
-+|||||++.++|.+ ...+|+||.-.+ .+|.+++... ..+...+.-
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHH
Confidence 469999999887653 235788888765 4788888655 345567778
Q ss_pred HHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE--cCCC--CEEEeecCCcccccCCC-----cceecccccCCcccchhh
Q 006906 501 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDL--NAKISDFGLAKLYEEDK-----THISTRIAGTIGYMAPEY 571 (626)
Q Consensus 501 i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~~--~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~ 571 (626)
|+.|+++|+.|||.++ |.|||+|+.|||+ |+|+ .+.|+|||++---.... ........|.-.-||||+
T Consensus 346 ~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 8899999999999998 9999999999999 4454 36789999875332211 111122347778899998
Q ss_pred hccCC------CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 572 AMRGY------LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 572 ~~~~~------~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....+ --.|+|.|+.|-+.||+++...||-.
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 85432 23489999999999999999999854
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=147.40 Aligned_cols=145 Identities=22% Similarity=0.267 Sum_probs=102.1
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhc----------------------------------------H
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG----------------------------------------N 435 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~----------------------------------------~ 435 (626)
.|+ .+.||+|++|.||+|++++|+.||||+.+...... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999999999999999986542110 0
Q ss_pred HHHHHHHHHHhcC----CCCceeeEEEEE-EeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHH-HH
Q 006906 436 REFVNEIGMISAQ----QHPNLVKLYGCC-VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR-GL 509 (626)
Q Consensus 436 ~~~~~E~~~l~~l----~H~nIv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L 509 (626)
-+|.+|++.+.++ +|.+-+.+-..+ ......+|||||+++++|.+....... .. .+.+++..++. .+
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFL 270 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHH
Confidence 1244455554444 233333333333 234457999999999999887642211 12 34556666666 46
Q ss_pred HHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 510 ~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
..+|..+ ++|+|+||.||+++.++.++++|||++..+..
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8889887 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-14 Score=160.78 Aligned_cols=214 Identities=26% Similarity=0.384 Sum_probs=166.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC--CcEEEEEEeccCC--hhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD--GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~--g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 469 (626)
..|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+-.... |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677889999999998887643 4456777665443 222233444666666665 99999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-EDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK 547 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~ 547 (626)
.||..++++.+-+...+. ...+.......+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999887732111 14566677889999999999999 776 99999999999999999 99999999999
Q ss_pred cccC--CCcceeccccc-CCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHH
Q 006906 548 LYEE--DKTHISTRIAG-TIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWA 615 (626)
Q Consensus 548 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~ 615 (626)
.+.. .........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++.....+ .....|.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~ 244 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWK 244 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeec
Confidence 7765 23333344668 999999999887 466788999999999999999999998765433 3444444
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.2e-13 Score=150.62 Aligned_cols=89 Identities=24% Similarity=0.391 Sum_probs=51.7
Q ss_pred CCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccccCcccccCCCCCCCCCCCcccccee
Q 006906 27 LKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESY 104 (626)
Q Consensus 27 L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l 104 (626)
++.|+|++|.|+|.+|..+++|++|+.|+|++|+|+|.+|..+ +++|+.|+|++|+++|.+|..+ +.+++|+.|
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l----~~L~~L~~L 495 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL----GQLTSLRIL 495 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHH----hcCCCCCEE
Confidence 4555555555555555555555555555555555555555544 3355555555555555555444 566666666
Q ss_pred ecCCCccCCCCCccc
Q 006906 105 SSPRNKLDKVHPCLR 119 (626)
Q Consensus 105 ~l~~N~l~~~~p~~~ 119 (626)
+|++|+|+|.+|..+
T Consensus 496 ~Ls~N~l~g~iP~~l 510 (623)
T PLN03150 496 NLNGNSLSGRVPAAL 510 (623)
T ss_pred ECcCCcccccCChHH
Confidence 666666666666544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.4e-13 Score=161.52 Aligned_cols=124 Identities=31% Similarity=0.431 Sum_probs=79.6
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|++++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|++++.+|..+ +.+|+.|+|+
T Consensus 141 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (968)
T PLN00113 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220 (968)
T ss_pred CCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence 45666666666666666666667777777777777766667667777777777777777666666665 3466666666
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD 129 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~ 129 (626)
+|++++.+|..+ +.+++|+.|++++|++++.+|..++.++....+.
T Consensus 221 ~n~l~~~~p~~l----~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 266 (968)
T PLN00113 221 YNNLSGEIPYEI----GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266 (968)
T ss_pred CCccCCcCChhH----hcCCCCCEEECcCceeccccChhHhCCCCCCEEE
Confidence 666666655544 5566666666666666666665555555444433
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=8e-12 Score=117.45 Aligned_cols=131 Identities=18% Similarity=0.144 Sum_probs=96.7
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceee-EEEEEEeCCeEEEEEEecCCCch
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK-LYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
.+.++.|.++.||+++.. ++.|++|....... ....+..|++++..+.+.++++ ++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999875 77899999765432 2234678888888876655544 44432 3345799999999877
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
... . .....++.+++++++.||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~---~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE---D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 542 0 012345678999999999886 22369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-12 Score=141.45 Aligned_cols=146 Identities=17% Similarity=0.185 Sum_probs=94.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChh----------------------------------cH---
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQ----------------------------------GN--- 435 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~----------------------------------~~--- 435 (626)
-..|+. +.||+|++|.||+|++++ |+.||||+.+..-.. -.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 799999999999999987 999999998754110 01
Q ss_pred ---HHHHHHHHHHhcC----CCCceeeEEEEEE-eCCeEEEEEEecCCCchhhhh--cCCCcccccCCCHHHHHHHHHHH
Q 006906 436 ---REFVNEIGMISAQ----QHPNLVKLYGCCV-EGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 505 (626)
Q Consensus 436 ---~~~~~E~~~l~~l----~H~nIv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~i 505 (626)
-+|.+|+..+.++ .+...+.+-.++. -....+|||||++|+.+.+.- ...+.+ ...+.......++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-~~~la~~~v~~~~--- 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-MKLLAERGVEVFF--- 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-HHHHHHHHHHHHH---
Confidence 1234444444443 2444444333332 245678999999999997642 211100 0012222222222
Q ss_pred HHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----CEEEeecCCcccccC
Q 006906 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISDFGLAKLYEE 551 (626)
Q Consensus 506 a~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~DfGla~~~~~ 551 (626)
..++..+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 274 ----~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 ----TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344455 99999999999999988 999999999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.8e-11 Score=129.24 Aligned_cols=166 Identities=17% Similarity=0.205 Sum_probs=127.1
Q ss_pred EcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCH
Q 006906 416 LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDW 495 (626)
Q Consensus 416 ~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~ 495 (626)
..++.+|.|+..+...........+-++.|+.+|||||+++++.+..++.+|+|+|-+. .|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 34788899988877665445567788899999999999999999999999999999875 35555532 234
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccC
Q 006906 496 PTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575 (626)
Q Consensus 496 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 575 (626)
....-.+.||+.||.|||+.+ +++|++|.-.-|++++.|+.||++|.++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 566677899999999999887 699999999999999999999999998865433221 01111112246667655333
Q ss_pred CCCChhhHHHHHHHHHHHHhC
Q 006906 576 YLTSKADVYSFGVVTLEIVSG 596 (626)
Q Consensus 576 ~~~~k~Dv~s~Gvil~elltG 596 (626)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 246999999999999999
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.6e-12 Score=114.43 Aligned_cols=103 Identities=24% Similarity=0.390 Sum_probs=64.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccc-cCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-PVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~ip~~~--~~~l~~l~l 78 (626)
+|+.|++++|+|+ .+|.+++.|++|+.|+++-|++. .+|..|+.++.|+.|||.+|+++. .+|..+ +..|+.|+|
T Consensus 57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 4566666666666 56666666666666666666665 666666666666666666666654 455544 346666666
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCcc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
+.|.|.-. |..+ +.+.+|+.|.+..|.|
T Consensus 135 ~dndfe~l-p~dv----g~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 135 GDNDFEIL-PPDV----GKLTNLQILSLRDNDL 162 (264)
T ss_pred cCCCcccC-Chhh----hhhcceeEEeeccCch
Confidence 66666533 2222 6777777777777765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.9e-10 Score=110.65 Aligned_cols=143 Identities=20% Similarity=0.280 Sum_probs=109.8
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCc--eeeEEEEEEeC---CeEEEEEEec
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPN--LVKLYGCCVEG---NQLLLVYEYM 473 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~---~~~~lV~e~~ 473 (626)
.+.|+.|..+.||++...+|+.+++|....... .....+..|++++..+++.. +.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999987778899999765422 23457889999999887643 56677776553 2568999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------------------------------------- 516 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 516 (626)
++.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888765431 14677788888888888888888531
Q ss_pred ----------------CCCeEEeCCCCCCEEEcC--CCCEEEeecCCccc
Q 006906 517 ----------------RIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKL 548 (626)
Q Consensus 517 ----------------~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~ 548 (626)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 66689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.5e-10 Score=105.98 Aligned_cols=137 Identities=16% Similarity=0.133 Sum_probs=96.4
Q ss_pred CCeeeccCceEEEEEEEcC-------CcEEEEEEeccCC--------------h--------hcHHHH----HHHHHHHh
Q 006906 400 ANKVGEGGFGSVYKGILSD-------GTVIAVKQLSSKS--------------R--------QGNREF----VNEIGMIS 446 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~-------g~~vAvK~l~~~~--------------~--------~~~~~~----~~E~~~l~ 446 (626)
...||.|--+.||.|.-.+ +..+|||+.+... + ...+.+ .+|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 4789999865210 0 001122 27888888
Q ss_pred cCCC--CceeeEEEEEEeCCeEEEEEEecCCCchhh-hhcCCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEE
Q 006906 447 AQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNCLSR-AIFGKDTEYRLKLDWPTRKKICIGIARGLAYL-HEDSRIKIVH 522 (626)
Q Consensus 447 ~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH 522 (626)
++.. -++..++++ ...++||||+.+..+.. .+.. ..++..+...+..+++.+|..| |+.+ ++|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 7754 344555544 45689999998754422 2211 1344556778889999999999 7776 999
Q ss_pred eCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 523 RDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 523 ~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|||++.||+++ ++.+.|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4679999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.9e-11 Score=125.79 Aligned_cols=196 Identities=24% Similarity=0.262 Sum_probs=151.5
Q ss_pred CCCCCCeeec--cCceEEEEEEE--c-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEE
Q 006906 396 NFDPANKVGE--GGFGSVYKGIL--S-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 396 ~f~~~~~IG~--G~fG~Vyk~~~--~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 467 (626)
.|.+.+.+|+ |.+|.||++.. . ++..+|+|+-+... ......=.+|.....++ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3557788999 99999999987 3 68889999844322 23333334566666666 4999999888999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEee
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISD 542 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~D 542 (626)
+-+|++. .+|..+.+.... .+.....+.+..+..+ |+.++|... ++|-|+||.||+...+ ...+++|
T Consensus 195 iqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999986 677777765432 3666677777777777 999999987 9999999999999999 8899999
Q ss_pred cCCcccccCCCcc----eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 543 FGLAKLYEEDKTH----ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 543 fGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
||+...+....-. ......|...|++||...+ -++...|+|++|.+.+|..++....
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 9999887654311 1122357788999997644 5588999999999999998886554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.3e-12 Score=130.69 Aligned_cols=127 Identities=20% Similarity=0.196 Sum_probs=76.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
.|++|+||.|.|...-+++|.-+.+|+.||||+|+|+.--|.+|..|.+|+.|.|++|+++ .+-+.. +++|+.|||
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcC
Confidence 5677777777777666677777777777777777777655667777777777777777766 444433 346666777
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
++|.+++.+.+.- .+...++.|+.|+|.+|+|....-..++.++..-.+++
T Consensus 373 r~N~ls~~IEDaa-~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL 423 (873)
T KOG4194|consen 373 RSNELSWCIEDAA-VAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDL 423 (873)
T ss_pred cCCeEEEEEecch-hhhccchhhhheeecCceeeecchhhhccCcccceecC
Confidence 7776666654432 12233555555555555554444444444444443333
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.3e-11 Score=126.66 Aligned_cols=134 Identities=15% Similarity=0.154 Sum_probs=78.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-----hhcCCcc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-----FNSNKNV 76 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-----~~~l~~l 76 (626)
+|++|+|++|+|+..-|.+|..|.+|+.|+|++|+++..-...|..+++|+.|||++|.|++.|-+.- +++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 46666666666664334456666666666666666664445556666666666666666666554432 3366666
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
+|.+|++....-.++ ..++.|++|+|.+|.+....|..+..| ....+-.-...+-|+|.
T Consensus 398 ~l~gNqlk~I~krAf----sgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAF----SGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQ 456 (873)
T ss_pred eecCceeeecchhhh----ccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEecc
Confidence 666666654433333 556666666666666666666666555 33333333344556665
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-11 Score=110.85 Aligned_cols=109 Identities=20% Similarity=0.340 Sum_probs=95.0
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+++.|.||+|+++ .+|+.+..|.+|++|++++|+|. .+|.+++.|++|+.|+++=|++. .+|..+ ++.|+.|||+
T Consensus 34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 5678999999999 88889999999999999999998 89999999999999999999999 899988 6699999999
Q ss_pred cCcccc-cCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 80 LNNFTW-ESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 80 ~N~l~~-~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
+|+++- ..|+.+ -.+..|+.|+|++|.|.-..|.
T Consensus 111 ynnl~e~~lpgnf----f~m~tlralyl~dndfe~lp~d 145 (264)
T KOG0617|consen 111 YNNLNENSLPGNF----FYMTTLRALYLGDNDFEILPPD 145 (264)
T ss_pred ccccccccCCcch----hHHHHHHHHHhcCCCcccCChh
Confidence 999974 344444 4578899999999998755554
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-10 Score=130.61 Aligned_cols=106 Identities=22% Similarity=0.362 Sum_probs=95.6
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccccc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISL 80 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~ 80 (626)
++.|+|++|.|+|.+|..++.|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+ +.+|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 6889999999999999999999999999999999999999999999999999999999999999988 56999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCcc
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
|+|+|.+|..+. ....++..+++.+|..
T Consensus 500 N~l~g~iP~~l~---~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 500 NSLSGRVPAALG---GRLLHRASFNFTDNAG 527 (623)
T ss_pred CcccccCChHHh---hccccCceEEecCCcc
Confidence 999999987762 2234566788888854
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-09 Score=98.48 Aligned_cols=144 Identities=19% Similarity=0.281 Sum_probs=103.9
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEE-EeccCCh-------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVK-QLSSKSR-------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK-~l~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..++|-+|+-+.|+++.++ |+...|| ++.+..+ -..+.-.+|++.|.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5788999999999999985 6665555 4443321 22356678899888876555554444566666778999
Q ss_pred EecCC-CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---CEEEeecCCc
Q 006906 471 EYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLA 546 (626)
Q Consensus 471 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla 546 (626)
||+++ .++.+++...... ....+.....+..|-+.+.-||.++ |+|+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 99987 3677776544322 2222333678888999999999998 99999999999996654 4589999998
Q ss_pred ccc
Q 006906 547 KLY 549 (626)
Q Consensus 547 ~~~ 549 (626)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-10 Score=113.05 Aligned_cols=153 Identities=22% Similarity=0.313 Sum_probs=116.3
Q ss_pred HHhcCCCCceeeEEEEEEeC-----CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006906 444 MISAQQHPNLVKLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518 (626)
Q Consensus 444 ~l~~l~H~nIv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 518 (626)
-|-.+.|.|||+++.|+.+. .+..++.|||..|++..+|+... .....+......+++.||..||.|||+- .|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 34556799999999998643 35789999999999999997653 3345677788889999999999999997 47
Q ss_pred CeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC----CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHH
Q 006906 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED----KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIV 594 (626)
Q Consensus 519 ~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ell 594 (626)
+|+|+++..+-|++..++-+|+.- +.-...... .......-.+-++|.|||+-....-+..+|||+||...+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999999888642 111111100 000111123568999999888777788999999999999998
Q ss_pred hCCCC
Q 006906 595 SGKSN 599 (626)
Q Consensus 595 tG~~p 599 (626)
-|..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 88653
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.1e-10 Score=104.84 Aligned_cols=160 Identities=39% Similarity=0.629 Sum_probs=98.6
Q ss_pred eeeeecCCccc-ccCCcccccccccCCccc-cccCCcceeEeeecccccCCCCCCCceEecceeecccccCcHHhhhhhc
Q 006906 134 TLHINCGGAKI-NTGHTKYEADMEARGASM-FYSSGQYWAFSSTGKFMDDDTDLDNYIRTNTSTLSKVSAVDLELYRTAR 211 (626)
Q Consensus 134 ~~~~~c~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 211 (626)
.+.+|||+... ...+..|..|....+.+. |+.. ....+.. ......-.++.+..||.+.|
T Consensus 2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~-----~~~~~~~-------------~~~~~~i~~t~d~~Lyqt~R 63 (174)
T PF11721_consen 2 VLRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVS-----SDNNGST-------------SSTNSSIPGTTDDPLYQTER 63 (174)
T ss_dssp EEEEEETSSSEEETTTEEE-SSSSSTTSS----------------SS-------------TTS--TTS-HHHHHTTT---
T ss_pred EEEEECCCCcccCCCCCEEcCCCCCCCCCcccccc-----ccccccc-------------ccccccccCCCchhhhHhhc
Confidence 46789998887 445677777666655554 2111 0000000 00111223467889999999
Q ss_pred ccCCcceeeeeccCCceeeEEEEEeeeeecCCccccccCceEEEEEecCccccccCCcccccCCcCcceeeee-eeeeec
Q 006906 212 VSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNF-PAEVTS 290 (626)
Q Consensus 212 ~~p~~l~~~~~~~~~g~~~~~l~~~~~~~~~~~~~~~l~~~~~~i~~~~~~~~~~~~~~~~~~g~~~~~~~~~-~~~~~~ 290 (626)
..|.+++|..-|+.+|.|.+.|+|+|+.+.....+...++|+|+|++++..+.+++++..++|+...+....+ .+.+++
T Consensus 64 ~g~~~f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~d 143 (174)
T PF11721_consen 64 YGPSSFSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTD 143 (174)
T ss_dssp --SSSEEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEET
T ss_pred CCCCceEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeC
Confidence 9999999998899999999999999998777666778999999999999999999999999999886665555 888899
Q ss_pred CeeEEEEEecCCceeeecCCC
Q 006906 291 HTLKIHLYWAGRGTTGIPLRG 311 (626)
Q Consensus 291 ~~~~~~~~~~~~~~~~~p~~~ 311 (626)
..+.+++.+++.+.+.+|..+
T Consensus 144 g~L~i~f~~~~~~~~~i~~~~ 164 (174)
T PF11721_consen 144 GTLNIQFVWAGKGTLCIPFIG 164 (174)
T ss_dssp TEEETTEEEE--SEEEEEEES
T ss_pred CcEEEEEEecCCCcEEeeccc
Confidence 999999999999999877643
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.7e-09 Score=97.53 Aligned_cols=132 Identities=22% Similarity=0.314 Sum_probs=97.8
Q ss_pred CeeeccCceEEEEEEEcCCcEEEEEE-eccCChh-------cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 401 NKVGEGGFGSVYKGILSDGTVIAVKQ-LSSKSRQ-------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~~vAvK~-l~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
..+++|+-+.+|.+.+.+.. +++|. +.+.... ....-.+|+.++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45889999999999875444 55554 3332111 123456788888887765655555566778888999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||.+..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999888877443 2445566667777899998 99999999999998765 999999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.4e-09 Score=108.46 Aligned_cols=171 Identities=19% Similarity=0.291 Sum_probs=131.5
Q ss_pred ceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEE----eCCeEEEEEEecCC-Cchhhh
Q 006906 408 FGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV----EGNQLLLVYEYMKN-NCLSRA 481 (626)
Q Consensus 408 fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----~~~~~~lV~e~~~~-gsL~~~ 481 (626)
-.+.||+... ||..|++|+++....+.......-+++++++.|.|+|++..++. .+..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999854 89999999996654444434456788999999999999999876 45678999999885 356554
Q ss_pred hcCCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 482 IFGKDT----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 482 l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
-..... ......++..++.++.|+..||.++|+.| +..+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 432211 11245788899999999999999999998 89999999999999999999998887776654
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p 599 (626)
+... .+ +--++-|.-.||.+++.|.||..-
T Consensus 446 d~~~---------------~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE---------------PL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc---------------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 4311 01 113478999999999999999654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.2e-10 Score=121.14 Aligned_cols=198 Identities=22% Similarity=0.224 Sum_probs=149.3
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEeccCChhcHHH--HHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSKSRQGNRE--FVNEIGMISAQ-QHPNLVKLYGCCVEGN 464 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAvK~l~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 464 (626)
....+.+|..+..||.|.|+.|++...+ ++..|++|.+.........+ -..|+.+...+ -|.+++++...+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445678999999999999999998754 57889999887653332222 23455554444 5888999888888888
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeec
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDF 543 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~Df 543 (626)
..++--||++++++...+. ....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence 8889999999998876551 1235788889999999999999999886 9999999999999876 78899999
Q ss_pred CCcccccCCCcceecccccCCccc--chhhhccCCCCChhhHHHHHHHHHHHHhCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYM--APEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p 599 (626)
|.+..+.... ......-+++ +++......+..+.|++|||.-+.|.++|..-
T Consensus 412 ~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 412 GCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccccceec----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 9987432111 1111233344 55555667789999999999999999988753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.5e-10 Score=103.15 Aligned_cols=104 Identities=21% Similarity=0.268 Sum_probs=42.0
Q ss_pred cceEEEeecCceeecCCcccc-CCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVD 77 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~ 77 (626)
++++|+|++|+|+ .|. .++ .+.+|+.||||+|.|+ .++ .+..+++|++|+|++|+|+ .++..+ +++|+.|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 5789999999998 554 577 5899999999999999 554 5888999999999999999 576543 57999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
+++|++....-. .++..++.|+.|++.+|.++.
T Consensus 95 L~~N~I~~l~~l---~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 95 LSNNKISDLNEL---EPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -TTS---SCCCC---GGGGG-TT--EEE-TT-GGGG
T ss_pred CcCCcCCChHHh---HHHHcCCCcceeeccCCcccc
Confidence 999999754221 244789999999999998863
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=7e-10 Score=85.28 Aligned_cols=61 Identities=33% Similarity=0.484 Sum_probs=55.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l 61 (626)
++|++|+|++|+|+..-+..|.++++|++|+|++|+|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5899999999999955557899999999999999999977778999999999999999986
|
... |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.5e-11 Score=118.29 Aligned_cols=123 Identities=19% Similarity=0.187 Sum_probs=92.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhh---hcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~---~~l~~l~l 78 (626)
.|++||...|.++ .+|+.++.|.+|.-|+|.+|+|. .+| +|.+|+.|+.|+++.|++. .+|...+ +++..|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 4778888888887 78888888888888888888887 777 7888888888888888888 7887775 37778888
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceee
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTL 135 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~ 135 (626)
..|++. +.|+. +..+.+|++||+|+|.+++.++. ++++ -..++.+.++|.
T Consensus 260 RdNklk-e~Pde----~clLrsL~rLDlSNN~is~Lp~s-Lgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 260 RDNKLK-EVPDE----ICLLRSLERLDLSNNDISSLPYS-LGNL-HLKFLALEGNPL 309 (565)
T ss_pred cccccc-cCchH----HHHhhhhhhhcccCCccccCCcc-cccc-eeeehhhcCCch
Confidence 888887 33333 36778888888888888776554 4666 455555566666
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.4e-10 Score=120.84 Aligned_cols=111 Identities=21% Similarity=0.339 Sum_probs=64.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCC-CCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
+|++|.+++|++. .+-.+++.|+.|+.+++.+|+|. ..||..+..|..|+.||||+|+|+ .+|..+ .+++..|+|
T Consensus 56 kLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence 4666666666666 44455666666666666666664 245556666666666666666666 566655 335566666
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCL 118 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~ 118 (626)
|+|++. ++|.++. -.+..|-.||||+|+|...+|..
T Consensus 134 S~N~Ie-tIPn~lf---inLtDLLfLDLS~NrLe~LPPQ~ 169 (1255)
T KOG0444|consen 134 SYNNIE-TIPNSLF---INLTDLLFLDLSNNRLEMLPPQI 169 (1255)
T ss_pred ccCccc-cCCchHH---HhhHhHhhhccccchhhhcCHHH
Confidence 666665 2333321 34555556666666666555544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-08 Score=95.58 Aligned_cols=126 Identities=27% Similarity=0.294 Sum_probs=83.4
Q ss_pred EEEEEEEcCCcEEEEEEeccCC--------------h------------hcHHHHHHHHHHHhcCCCCc--eeeEEEEEE
Q 006906 410 SVYKGILSDGTVIAVKQLSSKS--------------R------------QGNREFVNEIGMISAQQHPN--LVKLYGCCV 461 (626)
Q Consensus 410 ~Vyk~~~~~g~~vAvK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~ 461 (626)
.||.|...+|..+|||+.+... . .......+|.+.|.++..-. +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999899999999875320 0 01234667999999998764 4555544
Q ss_pred eCCeEEEEEEecC--CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 462 EGNQLLLVYEYMK--NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY-LHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 462 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
. ...+||||++ +..+.++... .++.+....++.+++..+.. +|..+ |+|+|+.+.||+++++ .+
T Consensus 79 ~--~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 N--RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp E--TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred e--CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 2 3479999998 5555443321 12244567788888886666 46766 9999999999999988 89
Q ss_pred EEeecCCccccc
Q 006906 539 KISDFGLAKLYE 550 (626)
Q Consensus 539 kl~DfGla~~~~ 550 (626)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-10 Score=110.95 Aligned_cols=126 Identities=18% Similarity=0.222 Sum_probs=100.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
.|++||||+|.|+ .|..+..-+++++.|+||+|.|. .+. .+..|++|+.||||+|.|+ .+-.+- +.+++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 4889999999999 89999988999999999999998 444 4899999999999999999 555554 5589999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCC-CCCcccCCCCCCCCCCCcceeeee
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK-VHPCLRQNFPCSAPADQYHYTLHI 137 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~-~~p~~~~~~p~~~~~~~~~~~~~~ 137 (626)
.|.+... .+++.+-+|..||+++|++.. .--...+++||.-.+.+.+||...
T Consensus 361 ~N~iE~L------SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 361 QNKIETL------SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhHhhh------hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 9988632 234788899999999999853 222346778887777666666554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.1e-08 Score=98.17 Aligned_cols=142 Identities=15% Similarity=0.047 Sum_probs=100.3
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChh-----------cHHHHHHHHHHHhcCCCCc--eeeEEEEEEe----
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPN--LVKLYGCCVE---- 462 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~---- 462 (626)
.+.+-+-....|++..+ +|+.|.||+....... ....+.+|...+.++...+ ..+++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555555556778776 6788999977543211 1124778888887764333 3334555543
Q ss_pred -CCeEEEEEEecCCC-chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC------
Q 006906 463 -GNQLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK------ 534 (626)
Q Consensus 463 -~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~------ 534 (626)
...-++|||++++. +|.+++..... ...+...+..++.+++..+.-||+.+ |+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCC
Confidence 23568999999986 78888742111 23456677899999999999999998 999999999999975
Q ss_pred -CCCEEEeecCCccc
Q 006906 535 -DLNAKISDFGLAKL 548 (626)
Q Consensus 535 -~~~~kl~DfGla~~ 548 (626)
+..+.++||+.+..
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46899999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1e-09 Score=123.24 Aligned_cols=202 Identities=20% Similarity=0.265 Sum_probs=146.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.+.|.+.+-+-+|.++.+..+.-. .|...+.|...... ..+.+....+-.++-..+||-+++....+.-....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 356777778889999999887643 24444444433221 12223333344444445667777666555566778999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
++|..+++|...||... ..+.+-.+.....+..+.+|||... +.|+|++|.|++...++..+++|||.....
T Consensus 883 ~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999888764 3555566666777889999999874 899999999999999999999999843322
Q ss_pred cC------C------------------------CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC
Q 006906 550 EE------D------------------------KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599 (626)
Q Consensus 550 ~~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p 599 (626)
.. . .........||+.|.+||...+......+|.|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 00112235689999999999999999999999999999999999999
Q ss_pred CCCC
Q 006906 600 TNYR 603 (626)
Q Consensus 600 ~~~~ 603 (626)
++..
T Consensus 1035 ~na~ 1038 (1205)
T KOG0606|consen 1035 FNAE 1038 (1205)
T ss_pred CCCc
Confidence 9754
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.1e-10 Score=112.46 Aligned_cols=137 Identities=21% Similarity=0.238 Sum_probs=117.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccC-ccccccCchhhhh---cCCccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPKYIFN---SNKNVD 77 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~ip~~~~~---~l~~l~ 77 (626)
+...|.|..|+|+...|..|+.+++|+.||||+|+|+-+-|+.|..|.+|..|-+-+ |+|+ .+|...+. +|+.|.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHh
Confidence 457899999999944446899999999999999999988899999999988876655 9999 89988754 788899
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCCcc
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGGAK 143 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~~~ 143 (626)
+.-|++.-.....+ ..+++|..|.+-+|.+...-...+..+-+..++-+..+++.|+|.-+.
T Consensus 147 lNan~i~Cir~~al----~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 147 LNANHINCIRQDAL----RDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred cChhhhcchhHHHH----HHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 99999987666555 788999999999999988777788888888888889999999999544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.9e-10 Score=111.38 Aligned_cols=124 Identities=18% Similarity=0.222 Sum_probs=89.8
Q ss_pred EEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccccCc
Q 006906 5 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNN 82 (626)
Q Consensus 5 ~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N~ 82 (626)
.+++++|.++ -+|..++.+++|+.|+|++|-+. .+|..++.+..|+.|++|+|+|. .+|..+ ...++.+-.++|+
T Consensus 416 ~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nq 492 (565)
T KOG0472|consen 416 DLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQ 492 (565)
T ss_pred HHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccc
Confidence 3556666665 67777888888888888888887 88888888888888888888888 788877 3355555566677
Q ss_pred ccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeee
Q 006906 83 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 136 (626)
Q Consensus 83 l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~ 136 (626)
+....|. +...|.+|..|||.+|.+.. +|..+++|.....+.+.++||.
T Consensus 493 i~~vd~~----~l~nm~nL~tLDL~nNdlq~-IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 493 IGSVDPS----GLKNMRNLTTLDLQNNDLQQ-IPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccChH----HhhhhhhcceeccCCCchhh-CChhhccccceeEEEecCCccC
Confidence 7644332 23778888888888888764 4555677777777666655554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.7e-09 Score=114.49 Aligned_cols=103 Identities=26% Similarity=0.296 Sum_probs=49.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccc-cCchhhhh--cCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-PVPKYIFN--SNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~ip~~~~~--~l~~l~l 78 (626)
+|+.|+||+|+|+ .+....+.+.+|++|+||+|+|+ .+|+.+.+|++|+.|++.+|+|+- .||+.+.+ +|+.+..
T Consensus 246 ~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~a 323 (1255)
T KOG0444|consen 246 NLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHA 323 (1255)
T ss_pred hhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHh
Confidence 4455555555555 44444445555555555555554 455555555555555555554432 34544422 4444555
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCcc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
++|+|.- .|..+ ..|..|+.|.|+.|+|
T Consensus 324 anN~LEl-VPEgl----cRC~kL~kL~L~~NrL 351 (1255)
T KOG0444|consen 324 ANNKLEL-VPEGL----CRCVKLQKLKLDHNRL 351 (1255)
T ss_pred hcccccc-Cchhh----hhhHHHHHhcccccce
Confidence 5554442 12221 4444444444444444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.4e-09 Score=116.64 Aligned_cols=15 Identities=13% Similarity=0.200 Sum_probs=8.2
Q ss_pred cccceeecCCCccCC
Q 006906 99 NLVESYSSPRNKLDK 113 (626)
Q Consensus 99 ~~l~~l~l~~N~l~~ 113 (626)
+.|+.|++++|+|+.
T Consensus 402 s~L~~LdLS~N~Lss 416 (788)
T PRK15387 402 SELKELMVSGNRLTS 416 (788)
T ss_pred cCCCEEEccCCcCCC
Confidence 345555666665553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=1e-08 Score=116.27 Aligned_cols=99 Identities=22% Similarity=0.190 Sum_probs=59.5
Q ss_pred CCCEEEeecCcCCCCChHHhhc-----------------cCCCCEEeccCccccccCchhhhhcCCccccccCcccccCC
Q 006906 26 KLKNIDLSFNNLTGGIPTTFEK-----------------LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESS 88 (626)
Q Consensus 26 ~L~~L~Ls~N~l~g~ip~~~~~-----------------l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N~l~~~~~ 88 (626)
+|++|+|++|+|++ +|....+ ..+|+.|+|++|+|+ .+|.. .+.|+.|++++|+|+. +|
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l-~s~L~~LdLS~N~Lss-IP 418 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVL-PSELKELMVSGNRLTS-LP 418 (788)
T ss_pred ccceEecCCCccCC-CCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCc-ccCCCEEEccCCcCCC-CC
Confidence 66666666666663 3321111 135667777777777 35542 3567777777777764 33
Q ss_pred CCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeee
Q 006906 89 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 136 (626)
Q Consensus 89 ~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~ 136 (626)
. ....|+.|++++|+|+ .+|..+..++....+.+.+|++.
T Consensus 419 ~-------l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 419 M-------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred c-------chhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 1 1235667777777776 56666666666666666555554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.8e-07 Score=91.54 Aligned_cols=133 Identities=23% Similarity=0.211 Sum_probs=96.6
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCC----------------------hhcHHHHHHHHHHHhcCCCC--cee
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS----------------------RQGNREFVNEIGMISAQQHP--NLV 454 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~----------------------~~~~~~~~~E~~~l~~l~H~--nIv 454 (626)
+.+.||-|--+.||.|..+.|.++|||.-+... ........+|.++|.++.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 568999999999999999999999999643210 01123456788888888655 555
Q ss_pred eEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 006906 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK 534 (626)
Q Consensus 455 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~ 534 (626)
+.+++ +...+||||+++-.|...- ++-+....|+..|++-+.-+-..| |||+|+++-||++++
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 55554 4568999999987665432 233344555555666555444555 999999999999999
Q ss_pred CCCEEEeecCCccc
Q 006906 535 DLNAKISDFGLAKL 548 (626)
Q Consensus 535 ~~~~kl~DfGla~~ 548 (626)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.2e-08 Score=111.15 Aligned_cols=98 Identities=21% Similarity=0.327 Sum_probs=55.0
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+..+|+.|++++|
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~N 272 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLFHN 272 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECcCC
Confidence 3556666666666 4554442 35666666666665 4555443 25666666666666 556555556666666666
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
+|+. +|..+ .++|+.|++++|+|+.
T Consensus 273 ~L~~-LP~~l------~~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 273 KISC-LPENL------PEELRYLSVYDNSIRT 297 (754)
T ss_pred ccCc-ccccc------CCCCcEEECCCCcccc
Confidence 6652 33322 1356666666666654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.3e-09 Score=115.94 Aligned_cols=101 Identities=22% Similarity=0.314 Sum_probs=49.9
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChH-HhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
|+.|+|.+|+|+...=+.|.+.+.|++|+|++|+|. .+|+ .+.++..|+.|+||+|+|+ .||+.+ +..|+.|...
T Consensus 361 Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ah 438 (1081)
T KOG0618|consen 361 LQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAH 438 (1081)
T ss_pred HHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhc
Confidence 444555555555443334555555555555555554 3332 3455555555555555555 455544 2255555555
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCcc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
.|++... | ....+++|+.+|++.|+|
T Consensus 439 sN~l~~f-P-----e~~~l~qL~~lDlS~N~L 464 (1081)
T KOG0618|consen 439 SNQLLSF-P-----ELAQLPQLKVLDLSCNNL 464 (1081)
T ss_pred CCceeec-h-----hhhhcCcceEEecccchh
Confidence 5555421 1 124455555555555555
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.6e-08 Score=113.58 Aligned_cols=121 Identities=17% Similarity=0.275 Sum_probs=86.7
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|+.|+|++|+|+ .+|..+. ++|+.|++++|.|++ +|..+. ++|+.|+|++|+|+ .+|..+.+.|+.|+|++|
T Consensus 305 sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp~~L~~LdLs~N 377 (754)
T PRK15370 305 GITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLPPTITTLDVSRN 377 (754)
T ss_pred hHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhcCCcCEEECCCC
Confidence 4778899999998 5776553 689999999999984 777664 68999999999998 688877778999999999
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCC---CCcccCCCCCCCCCCCcceeee
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKV---HPCLRQNFPCSAPADQYHYTLH 136 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~---~p~~~~~~p~~~~~~~~~~~~~ 136 (626)
+|+. +|..+ ...|+.|++++|+|+.. +|...+.+|....+.+..|++.
T Consensus 378 ~Lt~-LP~~l------~~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 378 ALTN-LPENL------PAALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred cCCC-CCHhH------HHHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 9884 34332 23688899999998743 2333444444444444444443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.5e-09 Score=115.20 Aligned_cols=102 Identities=23% Similarity=0.324 Sum_probs=88.6
Q ss_pred CcceEEEeecCceeecCCc-cccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPD-YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~l 78 (626)
++|+.|+|++|+|. .+|+ .+.+|..|+.|+||+|+|+ .+|..+.++..|++|...+|+|. ..|+.. ++.|+.+|+
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEec
Confidence 47999999999998 7886 5889999999999999999 99999999999999999999999 788544 669999999
Q ss_pred ccCccccc-CCCCCCCCCCCccccceeecCCCc
Q 006906 79 SLNNFTWE-SSDPIECPRGSVNLVESYSSPRNK 110 (626)
Q Consensus 79 s~N~l~~~-~~~~~~~~~~~~~~l~~l~l~~N~ 110 (626)
|.|+|+-. +|... ..++|++||+++|.
T Consensus 460 S~N~L~~~~l~~~~-----p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEAL-----PSPNLKYLDLSGNT 487 (1081)
T ss_pred ccchhhhhhhhhhC-----CCcccceeeccCCc
Confidence 99999843 33332 12899999999997
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.2e-07 Score=99.98 Aligned_cols=141 Identities=20% Similarity=0.269 Sum_probs=93.9
Q ss_pred CeeeccCceEEEEEEEcCCcEEEEEEeccCChh--------------------------c----HH----------HHHH
Q 006906 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ--------------------------G----NR----------EFVN 440 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~--------------------------~----~~----------~~~~ 440 (626)
+.|+.++-|.||+|++++|+.||||+.+..-.. . .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 789999999999999999999999987642110 0 01 1334
Q ss_pred HHHHHhcC----C-CCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHH-HHHHHh
Q 006906 441 EIGMISAQ----Q-HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG-LAYLHE 514 (626)
Q Consensus 441 E~~~l~~l----~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~ 514 (626)
|...+.++ + .+++.-..=|+.-.....|+|||++|-.+.+...-+. ..++ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence 44444333 2 3443332323334566789999999998887742221 1344 33444444443 333333
Q ss_pred CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 515 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
.+ ++|.|.+|.||+++.++++.+.|||+...+.+
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 44 99999999999999999999999999887653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.9e-08 Score=101.83 Aligned_cols=92 Identities=18% Similarity=0.214 Sum_probs=60.7
Q ss_pred hhccCCCCEEeccCccccccCchhh--hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCC
Q 006906 45 FEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNF 122 (626)
Q Consensus 45 ~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~ 122 (626)
|..|++|+.|+|++|++++.-+.++ ...++.|.|..|++...-...+ ..+..|+.|+|.+|+++...|..+..+
T Consensus 270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f----~~ls~L~tL~L~~N~it~~~~~aF~~~ 345 (498)
T KOG4237|consen 270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMF----QGLSGLKTLSLYDNQITTVAPGAFQTL 345 (498)
T ss_pred HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhh----hccccceeeeecCCeeEEEeccccccc
Confidence 4455555555555555553333333 2255555555555543322222 456778888888888888888888888
Q ss_pred CCCCCCCCcceeeeeecC
Q 006906 123 PCSAPADQYHYTLHINCG 140 (626)
Q Consensus 123 p~~~~~~~~~~~~~~~c~ 140 (626)
-....+.+..|||.|||-
T Consensus 346 ~~l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 346 FSLSTLNLLSNPFNCNCR 363 (498)
T ss_pred ceeeeeehccCcccCccc
Confidence 888888888999999997
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.8e-08 Score=104.92 Aligned_cols=104 Identities=20% Similarity=0.320 Sum_probs=82.7
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhh-cCCccccccC
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN-SNKNVDISLN 81 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~-~l~~l~ls~N 81 (626)
|+.|.+++|+++ .+|+.++.+..|..||.|.|.+. .+|..++.|.+|+.|.+..|++. .+|..+.. .|..||+|.|
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScN 221 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCN 221 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccC
Confidence 667778888877 77877887778888888888887 77778888888888888888887 67777755 7788999999
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
+++ .+|..| ..|..|++|-|.+|.|+..
T Consensus 222 kis-~iPv~f----r~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 222 KIS-YLPVDF----RKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred cee-ecchhh----hhhhhheeeeeccCCCCCC
Confidence 997 445454 8899999999999998654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.46 E-value=5e-08 Score=74.89 Aligned_cols=59 Identities=32% Similarity=0.446 Sum_probs=43.6
Q ss_pred CCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccccCcc
Q 006906 25 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNF 83 (626)
Q Consensus 25 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N~l 83 (626)
++|++|+|++|+|+..-+..|.++++|++|+|++|+++..-|..+ +++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 478899999999985556788899999999999999984333333 34666666666654
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=82.45 Aligned_cols=139 Identities=15% Similarity=0.117 Sum_probs=101.3
Q ss_pred eeccCceEEEEEEEcCCcEEEEEEeccC------ChhcHHHHHHHHHHHhcCCCCc--eeeEEEEEEe----CCeEEEEE
Q 006906 403 VGEGGFGSVYKGILSDGTVIAVKQLSSK------SRQGNREFVNEIGMISAQQHPN--LVKLYGCCVE----GNQLLLVY 470 (626)
Q Consensus 403 IG~G~fG~Vyk~~~~~g~~vAvK~l~~~------~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~----~~~~~lV~ 470 (626)
-|+||.+-|++..+. |+.+-+|+-... .......|.+|...|..+...+ +.++..+... .-.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 367899999998874 456888876422 1335678999999988875432 4444422222 12358999
Q ss_pred EecCC-CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC--EEEeecCCcc
Q 006906 471 EYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAK 547 (626)
Q Consensus 471 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~ 547 (626)
|-+++ -+|.+++..... .+.+...+..+..+++..+.-||+.+ +.|+|+.++||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 478887754321 24567788899999999999999998 999999999999986666 9999998766
Q ss_pred c
Q 006906 548 L 548 (626)
Q Consensus 548 ~ 548 (626)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3e-06 Score=87.17 Aligned_cols=195 Identities=14% Similarity=0.191 Sum_probs=127.2
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhc-CCCCceeeEEEEE------EeCCe-EEEEE
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCC------VEGNQ-LLLVY 470 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~------~~~~~-~~lV~ 470 (626)
..+.||+|+-+.+|-.--- +. -+.|+.+........+ .++.|.+ -.||-+-.=+.+- -++.. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4678999999999964321 12 2456665543332222 2233333 3555433312221 12222 56677
Q ss_pred EecCCCchhhhhcCC--CcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 471 EYMKNNCLSRAIFGK--DTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 471 e~~~~gsL~~~l~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
..+.+----..+... ........+|...++++..+|.+.+-||+.| .+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 776654222222221 1222346899999999999999999999998 78899999999999999999998654433
Q ss_pred ccCCCcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhC-CCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSG-KSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG-~~p~~~~ 603 (626)
-..+ ....--+|...|.+||.-. +-.-+...|-|.+||++++++.| +.||.+.
T Consensus 167 ~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2221 2222345889999999764 23457789999999999999876 9998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=2e-06 Score=83.61 Aligned_cols=107 Identities=20% Similarity=0.210 Sum_probs=81.7
Q ss_pred HHHHHHHHHHHhcCCCC--ceeeEEEEEEeC----CeEEEEEEecCCC-chhhhhcCCCcccccCCCHHHHHHHHHHHHH
Q 006906 435 NREFVNEIGMISAQQHP--NLVKLYGCCVEG----NQLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507 (626)
Q Consensus 435 ~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~----~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 507 (626)
.....+|...+..+... ...+.+++.... ...++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 34567777776666433 344566665542 2458999999874 7888875532 2556678899999999
Q ss_pred HHHHHHhCCCCCeEEeCCCCCCEEEcCCC---CEEEeecCCcccc
Q 006906 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLAKLY 549 (626)
Q Consensus 508 ~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~ 549 (626)
.+.-||+.+ |+|+|++++|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999998 99999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.2e-08 Score=93.92 Aligned_cols=108 Identities=23% Similarity=0.244 Sum_probs=87.3
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++++.|+||.|.|. .+-. +..|.+|+.||||+|.|+ .+..+=..|-+.+.|.|+.|.|. .+. .+ +-+|..||+
T Consensus 307 Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~LS-GL~KLYSLvnLDl 381 (490)
T KOG1259|consen 307 PKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TLS-GLRKLYSLVNLDL 381 (490)
T ss_pred cceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hhh-hhHhhhhheeccc
Confidence 46899999999998 4443 888999999999999998 66667778889999999999987 232 23 338999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
+.|++.-.-... .+|++|.|+.+.|.+|.+.+..-
T Consensus 382 ~~N~Ie~ldeV~---~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 382 SSNQIEELDEVN---HIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred cccchhhHHHhc---ccccccHHHHHhhcCCCccccch
Confidence 999997432221 34999999999999999987654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.1e-08 Score=102.98 Aligned_cols=112 Identities=15% Similarity=0.145 Sum_probs=58.4
Q ss_pred cceEEEeecCceeecCCccccCCCC---CCEEEeecCcCCC----CChHHhhcc-CCCCEEeccCccccccCchhh----
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTK---LKNIDLSFNNLTG----GIPTTFEKL-AKTNFMYLTGNKLTGPVPKYI---- 69 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~---L~~L~Ls~N~l~g----~ip~~~~~l-~~L~~L~ls~N~l~g~ip~~~---- 69 (626)
+|+.|+|++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|+|++|.+++..+..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 4666666666666545555544444 6666666666652 223344455 666666666666664322221
Q ss_pred --hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 70 --FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 70 --~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
...|+.|++++|++++.....+......++.|+.|++++|.+++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 12566666666666543211111011233466666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.40 E-value=7.3e-08 Score=100.18 Aligned_cols=112 Identities=17% Similarity=0.190 Sum_probs=86.5
Q ss_pred cceEEEeecCceee----cCCccccCC-CCCCEEEeecCcCCCC----ChHHhhccCCCCEEeccCccccccC----chh
Q 006906 2 NLKTLILTKCLIHG----EIPDYIGDM-TKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTGPV----PKY 68 (626)
Q Consensus 2 ~L~~L~L~~N~l~g----~~p~~~~~l-~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~i----p~~ 68 (626)
+|++|+|++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+.+|++|+|++|.+++.. +..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 59999999999983 344566777 9999999999999954 4556777889999999999999632 222
Q ss_pred h--hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 69 I--FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 69 ~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
+ .+.|+.|++++|.+++.....+......+++|+.|++++|.+++
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 2 23899999999999755433332223567899999999999875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-07 Score=86.11 Aligned_cols=99 Identities=17% Similarity=0.219 Sum_probs=44.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHh-hccCCCCEEeccCccccccCch--h--hhhcCCcc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF-EKLAKTNFMYLTGNKLTGPVPK--Y--IFNSNKNV 76 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L~ls~N~l~g~ip~--~--~~~~l~~l 76 (626)
+|+.|+|++|+|+ .++ .+..|++|+.|+|++|+|+ .++..+ ..+++|+.|+|++|+|.. +-+ . -++.|+.|
T Consensus 43 ~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 43 KLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVL 118 (175)
T ss_dssp T--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EE
T ss_pred CCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCccee
Confidence 6899999999999 565 5888999999999999999 554455 579999999999999984 322 1 26699999
Q ss_pred ccccCcccccCCCCCCCCCCCccccceee
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYS 105 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~ 105 (626)
+|.+|.++.. +.--..-+..+|+|+.||
T Consensus 119 ~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 119 SLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred eccCCcccch-hhHHHHHHHHcChhheeC
Confidence 9999998743 110000113456666655
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.8e-06 Score=81.48 Aligned_cols=139 Identities=18% Similarity=0.234 Sum_probs=85.3
Q ss_pred CeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCc--eeeEEEEEEeCCeEEEEEEecCCCc-
Q 006906 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYMKNNC- 477 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~e~~~~gs- 477 (626)
+.||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67999999999984 24567788876533 3345678888888776443 3566777777777889999999863
Q ss_pred hhhh---------------------hcCCCcccccCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEEe
Q 006906 478 LSRA---------------------IFGKDTEYRLKLDWPTRK-KICI----------GIAR-GLAYLHED-SRIKIVHR 523 (626)
Q Consensus 478 L~~~---------------------l~~~~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~~-~~~~iiH~ 523 (626)
+... +|.-... ........ ++.. .+.. ..++|... ..+.++|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 2111 1211000 00101100 0000 0111 12222211 22357899
Q ss_pred CCCCCCEEEcCCCCEEEeecCCccc
Q 006906 524 DIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 524 Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|+.|.||++++++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=77.62 Aligned_cols=138 Identities=18% Similarity=0.207 Sum_probs=92.6
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHH---------HHHHHHhcCC---CCceeeEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV---------NEIGMISAQQ---HPNLVKLYGCC 460 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~---------~E~~~l~~l~---H~nIv~l~~~~ 460 (626)
..++|...+++-......|.+-.. +|+.+.+|.........++.|. +++..+.+++ -.....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888777777777666 5788999998776443333332 2333333332 22333333332
Q ss_pred E-----eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 006906 461 V-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 535 (626)
Q Consensus 461 ~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 535 (626)
. -....+++|||++|..|.+.. .++. .++..+++++.-||+.| +.|+|..|+|++++.+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~---------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE---------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch---------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 2 234557899999998876543 1222 24566778899999998 9999999999999866
Q ss_pred CCEEEeecCCccc
Q 006906 536 LNAKISDFGLAKL 548 (626)
Q Consensus 536 ~~~kl~DfGla~~ 548 (626)
+ ++++||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 4 99999987664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-06 Score=105.84 Aligned_cols=116 Identities=16% Similarity=0.168 Sum_probs=83.6
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|+.|+|++|...+.+|.++++|++|+.|+|++|..-+.+|..+ ++++|+.|+|++|..-..+|.. ..+|+.|+|++|
T Consensus 779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-~~nL~~L~Ls~n 856 (1153)
T PLN03210 779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI-STNISDLNLSRT 856 (1153)
T ss_pred cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc-ccccCEeECCCC
Confidence 57788888887777888888888888888888876555777666 7888888888887554456643 457888888888
Q ss_pred cccccCCCCCCCCCCCccccceeecCC-CccCCCCCcccCCCCCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPR-NKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~-N~l~~~~p~~~~~~p~~ 125 (626)
.++ .+|..+ ..+++|+.|++++ |+|.. +|.....++..
T Consensus 857 ~i~-~iP~si----~~l~~L~~L~L~~C~~L~~-l~~~~~~L~~L 895 (1153)
T PLN03210 857 GIE-EVPWWI----EKFSNLSFLDMNGCNNLQR-VSLNISKLKHL 895 (1153)
T ss_pred CCc-cChHHH----hcCCCCCEEECCCCCCcCc-cCcccccccCC
Confidence 887 344443 7788888888888 45544 55444444433
|
syringae 6; Provisional |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.22 E-value=7.9e-07 Score=62.98 Aligned_cols=36 Identities=28% Similarity=0.515 Sum_probs=19.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT 38 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 38 (626)
+|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 45545555555555555555555
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.2e-06 Score=62.04 Aligned_cols=40 Identities=25% Similarity=0.509 Sum_probs=34.4
Q ss_pred CCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCc
Q 006906 25 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 66 (626)
Q Consensus 25 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip 66 (626)
++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 58999999999999 78888999999999999999998 444
|
... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.16 E-value=4e-06 Score=101.89 Aligned_cols=108 Identities=19% Similarity=0.167 Sum_probs=55.0
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|+.|+|++|+|. .+|..+..+++|+.|+|++|+.-+.+| .++.+++|+.|+|++|.....+|..+ +++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 4555555555555 455555555556666665554434555 25555556666665554444555554 3355555555
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
+|+.-..+|..+ .+++|+.|++++|.....+|
T Consensus 690 ~c~~L~~Lp~~i-----~l~sL~~L~Lsgc~~L~~~p 721 (1153)
T PLN03210 690 RCENLEILPTGI-----NLKSLYRLNLSGCSRLKSFP 721 (1153)
T ss_pred CCCCcCccCCcC-----CCCCCCEEeCCCCCCccccc
Confidence 544333333221 34555555555554333333
|
syringae 6; Provisional |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.6e-08 Score=100.98 Aligned_cols=102 Identities=21% Similarity=0.324 Sum_probs=61.0
Q ss_pred EEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhh-cCCccccccCcc
Q 006906 5 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN-SNKNVDISLNNF 83 (626)
Q Consensus 5 ~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~-~l~~l~ls~N~l 83 (626)
..||+.|++. ++|..++.+..|+.|.|.+|.|. .||..+.+|..|++|||+.|+++ .+|..++. -|+.|-+++|++
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl 155 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKL 155 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCcc
Confidence 4566666666 66666666666666666666666 66666666666666666666666 56666644 566666666666
Q ss_pred cccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 84 TWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 84 ~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
+ .+|..+ +.+..|..||.+.|.+...
T Consensus 156 ~-~lp~~i----g~~~tl~~ld~s~nei~sl 181 (722)
T KOG0532|consen 156 T-SLPEEI----GLLPTLAHLDVSKNEIQSL 181 (722)
T ss_pred c-cCCccc----ccchhHHHhhhhhhhhhhc
Confidence 5 223332 4445555555555555433
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.6e-05 Score=72.53 Aligned_cols=135 Identities=19% Similarity=0.294 Sum_probs=94.0
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCC----------------hhcHHHHHHHHHHHhcCC------CCceeeE
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS----------------RQGNREFVNEIGMISAQQ------HPNLVKL 456 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l 456 (626)
....||+|+.=.||. +++.....||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457899999999997 4556667888887654 223456666766555544 8899999
Q ss_pred EEEEEeCCeEEEEEEecCCC------chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 006906 457 YGCCVEGNQLLLVYEYMKNN------CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 530 (626)
Q Consensus 457 ~~~~~~~~~~~lV~e~~~~g------sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 530 (626)
+|+.+++...-+|+|.+.+. +|.+++... .++. ... ..+-+-.+||-+.+ |+.+|++|+||
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNI 149 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccE
Confidence 99999999999999987542 566666433 2333 223 33334456776665 99999999999
Q ss_pred EEcCC--C--CEEEee-cCCccc
Q 006906 531 LLDKD--L--NAKISD-FGLAKL 548 (626)
Q Consensus 531 Ll~~~--~--~~kl~D-fGla~~ 548 (626)
++... + .+.|+| ||-...
T Consensus 150 v~~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EEEecCCCceEEEEEeCCCCccc
Confidence 99533 2 477777 676554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=2e-05 Score=77.66 Aligned_cols=145 Identities=16% Similarity=0.122 Sum_probs=83.7
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCC--ceeeEEEEEE---eCCeEEEEEEecC
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP--NLVKLYGCCV---EGNQLLLVYEYMK 474 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~---~~~~~~lV~e~~~ 474 (626)
.+.++.|..+.||+....+ ..+++|..... ....++.+|..++..+... .+.+++.++. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999877 68999997654 4456677888887776433 3455666443 2345789999999
Q ss_pred CCchhh----------------h---hcCCCcccccCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 006906 475 NNCLSR----------------A---IFGKDTEYRLKLDWPT---------RKKI------------CIGIAR-GLAYLH 513 (626)
Q Consensus 475 ~gsL~~----------------~---l~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH 513 (626)
+..+.. . +|..... .....+.. .... ...+.. .++.++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPP-FSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTT-CCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhccccccc-ccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 887766 1 1111000 00011100 0000 111222 233333
Q ss_pred h----CCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCccc
Q 006906 514 E----DSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKL 548 (626)
Q Consensus 514 ~----~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~ 548 (626)
+ .....++|+|+.|+||+++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 2334599999999999999 566667999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=6e-05 Score=73.39 Aligned_cols=156 Identities=18% Similarity=0.195 Sum_probs=100.3
Q ss_pred CCcccHHHHHHHhcCCCCCCeee---ccCceEEEEEEEcCCcEEEEEEeccCChhc-------------------H----
Q 006906 382 TGLYTLRQIKAATNNFDPANKVG---EGGFGSVYKGILSDGTVIAVKQLSSKSRQG-------------------N---- 435 (626)
Q Consensus 382 ~~~~~~~~l~~~t~~f~~~~~IG---~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~-------------------~---- 435 (626)
....+++.+....+...+.+..| +|--+.||+|.-.++..+|||++....... .
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 34456677777777766666655 566678999998889999999986432111 0
Q ss_pred -HHHHHHHHHHhcCCC--CceeeEEEEEEeCCeEEEEEEecCCCch-hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHH
Q 006906 436 -REFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNCL-SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511 (626)
Q Consensus 436 -~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y 511 (626)
....+|..-|.++.- -.+.+.+++. .-.|||||+..... .=.|.. ..+.......+..++++.+.-
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHH
Confidence 112345555554422 2222333332 34789999965421 111111 123333567777888888887
Q ss_pred HHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 512 LH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|-... .+||+||+.=|||+. ++.+.|+|||-|....
T Consensus 182 l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 182 LYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 77633 499999999999999 8899999999887554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.5e-06 Score=93.36 Aligned_cols=101 Identities=28% Similarity=0.377 Sum_probs=60.5
Q ss_pred cceEEEeecCceeecCCccccCCC-CCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchh--hhhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMT-KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY--IFNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~--~~~~l~~l~l 78 (626)
.++.|++.+|+++ .+|+..+.++ +|+.|++++|++. .+|..+.++++|+.|++++|+++ .+|.. ....|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 4566666666666 5666566564 6666666666666 55566666666666666666666 55554 3446666666
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNK 110 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~ 110 (626)
++|+++-. |.. .+.+..|+.+.+++|+
T Consensus 194 s~N~i~~l-~~~----~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKISDL-PPE----IELLSALEELDLSNNS 220 (394)
T ss_pred cCCccccC-chh----hhhhhhhhhhhhcCCc
Confidence 66666522 111 1234446666666664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.6e-05 Score=76.13 Aligned_cols=142 Identities=14% Similarity=0.094 Sum_probs=84.8
Q ss_pred eeeccCc-eEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEecCCCchh
Q 006906 402 KVGEGGF-GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNCLS 479 (626)
Q Consensus 402 ~IG~G~f-G~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 479 (626)
.|-.|.. ..||+.... +..+.||+..... ..+..+|++++..+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 789999764 4678888876543 335667888877663 333556777776666789999999988776
Q ss_pred hhh-------------------cCCCcccccCCCH--HHHHHHHH--------------------HHHHHHHHHHh----
Q 006906 480 RAI-------------------FGKDTEYRLKLDW--PTRKKICI--------------------GIARGLAYLHE---- 514 (626)
Q Consensus 480 ~~l-------------------~~~~~~~~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~---- 514 (626)
... |..... ...+.. ........ .+....+.|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVA-DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcc-cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 432 111100 001110 00000000 01111222211
Q ss_pred CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 515 ~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
...+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1234589999999999999987788999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.3e-05 Score=87.30 Aligned_cols=142 Identities=15% Similarity=0.150 Sum_probs=89.8
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChh-------------------------------------cHHHHHHHH
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQ-------------------------------------GNREFVNEI 442 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~-------------------------------------~~~~~~~E~ 442 (626)
.+.||.-+.|.||+|++++|+.||||+-+..-+. .+-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4789999999999999999999999986542110 011244554
Q ss_pred HHHh----cCCCCce---eeEEEEE-EeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHH-HHHH
Q 006906 443 GMIS----AQQHPNL---VKLYGCC-VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL-AYLH 513 (626)
Q Consensus 443 ~~l~----~l~H~nI---v~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH 513 (626)
+-.. .++|-+. |.+=.++ .-.....|+||||+|..+.+.-.-.. ..++...+ +..+.++. +.+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~----~gi~~~~i---~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK----RGISPHDI---LNKLVEAYLEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH----cCCCHHHH---HHHHHHHHHHHHH
Confidence 4332 3345551 1122222 23446789999999998876632211 13444433 33333332 2222
Q ss_pred hCCCCCeEEeCCCCCCEEEcC----CCCEEEeecCCcccccC
Q 006906 514 EDSRIKIVHRDIKTSNVLLDK----DLNAKISDFGLAKLYEE 551 (626)
Q Consensus 514 ~~~~~~iiH~Dlkp~NILl~~----~~~~kl~DfGla~~~~~ 551 (626)
..| ++|+|=+|.||+++. ++++.+-|||+......
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 334 999999999999984 67899999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.8e-07 Score=98.11 Aligned_cols=183 Identities=18% Similarity=0.152 Sum_probs=134.4
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCc-eeeEEEEEEeCCeEEEEEEecCCC-
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN-LVKLYGCCVEGNQLLLVYEYMKNN- 476 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~e~~~~g- 476 (626)
.-+-.++|+++++||.+-...+....+.+... .+..-++++|.+++||| .++.++-+..++..+++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34557899999999988654555555555432 34556889999999999 777777788888899999999877
Q ss_pred chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcce
Q 006906 477 CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 477 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
+-.... ......+...+...+...-+++++|+|+.. =+|+| ||+..+ +..|..||+....+.... .
T Consensus 321 s~~~~~----~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 321 SSALEM----TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred cccccC----ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 222111 111123445555666777788999999863 47998 777765 578999999988776543 2
Q ss_pred ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 557 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
.....+++.++|||......+..+.|+|+.|+-..+|.-|-+|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 33466899999999999999999999999998777777666553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.2e-06 Score=92.18 Aligned_cols=103 Identities=29% Similarity=0.493 Sum_probs=57.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchh--hhhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY--IFNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~--~~~~l~~l~ls 79 (626)
+|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+++ .+|.. ....|+.++++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 4566666666665 55555666666666666666665 55555555666666666666666 55554 23346666666
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
+|+..- .+.....+..+..+.+.+|++.
T Consensus 218 ~N~~~~-----~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 218 NNSIIE-----LLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred CCccee-----cchhhhhcccccccccCCceee
Confidence 664211 1112245555555555566553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.7e-05 Score=87.17 Aligned_cols=150 Identities=17% Similarity=0.321 Sum_probs=93.0
Q ss_pred CCeeeccCceEEEEEEEcCC---cEEEEEEeccCC-hhcHHHHHHHHHHHhcCC-CCce--eeEEEEEEeC---CeEEEE
Q 006906 400 ANKVGEGGFGSVYKGILSDG---TVIAVKQLSSKS-RQGNREFVNEIGMISAQQ-HPNL--VKLYGCCVEG---NQLLLV 469 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~~~~~~~---~~~~lV 469 (626)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887654 467777765432 223457889999999885 6664 6777777654 457899
Q ss_pred EEecCCCchhhh-----------------------hcCCCcc------cccCCCH--HHHHHHH---------------H
Q 006906 470 YEYMKNNCLSRA-----------------------IFGKDTE------YRLKLDW--PTRKKIC---------------I 503 (626)
Q Consensus 470 ~e~~~~gsL~~~-----------------------l~~~~~~------~~~~l~~--~~~~~i~---------------~ 503 (626)
|||+++..+.+. ||.-... ...+..+ .++.++. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999997653221 1221110 0000011 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeEEeCCCCCCEEEcCC-CC-EEEeecCCcccc
Q 006906 504 GIARGLAYLHEDSR--------IKIVHRDIKTSNVLLDKD-LN-AKISDFGLAKLY 549 (626)
Q Consensus 504 ~ia~~L~yLH~~~~--------~~iiH~Dlkp~NILl~~~-~~-~kl~DfGla~~~ 549 (626)
.+...+++|..+-+ +.++|+|+++.||+++.+ .. +-|.||.++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667754322 249999999999999853 34 468999987754
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.4e-07 Score=98.43 Aligned_cols=105 Identities=25% Similarity=0.217 Sum_probs=80.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChH-HhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
.|+.|+|++|+|+.. +.+-.|.+|++|||++|+|. .+|. ....+. |+.|.|+||.++...--.-+++|+.||+|+
T Consensus 188 ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL~gie~LksL~~LDlsy 263 (1096)
T KOG1859|consen 188 ALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTLRGIENLKSLYGLDLSY 263 (1096)
T ss_pred Hhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhhhhHHhhhhhhccchhH
Confidence 478899999999832 26888999999999999998 5553 334454 999999999998433333477999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
|-|.+--... ++..+..|..|.|.+|.+..
T Consensus 264 Nll~~hseL~---pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 264 NLLSEHSELE---PLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hhhhcchhhh---HHHHHHHHHHHhhcCCcccc
Confidence 9887653222 34778889999999999854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 626 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-54 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-24 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-17 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 459 bits (1184), Expect = e-159
Identities = 109/255 (42%), Positives = 163/255 (63%), Gaps = 5/255 (1%)
Query: 371 ADKELRGLDL-QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSS 429
+E + L Q ++LR+++ A++NF N +G GGFG VYKG L+DGT++AVK+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64
Query: 430 KSRQGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE 488
+ QG +F E+ MIS H NL++L G C+ + LLVY YM N ++ + + E
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-E 123
Query: 489 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548
+ LDWP R++I +G ARGLAYLH+ KI+HRD+K +N+LLD++ A + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNE 606
+ TH++T + GTIG++APEY G + K DV+ +GV+ LE+++G+ + N+
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 607 DFVYLLDWAYVLQEE 621
D V LLDW L +E
Sbjct: 244 DDVMLLDWVKGLLKE 258
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 418 bits (1076), Expect = e-143
Identities = 105/238 (44%), Positives = 151/238 (63%), Gaps = 5/238 (2%)
Query: 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM 444
L ++ ATNNFD +G G FG VYKG+L DG +A+K+ + +S QG EF EI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 445 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 504
+S +HP+LV L G C E N+++L+Y+YM+N L R ++G D + + W R +ICIG
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIG 147
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGT 563
ARGL YLH + I+HRD+K+ N+LLD++ KI+DFG++K E D+TH+ST + GT
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEE 621
+GY+ PEY ++G LT K+DVYSFGVV E++ +S + V L +WA
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 413 bits (1065), Expect = e-142
Identities = 106/262 (40%), Positives = 153/262 (58%), Gaps = 20/262 (7%)
Query: 372 DKELRGLDLQTGLYTLRQIKAATNNFDP------ANKVGEGGFGSVYKGILSDGTVIAVK 425
+K L D + ++ ++K TNNFD NK+GEGGFG VYKG + + T +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 426 QLSS----KSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRA 481
+L++ + + ++F EI +++ QH NLV+L G +G+ L LVY YM N L
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 482 IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541
+ D L W R KI G A G+ +LHE+ I HRDIK++N+LLD+ AKIS
Sbjct: 121 LSCLD--GTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKIS 175
Query: 542 DFGLAKLY-EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600
DFGLA+ + +T +++RI GT YMAPE +RG +T K+D+YSFGVV LEI++G
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 601 NYRPNEDFVYLLDWAYVLQEEE 622
+ LLD +++EE
Sbjct: 235 DEHREPQ--LLLDIKEEIEDEE 254
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-77
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 25/246 (10%)
Query: 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMI 445
+ + G FG V+K L +AVK + +Q + E+ +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 446 SAQQHPNLVKLYGCCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 501
+H N+++ G G L L+ + + LS + + W I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126
Query: 502 CIGIARGLAYLHED-------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554
+ARGLAYLHED + I HRDIK+ NVLL +L A I+DFGLA +E K+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 555 HI-STRIAGTIGYMAPEYAMRGYLTS-----KADVYSFGVVTLEIVSGKSNTNYRPNEDF 608
+ GT YMAPE + D+Y+ G+V E+ S + + +E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 609 VYLLDW 614
+ +
Sbjct: 247 LPFEEE 252
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (548), Expect = 1e-64
Identities = 65/234 (27%), Positives = 100/234 (42%), Gaps = 37/234 (15%)
Query: 393 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQH 450
+N +G G +G+VYKG L D +AVK S +RQ F+NE I + +H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 451 PNLVKLYGCCVEGN-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 505
N+ + + LLV EY N L + + DW + ++ +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSV 120
Query: 506 ARGLAYLHED------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK------ 553
RGLAYLH + + I HRD+ + NVL+ D ISDFGL+ ++
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 554 -THISTRIAGTIGYMAPEYAM-------RGYLTSKADVYSFGVVTLEIVSGKSN 599
+ + GTI YMAPE + D+Y+ G++ EI ++
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-60
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 458
K+G G FG+V++ G+ +AVK L + EF+ E+ ++ +HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ L +V EY+ L R + + R +LD R + +A+G+ YLH
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLL--HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 577
IVHR++K+ N+L+DK K+ DFGL++L + S AGT +MAPE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS- 216
Query: 578 TSKADVYSFGVVTLEIVSGK 597
K+DVYSFGV+ E+ + +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-59
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
VG G FG V K +A+KQ+ S+S + + F+ E+ +S HPN+VKLYG C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ N + LV EY + L + G + C+ ++G+AYLH +
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 521 VHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 579
+HRD+K N+LL KI DFG A D T G+ +MAPE +
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 580 KADVYSFGVVTLEIVSGK 597
K DV+S+G++ E+++ +
Sbjct: 183 KCDVFSWGIILWEVITRR 200
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-57
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-------REFVNEIGMISAQQHPN 452
++G+GGFG V+KG + D +V+A+K L +G +EF E+ ++S HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+VKLYG N +V E++ L + K + W + ++ + IA G+ Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIEYM 138
Query: 513 HEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
+ IVHRD+++ N+ L + AK++DFGL++ H + + G +M
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWM 193
Query: 568 APE-YAMRGYL-TSKADVYSFGVVTLEIVSGK 597
APE T KAD YSF ++ I++G+
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-57
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 401 NKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
+G+G FG K G V+ +K+L + R F+ E+ ++ +HPN++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519
+ +L + EY+K L I D+ + W R IA G+AYLH +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-------------ISTRIAGTIGY 566
I+HRD+ + N L+ ++ N ++DFGLA+L ++KT + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
MAPE K DV+SFG+V EI+
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-57
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQL----SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+G GGFG VY+ G +AVK Q E + + +HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
G C++ L LV E+ + L+R + GK ++ + IARG+ YLH+++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 517 RIKIVHRDIKTSNVLLDKDL--------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
+ I+HRD+K+SN+L+ + + KI+DFGLA+ E +T + AG +MA
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMA 182
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
PE + +DV+S+GV+ E+++G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 458
K+ E G ++KG G I VK L + R+F E + HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 459 CCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
C L+ +M L + +D K + +ARG+A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLH-TL 130
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG- 575
I + + +V++D+D+ A+IS + ++ S ++APE A++
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKK 183
Query: 576 ---YLTSKADVYSFGVVTLEIVSGK 597
AD++SF V+ E+V+ +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 7e-55
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 458
++G G FG+VYKG G V AVK L+ + + F NE+G++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
L +V ++ + + L + +T K + I ARG+ YLH
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLH---AK 139
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL-YEEDKTHISTRIAGTIGYMAPEYAMRGYL 577
I+HRD+K++N+ L +D KI DFGLA +H +++G+I +MAPE +R
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQD 198
Query: 578 ----TSKADVYSFGVVTLEIVSGK 597
+ ++DVY+FG+V E+++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-54
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 458
VG+G +G V++G G +AVK SS + + + E + +H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 459 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+ QL L+ Y + L + LD + +I + IA GLA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 515 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 566
+ + I HRD+K+ N+L+ K+ I+D GLA ++ + + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 567 MAPE------YAMRGYLTSKADVYSFGVVTLEIVSG 596
MAPE + D+++FG+V E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-54
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 30/230 (13%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 458
++G+G +G V+ G G +AVK + + E I +H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 459 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
++G QL L+ +Y +N L + LD + K+ GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 515 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 566
+ + I HRD+K+ N+L+ K+ I+D GLA + D + GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 567 MAPE------YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
M PE AD+YSFG++ E+ + Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-52
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVKLYG 458
+G+G FG VY G G V A++ + + + + F E+ +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
C+ L ++ K L + LD ++I I +G+ YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKI----VLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKL----YEEDKTHISTRIAGTIGYMAPE---- 570
I+H+D+K+ NV D I+DFGL + + G + ++APE
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 571 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ + +DV++ G + E+ + +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNE--IGMISAQQHPNLVKLYG 458
+G+G FG V++G G +AVK SS + R + E I +H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 459 CCVEGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+ N QL LV +Y ++ L + R + K+ + A GLA+LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 515 D-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI---STRIAGTIGY 566
+ + I HRD+K+ N+L+ K+ I+D GLA ++ I GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 567 MAPEYAMRGYL-------TSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
MAPE + + +AD+Y+ G+V EI S + Y
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
++GEG FG V+ + ++AVK L S ++F E +++ QH ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCL----------SRAIFGKDTEYRLKLDWPTRKKICIG 504
+ +G C EG LL+V+EYM++ L ++ + G + L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT 563
+A G+ YL + + VHRD+ T N L+ + L KI DFG+++ +Y D + R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
I +M PE + T+++DV+SFGVV EI +
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 401 NKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
++GEG FG V+ D ++AVK L + ++F E +++ QH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKICI 503
K YG C +G+ L++V+EYMK+ L + G+ + + +L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAG 562
IA G+ YL + VHRD+ T N L+ +L KI DFG+++ +Y D +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-------GKSNT 600
I +M PE M T+++DV+SFGV+ EI + SNT
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 402 KVGEGGFGSVYKGILSDGTV-IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
++G G FG V+ G L +AVK + +F+ E ++ HPN+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519
C + + +V E ++ F + RL++ T ++ A G+ YL
Sbjct: 181 CTQKQPIYIVMELVQGGDFLT--FLRTEGARLRV--KTLLQMVGDAAAGMEYLES---KC 233
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT----IGYMAPEYAMRG 575
+HRD+ N L+ + KISDFG+++ + + G + + APE G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYG 290
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+S++DV+SFG++ E S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 401 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 456 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 511
G C + L L+ EY+ L +D +++ ++D + I +G+ Y
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSL------RDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAP 569
L + +HRD+ T N+L++ + KI DFGL K+ +DK + G I + AP
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVS 595
E + +DV+SFGVV E+ +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-44
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 401 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 454
+GEG FG V + G +AVK L + EI ++ H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 455 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
K G C E GN + L+ E++ + L + + ++ L + K + I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINL--KQQLKYAVQICKGMDYL 142
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPE 570
+ VHRD+ NVL++ + KI DFGL K E DK + + + + + APE
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVS 595
M+ +DV+SFGV E+++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-44
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSKSRQGNR-EFVNEIGMISAQQHPNL 453
++G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK---KICIGIAR 507
V+L G +G L++ E M L R++ L P+ ++ IA
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-RPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAGTIGY 566
G+AYL+ K VHRD+ N ++ +D KI DFG+ +YE D + + +
Sbjct: 150 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
M+PE G T+ +DV+SFGVV EI +
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 401 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
++G+G FGSV + G V+AVK+L + + R+F EI ++ + QH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 456 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
G C + L L+ EY+ L + + + R+ + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDH--IKLLQYTSQICKGMEYLG 162
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 571
+ +HRD+ T N+L++ + KI DFGL K+ +DK + + G I + APE
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 572 AMRGYLTSKADVYSFGVVTLEIVS 595
+ +DV+SFGVV E+ +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 453
++GE FG VYKG L +A+K L K EF +E + + QHPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRKKIC 502
V L G + L +++ Y + L D + L+ P +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHISTR 559
IA G+ YL S +VH+D+ T NVL+ LN KISD GL ++Y D K ++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ I +MAPE M G + +D++S+GVV E+ S
Sbjct: 192 LP--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
++G G FG V G +A+K + S S EF+ E ++ H LV+LYG
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
C + + ++ EYM N CL + ++ +R + ++C + + YL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLN--YLREMRHRFQT--QQLLEMCKDVCEAMEYL---ESK 139
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 575
+ +HRD+ N L++ K+SDFGL++ +D T G+ + + PE M
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYS 196
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+SK+D+++FGV+ EI S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 63/207 (30%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 401 NKVGEGGFGSVYKGIL-----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 454
+GEG FG V G ++AVK L + Q + EI ++ H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 455 KLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEY--RLKLDWPTRKKICIGIARGLA 510
K GCC + L LV EY+ L +Y R + I G+A
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLR--------DYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMA 568
YLH +HRD+ NVLLD D KI DFGLAK E + R G + + A
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVS 595
PE +DV+SFGV E+++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 401 NKVGEGGFGSVYKGILSDGTV-IAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
+K+G G +G VY+G+ ++ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G C ++ E+M L + ++ R ++ + I+ + YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEYAMRG 575
+HRD+ N L+ ++ K++DFGL++L D H + I + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN 187
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+ K+DV++FGV+ EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 401 NKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK 455
+++G+G FGSV + G ++AVKQL R+F EI ++ A +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 456 LYGCCVEGNQ--LLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAY 511
G + L LV EY+ + CL +D +R +LD I +G+ Y
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCL------RDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAP 569
L + VHRD+ N+L++ + + KI+DFGLAKL DK + R G I + AP
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVS 595
E + ++DV+SFGVV E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 9e-43
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 16/199 (8%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
++G G FG V+ G + +A+K + + S + +F+ E ++ HP LV+LYG
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
C+E + LV E+M++ CLS + + T +C+ + G+AYL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAA--ETLLGMCLDVCEGMAYL---EEA 123
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMAPEYAMRGY 576
++HRD+ N L+ ++ K+SDFG+ + +D + T+ + + +PE
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSR 181
Query: 577 LTSKADVYSFGVVTLEIVS 595
+SK+DV+SFGV+ E+ S
Sbjct: 182 YSSKSDVWSFGVLMWEVFS 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 68/248 (27%), Positives = 111/248 (44%), Gaps = 31/248 (12%)
Query: 401 NKVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPNLVK 455
+ +GEG FG V K + A+K++ S+ +R+F E+ + HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------KICIG 504
L G C L L EY + L R +T+ + T
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
+ARG+ YL S+ + +HRD+ N+L+ ++ AKI+DFGL++ E R+ +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--V 205
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQE- 620
+MA E T+ +DV+S+GV+ EIVS G T Y + L Y L++
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKLPQGYRLEKP 263
Query: 621 ----EEIY 624
+E+Y
Sbjct: 264 LNCDDEVY 271
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-42
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
++G G FG V G +AVK + S S EF E + HP LVK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLAYLHED 515
C + + +V EY+ N CL Y L+ ++C + G+A+L
Sbjct: 72 CSKEYPIYIVTEYISNGCLL--------NYLRSHGKGLEPSQLLEMCYDVCEGMAFL--- 120
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYA 572
+ +HRD+ N L+D+DL K+SDFG+ + +D+ GT + + APE
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVF 177
Query: 573 MRGYLTSKADVYSFGVVTLEIVS 595
+SK+DV++FG++ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 401 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 454
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+L G C+ + + L+ + M CL + E++ + C+ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 573
++VHRD+ NVL+ + KI+DFGLAKL ++ I +MA E +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
T ++DV+S+GV E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-42
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
+G+G +G VY G LS+ IA+K++ + + ++ EI + +H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 462 EGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
E + + E + LS R+ +G LK + T I GL YLH++
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 519 KIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMR 574
+IVHRDIK NVL++ KISDFG +K T GT+ YMAPE R
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPR 200
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
GY AD++S G +E+ +GK
Sbjct: 201 GY-GKAADIWSLGCTIIEMATGK 222
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
++G G F +VYKG+ +A + ++ + F E M+ QHPN+V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 459 CCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
++LV E M + L + ++ + + C I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFK-VMKIKVLRSWCRQILKGLQFLHT 147
Query: 515 DSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYE 203
Query: 574 RGYLTSKADVYSFGVVTLEIVSGK 597
Y DVY+FG+ LE+ + +
Sbjct: 204 EKY-DESVDVYAFGMCMLEMATSE 226
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-41
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 401 NKVGEGGFGSVYKGIL-SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
+K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G C ++ E+M L + ++ R ++ + I+ + YL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLD--YLRECN-RQEVSAVVLLYMATQISSAMEYL---EK 336
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 577
+HR++ N L+ ++ K++DFGL++L D I + APE
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 578 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 618
+ K+DV++FGV+ EI + G S LL+ Y +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 61/202 (30%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 402 KVGEGGFGSVYKGILSDGTV-----IAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
+G G FG VYKG+L + +A+K L + + + +F+ E G++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
L G + ++++ EYM+N L + F ++ + + + GIA G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSV--LQLVGMLRGIAAGMKYL--- 163
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 573
+ + VHRD+ N+L++ +L K+SDFGL+++ E+D T G I + APE
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
TS +DV+SFG+V E+++
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMT 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 28/249 (11%)
Query: 401 NKVGEGGFGSVYKGILSD------GTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 452
+G G FG V + +AVK L S+ ++E+ M QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK---KICI 503
+V L G C G +L++ EY L + D + + + +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHISTRIAG 562
+A+G+A+L + +HRD+ NVLL AKI DFGLA + + +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSN-TNYRPNEDFVYLLDWAYVLQE 620
+ +MAPE T ++DV+S+G++ EI S G + N F L+ Y + +
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288
Query: 621 -----EEIY 624
+ IY
Sbjct: 289 PAFAPKNIY 297
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 77/261 (29%), Positives = 117/261 (44%), Gaps = 44/261 (16%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNL 453
+GEG FG V K T +AVK L + S R+ ++E ++ HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK-------- 499
+KLYG C + LLL+ EY K L SR + + +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 500 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED- 552
I++G+ YL + +K+VHRD+ N+L+ + KISDFGL+ +YEED
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 553 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDF 608
RI + +MA E T+++DV+SFGV+ EIV+ G Y P E
Sbjct: 206 YVKRSQGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPGIPPERL 261
Query: 609 VYLLDWAYVLQE-----EEIY 624
LL + ++ EE+Y
Sbjct: 262 FNLLKTGHRMERPDNCSEEMY 282
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 401 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
+G+G FG VY G D A+K L Q F+ E ++ HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 456 LYGCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
L G + ++ YM + L + F + + + + +ARG+ YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTV--KDLISFGLQVARGMEYL-- 140
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYMAPEY 571
+ K VHRD+ N +LD+ K++DFGLA+ + + + + + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 572 AMRGYLTSKADVYSFGVVTLEIVS 595
T+K+DV+SFGV+ E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 62/196 (31%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 461 VEGN-QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519
VE L +V EYM L + + R L K + + + YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVD--YLRSRG-RSVLGGDCLLKFSLDVCEAMEYL---EGNN 137
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTS 579
VHRD+ NVL+ +D AK+SDFGL K E T + ++ + + APE ++
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFST 193
Query: 580 KADVYSFGVVTLEIVS 595
K+DV+SFG++ EI S
Sbjct: 194 KSDVWSFGILLWEIYS 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-41
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
++G G FG V+ G + T +AVK L S S F+ E ++ QH LV+LY
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ + ++ EYM+N L F K +KL + IA G+A++
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVD--FLKTPS-GIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAMRG 575
+HRD++ +N+L+ L+ KI+DFGLA+L E++ T G I + APE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYG 185
Query: 576 YLTSKADVYSFGVVTLEIVS 595
T K+DV+SFG++ EIV+
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 401 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
+G G G V G L +A+K L + + + R+F++E ++ HPN+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
L G G ++V EYM+N L F + + + + + G+ G+ YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTI--MQLVGMLRGVGAGMRYL--- 167
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 573
S + VHRD+ NVL+D +L K+SDFGL+++ E+D T G I + APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
+S +DV+SFGVV E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 34/224 (15%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 453
+GEG FG V++ T++AVK L + S +F E +++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCL-----------SRAIFGKDTEYRLKLDWPTRK--- 499
VKL G C G + L++EYM L ++ D R ++ P
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 500 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED- 552
I +A G+AYL S K VHRD+ T N L+ +++ KI+DFGL+ +Y D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 553 -KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
K + I I +M PE T+++DV+++GVV EI S
Sbjct: 230 YKADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 30/243 (12%)
Query: 401 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 456 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 510
L G C+ L+V YMK+ L + + +A+G+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDL--------RNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYM 567
YL K VHRD+ N +LD+ K++DFGLA+ +Y+++ + + + +M
Sbjct: 143 YLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE-----E 621
A E T+K+DV+SFGV+ E+++ G D L L + +
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259
Query: 622 EIY 624
+Y
Sbjct: 260 PLY 262
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-41
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 401 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 452
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 453 LVKLYGCC-VEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK--------K 500
+V L G C G L+++ E+ K LS R+ + Y++ + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 501 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHIS 557
+A+G+ +L + K +HRD+ N+LL + KI DFGLA +Y++
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
R+ + +MAPE T ++DV+SFGV+ EI S
Sbjct: 210 ARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 401 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 450
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 499
N++ L G C + L ++ EY L RA EY ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 556
+ARG+ YL + K +HRD+ NVL+ ++ KI+DFGLA + D K
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ R+ + +MAPE T ++DV+SFGV+ EI +
Sbjct: 218 NGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-41
Identities = 63/209 (30%), Positives = 88/209 (42%), Gaps = 18/209 (8%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 453
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
V+ G ++ ++ E M L R + ++ L + IA G
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQ 154
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 566
YL +HRDI N LL AKI DFG+A+ +Y + +
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
M PE M G TSK D +SFGV+ EI S
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-41
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 402 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
++G G FGSV +G+ +A+K L + E + E ++ +P +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G C + L+LV E L + + GK ++ ++ ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYL---EE 128
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 575
VHRD+ NVLL AKISDFGL+K D ++ + R AG + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+S++DV+S+GV E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-41
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 401 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 454
+G G FG+V+KG+ + +K + RQ + + + I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+L G C G+ L LV +Y+ L + L + IA+G+ YL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLD--HVRQHRGALGP--QLLLNWGVQIAKGMYYL-- 131
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 573
+VHR++ NVLL +++DFG+A L D + A T I +MA E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
G T ++DV+S+GV E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-41
Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 35/250 (14%)
Query: 401 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 454
+G+G FGSV + L +AVK L + EF+ E + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 455 KLYGCCVEG------NQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGI 505
KL G + +++ +MK+ L A + + L L T + + I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL--QTLVRFMVDI 146
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHISTRIAG 562
A G+ YL S +HRD+ N +L +D+ ++DFGL+ K+Y D + ++++
Sbjct: 147 ACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP- 202
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQ 619
+ ++A E T +DV++FGV EI++ G+ T Y N + L L+
Sbjct: 203 -VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ--TPYAGIENAEIYNYLIGGNRLK 259
Query: 620 E-----EEIY 624
+ EE+Y
Sbjct: 260 QPPECMEEVY 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 401 NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
VG G FG V G L +A+K L + + R+F+ E ++ HPN+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
L G + +++V EYM+N L F + + + + + GIA G+ YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTV--IQLVGMLRGIASGMKYL--- 163
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAM 573
S + VHRD+ N+L++ +L K+SDFGL ++ E+D T G I + +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
TS +DV+S+G+V E++S
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 9/219 (4%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV+LY
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
E + +V EYM L + G+ L P + IA G+AY+ R+
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYV---ERMNY 301
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
VHRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+ G T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 581 ADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 618
+DV+SFG++ E+ + G+ N + + ++ Y +
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 400
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 68/249 (27%), Positives = 116/249 (46%), Gaps = 34/249 (13%)
Query: 401 NKVGEGGFGSVYKGILSDG----TVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLV 454
+GEG FGSV +G L +AVK + + S++ EF++E + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 455 KLYGCCVEGN-----QLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIA 506
+L G C+E + + +++ +MK L + + L T K + IA
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVDIA 157
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED--KTHISTRIAGT 563
G+ YL S +HRD+ N +L D+ ++DFGL+K +Y D + ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-- 212
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY--RPNEDFVYLLDWAYVLQE 620
+ ++A E TSK+DV++FGV EI + G T Y N + L + L++
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM--TPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 621 -----EEIY 624
+E+Y
Sbjct: 271 PEDCLDELY 279
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-40
Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 15/222 (6%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+G+G FG V+ G + T +A+K L + F+ E ++ +H LV+LY
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
E + +V EYM L D E L P + IA G+AY+ R
Sbjct: 332 SE-EPIYIVTEYMSKGSL------LDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ER 381
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL 577
+ VHRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+ G
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 578 TSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 618
T K+DV+SFG++ E+ + G+ N + + ++ Y +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 401 NKVGEGGFGSVYKGILSD--------GTVIAVKQLSSK-SRQGNREFVNEIG-MISAQQH 450
+GEG FG V +AVK L + + + V+E+ M +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRK-------- 499
N++ L G C + L ++ EY L RA EY ++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 556
+ARG+ YL + K +HRD+ NVL+ ++ KI+DFGLA + D K
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ R+ + +MAPE T ++DV+SFGV+ EI +
Sbjct: 264 NGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 401 NKVGEGGFGSVYKGILSDG-----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLV 454
+G G FG+VYKG+ +A+K+L + S + N+E ++E ++++ +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+L G C+ + + L+ + M CL + E++ + C+ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYAM 573
++VHRD+ NVL+ + KI+DFGLAKL ++ I +MA E +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
T ++DV+S+GV E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
+G+G FG V G V AVK + K+ + F+ E +++ +H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV-AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 461 VEGN-QLLLVYEYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
VE L +V EYM L D + R L K + + + YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSL------VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---E 306
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 576
VHRD+ NVL+ +D AK+SDFGL K E T + ++ + + APE
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKK 362
Query: 577 LTSKADVYSFGVVTLEIVS 595
++K+DV+SFG++ EI S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 25/217 (11%)
Query: 401 NKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNR-EFVNEIG-MISAQQHPN 452
+G G FG V + +AVK L + R ++E+ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 499
+V L G C G L++ EY L R F ++
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTHIST 558
+A+G+A+L + +HRD+ N+LL KI DFGLA + + +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ +MAPE T ++DV+S+G+ E+ S
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL------SSKSRQGNREFVNEIGMISA 447
NF K+G G F VY+ L DG +A+K++ +K+R + + EI ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQ 88
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGI 505
HPN++K Y +E N+L +V E LSR I F K + T K + +
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTVWKYFVQL 145
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
L ++H +++HRDIK +NV + K+ D GL + + T + + GT
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 566 YMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK 597
YM+PE GY K+D++S G + E+ + +
Sbjct: 202 YMSPERIHENGY-NFKSDIWSLGCLLYEMAALQ 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 57/211 (27%), Positives = 83/211 (39%), Gaps = 23/211 (10%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-QH 450
+F +++G G +G V+K DG + AVK+ S +G ++ + E+G QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNC---LSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
P V+L EG L L E C L + + L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL----CGPSLQQHC----EAWGASLPEAQVWGYLRDTLL 168
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
LA+LH +VH D+K +N+ L K+ DFGL G YM
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYM 223
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
APE Y + ADV+S G+ LE+
Sbjct: 224 APELLQGSY-GTAADVFSLGLTILEVACNME 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 402 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
G E N + ++ E L F + +Y L L + ++ LAYL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDL--ASLILYAYQLSTALAYL---E 133
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 576
+ VHRDI NVL+ + K+ DFGL++ E+ + +++ I +MAPE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 577 LTSKADVYSFGVVTLEIVS 595
TS +DV+ FGV EI+
Sbjct: 194 FTSASDVWMFGVCMWEILM 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-40
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 402 KVGEGGFGSVYKGIL----SDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+GEG FG VY+G+ + +AVK + +F++E ++ HP++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
G E ++ E L + + + LK+ T + I + +AYL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGH--YLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT---IGYMAPEYAM 573
I VHRDI N+L+ K+ DFGL++ E++ + + T I +M+PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESIN 187
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
T+ +DV+ F V EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-40
Identities = 63/209 (30%), Positives = 85/209 (40%), Gaps = 18/209 (8%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNL 453
+G G FG VY+G +S +AVK L S Q +F+ E +IS H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
V+ G ++ ++ E M L R L + IA G
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK-LYEEDKTHISTRIAGTIGY 566
YL +HRDI N LL AKI DFG+A+ +Y + +
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
M PE M G TSK D +SFGV+ EI S
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-40
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 30/243 (12%)
Query: 401 NKVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVK 455
+G G FG VY G L D AVK L +F+ E ++ HPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 456 LYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----RLKLDWPTRKKICIGIARGLA 510
L G C+ L+V YMK+ L + + +A+G+
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLR--------NFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIAGT--IGYM 567
+L + K VHRD+ N +LD+ K++DFGLA+ +Y+++ + + + +M
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQE-----E 621
A E T+K+DV+SFGV+ E+++ G D L L + +
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 323
Query: 622 EIY 624
+Y
Sbjct: 324 PLY 326
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 29/211 (13%)
Query: 402 KVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
+G+G F ++KG+ T + +K L R + F M+S H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
V YG CV G++ +LV E++K L + K + + + + ++ +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINI--LWKLEVAKQLAAAMHFL- 129
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLN--------AKISDFGLAKLYEEDKTHISTRIAGTIG 565
++H ++ N+LL ++ + K+SD G++ + I
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--IP 182
Query: 566 YMAPE-YAMRGYLTSKADVYSFGVVTLEIVS 595
++ PE L D +SFG EI S
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 451
+ K+GEG FG DG +K+ +S S + E E+ +++ +HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
N+V+ E L +V +Y + L + I + + I L +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKH 140
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 570
+H+ KI+HRDIK+ N+ L KD ++ DFG+A++ I GT Y++PE
Sbjct: 141 VHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI 196
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ Y +K+D+++ G V E+ + K
Sbjct: 197 CENKPY-NNKSDIWALGCVLYELCTLK 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 402 KVGEGGFGSVYKGIL---SDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
++G G FG+V KG +AVK L + E + E ++ +P +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RLKLDWPTRKKICIGIARGLAYLH 513
G C E +LV E + L+ +Y + ++ ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLN--------KYLQQNRHVKDKNIIELVHQVSMGMKYL- 133
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEY 571
VHRD+ NVLL AKISDFGL+K D+ + + G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 572 AMRGYLTSKADVYSFGVVTLEIVS 595
+SK+DV+SFGV+ E S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 55/222 (24%), Positives = 82/222 (36%), Gaps = 30/222 (13%)
Query: 401 NKVGEGGFGSVYKGILSDG------TVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 452
+G G FG V +AVK L ++E+ M H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRK------- 499
+V L G C + L++EY L R F +D +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 500 -----KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDK 553
+A+G+ +L VHRD+ NVL+ KI DFGLA + +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ + +MAPE G T K+DV+S+G++ EI S
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 17/203 (8%)
Query: 402 KVGEGGFGSVYKGIL----SDGTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLV 454
K+G+G FG V +G +AVK L + +F+ E+ + + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+LYG + + +V E L + + L T + + +A G+ YL
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLD--RLRKHQGHFLL--GTLSRYAVQVAEGMGYL-- 137
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYA 572
+ +HRD+ N+LL KI DFGL + ++ H + + APE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 573 MRGYLTSKADVYSFGVVTLEIVS 595
+ +D + FGV E+ +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 401 NKVGEGGFGSVYKGIL--------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQH 450
+GEG FG V + T +AVK L S + + + ++E+ M +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIG--- 504
N++ L G C + L ++ EY L +A EY +++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 505 -----IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEED--KTHI 556
+ARG+ YL + K +HRD+ NVL+ +D KI+DFGLA ++ D K
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ R+ + +MAPE T ++DV+SFGV+ EI +
Sbjct: 252 NGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+G G FG V+ + T +AVK + S F+ E ++ QH LVKL+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+ + ++ E+M L F K E K P IA G+A++ +
Sbjct: 253 TK-EPIYIITEFMAKGSLLD--FLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNY 305
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSK 580
+HRD++ +N+L+ L KI+DFGLA++ E+++ I + APE G T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 581 ADVYSFGVVTLEIVS 595
+DV+SFG++ +EIV+
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 59/218 (27%), Positives = 112/218 (51%), Gaps = 17/218 (7%)
Query: 387 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 439
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQIA 119
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
+C + L +LH + I HRDIK+ N+LL D + K++DFG +++ ST
Sbjct: 120 AVCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ GT +MAPE R K D++S G++ +E++ G+
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-39
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 402 KVGEGGFGSVYKGILSDG---TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKLY 457
++G G FGSV +G+ +A+K L + E + E ++ +P +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
G C + L+LV E L + + R ++ ++ ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT--IGYMAPEYAMRG 575
VHR++ NVLL AKISDFGL+K D ++ + R AG + + APE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 576 YLTSKADVYSFGVVTLEIVS 595
+S++DV+S+GV E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 4e-39
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
+VG G FG V++ G AVK++ + + V E+ + P +V LYG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 460 CVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
EG + + E ++ + + G E GL YLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQ--MGCLPE-------DRALYYLGQALEGLEYLHTR 169
Query: 516 SRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTR----IAGTIGYMAPE 570
+I+H D+K NVLL D A + DFG A + D S I GT +MAPE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 571 YAM-RGYLTSKADVYSFGVVTLEIVSGK 597
M + +K D++S + L +++G
Sbjct: 227 VVMGKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 17/218 (7%)
Query: 387 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 439
++ + DP K+GEG G V G +AVK + + +Q
Sbjct: 31 KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
NE+ ++ QH N+V++Y + G +L ++ E+++ L+ D +++L+
Sbjct: 91 NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT------DIVSQVRLNEEQIA 144
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
+C + + LAYLH I HRDIK+ ++LL D K+SDFG +D +
Sbjct: 145 TVCEAVLQALAYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ GT +MAPE R ++ D++S G++ +E+V G+
Sbjct: 202 V-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-38
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 402 KVGEGGFGSVYKGILSDG----TVIAVKQL-SSKSRQGNREFVNEIGMISAQQHPNLVKL 456
+GEG FG V++GI +A+K + S +F+ E + HP++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
G E N + ++ E L F + ++ L L + ++ LAYL
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRS--FLQVRKFSLDL--ASLILYAYQLSTALAYL---E 508
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY 576
+ VHRDI NVL+ + K+ DFGL++ E+ + +++ I +MAPE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 577 LTSKADVYSFGVVTLEIVS 595
TS +DV+ FGV EI+
Sbjct: 569 FTSASDVWMFGVCMWEILM 587
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 1e-37
Identities = 36/207 (17%), Positives = 63/207 (30%), Gaps = 40/207 (19%)
Query: 128 ADQYHYTLHINCGGAKIN-TGHTKYEADMEARGASMFYSSGQYWAFSSTGKFMDDDTDLD 186
AD+ + +N GG Y D + G+ + + + +
Sbjct: 3 ADKVIW--AVNAGGESHVDVHGIHYRKD------PLEGRVGRASDYGMKLPILRSNPE-- 52
Query: 187 NYIRTNTSTLSKVSAVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTF 246
D LY+T R + S Y G Y + L FAE F
Sbjct: 53 ----------------DQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAE------VYF 90
Query: 247 NSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTSHTLKIHL---YWAGRG 303
+++FD+ + V KD +I D G + P + L + + G+
Sbjct: 91 AQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKL 149
Query: 304 TTGIPLRGTYGPLISAISVKSNFKPPV 330
+ P + A+ + K
Sbjct: 150 SVEFVKGYYDNPKVCALFI---MKGTA 173
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHP 451
+++ +G G +G K SDG ++ K+ S + + V+E+ ++ +HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 452 NLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
N+V+ Y ++ L +V EY + L+ I K T+ R LD ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 510 AYLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
H D ++HRD+K +NV LD N K+ DFGLA++ D + T + GT YM
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 568 APE-YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+PE Y K+D++S G + E+ +
Sbjct: 184 SPEQMNRMSY-NEKSDIWSLGCLLYELCALM 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 35/229 (15%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ-Q 449
T F K+G G FGSV+K + DG + A+K+ + + E+ + Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
H ++V+ + E + +L+ EY L+ AI K + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGL 128
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKD-------------------LNAKISDFGLAKLYE 550
Y+H +VH DIK SN+ + + + KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 551 EDKTHISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
+ G ++A E +L KAD+++ + + +
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 387 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 439
L+++ + P K+GEG +GSVYK I G ++A+KQ+ +S +E +
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEII 72
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
EI ++ P++VK YG + L +V EY +S I + L D
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT- 129
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
I +GL YLH +I HRDIK N+LL+ + +AK++DFG+A + +T
Sbjct: 130 -ILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
I GT +MAPE AD++S G+ +E+ GK
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-37
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
+F +G GGFG V+K DG +K++ + N + E+ ++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 454 VKLYGCCVE----------------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
V GC L + E+ L + I + E LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVL 123
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
++ I +G+ Y+H K+++RD+K SN+ L KI DFGL + D
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 558 TRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGKS 598
TR GT+ YM+PE + + Y + D+Y+ G++ E++
Sbjct: 179 TRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCD 219
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 27/235 (11%)
Query: 373 KELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR 432
E D +T + + +I F P + +G G G++ + D +AVK++ +
Sbjct: 7 LEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 433 QGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL 491
E+ + + +HPN+++ + + + E L + KD +
Sbjct: 62 SFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT-LQEYVEQKDFAHLG 117
Query: 492 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----DKDLNAKISDFGLA 546
+ GLA+LH + IVHRD+K N+L+ + A ISDFGL
Sbjct: 118 LE----PITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 547 KLYEEDKTHISTR--IAGTIGYMAPEY---AMRGYLTSKADVYSFGVVTLEIVSG 596
K + S R + GT G++APE + T D++S G V ++S
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 387 LRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV 439
R+ + + DP ++G+G FG VYK G + A K + +KS + +++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
EI +++ HP +VKL G +L ++ E+ + + E L P +
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQ 120
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
+C + L +LH I HRD+K NVL+ + + +++DFG++ + +
Sbjct: 121 VVCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177
Query: 560 IAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGK 597
I GT +MAPE M Y KAD++S G+ +E+ +
Sbjct: 178 I-GTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIE 219
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 36/231 (15%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
++F+ +G+G FG V K D A+K++ + + ++E+ ++++ H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 453 LVKLYGCCVEGNQ-------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
+V+ Y +E L + EY +N L I L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS-- 557
++ I L+Y+H I+HRD+K N+ +D+ N KI DFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 558 -----------TRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSG 596
T GT Y+A E G+ K D+YS G++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMI-SAQQHP 451
+ ++G G +GSV K + G ++AVK++ S+ + ++ + ++ ++ + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
+V+ YG + E M + + + + KI + + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 570
L E+ KI+HRDIK SN+LLD+ N K+ DFG++ + + TR AG YMAPE
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPER 196
Query: 571 ----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ +GY ++DV+S G+ E+ +G+
Sbjct: 197 IDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 452
++++ +G G V +A+K+++ + Q + + + EI +S HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLS---RAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
+V Y V ++L LV + + + + I K LD T I + GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL-AKLYEE-DKTHISTR--IAGTIG 565
YLH++ +I HRD+K N+LL +D + +I+DFG+ A L D T R GT
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 566 YMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 597
+MAPE + GY KAD++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGY-DFKADIWSFGITAIELATGA 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLV 454
F K+G+G FG V+KGI V+A+K + + + E EI ++S P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAI-FGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
K YG ++ +L ++ EY+ + G E ++ I I +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYLH 136
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
+ +I HRDIK +NVLL + K++DFG+A + + +T + GT +MAPE
Sbjct: 137 SEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192
Query: 574 RGYLTSKADVYSFGVVTLEIVSGK 597
+ SKAD++S G+ +E+ G+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGE 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL-SSKSRQGNREFVNEIGMISAQ-QHP 451
++ +P ++G G +G V K + G ++AVK++ ++ + Q + + ++ + P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
V YG + + E M + L + + + + + KI + I + L +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE- 570
LH S++ ++HRD+K SNVL++ K+ DFG++ AG YMAPE
Sbjct: 125 LH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPER 180
Query: 571 ----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+GY + K+D++S G+ +E+ +
Sbjct: 181 INPELNQKGY-SVKSDIWSLGITMIELAILR 210
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 20/227 (8%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS 446
+ ++ K+GEGGF V L DG A+K++ +Q E E M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 447 AQQHPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 502
HPN+++L C+ ++ L+ + K L I + + L +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLL 140
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA- 561
+GI RGL +H HRD+K +N+LL + + D G +
Sbjct: 141 LGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 562 -------GTIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGKS 598
TI Y APE + + DV+S G V ++ G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 53/237 (22%), Positives = 97/237 (40%), Gaps = 26/237 (10%)
Query: 377 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQG 434
G+DL T + + + ++G GG V++ + + A+K L Q
Sbjct: 10 GVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 69
Query: 435 NREFVNEIGMISAQQHPNL--VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 492
+ NEI ++ Q + ++LY + + +V E N L+ + + +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKS 123
Query: 493 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552
+D RK + + +H+ IVH D+K +N L+ K+ DFG+A + D
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD 179
Query: 553 KTHISTR-IAGTIGYMAPE-----------YAMRGYLTSKADVYSFGVVTLEIVSGK 597
T + GT+ YM PE + ++ K+DV+S G + + GK
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 32/233 (13%)
Query: 381 QTGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ 433
+ G + DP ++G G FG+VY + + V+A+K++S +Q
Sbjct: 34 RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93
Query: 434 GNREF---VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC--LSRAIFGKDTE 488
N ++ + E+ + +HPN ++ GC + + LV EY + L E
Sbjct: 94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 153
Query: 489 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548
+ + G +GLAYLH + I HRD+K N+LL + K+ DFG A +
Sbjct: 154 VEIAA-------VTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 549 YEEDKTHISTRIAGTIGYMAPEYAMR----GYLTSKADVYSFGVVTLEIVSGK 597
+ + GT +MAPE + Y K DV+S G+ +E+ K
Sbjct: 204 MAPANSFV-----GTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERK 250
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-34
Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPN 452
++F+ +++G G G V+K G V+A K + + + + + E+ ++ P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLA 510
+V YG ++ + E+M L + + G+ E L K+ I + +GL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVSIAVIKGLT 145
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGYMA 568
YL E KI+HRD+K SN+L++ K+ DFG++ + + + GT YM+
Sbjct: 146 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMS 198
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
PE + + ++D++S G+ +E+ G+
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 456
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
Y + + +V E N L+ + + + +D RK + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 174
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPE----- 570
IVH D+K +N L+ K+ DFG+A + D T + G + YM PE
Sbjct: 175 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 571 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ ++ K+DV+S G + + GK
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQQHPNL--VKL 456
++G GG V++ + + A+K L Q + NEI ++ Q + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS 516
Y + + +V E N L+ + + + +D RK + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 127
Query: 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR-IAGTIGYMAPE----- 570
IVH D+K +N L+ K+ DFG+A + D T + GT+ YM PE
Sbjct: 128 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 571 ------YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ ++ K+DV+S G + + GK
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 52/225 (23%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 452
+F+P +G GGFG V++ D A+K++ +R+ RE + E+ ++ +HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 453 LVKLYGCCVEGNQ------------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 500
+V+ + +E N L + + + L + + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLH 122
Query: 501 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRI 560
I + IA + +LH ++HRD+K SN+ D K+ DFGL ++D+ +
Sbjct: 123 IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 561 A-----------GTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEI 593
GT YM+PE Y + K D++S G++ E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFEL 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 41/218 (18%), Positives = 84/218 (38%), Gaps = 21/218 (9%)
Query: 394 TNNFDPANKVGEG--GFGSVYKGI-LSDGTVIAVKQ--LSSKSRQGNREFVNEIGMISAQ 448
++ +G+G +V G + V++ L + S + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
HPN+V + N+L +V +M I T + ++ I G+ +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKA 140
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG-LAKLYEEDK-----THISTRIAG 562
L Y+H + HR +K S++L+ D +S + +
Sbjct: 141 LDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 563 TIGYMAPE---YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ +++PE ++GY +K+D+YS G+ E+ +G
Sbjct: 198 VLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 29/243 (11%)
Query: 367 GKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK 425
G + + G G ++ +A N+ + ++G G G V+K G VIAVK
Sbjct: 1 GSSGSSGKQTGYLTIGG----QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 426 QL-SSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLS---R 480
Q+ S +++ N+ + ++ ++ P +V+ +G + + + E M C +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKK 115
Query: 481 AIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540
+ G E L K+ + I + L YL E ++HRD+K SN+LLD+ K+
Sbjct: 116 RMQGPIPERILG-------KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKL 166
Query: 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPE------YAMRGYLTSKADVYSFGVVTLEIV 594
DFG++ R AG YMAPE Y +ADV+S G+ +E+
Sbjct: 167 CDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELA 223
Query: 595 SGK 597
+G+
Sbjct: 224 TGQ 226
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 33/228 (14%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNL 453
N +G G G+V G +AVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAY 511
++ Y L + E N L + E + IA G+A+
Sbjct: 72 IRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 512 LHEDSRIKIVHRDIKTSNVLLD-------------KDLNAKISDFGLAKLYEEDKTHIST 558
LH +KI+HRD+K N+L+ ++L ISDFGL K + ++ T
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 559 R---IAGTIGYMAPE-------YAMRGYLTSKADVYSFGVVTLEIVSG 596
+GT G+ APE + LT D++S G V I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 402 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 454
K+G GG +VY IL +A+K + + E + E+ S H N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+ E + LV EY++ LS I E L T I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH- 128
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
++IVHRDIK N+L+D + KI DFG+AK E + + GT+ Y +PE A
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
D+YS G+V E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLV 454
F+ VG G +G VYKG + G + A+K + E EI M+ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 455 KLYGC------CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
YG +QL LV E+ ++ I K+T+ L IC I RG
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGN-TLKEEWIAYICREILRG 141
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
L++LH+ K++HRDIK NVLL ++ K+ DFG++ + +T I GT +MA
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 197
Query: 569 PEYAMR------GYLTSKADVYSFGVVTLEIVSGK 597
PE Y K+D++S G+ +E+ G
Sbjct: 198 PEVIACDENPDATY-DFKSDLWSLGITAIEMAEGA 231
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 23/212 (10%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 459
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 460 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+L+ E+ L + ++ L + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE--- 130
Query: 518 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--- 570
IVHR+IK N++ D K++DFG A+ E+D + GT Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 571 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ + D++S GV +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 61/264 (23%), Positives = 96/264 (36%), Gaps = 37/264 (14%)
Query: 359 MRWKGCLGGKVSADK-ELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-L 416
M G LGG D+ + G ++ G LR + + EGGF VY+ +
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDV 50
Query: 417 SDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV-------EGNQLLL 468
G A+K+L S + NR + E+ M HPN+V+ G L
Sbjct: 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110
Query: 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 528
+ + L + K E R L T KI R + ++H + I+HRD+K
Sbjct: 111 LLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVE 167
Query: 529 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-----------GTIGYMAPE---YAMR 574
N+LL K+ DFG A + + T Y PE
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 575 GYLTSKADVYSFGVVTLEIVSGKS 598
+ K D+++ G + + +
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQH 251
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLY---- 457
G GGFG V + I G +A+KQ + NRE EI ++ HPN+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 458 --GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
+ LL EY + L + + + LK + + I+ L YLHE
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSALRYLHE- 139
Query: 516 SRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-Y 571
+I+HRD+K N++L + L KI D G AK ++ + + GT+ Y+APE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAPELL 195
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGK 597
+ Y T D +SFG + E ++G
Sbjct: 196 EQKKY-TVTVDYWSFGTLAFECITGF 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 23/212 (10%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLYGC 459
+G+G +V++G G + A+K ++ S + + E ++ H N+VKL+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 460 --CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
+L+ E+ L + Y L + + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRE--- 130
Query: 518 IKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE--- 570
IVHR+IK N++ D K++DFG A+ E+D + GT Y+ P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 571 -----YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ + D++S GV +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-30
Identities = 63/248 (25%), Positives = 97/248 (39%), Gaps = 23/248 (9%)
Query: 359 MRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LS 417
M L G++ + + + K+G G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 418 DGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474
A+K + K+ + E+ ++ HPN++KLY + LV E K
Sbjct: 61 THVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 475 NNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532
L I + E I + G+ YLH+ IVHRD+K N+LL
Sbjct: 120 GGELFDEIIHRMKFNEV-------DAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLL 169
Query: 533 ---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVV 589
+KD KI DFGL+ ++E K GT Y+APE + Y K DV+S GV+
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRKKY-DEKCDVWSIGVI 226
Query: 590 TLEIVSGK 597
+++G
Sbjct: 227 LFILLAGY 234
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ 449
+F+ +G+G FG+VY ++A+K L K+ ++ E+ + S +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
HPN+++LYG + ++ L+ EY + + + + K D +A L
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLS-KFDEQRTATYITELANAL 122
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
+Y H +++HRDIK N+LL KI+DFG + + + GT+ Y+ P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPP 176
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVSGK 597
E K D++S GV+ E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 82
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ + + +V E + L + R L P + I G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 134
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
+++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 579 SKADVYSFGVVTLEIVSGK 597
+ DV+S G + ++ GK
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 29/237 (12%), Positives = 65/237 (27%), Gaps = 51/237 (21%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------- 437
G+ + + G V R +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 438 ---FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEY---RL 491
F+ ++ Q ++++ + L + Y + + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 492 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551
L R ++ + + R LA LH +VH ++ +++LD+ ++ F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 552 DKTHISTRIAGTIGYMAPEY-----------AMRGYLTSKADVYSFGVVTLEIVSGK 597
+ + G+ PE R +T D ++ G+V I
Sbjct: 259 RVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 21/227 (9%), Positives = 46/227 (20%), Gaps = 40/227 (17%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKLYGC 459
G V+ + A+K + + E + + +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 460 C--------------------------VEGNQLLLVYEYMK-NNCLSRAIFGKDTEYRLK 492
LL+ + L + +R
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 493 LDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552
+ + R A L +VH N+ + D + D
Sbjct: 191 EGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT- 246
Query: 553 KTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGK 597
+ + Y E+ T + + G+ +
Sbjct: 247 ---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 402 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 454
+G GG V+ +AVK L + + F E +A HP +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 455 KLY--GCCVEGNQLLLVY---EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
+Y G E L Y EY+ L + + ++ + L
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQAL 129
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGTIGYM 567
+ H + I+HRD+K +N+++ K+ DFG+A+ + + + + GT Y+
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+PE A + +++DVYS G V E+++G+
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 20/204 (9%)
Query: 402 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNREFV----NEIGMISAQQHPNLV 454
VG GG G VY+ + ++A+K +S + + F E Q P++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
++ QL + + L+ + + L I I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVA--IVRQIGSALDAAHA 152
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAM 573
HRD+K N+L+ D A + DFG+A ++K T + + GT+ YMAPE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFS 208
Query: 574 RGYLTSKADVYSFGVVTLEIVSGK 597
+ T +AD+Y+ V E ++G
Sbjct: 209 ESHATYRADIYALTCVLYECLTGS 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
G+GGF ++ V A K + K Q + EI + + H ++V +G
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 108
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ + + +V E + L + R L P + I G YLH R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLH---RN 160
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
+++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 579 SKADVYSFGVVTLEIVSGK 597
+ DV+S G + ++ GK
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 24/229 (10%)
Query: 378 LDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR 436
L G++ ++ + +G+G FG V G AVK +S K + +
Sbjct: 9 LHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQK 67
Query: 437 EFV----NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYR 490
E+ ++ HPN++KLY + LV E L I + +E
Sbjct: 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD 127
Query: 491 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAK 547
+I + G+ Y+H+ KIVHRD+K N+LL KD N +I DFGL+
Sbjct: 128 A-------ARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG 596
+E K GT Y+APE Y K DV+S GV+ ++SG
Sbjct: 178 HFEASKKM--KDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSG 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 36/247 (14%), Positives = 72/247 (29%), Gaps = 31/247 (12%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNREFVNE 441
+ + + + +GEG F VY+ D +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 442 IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI 501
+ + +K Y + N +LV E L AI +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 502 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL-----------DKDLNAKISDFGLAKLYE 550
+ + + +H+ +I+H DIK N +L D + D G + +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 551 --EDKTHISTRIAGTIGYMAPE-YAMRGYLTSKADVYSFGVVTLEIVSGK------SNTN 601
T + + T G+ E + + + + D + ++ G
Sbjct: 235 LFPKGTIFTAKC-ETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 602 YRPNEDF 608
+P F
Sbjct: 293 CKPEGLF 299
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 52/244 (21%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 368 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 426
K + + + + + L K +DP + +G G V + + + G AVK
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 427 LSSKSRQGNREFV--------NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 477
+ + + + E + E + HP+++ L + + LV++ M+
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 478 LSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 533
L + +E ++ I + +++LH IVHRD+K N+LLD
Sbjct: 187 LFDYLTEKVALSE---------KETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 534 KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-------YAMRGYLTSKADVYSF 586
++ ++SDFG + E + + GT GY+APE GY + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWAC 291
Query: 587 GVVT 590
GV+
Sbjct: 292 GVIL 295
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 28/225 (12%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFV--------------- 439
N++ + +G F + D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 440 --NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL---SRAIFGKDTEYRLKLD 494
NE+ +I+ ++ + G +++ ++YEYM+N+ + F D Y +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 495 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554
K I + +Y+H + I HRD+K SN+L+DK+ K+SDFG ++ + K
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 555 HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGK 597
S GT +M PE+ Y +K D++S G+ +
Sbjct: 208 KGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-29
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQHPNLVKL 456
+G+G FG V K AVK ++ K+ N++ + E+ ++ HPN++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHE 514
+ + + +V E L I + +E+ +I + G+ Y+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHK 139
Query: 515 DSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
IVHRD+K N+LL +KD + KI DFGL+ ++++ GT Y+APE
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEV 194
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSG 596
Y K DV+S GV+ ++SG
Sbjct: 195 LRGTY-DEKCDVWSAGVILYILLSG 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 32/248 (12%)
Query: 368 KVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQ 426
+ +G+ + G+Y ++ ++ K+G G +G V + + A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 427 LS------------SKSRQGNREFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473
+ +K+ + E + NEI ++ + HPN++KL+ + LV E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 474 KNNCLSRAI--FGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVL 531
+ L I K E I I G+ YLH+ IVHRDIK N+L
Sbjct: 129 EGGELFEQIINRHKFDECDA-------ANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 532 L---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGV 588
L + LN KI DFGL+ + +D GT Y+APE + Y K DV+S GV
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLKKKY-NEKCDVWSCGV 235
Query: 589 VTLEIVSG 596
+ ++ G
Sbjct: 236 IMYILLCG 243
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 26/234 (11%), Positives = 62/234 (26%), Gaps = 42/234 (17%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------------------------ 437
+G+ + + G V R +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 438 ----FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC----LSRAIFGKDTEY 489
F+ ++ Q ++++ + L + Y + + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 490 RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549
+ L R ++ + + R LA LH +VH ++ +++LD+ ++ F
Sbjct: 206 K-SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 550 EEDKTHISTRIAGTIGYMAPE-----YAMRGYLTSKADVYSFGVVTLEIVSGKS 598
R A +T D ++ G+ I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 449
++ +G+G FG V K AVK ++ K+ N++ + E+ ++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIAR 507
HPN++KL+ + + +V E L I + +E+ +I +
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFS 132
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
G+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ ++++ GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVT 590
Y+APE Y K DV+S GV+
Sbjct: 188 YYIAPEVLRGTY-DEKCDVWSAGVIL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 459
K+G G FG V+ S G +K ++ Q E + EI ++ + HPN++K++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 460 CVEGNQLLLVYEYMKNNCL------SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ + + +V E + L ++A +E + ++ + LAY H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-------ELMKQMMNALAYFH 141
Query: 514 EDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
+VH+D+K N+L KI DFGLA+L++ D+ T AGT YMAPE
Sbjct: 142 S---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE 196
Query: 571 YAMRGYLTSKADVYSFGVVT 590
R T K D++S GVV
Sbjct: 197 VFKRDV-TFKCDIWSAGVVM 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 43/205 (20%), Positives = 77/205 (37%), Gaps = 27/205 (13%)
Query: 402 KVGEGGFGSVYKG---ILSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPNLVKLY 457
+ GG G +Y ++ V +K L + + E ++ HP++V+++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 458 GCCVEGNQLL-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
++ +V EY+ L R+ K L + I L+YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H I +V+ D+K N++L ++ K+ D G + GT G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGY-LYGTPGFQAPEIV 249
Query: 573 MRGYLTSKADVYSFGVVTLEIVSGK 597
R T D+Y+ G +
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDL 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNRE--FVNEIGMISAQQH 450
++FD +G+G FG+VY + ++A+K L S+ + E EI + S +H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
PN++++Y + ++ L+ E+ L + + ++ + D +A L
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHG-RFDEQRSATFMEELADALH 128
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
Y H K++HRDIK N+L+ KI+DFG + + T + GT+ Y+ PE
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE 182
Query: 571 YAM-RGYLTSKADVYSFGVVTLEIVSGK 597
+ + K D++ GV+ E + G
Sbjct: 183 MIEGKTH-DEKVDLWCAGVLCYEFLVGM 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
G+G F VY+ + G +A+K + K+ R NE+ + +HP++++LY
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELYN 78
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ N + LV E N ++R + K+ + R + I G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFS-ENEARHFM-HQIITGMLYLH---SH 131
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
I+HRD+ SN+LL +++N KI+DFGLA + T + GT Y++PE A R
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHG 190
Query: 579 SKADVYSFGVVTLEIVSGK 597
++DV+S G + ++ G+
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK--------QLSSKSRQGNREF 438
N++P +G G V + I AVK S++ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 439 V-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLD 494
E+ + HPN+++L LV++ MK L + +E
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE------ 123
Query: 495 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554
+KI + + LH+ + IVHRD+K N+LLD D+N K++DFG + + +
Sbjct: 124 -KETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 555 HISTRIAGTIGYMAPE-------YAMRGYLTSKADVYSFGVVT 590
+ GT Y+APE GY + D++S GV+
Sbjct: 180 L--REVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
T+ ++ +G G + + I + AVK + R E EI ++ QHPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPN 77
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARG 508
++ L +G + +V E MK L I + +E R+ + I +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---------REASAVLFTITKT 128
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRIAGTI 564
+ YLH +VHRD+K SN+L D+ N +I DFG AK + + T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTA 184
Query: 565 GYMAPE-YAMRGYLTSKADVYSFGVVT 590
++APE +GY + D++S GV+
Sbjct: 185 NFVAPEVLERQGY-DAACDIWSLGVLL 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 46/195 (23%), Positives = 77/195 (39%), Gaps = 19/195 (9%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
+G G +G V + A K++ + F EI ++ + HPN+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 461 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ + LV E L + E +I + +AY H+ +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVLSAVAYCHK---L 125
Query: 519 KIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
+ HRD+K N L D K+ DFGLA ++ K GT Y++P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEGL 183
Query: 576 YLTSKADVYSFGVVT 590
Y + D +S GV+
Sbjct: 184 Y-GPECDEWSAGVMM 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 51/253 (20%), Positives = 82/253 (32%), Gaps = 53/253 (20%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISA 447
+ +G+G +G V I + A+K ++ + + E+ ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--------- 498
HPN+ +LY + + LV E L + + K
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 499 --------------------------KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532
I I L YLH I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLF 201
Query: 533 DKDLNA--KISDFGLAKLYEEDKTHISTR---IAGTIGYMAPE---YAMRGYLTSKADVY 584
+ + K+ DFGL+K + + AGT ++APE Y K D +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAW 260
Query: 585 SFGVVTLEIVSGK 597
S GV+ ++ G
Sbjct: 261 SAGVLLHLLLMGA 273
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
+G G FG V+K + G +A K + ++ + E NEI +++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----GLA 510
+LY N ++LV EY+ L I + T I + G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL-------TELD-TILFMKQICEGIR 201
Query: 511 YLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
++H+ + I+H D+K N+L ++D KI DFGLA+ Y+ + GT ++A
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLA 256
Query: 569 PEYAMRGYLTSKADVYSFGVVT 590
PE +++ D++S GV+
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 25/198 (12%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPNLVKLYGC 459
+G G F V+ G + A+K + KS + NEI ++ +H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHED 515
LV + + L I G TE + + + + YLHE
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTE---------KDASLVIQQVLSAVKYLHE- 124
Query: 516 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
IVHRD+K N+L +++ I+DFGL+K+ + + GT GY+APE
Sbjct: 125 --NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVL 179
Query: 573 MRGYLTSKADVYSFGVVT 590
+ + D +S GV+T
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 391 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGM 444
+ + KVGEG +G VYK S G ++A+K + R E + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72
Query: 445 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 504
+ HPN+V L L LV+E+M+ + L + + E + L K
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQ 127
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
+ RG+A+ H+ +I+HRD+K N+L++ D K++DFGLA+ + + + T+
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TL 183
Query: 565 GYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y AP+ + Y TS D++S G + E+++GK
Sbjct: 184 WYRAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 28/205 (13%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGMISAQQHPN 452
+G G G V +A++ +S ++ EI ++ HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
++K+ + +V E M+ L + G +L T K + + YL
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYL 255
Query: 513 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
HE I+HRD+K NVLL ++D KI+DFG +K+ E + + GT Y+AP
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAP 310
Query: 570 E----YAMRGYLTSKADVYSFGVVT 590
E GY D +S GV+
Sbjct: 311 EVLVSVGTAGY-NRAVDCWSLGVIL 334
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 390 IKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG 443
+K+ ++ + +GEG F +VYK + ++A+K++ R ++ +N EI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 444 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 503
++ HPN++ L + + LV+++M+ + L I KD L L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII--KDN--SLVLTPSHIKAYML 119
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
+GL YLH+ I+HRD+K +N+LLD++ K++DFGLAK + + ++ T
Sbjct: 120 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-T 175
Query: 564 IGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y APE + R Y D+++ G + E++
Sbjct: 176 RWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 64/215 (29%), Positives = 114/215 (53%), Gaps = 19/215 (8%)
Query: 392 AATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMI 445
++++ F K+G G + +VYKG+ + G +A+K + + + E EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 446 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK-LDWPTRKKICIG 504
+H N+V+LY N+L LV+E+M N+ L + + + + L+ K
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
+ +GLA+ HE+ KI+HRD+K N+L++K K+ DFGLA+ + S+ + T+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 565 GYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y AP+ R Y TS D++S G + E+++GK
Sbjct: 173 WYRAPDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
+ F G+G FG+V G G +A+K++ R NRE + + ++ HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 453 LVKLYGCCVEGNQ-------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICI 503
+V+L + L +V EY+ + L R YR ++ P K
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCC---RNYYRRQVAPPPILIKVFLF 136
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHIS--- 557
+ R + LH S + HRDIK NVL+++ L K+ DFG AK + +++
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193
Query: 558 TRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+R Y APE + + Y T+ D++S G + E++ G+
Sbjct: 194 SRY-----YRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 3e-26
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 22/211 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISAQ 448
+ K+GEG +G VYK + G A+K K R E + EI ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
+H N+VKLY +L+LV+E++ + L + + L+ T K + + G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLNG 112
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
+AY H+ +++HRD+K N+L++++ KI+DFGLA+ + + I T+ Y A
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRA 168
Query: 569 PE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
P+ + Y T+ D++S G + E+V+G
Sbjct: 169 PDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 33/211 (15%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----------SAQQHP 451
G+GGFG+V+ G L+D +A+K + ++R +++ + HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIAR 507
+++L +LV E +D + L + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLP--------AQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
+ + H +VHRDIK N+L+D AK+ DFG L ++ GT Y
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVY 204
Query: 567 MAPEY-AMRGYLTSKADVYSFGVVTLEIVSG 596
PE+ + Y A V+S G++ ++V G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR----G 508
L+ L+ + +++L+ E++ L I +D + + + I R G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-------SEAE-VINYMRQACEG 161
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGY 566
L ++HE IVH DIK N++ K + KI DFGLA D+ T +
Sbjct: 162 LKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEF 216
Query: 567 MAPEYAMRGYLTSKADVYSFGVVT 590
APE R + D+++ GV+
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--------SKSRQGNREFVNEIGM 444
+ + + +G G G V +A+K +S ++ EI +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 445 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 504
+ HP ++K+ + +V E M+ L + G +L T K
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQ 122
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIA 561
+ + YLHE I+HRD+K NVLL ++D KI+DFG +K+ E + T +
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT-LC 177
Query: 562 GTIGYMAPE----YAMRGYLTSKADVYSFGVVT 590
GT Y+APE GY D +S GV+
Sbjct: 178 GTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVIL 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 450
++N+D ++G+G F V + + + G A K ++ K + + + E + QH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRKKICIGIARG 508
PN+V+L+ E + LV++ + L I +E I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD-------ASHCIQQILES 117
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
+AY H IVHR++K N+LL K K++DFGLA + + AGT G
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPG 172
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVT 590
Y++PE + + D+++ GV+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 50/203 (24%), Positives = 77/203 (37%), Gaps = 14/203 (6%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFVNEIGMISAQQH 450
++ +G+G F V + I G AVK + +S + E + +H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
P++V+L L +V+E+M L I + I L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-VYSEAVASHYMRQILEALR 144
Query: 511 YLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
Y H+ I+HRD+K VLL + K+ FG+A E R+ GT +M
Sbjct: 145 YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 568 APEYAMRGYLTSKADVYSFGVVT 590
APE R DV+ GV+
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 25/198 (12%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGC 459
+GEG F K + AVK +S + + EI + + HPN+VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHED 515
+ LV E + L I K +E + I + ++++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSE---------TEASYIMRKLVSAVSHMHD- 124
Query: 516 SRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
+ +VHRD+K N+L + +L KI DFG A+L D + T T+ Y APE
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELL 181
Query: 573 MRGYLTSKADVYSFGVVT 590
+ D++S GV+
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 447
++ K+GEG +G V+K G ++A+K K + + EI M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
+HPNLV L +L LV+EY + + + Y+ + K I +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL----DRYQRGVPEHLVKSITWQTLQ 113
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
+ + H+ +HRD+K N+L+ K K+ DFG A+L + +A T Y
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169
Query: 568 APE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+PE Y DV++ G V E++SG
Sbjct: 170 SPELLVGDTQYGPP-VDVWAIGCVFAELLSGV 200
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 62/228 (27%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLS----SKSRQGNREFVNEIGMISAQQ--------- 449
G+G +G V +D T A+K LS + R +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 450 -------------HPNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLK 492
HPN+VKL V + L +V+E + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV-------------- 125
Query: 493 LDWPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544
++ PT K + AR G+ YLH KI+HRDIK SN+L+ +D + KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 545 LAKLYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYSFGVV 589
++ ++ +S GT +MAPE + + DV++ GV
Sbjct: 183 VSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 451
+++D ++G G FG V++ + G A K + + ++E V EI +S +HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHP 214
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 507
LV L+ + N+++++YE+M L + + + + + + R
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-------SEDE-AVEYMRQVCK 266
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA-KISDFGLAKLYEEDKTHISTRIAGTIG 565
GL ++HE VH D+K N++ K N K+ DFGL + ++ GT
Sbjct: 267 GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAE 321
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
+ APE A + D++S GV++ ++SG S
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 26/221 (11%)
Query: 383 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNR 436
G+ T +Q + + +D ++G G F V K S G A K Q + R R
Sbjct: 1 GMETFKQ-QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR 59
Query: 437 EFV-NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKL 493
E + E+ ++ HPN++ L+ ++L+ E + L + K+ +E
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-- 117
Query: 494 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLY 549
I G+ YLH KI H D+K N++L + K+ DFGLA
Sbjct: 118 -----TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590
E+ I GT ++APE L +AD++S GV+T
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 446
++++ ++G G F V K G A K +LSS R +RE + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKLDWPTRKKI 501
+HPN++ L+ ++L+ E + + + TE +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TE-------DEATQF 113
Query: 502 CIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLAKLYEEDKTHIS 557
I G+ YLH +I H D+K N++L + K+ DFG+A E
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590
I GT ++APE L +AD++S GV+T
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 34/231 (14%)
Query: 377 GLDLQTGLYTLRQIKAATNNFDPANKV-GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQ 433
G+DL T + ++ N + +K G G F V + I S G A K L + Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 434 GNREFV-NEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKD 486
R + +EI + A+ P ++ L+ ++++L+ EY + CL
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMV 128
Query: 487 TEYRLKLDWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAK 539
+E I + + G+ YLH+ IVH D+K N+LL + K
Sbjct: 129 SE-----------NDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 540 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590
I DFG+++ I GT Y+APE +T+ D+++ G++
Sbjct: 175 IVDFGMSRKIGHACEL--REIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 39/205 (19%), Positives = 81/205 (39%), Gaps = 23/205 (11%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHP 451
+ A +G G FG V++ + S K + K ++ V EI +++ +H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHR 61
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR---- 507
N++ L+ +L++++E++ + I E ++ +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL-------NERE-IVSYVHQVCE 113
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
L +LH + I H DI+ N++ + KI +FG A+ + +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVT 590
Y APE +++ D++S G +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 447
++ VGEG +G V K G ++A+K K + + + V EI ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
+H NLV L C + + LV+E++ + + + + LD+ +K I
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL----ELFPNGLDYQVVQKYLFQIIN 135
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
G+ + H I+HRDIK N+L+ + K+ DFG A+ +A T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191
Query: 568 APE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
APE Y + DV++ G + E+ G+
Sbjct: 192 APELLVGDVKYGKA-VDVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIGMISAQ 448
+ +K+GEG + +VYKG ++A+K + R + E E+ ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDL 57
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
+H N+V L+ L LV+EY+ + L + + + ++ K + RG
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYL----DDCGNIINMHNVKLFLFQLLRG 112
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
LAY H K++HRD+K N+L+++ K++DFGLA+ + T+ Y
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 569 PE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
P+ Y T D++ G + E+ +G+
Sbjct: 169 PDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 393 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-----EIG--- 443
AT+ ++P ++G G +G+VYK G +A+K + + G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 444 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 498
+ A +HPN+V+L C ++ LV+E++ + L + D L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122
Query: 499 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558
K + RGL +LH + IVHRD+K N+L+ K++DFGLA++Y T
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--T 177
Query: 559 RIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 597
+ T+ Y APE + Y T D++S G + E+ K
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV-NEIGMIS 446
+ +D ++G G F V K S G A K Q + R +RE + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIG 504
H N++ L+ ++L+ E + L + K+ +E
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-------TSFIKQ 123
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLL-DKDLNA---KISDFGLAKLYEEDKTHISTRI 560
I G+ YLH KI H D+K N++L DK++ K+ DFGLA E+ I
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNI 178
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590
GT ++APE L +AD++S GV+T
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 50/276 (18%), Positives = 92/276 (33%), Gaps = 65/276 (23%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFV-NEIGMISAQQHPN 452
+F+P +G GGFG V++ D A+K++ +R+ RE V E+ ++ +HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKI----------- 501
+V+ + +E E + + + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 502 -----------------CIG------IARGLAYLHEDSRI------------------KI 520
C + R + + + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-----------KTHISTRIAGTIGYMAP 569
+HRD+K SN+ D K+ DFGL ++D T GT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605
E + K D++S G++ E++ S R
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFV-NEIGMISAQQH 450
T + ++G+G F V + + + G A ++ K + + + E + +H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIA 506
PN+V+L+ E L+++ + L I +E I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE---------ADASHCIQQIL 120
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGT 563
+ + H+ + +VHR++K N+LL K K++DFGLA E ++ AGT
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGT 176
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVT 590
GY++PE + D+++ GV+
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 48/208 (23%), Positives = 76/208 (36%), Gaps = 34/208 (16%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPNLVKLYGCCV 461
GEG V I L AVK + + E+ + Q H N+++L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRK--KICIGIARGLAYLHEDSR 517
E ++ LV+E M+ + I + E + + +A L +LH
Sbjct: 82 EEDRFYLVFEKMRGGSILSHIHKRRHFNE---------LEASVVVQDVASALDFLHN--- 129
Query: 518 IKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTR------IAGTIGYMA 568
I HRD+K N+L ++ KI DF L + + G+ YMA
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 569 PE------YAMRGYLTSKADVYSFGVVT 590
PE Y + D++S GV+
Sbjct: 190 PEVVEAFSEEASIY-DKRCDLWSLGVIL 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 29/208 (13%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIGMISAQQHPNL 453
G G FG V+ + + VK + K + ++ EI ++S +H N+
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRKKICIGIARGL 509
+K+ LV E + G D + +LD P I + +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGS--------GLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
YL I+HRDIK N+++ +D K+ DFG A E K T GTI Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYCAP 198
Query: 570 E-YAMRGYLTSKADVYSFGVVTLEIVSG 596
E Y + +++S GV +V
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
+ +G G FG V++ L + +A+K++ R NR E+ ++ +HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 454 VKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIGI 505
V L L LV EY+ + RA +LK P K +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRAS---RHYAKLKQTMPMLLIKLYMYQL 150
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTRIA 561
R LAY+H I I HRDIK N+LLD K+ DFG AK+ + I +R
Sbjct: 151 LRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY- 206
Query: 562 GTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y APE + Y T+ D++S G V E++ G+
Sbjct: 207 ----YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVK-----QLSSKSRQGNREFV 439
T+ + + + +D ++G G F V K S G A K + S R +RE +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 440 -NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK-----NNCLSRAIFGKDTEYRLKL 493
E+ ++ QHPN++ L+ ++L+ E + + + TE
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TE----- 113
Query: 494 DWPTRKKICIGIAR----GLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGL 545
+ + G+ YLH ++I H D+K N++L KI DFGL
Sbjct: 114 ------EEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590
A + I GT ++APE L +AD++S GV+T
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 447
++ K+GEG +G+V+K ++A+K + R + E V EI ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
+H N+V+L+ +L LV+E+ + L + LD K + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF----DSCNGDLDPEIVKSFLFQLLK 112
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
GL + H ++HRD+K N+L++++ K+++FGLA+ + S + T+ Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYR 168
Query: 568 APE--YAMRGYLTSKADVYSFGVVTLEIVS 595
P+ + + Y TS D++S G + E+ +
Sbjct: 169 PPDVLFGAKLYSTS-IDMWSAGCIFAELAN 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 23/206 (11%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-------EIGMISAQQH--PNL 453
G GGFGSVY GI +SD +A+K + K R + + E+ ++ +
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
++L + +L+ E + + +F TE R L + + + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEP---VQDLFDFITE-RGALQEELARSFFWQVLEAVRHCH 166
Query: 514 EDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY- 571
++HRDIK N+L+D + K+ DFG L ++ GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWI 220
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGK 597
Y A V+S G++ ++V G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQ 449
++N+D ++G+G F V + + + G A K ++ + R+ E + Q
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 86
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGI 505
HPN+V+L+ E + LV++ + L I +E I
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---------ADASHCIQQI 137
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAG 562
+AY H IVHR++K N+LL K K++DFGLA + + AG
Sbjct: 138 LESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAG 192
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVT 590
T GY++PE + + D+++ GV+
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 24/197 (12%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
++G G VY+ A+K L + EIG++ HPN++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIF 117
Query: 461 VEGNQLLLVYEYMKNNCLSRAIF--GKDTEYRLKLDWPTRK--KICIGIARGLAYLHEDS 516
++ LV E + L I G +E R I +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE---------RDAADAVKQILEAVAYLHE-- 166
Query: 517 RIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
IVHRD+K N+L D KI+DFGL+K+ E + GT GY APE
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILR 223
Query: 574 RGYLTSKADVYSFGVVT 590
+ D++S G++T
Sbjct: 224 GCAYGPEVDMWSVGIIT 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNE-- 441
I N+F +G GGFG VY +D G + A+K L K +QG +NE
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 442 -IGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWP 496
+ ++S P +V + ++L + + M G D Y L
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN---------GGDLHYHLSQHGVFSEA 292
Query: 497 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI 556
+ I GL ++H +V+RD+K +N+LLD+ + +ISD GLA + + K H
Sbjct: 293 DMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH- 348
Query: 557 STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKS 598
GT GYMAPE + Y S AD +S G + +++ G S
Sbjct: 349 -AS-VGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHS 389
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLS-SKSRQGNREFVN-EIGMISAQQHPNLVKLYGCC 460
G+G F V + G +A+K + ++ + + + E+ ++ HPN+VKL+
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
L L+ EY + + ++ + I + Y H + +I
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH---QKRI 135
Query: 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYLTS 579
VHRD+K N+LLD D+N KI+DFG + + + G Y APE + + Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF-CGAPPYAAPELFQGKKYDGP 193
Query: 580 KADVYSFGVVTLEIVSGK 597
+ DV+S GV+ +VSG
Sbjct: 194 EVDVWSLGVILYTLVSGS 211
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 447
+ + K+GEG +G VYK I +A+K + R + E V E+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
QH N+++L ++L L++EY +N+ L + + + + K +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM-----DKNPDVSMRVIKSFLYQLIN 143
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-----KISDFGLAKLYEEDKTHISTRIAG 562
G+ + H + +HRD+K N+LL + KI DFGLA+ + + I
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 563 TIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
T+ Y PE R Y TS D++S + E++
Sbjct: 200 TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 66/219 (30%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
++ +G G FG VY+ L D G ++A+K++ R NRE + ++ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 453 LVKLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR--KKICIG 504
+V+L + L LV +Y+ + R R K P K
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVA---RHYSRAKQTLPVIYVKLYMYQ 164
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDK--TH-ISTRI 560
+ R LAY+H I HRDIK N+LLD D K+ DFG AK + I +R
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 561 AGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y APE + Y TS DV+S G V E++ G+
Sbjct: 222 -----YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 395 NNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGN----------REFVNEI 442
++ ++GEG +G V+K + + G +A+K + R RE V +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIRE-VAVL 65
Query: 443 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
+ +HPN+V+L+ C +L LV+E++ + L+ + D + T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPTET 121
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
K + + RGL +LH ++VHRD+K N+L+ K++DFGLA++Y
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 558 TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 597
T + T+ Y APE + Y T D++S G + E+ K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 20/194 (10%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 461
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 517
EGN L EY L I + ++ + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE-YAMRG 575
I I HRDIK N+LLD+ N KISDFGLA ++ ++ + ++ GT+ Y+APE R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 576 YLTSKADVYSFGVV 589
+ DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 35/202 (17%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 460
G G G V + G A+K L S + +E + A P++V +
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVYEN 93
Query: 461 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 512
LL++ E M+ L I + TE R+ +I I + +L
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE---------REAAEIMRDIGTAIQFL 144
Query: 513 HEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
H I HRD+K N+L +KD K++DFG AK ++ + T T Y+AP
Sbjct: 145 HS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAP 198
Query: 570 E-YAMRGYLTSKADVYSFGVVT 590
E Y D++S GV+
Sbjct: 199 EVLGPEKY-DKSCDMWSLGVIM 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 62/194 (31%), Positives = 88/194 (45%), Gaps = 20/194 (10%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN-EIGMISAQQHPNLVKLYGCCV 461
GEG +G V + +AVK + K E + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSR 517
EGN L EY L I + ++ + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEP-DAQRFFHQLMA-----GVVYLH---G 123
Query: 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE-EDKTHISTRIAGTIGYMAPE-YAMRG 575
I I HRDIK N+LLD+ N KISDFGLA ++ ++ + ++ GT+ Y+APE R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 576 YLTSKADVYSFGVV 589
+ DV+S G+V
Sbjct: 184 FHAEPVDVWSCGIV 197
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 402 KVGEGGFGSVYKGI---LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG 458
KVG G +G VYK D A+KQ+ + EI ++ +HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 459 CCVE--GNQLLLVYEYMKN---NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ ++ L+++Y ++ + + K + ++L K + I G+ YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNA----KISDFGLAKLY---EEDKTHISTRIAGTIGY 566
+ ++HRD+K +N+L+ + KI+D G A+L+ + + + T Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 567 MAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
APE + R Y T D+++ G + E+++ +
Sbjct: 202 RAPELLLGARHY-TKAIDIWAIGCIFAELLTSE 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 51/211 (24%), Positives = 76/211 (36%), Gaps = 31/211 (14%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----------QHP 451
GEG +G V + + AVK L ++ + I A +H
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 452 NLVKLYG--CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
N+++L E ++ +V EY + E R C + GL
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFP-VCQAHGYFC-QLIDGL 122
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMA 568
YLH IVH+DIK N+LL KIS G+A+ G+ +
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 569 PEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
PE A + K D++S GV I +G
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN-REFVN-----EIGMISA 447
+ ++ K+G+G FG V+K G +A+K K N +E EI ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQL 72
Query: 448 QQHPNLVKLYGCCVE--------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK 499
+H N+V L C + LV+++ +++ L+ + + +K K
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL----SNVLVKFTLSEIK 127
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
++ + GL Y+H + KI+HRD+K +NVL+ +D K++DFGLA+ + K R
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 560 IAG---TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
T+ Y PE + R Y D++ G + E+ +
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 55/201 (27%), Positives = 78/201 (38%), Gaps = 32/201 (15%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYG---- 458
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 126
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 512
LL+V E + L I + TE R+ +I I + YL
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 177
Query: 513 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
H I I HRD+K N+L K NA K++DFG AK + T T Y+AP
Sbjct: 178 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAP 232
Query: 570 EYAMRGYLTSKADVYSFGVVT 590
E D++S GV+
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 58/192 (30%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 458
G G FG V G G +AVK L+ + + + + V EI + +HP+++KLY
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+V EY+ L I +++ +++ I + Y H R
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH---RH 130
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 577
+VHRD+K NVLLD +NAKI+DFGL+ + + + + T G+ Y APE + R Y
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPEVISGRLYA 188
Query: 578 TSKADVYSFGVV 589
+ D++S GV+
Sbjct: 189 GPEVDIWSCGVI 200
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 450
+ F +G GGFG V+ + G + A K+L+ K R+G + + E +++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR--- 507
+V L L LV M G D Y + A
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMN---------GGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 508 -----GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAG 562
GL +LH+ I++RD+K NVLLD D N +ISD GLA + +T AG
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AG 351
Query: 563 TIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
T G+MAPE + D ++ GV E+++ +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 450
N F +G+GGFG V + G + A K+L K R+G +NE ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT-----RKKICIG- 504
+V L + L LV M G D ++ + R
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMN---------GGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
I GL LH + +IV+RD+K N+LLD + +ISD GLA E +T I R GT+
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGR-VGTV 349
Query: 565 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
GYMAPE Y T D ++ G + E+++G+S
Sbjct: 350 GYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQS 383
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 61/192 (31%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 458
G G FG V G G +AVK L+ + + + + V EI + +HP+++KLY
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+ + +V EY+ L I +LD +++ I G+ Y H R
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCH---RH 135
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 577
+VHRD+K NVLLD +NAKI+DFGL+ + + + + T G+ Y APE + R Y
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS-CGSPNYAAPEVISGRLYA 193
Query: 578 TSKADVYSFGVV 589
+ D++S GV+
Sbjct: 194 GPEVDIWSSGVI 205
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 52/194 (26%), Positives = 76/194 (39%), Gaps = 23/194 (11%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462
G G FG ++AVK + + + EI + +HPN+V+ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK----ICIGIARGLAYLHEDSRI 518
L ++ EY L I R D R + G++Y H +
Sbjct: 88 PTHLAIIMEYASGGELYERICNAG---RFSED-EARFFFQQLLS-----GVSYCH---SM 135
Query: 519 KIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRG 575
+I HRD+K N LLD KI DFG +K + + GT Y+APE +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAYIAPEVLLRQE 193
Query: 576 YLTSKADVYSFGVV 589
Y ADV+S GV
Sbjct: 194 YDGKIADVWSCGVT 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 395 NNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEIGMIS 446
++F+ +G+G FG V + A+K ++ K + R V E+ ++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQ 70
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRKKIC 502
+HP LV L+ + + +V + + L + E +KL + IC
Sbjct: 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKL-F-----IC 122
Query: 503 -IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA 561
+ +A L YL +I+HRD+K N+LLD+ + I+DF +A + + + +A
Sbjct: 123 ELVMA--LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MA 175
Query: 562 GTIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGKS 598
GT YMAPE GY + D +S GV E++ G+
Sbjct: 176 GTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN----EIGMISAQQHPNLVKLYG 458
GEG FG V +A+K +S + + EI + +HP+++KLY
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRI 518
+++V EY +F E + ++ ++ I + Y H R
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RH 127
Query: 519 KIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE-YAMRGYL 577
KIVHRD+K N+LLD +LN KI+DFGL+ + + + T G+ Y APE + Y
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS-CGSPNYAAPEVINGKLYA 185
Query: 578 TSKADVYSFGVVTLEIVSGK 597
+ DV+S G+V ++ G+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 5e-20
Identities = 66/301 (21%), Positives = 111/301 (36%), Gaps = 79/301 (26%)
Query: 401 NKVGEGGFGSVYKGIL------SDGTVIAVKQL-SSKSRQGNREFVNEIG-MISAQQHPN 452
+G G FG V + + +AVK L + +R ++E+ +I H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 453 LVKLYGCC-VEGNQLLLVYEYMKNNCLS--------------------------RAIFGK 485
+V L G C G L+++ E+ K LS
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 486 DTEYRLKLDWPTRKKICIGI--ARGLAYLHEDSRIKIVHRDIKTSNVLLD---------- 533
D + RL ++ G + L+ + E+ + +++D T L+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 534 ---------KDLNA-----------KISDFGLAKLYEEDKTHISTRIAGT-IGYMAPEYA 572
+DL A KI DFGLA+ +D ++ A + +MAPE
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267
Query: 573 MRGYLTSKADVYSFGVVTLEIVS-GKSNTNY---RPNEDFVYLLDWAYVLQE-----EEI 623
T ++DV+SFGV+ EI S G + Y + +E+F L ++ E+
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325
Query: 624 Y 624
Y
Sbjct: 326 Y 326
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 27/230 (11%)
Query: 380 LQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQ 433
LQ + K +F +GEG F +V + A+K L + ++
Sbjct: 15 LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKE 71
Query: 434 GNREFVN-EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTE 488
+V E ++S HP VKLY + +L Y KN + + G E
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDE 129
Query: 489 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548
+ I L YLH I+HRD+K N+LL++D++ +I+DFG AK+
Sbjct: 130 TCTRF-------YTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 549 YEEDKTHISTR-IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ GT Y++PE +D+++ G + ++V+G
Sbjct: 180 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 6e-19
Identities = 54/251 (21%), Positives = 92/251 (36%), Gaps = 64/251 (25%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
+ + +G G FG V + + G A+K++ R NRE + ++ H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 453 LVKLYGC--------------------------------------CVEGNQLLLVYEYMK 474
++KL + L ++ EY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 475 NNCLSRAIFGKDTEYRLKLDWPTR--KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532
+ L + + + R P + R + ++H + I HRDIK N+L+
Sbjct: 122 DT-LHKVL---KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 533 D-KDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAPE--YAMRGYLTSKADVYSF 586
+ KD K+ DFG AK + ++ +R Y APE Y T D++S
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-TPSIDLWSI 228
Query: 587 GVVTLEIVSGK 597
G V E++ GK
Sbjct: 229 GCVFGELILGK 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 48/237 (20%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFVN 440
++Q++ +F+ +G G FG V K V A+K L+ ++
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFR 122
Query: 441 -EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDW 495
E ++ + L+ + N L LV +Y LS+ E RL +
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF------EDRLPEEM 176
Query: 496 PTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547
AR + +H+ + VHRDIK N+L+D + + +++DFG
Sbjct: 177 ----------ARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 548 LYEEDKTHISTRIAGTIGYMAPE------YAMRGYLTSKADVYSFGVVTLEIVSGKS 598
ED T S+ GT Y++PE Y + D +S GV E++ G++
Sbjct: 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGET 279
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 443
+ VG G +GSV I G +A+K+LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 444 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
++ QH N++ L LV +M+ + L + + LK
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM-------GLKFSEEK 127
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH-I 556
+ + + +GL Y+H +VHRD+K N+ +++D KI DFGLA+ + + T +
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 184
Query: 557 STRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
TR Y APE + Y D++S G + E+++GK
Sbjct: 185 VTRW-----YRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 37/253 (14%)
Query: 366 GGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVY---KGILSD-GTV 421
GG +L+T T K NF+ +G G +G V+ K D G +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 422 IAVKQLSSKSRQGNREFV------NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475
A+K L + + ++ + +Q P LV L+ +L L+ +Y+
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTETKLHLILDYIN- 142
Query: 476 NCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IARGLAYLHEDSRIKIVHRDIKTS 528
G + R +I +G I L +LH+ + I++RDIK
Sbjct: 143 --------GGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHK---LGIIYRDIKLE 188
Query: 529 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE---YAMRGYLTSKADVYS 585
N+LLD + + ++DFGL+K + D+T + GTI YMAP+ G+ + D +S
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWS 247
Query: 586 FGVVTLEIVSGKS 598
GV+ E+++G S
Sbjct: 248 LGVLMYELLTGAS 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 36/220 (16%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 443
+ +G G G V + +A+K+LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 444 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
++ H N++ L E + +V E M N L + I +++LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI-------QMELDHER 128
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
+ + G+ +LH I+HRD+K SN+++ D KI DFGLA+ +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 183
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
T T Y APE + D++S G + E++ G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKSRQGNREFVN---------EI 442
+ + + G +G+V G+ S+G +A+K++ + + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 443 GMISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
+++ HPN++ L V ++L LV E M+ + L++ I D +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVI--HDQRIVISPQ--- 134
Query: 498 RKKICI-GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-- 554
+ + I GL LHE +VHRD+ N+LL + + I DF LA+ D
Sbjct: 135 HIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 555 -HISTRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+++ R Y APE +G+ T D++S G V E+ + K
Sbjct: 192 HYVTHRW-----YRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRK 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 84.5 bits (208), Expect = 7e-18
Identities = 45/236 (19%), Positives = 71/236 (30%), Gaps = 48/236 (20%)
Query: 381 QTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--------SSKSR 432
Q G T K+GEG FG V++ I D T +A+K + + +
Sbjct: 7 QKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 433 QGNREFVNEIGM---------ISAQQHPNLVKLYGC-CVEGN---QLLLVYEYMKNNCLS 479
+ E + EI + + + L CV+G+ LL +++ + S
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 480 ----RAIFGKDTEYRL----------------KLDWPTRKKICIGIARGLAYLHEDSRIK 519
F D + + T K I + LA ++
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLR 182
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
HRD+ NVLL K K+ K I Y G
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSS---TIPSCGLQVSIIDYTLSRLERDG 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 391 KAATNNFDPANKVGEGGFGSVY---KGILSD-GTVIAVKQLSSKSRQGNREFV----NEI 442
K F+ +G+GG+G V+ K ++ G + A+K L N + E
Sbjct: 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 443 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWP 496
++ +HP +V L G +L L+ EY+ G + E D
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLS---------GGELFMQLEREGIFMED-- 121
Query: 497 TRKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDK 553
+ I+ L +LH+ I++RD+K N++L+ + K++DFGL K +++
Sbjct: 122 -TACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 554 THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
TH T GTI YMAPE MR G+ D +S G + ++++G
Sbjct: 178 TH--T-FCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAP 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 391 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREF---VNEIG 443
+ N F+ +G+G FG V K G A+K L + E + E
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 444 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRK 499
++ +HP L L ++L V EY G + + L +
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYAN---------GGELFFHLSRERVFSEDRAR 251
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
I L YLH S +V+RD+K N++LDKD + KI+DFGL K +D + T
Sbjct: 252 FYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT- 308
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
GT Y+APE D + GVV E++ G+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)
Query: 391 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVN---EIG 443
KA + F+ +G+G FG V+ + A+K L K+ R+ V E
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERD 78
Query: 444 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPT 497
++ HP +VKL+ +L L+ ++++ G D E +
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLR---------GGDLFTRLSKEVMFTEE--- 126
Query: 498 RKKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKT 554
K + +A L +LH + I++RD+K N+LLD++ + K++DFGL+K + E K
Sbjct: 127 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 555 HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
+ + GT+ YMAPE R G+ T AD +SFGV+ E+++G
Sbjct: 184 Y--S-FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTL 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 36/220 (16%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 443
+ +G G G V +A+K+LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 444 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
++ H N++ L E + LV E M N L + I +++LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI-------QMELDHER 165
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
+ + G+ +LH S I+HRD+K SN+++ D KI DFGLA+ +
Sbjct: 166 MSYLLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 220
Query: 558 TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
T T Y APE + D++S G + E+V K
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 19/202 (9%), Positives = 48/202 (23%), Gaps = 46/202 (22%)
Query: 402 KVGEGGFGSVYKGILSD---GTVIAVKQL---SSKSRQGNREFVNEIGMISAQQHPNLVK 455
G ++ + D +A+ + +E ++ +S P + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
+ L+V E+++ L + +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAH-- 146
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG 575
R + S V + D + ++ M
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA----- 179
Query: 576 YLTSKADVYSFGVVTLEIVSGK 597
+ D+ G ++ +
Sbjct: 180 --NPQDDIRGIGASLYALLVNR 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 3/86 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L L +T + G IPD++ + L +D S+N L+G +P + L + GN++
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 62 TGPVPKYIFNSNKNV---DISLNNFT 84
+G +P + +K IS N T
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLT 187
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 3e-15
Identities = 18/86 (20%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 2 NLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
L L + + G IP I +T+L + ++ N++G IP ++ + + N
Sbjct: 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136
Query: 61 LTGPVPKYIFNSNK--NVDISLNNFT 84
L+G +P I + + N +
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRIS 162
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 17/86 (19%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
+NL + L++ ++ G+ G + I L+ N+L + N + L N+
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255
Query: 61 LTGPVPKYIFNSN--KNVDISLNNFT 84
+ G +P+ + ++++S NN
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-14
Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 2/83 (2%)
Query: 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62
++ +++ + G+IP ++ L +DLS N L G F T ++L N L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 63 GPVPKYIFNSN-KNVDISLNNFT 84
+ K + N +D+ N
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIY 257
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 2/82 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
N + + L K + ++ +G L +DL N + G +P +L + + ++ N L
Sbjct: 222 NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 62 TGPVPKY-IFNSNKNVDISLNN 82
G +P+ + N
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 9e-08
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 5/79 (6%)
Query: 11 CLIHGEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKLAKTNFMYLTG-NKLTGPVPK 67
G + D ++ N+DLS NL IP++ L NF+Y+ G N L GP+P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 68 YIFN-SN-KNVDISLNNFT 84
I + + I+ N +
Sbjct: 96 AIAKLTQLHYLYITHTNVS 114
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 42/223 (18%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 443
+ VG G +G+V + G +A+K+L R F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 444 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPT 497
++ +H N++ L + LV +M + L + + KL
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM------KHEKLGEDR 129
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-HI 556
+ + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + + T ++
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 557 STRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
TR Y APE Y T D++S G + E+++GK
Sbjct: 187 VTRW-----YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 391 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFV----NEI 442
A + FD +G G FG V K G A+K L K + + + NE
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILD-KQKVVKLKQIEHTLNEK 92
Query: 443 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTR 498
++ A P LVKL + + L +V EY+ + L R G+ +E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPH-------- 142
Query: 499 KKICIG-IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557
+ I YLH + +++RD+K N+L+D+ +++DFG AK + +T
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTW-- 196
Query: 558 TRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKS 598
T + GT +APE + +GY + D ++ GV+ E+ +G
Sbjct: 197 T-LCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYP 236
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-16
Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L L G+IP + + ++L ++ LSFN L+G IP++ L+K + L N L
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454
Query: 62 TGPVPKYIFNSNK--NVDISLNNFT 84
G +P+ + + + N+ T
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLT 479
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-16
Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+TLIL + GEIP + + T L I LS N LTG IP +L + L+ N
Sbjct: 467 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526
Query: 62 TGPVPKYIFNSNK--NVDISLNNFT 84
+G +P + + +D++ N F
Sbjct: 527 SGNIPAELGDCRSLIWLDLNTNLFN 551
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-15
Identities = 21/83 (25%), Positives = 41/83 (49%), Gaps = 1/83 (1%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL+ L ++ IP +GD + L+++D+S N L+G + + ++ N+
Sbjct: 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
GP+P S + + ++ N FT
Sbjct: 260 VGPIPPLPLKSLQYLSLAENKFT 282
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-14
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 2 NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT-NFMYLTGN 59
L++L L+ GE+P D + M LK +DLSFN +G +P + L+ + + L+ N
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 60 KLTGPVPKYIFNSNKN----VDISLNNFT 84
+GP+ + + KN + + N FT
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-14
Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L L ++ GEIP + + L+ + L FN+LTG IP+ N++ L+ N+L
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 62 TGPVPKYIFNSNK--NVDISLNNFT 84
TG +PK+I + +S N+F+
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFS 527
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-14
Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L +L L+ + G IP +G ++KL+++ L N L G IP + + L N L
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 62 TGPVPKYIFNSNK--NVDISLNNFT 84
TG +P + N + +S N T
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLT 503
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-14
Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
+L+ L L + GEIPD++ G L +DLS N+ G +P F + + L+ N
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFT 84
+G +P + +D+S N F+
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFS 356
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-13
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
LK L ++ I G++ + L+ +D+S NN + GIP + + ++GNKL
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 62 TGPVPKYIFN-SN-KNVDISLNNFT 84
+G + I + K ++IS N F
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFV 260
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-12
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 2/83 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL + L+ + GEIP +IG + L + LS N+ +G IP ++ L N
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
G +P +F + I+ N
Sbjct: 551 NGTIPAAMFKQSG--KIAANFIA 571
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-12
Identities = 23/90 (25%), Positives = 31/90 (34%), Gaps = 4/90 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL L L+ G IP +GD L +DL+ N G IP K + + N +
Sbjct: 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFI 570
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPI 91
G YI N + E
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-12
Identities = 22/88 (25%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGD--MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 58
+L TL L+ G I + L+ + L N TG IP T ++ ++L+
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 59 NKLTGPVPKYIFNSNK--NVDISLNNFT 84
N L+G +P + + +K ++ + LN
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 2/72 (2%)
Query: 15 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNS 72
G IP IG M L ++L N+++G IP L N + L+ NKL G +P+ +
Sbjct: 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705
Query: 73 NKNVDISLNNFT 84
+D+S NN +
Sbjct: 706 LTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 16/85 (18%), Positives = 33/85 (38%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+T + G + + +D+S+N L+G IP + + L N +
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 62 TGPVPKYIFNSNK--NVDISLNNFT 84
+G +P + + +D+S N
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLD 693
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 5/86 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE-KLAKTNFMYLTGNK 60
LK L ++ G IP + L+ + L+ N TG IP + L+GN
Sbjct: 248 ELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 61 LTGPVPKYIFN-SN-KNVDISLNNFT 84
G VP + + S +++ +S NNF+
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFS 331
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 4e-10
Identities = 20/91 (21%), Positives = 40/91 (43%), Gaps = 8/91 (8%)
Query: 2 NLKTLILTKCLIHGEIPDY--IGDMTKLKNIDLSFNNLTGGIPTT-FEKLAKTNFMYLTG 58
+L +L L++ + G + +G + LK +++S N L + KL + L+
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160
Query: 59 NKLTGPVPKYIFNSN-----KNVDISLNNFT 84
N ++G S+ K++ IS N +
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKIS 191
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-10
Identities = 23/54 (42%), Positives = 30/54 (55%)
Query: 13 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 66
I G IPD +GD+ L +DLS N L G IP L + L+ N L+GP+P
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 19/89 (21%), Positives = 40/89 (44%), Gaps = 8/89 (8%)
Query: 2 NLKTLILTKCLIHGEIPD-YIGDMTKLKNIDLSFNNLTGGIPTTFE---KLAKTNFMYLT 57
LK L ++ + + L+ +DLS N+++G + + + ++
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 58 GNKLTGPVPKYIFNSN--KNVDISLNNFT 84
GNK++G V + + +D+S NNF+
Sbjct: 187 GNKISGDVD--VSRCVNLEFLDVSSNNFS 213
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-09
Identities = 12/74 (16%), Positives = 31/74 (41%), Gaps = 2/74 (2%)
Query: 13 IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNS 72
G + + ++ +++ G TF+ F+ ++ N L+G +PK I +
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 655
Query: 73 N--KNVDISLNNFT 84
+++ N+ +
Sbjct: 656 PYLFILNLGHNDIS 669
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 16/83 (19%), Positives = 35/83 (42%), Gaps = 5/83 (6%)
Query: 15 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSN- 73
+ + +T L+++ LS +++ G + F+ A + L+ N L+GPV +
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSC 125
Query: 74 ---KNVDISLNNFTWESSDPIEC 93
K +++S N +
Sbjct: 126 SGLKFLNVSSNTLDFPGKVSGGL 148
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 15/84 (17%), Positives = 27/84 (32%), Gaps = 4/84 (4%)
Query: 5 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFN--NLTGGIPTTFEKLAKTNFMYLTGNKLT 62
+ + I G+ YI + K + N G +L+ N +T
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 63 GPVPKYIFNSNK--NVDISLNNFT 84
G N+ +D+S N +
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 19/48 (39%), Positives = 23/48 (47%), Gaps = 5/48 (10%)
Query: 15 GEIPDYIGDMTKLKNIDLSFNNLTGGIPTT--FEKLAKTNFMYLTGNK 60
G IP + +T L IDLS NNL+G IP FE F+ N
Sbjct: 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL---NNP 738
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVN---------EIG 443
+ + VG G +GSV + G +AVK+LS R F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 444 MISAQQHPNLVKLY------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWP 496
++ +H N++ L E N + LV M + L+ + + T+ ++
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQF--- 136
Query: 497 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-H 555
+ I RGL Y+H I+HRD+K SN+ +++D KI DFGLA+ ++ T +
Sbjct: 137 ----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 556 ISTRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
++TR Y APE Y D++S G + E+++G+
Sbjct: 190 VATRW-----YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-16
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 391 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-- 444
+ +F+ +G+G FG V KG + AVK L K + V +
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILK-KDVVIQDDDVECTMVEK 392
Query: 445 ---ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPT 497
+ P L +L+ C ++L V EY+ G D Y + + P
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPH 443
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTH 555
IA GL +L I++RD+K NV+LD + + KI+DFG+ K +++ T
Sbjct: 444 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT- 499
Query: 556 ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
T GT Y+APE Y D ++FGV+ E+++G++
Sbjct: 500 -KT-FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 540
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 60/219 (27%), Positives = 89/219 (40%), Gaps = 50/219 (22%)
Query: 403 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 454
+G+G FG V K + AVK L K+ +E + + ++ +HP LV
Sbjct: 46 IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 455 KLYGCCVEGNQLLLVYEYM----------KNNCLS--RAIFGKDTEYRLKLDWPTRKKIC 502
L+ ++L V +Y+ + C RA F Y
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-----Y------------A 145
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRI 560
IA L YLH + IV+RD+K N+LLD + ++DFGL K + T ST
Sbjct: 146 AEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-F 199
Query: 561 AGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
GT Y+APE + Y D + G V E++ G
Sbjct: 200 CGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLP 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 54/239 (22%), Positives = 89/239 (37%), Gaps = 50/239 (20%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 438
L++++ ++F+ +G G F V K G V A+K ++ K R F
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCF 108
Query: 439 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLD 494
E ++ + +L+ + N L LV EY LS+ R+ +
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF------GERIPAE 162
Query: 495 WPTRKKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546
AR + +H + VHRDIK N+LLD+ + +++DFG
Sbjct: 163 M----------ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209
Query: 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVY-------SFGVVTLEIVSGKS 598
D T S GT Y++PE Y + GV E+ G++
Sbjct: 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 41/232 (17%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNRE----F 438
+R ++ +++ +G G FG V K V A+K LS K R F
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLS-KFEMIKRSDSAFF 116
Query: 439 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 498
E +++ P +V+L+ + L +V EYM G D +
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP---------GGDLVNLMS-----N 162
Query: 499 KKICIGIAR--------GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550
+ AR L +H + +HRD+K N+LLDK + K++DFG
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 551 EDKTHISTRIAGTIGYMAPE----YAMRGYLTSKADVYSFGVVTLEIVSGKS 598
++ GT Y++PE GY + D +S GV E++ G +
Sbjct: 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 391 KAATNNFDPANKVGEGGFGSVY----KGILSDGTVIAVKQLSSKS--RQGNREFV-NEIG 443
K + +F +G G FG V+ + +G A+K L + R E +E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 444 MISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN----NCLSRAIFGKDTEYRLKLDWPTRK 499
M+S HP +++++G + Q+ ++ +Y++ + L ++ + K
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKF------ 110
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
+ L YLH I++RD+K N+LLDK+ + KI+DFG AK Y D T+ T
Sbjct: 111 -YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTY--T- 162
Query: 560 IAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSG 596
+ GT Y+APE Y S D +SFG++ E+++G
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAG 199
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 68/227 (29%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG 443
QIK +F +G+G FG V +K A+K L K + V
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALK-KDVVLMDDDVECTM 65
Query: 444 M-----ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLD 494
+ A +HP L ++ L V EY+ G D Y + K D
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN---------GGDLMYHIQSCHKFD 116
Query: 495 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEED 552
I GL +LH IV+RD+K N+LLDKD + KI+DFG+ K + +
Sbjct: 117 LSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173
Query: 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
KT +T GT Y+APE + Y D +SFGV+ E++ G+S
Sbjct: 174 KT--NT-FCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQS 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 63/223 (28%), Positives = 90/223 (40%), Gaps = 35/223 (15%)
Query: 391 KAATNNFDPANKVGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVN----EI 442
K N+FD +G+G FG V K G A+K L K ++ V E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILR-KEVIIAKDEVAHTVTES 56
Query: 443 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTR 498
++ +HP L L ++L V EY G + + L
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN---------GGELFFHLSRERVFTEERA 107
Query: 499 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHI 556
+ I L YLH +V+RDIK N++LDKD + KI+DFGL K + +
Sbjct: 108 RFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-- 162
Query: 557 STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
T GT Y+APE Y D + GVV E++ G+
Sbjct: 163 KT-FCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 50/201 (24%), Positives = 71/201 (35%), Gaps = 53/201 (26%)
Query: 404 GEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-- 460
G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYEN 82
Query: 461 --VEGNQLLLVYEYMKNNCLSRAIFGKD----TEYRLKLDWPTRK--KICIGIARGLAYL 512
LL+V E + L I + TE R+ +I I + YL
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYL 133
Query: 513 HEDSRIKIVHRDIKTSNVLL-DKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
H I I HRD+K N+L K NA K++DFG A
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------AK 168
Query: 570 EYAMRGYLTSKADVYSFGVVT 590
E Y D++S GV+
Sbjct: 169 ETTGEKY-DKSCDMWSLGVIM 188
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 50/235 (21%)
Query: 403 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 453
+G G + V K + A+K + K + E ++ + A HP L
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 506
V L+ C ++L V EY+ G D + +L + + I+
Sbjct: 73 VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 120
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 564
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T T GT
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FCGTP 174
Query: 565 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS--------NTNYRPNEDFVY 610
Y+APE Y D ++ GV+ E+++G+S + + ED+++
Sbjct: 175 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 403 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIG-----MISAQQHPNL 453
+G G + V K + A++ + K + E ++ + A HP L
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------TEYRLKLDWPTRKKICIG-IA 506
V L+ C ++L V EY+ G D + +L + + I+
Sbjct: 116 VGLHSCFQTESRLFFVIEYVN---------GGDLMFHMQRQRKLPEE---HARFYSAEIS 163
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTI 564
L YLHE I++RD+K NVLLD + + K++D+G+ K L D T GT
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTP 217
Query: 565 GYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKS--------NTNYRPNEDFVY 610
Y+APE Y D ++ GV+ E+++G+S + + ED+++
Sbjct: 218 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 403 VGEGGFGSVY----KGILSDGTVIAVKQLSSKSRQGNREFVNEIGM-----ISAQQHPNL 453
+G+G FG V K G + AVK L K + V A+ HP L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGL 509
+L+ C ++L V E++ G D + + + D + I L
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVN---------GGDLMFHIQKSRRFDEARARFYAAEIISAL 137
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYM 567
+LH+ I++RD+K NVLLD + + K++DFG+ K + T +T GT Y+
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT-FCGTPDYI 191
Query: 568 APEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
APE Y D ++ GV+ E++ G +
Sbjct: 192 APEILQEMLY-GPAVDWWAMGVLLYEMLCGHA 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 450
+ + +GEG +G V + +A+K++S R EI ++ +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 451 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 504
N++ + + + +V + M+ + L + + + + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICY-------FLYQ 136
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAG 562
I RGL Y+H + ++HRD+K SN+LL+ + KI DFGLA++ + D H T
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 563 TIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGK 597
T Y APE + +GY T D++S G + E++S +
Sbjct: 194 TRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 403 VGEGGFGSV----YKGILSDGTVIAVKQLSSKSRQGNREFVNEIG----MISAQQHPNLV 454
+G+G FG V KG + AVK L + + + + + P L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKICIGIARGLA 510
+L+ C ++L V EY+ G D Y + + P IA GL
Sbjct: 85 QLHSCFQTMDRLYFVMEYVN---------GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK--LYEEDKTHISTRIAGTIGYMA 568
+L I++RD+K NV+LD + + KI+DFG+ K +++ T T GT Y+A
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYIA 189
Query: 569 PEYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
PE Y D ++FGV+ E+++G++
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 394 TNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN 452
+ + +G GG G V+ + +D +A+K++ Q + + EI +I H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 453 LVKLY--------------GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPT 497
+VK++ G E N + +V EYM+ + L+ + E +L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHARL---- 124
Query: 498 RKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHI 556
+ RGL Y+H + ++HRD+K +N+ ++ +DL KI DFGLA++ + +H
Sbjct: 125 ---FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 557 S--TRIAGTIGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ T Y +P + Y T D+++ G + E+++GK
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSS-KSRQGNREFVNEIGMISA---- 447
+++ K+G G + V++ I +++ + VK L K ++ RE I
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87
Query: 448 QQHPNLVKLYGCCV---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 504
+ PN++ L V LV+E++ NN + ++ T+Y ++
Sbjct: 88 RGGPNIITLA-DIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIR-------FYMYE 138
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-KISDFGLAKLYEEDKTHISTRIAGT 563
I + L Y H S I+HRD+K NV++D + ++ D+GLA+ Y + + + R+A +
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-S 193
Query: 564 IGYMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ PE + Y S D++S G + ++ K
Sbjct: 194 RYFKGPELLVDYQMYDYS-LDMWSLGCMLASMIFRK 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 450
+++F + +GEG +G V G ++A+K++ K R EI ++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 451 PNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRKKICIG 504
N++ ++ N++ ++ E M+ + L R I + ++ ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVISTQMLSDDHIQY-------FIYQ 120
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
R + LH + ++HRD+K SN+L++ + + K+ DFGLA++ +E S
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 565 G---------YMAPE--YAMRGYLTSKADVYSFGVVTLEIVSGK 597
G Y APE Y + DV+S G + E+ +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 38/181 (20%), Positives = 79/181 (43%), Gaps = 31/181 (17%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 443
+ ++ + +G G +G V + + V+A+K++ R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 444 MISAQQHPNLVKLY-----GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 498
+++ H ++VK+ + ++L +V E ++ + T L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLF---RTPVYLTEL--HI 158
Query: 499 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558
K + + G+ Y+H I+HRD+K +N L+++D + K+ DFGLA+ + + S
Sbjct: 159 KTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 559 R 559
Sbjct: 216 L 216
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 443
+N+ + +G G +G VY + +A+K+++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 444 MISAQQHPNLVKLYGCCV-----EGNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWP 496
+++ + +++LY + + ++L +V E ++ L + TE +K
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPIFLTEEHIKT--- 133
Query: 497 TRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA-KLYEEDKTH 555
I + G ++HE I+HRD+K +N LL++D + K+ DFGLA + E T+
Sbjct: 134 ----ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 556 ISTRIAGTIGYMAPEYAMRGYLT 578
I + ++ LT
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLT 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 45/199 (22%), Positives = 83/199 (41%), Gaps = 32/199 (16%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVN---------EIG 443
++ K+G+G +G V+K I G V+AVK++ F N EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 444 MISA-QQHPNLVKLYGCCV--EGNQLLLVYEYMKNNCLSRAIFGKD-TEYRLKLDWPTRK 499
+++ H N+V L + LV++YM+ + L I +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPVHKQY------ 113
Query: 500 KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR 559
+ + + + YLH S ++HRD+K SN+LL+ + + K++DFGL++ + + +
Sbjct: 114 -VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 560 IAGTIGYMAPEYAMRGYLT 578
+ LT
Sbjct: 170 PLSINENTENFDDDQPILT 188
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNRE-----FVNEIGMI--SAQQH 450
K+G G F +V+ + + T +A+K + E VN+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 451 PNLVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
+++KL G +++V+E + N L+ K E+R + K+I +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHR-GIPLIYVKQISKQLL 141
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLD------KDLNAKISDFGLAKLYEEDKT-HISTR 559
GL Y+H R I+H DIK NVL++ + KI+D G A Y+E T I TR
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y +PE + AD++S + E+++G
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 48/192 (25%), Positives = 70/192 (36%), Gaps = 35/192 (18%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
NF K+G G FG + G L +A+K KSR +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGI 67
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA---- 506
++Y G +V E + G E D R K + IA
Sbjct: 68 PQVYYFGPCGKYNAMVLELL----------GPSLED--LFDLCDRTFSLKTVLMIAIQLI 115
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR 559
+ Y+H + +++RD+K N L+ + N I DF LAK Y + +T HI R
Sbjct: 116 SRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 560 ----IAGTIGYM 567
+ GT YM
Sbjct: 173 EHKSLTGTARYM 184
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 3/86 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L TLILT I ++ L+ + NL L + + N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 62 TG-PVPKYIFNSN--KNVDISLNNFT 84
+P+Y N +++D+S N
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 14/86 (16%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL L L++C + P ++ L+ +++S NN ++ L + + N +
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + + + ++++ N+F
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 14/85 (16%), Positives = 29/85 (34%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L L++C I ++ L + L+ N + F L+ + L
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 62 TGPVPKYIFNSN--KNVDISLNNFT 84
I + K ++++ N
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 16/93 (17%), Positives = 34/93 (36%), Gaps = 4/93 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ K L L+ + +L+ +DLS + ++ L+ + + LTGN +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 62 TGPVPKYIFNSNKN---VDISLNNFTWESSDPI 91
+ F+ + + N + PI
Sbjct: 89 QS-LALGAFSGLSSLQKLVAVETNLASLENFPI 120
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 18/129 (13%), Positives = 34/129 (26%), Gaps = 14/129 (10%)
Query: 2 NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
L+ L + + L +D+S + F L+ + + GN
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456
Query: 61 LTGPVPKYIFNSNKNV---DISLNNFTWESSDPIECPRGSVNLVE---SYSSPRNKLDKV 114
IF +N+ D+S S +L S+ N +
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF---NSLSSLQVLNMSH----NNFFSL 509
Query: 115 HPCLRQNFP 123
+
Sbjct: 510 DTFPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 2 NLKTLILT--KCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
+L+ L L+ G T LK +DLSFN + + + F L + + +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 406
Query: 60 KLTGPVPKYIFNSNKN---VDISLNNFT 84
L +F S +N +DIS +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 6/94 (6%)
Query: 2 NLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM----YL 56
LK L + LI ++P+Y ++T L+++DLS N + T L + + L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 57 TGNKLTGPVPKYIFNSN-KNVDISLNNFTWESSD 89
+ N + P + + N +
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 15/72 (20%), Positives = 29/72 (40%), Gaps = 6/72 (8%)
Query: 16 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 75
+IPD + KN+DLSFN L +F + + L+ ++ + S +
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-AYQSLSH 77
Query: 76 V---DISLNNFT 84
+ ++ N
Sbjct: 78 LSTLILTGNPIQ 89
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 45/182 (24%), Positives = 71/182 (39%), Gaps = 31/182 (17%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 459
K+G G FG +Y G ++ G +A+K K++ E + Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 514
EG+ ++V E + G E K T + + + Y+H
Sbjct: 74 GAEGDYNVMVMELL----------GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR----IAGTIG 565
+ +HRD+K N L+ I DFGLAK Y + +T HI R + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 566 YM 567
Y
Sbjct: 181 YA 182
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 27/132 (20%), Positives = 44/132 (33%), Gaps = 14/132 (10%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L L L + D+ +LK IDL NNL + F + L N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 62 TGPVPKYIFNSNKN---VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCL 118
T K + +N +D+ N F C + V + + P L
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFD------CTCESIA-WFVNWINETHTNI----PEL 645
Query: 119 RQNFPCSAPADQ 130
++ C+ P
Sbjct: 646 SSHYLCNTPPHY 657
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 6/88 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL L L I + L +DLS N L+ T +L + L+ NK+
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 62 TGPVPKYIFNSNKN-----VDISLNNFT 84
+ + N +++S N
Sbjct: 158 QA-LKSEELDIFANSSLKKLELSSNQIK 184
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 15/85 (17%), Positives = 25/85 (29%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
LK L L + T L + L N++ F K + L+ N L
Sbjct: 74 MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL 133
Query: 62 TGPVPKYIFNSN--KNVDISLNNFT 84
+ + + +S N
Sbjct: 134 SSTKLGTQVQLENLQELLLSNNKIQ 158
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 18/93 (19%), Positives = 37/93 (39%), Gaps = 4/93 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
N+ L LT + ++L ++D+ FN ++ P +KL + L N+L
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 62 TGPVPKYIFNSNKNV---DISLNNFTWESSDPI 91
+ + F N+ + N+ ++P
Sbjct: 86 SQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNK 60
L L LTK I D + L+ +DL N + + + L +YL+ NK
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFTWESSDP 90
+ + F + + + S P
Sbjct: 442 YLQ-LTRNSFALVPSLQRLMLRRVALKNVDSSP 473
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 17/95 (17%), Positives = 39/95 (41%), Gaps = 7/95 (7%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDM--TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
NL+ L+L+ I + + + LK ++LS N + P F + + ++L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 60 KLTGPVPKYIFNSNKN-----VDISLNNFTWESSD 89
+L + + + N + +S + + S+
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 12/94 (12%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT--------GGIPTTFEKLAKTNF 53
NL L L+ I D + + KL+ +DL NNL GG + L+ +
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 54 MYLTGNKLTGPVPKYIFNSNKNV---DISLNNFT 84
+ L N +P +F + D+ LNN
Sbjct: 541 LNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLN 573
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 15/100 (15%), Positives = 34/100 (34%), Gaps = 11/100 (11%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
NL L L+ ++ D + +L+ L +NN+ + L ++ L +
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 61 LTGP--------VPKYIFNSNKNV---DISLNNFTWESSD 89
+ + F K + ++ N+ S+
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 15/83 (18%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDM--TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
+++ L L+ + + T L +DLS+NNL +F L + + +L N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282
Query: 60 KLTGPVPKYIFNSNKNVDISLNN 82
+ + ++L
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKR 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 12/94 (12%)
Query: 2 NLKTLILTKCLIH--------GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNF 53
L+ L L + G ++ ++ L ++L N F+ L +
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 54 MYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 84
+ L N L +P +FN+ + +++ N T
Sbjct: 565 IDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLIT 597
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 17/92 (18%), Positives = 30/92 (32%), Gaps = 9/92 (9%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTF---EKLAKTNFMYLT 57
+LK L L+ I P + +L + L+ L + + L+
Sbjct: 171 SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLS 230
Query: 58 GNKLTGPVPKYIFNSNKNV-----DISLNNFT 84
++L+ F K D+S NN
Sbjct: 231 NSQLST-TSNTTFLGLKWTNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 15/114 (13%), Positives = 33/114 (28%), Gaps = 31/114 (27%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNI----------------------------DLS 33
L+ L + I G + + LK + +L+
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389
Query: 34 FNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 84
N ++ F L + L N++ + + +N + +S N +
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 23/130 (17%), Positives = 40/130 (30%), Gaps = 22/130 (16%)
Query: 2 NLKTLILTKCLIHG--EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
+L+ L+L + + P + L +DLS NN+ E L K + L N
Sbjct: 455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514
Query: 60 KLT-------GPVPKYIFNSNKNV---DISLNNFTWESSDPIECPRGSVNLVE---SYSS 106
L P Y ++ ++ N F + + L
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF---KDLFELKIIDLGL-- 569
Query: 107 PRNKLDKVHP 116
N L+ +
Sbjct: 570 --NNLNTLPA 577
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 9/89 (10%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ ++ + + L+++++ N++ G F L ++ L+ +
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 62 T-GPVPKYIFNSNKN-----VDISLNNFT 84
+ + F S + ++++ N +
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKIS 394
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 9/86 (10%), Positives = 33/86 (38%), Gaps = 7/86 (8%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ + + + ++PD + T + ++L+ N L F + ++ + + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + + +++ N +
Sbjct: 62 SK-LEPELCQKLPMLKVLNLQHNELS 86
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 31/182 (17%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGC 459
K+G G FG +Y G + +A+K + K++ + + + E + Q + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL-----KLDWPTRKKICIGIARGLAYLHE 514
VEG+ +LV + + G E KL T + + + ++H
Sbjct: 72 GVEGDYNVLVMDLL----------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAK---ISDFGLAKLYEEDKT--HISTR----IAGTIG 565
S +HRDIK N L+ A I DFGLAK Y + T HI R + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 566 YM 567
Y
Sbjct: 179 YA 180
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 27/203 (13%), Positives = 63/203 (31%), Gaps = 39/203 (19%)
Query: 395 NNFDPANKVGEGGFGSVYKGI---------LSDGTVIAVKQLSSKSRQGNREFVNEIGMI 445
+ + G +Y+ ++K L +K + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 446 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI----FGKDTEYRLKLDWPTRKK- 500
Q KLY + + + + R + G+ + LD +
Sbjct: 101 KPLQVNKWKKLYSTPLLA--IPTCMGFGVHQDKYRFLVLPSLGRSLQS--ALDVSPKHVL 156
Query: 501 -----ICIG---IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYE 550
+ + + L +LHE+ VH ++ N+ +D + +++ + +G A Y
Sbjct: 157 SERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 551 EDKTHISTR------IAGTIGYM 567
H++ G + ++
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFI 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 46/185 (24%), Positives = 72/185 (38%), Gaps = 35/185 (18%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
++GEG FG +++G L + +A+K +S + +Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFG 75
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK---KICIGIA----RGLAYLH 513
EG +LV + + G E LD RK K A + +H
Sbjct: 76 QEGLHNVLVIDLL----------GPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAK-----ISDFGLAKLYEEDKT--HISTR----IAG 562
E S +V+RDIK N L+ + + + DFG+ K Y + T HI R ++G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 563 TIGYM 567
T YM
Sbjct: 181 TARYM 185
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 37/198 (18%), Positives = 68/198 (34%), Gaps = 43/198 (21%)
Query: 402 KVGEGGFGSVYKGILSDGTVI------AVKQLSSKSRQ-----------GNREFVNEIGM 444
+G+GGFG +Y ++ + VK S + E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 445 ISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRK----- 499
++ + K +G + + FG D + + ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKN------GKSYRFMIMDRFGSDLQK--IYEANAKRFSRKT 153
Query: 500 --KICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKT- 554
++ + I L Y+HE VH DIK SN+LL+ ++ D+GLA Y +
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 555 -HISTR----IAGTIGYM 567
+ GTI +
Sbjct: 211 KAYAADPKRCHDGTIEFT 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHP---NLVK 455
+G+G FG V K +A+K + ++ R Q E + + + Q N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDNTMNVIH 163
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
+ N + + +E + N K +++ P +K I + L LH
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYE---LIKKNKFQ-GFSLPLVRKFAHSILQCLDALH-- 217
Query: 516 SRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDK--THISTRIAGTIGYMAPEY 571
+ +I+H D+K N+LL K+ DFG + YE + T+I +R Y APE
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-YEHQRVYTYIQSRF-----YRAPEV 270
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGK 597
+ D++S G + E+++G
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 15/87 (17%), Positives = 32/87 (36%), Gaps = 6/87 (6%)
Query: 2 NLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
++ + + L + + M KL ++ +N L G +P F K + L N+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQ 364
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFT 84
+T +P + + + N
Sbjct: 365 ITE-IPANFCGFTEQVENLSFAHNKLK 390
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L L + G++P G KL +++L++N +T + + NKL
Sbjct: 331 KLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389
Query: 62 TGPVPKYIFNSN----KNVDISLNNFT 84
+P + +D S N
Sbjct: 390 KY-IPNIFDAKSVSVMSAIDFSYNEIG 415
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 10/86 (11%), Positives = 22/86 (25%), Gaps = 9/86 (10%)
Query: 2 NLKTLILTKCL------IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 55
LK + E P+ I L + + N++ + + +
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNI---SVLD 593
Query: 56 LTGNKLTGPVPKYIFNSNKNVDISLN 81
+ N Y+ + L
Sbjct: 594 IKDNPNISIDLSYVCPYIEAGMYMLF 619
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 13/93 (13%), Positives = 23/93 (24%), Gaps = 8/93 (8%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLT 57
+ L L G +PD IG +T+L+ + L + P
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 58 GNKLTGPVPKYIFNSN----KNVDISLNNFTWE 86
Y + I+ +
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 16/100 (16%), Positives = 32/100 (32%), Gaps = 18/100 (18%)
Query: 2 NLKTLILTKCLIHG-------EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM 54
+ + + I + + +I+LS N ++ F + + +
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 55 YLTGNKLTGPVPKYIFNSN----------KNVDISLNNFT 84
L GN LT +PK ++D+ N T
Sbjct: 463 NLMGNMLTE-IPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 16/95 (16%), Positives = 38/95 (40%), Gaps = 14/95 (14%)
Query: 2 NLKTLILTKCLIHGEIPDY--IGDMTKLKNIDLSFNNLTG-------GIPTTFEKLAKTN 52
++ L + IP+ ++ + ID S+N + + T K +
Sbjct: 378 QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 53 FMYLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 84
+ L+ N+++ PK +F++ +++ N T
Sbjct: 437 SINLSNNQISK-FPKELFSTGSPLSSINLMGNMLT 470
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 15/94 (15%), Positives = 37/94 (39%), Gaps = 12/94 (12%)
Query: 2 NLKTLILTKCLIH--------GEIPDYIGDMTKLKNIDLSFNNLTGG-IPTTFEKLAKTN 52
++ + + + K++ I + +NNL + T+ +K+ K
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333
Query: 53 FMYLTGNKLTGPVPKYIFNSNK--NVDISLNNFT 84
+ N+L G +P + K +++++ N T
Sbjct: 334 MLECLYNQLEGKLPA-FGSEIKLASLNLAYNQIT 366
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 19/100 (19%), Positives = 32/100 (32%), Gaps = 19/100 (19%)
Query: 2 NLKTLILTKCLIHG-------EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE--KLAKTN 52
L ++ L ++ + + + L +IDL FN LT + F L
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLV 516
Query: 53 FMYLTGNKLTGPVPKYIFNSNK--------NVDISLNNFT 84
+ L+ N + P NS+ D N
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 8/93 (8%), Positives = 24/93 (25%), Gaps = 10/93 (10%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ + ++ L ++++ +PT + L + + + N+
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
Query: 62 TGPVPKYIFNSN----------KNVDISLNNFT 84
+ + I NN
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 12/93 (12%)
Query: 2 NLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIP------TTFEKLAKTNF 53
L ++ L + + D + L IDLS+N+ + P +T + N
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 54 MYLTGNKLTGPVPKYIFNSN--KNVDISLNNFT 84
GN+ P+ I + I N+
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 6/90 (6%), Positives = 24/90 (26%), Gaps = 21/90 (23%)
Query: 16 EIPDYIGDMTKLKNIDLSFNNLTGGIPTT-------------------FEKLAKTNFMYL 56
+ + +TKL+ + + ++ L + +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEV 256
Query: 57 TGNKLTGPVPKYIFN-SN-KNVDISLNNFT 84
+P ++ + ++++ N
Sbjct: 257 YNCPNLTKLPTFLKALPEMQLINVACNRGI 286
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 6/70 (8%), Positives = 21/70 (30%), Gaps = 6/70 (8%)
Query: 21 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN------SNK 74
+ ++ + L +G +P +L + + L + + S++
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 75 NVDISLNNFT 84
++
Sbjct: 137 QKQKMRMHYQ 146
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 8/61 (13%), Positives = 18/61 (29%), Gaps = 3/61 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L L + I + + I + +D+ N + + L +K
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
Query: 62 T 62
Sbjct: 624 Q 624
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 56/260 (21%), Positives = 96/260 (36%), Gaps = 75/260 (28%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMI-----SAQQHPN--- 452
K+G G F +V+ + +A+K + S ++EI ++ S PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 453 LVKLYGC----CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
+V+L V G + +V+E + ++ L + + Y+ L P KKI + +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLK---WIIKSNYQG-LPLPCVKKIIQQVLQG 158
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLL------------------------------------ 532
L YLH ++ +I+H DIK N+LL
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 533 -------------DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLT 578
+ L KI+D G A + T I TR Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 579 SKADVYSFGVVTLEIVSGKS 598
+ AD++S + E+ +G
Sbjct: 272 TPADIWSTACMAFELATGDY 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 34/193 (17%), Positives = 65/193 (33%), Gaps = 36/193 (18%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQ--------------GNREFVNEIGMIS 446
K+G GGFG +Y + A + + ++ ++ + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRL----KLDWPTRKKIC 502
+ + YG + + + G D + T ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFK------GRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI--SDFGLAKLYEEDKTHI---- 556
I + L Y+HE+ VH DIK +N+LL ++ +D+GL+ Y + H
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 557 --STRIAGTIGYM 567
GTI +
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 14/85 (16%), Positives = 26/85 (30%), Gaps = 2/85 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L TL+LT + + LK++ ++ +YL N +
Sbjct: 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141
Query: 62 TGPVPKYIFNSN--KNVDISLNNFT 84
+ F + K +D N
Sbjct: 142 SSIKLPKGFPTEKLKVLDFQNNAIH 166
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 14/86 (16%), Positives = 31/86 (36%), Gaps = 5/86 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L+L+ C + + + ++DLS N LT L ++ L N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + + +++ N
Sbjct: 536 SI-ILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 13/99 (13%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
LK L + I + + L+++ L N+++ K + N +
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
Query: 62 TGPVPKYIFNS-----NKNVDISLNNFTWESSDPIECPR 95
+ K +S N +++++ N+ +
Sbjct: 166 HY-LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L LT + E+P + ++ LK + LS N + + + GN
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + +N +D+S ++
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIE 363
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 24/128 (18%), Positives = 49/128 (38%), Gaps = 12/128 (9%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI---PTTFEKLAKTNFMYLTG 58
LK L L+ L+ + L++++L N+ G + + L + + L+
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
Query: 59 NKLTGPVPKYIFNSNKN---VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 115
L+ + ++ F S K VD+S N T S + + + + + N + +
Sbjct: 486 CDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEAL---SHLKGIYLNLA--SNHISIIL 539
Query: 116 PCLRQNFP 123
P L
Sbjct: 540 PSLLPILS 547
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 14/88 (15%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 2 NLKTLILTKCLIH--GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
NL+ L L+ I + +++ L++++LS+N F++ + + L
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410
Query: 60 KLTGPVPKYIFNSNKN---VDISLNNFT 84
+L + F + +++S +
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 11/86 (12%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ + L + ++ + L +DL+ + TF+ + + + LT N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 62 TGPVPKYIFNSNKNV---DISLNNFT 84
+ + + K + +
Sbjct: 94 IF-MAETALSGPKALKHLFFIQTGIS 118
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 14/86 (16%), Positives = 37/86 (43%), Gaps = 5/86 (5%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
M+++++ L K + + L+ +DL+ +L+ +P+ L+ + L+ NK
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANK 312
Query: 61 LTGPVPKYIFNSNKNV---DISLNNF 83
+ + ++ ++ I N
Sbjct: 313 FEN-LCQISASNFPSLTHLSIKGNTK 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 14/89 (15%), Positives = 29/89 (32%), Gaps = 6/89 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
L+ L L + + ++ LK ++LS + L F+ L + L GN
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460
Query: 61 LTG--PVPKYIFNSNKNV---DISLNNFT 84
+ + +S + +
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 14/107 (13%), Positives = 34/107 (31%), Gaps = 9/107 (8%)
Query: 2 NLKTLILTKCLIHGEIPDY-IGDMTKLKNIDLSFNNLT--GGIPTTFEKLAKTNFMYLTG 58
+L L + E+ + ++ L+ +DLS +++ L+ + L+
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385
Query: 59 NKLTGPVPKYIFNSNKN---VDISLNNFTWESSDPIECPRGSVNLVE 102
N+ + F +D++ D + L
Sbjct: 386 NEPLS-LKTEAFKECPQLELLDLAFTRLK--VKDAQSPFQNLHLLKV 429
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 8/62 (12%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ + L+ + + + + + ++L+ N+++ +P+ L++ + L N L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 62 TG 63
Sbjct: 560 DC 561
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 15/86 (17%), Positives = 38/86 (44%), Gaps = 4/86 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL L L+KC + + +L+ +++S NNL + + +L + + + N++
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + K+ +++ N+
Sbjct: 534 ET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 19/86 (22%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L LILT I P +T L+N+ L +L + + N +
Sbjct: 81 HLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
F++ N VD+S N
Sbjct: 141 HSCKLPAYFSNLTNLVHVDLSYNYIQ 166
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 15/86 (17%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L L++C I + L N+ L+ N + P +F L + KL
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + ++++ N
Sbjct: 117 AS-LESFPIGQLITLKKLNVAHNFIH 141
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 2 NLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM----YL 56
LK L + IH ++P Y ++T L ++DLS+N + + L + + +
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 57 TGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 100
+ N + + F K +++L S+ C + L
Sbjct: 189 SLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 17/92 (18%), Positives = 29/92 (31%), Gaps = 4/92 (4%)
Query: 2 NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
L+ L + + KL +D+S+ N F L N + + GN
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459
Query: 61 LTGPVPKYIFNSNKNV---DISLNNFTWESSD 89
+F + N+ D+S S
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 15/94 (15%), Positives = 32/94 (34%), Gaps = 4/94 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ K + L+ + + ++L+ +DLS + + L + + LTGN +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 62 TGPVPKYIFNSNKN---VDISLNNFTWESSDPIE 92
F+ + + S PI
Sbjct: 93 QS-FSPGSFSGLTSLENLVAVETKLASLESFPIG 125
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 18/126 (14%), Positives = 33/126 (26%), Gaps = 10/126 (7%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN--FMYLTGN 59
LK+L LT I + L +DLS N L+ ++ L + + L+ N
Sbjct: 329 FLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 60 KLTGPVPKYIFNSN--KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117
+++D + L+ S
Sbjct: 387 GAIIM-SANFMGLEELQHLDFQHSTLK--RVTEFSAFLSLEKLLYLDIS-YTNTKIDFDG 442
Query: 118 LRQNFP 123
+
Sbjct: 443 IFLGLT 448
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 23/232 (9%)
Query: 377 GLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR--- 432
G D Y ++ + + ++ + +G+G FG V K + +A+K + +K
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN 95
Query: 433 QGNRE--FVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 490
Q E + + + +V L + N L LV+E + N L + ++T +R
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLL--RNTNFR 152
Query: 491 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKL 548
+ +K + L +L + I+H D+K N+LL K KI DFG +
Sbjct: 153 -GVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-C 209
Query: 549 YEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 597
+ +I +R Y +PE + Y D++S G + +E+ +G+
Sbjct: 210 QLGQRIYQYIQSRF-----YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 26/118 (22%), Positives = 50/118 (42%), Gaps = 12/118 (10%)
Query: 2 NLKTLILTKCLIH--GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
+L+TL+L++ + + + + + L ++D+S N +P + + K F+ L+
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
Query: 60 KLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117
+ V I + + +D+S NN L E Y S RNKL +
Sbjct: 421 GIRV-VKTCIPQTLEVLDVSNNNLD-------SFSLFLPRLQELYIS-RNKLKTLPDA 469
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 13/87 (14%), Positives = 33/87 (37%), Gaps = 4/87 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNK 60
+L+ L L+ + + G ++ LK ++L N G+ + F L + + +
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFT 84
+ + F + ++I +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 15/127 (11%), Positives = 41/127 (32%), Gaps = 5/127 (3%)
Query: 2 NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
NL+TL + EI +T L +++ +L + + + + + L ++
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117
+ + + + +++ N P+ S + + D+
Sbjct: 184 SAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 118 LRQNFPC 124
L +
Sbjct: 243 LLKLLRY 249
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 23/101 (22%), Positives = 39/101 (38%), Gaps = 20/101 (19%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT---GGIPTTFEKLAKTN------ 52
NL +L +++ H +PD K++ ++LS + IP T E L +N
Sbjct: 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSF 446
Query: 53 --------FMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFT 84
+Y++ NKL +P + IS N
Sbjct: 447 SLFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISRNQLK 486
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 7/120 (5%), Positives = 28/120 (23%), Gaps = 9/120 (7%)
Query: 11 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP------ 64
+ + + + ++ + L+ G +P +L + + + T
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 65 ---VPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
P + + + + + + + L+
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 7/95 (7%), Positives = 24/95 (25%), Gaps = 11/95 (11%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
++ + + ++ L +++L +P L + + + N+
Sbjct: 467 VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526
Query: 61 LTGPVPKYIFNSN-----------KNVDISLNNFT 84
+ + + NN
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 13/78 (16%), Positives = 32/78 (41%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ L L G +PD IG +T+LK + ++ T ++ + +++
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 62 TGPVPKYIFNSNKNVDIS 79
K + ++ +++S
Sbjct: 384 RMHYKKMFLDYDQRLNLS 401
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 7/87 (8%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L L + + G KL ++ L +N + + + + NKL
Sbjct: 574 KLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL 631
Query: 62 TGPVPKYIFNSN----KNVDISLNNFT 84
+P + +VD S N
Sbjct: 632 KY-IPNIFNAKSVYVMGSVDFSYNKIG 657
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 14/100 (14%), Positives = 26/100 (26%), Gaps = 19/100 (19%)
Query: 2 NLKTLILTKCL------IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMY 55
LK + I + P I L + + N++ +L +
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQL---YILD 833
Query: 56 LTGNKLT-GPVP---------KYIFNSNKNVDISLNNFTW 85
+ N V Y+ +K DI +
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 13/93 (13%), Positives = 33/93 (35%), Gaps = 12/93 (12%)
Query: 2 NLKTLILTKCLIHGEIPDY--IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM----- 54
++ L + + IP+ + + ++D S+N + + +
Sbjct: 620 QVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 55 YLTGNKLTGPVPKYIFNSNKN---VDISLNNFT 84
L+ N++ P +F + + +S N T
Sbjct: 679 TLSYNEIQK-FPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 20/100 (20%), Positives = 32/100 (32%), Gaps = 19/100 (19%)
Query: 2 NLKTLILTKCLI-------HGEIPDYIGDMTKLKNIDLSFNNLTGGIPT--TFEKLAKTN 52
+ T+IL+ L+ + L IDL FN LT + L +
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS 756
Query: 53 FMYLTGNKLTGPVPKYIFNSNK--------NVDISLNNFT 84
M ++ N + P NS++ D N
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 13/94 (13%), Positives = 31/94 (32%), Gaps = 12/94 (12%)
Query: 2 NLKTLILTKCLIHG---------EIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKT 51
L++L + + D K++ + +NNL + +K+ K
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKL 575
Query: 52 NFMYLTGNKLTGPVPKYIFNSN-KNVDISLNNFT 84
+ NK+ + + N ++ + N
Sbjct: 576 GLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQIE 608
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 15/97 (15%), Positives = 31/97 (31%), Gaps = 14/97 (14%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDM-----TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 56
+ ++ + I E + M + LS+N + F + + + L
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 57 TGNKLT-------GPVPKYIFNSNK--NVDISLNNFT 84
+ N +T P N+ +D+ N T
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT 741
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 12/91 (13%), Positives = 29/91 (31%), Gaps = 21/91 (23%)
Query: 15 GEIPDYIGDMTKLKNIDLSFNNLTG-------------------GIPTTFEKLAKTNFMY 55
I I +TKL+ I + + T ++ L +
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 56 LTGNKLTGPVPKYIFNSNK--NVDISLNNFT 84
L +P ++++ + +++I+ N
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 2 NLKTLILTKCLIH--GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
+L+ L L++ + G T LK +DLSFN + + + F L + + +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406
Query: 60 KLTGPVPKYIFNSNKNV---DISLNNFT 84
L +F S +N+ DIS +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 3/86 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L TLILT I ++ L+ + NL L + + N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 62 T-GPVPKYIFNSN--KNVDISLNNFT 84
+P+Y N +++D+S N
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
+L+ L + I ++ L +DLS L PT F L+ + + N+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505
Query: 61 LTGPVPKYIFNSNKN---VDISLNNF 83
L VP IF+ + + + N +
Sbjct: 506 LKS-VPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 13/86 (15%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L L++C I ++ L + L+ N + F L+ + L
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + K ++++ N
Sbjct: 113 AS-LENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 2 NLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM----YL 56
LK L + + ++P+Y ++T L+++DLS N + T L + + L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 57 TGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNL 100
+ N + + F + ++L N + C +G L
Sbjct: 185 SLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 20/120 (16%), Positives = 48/120 (40%), Gaps = 11/120 (9%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP--TTFEKLAKTNFMYLTGN 59
+LK L L+ + + + +L+++D +NL + + F L ++ ++
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 431
Query: 60 KLTGPVPKYIFNSNKNV---DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116
IFN ++ ++ N+F + + NL S + +L+++ P
Sbjct: 432 HTRV-AFNGIFNGLSSLEVLKMAGNSFQ--ENFLPDIFTELRNLTFLDLS-QCQLEQLSP 487
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 14/89 (15%), Positives = 30/89 (33%), Gaps = 6/89 (6%)
Query: 1 MNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG 58
L+ L + ++ ++ + L +D+S + F L+ + + G
Sbjct: 396 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 59 NKLTGPVPKYIFNSNKNV---DISLNNFT 84
N IF +N+ D+S
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 16/94 (17%), Positives = 34/94 (36%), Gaps = 4/94 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ K L L+ + +L+ +DLS + ++ L+ + + LTGN +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 62 TGPVPKYIFNSNKN---VDISLNNFTWESSDPIE 92
+ F+ + + N + PI
Sbjct: 89 QS-LALGAFSGLSSLQKLVAVETNLASLENFPIG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 15/92 (16%), Positives = 26/92 (28%), Gaps = 3/92 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
LKTL L+ + + + I L N L I L GN
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 62 T-GPVPKYIFNSNKNVDISLNNFTWESSDPIE 92
G + + + + ++ + E
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 14/85 (16%), Positives = 27/85 (31%), Gaps = 3/85 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNK 60
K + L I G ++++ +DL N + + L N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 61 LTGPVPKYIFNSN-KNVDISLNNFT 84
+ V + + K +D+S N
Sbjct: 181 IYD-VKGQVVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 15/86 (17%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
K +T + + +K +DLS N L+ K + L+ N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ S +D++ N
Sbjct: 71 YETLD---LESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 9/71 (12%), Positives = 26/71 (36%), Gaps = 4/71 (5%)
Query: 17 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN- 75
I + + + K ++ ++L + + + + L+GN L+ +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKL 60
Query: 76 --VDISLNNFT 84
+++S N
Sbjct: 61 ELLNLSSNVLY 71
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 2/61 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L L + + PD ++ L+++ + L +P T ++ A + L N L
Sbjct: 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139
Query: 62 T 62
Sbjct: 140 R 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 14/62 (22%), Positives = 23/62 (37%), Gaps = 2/62 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NK 60
NLK+L + + + I + KL+ +DL P F A + L +
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSN 265
Query: 61 LT 62
L
Sbjct: 266 LL 267
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 18/83 (21%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLS-FNNLTGGIPTTFEKLAKTNFMYLTGNK 60
L+ L L C P G LK + L +NL +P +L + + L G
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCV 288
Query: 61 LTGPVPKYIFN--SNKNVDISLN 81
+P I +N + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 4/71 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NK 60
NL++L L I +P I ++ LK++ + + L+ + L K + L G
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTA 241
Query: 61 LTGPVPKYIFN 71
L P
Sbjct: 242 LRN-YPPIFGG 251
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 12/79 (15%), Positives = 25/79 (31%), Gaps = 11/79 (13%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFM------- 54
L+TL L + + +P I + +L+ + + +P +
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 55 --YLTGNKLTGPVPKYIFN 71
L + +P I N
Sbjct: 187 SLRLEWTGIRS-LPASIAN 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 17/92 (18%), Positives = 27/92 (29%), Gaps = 3/92 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
LKTL L+ + + + I L N L I L GN
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
Query: 62 TGPVPKYIFNSNKNV-DISLNNFTWESSDPIE 92
+ F+ N+ V ++ + E
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L L I+ ++ + KLK +DLS N L + F+ A ++ L NKL
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 62 TGPVPKYIFNSN--KNVDISLNNFTWES 87
+ K + S ++ D+ N F +
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 15/86 (17%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
K +T + + +K +DLS N L+ K + L+ N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ S +D++ N
Sbjct: 71 YETLD---LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 9/71 (12%), Positives = 26/71 (36%), Gaps = 4/71 (5%)
Query: 17 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN- 75
I + + + K ++ ++L + + + + L+GN L+ +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKL 60
Query: 76 --VDISLNNFT 84
+++S N
Sbjct: 61 ELLNLSSNVLY 71
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 8e-06
Identities = 42/285 (14%), Positives = 76/285 (26%), Gaps = 95/285 (33%)
Query: 19 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDI 78
++ I+ S N L P + K+ F L+ +F + I
Sbjct: 348 KHVNCDKLTTIIESSLNVLE---PAEYRKM----FDRLS-----------VFP--PSAHI 387
Query: 79 SLNNFT--WESSDPIECPRGSVNLVESYS---------------------SPRNKLDKVH 115
+ W VN + YS +H
Sbjct: 388 PTILLSLIWFDVIK-SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 116 ---------PCLRQNFPCSAP-ADQYHYTLHINCGGAKINTGHTKYEADMEARGASMF-- 163
P + P DQY Y+ HI GH + R ++F
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYS-HI---------GHHLKNIEHPER-MTLFRM 495
Query: 164 -Y-----------SSGQYWAFSSTGKFMDDDTDLDNY---IRTNTSTLSKVSAVDLELYR 208
+ W +++G ++ L Y I N ++ + +
Sbjct: 496 VFLDFRFLEQKIRHDSTAW--NASGSILNTLQQLKFYKPYICDNDPKYERLVN-AILDF- 551
Query: 209 TARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRI 253
L L YT L A ++ ++++ F K++
Sbjct: 552 --------LPKIEENLICSKYTDLLRIA-LMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 57/341 (16%), Positives = 98/341 (28%), Gaps = 103/341 (30%)
Query: 251 KRIFDIYIQEKLVKKDFNIEDEAGGTGIPIVKNFPAEVTS-----HTLKI--------HL 297
K I ++ +F+ +D V++ P + S H + L
Sbjct: 19 KDILSVFEDA--FVDNFDCKD---------VQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 298 YWA--GRGTTGI------PLRGTYGPLISAISVKSNFKPPVVHSKKNHVMIMAAIVGASV 349
+W + + LR Y L+S I + +P S + I +
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QP----SMMTRMYIEQRDRLYND 122
Query: 350 LLVLLILFIMRWKGCLGGKVSADKELRGLDLQTGLYTLRQIKAATNNFDPANKV---GEG 406
V + R + L L+ L LR PA V G
Sbjct: 123 NQVFAKYNVSRLQ-----PY--------LKLRQALLELR----------PAKNVLIDGVL 159
Query: 407 GFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466
G G K T +A+ S Q + +I ++ C +
Sbjct: 160 GSG---K------TWVALDVCLSYKVQ--CKMDFKIFWLN----------LKNCNSPETV 198
Query: 467 L-----LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521
L L+Y+ N SR+ + + R+ R L +V
Sbjct: 199 LEMLQKLLYQIDPNWT-SRSDHSSNIKLRIH-SIQAEL-------RRLLKSKPYENCLLV 249
Query: 522 HRDIKTSNVLLDKDLNAKI----SDFGLA-KLYEEDKTHIS 557
+++ + +L+ KI + L THIS
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 6/98 (6%)
Query: 2 NLKTLILTKCL---IHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLT 57
L+ L L G +L+ +DLS N+L + + ++ N + L+
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 58 GNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPR 95
L VPK + +D+S N + P E P+
Sbjct: 262 FTGLKQ-VPKGLPAKLSVLDLSYNRLD-RNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 21/132 (15%), Positives = 38/132 (28%), Gaps = 18/132 (13%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP----TTFEKLAKTNFMYLT 57
LK L + + + + L +DLS N G K + L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 58 GNKLT--GPVPKYIFNSNKN---VDISLNNFTWESSDPIECPRGSVNLVE---SYSSPRN 109
+ V + + +D+S N+ +++ C L S+
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLR-DAAGAPSC-DWPSQLNSLNLSF----T 263
Query: 110 KLDKVHPCLRQN 121
L +V L
Sbjct: 264 GLKQVPKGLPAK 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 15/61 (24%), Positives = 25/61 (40%), Gaps = 2/61 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L +L L + E + IG +T L + LS N++T P L+K + +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
Query: 62 T 62
Sbjct: 346 K 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 13/62 (20%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL+ L L + I P + ++TK+ +++L N+ + + N++ +T +K+
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 62 TG 63
Sbjct: 168 KD 169
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 12/62 (19%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
LK L + I + ++++L ++ L+ N L L ++L+ N +
Sbjct: 266 KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
Query: 62 TG 63
T
Sbjct: 324 TD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 13/83 (15%), Positives = 28/83 (33%), Gaps = 4/83 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+L K + + ++ + + ++ + E L ++ L GN++
Sbjct: 23 EGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQI 78
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
T P N+ I N T
Sbjct: 79 TDISPLSNLVKLTNLYIGTNKIT 101
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 5e-04
Identities = 15/65 (23%), Positives = 29/65 (44%), Gaps = 4/65 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
++ L++ + I I +T L+ ++L+ N +T P L K +Y+ NK+
Sbjct: 45 SITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100
Query: 62 TGPVP 66
T
Sbjct: 101 TDISA 105
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 14/60 (23%), Positives = 25/60 (41%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL+ L + + + + +T L +D+S + I T L K N + L+ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 12/83 (14%), Positives = 29/83 (34%), Gaps = 4/83 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
N+K L + P I ++ L+ + + ++T L + ++ +
Sbjct: 67 NIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 62 TGPVPKYIFN-SN-KNVDISLNN 82
+ I ++D+S N
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNG 147
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 5/88 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYL 56
+L+ L L + ++ + ++ L+ + L+ N L P F L + L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 57 TGNKLTGPVPKYIFNSNKNVDISLNNFT 84
N+LT + + + +DIS N
Sbjct: 512 NSNRLTVLSHNDLPANLEILDISRNQLL 539
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 15/87 (17%), Positives = 31/87 (35%), Gaps = 4/87 (4%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
+++ L L+ + + LK ++L++N + F L + L+ N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL 325
Query: 61 LTGPVPKYIFNSNKNV---DISLNNFT 84
L + F V D+ N+
Sbjct: 326 LGE-LYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
NL+ L L+ L+ E+ + K+ IDL N++ TF+ L K + L N
Sbjct: 315 NLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373
Query: 61 LTGPVPKYIFNSNKNVDISLNNFT 84
LT + S ++ +S N
Sbjct: 374 LTTI---HFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 17/88 (19%), Positives = 31/88 (35%), Gaps = 5/88 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
L+ L L I ++ L+ +DL + + P F+ L + L
Sbjct: 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG 108
Query: 61 LT-GPVPKYIFNSNKN---VDISLNNFT 84
L+ + F + K +D+S N
Sbjct: 109 LSDAVLKDGYFRNLKALTRLDLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 11/93 (11%), Positives = 27/93 (29%), Gaps = 5/93 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMYLTGNK 60
+ L+L+ I + +L+ ++L I F L + L +K
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 61 LTGPVPKYIFNSNKNV---DISLNNFTWESSDP 90
+ + F ++ + +
Sbjct: 85 IYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKD 116
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 10/93 (10%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPT-----TFEKLAKTNFMY 55
+L+ LIL + D + L+ + L N L T FE L+ +Y
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 56 LTGNKLTGPVPKYIFNSNKNV---DISLNNFTW 85
L N L +P +F+ + ++ N T
Sbjct: 487 LNHNYLNS-LPPGVFSHLTALRGLSLNSNRLTV 518
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-04
Identities = 12/73 (16%), Positives = 28/73 (38%), Gaps = 6/73 (8%)
Query: 16 EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKN 75
++P + + + LSFN + ++F L + + L + K F + N
Sbjct: 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 76 ---VDISLNNFTW 85
+D+ + +
Sbjct: 75 LRILDLGSSKIYF 87
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 9e-04
Identities = 23/99 (23%), Positives = 33/99 (33%), Gaps = 11/99 (11%)
Query: 2 NLKTLILTKCLIHG-EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTN--FMYLTG 58
L L L+K I + G + LK+ID S N + E L F L
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 59 NKLTGPVPKYIFNSNKN--------VDISLNNFTWESSD 89
N L V +D+S N +T + +
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 10/87 (11%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
N K + + ++P + +++ ++L+ + F +Y+ N
Sbjct: 52 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFT 84
+ +P ++F + + + N+ +
Sbjct: 111 IRY-LPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
++ L L I EI Y ++ + + FN + P F+ + + L N
Sbjct: 76 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFT 84
L+ +P+ IF++ + +S NN
Sbjct: 135 LSS-LPRGIFHNTPKLTTLSMSNNNLE 160
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 16/83 (19%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL + + + P + ++TKL +I ++ N + P L + L N++
Sbjct: 69 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI 124
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
T P + +++S N +
Sbjct: 125 TDIDPLKNLTNLNRLELSSNTIS 147
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 19/83 (22%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL L L I P + +TKL + L N ++ P L + L N+L
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL 299
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
P + + + NN +
Sbjct: 300 EDISPISNLKNLTYLTLYFNNIS 322
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L L L + + P I ++ L + L FNN++ P L K ++ NK+
Sbjct: 288 ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
+ + + N +
Sbjct: 344 SDVSSLANLTNINWLSAGHNQIS 366
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 13/91 (14%), Positives = 29/91 (31%), Gaps = 6/91 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L + + ++T + + N ++ P L + + L
Sbjct: 332 KLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIE 92
T Y +N ++ ++ N T P
Sbjct: 388 TNAPVNY--KANVSIPNTVKNVTGALIAPAT 416
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 15/65 (23%), Positives = 26/65 (40%), Gaps = 4/65 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
+ TL + I + D + + L I+ S N LT P + L K + + N++
Sbjct: 47 QVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 102
Query: 62 TGPVP 66
P
Sbjct: 103 ADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 13/83 (15%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L ++ + + +T L+++ + N ++ P L + + L GN+L
Sbjct: 178 TLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL 233
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
+ ++D++ N +
Sbjct: 234 KDIGTLASLTNLTDLDLANNQIS 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 42/233 (18%), Positives = 80/233 (34%), Gaps = 59/233 (25%)
Query: 402 KVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSR---QGNRE--FVNEIGMISAQQHPNLV 454
+GEG FG V + + + +A+K + + + E + +I + V
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 455 KLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
+ + + +E++K N Y L + + +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP--------YPLPH----VRHMAYQLC 133
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------KISDFGLAK 547
L +LHE ++ H D+K N+L +++DFG A
Sbjct: 134 HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 548 LYEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 597
++ + T ++TR Y PE + G+ DV+S G + E G
Sbjct: 190 TFDHEHHTTIVATRH-----YRPPEVILELGWAQP-CDVWSIGCILFEYYRGF 236
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 6/87 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
++ L L I EI Y ++ + + FN + P F+ + + L N
Sbjct: 70 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFT 84
L+ +P+ IF++ + +S NN
Sbjct: 129 LSS-LPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 10/87 (11%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
N K + + ++P + +++ ++L+ + F +Y+ N
Sbjct: 46 NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104
Query: 61 LTGPVPKYIFNSNKN---VDISLNNFT 84
+ +P ++F + + + N+ +
Sbjct: 105 IRY-LPPHVFQNVPLLTVLVLERNDLS 130
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 5/87 (5%)
Query: 2 NLKTLILTKCLIHGEIPDYIG---DMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLT 57
L+TLIL + E+ M L+ +D+S N+++ + ++
Sbjct: 349 ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 58 GNKLTGPVPKYIFNSNKNVDISLNNFT 84
N LT + + + K +D+ N
Sbjct: 408 SNILTDTIFRCLPPRIKVLDLHSNKIK 434
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/88 (22%), Positives = 41/88 (46%), Gaps = 6/88 (6%)
Query: 1 MNLKTLILTKCLIHGEIPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN 59
+NL +L +T C + +P + + L+ ++LS+N ++ + +L + + L G
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 60 KLTGPVPKYIFNSNKNV---DISLNNFT 84
+L V Y F + ++S N T
Sbjct: 283 QLAV-VEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 6/86 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
L+ L L+ I I + ++ +L+ I L L P F L + ++GN+
Sbjct: 249 YLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 61 LTGPVPKYIFNSNKN---VDISLNNF 83
LT + + +F+S N + + N
Sbjct: 308 LTT-LEESVFHSVGNLETLILDSNPL 332
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 28/142 (19%), Positives = 56/142 (39%), Gaps = 13/142 (9%)
Query: 2 NLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGN 59
+L +L+L I E+P + + + L+ + L+ N + + F+ L N + L N
Sbjct: 81 SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDN 138
Query: 60 KLTGPVPKYIFNSNKNV-DISLNNFTWES-------SDPIECPRGSVNLVESYSSPRNKL 111
KL + K F+ + + + L + +D + + S R
Sbjct: 139 KLQT-IAKGTFSPLRAIQTMHLAQNPFICDCHLKWLADYLHTNPIETSGARCTSPRRLAN 197
Query: 112 DKVHPCLRQNFPCSAPADQYHY 133
++ + F CSA A +H+
Sbjct: 198 KRIGQIKSKKFRCSAAAHHHHH 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 8/93 (8%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L L L+ + P + L+ + + + + F+ L + L N L
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL 267
Query: 62 TGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 93
T +P +F + I L++ +P C
Sbjct: 268 TL-LPHDLFTPLHHLERIHLHH------NPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 22/86 (25%), Positives = 48/86 (55%), Gaps = 6/86 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL+ L L C + EIP+ + + KL +DLS N+L+ P +F+ L +++ +++
Sbjct: 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + F++ ++ ++++ NN T
Sbjct: 244 QV-IERNAFDNLQSLVEINLAHNNLT 268
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 21/87 (24%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 2 NLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGN 59
+L L L++ + G I + + + KL+ +DLS+N++ + +F L + L N
Sbjct: 324 HLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTN 381
Query: 60 KLTGPVPKYIFNSNKN---VDISLNNF 83
+L VP IF+ + + + N +
Sbjct: 382 QLKS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 17/93 (18%), Positives = 38/93 (40%), Gaps = 8/93 (8%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+ L ++ P ++ LK + + + ++ F+ LA + L N L
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 62 TGPVPKYIFNSNKN-VDISLNNFTWESSDPIEC 93
+ +P +F + V++ L++ +P C
Sbjct: 279 SS-LPHDLFTPLRYLVELHLHH------NPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 17/86 (19%), Positives = 45/86 (52%), Gaps = 6/86 (6%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NLK L L C I ++P+ + + L+ +++S N+ P +F L+ +++ +++
Sbjct: 197 NLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254
Query: 62 TGPVPKYIFNSNKN---VDISLNNFT 84
+ + + F+ + ++++ NN +
Sbjct: 255 SL-IERNAFDGLASLVELNLAHNNLS 279
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 20/121 (16%), Positives = 35/121 (28%), Gaps = 24/121 (19%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-------------------GIP 42
LK LI++ + +P +LK + +S N LT +P
Sbjct: 222 GLKELIVSGNRL-TSLPVLPS---ELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLTRLP 277
Query: 43 TTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVE 102
+ L+ + L GN L+ + PR + L
Sbjct: 278 ESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL 336
Query: 103 S 103
+
Sbjct: 337 A 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 10/83 (12%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
L+TL ++ + +P + +L +L +P+ KL ++ GN+L
Sbjct: 82 ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKL------WIFGNQL 133
Query: 62 TGPVPKYIFNSNKNVDISLNNFT 84
T +P + + +S N
Sbjct: 134 TS-LPVLPPGL-QELSVSDNQLA 154
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 20/127 (15%), Positives = 37/127 (29%), Gaps = 16/127 (12%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAK----TNFMYLT 57
+L+ L + + +P+ + L D+S N L +P + F
Sbjct: 161 SLEVLSVRNNQL-TFLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCR 215
Query: 58 GNKLTGPVPKYIFN--SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 115
N++T +P+ I + + + N S I Y PR
Sbjct: 216 ENRITH-IPENILSLDPTCTIILEDNPL----SSRIRESLSQQTAQPDYHGPRIYFSMSD 270
Query: 116 PCLRQNF 122
Sbjct: 271 GQQNTLH 277
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 59/233 (25%)
Query: 402 KVGEGGFGSVYKGI--LSDGTVIAVKQLSSKSR---QGNRE--FVNEIGMISAQQHPNLV 454
+GEG FG V + I + G +AVK + + R E + + V
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 455 KLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
++ + +V Y+++K N +RL +K+ I
Sbjct: 81 QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP--------FRLDH----IRKMAYQIC 128
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------KISDFGLAK 547
+ + +LH K+ H D+K N+L + K+ DFG A
Sbjct: 129 KSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 548 LYEEDK--THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGK 597
Y+++ T +STR Y APE + G+ + DV+S G + +E G
Sbjct: 185 TYDDEHHSTLVSTRH-----YRAPEVILALGW-SQPCDVWSIGCILIEYYLGF 231
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKT------NFMY 55
L+ L L + +P + D+ L+ + L NN+T F + N +
Sbjct: 242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGIS 300
Query: 56 LTGNKLT-GPVPKYIFNSNKN-VDISLNNF 83
L N + V F + + I N+
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGN 59
NL +L+L+ ++ I + L+ +DLS N+L + F L + L N
Sbjct: 65 NLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNN 122
Query: 60 KLTGPVPKYIFNSN---KNVDISLNNFTW 85
+ V + F + + +S N +
Sbjct: 123 HIVV-VDRNAFEDMAQLQKLYLSQNQISR 150
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSR---QGNREFVNEIGMIS--AQQHP---N 452
K+G+G FG V + + AVK + + + E ++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 453 LVKLYGCCVEGNQLLLV--------YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 504
+VK +G + + + L+ YE + N + + ++ K CI
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG--------FHIED----IKLYCIE 145
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA-------------------------K 539
I + L YL + + + H D+K N+LLD K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 540 ISDFGLAKLYEEDK--THISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSG 596
+ DFG A ++ D + I+TR Y APE + G+ +D++SFG V E+ +G
Sbjct: 203 LIDFGCA-TFKSDYHGSIINTRQ-----YRAPEVILNLGW-DVSSDMWSFGCVLAELYTG 255
Query: 597 K 597
Sbjct: 256 S 256
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 11/92 (11%)
Query: 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGN 59
+L+ L+ + + + ++ G + LK ++++ N + +P F L + L+ N
Sbjct: 101 SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 60 KLTGPVPKYIFNS-------NKNVDISLNNFT 84
K+ + N ++D+SLN
Sbjct: 160 KIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 626 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.98 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.69 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.68 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.63 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.61 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.61 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.6 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.6 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.59 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.58 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.57 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.57 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.57 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.55 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.55 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.54 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.54 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.54 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.53 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.52 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.51 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.5 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.49 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.49 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.48 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.48 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.47 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.46 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.46 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.46 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.46 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.46 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.46 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.46 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.45 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.45 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.44 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.43 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.43 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.43 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.42 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.42 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.4 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.4 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.39 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.38 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.38 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.38 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.38 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.38 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.37 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.36 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.35 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.35 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.35 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.35 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.34 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.34 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.34 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.33 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.33 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.32 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.31 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.31 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.31 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.3 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.29 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.28 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.28 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.28 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.27 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.26 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.24 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.24 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.24 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.24 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.23 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.23 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.21 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.21 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.21 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.2 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.19 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.17 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.16 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.14 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.13 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.12 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.12 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.1 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.08 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.04 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.03 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.01 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.0 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.96 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.96 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.94 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.94 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.8 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.78 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.74 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.46 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.23 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.08 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.99 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.8 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.31 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.31 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.26 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.14 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.03 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.98 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.88 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.86 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.85 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.83 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.2 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.08 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.39 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.9 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.32 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 91.94 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 91.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.03 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 88.31 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.32 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.16 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=394.96 Aligned_cols=206 Identities=33% Similarity=0.532 Sum_probs=179.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|++++++++|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999874 477899999988777777899999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc--------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 469 VYEYMKNNCLSRAIFGKDT--------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
|||||++|+|.++|+.... .....++|.++.+|+.|||+||+|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 9999999999999975421 12247999999999999999999999987 999999999999999999999
Q ss_pred eecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 541 SDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 541 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+|||+|+........ ......||++|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999876543322 2334569999999999999999999999999999999999 89999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=395.09 Aligned_cols=206 Identities=31% Similarity=0.511 Sum_probs=173.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|++++++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999874 478899999988777777899999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 469 VYEYMKNNCLSRAIFGKDTE----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
|||||++|+|.++++..... ....++|.++++|+.|||+||+|||+++ |+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 99999999999999764321 1246999999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccCCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 539 KISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 999999999765432 223345679999999999999999999999999999999999 89999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=393.77 Aligned_cols=198 Identities=27% Similarity=0.514 Sum_probs=180.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999986 68999999997665555677899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999998542 5899999999999999999999997 9999999999999999999999999999775433
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. .....+||+.|||||++....|+.++|||||||++|||++|+.||..
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 23457899999999999999999999999999999999999999964
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=390.39 Aligned_cols=205 Identities=31% Similarity=0.453 Sum_probs=176.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++++.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456789999999999999973 46789999997653 3445789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 469 VYEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
|||||++|+|.++|+.... .....++|.++.+|+.|||+||+|||+++ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999965421 11246999999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccCCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+||+|||+++...... ........||++|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 9999999998765432 223345679999999999999999999999999999999998 89999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=386.05 Aligned_cols=200 Identities=28% Similarity=0.498 Sum_probs=168.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.+++.+.+.||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||+++++|.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567778999999999999999753 5899998754 34456789999999999999999999998864 56899999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||++|+|.++|+... ..++|.++.+|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 999999999997653 26999999999999999999999986 99999999999999999999999999987653
Q ss_pred CC-cceecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DK-THISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .......+||+.|||||++.. ..|+.++|||||||+||||+||+.||...
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 22 223345679999999999964 46899999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=392.77 Aligned_cols=202 Identities=25% Similarity=0.418 Sum_probs=173.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999975 6899999999754 23445679999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
||++|+|.+++..... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999964422 35789999999999999999999997 99999999999999999999999999997653
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22 1234467999999999999999999999999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=385.79 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=180.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|++++++++|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999975 6899999999754 2334577999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999643 26999999999999999999999997 9999999999999999999999999999775
Q ss_pred CCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||..
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 432 2234557899999999999999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=395.50 Aligned_cols=198 Identities=27% Similarity=0.514 Sum_probs=180.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56889999999999999999986 68999999998766666677899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+++... .+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999998543 5899999999999999999999997 9999999999999999999999999999775433
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 33457899999999999999999999999999999999999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=373.65 Aligned_cols=196 Identities=28% Similarity=0.475 Sum_probs=169.5
Q ss_pred CCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeEEEEE
Q 006906 398 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY 470 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 470 (626)
+..++||+|+||+||+|.+. ++..||||++... .....+.|.+|++++++++|||||+++++|.+ ++.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999986 5889999998654 33445679999999999999999999999875 34689999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCcccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY 549 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~ 549 (626)
|||++|+|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||||+|||++ .++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999643 36899999999999999999999985 4599999999999998 4799999999999864
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 432 2345689999999998864 6999999999999999999999999643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=381.45 Aligned_cols=197 Identities=28% Similarity=0.322 Sum_probs=171.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+.|...++||+|+||+||+|+.. +|+.||||+++.... ..+|++++++++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999976 689999999976422 246999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcccccCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLYEED 552 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~~~~ 552 (626)
++|+|.++++.. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+...
T Consensus 133 ~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 133 EGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999643 26999999999999999999999997 99999999999999987 6999999999977543
Q ss_pred Ccc----eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 553 KTH----ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 553 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 221 1233579999999999999999999999999999999999999997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=379.62 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=170.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999863 46899999997542 2234468899999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999653 26999999999999999999999997 99999999999999999999999999986
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 543322 234468999999999999999999999999999999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=366.68 Aligned_cols=197 Identities=28% Similarity=0.484 Sum_probs=162.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 68999999997542 233567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+ +|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 67898888654 26999999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 432 2334679999999999988765 6799999999999999999999964
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=372.39 Aligned_cols=199 Identities=30% Similarity=0.393 Sum_probs=162.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC----eEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 470 (626)
++|.+.+.||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++++|.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3466778999999999999998 589999999975422 1222334555567889999999999998654 689999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-----SRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
|||++|+|.++++.. .++|+.+.+++.|+|+||+|||++ +.++|+||||||+|||++.++++||+|||+
T Consensus 81 Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999653 589999999999999999999986 234699999999999999999999999999
Q ss_pred cccccCCCcce---ecccccCCcccchhhhccC------CCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 546 AKLYEEDKTHI---STRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 546 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
++......... ....+||+.|||||++.+. .++.++|||||||++|||+||+.|+.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 98775433222 2235799999999999754 36789999999999999999987764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=379.56 Aligned_cols=215 Identities=27% Similarity=0.403 Sum_probs=182.6
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCC-CceeeEEE
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQH-PNLVKLYG 458 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H-~nIv~l~~ 458 (626)
..+.+...++|++.+.||+|+||+||+|++.. ++.||||++.... ....++|.+|++++++++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34455566889999999999999999998653 3689999997653 3445789999999999965 89999999
Q ss_pred EEEeC-CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 006906 459 CCVEG-NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 526 (626)
Q Consensus 459 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 526 (626)
+|.+. +.+++|||||++|+|.++|+..... ....++|.++..++.|||+||+|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 99764 5689999999999999999754321 1235899999999999999999999997 9999999
Q ss_pred CCCEEEcCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 527 TSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 527 p~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
|+|||+++++.+||+|||+|+....+... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999976544332 3345679999999999999999999999999999999998 999997643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=363.51 Aligned_cols=199 Identities=26% Similarity=0.477 Sum_probs=162.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC--------
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-------- 464 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------- 464 (626)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999976 68999999997543 334567899999999999999999999987544
Q ss_pred ----eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 465 ----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 465 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
.+|+|||||++|+|.+++...... ...++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 379999999999999999765322 24567788999999999999999997 999999999999999999999
Q ss_pred eecCCcccccCCCcc-----------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 541 SDFGLAKLYEEDKTH-----------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 541 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
+|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 999999976543211 1233579999999999999999999999999999999996 664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=364.21 Aligned_cols=201 Identities=22% Similarity=0.376 Sum_probs=173.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe------CC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GN 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~ 464 (626)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357899999999999999999975 69999999997542 3345678899999999999999999998764 36
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.+|+|||||+ |+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecc
Confidence 7899999996 67999886542 6999999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCC---cceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDK---THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+|+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 998764321 2233457899999999998775 5799999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=375.74 Aligned_cols=200 Identities=28% Similarity=0.405 Sum_probs=173.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHH---HHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREF---VNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|++.++||+|+||+||+|+.. +|+.||||++.+.. ......+ ..++++++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999986 68999999996531 1222223 34466778889999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||++||+|.++|... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999653 26999999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
.+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.....
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 765433 234689999999999975 5799999999999999999999999975433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.71 Aligned_cols=199 Identities=26% Similarity=0.416 Sum_probs=171.6
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 466 (626)
...++|++.+.||+|+||+||+|+.+ .++.||||++... ....++.+|++++..+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999863 4678999998764 3356788999999988 699999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeecCC
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGL 545 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGl 545 (626)
++||||+++|+|.+++. .+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 99999999999999882 4889999999999999999999998 9999999999999877 7999999999
Q ss_pred cccccCCCc---------------------------ceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCC
Q 006906 546 AKLYEEDKT---------------------------HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGK 597 (626)
Q Consensus 546 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~ 597 (626)
|+....... ......+||+.|+|||++.+. .++.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986543211 112235799999999999875 5899999999999999999999
Q ss_pred CCCCCC
Q 006906 598 SNTNYR 603 (626)
Q Consensus 598 ~p~~~~ 603 (626)
.||...
T Consensus 245 ~Pf~~~ 250 (361)
T 4f9c_A 245 YPFYKA 250 (361)
T ss_dssp SSSSCC
T ss_pred CCCCCC
Confidence 999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=369.46 Aligned_cols=201 Identities=25% Similarity=0.402 Sum_probs=181.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+++.+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999986 6899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC--CCEEEeecCCccccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYE 550 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~ 550 (626)
|++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 236 ~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999986543 26899999999999999999999997 9999999999999854 899999999999875
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 433 233467999999999999999999999999999999999999999653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.99 Aligned_cols=231 Identities=45% Similarity=0.797 Sum_probs=199.4
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 464 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 464 (626)
+++.++..++++|+..+.||+|+||.||+|++++++.||||++........+.+.+|+++++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445566788999999999999999999998889999999998776666788999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999976532 2236899999999999999999999987 9999999999999999999999999
Q ss_pred CcccccCCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCChhhHHHHHHHHh
Q 006906 545 LAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQ 619 (626)
Q Consensus 545 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~~~l~~w~~~~~ 619 (626)
+++...... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||......+...+..|.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 998654322 222334568999999999998999999999999999999999999998766666667777765543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=353.11 Aligned_cols=211 Identities=25% Similarity=0.340 Sum_probs=184.4
Q ss_pred cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006906 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCV 461 (626)
Q Consensus 386 ~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 461 (626)
.+++++..+++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 44556667789999999999999999999987 47899999997532 122234889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 462 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999997632 26899999999999999999999997 9999999999999999999999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 99999877655444445568999999999987 567899999999999999999999999753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.95 Aligned_cols=236 Identities=44% Similarity=0.796 Sum_probs=200.0
Q ss_pred CCcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006906 382 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCC 460 (626)
Q Consensus 382 ~~~~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 460 (626)
...++++++..++++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456889999999999999999999999999999988899999999976532 2334789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 461 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
.+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999976532 2346999999999999999999999993334999999999999999999999
Q ss_pred eecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC--CCCChhhHHHHHHHH
Q 006906 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR--PNEDFVYLLDWAYVL 618 (626)
Q Consensus 541 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~--~~~~~~~l~~w~~~~ 618 (626)
+|||+++..............||+.|+|||.+....++.++|||||||++|||+||+.||+.. .......+.+|+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999977655554555567999999999999888999999999999999999999999632 122334455555443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=324.50 Aligned_cols=213 Identities=30% Similarity=0.508 Sum_probs=187.6
Q ss_pred CCCCcccHHHHHHHhcC----------CCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC
Q 006906 380 LQTGLYTLRQIKAATNN----------FDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ 448 (626)
Q Consensus 380 ~~~~~~~~~~l~~~t~~----------f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l 448 (626)
.+.+.++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 34566888999888865 666789999999999999987 7999999999877666678899999999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 006906 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTS 528 (626)
Q Consensus 449 ~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~ 528 (626)
+||||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~ 170 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999999999999999999999999999999988643 5899999999999999999999997 999999999
Q ss_pred CEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 529 NVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 529 NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999987654322 22345799999999999999999999999999999999999999964
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=320.99 Aligned_cols=200 Identities=26% Similarity=0.520 Sum_probs=180.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|.+.+.||+|+||+||+|... +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 467999999999999999999964 6899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999998543 5899999999999999999999997 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32 233457999999999999999999999999999999999999999643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=342.55 Aligned_cols=208 Identities=24% Similarity=0.343 Sum_probs=181.6
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 462 (626)
+++++...++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455556788999999999999999999986 58899999986531 1223457899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
.+..++||||+++|+|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence 99999999999999999998543 5899999999999999999999997 99999999999999999999999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCC----CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY----LTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+++.............+||+.|+|||++.... ++.++|||||||++|||++|+.||...
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 9999877654433444578999999999998655 789999999999999999999999643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.19 Aligned_cols=211 Identities=24% Similarity=0.318 Sum_probs=183.4
Q ss_pred cHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEE
Q 006906 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCV 461 (626)
Q Consensus 386 ~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 461 (626)
.+++.+...++|++.+.||+|+||+||+++.+ +++.||||++.+.. ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555566789999999999999999999986 68999999997532 222345788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 462 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999996432 26899999999999999999999997 9999999999999999999999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhc-------cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-------RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 99999877654443344567999999999987 356899999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.36 Aligned_cols=202 Identities=31% Similarity=0.527 Sum_probs=179.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|.+.+.||+|+||+||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56778899999999999999986 68999999998777777889999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 90 KGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp TTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999996542 36899999999999999999999997 9999999999999999999999999998765432
Q ss_pred cce-------------ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THI-------------STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 211 11356999999999999999999999999999999999999988653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=326.10 Aligned_cols=199 Identities=29% Similarity=0.371 Sum_probs=177.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+++.. +++.||+|++... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999986 6899999999754 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999988643 26899999999999999999999997 9999999999999999999999999998643
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 3222 23346799999999999999999999999999999999999999964
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.37 Aligned_cols=202 Identities=29% Similarity=0.417 Sum_probs=172.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357889999999999999999975 68899999985432 33456789999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999998543 26899999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
............||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 544333344467999999999999999999999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.98 Aligned_cols=200 Identities=26% Similarity=0.433 Sum_probs=177.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788999999999999999998 47999999998754 3344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999998543 25899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCC-ChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLT-SKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 432 23446799999999999887765 7999999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.85 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=173.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|.+++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999976 5899999999754 233456678899999987 79999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999998653 26899999999999999999999997 99999999999999999999999999985
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 43322 2234467999999999999888999999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=325.74 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=178.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999976 58899999986532 334577889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999998754 26899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCCh
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDF 608 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~~ 608 (626)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 225 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH
Confidence 432 2344679999999999864 4589999999999999999999999976544333
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.43 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=174.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 56889999999999999999986 57899999997642 22334578899988776 899999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999988643 26999999999999999999999997 999999999999999999999999999863
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 3222 2234467999999999999999999999999999999999999999643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.29 Aligned_cols=204 Identities=18% Similarity=0.178 Sum_probs=174.3
Q ss_pred HhcCCCCCCeeeccCceEEEEEE------EcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC---CCceeeEEEEEEeC
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEG 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~------~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 463 (626)
..++|.+.+.||+|+||+||+|. ..+++.||||++... ...++..|++++..++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35678889999999999999994 446889999999764 3457778888888777 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---------
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--------- 534 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------- 534 (626)
+..++||||+++|+|.+++..........+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999996422112246999999999999999999999987 999999999999998
Q ss_pred --CCCEEEeecCCcccccC-CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 535 --DLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 535 --~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999986542 222334456799999999999999999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=318.94 Aligned_cols=196 Identities=27% Similarity=0.446 Sum_probs=176.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999986 68999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999998654 26899999999999999999999997 9999999999999999999999999998754
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 32 2345799999999999999999999999999999999999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.17 Aligned_cols=204 Identities=29% Similarity=0.427 Sum_probs=177.0
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
....++|.+.+.||+|+||+||+|+.+ +++.||||+++... ....+.+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 344578999999999999999999986 68999999997642 23456678899988876 99999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence 99999999999999998643 26899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 986432222 234467999999999999999999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.97 Aligned_cols=200 Identities=27% Similarity=0.364 Sum_probs=177.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh------cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|++.+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999986 6899999999765321 357889999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----CEEEee
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 542 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~D 542 (626)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999654 26899999999999999999999997 99999999999998877 799999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||++....... ......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99998765432 223457999999999999989999999999999999999999999653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=322.15 Aligned_cols=199 Identities=27% Similarity=0.394 Sum_probs=175.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999986 58899999997642 33445688899999887 899999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999988643 26899999999999999999999997 999999999999999999999999999864
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 3222 123446799999999999999999999999999999999999999965
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.66 Aligned_cols=206 Identities=32% Similarity=0.512 Sum_probs=170.5
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..++|++.+.||+|+||+||+|+. +++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346788899999999999999987 68889999987653 344567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++...... ..+++..+..++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999765321 24899999999999999999999985 349999999999999999999999999998654
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 223456899999999999999999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.59 Aligned_cols=204 Identities=28% Similarity=0.448 Sum_probs=174.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||+||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467889999999999999999998899999999875432 234678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++ +|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FMEK-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCSE-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCCC-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9985 7777775543 35899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPNE 606 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~ 606 (626)
... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....+.
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 322 2233568999999999876 56899999999999999999999999865443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=317.42 Aligned_cols=202 Identities=31% Similarity=0.481 Sum_probs=175.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999986 789999999875432 2346688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 87 CSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999986542 5899999999999999999999997 999999999999999999999999999866432
Q ss_pred C-cceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 553 K-THISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 553 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
. ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 2 222334679999999999987765 779999999999999999999997644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=322.41 Aligned_cols=201 Identities=27% Similarity=0.371 Sum_probs=176.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999987 47899999997642 23456788899999887 89999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 99 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999998643 25899999999999999999999997 99999999999999999999999999986
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 432221 234467999999999999999999999999999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=310.14 Aligned_cols=201 Identities=30% Similarity=0.554 Sum_probs=178.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5678889999999999999999889999999997653 345779999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999996543 25899999999999999999999997 99999999999999999999999999987654333
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 33334557788999999999999999999999999999999 99998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=323.96 Aligned_cols=207 Identities=27% Similarity=0.437 Sum_probs=176.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
.++|.+.+.||+|+||.||+|+.. ++..||||++.... ....+++.+|+++++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888999999999999999863 35679999997653 33456799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.+++...... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 9999999999999999998654211 1235899999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999866543221 1223457789999999999999999999999999999999 99999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.68 Aligned_cols=217 Identities=44% Similarity=0.709 Sum_probs=188.4
Q ss_pred CCCcccHHHHHHHhcCCCCC------CeeeccCceEEEEEEEcCCcEEEEEEeccCC----hhcHHHHHHHHHHHhcCCC
Q 006906 381 QTGLYTLRQIKAATNNFDPA------NKVGEGGFGSVYKGILSDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQH 450 (626)
Q Consensus 381 ~~~~~~~~~l~~~t~~f~~~------~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H 450 (626)
....|++.++..++++|+.. +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999888 8999999999999987 68899999986532 3345778999999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 006906 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 530 (626)
Q Consensus 451 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 530 (626)
|||+++++++.+.+..++||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999865321 246899999999999999999999997 99999999999
Q ss_pred EEcCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 531 LLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 531 Ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 9999999999999999876543222 2334568999999998864 57899999999999999999999997653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.63 Aligned_cols=200 Identities=20% Similarity=0.310 Sum_probs=177.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|.+.+.||+|+||.||+++.. +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467889999999999999999986 5889999998754 34456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--CCCEEEeecCCccccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE 550 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~ 550 (626)
+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 83 ~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999986543 26899999999999999999999997 999999999999987 7899999999998775
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 433 223456899999999999888999999999999999999999999653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.50 Aligned_cols=197 Identities=25% Similarity=0.356 Sum_probs=176.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888999999999999999986 68999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999998643 25899999999999999999999997 9999999999999999999999999998764
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 32 22357999999999999999999999999999999999999999643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=317.76 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=167.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEE----cCCcEEEEEEeccCC----hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
.++|++.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999997 478999999997642 2334567889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999988643 25889999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 986443222 233457999999999999989999999999999999999999999753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.38 Aligned_cols=202 Identities=30% Similarity=0.508 Sum_probs=179.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.+.||+|+||.||+|...++..||||++.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45688899999999999999999888899999997653 34577999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999986532 35899999999999999999999997 9999999999999999999999999998766544
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........+|+.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 333334456778999999998889999999999999999999 99998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.31 Aligned_cols=204 Identities=25% Similarity=0.379 Sum_probs=176.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356889999999999999999976 68999999986431 224678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC---EEEeecC
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFG 544 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfG 544 (626)
+||||+++++|.+.+.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999988775431 12235899999999999999999999997 999999999999987654 9999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 9987654322 23345799999999999999999999999999999999999999965
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=313.15 Aligned_cols=200 Identities=27% Similarity=0.363 Sum_probs=177.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999986 689999999876432 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----CEEEee
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 542 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~D 542 (626)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999998654 26899999999999999999999997 99999999999999887 799999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 162 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 162 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 999987653322 23456999999999999899999999999999999999999999653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.25 Aligned_cols=200 Identities=26% Similarity=0.414 Sum_probs=176.7
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999976 68999999997642 33456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CCEEEeecCCc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGLA 546 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGla 546 (626)
|||+++|+|.+.+.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 107 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999886542 5899999999999999999999997 9999999999999865 45999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 179 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp BCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 8765432 22345799999999999998999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=317.75 Aligned_cols=202 Identities=30% Similarity=0.494 Sum_probs=173.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|.+.+.||+|+||.||+|.+. .+..||||++... .....+++.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999985 3556999999765 344457899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 129 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999996543 26899999999999999999999997 999999999999999999999999999976
Q ss_pred cCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 550 EEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
...... ......+|+.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 543222 1222346778999999998899999999999999999999 99998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.34 Aligned_cols=201 Identities=26% Similarity=0.398 Sum_probs=179.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467899999999999999999986 6889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--CCCEEEeecCCccccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE 550 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~ 550 (626)
+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 130 LSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999986543 25899999999999999999999997 999999999999974 4779999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 4332 23346999999999999999999999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=314.61 Aligned_cols=204 Identities=23% Similarity=0.288 Sum_probs=177.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .+.+.+|+++++++ +|+||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 367889999999999999999974 789999999875432 34688999999999 99999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC-----EEEeecCCc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLA 546 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla 546 (626)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99 999999986542 36999999999999999999999997 999999999999998887 999999999
Q ss_pred ccccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 006906 547 KLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607 (626)
Q Consensus 547 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~ 607 (626)
+.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 976543221 1234679999999999999999999999999999999999999998764443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=318.28 Aligned_cols=203 Identities=31% Similarity=0.455 Sum_probs=170.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC----eEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV 469 (626)
.++|++.+.||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357888999999999999999985 7899999997643 33445667888999999999999999998744 47999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-------SRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. +.++|+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999643 489999999999999999999988 011299999999999999999999999
Q ss_pred cCCcccccCCCcc-eecccccCCcccchhhhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 543 FGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRG-----YLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 543 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999876543322 22335799999999999763 45668899999999999999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=308.35 Aligned_cols=198 Identities=28% Similarity=0.418 Sum_probs=168.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--------------------------hcHHHHHHHHHHHhc
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------------------------QGNREFVNEIGMISA 447 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--------------------------~~~~~~~~E~~~l~~ 447 (626)
++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999975 688999999875421 113568899999999
Q ss_pred CCCCceeeEEEEEEe--CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC
Q 006906 448 QQHPNLVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 525 (626)
Q Consensus 448 l~H~nIv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 525 (626)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++ |+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 999999999999986 6689999999999999887543 26899999999999999999999997 999999
Q ss_pred CCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 526 KTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 526 kp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
||+|||++.++.+||+|||+++....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233457999999999997654 47889999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.84 Aligned_cols=199 Identities=27% Similarity=0.400 Sum_probs=166.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHH-HhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGM-ISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999986 58899999997643 2234456667766 5778999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999988643 26889999999999999999999997 999999999999999999999999999864
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 190 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 190 IEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp BCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 33222 23446799999999999999999999999999999999999999964
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.40 Aligned_cols=202 Identities=25% Similarity=0.449 Sum_probs=171.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-------
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------- 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------- 464 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456889999999999999999987 78999999997543 334578999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEecCCCchhhhhcCCCcccccCCC
Q 006906 465 --------------------------------------------------QLLLVYEYMKNNCLSRAIFGKDTEYRLKLD 494 (626)
Q Consensus 465 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~ 494 (626)
..++||||+++++|.+++...... ...+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL--EDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG--GGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc--cchh
Confidence 389999999999999999765432 3567
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc-----------ceecccccC
Q 006906 495 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT-----------HISTRIAGT 563 (626)
Q Consensus 495 ~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt 563 (626)
+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7889999999999999999997 99999999999999999999999999987754321 112335699
Q ss_pred CcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 564 ~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
+.|+|||.+.+..++.++|||||||++|||++|..|+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999999998765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.85 Aligned_cols=202 Identities=27% Similarity=0.483 Sum_probs=175.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.+.||+|+||.||++.+.++..||||++.... ...+++.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45688889999999999999999988899999998653 34578999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 102 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp TTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999996532 36899999999999999999999997 9999999999999999999999999998765433
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........+|+.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 222333456788999999998899999999999999999998 99998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=323.41 Aligned_cols=202 Identities=30% Similarity=0.506 Sum_probs=164.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||.||+|++. ++..||||+++.. .....++|.+|++++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999875 5678999999765 334456899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.++++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 125 ~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999997643 36899999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCccee--cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 550 EEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........ ....+++.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 54322111 12235678999999999999999999999999999998 99998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=306.14 Aligned_cols=199 Identities=22% Similarity=0.399 Sum_probs=170.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999986 68999999997543 2334778899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|++++ +.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~-l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQD-LKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEE-HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCCC-HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 99864 444443321 36899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCcceecccccCCcccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+..
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 322 223456899999999997765 79999999999999999999988643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=332.70 Aligned_cols=203 Identities=31% Similarity=0.416 Sum_probs=179.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 466889999999999999999986 68999999996542 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999876432 25899999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 54322 233579999999999999889999999999999999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.77 Aligned_cols=200 Identities=28% Similarity=0.447 Sum_probs=171.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|.+.+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999998899999999875432 2346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++ +|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 985 8888886542 26899999999999999999999997 999999999999999999999999999876432
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22 2233468999999999876 45899999999999999999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=326.24 Aligned_cols=201 Identities=23% Similarity=0.353 Sum_probs=175.8
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
..++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999875 68999999987653 23456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCCEEEeecCCc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLA 546 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla 546 (626)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 89 ~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp ECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999988654 25899999999999999999999997 99999999999998 4678999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
........ ......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 87654332 22346799999999999999999999999999999999999999954
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=330.89 Aligned_cols=204 Identities=29% Similarity=0.418 Sum_probs=179.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999986 68999999997542 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999865431 1236999999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 4332 223357999999999999999999999999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=331.95 Aligned_cols=205 Identities=28% Similarity=0.470 Sum_probs=178.5
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34457788899999999999999999888999999998653 45778999999999999999999999986 66789999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.++++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 262 e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp CCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred eecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999975422 36889999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
...........++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 432222223446788999999998999999999999999999999 99999653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=331.80 Aligned_cols=201 Identities=27% Similarity=0.361 Sum_probs=167.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357889999999999999999975 6899999999753 233446678899999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999988543 268999999999999999999998 76 99999999999999999999999999986
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 443222 233467999999999999999999999999999999999999999653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=308.93 Aligned_cols=203 Identities=23% Similarity=0.335 Sum_probs=175.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC--eEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 470 (626)
++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999986 48999999997643 344577889999999999999999999998765 789999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCCEEEeecCCc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 546 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 546 (626)
||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp ECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred eCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999976432 134899999999999999999999997 9999999999999 77888999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhc--------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAM--------RGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+....... .....||+.|+|||++. ...++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 87654332 23356899999999986 4678999999999999999999999997543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=318.28 Aligned_cols=195 Identities=28% Similarity=0.421 Sum_probs=169.3
Q ss_pred CCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 400 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
.+.||+|+||.||+|+.. +++.||+|++........+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 578999999999999975 6899999999887666678899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE--cCCCCEEEeecCCcccccCCCcce
Q 006906 479 SRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL--DKDLNAKISDFGLAKLYEEDKTHI 556 (626)
Q Consensus 479 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~~~~kl~DfGla~~~~~~~~~~ 556 (626)
.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 98886442 35899999999999999999999997 9999999999999 5678899999999987654322
Q ss_pred ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 557 STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 557 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.....||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23346999999999999889999999999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.86 Aligned_cols=205 Identities=29% Similarity=0.481 Sum_probs=161.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999975 689999999876532 334678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|++ ++|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 589888753211 11135899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3322 2233568999999999976 46899999999999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.81 Aligned_cols=202 Identities=23% Similarity=0.387 Sum_probs=167.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC----e
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 465 (626)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|++++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999997 4789999999976532 33457889999999999999999999987544 3
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 49999999999999998643 26899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9876543221 223356899999999999999999999999999999999999999654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.74 Aligned_cols=211 Identities=26% Similarity=0.339 Sum_probs=183.2
Q ss_pred CCcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-----CCceee
Q 006906 382 TGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----HPNLVK 455 (626)
Q Consensus 382 ~~~~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~ 455 (626)
...+++++.....++|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+..|++++..++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 344566666677889999999999999999999985 6889999999753 344567788999999886 999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-
Q 006906 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK- 534 (626)
Q Consensus 456 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~- 534 (626)
+++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 999999999999999999 8999999865432 25899999999999999999999997 999999999999975
Q ss_pred ------------------------CCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHH
Q 006906 535 ------------------------DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVT 590 (626)
Q Consensus 535 ------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil 590 (626)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 7899999999998654322 335689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 006906 591 LEIVSGKSNTNYRP 604 (626)
Q Consensus 591 ~elltG~~p~~~~~ 604 (626)
|||+||+.||....
T Consensus 250 ~ell~g~~pf~~~~ 263 (360)
T 3llt_A 250 AELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred HHHHHCCCCCCCCc
Confidence 99999999997543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.50 Aligned_cols=201 Identities=30% Similarity=0.494 Sum_probs=171.7
Q ss_pred cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 467 (626)
++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688899999999999999985 2688999999987777777889999999999999999999999864 35689
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999996553 25899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 548 LYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 548 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
........ ......++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 76543221 22234577789999999999999999999999999999999988754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=311.25 Aligned_cols=192 Identities=27% Similarity=0.372 Sum_probs=152.0
Q ss_pred CCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEecCCCc
Q 006906 400 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNC 477 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gs 477 (626)
.+.||+|+||.||+|+.. +++.||||++... ....+.+|++++..+. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999986 6899999999653 3467788999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---CEEEeecCCcccccCCCc
Q 006906 478 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 478 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~DfGla~~~~~~~~ 554 (626)
|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99998654 26899999999999999999999997 99999999999998765 799999999986654322
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 223456899999999999999999999999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.09 Aligned_cols=198 Identities=27% Similarity=0.443 Sum_probs=173.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56888999999999999999974 78999999986532 223457889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 67888887543 26899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 432 2234569999999999987765 78999999999999999999999653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.37 Aligned_cols=199 Identities=29% Similarity=0.419 Sum_probs=161.3
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3567889999999999999999987 57899999997642 34678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEeecCCccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAKL 548 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~~ 548 (626)
|+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 129 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred eCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999986542 5899999999999999999999997 999999999999975 88999999999986
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 64322 223456899999999999999999999999999999999999999653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.95 Aligned_cols=206 Identities=18% Similarity=0.285 Sum_probs=177.6
Q ss_pred hcCCCCCCeeecc--CceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEG--GFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G--~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|++.+.||+| +||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4568889999999 99999999986 68999999997542 3445678889999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999865422 25899999999999999999999997 99999999999999999999999999875
Q ss_pred ccCCCc------ceecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 549 YEEDKT------HISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 549 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 432211 11122468999999999987 5789999999999999999999999976443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=324.30 Aligned_cols=203 Identities=27% Similarity=0.439 Sum_probs=175.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ....++|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999987 78999999987643 2334578899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 193 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999986432 35899999999999999999999997 99999999999999999999999999986543
Q ss_pred CCccee-cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 552 DKTHIS-TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
...... ....++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221111 11235678999999998899999999999999999998 99998653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.25 Aligned_cols=204 Identities=26% Similarity=0.452 Sum_probs=179.4
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
..++|++.+.||+|+||.||+|++.. +..||||++.... ...++|.+|++++++++||||++++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34568888999999999999999874 8899999997653 346789999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 297 ~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred ccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999965322 36899999999999999999999997 99999999999999999999999999997654
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
..........++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 43333333456789999999998899999999999999999999 99998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.58 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=164.4
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCC--e
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGN--Q 465 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~ 465 (626)
...++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999975 6899999998653 3445567889999999997 999999999998554 7
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999998 5888888543 5899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCC--------------------CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEED--------------------KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++.+... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865321 1112234579999999999976 67899999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=308.03 Aligned_cols=197 Identities=27% Similarity=0.346 Sum_probs=164.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.++||+|+||+||+|+.. +++.||||++.... .....++..|+..+.+ .+|+||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999987 78999999986542 2333445555555544 4999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+ +++|.+++.... ..++|..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 136 ~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 678888875432 36999999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
.... ......||++|+|||++.+ .++.++|||||||++|||++|+.|+.
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 4332 2234569999999998875 78999999999999999999977654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.68 Aligned_cols=202 Identities=21% Similarity=0.302 Sum_probs=176.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|++++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788999999999999999996 478999999986542 334678899999998 89999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC-----EEEeecCCc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLA 546 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~DfGla 546 (626)
|+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 87 ~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99 999999996542 25899999999999999999999987 999999999999988776 999999999
Q ss_pred ccccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 547 KLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 547 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 876543221 22345699999999999999999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.07 Aligned_cols=201 Identities=26% Similarity=0.393 Sum_probs=170.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999986 589999999865432 335678899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999887654 25899999999999999999999997 99999999999999999999999999987653
Q ss_pred CCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2234568999999999876 678999999999999999999999997643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=314.16 Aligned_cols=209 Identities=31% Similarity=0.473 Sum_probs=177.6
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 464 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 464 (626)
...++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34577889999999999999999975 34889999998653 344577999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCcc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTE-------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 525 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 525 (626)
..++||||+++++|.+++...... ....+++..++.++.||+.||+|||+++ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999998653211 0146899999999999999999999997 999999
Q ss_pred CCCCEEEcCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 526 KTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 526 kp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+|||++.++.+||+|||+++....... .......+|+.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986643221 12233567899999999999899999999999999999999 99998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.27 Aligned_cols=217 Identities=27% Similarity=0.410 Sum_probs=182.1
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeE
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKL 456 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l 456 (626)
+...+.+...++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445566667788999999999999999999842 45789999997653 34456799999999999 89999999
Q ss_pred EEEEEeCCe-EEEEEEecCCCchhhhhcCCCccc----------------------------------------------
Q 006906 457 YGCCVEGNQ-LLLVYEYMKNNCLSRAIFGKDTEY---------------------------------------------- 489 (626)
Q Consensus 457 ~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~---------------------------------------------- 489 (626)
++++.+.+. .++||||+++|+|.++++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 899999999999999997653210
Q ss_pred ---------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 490 ---------------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 490 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 112899999999999999999999997 99999999999999999999999999986644322
Q ss_pred -ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 555 -HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 555 -~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 22334568899999999999999999999999999999998 999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=313.36 Aligned_cols=212 Identities=24% Similarity=0.317 Sum_probs=174.5
Q ss_pred HHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-----ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 006906 389 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-----SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462 (626)
Q Consensus 389 ~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 462 (626)
++....++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34566788999999999999999999975 6889999998653 23445789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCc-----------------------------------ccccCCCHHHHHHHHHHHHH
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDT-----------------------------------EYRLKLDWPTRKKICIGIAR 507 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~ia~ 507 (626)
.+..++||||+++|+|.+++..... .....+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999998852100 00123467788899999999
Q ss_pred HHHHHHhCCCCCeEEeCCCCCCEEEcCCC--CEEEeecCCcccccCCCc---ceecccccCCcccchhhhcc--CCCCCh
Q 006906 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDL--NAKISDFGLAKLYEEDKT---HISTRIAGTIGYMAPEYAMR--GYLTSK 580 (626)
Q Consensus 508 ~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~k 580 (626)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.. ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999997 99999999999998776 899999999986643221 12234569999999999975 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Q 006906 581 ADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 581 ~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+|||||||++|||++|+.||...
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.30 Aligned_cols=199 Identities=24% Similarity=0.374 Sum_probs=176.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|.+.+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456889999999999999999986 4778999999876666678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCCEEEeecCCcccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLY 549 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 549 (626)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 88 CTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999888543 25899999999999999999999997 9999999999999 78899999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 5433 22335689999999988654 899999999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=312.16 Aligned_cols=202 Identities=30% Similarity=0.552 Sum_probs=167.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|++.+.||+|+||+||+|++. +++ .||+|.+... .....+++.+|++++++++||||++++++|.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999965 344 3688888654 3345678999999999999999999999998765 789
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|+||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999986543 36899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 549 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 549 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
....... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 6543322 2223456889999999999999999999999999999999 999997643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.62 Aligned_cols=197 Identities=28% Similarity=0.451 Sum_probs=166.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhc--CCCCceeeEEEEEEe----CCeEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVE----GNQLL 467 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~----~~~~~ 467 (626)
.++|++.+.||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788999999999999999998 6899999998653 34556667776665 899999999998764 24589
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEeCCCCCCEEEcCCCCEE
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--------EDSRIKIVHRDIKTSNVLLDKDLNAK 539 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~~k 539 (626)
+||||+++|+|.++++.. .+++..+.+++.|++.||+||| +.+ |+||||||+|||++.++.+|
T Consensus 83 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 999999999999999543 5899999999999999999999 665 99999999999999999999
Q ss_pred EeecCCcccccCCCcce---ecccccCCcccchhhhccC------CCCChhhHHHHHHHHHHHHhC----------CCCC
Q 006906 540 ISDFGLAKLYEEDKTHI---STRIAGTIGYMAPEYAMRG------YLTSKADVYSFGVVTLEIVSG----------KSNT 600 (626)
Q Consensus 540 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~s~Gvil~elltG----------~~p~ 600 (626)
|+|||+++......... .....||+.|+|||.+... .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998765433222 2234799999999999876 445799999999999999999 8887
Q ss_pred CCC
Q 006906 601 NYR 603 (626)
Q Consensus 601 ~~~ 603 (626)
...
T Consensus 234 ~~~ 236 (301)
T 3q4u_A 234 YDV 236 (301)
T ss_dssp TTT
T ss_pred ccc
Confidence 543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.69 Aligned_cols=198 Identities=30% Similarity=0.480 Sum_probs=172.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC-eEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN-QLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e~ 472 (626)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456888899999999999999985 7899999997653 4578999999999999999999999988765 79999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999965421 24799999999999999999999997 999999999999999999999999999854322
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
. ....++..|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 343 ~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 343 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred c----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 12356889999999999999999999999999999998 999997654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=301.40 Aligned_cols=200 Identities=30% Similarity=0.537 Sum_probs=177.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5678889999999999999999889999999998653 345789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999986542 25899999999999999999999997 99999999999999999999999999987654322
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
.......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 22233457788999999998899999999999999999999 8999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=303.79 Aligned_cols=202 Identities=28% Similarity=0.402 Sum_probs=162.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4568889999999999999999753 4579999987643 34456789999999999999999999997 4567899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999986542 36899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.............+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 65443323333456789999999998899999999999999999996 99999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.93 Aligned_cols=201 Identities=27% Similarity=0.379 Sum_probs=173.4
Q ss_pred cCCCCCCeeeccCceEEEEEEE----cCCcEEEEEEeccCC----hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSKS----RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
++|++.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++..+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5688899999999999999997 368999999987532 22345677899999998 69999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999998643 26899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++.+............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 98765443333445679999999999985 35789999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=307.46 Aligned_cols=204 Identities=26% Similarity=0.454 Sum_probs=181.1
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
..++|++.+.||+|+||.||+|.... ++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45678889999999999999999874 888999999764 3446788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp CCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred cCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999965432 36899999999999999999999997 99999999999999999999999999997765
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
..........+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54444444567889999999999999999999999999999999 99998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=327.55 Aligned_cols=203 Identities=31% Similarity=0.519 Sum_probs=171.1
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
..++|.+.+.||+|+||.||+|.+.++..||||++.... ...++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788889999999999999999888889999998653 345789999999999999999999999876 678999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 260 ~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 260 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999996431 235899999999999999999999997 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.........++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 3222333457789999999999999999999999999999999 99999653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.16 Aligned_cols=199 Identities=31% Similarity=0.560 Sum_probs=164.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh----hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|++. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 56888899999999999999985 88999999875432 23467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--------CCCEEEee
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--------DLNAKISD 542 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~~kl~D 542 (626)
||+++++|.+++... .+++..+..++.|++.||+|||+++..+|+||||||+|||++. ++.+||+|
T Consensus 86 e~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp ECCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EcCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998543 5899999999999999999999997556999999999999986 67899999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999986654322 2346899999999999999999999999999999999999999753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.92 Aligned_cols=202 Identities=31% Similarity=0.523 Sum_probs=176.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 45688899999999999999999888899999997643 34678999999999999999999999986 45689999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999986532 136899999999999999999999997 9999999999999999999999999998776544
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 333334557889999999998889999999999999999999 99998653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=314.84 Aligned_cols=202 Identities=20% Similarity=0.281 Sum_probs=168.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCChhc-----------HHHHHHHHHHHhcCCCCceeeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQG-----------NREFVNEIGMISAQQHPNLVKL 456 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l 456 (626)
.++|.+.+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999999864 4789999987654221 1234456667788899999999
Q ss_pred EEEEEeC----CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 457 YGCCVEG----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 457 ~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 9998764 4589999999 999999986542 36999999999999999999999997 9999999999999
Q ss_pred c--CCCCEEEeecCCcccccCCCcce------ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 533 D--KDLNAKISDFGLAKLYEEDKTHI------STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 533 ~--~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+ .++.+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9 88999999999998765432111 12345999999999999999999999999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.13 Aligned_cols=202 Identities=29% Similarity=0.473 Sum_probs=169.9
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHhcC---CCCceeeEEEEEEeC
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-----RQGNREFVNEIGMISAQ---QHPNLVKLYGCCVEG 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~ 463 (626)
.+++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999964 68999999986432 12234566777776665 599999999999876
Q ss_pred C-----eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 464 N-----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 464 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
. ..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 5 5899999997 599998876532 24899999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998765332 224467899999999999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.04 Aligned_cols=200 Identities=27% Similarity=0.365 Sum_probs=177.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh------cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+++.+|+++++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456889999999999999999986 6899999998764321 357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----CEEEee
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 542 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~D 542 (626)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999996542 5889999999999999999999997 99999999999999888 799999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||++........ .....||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 999987654322 23356899999999999999999999999999999999999999653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.03 Aligned_cols=208 Identities=31% Similarity=0.480 Sum_probs=177.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46688899999999999999986 245789999997643 34457889999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTE-------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 527 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp 527 (626)
++||||+++++|.+++...... ....+++..+..++.||+.||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 9999999999999998654210 1124899999999999999999999997 99999999
Q ss_pred CCEEEcCCCCEEEeecCCcccccCCCcce-ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 528 SNVLLDKDLNAKISDFGLAKLYEEDKTHI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 528 ~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
+||+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998765433221 223457788999999998889999999999999999999 999997543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.00 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=165.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|.+.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457889999999999999999986 78999999997643 3346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC--EEEeecCCccccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLYE 550 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~~~ 550 (626)
+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 98 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 98 ASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999988543 26899999999999999999999997 999999999999987765 9999999998543
Q ss_pred CCCcceecccccCCcccchhhhccCCCCCh-hhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSK-ADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 222 2233569999999999988877665 89999999999999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.13 Aligned_cols=202 Identities=24% Similarity=0.355 Sum_probs=169.8
Q ss_pred cCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhc-CCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISA-QQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
+.|.+. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.+ .+||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 78999999999999965 689999999987666667889999999988 579999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC---EEEeecCCccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGLAKL 548 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~~ 548 (626)
|+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 92 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred cCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999998653 26899999999999999999999997 999999999999998776 99999999986
Q ss_pred ccCCCc------ceecccccCCcccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 549 YEEDKT------HISTRIAGTIGYMAPEYAMR-----GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 549 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
...... .......||+.|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 542211 11123458999999999875 457899999999999999999999997653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.75 Aligned_cols=200 Identities=26% Similarity=0.428 Sum_probs=171.6
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..++|++.+.||+|+||.||+++.+ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567899999999999999999986 688999999976533 234677777776 7999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC----CCEEEeecCCc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLA 546 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla 546 (626)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||++
T Consensus 96 E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp CCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999999986542 5899999999999999999999997 9999999999998543 35999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 87654332 22345789999999999888889999999999999999999999976443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.72 Aligned_cols=201 Identities=28% Similarity=0.477 Sum_probs=156.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999999999999974 78999999986542 123467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp ECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999987543 36899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 3222 122356899999999999888999999999999999999999999754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=310.86 Aligned_cols=210 Identities=25% Similarity=0.424 Sum_probs=161.7
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEcCCc----EEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILSDGT----VIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 464 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~----~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 464 (626)
....++|++.+.||+|+||.||+|+..... .||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 344567999999999999999999975432 7999999765 3344678999999999999999999999998776
Q ss_pred eE------EEEEEecCCCchhhhhcCCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC
Q 006906 465 QL------LLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN 537 (626)
Q Consensus 465 ~~------~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~ 537 (626)
.. ++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 65 999999999999998854321 11225899999999999999999999997 999999999999999999
Q ss_pred EEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 99999999987644322 12223456789999999999999999999999999999999 99999754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.42 Aligned_cols=202 Identities=29% Similarity=0.465 Sum_probs=170.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|.+.+.||+|+||+||+|++. +++ .||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999975 344 38888875442 333456788999999999999999999986 456899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999997653 26899999999999999999999997 99999999999999999999999999997
Q ss_pred ccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 549 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 549 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
....... ......++..|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 7543322 2334567889999999999999999999999999999999 999997643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.41 Aligned_cols=206 Identities=31% Similarity=0.411 Sum_probs=174.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|.+.+.||+|+||+||+|++. +++.||||++... ......++.+|+.++++++||||+++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888999999999999999953 4678999999754 3445567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---CEEEee
Q 006906 468 LVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL---NAKISD 542 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~~kl~D 542 (626)
+||||+++|+|.+++..... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999865321 11235899999999999999999999997 99999999999999555 599999
Q ss_pred cCCcccccCCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 543 FGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998653221 122233557899999999999999999999999999999998 99998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.68 Aligned_cols=202 Identities=27% Similarity=0.371 Sum_probs=177.3
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 467 (626)
..++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+..|.+++..+ +|++|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999999999999976 5889999999753 223456778899999887 7999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999998653 26899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....... ......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 491 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 491 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp ECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 6433222 234467999999999999999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.50 Aligned_cols=207 Identities=29% Similarity=0.427 Sum_probs=177.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
.++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+++.+|+++++++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457888999999999999999863 23579999997653 34457789999999999 999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 9999999999999999998654211 1235999999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999987654322 22233457889999999999999999999999999999999 99998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=310.41 Aligned_cols=195 Identities=29% Similarity=0.494 Sum_probs=170.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+.|...+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 44788899999999999999974 78999999987542 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+. |+|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9997 67777764321 36899999999999999999999997 9999999999999999999999999998664
Q ss_pred CCCcceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32 2356899999999985 56789999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.13 Aligned_cols=199 Identities=29% Similarity=0.468 Sum_probs=176.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999986 78999999997542 223467889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999998654 26899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 432 2234579999999999988765 78999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=314.26 Aligned_cols=196 Identities=24% Similarity=0.311 Sum_probs=162.2
Q ss_pred cCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHH-hcCCCCceeeEEEEEEe----CCeEE
Q 006906 395 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMI-SAQQHPNLVKLYGCCVE----GNQLL 467 (626)
Q Consensus 395 ~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~ 467 (626)
++|.+. +.||+|+||+||++... +++.||||++... ..+.+|++++ +..+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455555 68999999999999976 6889999998642 4567788876 45689999999999875 56789
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEeecC
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG 544 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfG 544 (626)
+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 136 lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999976432 36899999999999999999999987 999999999999997 7899999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 998654322 223457899999999999999999999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.61 Aligned_cols=201 Identities=25% Similarity=0.310 Sum_probs=166.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
-++|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367889999999999999999976 688999999976532 2346788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999998643 26899999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
............|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 54433333345689999999999998999999999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.45 Aligned_cols=197 Identities=26% Similarity=0.354 Sum_probs=166.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 464 (626)
.++|++.+.||+|+||+||+|... +++.||||++... .....+++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999976 6899999999764 344567788999999999999999999999654 4
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||++++ |.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 679999999865 5555532 4889999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 998765322 234467999999999999999999999999999999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=295.58 Aligned_cols=203 Identities=31% Similarity=0.487 Sum_probs=177.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356889999999999999999986 68999999987543 3345778999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998654 25899999999999999999999997 99999999999999999999999999986643
Q ss_pred CCc-ceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DKT-HISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
... .......||+.|+|||.+....+ +.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 221 22334568999999999987664 779999999999999999999997654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=296.89 Aligned_cols=199 Identities=26% Similarity=0.418 Sum_probs=175.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999976 5889999998654 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC---EEEeecCCcc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDFGLAK 547 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~DfGla~ 547 (626)
||+++++|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 85 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999998887543 36899999999999999999999997 999999999999987655 9999999998
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 6654322 2335689999999999999999999999999999999999999854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.11 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=175.1
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 463 (626)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3567999999999999999999965 688999999876531 1234577899999999999999999999999
Q ss_pred CeEEEEEEecCCC-chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEee
Q 006906 464 NQLLLVYEYMKNN-CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISD 542 (626)
Q Consensus 464 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~D 542 (626)
+..++||||+.+| +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999777 9999886552 5899999999999999999999997 99999999999999999999999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
||+++....... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||..
T Consensus 174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 999987654332 233569999999999988776 8899999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=298.41 Aligned_cols=201 Identities=25% Similarity=0.392 Sum_probs=176.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888999999999999999986 5789999998654 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999987543 36899999999999999999999997 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 53322 223356899999999999888999999999999999999999999653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.44 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=167.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCC--CceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++| +||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568889999999999999999988999999998754 33445778999999999977 9999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 5678999998654 26899999999999999999999997 99999999999997 578999999999876
Q ss_pred cCCCcc-eecccccCCcccchhhhcc-----------CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTH-ISTRIAGTIGYMAPEYAMR-----------GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 543322 2334679999999999864 6789999999999999999999999965
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=298.87 Aligned_cols=199 Identities=28% Similarity=0.471 Sum_probs=172.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888999999999999999976 57789999986532 23356788999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999988543 26899999999999999999999987 999999999999999999999999998654
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 4322 23356899999999999999999999999999999999999999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.83 Aligned_cols=202 Identities=28% Similarity=0.396 Sum_probs=170.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888999999999999999975 68899999987653 34467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCCEEEeecCCcccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLY 549 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 549 (626)
+++++|.+.+.... .....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999998885431 11246899999999999999999999997 9999999999999 45688999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||...
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 5432 223456899999999885 56899999999999999999999999653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.73 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=176.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56778899999999999999986 5789999998754 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 121 e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp CCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999987543 36899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 3322 223456899999999999988999999999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.06 Aligned_cols=200 Identities=24% Similarity=0.425 Sum_probs=165.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhc-HHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|.+.+.||+|+||+||+|+.. +++.||||++....... ...+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999986 68999999987543221 22456799999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 98 58888876542 25899999999999999999999997 999999999999999999999999999865433
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 154 TK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22 2233468999999999876 56899999999999999999999999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=308.71 Aligned_cols=209 Identities=29% Similarity=0.441 Sum_probs=176.1
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCC
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGN 464 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 464 (626)
..++|.+.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3567889999999999999999962 45689999997642 33456789999999999 9999999999999999
Q ss_pred eEEEEEEecCCCchhhhhcCCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTE------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIK 526 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk 526 (626)
..++||||+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999765321 0124899999999999999999999997 9999999
Q ss_pred CCCEEEcCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 527 TSNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 527 p~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
|+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876543322 2334557889999999999999999999999999999998 999997653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.25 Aligned_cols=194 Identities=24% Similarity=0.404 Sum_probs=154.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Ce
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 465 (626)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++++.++|||||++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367889999999999999999976 6899999998653 334457889999999999999999999998533 57
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+. ++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence 899999985 6888888654 26899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCc--------------------------ceecccccCCcccchhhh-ccCCCCChhhHHHHHHHHHHHHhC
Q 006906 546 AKLYEEDKT--------------------------HISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVSG 596 (626)
Q Consensus 546 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~s~Gvil~elltG 596 (626)
++....... ......+||+.|+|||++ ....++.++|||||||++|||+||
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 987643211 122345789999999986 456799999999999999999993
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.19 Aligned_cols=198 Identities=25% Similarity=0.405 Sum_probs=167.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Ce
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 465 (626)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++++.++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467889999999999999999976 5889999999764 334457889999999999999999999999766 57
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+. ++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 999999987 5999988654 25899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCc---------------------ceecccccCCcccchhhh-ccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 546 AKLYEEDKT---------------------HISTRIAGTIGYMAPEYA-MRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 546 a~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
++....... ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 997653321 112456799999999986 4567999999999999999999865544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=303.62 Aligned_cols=217 Identities=23% Similarity=0.351 Sum_probs=180.6
Q ss_pred CCCCCcccHHHHHHHhcCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcC-CCCce
Q 006906 379 DLQTGLYTLRQIKAATNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQ-QHPNL 453 (626)
Q Consensus 379 ~~~~~~~~~~~l~~~t~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~H~nI 453 (626)
+...+...++..+...+.|.+. +.||+|+||.||+|+.. +++.||||++.... .....++.+|+.++..+ +||||
T Consensus 12 ~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i 91 (327)
T 3lm5_A 12 DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91 (327)
T ss_dssp ----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred cccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence 3444455566667777778877 89999999999999976 68999999987642 33467889999999998 56999
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 006906 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 533 (626)
Q Consensus 454 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 533 (626)
+++++++.+.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~ 165 (327)
T 3lm5_A 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS 165 (327)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEES
T ss_pred EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEe
Confidence 9999999999999999999999999999865422 36899999999999999999999997 99999999999998
Q ss_pred C---CCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 534 K---DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 534 ~---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ++.+||+|||+++....... .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 8 78999999999987653322 23356999999999999999999999999999999999999999653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.22 Aligned_cols=194 Identities=25% Similarity=0.434 Sum_probs=170.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-C-------cEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-G-------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|++++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 567888999999999999998653 3 57999999877667778899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC--------E
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--------A 538 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------~ 538 (626)
++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999996543 24899999999999999999999997 999999999999998887 9
Q ss_pred EEeecCCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 539 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
||+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 99999999755332 22457899999999987 67899999999999999999965544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=331.72 Aligned_cols=204 Identities=30% Similarity=0.515 Sum_probs=176.8
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
...++|.+.+.||+|+||.||+|++.++..||||+++... ...++|.+|++++++++|+||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788899999999999999999888889999998653 345789999999999999999999999866 67899999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999996432 135899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
..........++..|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32222223446789999999999999999999999999999999 99999654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.37 Aligned_cols=208 Identities=28% Similarity=0.450 Sum_probs=178.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccCCh-hcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
.++|.+.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999985 2467899999976533 3457789999999999 99999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTE-------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
.++||||+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 99999999999999998654311 1235899999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999876544322 2233457889999999999999999999999999999999 999997643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.63 Aligned_cols=201 Identities=26% Similarity=0.413 Sum_probs=164.6
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--------hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--------RQGNREFVNEIGMISAQQHPNLVKLYGCCVE 462 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 462 (626)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999976 57899999987532 112235789999999999999999999975
Q ss_pred CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CCEE
Q 006906 463 GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAK 539 (626)
Q Consensus 463 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~k 539 (626)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.+ ..+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 556899999999999999886542 6899999999999999999999997 9999999999999754 4599
Q ss_pred EeecCCcccccCCCcceecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 540 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 540 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999998765322 2334679999999999853 56888999999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=296.52 Aligned_cols=199 Identities=32% Similarity=0.566 Sum_probs=169.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhc-------HHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-------NREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
++|++.+.||+|+||+||+|+.. +++.||||++....... .+++.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 56888899999999999999985 78999999986543221 167899999999999999999999987655
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC-----EEEe
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-----AKIS 541 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----~kl~ 541 (626)
++||||+++++|.+.+.... ..+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 69999999999998886543 36899999999999999999999985 34999999999999988776 9999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM--RGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
|||+++..... .....||+.|+|||.+. ...++.++|||||||++|||++|+.||....
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99999854332 23356899999999984 4567899999999999999999999997543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=313.07 Aligned_cols=199 Identities=25% Similarity=0.393 Sum_probs=168.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCC--CCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998654 3344578899999999996 599999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
| +.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 57889999986542 6889999999999999999999997 99999999999996 5789999999998765
Q ss_pred CCCcc-eecccccCCcccchhhhcc-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTH-ISTRIAGTIGYMAPEYAMR-----------GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 43322 2334679999999999865 46899999999999999999999999653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.98 Aligned_cols=199 Identities=26% Similarity=0.375 Sum_probs=173.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999987 689999999875421 23678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----CEEEeec
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISDF 543 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~Df 543 (626)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999998543 36899999999999999999999997 99999999999998877 8999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|++........ .....|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 99987654322 23356899999999999899999999999999999999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=298.98 Aligned_cols=202 Identities=27% Similarity=0.403 Sum_probs=170.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|.+.+.||+|+||.||+|++.+ +..||+|.+... .....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999998643 346999999765 33456789999999999999999999999765 45689
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 90 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999986432 35899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.............+++.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 65443333334557889999999998899999999999999999998 99999653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.49 Aligned_cols=198 Identities=30% Similarity=0.513 Sum_probs=176.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45888999999999999999975 68899999997653 34467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 102 ~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 102 LGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999998542 5899999999999999999999997 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ......||+.|+|||.+....++.++||||||+++|||++|+.|+..
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 22 22345689999999999999999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=296.75 Aligned_cols=201 Identities=30% Similarity=0.483 Sum_probs=172.5
Q ss_pred cCCCCCC-eeeccCceEEEEEEEc---CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~-~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|.+.+ .||+|+||.||+|+.. ++..||||++.... ....+++.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 57889999998753 34567899999999999999999999999 55679999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999986542 36899999999999999999999997 999999999999999999999999999877
Q ss_pred cCCCcce--ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 550 EEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
....... .....+|+.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 5433221 122346889999999988889999999999999999998 99999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=305.82 Aligned_cols=201 Identities=25% Similarity=0.419 Sum_probs=170.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--------C
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G 463 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 463 (626)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57889999999999999999985 78999999986543 2334678899999999999999999999987 4
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
+..++||||+++ +|.+.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 568999999985 6666665442 25899999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCC---cceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDK---THISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++.+.... ........||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998765322 112234568999999999876 45899999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.71 Aligned_cols=198 Identities=24% Similarity=0.447 Sum_probs=175.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888999999999999999986 6899999999765 334457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999998643 2589999999999999999999986 6 99999999999999999999999999976543
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 123356899999999999999999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=296.27 Aligned_cols=198 Identities=25% Similarity=0.432 Sum_probs=175.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999986 57889999986532 223567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999988643 25899999999999999999999987 9999999999999999999999999997654
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 322 23356899999999999999999999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.82 Aligned_cols=200 Identities=30% Similarity=0.474 Sum_probs=171.2
Q ss_pred cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 466 (626)
+.|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3477889999999999999984 368899999997543 34457889999999999999999999999876 668
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 99999999999999985432 35899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 547 KLYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 547 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
......... ......||..|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 877654321 2233568888999999999999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=303.01 Aligned_cols=200 Identities=26% Similarity=0.439 Sum_probs=169.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888999999999999999986 58999999986543 2334668899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999988765442 5899999999999999999999997 99999999999999999999999999986654
Q ss_pred CCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322 22335689999999999875 7899999999999999999999999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.93 Aligned_cols=207 Identities=27% Similarity=0.441 Sum_probs=175.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS--------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
.++|.+.+.||+|+||.||+|+.. ++..||||++.... ....+++.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999873 46789999997653 34456789999999999 999999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999765321 1125899999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999876543221 1223456789999999998889999999999999999999 99998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.84 Aligned_cols=199 Identities=22% Similarity=0.303 Sum_probs=165.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCChh-----------cHHHHHHHHHHHhcCCCCceeeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKSRQ-----------GNREFVNEIGMISAQQHPNLVKLYGC 459 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~~ 459 (626)
++|.+.+.||+|+||.||+|... ++..||||++...... ..+.+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999986 5678999998765321 12346778889999999999999999
Q ss_pred EEe----CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 006906 460 CVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 535 (626)
Q Consensus 460 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 535 (626)
+.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 988 77899999999 999999986542 6899999999999999999999997 9999999999999988
Q ss_pred C--CEEEeecCCcccccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 536 L--NAKISDFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 536 ~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 9999999999876432211 11345799999999999999999999999999999999999999964
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.01 Aligned_cols=198 Identities=23% Similarity=0.369 Sum_probs=170.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC--CeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG--NQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|++. ++.||||++.... ....+++.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999985 8889999997653 34456799999999999999999999999877 7789999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999976532 25899999999999999999999874 349999999999999999999999998876433
Q ss_pred CCCcceecccccCCcccchhhhccCCCCC---hhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTS---KADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||...
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 2 2245899999999998765444 899999999999999999999643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.00 Aligned_cols=201 Identities=30% Similarity=0.423 Sum_probs=170.9
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
+|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455669999999999999975 688999999987666667789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCCEEEeecCCcccccCCC
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-DLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~~kl~DfGla~~~~~~~ 553 (626)
+++|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999865422 235678999999999999999999997 999999999999987 8999999999998765322
Q ss_pred cceecccccCCcccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 1 223456899999999987643 78999999999999999999999964
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.67 Aligned_cols=216 Identities=26% Similarity=0.420 Sum_probs=181.2
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEE
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLY 457 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 457 (626)
+..++.+...++|.+.+.||+|+||.||+|+.. +++.||||++.... .....++.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455556788999999999999999999864 36789999997653 33456789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhcCCCcc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTE-----YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 458 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+++.+.+..++||||+++|+|.+++...... ....+++..+.+++.||+.||+|||+++ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 9999999999999999999999998643210 1135789999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999999866433221 1223456889999999999999999999999999999999 88888653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.90 Aligned_cols=196 Identities=26% Similarity=0.426 Sum_probs=165.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 464 (626)
.++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 356888999999999999999975 6899999998653 233456788999999999999999999999765 3
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||+ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 78999988542 5899999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99875432 233568999999999887 67999999999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.53 Aligned_cols=201 Identities=31% Similarity=0.471 Sum_probs=176.4
Q ss_pred cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEE--eCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~~ 467 (626)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999984 368899999998877667788999999999999999999999987 456789
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999986432 25899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 548 LYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 548 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 76543322 22334578889999999998899999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=304.87 Aligned_cols=200 Identities=24% Similarity=0.384 Sum_probs=164.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.++|.+.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 457889999999999999999975 689999999975532 23456789999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-----CCCCEEEeecCC
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-----KDLNAKISDFGL 545 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~~kl~DfGl 545 (626)
||+++ +|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 113 e~~~~-~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp ECCSE-EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred ecCCC-CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99984 8998886542 5899999999999999999999997 99999999999994 455699999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 987653322 22335689999999999874 5899999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=300.05 Aligned_cols=198 Identities=26% Similarity=0.399 Sum_probs=173.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456889999999999999999986 6899999999876555567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCCEEEeecCCcccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKLY 549 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~~ 549 (626)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 88 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 88 VSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999988543 25899999999999999999999997 9999999999999 78899999999999765
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 432 12234689999999999999999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=298.65 Aligned_cols=200 Identities=32% Similarity=0.541 Sum_probs=161.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|.+.+.||+|+||.||+|+.. ..||||++.... ....+.+.+|++++++++|+||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467888999999999999999864 359999987543 34457799999999999999999999965 5566899999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999986543 36899999999999999999999997 99999999999999999999999999986543
Q ss_pred CC-cceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DK-THISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ........||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 21 22223456899999999986 567888999999999999999999999754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=300.80 Aligned_cols=198 Identities=31% Similarity=0.525 Sum_probs=164.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46778899999999999999985 788999998753 34578999999999999999999999876 34789999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC-EEEeecCCcccccCCC
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN-AKISDFGLAKLYEEDK 553 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-~kl~DfGla~~~~~~~ 553 (626)
+++|.+++..... ...+++..+..++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 83 GGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp TCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 9999999976532 235789999999999999999999943234999999999999998887 7999999998654321
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred ----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 2345899999999999999999999999999999999999999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=307.00 Aligned_cols=208 Identities=26% Similarity=0.381 Sum_probs=171.6
Q ss_pred cHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh-----------hcHHHHHHHHHHHhcCCCCcee
Q 006906 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR-----------QGNREFVNEIGMISAQQHPNLV 454 (626)
Q Consensus 386 ~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~nIv 454 (626)
..+++....++|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45678888999999999999999999999988899999999865321 1237899999999999999999
Q ss_pred eEEEEEEeC-----CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 006906 455 KLYGCCVEG-----NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 529 (626)
Q Consensus 455 ~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 529 (626)
++++++... ...++||||++ |+|.+.+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999998643 36899999998 57887776542 36899999999999999999999997 9999999999
Q ss_pred EEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 530 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 530 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998554322 2233568999999999877 67899999999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.91 Aligned_cols=200 Identities=25% Similarity=0.406 Sum_probs=171.3
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 468 (626)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567889999999999999999986 7899999998764 234456788999999998 99999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-------------
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD------------- 535 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------------- 535 (626)
||||+++++|.+++.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999986532 11236899999999999999999999997 9999999999999844
Q ss_pred ------CCEEEeecCCcccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 536 ------LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 536 ------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
..+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|++++.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998765432 23589999999999866 56789999999999999999997653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.09 Aligned_cols=206 Identities=24% Similarity=0.421 Sum_probs=178.2
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--------hcHHHHHHHHHHHhcC-CCCceeeE
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQ-QHPNLVKL 456 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l 456 (626)
........++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999986 699999999875431 1135678899999998 89999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 006906 457 YGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL 536 (626)
Q Consensus 457 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~ 536 (626)
++++...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 99999999999999999999999998643 36899999999999999999999997 99999999999999999
Q ss_pred CEEEeecCCcccccCCCcceecccccCCcccchhhhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 537 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 238 ~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 999999999987654322 234579999999999863 3578899999999999999999999964
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=312.76 Aligned_cols=203 Identities=23% Similarity=0.341 Sum_probs=174.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC--eEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 470 (626)
++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888999999999999999986 48999999997643 334577889999999999999999999998765 789999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCCEEEeecCCc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKISDFGLA 546 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl~DfGla 546 (626)
||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 89 e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred ecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999965432 234899999999999999999999997 9999999999999 77788999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhcc--------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMR--------GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+....... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 87654322 233569999999999865 467789999999999999999999997543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=328.44 Aligned_cols=195 Identities=29% Similarity=0.479 Sum_probs=165.6
Q ss_pred eeeccCceEEEEEEEc---CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCCCc
Q 006906 402 KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNC 477 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~gs 477 (626)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 46679999998653 3456789999999999999999999999976 56999999999999
Q ss_pred hhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCccee
Q 006906 478 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS 557 (626)
Q Consensus 478 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 557 (626)
|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999996543 36899999999999999999999997 99999999999999999999999999987654322211
Q ss_pred --cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 558 --TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 558 --~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
....+++.|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 12335689999999999999999999999999999998 999997643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.43 Aligned_cols=200 Identities=27% Similarity=0.464 Sum_probs=164.3
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC--CCCceeeEEEEEEeC-
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ--QHPNLVKLYGCCVEG- 463 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~- 463 (626)
........++|++.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++... +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344455678999999999999999999985 899999998643 234555666666554 999999999999887
Q ss_pred ---CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCCEEEcCC
Q 006906 464 ---NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS-----RIKIVHRDIKTSNVLLDKD 535 (626)
Q Consensus 464 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~ 535 (626)
...++||||+++|+|.++++.. .+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 7899999999999999999543 5899999999999999999999871 1239999999999999999
Q ss_pred CCEEEeecCCcccccCCCcce---ecccccCCcccchhhhccCCCCCh------hhHHHHHHHHHHHHhC
Q 006906 536 LNAKISDFGLAKLYEEDKTHI---STRIAGTIGYMAPEYAMRGYLTSK------ADVYSFGVVTLEIVSG 596 (626)
Q Consensus 536 ~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~Dv~s~Gvil~elltG 596 (626)
+.+||+|||+++......... .....||+.|+|||.+.+.....+ +|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 999999999998765433221 123569999999999987766655 9999999999999999
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.76 Aligned_cols=203 Identities=28% Similarity=0.421 Sum_probs=168.1
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh-----cHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ-----GNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 465 (626)
...++|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34577999999999999999999976 5899999998754221 13468899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999986 8888876543 36889999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 987654322 23345689999999998754 5899999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.24 Aligned_cols=202 Identities=30% Similarity=0.552 Sum_probs=166.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|++.+.||+|+||.||+|++. +++ .||+|.+... .....+++.+|++++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888999999999999999975 344 3578877544 3455678999999999999999999999998765 789
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
|+||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999986543 36899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 549 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 549 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 6543221 2223446788999999999999999999999999999999 999997643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=293.50 Aligned_cols=203 Identities=24% Similarity=0.339 Sum_probs=169.3
Q ss_pred HhcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEE-EeCCeEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLVY 470 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 470 (626)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++..++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 4789999998765432 24578899999999988877766655 6778889999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCCEEEeecCCcc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAK 547 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~ 547 (626)
||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred Ecc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 999 999999986432 25899999999999999999999997 9999999999999 788999999999998
Q ss_pred cccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 548 LYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 548 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 76543321 22345789999999999999999999999999999999999999986543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=303.19 Aligned_cols=201 Identities=30% Similarity=0.515 Sum_probs=166.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|...+.||+|+||.||+|.... +..||||++.... .....++.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998753 2469999997653 3345678999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999986542 36899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 549 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
....... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 6543221 1122346788999999999999999999999999999999 9999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=292.52 Aligned_cols=201 Identities=24% Similarity=0.343 Sum_probs=172.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEE-EeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC-VEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999997 4789999999876432 34688999999999998876666555 57788899999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCCEEEeecCCccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL 548 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~ 548 (626)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 99 899999986432 26899999999999999999999997 9999999999999 5889999999999987
Q ss_pred ccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 549 YEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 549 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 6543321 1234579999999999999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.32 Aligned_cols=201 Identities=22% Similarity=0.372 Sum_probs=175.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhc-----------------HHHHHHHHHHHhcCCCCceeeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQG-----------------NREFVNEIGMISAQQHPNLVKL 456 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l 456 (626)
.++|.+.+.||+|+||.||+|.. +++.||||++....... .+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36788999999999999999999 89999999987542211 1789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhhh------hcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCC
Q 006906 457 YGCCVEGNQLLLVYEYMKNNCLSRA------IFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSN 529 (626)
Q Consensus 457 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~N 529 (626)
++++.+.+..++||||+++++|.++ +.... ...+++..+..++.|++.||+|||+ .+ |+||||||+|
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 9999999999999999999999998 54321 2479999999999999999999998 76 9999999999
Q ss_pred EEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccC-CCCC-hhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 530 VLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTS-KADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 530 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
|+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999876443 23345689999999999877 5666 9999999999999999999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.43 Aligned_cols=216 Identities=27% Similarity=0.407 Sum_probs=180.8
Q ss_pred cHHHHHHHhcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEE
Q 006906 386 TLRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLY 457 (626)
Q Consensus 386 ~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~ 457 (626)
...+.....++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444455567899999999999999999985 246889999997653 33456789999999999 799999999
Q ss_pred EEEEeCC-eEEEEEEecCCCchhhhhcCCCccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC
Q 006906 458 GCCVEGN-QLLLVYEYMKNNCLSRAIFGKDTEY-----------RLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDI 525 (626)
Q Consensus 458 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl 525 (626)
+++...+ ..++||||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988754 4899999999999999997653211 123889999999999999999999997 999999
Q ss_pred CCCCEEEcCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 526 KTSNVLLDKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 526 kp~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986654332 22334567889999999999999999999999999999998 99999764
Q ss_pred C
Q 006906 604 P 604 (626)
Q Consensus 604 ~ 604 (626)
.
T Consensus 255 ~ 255 (316)
T 2xir_A 255 K 255 (316)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.29 Aligned_cols=197 Identities=30% Similarity=0.470 Sum_probs=171.4
Q ss_pred CCCCCeeeccCceEEEEEEEc-----CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILS-----DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL 468 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 468 (626)
|++.+.||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 58899999998653 3445678999999999999999999999987 467899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999998653 4899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 549 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....... ......+|..|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 7543321 22334578889999999998899999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=296.66 Aligned_cols=204 Identities=27% Similarity=0.440 Sum_probs=164.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|... +++.||||++... ......++.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 46888999999999999999974 7899999999753 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999885421 11236899999999999999999999997 9999999999999999999999999998665
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... ......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 4322 223356899999999999999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.99 Aligned_cols=201 Identities=14% Similarity=0.156 Sum_probs=163.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccC---ChhcHHHHHHHH---HHHhcCCCCceeeEE-------EE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEI---GMISAQQHPNLVKLY-------GC 459 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~ 459 (626)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ +.++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45688889999999999999996 46999999999743 334457888999 556666899999998 66
Q ss_pred EEeCCe-----------------EEEEEEecCCCchhhhhcCCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006906 460 CVEGNQ-----------------LLLVYEYMKNNCLSRAIFGKDT--EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520 (626)
Q Consensus 460 ~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 520 (626)
+.+.+. .++||||+ +|+|.+++..... .....+++..+..|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 6899999864321 00123446888999999999999999997 9
Q ss_pred EEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccC-----------CCCChhhHHHHHHH
Q 006906 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-----------YLTSKADVYSFGVV 589 (626)
Q Consensus 521 iH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~s~Gvi 589 (626)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985432 2234567 999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 006906 590 TLEIVSGKSNTNYR 603 (626)
Q Consensus 590 l~elltG~~p~~~~ 603 (626)
+|||+||+.||...
T Consensus 303 l~elltg~~Pf~~~ 316 (377)
T 3byv_A 303 IYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHSSCCC---
T ss_pred HHHHHHCCCCCccc
Confidence 99999999999654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.96 Aligned_cols=196 Identities=27% Similarity=0.472 Sum_probs=171.6
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe---------
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------- 462 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 462 (626)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467889999999999999999986 78999999997653 356789999999999999999998864
Q ss_pred -------CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 006906 463 -------GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD 535 (626)
Q Consensus 463 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~ 535 (626)
....++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 445899999999999999986432 136899999999999999999999997 9999999999999999
Q ss_pred CCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 536 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 536 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
+.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 9999999999987654322 23346899999999999999999999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=295.74 Aligned_cols=208 Identities=27% Similarity=0.443 Sum_probs=173.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 468 (626)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999986 68999999997542 3445678999999999999999999998864 578999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS--RIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||++
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999986432 12235899999999999999999999985 123999999999999999999999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 87654322 122356899999999999989999999999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.81 Aligned_cols=199 Identities=30% Similarity=0.474 Sum_probs=169.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.++|.+.+.||+|+||+||+|+.. ++..||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456889999999999999999986 68899999987643 334577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEeecCCcc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFGLAK 547 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfGla~ 547 (626)
||+++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 116 e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999998887543 36899999999999999999999997 999999999999976 4559999999998
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... ......||+.|+|||++. ..++.++||||+||++|||++|+.||...
T Consensus 188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 765432 223457999999999886 56899999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.38 Aligned_cols=200 Identities=33% Similarity=0.517 Sum_probs=171.9
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+++.+|++++..++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999986 58999999997642 45678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999985321 36899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ......|++.|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 322 22335689999999999998999999999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.90 Aligned_cols=211 Identities=28% Similarity=0.410 Sum_probs=178.4
Q ss_pred HHHHhcCCCCCCeeeccCceEEEEEEEcC------CcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEE
Q 006906 390 IKAATNNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCV 461 (626)
Q Consensus 390 l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 461 (626)
.+...++|.+.+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44456789999999999999999999752 2479999997653 33456789999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCcc---------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 462 EGNQLLLVYEYMKNNCLSRAIFGKDTE---------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 462 ~~~~~~lV~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+.+..++||||+++|+|.+++...... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 999999999999999999998643210 0235899999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999866443222 2233457889999999999999999999999999999998 99998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.66 Aligned_cols=201 Identities=30% Similarity=0.456 Sum_probs=173.2
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-------------hcHHHHHHHHHHHhcCCCCceeeEE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------------QGNREFVNEIGMISAQQHPNLVKLY 457 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~ 457 (626)
...++|.+.+.||+|+||+||+|+.. +++.||||++..... ...+++.+|++++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999986 578999999875421 2356789999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-
Q 006906 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL- 536 (626)
Q Consensus 458 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~- 536 (626)
+++.+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 9999999999999999999999888543 26899999999999999999999997 99999999999998775
Q ss_pred --CEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 537 --NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 537 --~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|||++|+.||...
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp CSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 69999999998765432 223456999999999986 46899999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.68 Aligned_cols=197 Identities=24% Similarity=0.338 Sum_probs=162.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 464 (626)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999975 6889999999753 2344567889999999999999999999997654
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence 78999999985 67777642 4889999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 998664322 223456899999999999999999999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.20 Aligned_cols=202 Identities=24% Similarity=0.341 Sum_probs=165.8
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------ 463 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 463 (626)
+...++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999974 789999999865432 233799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHH
Q 006906 464 --------------------------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511 (626)
Q Consensus 464 --------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y 511 (626)
...++||||++ ++|.+.+.... .....+++..+..++.||++||+|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34889999998 57777664311 112368999999999999999999
Q ss_pred HHhCCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHH
Q 006906 512 LHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVV 589 (626)
Q Consensus 512 LH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvi 589 (626)
||+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||+
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99987 99999999999998 688999999999987654332 2335689999999998765 58999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 006906 590 TLEIVSGKSNTNYR 603 (626)
Q Consensus 590 l~elltG~~p~~~~ 603 (626)
+|||++|+.||...
T Consensus 232 l~ell~g~~pf~~~ 245 (383)
T 3eb0_A 232 FGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHSSCSSCCS
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.89 Aligned_cols=196 Identities=29% Similarity=0.436 Sum_probs=154.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------C
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------N 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 464 (626)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467889999999999999999965 6899999998653 334457788999999999999999999998754 5
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++|+||+ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 68998887542 5899999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865432 233568999999999877 67899999999999999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=318.06 Aligned_cols=199 Identities=30% Similarity=0.484 Sum_probs=176.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456889999999999999999986 78999999986542 34567899999999999999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCCEEEeecCCc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLA 546 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla 546 (626)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 105 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999886542 5899999999999999999999997 9999999999999 56789999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+.+..... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 87654332 234569999999999866 6899999999999999999999999753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.81 Aligned_cols=198 Identities=21% Similarity=0.314 Sum_probs=171.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC------CCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ------QHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~ 466 (626)
..+|++.+.||+|+||.||+|... +++.||||++... ....+++.+|++++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456889999999999999999876 5889999999764 33446677788877765 677999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC--EEEeecC
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN--AKISDFG 544 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--~kl~DfG 544 (626)
++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999996 688888865432 25899999999999999999999997 999999999999999887 9999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99765432 22356899999999999999999999999999999999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=308.20 Aligned_cols=201 Identities=29% Similarity=0.447 Sum_probs=160.4
Q ss_pred CCCCCCeeeccCceEEEEEEEc--CC--cEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeEEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS--DG--TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLV 469 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~--~g--~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV 469 (626)
.|.+.+.||+|+||.||+|++. ++ ..||||.+.... ....++|.+|++++++++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999864 22 368999987543 3445789999999999999999999998764 4578999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++.... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999997543 25889999999999999999999997 999999999999999999999999999866
Q ss_pred cCCCcc---eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 550 EEDKTH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
...... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 432211 1223457789999999999999999999999999999999 67777543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.27 Aligned_cols=202 Identities=26% Similarity=0.482 Sum_probs=171.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467889999999999999999986 5889999999877666778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999875422 36899999999999999999999997 999999999999999999999999987643221
Q ss_pred CcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. .......||+.|+|||.+. ...++.++||||||+++|||++|+.|+...
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 1 1122346899999999983 567899999999999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.48 Aligned_cols=201 Identities=25% Similarity=0.393 Sum_probs=172.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 466 (626)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457889999999999999999976 68899999997543 33447789999999999999999999999754 468
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+. ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 99999998 5898888543 5899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCcce--ecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 547 KLYEEDKTHI--STRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 547 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 8765432221 234579999999998754 458999999999999999999999997654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=300.57 Aligned_cols=205 Identities=25% Similarity=0.341 Sum_probs=171.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 468 (626)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35688899999999999999997 4789999999977666677889999999999999999999999873 347899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++.... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 108 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999886421 11236899999999999999999999997 99999999999999999999999999876
Q ss_pred ccCCCcc--------eecccccCCcccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 549 YEEDKTH--------ISTRIAGTIGYMAPEYAMRGY---LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 5321110 011245799999999987543 68999999999999999999999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=291.57 Aligned_cols=198 Identities=28% Similarity=0.459 Sum_probs=169.7
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLL 468 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~l 468 (626)
.|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3667789999999999999975 5788999998754 34445778999999999999999999999875 456899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCcc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAK 547 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~ 547 (626)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||||||+|||++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999998643 36899999999999999999999985 3499999999999997 78999999999997
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 181 LKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 654332 23356899999999876 45899999999999999999999999653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.33 Aligned_cols=199 Identities=27% Similarity=0.454 Sum_probs=173.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.++|++.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456899999999999999999986 6899999998653 2334678899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCCEEEeecCCcc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAK 547 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~ 547 (626)
||+++++|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 101 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999888543 26899999999999999999999997 99999999999995 45679999999998
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 765432 2234569999999999875 5899999999999999999999999653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.83 Aligned_cols=201 Identities=26% Similarity=0.403 Sum_probs=169.1
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh--------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeC
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEG 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 463 (626)
..++|.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467899999999999999999976 578999999865421 2234588999999999999999999998765
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC---EEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKI 540 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl 540 (626)
+ .++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 5 89999999999999988654 26899999999999999999999997 999999999999987654 999
Q ss_pred eecCCcccccCCCcceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 541 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999998765322 223356899999999974 4678999999999999999999999997543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.22 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=170.6
Q ss_pred HHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEe---
Q 006906 388 RQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVE--- 462 (626)
Q Consensus 388 ~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~--- 462 (626)
.++....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+++.+|++++.++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344445778999999999999999999985 68999999987543 3457888999999998 89999999999987
Q ss_pred ---CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEE
Q 006906 463 ---GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 539 (626)
Q Consensus 463 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 539 (626)
.+..++||||+++++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 5688999999999999999865422 36899999999999999999999997 99999999999999999999
Q ss_pred EeecCCcccccCCCcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 540 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 540 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|+|||++........ ......||+.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999986643221 223356899999999987 56789999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.42 Aligned_cols=200 Identities=30% Similarity=0.492 Sum_probs=173.9
Q ss_pred cCCCCCCeeeccCceEEEEEEE-----cCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC--eEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGIL-----SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN--QLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~ 467 (626)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999984 368899999998776666788999999999999999999999987544 679
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 121 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999986542 25899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcce--ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 548 LYEEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 548 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 775443221 223456778999999998889999999999999999999998875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=298.53 Aligned_cols=204 Identities=30% Similarity=0.467 Sum_probs=170.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcE--EEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTV--IAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~--vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||.||+|+.. ++.. ||+|++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999975 5554 499988753 233456789999999999 999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 470 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
|||+++++|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 999999999999976531 11236899999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 999999997443211 1122346889999999998889999999999999999998 99998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=296.56 Aligned_cols=210 Identities=28% Similarity=0.419 Sum_probs=165.1
Q ss_pred HHHhcCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC
Q 006906 391 KAATNNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN 464 (626)
Q Consensus 391 ~~~t~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 464 (626)
....++|.+.+.||+|+||.||+|... .++.||||++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334567888999999999999999864 2458999998754 2344567899999999999999999999998655
Q ss_pred -----eEEEEEEecCCCchhhhhcCCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 465 -----QLLLVYEYMKNNCLSRAIFGKDT-EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 465 -----~~~lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
..++||||+++++|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 35999999999999998843211 12246999999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 539 KISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999999987654322 12223457889999999999999999999999999999999 88888754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=291.27 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=174.2
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---------hhcHHHHHHHHHHHhcCC-CCceeeEEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---------RQGNREFVNEIGMISAQQ-HPNLVKLYGCCV 461 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 461 (626)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467889999999999999999986 68999999987542 122456789999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 462 EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 462 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
..+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999998643 36899999999999999999999997 9999999999999999999999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhc------cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|||++........ .....|++.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 167 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 9999987654322 23356899999999985 45688999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=295.93 Aligned_cols=200 Identities=26% Similarity=0.396 Sum_probs=165.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEE-----------
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV----------- 461 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----------- 461 (626)
.++|.+.+.||+|+||.||+|+.. +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357888999999999999999987 48999999998776667788999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCC
Q 006906 462 ---EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLN 537 (626)
Q Consensus 462 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~ 537 (626)
+.+..++||||++ |+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++ +++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 4467899999998 6999988542 5889999999999999999999997 99999999999997 5679
Q ss_pred EEEeecCCcccccCCCc--ceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKT--HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+||+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999999987643211 11223457899999998865 67899999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=290.87 Aligned_cols=198 Identities=27% Similarity=0.451 Sum_probs=166.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999986 78999999986542 233567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999998543 25899999999999999999999997 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 432 1233468999999999987665 6899999999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=293.83 Aligned_cols=201 Identities=30% Similarity=0.447 Sum_probs=167.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEE-eCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCV-EGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~l 468 (626)
.+|++.+.||+|+||.||+|++.+ ...||+|.+.... ....+.+.+|++++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999999643 2368999987643 344577899999999999999999999865 4567899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999996543 35899999999999999999999997 99999999999999999999999999986
Q ss_pred ccCCCc---ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 549 YEEDKT---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 549 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 644321 11233457889999999999999999999999999999999 5555543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=294.82 Aligned_cols=193 Identities=21% Similarity=0.362 Sum_probs=169.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEe--CCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--GNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|+.. +++.||||++... ..+.+.+|++++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 56888999999999999999874 7899999999753 3467899999999997 9999999999987 66789999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLY 549 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 549 (626)
||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999988873 3788999999999999999999997 99999999999999776 8999999999876
Q ss_pred cCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... .....|+..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 54332 233568999999999877 67899999999999999999999999654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=294.01 Aligned_cols=200 Identities=30% Similarity=0.435 Sum_probs=169.1
Q ss_pred cCCCCCC-eeeccCceEEEEEEEc---CCcEEEEEEeccCCh--hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKSR--QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~-~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|.+.+ .||+|+||.||+|.+. +++.||||++..... ...+++.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566777 9999999999999653 468899999976532 2356799999999999999999999999 6677899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 95 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999998654 25899999999999999999999997 99999999999999999999999999987
Q ss_pred ccCCCccee--cccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 549 YEEDKTHIS--TRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 549 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......... ....+++.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 654433221 22346788999999998889999999999999999999 99999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.72 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=174.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCC-CceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|.+.++||+|+||.||+|+.. +++.||||++..... ..++.+|++++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 467999999999999999999974 689999998865432 3457889999999987 556666677778889999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCCEEEeecCCccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL---DKDLNAKISDFGLAKL 548 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~~kl~DfGla~~ 548 (626)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99 999999986432 26999999999999999999999997 9999999999999 6889999999999987
Q ss_pred ccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 006906 549 YEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607 (626)
Q Consensus 549 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~ 607 (626)
+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 7543321 1224679999999999999999999999999999999999999998765443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=292.18 Aligned_cols=197 Identities=28% Similarity=0.412 Sum_probs=167.5
Q ss_pred CCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE-EEEE
Q 006906 397 FDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL-LLVY 470 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV~ 470 (626)
|...+.||+|+||+||+|.+.+ +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4556899999999999998642 2379999987643 34457889999999999999999999999876655 9999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+.+++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 103 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred ecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999997643 36899999999999999999999997 9999999999999999999999999998654
Q ss_pred CCCc---ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 551 EDKT---HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 551 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
.... .......+++.|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 3221 1222345788999999999999999999999999999999966554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=326.21 Aligned_cols=194 Identities=30% Similarity=0.438 Sum_probs=164.5
Q ss_pred CeeeccCceEEEEEEEc---CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILS---DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
+.||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 46789999997643 2346789999999999999999999999964 568999999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999644 26899999999999999999999997 999999999999999999999999999876543321
Q ss_pred --eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 556 --ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 556 --~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
......+|+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223346789999999999999999999999999999998 99999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=305.69 Aligned_cols=198 Identities=16% Similarity=0.232 Sum_probs=170.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC---------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceee----------
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD---------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK---------- 455 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~---------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------- 455 (626)
++|.+.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 568889999999999999999764 788999998754 46789999999999999987
Q ss_pred -----EEEEEEe-CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 006906 456 -----LYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSN 529 (626)
Q Consensus 456 -----l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N 529 (626)
+++++.. ++..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777776 78899999999 999999997542 136999999999999999999999997 9999999999
Q ss_pred EEEcCCC--CEEEeecCCcccccCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 530 VLLDKDL--NAKISDFGLAKLYEEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 530 ILl~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
||++.++ .+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999876543211 1133479999999999999999999999999999999999999997
Q ss_pred CCC
Q 006906 602 YRP 604 (626)
Q Consensus 602 ~~~ 604 (626)
...
T Consensus 270 ~~~ 272 (352)
T 2jii_A 270 NCL 272 (352)
T ss_dssp GGT
T ss_pred cCC
Confidence 643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=304.35 Aligned_cols=200 Identities=25% Similarity=0.350 Sum_probs=169.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC--------CCceeeEEEEEE---
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ--------HPNLVKLYGCCV--- 461 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~--- 461 (626)
.++|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467889999999999999999875 6889999999754 344567889999998885 788999999987
Q ss_pred -eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEcCCC---
Q 006906 462 -EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDL--- 536 (626)
Q Consensus 462 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~--- 536 (626)
.....++||||+. ++|.+.+..... ..+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 4567899999995 555555433211 3689999999999999999999998 6 99999999999999775
Q ss_pred ----------------------------------------------CEEEeecCCcccccCCCcceecccccCCcccchh
Q 006906 537 ----------------------------------------------NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570 (626)
Q Consensus 537 ----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 570 (626)
.+||+|||+++..... .....||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 8999999999876533 22346899999999
Q ss_pred hhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 571 YAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 571 ~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
++.+..++.++|||||||++|||+||+.||.....
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999999999999999999999999999986544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.93 Aligned_cols=198 Identities=31% Similarity=0.507 Sum_probs=160.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHH--HhcCCCCceeeEEEEEEe-----CCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGM--ISAQQHPNLVKLYGCCVE-----GNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~-----~~~~~ 467 (626)
++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++++.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788899999999999999987 68999999997542 3444555554 445899999999986643 23678
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------RIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
+||||+++|+|.+++... ..++..+.+++.||+.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 999999999999999644 3589999999999999999999981 1139999999999999999999999
Q ss_pred ecCCcccccCCCc-------ceecccccCCcccchhhhcc-------CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 542 DFGLAKLYEEDKT-------HISTRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 542 DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|||+++.+..... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.|+..
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 9999987653221 11223569999999999976 3566789999999999999999777643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.73 Aligned_cols=198 Identities=29% Similarity=0.390 Sum_probs=162.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC----C--eEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG----N--QLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~--~~~ 467 (626)
.+|++.+.||+|+||.||+|++. +++.||||++..... .+.+|+++++.++|+|||++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999986 589999999865422 234799999999999999999998642 2 367
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeecCCc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLA 546 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~DfGla 546 (626)
+||||+++ ++.+.+... ......+++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 130 lv~e~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEECCCE-EHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eehhcccc-cHHHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 99999986 555554321 111246899999999999999999999987 9999999999999965 56899999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 87654322 2335689999999998764 7899999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=296.97 Aligned_cols=206 Identities=28% Similarity=0.408 Sum_probs=173.9
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhc--CCCCceeeEEEEEEe
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISA--QQHPNLVKLYGCCVE 462 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~ 462 (626)
..........++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 33444455677899999999999999999998 5899999999643 34677888888877 799999999999987
Q ss_pred CC----eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEeCCCCCCE
Q 006906 463 GN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--------EDSRIKIVHRDIKTSNV 530 (626)
Q Consensus 463 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlkp~NI 530 (626)
.+ ..++||||+++|+|.+++... .+++..+..++.|++.||+||| +.+ |+||||||+||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 76 799999999999999999543 5899999999999999999999 665 99999999999
Q ss_pred EEcCCCCEEEeecCCcccccCCCcc---eecccccCCcccchhhhccCC------CCChhhHHHHHHHHHHHHhC-----
Q 006906 531 LLDKDLNAKISDFGLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVSG----- 596 (626)
Q Consensus 531 Ll~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~s~Gvil~elltG----- 596 (626)
|++.++.+||+|||++......... ......||+.|+|||.+.... ++.++|||||||++|||+||
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999876544322 123456899999999997652 33689999999999999999
Q ss_pred -----CCCCCCC
Q 006906 597 -----KSNTNYR 603 (626)
Q Consensus 597 -----~~p~~~~ 603 (626)
+.||...
T Consensus 259 ~~~~~~~p~~~~ 270 (342)
T 1b6c_B 259 IHEDYQLPYYDL 270 (342)
T ss_dssp BCCCCCCTTTTT
T ss_pred cccccccCcccc
Confidence 6777543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.47 Aligned_cols=204 Identities=25% Similarity=0.422 Sum_probs=155.8
Q ss_pred cCCCC-CCeeeccCceEEEEEEEc---CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEEE
Q 006906 395 NNFDP-ANKVGEGGFGSVYKGILS---DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLL 468 (626)
Q Consensus 395 ~~f~~-~~~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 468 (626)
+.|++ .++||+|+||+||+|+.. +++.||||++.... ....+.+|++++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 568999999999999976 47889999997542 33578899999999999999999999964 678999
Q ss_pred EEEecCCCchhhhhcCCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCCEEE
Q 006906 469 VYEYMKNNCLSRAIFGKDT----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL----DKDLNAKI 540 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~~kl 540 (626)
||||+.+ +|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 77766642211 11235999999999999999999999997 9999999999999 77899999
Q ss_pred eecCCcccccCCCc--ceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 541 SDFGLAKLYEEDKT--HISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 541 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987654221 222346789999999999874 58999999999999999999999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.36 Aligned_cols=202 Identities=25% Similarity=0.385 Sum_probs=157.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhc-HHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQG-NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ... .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467889999999999999999975 78999999997652 222 233445555688899999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
||++ |+|.+++.... .....+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9998 48877664311 1123699999999999999999999997 7 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhh----ccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYA----MRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... .....||+.|+|||.+ ....++.++||||||+++|||+||+.||..
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 54322 2234689999999996 456789999999999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.73 Aligned_cols=197 Identities=30% Similarity=0.475 Sum_probs=164.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-CeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-NQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e~ 472 (626)
.++|++.+.||+|+||.||++.. +++.||||++... ...+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35688899999999999999988 4889999999764 3457889999999999999999999997654 468999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999986432 124889999999999999999999997 999999999999999999999999999865432
Q ss_pred CcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
. ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 171 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 171 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred c----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 22357889999999999999999999999999999998 99998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.23 Aligned_cols=196 Identities=11% Similarity=0.062 Sum_probs=153.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHH---HHHHhcCCCCceeeEE-------EEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNE---IGMISAQQHPNLVKLY-------GCC 460 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E---~~~l~~l~H~nIv~l~-------~~~ 460 (626)
.+|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+| ++.++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45788899999999999999976 789999999987542 334556677 455566 799988755 455
Q ss_pred EeC-----------------CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHH------HHHHHHHHHHHHHHHhCCC
Q 006906 461 VEG-----------------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR------KKICIGIARGLAYLHEDSR 517 (626)
Q Consensus 461 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~ 517 (626)
... ...++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 433 34899999999 89999996542 24566666 788899999999999997
Q ss_pred CCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHh
Q 006906 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVS 595 (626)
Q Consensus 518 ~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~ellt 595 (626)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||.+.+ ..++.++|||||||++|||+|
T Consensus 215 --ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 --LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp --EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred --CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999998664321 13456799999999987 679999999999999999999
Q ss_pred CCCCCCCC
Q 006906 596 GKSNTNYR 603 (626)
Q Consensus 596 G~~p~~~~ 603 (626)
|+.||...
T Consensus 289 g~~Pf~~~ 296 (371)
T 3q60_A 289 LFLPFGLV 296 (371)
T ss_dssp SSCSTTBC
T ss_pred CCCCCCCc
Confidence 99999765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.79 Aligned_cols=208 Identities=26% Similarity=0.429 Sum_probs=158.1
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3567899999999999999999864 68899999987543 334567889999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCC---cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 471 EYMKNNCLSRAIFGKD---TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
||+++++|.+++.... ......+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999999885310 011235899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCc----ceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKT----HISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 6643211 11233568999999999875 56899999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.65 Aligned_cols=202 Identities=25% Similarity=0.329 Sum_probs=168.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC----hhcHHHHHHHHHHHhcCCCCceeeEEEEEE--eCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQHPNLVKLYGCCV--EGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 466 (626)
.++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 68899999997542 234577899999999999999999999985 45578
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||++++ |.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 9999999977 6666543221 36899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCC-cceecccccCCcccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 547 KLYEEDK-THISTRIAGTIGYMAPEYAMRGY--LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 547 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
....... ........||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 8765322 22223456899999999987643 47899999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=295.72 Aligned_cols=199 Identities=22% Similarity=0.350 Sum_probs=172.1
Q ss_pred hcCCCCCCeeeccCceEEEEEEE-c-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCC------ceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL-S-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP------NLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~-~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~ 465 (626)
.++|++.+.||+|+||.||+|.. . +++.||||++... ....+.+.+|++++..++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788999999999999999987 3 6889999999754 34456788899988887665 49999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----------
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK----------- 534 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----------- 534 (626)
.++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999 8899998865432 36899999999999999999999997 999999999999987
Q ss_pred --------CCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 535 --------DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 535 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6789999999998654322 23568999999999999899999999999999999999999997643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.07 Aligned_cols=205 Identities=24% Similarity=0.321 Sum_probs=158.7
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEE--------eC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCV--------EG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~--------~~ 463 (626)
..+|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 356888999999999999999975 68999999997776667788999999999996 999999999995 33
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
...++||||+. |+|.+++.... ....+++..+..++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999996 78888875421 1136999999999999999999999884 34999999999999999999999999
Q ss_pred CCcccccCCCcce-----------ecccccCCcccchhhh---ccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 544 GLAKLYEEDKTHI-----------STRIAGTIGYMAPEYA---MRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|+++......... .....||+.|+|||.+ ....++.++|||||||++|||+||+.||..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9998765432211 1134589999999998 566789999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=305.48 Aligned_cols=198 Identities=27% Similarity=0.393 Sum_probs=163.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe------EEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ------LLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~l 468 (626)
.+|.+.+.||+|+||.||+|+..++..||+|++...... ..+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 457889999999999999999987777999988654322 2369999999999999999999965433 789
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCcc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAK 547 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~ 547 (626)
||||++++.+....+.. .....+++..++.++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 116 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEECCSEEHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeeccCccHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999876544332211 11236899999999999999999999997 99999999999999 79999999999998
Q ss_pred cccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7644332 2345689999999998764 5899999999999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=298.46 Aligned_cols=200 Identities=24% Similarity=0.399 Sum_probs=170.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----CeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 466 (626)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999986 68999999997543 33456788999999999999999999998754 678
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+. ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 99999997 5898887542 5899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCcc---------eecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 547 KLYEEDKTH---------ISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+........ ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 876532211 1123468999999998765 67899999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=295.93 Aligned_cols=202 Identities=27% Similarity=0.473 Sum_probs=169.9
Q ss_pred HhcCCCCCCeeeccCceEEEEEEE--cCCcEEEEEEeccCCh--hcHHHHHHHHHHHhcC---CCCceeeEEEEEE----
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGIL--SDGTVIAVKQLSSKSR--QGNREFVNEIGMISAQ---QHPNLVKLYGCCV---- 461 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~--~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~---- 461 (626)
+.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999998 3688999999865321 2223556677666555 8999999999987
Q ss_pred -eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 462 -EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 462 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
.....++||||++ |+|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEE
Confidence 4567899999998 699998865422 25899999999999999999999997 999999999999999999999
Q ss_pred eecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 541 SDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 541 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999998664322 223456899999999999999999999999999999999999999754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.69 Aligned_cols=207 Identities=30% Similarity=0.412 Sum_probs=171.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEE------cCCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~------~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|.+.+.||+|+||.||+|++ .+++.||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45788899999999999999984 24678999999754 344567889999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEe
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTE--YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKIS 541 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~ 541 (626)
++||||+++++|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999654321 1235899999999999999999999997 999999999999984 4569999
Q ss_pred ecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 542 DFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 542 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
|||+++....... .......+|+.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999986543221 12233457889999999999999999999999999999998 99998643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.40 Aligned_cols=195 Identities=27% Similarity=0.432 Sum_probs=166.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE----
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL---- 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 466 (626)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999976 6899999999764 233457788999999999999999999999877654
Q ss_pred --EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 467 --LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 467 --~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
++||||+. ++|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 578777632 4899999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865432 233568999999999987 68899999999999999999999999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=301.52 Aligned_cols=209 Identities=21% Similarity=0.299 Sum_probs=174.6
Q ss_pred ccHHHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CC-----ceeeEE
Q 006906 385 YTLRQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HP-----NLVKLY 457 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~ 457 (626)
+..+......++|.+.+.||+|+||+||+|+.. +++.||||++... ....+++..|++++..++ |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 334444555788999999999999999999976 6889999999754 334566778888887774 44 499999
Q ss_pred EEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CC
Q 006906 458 GCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KD 535 (626)
Q Consensus 458 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~ 535 (626)
+++...+..++||||++ ++|.+++..... ..+++..++.++.|++.||+|||++ ..+|+||||||+|||++ .+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence 99999999999999996 599998865432 2589999999999999999999953 12499999999999994 47
Q ss_pred CCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 536 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 536 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 198 ~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 88999999999876432 22356899999999999999999999999999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.70 Aligned_cols=208 Identities=24% Similarity=0.343 Sum_probs=160.1
Q ss_pred HHHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-
Q 006906 388 RQIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ- 465 (626)
Q Consensus 388 ~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~- 465 (626)
.+.....++|.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999985 68999999986543 233456778888899999999999999976443
Q ss_pred ------EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEeCCCCCCEEEcC-CC
Q 006906 466 ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH--EDSRIKIVHRDIKTSNVLLDK-DL 536 (626)
Q Consensus 466 ------~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiH~Dlkp~NILl~~-~~ 536 (626)
.++||||++++ |.+.+... ......+++..+..++.|++.||+||| +.+ |+||||||+|||++. ++
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred cccceeEEEEeeccccc-HHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 78999999865 43333211 011236889999999999999999999 776 999999999999997 89
Q ss_pred CEEEeecCCcccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 537 NAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 537 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 999999999987654332 2345689999999998654 4899999999999999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=291.66 Aligned_cols=201 Identities=25% Similarity=0.432 Sum_probs=162.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc--CCc--EEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS--DGT--VIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~--~g~--~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|++.+.||+|+||.||+|++. +++ .||||++... .....+.+.+|++++++++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888999999999999999864 233 6899998754 2344578899999999999999999999998765 88
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999986432 35899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 548 LYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
........ ......+|..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 76543322 1223457889999999998889999999999999999999 99999653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.11 Aligned_cols=194 Identities=28% Similarity=0.479 Sum_probs=162.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe----------
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE---------- 462 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 462 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467889999999999999999975 7899999999653 3445778999999999999999999999865
Q ss_pred ---CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEE
Q 006906 463 ---GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 539 (626)
Q Consensus 463 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~k 539 (626)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 356899999999999999996542 35788999999999999999999997 99999999999999999999
Q ss_pred EeecCCcccccCCC-------------cceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHh
Q 006906 540 ISDFGLAKLYEEDK-------------THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVS 595 (626)
Q Consensus 540 l~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~ellt 595 (626)
|+|||++....... ........||+.|+|||.+.+. .++.++|||||||++|||++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999998664321 1112335689999999999764 78999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.15 Aligned_cols=202 Identities=27% Similarity=0.448 Sum_probs=150.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHH-HHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIG-MISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|.+.+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888999999999999999985 68999999997653 333455666666 7778899999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|+++ +|.+++..........+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 777766421111123689999999999999999999998 7 9999999999999999999999999998765
Q ss_pred CCCcceecccccCCcccchhhh----ccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYA----MRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4322 2234689999999998 456789999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=295.21 Aligned_cols=211 Identities=23% Similarity=0.361 Sum_probs=171.1
Q ss_pred CcccHHHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCC--CCceeeEEE
Q 006906 383 GLYTLRQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQ--HPNLVKLYG 458 (626)
Q Consensus 383 ~~~~~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~~ 458 (626)
..+.++.+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ |+||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 334444455556789999999999999999999988999999998654 2344577899999999997 599999999
Q ss_pred EEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 459 CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 459 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
++.+.+..++||| +.+++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++ +.+
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~ 165 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeE
Confidence 9999999999999 6688999998654 26899999999999999999999997 999999999999975 789
Q ss_pred EEeecCCcccccCCCcc-eecccccCCcccchhhhcc-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 539 KISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMR-----------GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 539 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+|||+++........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 99999999876543221 2233568999999999865 46888999999999999999999999653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.25 Aligned_cols=195 Identities=27% Similarity=0.422 Sum_probs=166.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-----
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 465 (626)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 356888999999999999999975 68999999997642 3335678899999999999999999999987654
Q ss_pred -EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 466 -LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 466 -~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.++||||+. ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence 499999998 588777632 4899999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865432 223568999999999877 67899999999999999999999999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=292.83 Aligned_cols=199 Identities=21% Similarity=0.339 Sum_probs=169.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CC-cEEEEEEeccCChhcHHHHHHHHHHHhcCCCCc------eeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DG-TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN------LVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 465 (626)
.++|++.+.||+|+||+||+|... ++ +.||||++... ....+.+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467889999999999999999975 34 78999999754 344567888999998887765 9999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE-------------
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL------------- 532 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl------------- 532 (626)
.++||||+ ++++.+.+..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 99999999 5566666544321 36899999999999999999999987 9999999999999
Q ss_pred ------cCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 533 ------DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 533 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
+.++.+||+|||+++...... ....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 668899999999998654322 33568999999999999999999999999999999999999997543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=320.09 Aligned_cols=204 Identities=27% Similarity=0.401 Sum_probs=170.8
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
...++|++.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 344668888999999999999999742 4679999987643 334567999999999999999999999984 5668
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCc
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLA 546 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla 546 (626)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 99999999999999986542 35899999999999999999999997 999999999999999999999999999
Q ss_pred ccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 547 KLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 547 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+..............+|+.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 8765443333333457789999999998899999999999999999997 99998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=285.19 Aligned_cols=201 Identities=26% Similarity=0.442 Sum_probs=173.8
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999986 68999999986542 3456789999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CCEEEeecCC
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD---LNAKISDFGL 545 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~~kl~DfGl 545 (626)
||||+++++|.+.+... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.+ +.+||+|||+
T Consensus 99 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999998887543 26899999999999999999999997 9999999999999764 4699999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 987654322 223458899999998865 4899999999999999999999998653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.90 Aligned_cols=198 Identities=24% Similarity=0.337 Sum_probs=167.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-----------CCceeeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCVE 462 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~ 462 (626)
++|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 56888999999999999999974 6899999999753 344567888999888776 8999999999886
Q ss_pred CC----eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEc----
Q 006906 463 GN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLD---- 533 (626)
Q Consensus 463 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~---- 533 (626)
.+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 54 789999999 8899998865322 2589999999999999999999998 7 99999999999994
Q ss_pred --CCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 534 --KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 534 --~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4457999999999876532 223468999999999999999999999999999999999999997643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.42 Aligned_cols=201 Identities=23% Similarity=0.407 Sum_probs=166.6
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..++|++.+.||+|+||.||+|...+ .||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35678899999999999999999854 48999987542 233456788999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++ ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp BCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999996543 36899999999999999999999997 99999999999998 6799999999987653
Q ss_pred CCC----cceecccccCCcccchhhhcc---------CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDK----THISTRIAGTIGYMAPEYAMR---------GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 111223458999999999864 45788999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=291.99 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=163.4
Q ss_pred HHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh------cHHHHHHHHHHHhcC----CCCceeeEE
Q 006906 389 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQ----QHPNLVKLY 457 (626)
Q Consensus 389 ~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~ 457 (626)
+.+...++|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|++++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999874 6889999999764321 223455788888887 899999999
Q ss_pred EEEEeCCeEEEEEEe-cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CC
Q 006906 458 GCCVEGNQLLLVYEY-MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KD 535 (626)
Q Consensus 458 ~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~ 535 (626)
+++...+..++|||| +.+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++ .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 999999999999999 7899999998643 25899999999999999999999997 99999999999999 88
Q ss_pred CCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCC-ChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 536 LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT-SKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 536 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+.+||+|||++....... .....|+..|+|||.+....+. .++||||||+++|||++|+.||..
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999999998765432 2335689999999998876654 589999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=290.71 Aligned_cols=197 Identities=23% Similarity=0.301 Sum_probs=146.5
Q ss_pred hcCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeEE
Q 006906 394 TNNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLL 467 (626)
Q Consensus 394 t~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 467 (626)
.++|.+. ++||+|+||.||+|... +++.||||++.... +...+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4677775 46999999999999987 68999999986531 222223334567899999999999876 45589
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEeecC
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG 544 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfG 544 (626)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 103 lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 99999999999999976532 36899999999999999999999997 999999999999976 4559999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++...... .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 998654322 23356899999999998888999999999999999999999999654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=300.12 Aligned_cols=200 Identities=28% Similarity=0.343 Sum_probs=157.1
Q ss_pred CCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 397 FDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++.+.+..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456889999999998777778999999998653 245678899999875 89999999999999999999999996
Q ss_pred CchhhhhcCCCcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-------------CCEEE
Q 006906 476 NCLSRAIFGKDTEYR--LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-------------LNAKI 540 (626)
Q Consensus 476 gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~~kl 540 (626)
|+|.+++........ ...++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 699999976532111 11244466889999999999999997 9999999999999754 48999
Q ss_pred eecCCcccccCCCcc---eecccccCCcccchhhhcc-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 541 SDFGLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMR-------GYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 541 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 999999977543322 1223579999999999965 678999999999999999999 99998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.73 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=171.7
Q ss_pred HHHHHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChh------cHHHHHHHHHHHhcCC--CCceeeEEEE
Q 006906 389 QIKAATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQ------GNREFVNEIGMISAQQ--HPNLVKLYGC 459 (626)
Q Consensus 389 ~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~ 459 (626)
+.+...++|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445677999999999999999999965 6899999998764221 2245678999999986 5999999999
Q ss_pred EEeCCeEEEEEEecCC-CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCC
Q 006906 460 CVEGNQLLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLN 537 (626)
Q Consensus 460 ~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~ 537 (626)
+...+..++||||+.+ ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCC
Confidence 9999999999999986 8999988543 36899999999999999999999997 99999999999999 7899
Q ss_pred EEEeecCCcccccCCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 538 AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 538 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
+||+|||+++...... .....||+.|+|||.+....+ +.++||||||+++|||++|+.||..
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9999999998765432 233568999999999987665 6789999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=316.30 Aligned_cols=192 Identities=22% Similarity=0.377 Sum_probs=166.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc--CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCe-----
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS--DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQ----- 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~--~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 465 (626)
.++|.+.+.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 467889999999999999999986 5899999998654 33445678899999999999999999999987665
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+++++|.+++.. .+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999887633 5899999999999999999999997 9999999999999986 899999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+..
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 9876543 3356999999999987654 8899999999999999999988764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=297.61 Aligned_cols=197 Identities=26% Similarity=0.358 Sum_probs=158.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++++ +|||||++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 457788999999999976655668999999999754322 356799999998 8999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----CCCEEEeecCCccc
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLAKL 548 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla~~ 548 (626)
. |+|.+++..... .+.+..+..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 101 ~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 101 A-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp S-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred C-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 7 599999876532 3555677899999999999999997 999999999999953 33688999999987
Q ss_pred ccCCCc--ceecccccCCcccchhhhc---cCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 549 YEEDKT--HISTRIAGTIGYMAPEYAM---RGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 549 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
...... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 654321 1223467999999999997 4567889999999999999999 8988854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=284.22 Aligned_cols=199 Identities=29% Similarity=0.493 Sum_probs=150.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-hcH-HHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-QGN-REFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-~~~-~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ... +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356788899999999999999986 689999999976532 222 33445556788899999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
||+ ++.+..+.... ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 104 e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 44554444321 13689999999999999999999985 6 999999999999999999999999999866
Q ss_pred cCCCcceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 176 VDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 44322 23346899999999984 45688999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-34 Score=297.53 Aligned_cols=191 Identities=21% Similarity=0.238 Sum_probs=161.0
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC--------hhcHHHHHHHHHHHhcCC---------CCceeeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--------RQGNREFVNEIGMISAQQ---------HPNLVKL 456 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l 456 (626)
.++|.+.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|++++++++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999998 68999999997652 223477889999888875 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHH
Q 006906 457 YGCCV------------------------------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506 (626)
Q Consensus 457 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 506 (626)
.+++. ..+..++||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 77653 26789999999999977666643 2589999999999999
Q ss_pred HHHHHHH-hCCCCCeEEeCCCCCCEEEcCCC--------------------CEEEeecCCcccccCCCcceecccccCCc
Q 006906 507 RGLAYLH-EDSRIKIVHRDIKTSNVLLDKDL--------------------NAKISDFGLAKLYEEDKTHISTRIAGTIG 565 (626)
Q Consensus 507 ~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 565 (626)
.||+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 887 99999999999999887 8999999999976532 2469999
Q ss_pred ccchhhhccCCCCChhhHHHHHHH-HHHHHhCCCCCC
Q 006906 566 YMAPEYAMRGYLTSKADVYSFGVV-TLEIVSGKSNTN 601 (626)
Q Consensus 566 y~aPE~~~~~~~~~k~Dv~s~Gvi-l~elltG~~p~~ 601 (626)
|+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999998766 889999998777 777889998874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=307.80 Aligned_cols=201 Identities=28% Similarity=0.449 Sum_probs=173.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe------CCeE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQL 466 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~ 466 (626)
++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999975 6889999998764 34445678999999999999999999998755 6678
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCC---EEEeec
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLN---AKISDF 543 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---~kl~Df 543 (626)
++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 999999999999999976432 235899999999999999999999997 999999999999997765 899999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9998765432 22345789999999999999999999999999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=271.38 Aligned_cols=171 Identities=10% Similarity=0.042 Sum_probs=150.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|.+.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|++.+.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888999999999999999986 489999999976532 33478899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++++|.+++... ....++.+++.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999998532 345578899999999999999997 9999999999999999999998443
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|++| ++.++|||||||++|||+||+.||...
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3333 588999999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=266.51 Aligned_cols=174 Identities=24% Similarity=0.336 Sum_probs=150.1
Q ss_pred cCCCCC-CeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHH-hcCCCCceeeEEEEEEe----CCeEE
Q 006906 395 NNFDPA-NKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMI-SAQQHPNLVKLYGCCVE----GNQLL 467 (626)
Q Consensus 395 ~~f~~~-~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~ 467 (626)
++|.+. +.||+|+||.||++... +++.||+|++... ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 78999999999999975 6899999998642 4567888887 66799999999999987 67789
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEeecC
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDFG 544 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~DfG 544 (626)
+||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999875432 36899999999999999999999997 999999999999998 7899999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
++..... ..++.++|||||||++|||+||+.||..
T Consensus 166 ~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 166 FAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp TCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 9875432 2356799999999999999999999954
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=285.14 Aligned_cols=200 Identities=15% Similarity=0.134 Sum_probs=153.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCC-Cce----------e-----
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQH-PNL----------V----- 454 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H-~nI----------v----- 454 (626)
.+|...+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++..++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 44667789999999999999965 689999999874322 335778999999999987 221 1
Q ss_pred eE------EEEEEe-----CCeEEEEEEecCCCchhhhhcCCC--cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 006906 455 KL------YGCCVE-----GNQLLLVYEYMKNNCLSRAIFGKD--TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIV 521 (626)
Q Consensus 455 ~l------~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 521 (626)
.+ ..++.. ....+++|+++ +++|.+++.... ......+++..+..++.||++||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 11 111111 22356777765 588988874110 001135788999999999999999999997 99
Q ss_pred EeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhh----------ccCCCCChhhHHHHHHHHH
Q 006906 522 HRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA----------MRGYLTSKADVYSFGVVTL 591 (626)
Q Consensus 522 H~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~Dv~s~Gvil~ 591 (626)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865432 334567 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCC
Q 006906 592 EIVSGKSNTNYR 603 (626)
Q Consensus 592 elltG~~p~~~~ 603 (626)
||+||+.||...
T Consensus 309 elltg~~Pf~~~ 320 (413)
T 3dzo_A 309 WIWCADLPNTDD 320 (413)
T ss_dssp HHHHSSCCCCTT
T ss_pred HHHHCCCCCCCc
Confidence 999999999754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=279.41 Aligned_cols=183 Identities=18% Similarity=0.134 Sum_probs=128.8
Q ss_pred eeeccCceEEEEEEE-cCCcEEEEEEeccCC----------hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEE
Q 006906 402 KVGEGGFGSVYKGIL-SDGTVIAVKQLSSKS----------RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 402 ~IG~G~fG~Vyk~~~-~~g~~vAvK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 469 (626)
..+.|+.|.+..++. --|+.+|||++.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 345566666665442 258889999986541 22346799999999999 799999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||++|++|.++|.... .++. .+|+.||+.||+|+|+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhCC-----CCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999997653 4554 358999999999999998 999999999999999999999999999876
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~ 597 (626)
..... .....+||++|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 54332 2344679999999999865 4567899999999887765553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=257.19 Aligned_cols=185 Identities=18% Similarity=0.205 Sum_probs=146.7
Q ss_pred CCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh--------hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 398 DPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
...++||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999955 577788887654321 1134589999999999999999777777788888999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999998854 4589999999999999997 999999999999998 9999999999987
Q ss_pred cCCCcce------ecccccCCcccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 550 EEDKTHI------STRIAGTIGYMAPEYAMR--GYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 550 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
....... .....||+.|||||++.. ..|+...|+|+..+-.++.+.++.++.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 5432211 234679999999999976 567888999999999999998887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=210.89 Aligned_cols=151 Identities=17% Similarity=0.068 Sum_probs=121.2
Q ss_pred HHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh------------------hcHHHHHHHHHHHhcCCC
Q 006906 389 QIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQH 450 (626)
Q Consensus 389 ~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~l~~l~H 450 (626)
.+......|.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444556777899999999999999997799999999964321 13456889999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 006906 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 530 (626)
Q Consensus 451 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 530 (626)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||+.+ |+||||||+||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 4 666665544 45699999999999988 421 234579999999999999997 99999999999
Q ss_pred EEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhc
Q 006906 531 LLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573 (626)
Q Consensus 531 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 573 (626)
|++ ++.+||+|||+++. +..|+|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999 99999999999973 33478999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-19 Score=178.97 Aligned_cols=136 Identities=17% Similarity=0.153 Sum_probs=105.1
Q ss_pred CCCCCeeeccCceEEEEEEE-cCCcE--EEEEEeccCChh------------------------cHHHHHHHHHHHhcCC
Q 006906 397 FDPANKVGEGGFGSVYKGIL-SDGTV--IAVKQLSSKSRQ------------------------GNREFVNEIGMISAQQ 449 (626)
Q Consensus 397 f~~~~~IG~G~fG~Vyk~~~-~~g~~--vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 449 (626)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 68888 999987543111 1136788999999998
Q ss_pred CCce--eeEEEEEEeCCeEEEEEEecCC-C----chhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 006906 450 HPNL--VKLYGCCVEGNQLLLVYEYMKN-N----CLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH-EDSRIKIV 521 (626)
Q Consensus 450 H~nI--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ii 521 (626)
|+++ ..++++ +..++||||+.+ | +|.+... ..++..+..++.|++.||.||| +.+ |+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 8764 333332 246899999952 4 4544432 1235577899999999999999 876 99
Q ss_pred EeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 522 HRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 522 H~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
||||||.|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999864
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.7e-17 Score=159.59 Aligned_cols=135 Identities=21% Similarity=0.247 Sum_probs=124.3
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~ 77 (626)
++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|... +++|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~ 110 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEE
Confidence 36899999999999777778999999999999999999888999999999999999999999 566654 45999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
|++|++++..|..+ ..+++|+.|+|++|++++..+..+..++....+.+..|+|.|+|.
T Consensus 111 L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 111 LNANKINCLRVDAF----QDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCSSCCCCCCTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCCCEeCHHHc----CCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 99999998887776 889999999999999999999999999999999999999999997
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.5e-17 Score=157.84 Aligned_cols=135 Identities=20% Similarity=0.191 Sum_probs=123.1
Q ss_pred cceEEEeecCceeecCC-ccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
.+++|+|++|+|++..| ..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ +++|+.|+|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 112 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence 57899999999997766 458999999999999999998888899999999999999999997666555 459999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++|++++..|..+ ..+++|+.|++++|++++..|..+..++....+.+..|+|.|+|.
T Consensus 113 s~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 113 RSNRITCVGNDSF----IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTSS----TTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCeECHhHc----CCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999999888776 789999999999999999999999999999999999999999997
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.3e-16 Score=156.83 Aligned_cols=135 Identities=19% Similarity=0.182 Sum_probs=120.2
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+ +++|+.|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 479999999999998889999999999999999999986666778999999999999999995444444 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++|+++ .+|..+ ..+++|+.|++++|+|++..+..+..++....+.+.+|+|.|+|.
T Consensus 120 s~N~l~-~lp~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 120 CCNKLT-ELPRGI----ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCC-SCCTTG----GGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccc-ccCccc----ccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 999998 555544 889999999999999999988889999999999999999999986
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1e-16 Score=167.53 Aligned_cols=138 Identities=11% Similarity=0.114 Sum_probs=100.0
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh--------------hcHHH--------HHHHHHHHhcCCCCce
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR--------------QGNRE--------FVNEIGMISAQQHPNL 453 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~--------------~~~~~--------~~~E~~~l~~l~H~nI 453 (626)
-|.+.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999998999999998753210 00111 2345566666654443
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 006906 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD 533 (626)
Q Consensus 454 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~ 533 (626)
....-+.... .+|||||+++++|.++.. .+....++.|++.+|.|||+.+ ||||||||.|||++
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 2221122222 379999999988866532 1234678899999999999987 99999999999998
Q ss_pred CCCC----------EEEeecCCcccc
Q 006906 534 KDLN----------AKISDFGLAKLY 549 (626)
Q Consensus 534 ~~~~----------~kl~DfGla~~~ 549 (626)
+++. +.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 8773 899999977654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.7e-16 Score=154.83 Aligned_cols=133 Identities=17% Similarity=0.195 Sum_probs=89.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+ +++|+.|+|+
T Consensus 60 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 139 (251)
T 3m19_A 60 KLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN 139 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred cCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECc
Confidence 56666666666666555566666677777777777765555666667777777777777764333323 3467777777
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeee
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHIN 138 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~ 138 (626)
+|++++..+..+ +.+++|+.|++++|++++..|..+..++....+.+.+++|.|.
T Consensus 140 ~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 140 TNQLQSIPAGAF----DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCCCCCTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCCccCHHHc----CcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 777775554444 6677778888888888777777777777777777777777776
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.7e-16 Score=181.90 Aligned_cols=130 Identities=25% Similarity=0.261 Sum_probs=109.6
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+++|.+|..++++++|++|+|++|+++|.+|.+|+++++|++|+|++|+++|.+|..+ +++|+.|++
T Consensus 466 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 545 (768)
T 3rgz_A 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEEC
T ss_pred CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEEC
Confidence 468999999999999999999999999999999999999999999999999999999999999999888 458999999
Q ss_pred ccCcccccCCCCCCC-----------------------------------------------------------------
Q 006906 79 SLNNFTWESSDPIEC----------------------------------------------------------------- 93 (626)
Q Consensus 79 s~N~l~~~~~~~~~~----------------------------------------------------------------- 93 (626)
++|+++|.+|..+..
T Consensus 546 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~ 625 (768)
T 3rgz_A 546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625 (768)
T ss_dssp CSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred CCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence 999998887754311
Q ss_pred -CCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 94 -PRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 94 -~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
..+.++.|+.|++++|+++|.+|..++.++....+.+
T Consensus 626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~L 663 (768)
T 3rgz_A 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663 (768)
T ss_dssp CSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEEC
T ss_pred hhhhccccccEEECcCCcccccCCHHHhccccCCEEeC
Confidence 1234577889999999999999999888887665444
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=8.4e-16 Score=177.73 Aligned_cols=131 Identities=24% Similarity=0.328 Sum_probs=91.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhh----------
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---------- 70 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~---------- 70 (626)
++|++|+|++|+++|.+|.+++++++|++|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++
T Consensus 490 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhc
Confidence 3577777777777777777777777777777777777777777777777777777777777777776542
Q ss_pred --------------------------------------------------------------hcCCccccccCcccccCC
Q 006906 71 --------------------------------------------------------------NSNKNVDISLNNFTWESS 88 (626)
Q Consensus 71 --------------------------------------------------------------~~l~~l~ls~N~l~~~~~ 88 (626)
+.|+.|||++|+++|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 235567777777777766
Q ss_pred CCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceee
Q 006906 89 DPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTL 135 (626)
Q Consensus 89 ~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~ 135 (626)
..+ +.++.|+.|+|++|+++|.+|..++.++....+.+.++.+
T Consensus 650 ~~l----~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l 692 (768)
T 3rgz_A 650 KEI----GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692 (768)
T ss_dssp GGG----GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred HHH----hccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc
Confidence 655 6667777777777777777777666666665555544433
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=153.06 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=107.3
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..+ +++|+.|++
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 367888888888886666667888888888888888887777778888888888888888885444443 458888888
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++|++++..+..+ +.+++|+.|++++|++++..|..+..++....+.+..++|.|.|.
T Consensus 165 ~~n~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 165 SYNQLQSLPEGVF----DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CSSCCCCCCTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCccCHHHh----cCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 8888886655444 678888888888888888888888888888888888888887776
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-15 Score=145.18 Aligned_cols=137 Identities=15% Similarity=0.139 Sum_probs=118.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..+..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+ +++|+.|++
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 368999999999996666678999999999999999997777778999999999999999995444444 559999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~ 141 (626)
++|++++..+..+ ..+++|+.|++++|++++..+..+..++....+.+..+++.+.|..
T Consensus 108 ~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 108 NTNQLQSLPDGVF----DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp CSSCCCCCCTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred CCCcCcccCHhHh----ccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence 9999997666555 7899999999999999998888888899888888888888887763
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=145.43 Aligned_cols=130 Identities=18% Similarity=0.156 Sum_probs=114.7
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChH-HhhccCCCCEEeccCccccccCchhh--hhcCCcccccc
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISL 80 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~ 80 (626)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..|. .|+++++|++|+|++|+|++..|..+ +++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57899999997 88887754 899999999999876664 48999999999999999998778777 45999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
|++++..+..+ ..+++|+.|++++|++++.+|..+..++....+.+.+|+|.|+|.
T Consensus 88 N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMF----LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSS----TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHh----cCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998877666 788999999999999999999999999999999999999999987
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=153.29 Aligned_cols=134 Identities=21% Similarity=0.171 Sum_probs=111.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+ +++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 46888999999988 788889999999999999999997777889999999999999999995444333 458999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++|+++...+..+ ..+++|+.|++++|+|+ .+|.....++....+.+.+|+|.|+|.
T Consensus 156 ~~N~l~~l~~~~~----~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 156 ANNNLTELPAGLL----NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp TTSCCSCCCTTTT----TTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCCcCCccCHHHh----cCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 9999986555444 67899999999999998 556666666777777889999999996
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.5e-15 Score=142.46 Aligned_cols=129 Identities=12% Similarity=0.135 Sum_probs=116.2
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccccC
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLN 81 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N 81 (626)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..+ +.+|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57899999999 7887664 68999999999998 888999999999999999999996655555 469999999999
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++++..+..+ ..+++|+.|+|++|+++...+..+..++....+.+.+|+|.|+|.
T Consensus 89 ~l~~i~~~~f----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTF----DGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTT----TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHh----CCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9998877776 789999999999999999888889999999999999999999997
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.7e-15 Score=150.02 Aligned_cols=136 Identities=18% Similarity=0.216 Sum_probs=100.3
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+ +++|+.|+|+
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 165 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLY 165 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEec
Confidence 56777777777775444556777777777777777776666667777777777777777774333323 4577888888
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~ 141 (626)
+|++++..+..+ ..+++|+.|++++|++++..+..+..++....+.+.+++|.|+|..
T Consensus 166 ~n~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 166 NNQLKRVPEGAF----DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp SSCCSCCCTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred CCcCcEeChhHh----ccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 888876655444 6788899999999999888887788888888888889999999873
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-15 Score=156.95 Aligned_cols=130 Identities=20% Similarity=0.333 Sum_probs=101.4
Q ss_pred cceEEEeecCceee--cCCccccCCCCCCEEEeec-CcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcc
Q 006906 2 NLKTLILTKCLIHG--EIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNV 76 (626)
Q Consensus 2 ~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l 76 (626)
+++.|+|++|+|+| .+|..|+++++|++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..+ +++|+.|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 57788888888888 7888888888888888884 88888888888888888888888888888888777 4588888
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCC-CCCCCCCcceee
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFP-CSAPADQYHYTL 135 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p-~~~~~~~~~~~~ 135 (626)
+|++|++++.+|..+ +.+++|++|++++|++++.+|..+..++ ....+.+..+.+
T Consensus 131 ~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 131 DFSYNALSGTLPPSI----SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp ECCSSEEESCCCGGG----GGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred eCCCCccCCcCChHH----hcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCee
Confidence 888888887776665 7788888888888888888887777776 455444444433
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-15 Score=155.88 Aligned_cols=119 Identities=24% Similarity=0.331 Sum_probs=110.9
Q ss_pred CcceEEEeec-CceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|++|+|++ |++++.+|..|+++++|++|+|++|+|++.+|..|.++++|++|+|++|+|++.+|..+ +++|+.|+
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEE
Confidence 4799999995 99999999999999999999999999999999999999999999999999999999988 56999999
Q ss_pred cccCcccccCCCCCCCCCCCcc-ccceeecCCCccCCCCCcccCCCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVN-LVESYSSPRNKLDKVHPCLRQNFP 123 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~-~l~~l~l~~N~l~~~~p~~~~~~p 123 (626)
+++|++++.+|..+ +.++ .|+.|++++|++++.+|..+..+.
T Consensus 156 L~~N~l~~~~p~~l----~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 156 FDGNRISGAIPDSY----GSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp CCSSCCEEECCGGG----GCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred CcCCcccCcCCHHH----hhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 99999999888776 7777 999999999999999999888765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=3.4e-15 Score=151.45 Aligned_cols=135 Identities=16% Similarity=0.188 Sum_probs=95.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|++++..|..+.++++|++|+|++|++++..+..|+++++|++|+|++|+|++..+..+ +++|+.|+++
T Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 185 (285)
T 1ozn_A 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (285)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence 56667777777766556666677777777777777765555566777777777777777774333333 3467777777
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
+|++++..|..+ +.+++|+.|++++|++++..+..+..++....+.+.+++|.|+|.
T Consensus 186 ~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 186 QNRVAHVHPHAF----RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SSCCCEECTTTT----TTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CCcccccCHhHc----cCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 777776666555 677888888888888888777777888888888888888888887
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=5.1e-15 Score=160.27 Aligned_cols=136 Identities=15% Similarity=0.131 Sum_probs=126.6
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|+.|+|++|++++.+|..++.+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..+ +++|+.|+|+
T Consensus 276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 355 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355 (455)
T ss_dssp CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence 68999999999999999999999999999999999999889999999999999999999997777776 5699999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~ 141 (626)
+|++++..|..+ ..+++|+.|++++|++++..+..+..++....+.+.++++.|+|..
T Consensus 356 ~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 356 YNHIRALGDQSF----LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp SSCCCEECTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CCcccccChhhc----cccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 999998888776 8899999999999999998888889999999999999999999974
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.55 E-value=6.3e-15 Score=140.50 Aligned_cols=111 Identities=20% Similarity=0.243 Sum_probs=100.7
Q ss_pred cceEEEeecCceeecCCc-cccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPD-YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
+|++|+|++|+|++..|. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ +++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 689999999999966654 48999999999999999999999999999999999999999998777656 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
++|++++..|..+ ..+++|+.|++++|++++..+
T Consensus 110 ~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSF----EHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSS----TTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHh----hcCCCCCEEEeCCCCccCcCc
Confidence 9999999888776 889999999999999988765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=141.78 Aligned_cols=112 Identities=13% Similarity=0.106 Sum_probs=102.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ +++|+.|+|
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 479999999999998777899999999999999999998888899999999999999999998778777 469999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
++|++++..|..+ ..+++|+.|++++|.+.+..+
T Consensus 137 ~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 137 YDNQITTVAPGAF----DTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTTT----TTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCEECHHHh----cCCCCCCEEEecCcCCcCCCc
Confidence 9999999888777 789999999999999987654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.9e-15 Score=152.55 Aligned_cols=135 Identities=19% Similarity=0.232 Sum_probs=100.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCC-CChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
+|++|+|++|++++..|..+..+++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+ +++|+.|+|
T Consensus 127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 56777777777776666677777777777777777765 467777777777777777777776556655 347778888
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCC-CCCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFP-CSAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p-~~~~~~~~~~~~~~~c~ 140 (626)
++|++++..+..+ ..+++|+.|++++|++++..|..+..+| ....+.+.++++.|+|.
T Consensus 207 ~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 207 SHNNFFSLDTFPY----KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp TTSCCSBCCSGGG----TTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred CCCccCccChhhc----cCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 8887776544443 6678888888888888888888888875 67777778888888887
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=144.08 Aligned_cols=127 Identities=13% Similarity=0.109 Sum_probs=109.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ +++|+.|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 368999999999998888889999999999999999999888889999999999999999996555544 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY 131 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~ 131 (626)
++|++++..+..+ ..+++|+.|++++|++++..+..++.++....+.+.
T Consensus 115 ~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 163 (251)
T 3m19_A 115 GGNQLKSLPSGVF----DRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLS 163 (251)
T ss_dssp CSSCCCCCCTTTT----TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCcCCCcChhHh----ccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECC
Confidence 9999997665555 788999999999999998888888888776655443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.53 E-value=3e-15 Score=157.42 Aligned_cols=138 Identities=15% Similarity=0.107 Sum_probs=66.0
Q ss_pred ceEEEeecCceeecCCcccc-CCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 3 LKTLILTKCLIHGEIPDYIG-DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
|+.|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+ +.+|+.|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44555555555544444444 55555555555555554444445555555555555555553222222 2345555555
Q ss_pred cCcccccCCCCC-----------------------CCCCCCccccceeecCCCccCCCCCcccCCCCCC--CCCCCccee
Q 006906 80 LNNFTWESSDPI-----------------------ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS--APADQYHYT 134 (626)
Q Consensus 80 ~N~l~~~~~~~~-----------------------~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~--~~~~~~~~~ 134 (626)
+|++++..|..+ ......+++|+.|+|++|+|+...+..+..++.. ..+.+.+|+
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 555544443333 0000234445555555555554443334444331 345566778
Q ss_pred eeeecC
Q 006906 135 LHINCG 140 (626)
Q Consensus 135 ~~~~c~ 140 (626)
|.|+|.
T Consensus 201 ~~C~C~ 206 (361)
T 2xot_A 201 LECDCK 206 (361)
T ss_dssp EECCHH
T ss_pred ccCCcC
Confidence 888875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.4e-14 Score=150.25 Aligned_cols=119 Identities=12% Similarity=0.185 Sum_probs=59.1
Q ss_pred cceEEEeecCceeecCCccccC---------CCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--h
Q 006906 2 NLKTLILTKCLIHGEIPDYIGD---------MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--F 70 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~---------l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~ 70 (626)
+|++|+|++|++.+.+|..++. +++|++|+|++|+|+ .+|..++++++|++|+|++|++++ +|..+ +
T Consensus 151 ~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l 228 (328)
T 4fcg_A 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHL 228 (328)
T ss_dssp TCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGC
T ss_pred CCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccC
Confidence 4555555555555555544433 555555555555555 455555555555555555555552 33333 2
Q ss_pred hcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCC
Q 006906 71 NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 71 ~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~ 126 (626)
++|+.|+|++|++.+.+|..+ +.+++|+.|++++|++.+.+|..+..++...
T Consensus 229 ~~L~~L~Ls~n~~~~~~p~~~----~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~ 280 (328)
T 4fcg_A 229 PKLEELDLRGCTALRNYPPIF----GGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280 (328)
T ss_dssp TTCCEEECTTCTTCCBCCCCT----TCCCCCCEEECTTCTTCCBCCTTGGGCTTCC
T ss_pred CCCCEEECcCCcchhhhHHHh----cCCCCCCEEECCCCCchhhcchhhhcCCCCC
Confidence 345555555555555444433 4445555555555555555554444444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6.7e-15 Score=133.99 Aligned_cols=121 Identities=15% Similarity=0.199 Sum_probs=104.3
Q ss_pred CcceEEEeecCcee-ecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|+.|+|++|+++ +.+|..++.+++|++|+|++|+|++. ..++++++|++|+|++|++++.+|..+ +++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 36899999999999 89999999999999999999999976 789999999999999999998788876 56999999
Q ss_pred cccCccccc-CCCCCCCCCCCccccceeecCCCccCCCCC---cccCCCCCCCC
Q 006906 78 ISLNNFTWE-SSDPIECPRGSVNLVESYSSPRNKLDKVHP---CLRQNFPCSAP 127 (626)
Q Consensus 78 ls~N~l~~~-~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p---~~~~~~p~~~~ 127 (626)
+++|++++. .+..+ +.+++|+.|++++|++++..+ ..+..+|....
T Consensus 95 ls~N~i~~~~~~~~~----~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 144 (149)
T 2je0_A 95 LSGNKIKDLSTIEPL----KKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTY 144 (149)
T ss_dssp CTTSCCCSHHHHGGG----GGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCE
T ss_pred CCCCcCCChHHHHHH----hhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccc
Confidence 999999874 22333 789999999999999998877 45666665543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.8e-14 Score=133.95 Aligned_cols=123 Identities=17% Similarity=0.255 Sum_probs=106.3
Q ss_pred CcceEEEeecCcee-ecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|+.|+|++|+|+ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+ +++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 46899999999998 88999999999999999999999966 789999999999999999998788877 56999999
Q ss_pred cccCcccccCC-CCCCCCCCCccccceeecCCCccCCCCC---cccCCCCCCCCCC
Q 006906 78 ISLNNFTWESS-DPIECPRGSVNLVESYSSPRNKLDKVHP---CLRQNFPCSAPAD 129 (626)
Q Consensus 78 ls~N~l~~~~~-~~~~~~~~~~~~l~~l~l~~N~l~~~~p---~~~~~~p~~~~~~ 129 (626)
+++|++++... .. ...+++|+.|++++|++++..+ ..+..+|....+.
T Consensus 102 Ls~N~l~~~~~~~~----l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~ 153 (168)
T 2ell_A 102 LSGNKLKDISTLEP----LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153 (168)
T ss_dssp CBSSSCCSSGGGGG----GSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEET
T ss_pred ccCCccCcchhHHH----HhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEec
Confidence 99999987432 23 3789999999999999998877 5677777665543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.1e-14 Score=134.94 Aligned_cols=109 Identities=17% Similarity=0.196 Sum_probs=97.6
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ +++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 36899999999999 899999999999999999999998888899999999999999999997666666 469999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
++|+++...+..+ ..+++|+.|++++|.+...
T Consensus 110 ~~N~l~~~~~~~~----~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 110 HGNDISVVPEGAF----NDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CSSCCCBCCTTTT----TTCTTCCEEECCSSCEECS
T ss_pred CCCCCCeeChhhh----hcCccccEEEeCCCCeecC
Confidence 9999997665555 7889999999999999653
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.9e-14 Score=132.28 Aligned_cols=130 Identities=12% Similarity=0.105 Sum_probs=85.3
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccccC
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLN 81 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N 81 (626)
+.+++++|+++ .+|..+ .++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..+ +++|+.|++++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45677777776 566443 3577777777777776555566777777777777777774333333 346777777777
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++++..+..+ ..+++|+.|++++|++++..+..+..++....+.+..+++.++|.
T Consensus 87 ~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVF----DKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHh----hCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 7775544433 566777777777777776666666666666666666777766664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.49 E-value=5.2e-14 Score=137.19 Aligned_cols=109 Identities=16% Similarity=0.164 Sum_probs=98.3
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..+ +++|+.|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 479999999999998889999999999999999999996666678999999999999999998777776 469999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
++|++++..+..+ ..+++|+.|++++|++..
T Consensus 136 ~~N~l~~~~~~~~----~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 136 YDNKLQTIAKGTF----SPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CSSCCSCCCTTTT----TTCTTCCEEECCSSCEEC
T ss_pred CCCcCCEECHHHH----hCCCCCCEEEeCCCCcCC
Confidence 9999998877666 789999999999999965
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.48 E-value=3.6e-14 Score=147.09 Aligned_cols=125 Identities=14% Similarity=0.143 Sum_probs=109.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhc---------cCCCCEEeccCccccccCchhh--
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEK---------LAKTNFMYLTGNKLTGPVPKYI-- 69 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~---------l~~L~~L~ls~N~l~g~ip~~~-- 69 (626)
++|++|+|++|+|+ .+|..++++++|++|+|++|++.+.+|..++. +++|++|+|++|+|+ .+|..+
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~ 204 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204 (328)
T ss_dssp TTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred CCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC
Confidence 47999999999999 89999999999999999999999999988765 999999999999999 899887
Q ss_pred hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcc
Q 006906 70 FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYH 132 (626)
Q Consensus 70 ~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~ 132 (626)
+++|+.|+|++|++++. |..+ +.+++|+.|++++|++.+.+|..++.++....+.+..
T Consensus 205 l~~L~~L~L~~N~l~~l-~~~l----~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~ 262 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLSAL-GPAI----HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262 (328)
T ss_dssp CTTCCEEEEESSCCCCC-CGGG----GGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTT
T ss_pred CCCCCEEEccCCCCCcC-chhh----ccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCC
Confidence 45999999999999963 3333 7899999999999999999999988888776655543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=7.8e-14 Score=140.64 Aligned_cols=135 Identities=16% Similarity=0.219 Sum_probs=88.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCC-CChHHhhccCCCCEEeccCccccccCchhh--hhcCC----
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNK---- 74 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~---- 74 (626)
+|++|+|++|++++..+..++++++|++|+|++|++++ .+|..|.++++|++|+|++|++++..+..+ +..|+
T Consensus 101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l 180 (276)
T 2z62_A 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180 (276)
T ss_dssp TCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE
T ss_pred cccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce
Confidence 45555555555554333345555666666666666654 246666666666666666666664433333 22444
Q ss_pred ccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCC
Q 006906 75 NVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 75 ~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~ 141 (626)
.|++++|++++..+..+ ...+|+.|++++|++++..+..+..++....+.+.+++|.|+|..
T Consensus 181 ~L~ls~n~l~~~~~~~~-----~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 181 SLDLSLNPMNFIQPGAF-----KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp EEECCSSCCCEECTTSS-----CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred eeecCCCcccccCcccc-----CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 56666666665444332 334799999999999998888889999999999999999999974
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=1e-13 Score=130.04 Aligned_cols=113 Identities=19% Similarity=0.200 Sum_probs=97.6
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..+..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+ +++|+.|++
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 368999999999997666678999999999999999997777778999999999999999996555444 469999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
++|++++..+..+ ..+++|+.|++++|++.+..|.
T Consensus 108 ~~N~l~~~~~~~~----~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 108 DTNQLKSVPDGIF----DRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CSSCCSCCCTTTT----TTCTTCCEEECCSSCBCCCHHH
T ss_pred cCCcceEeCHHHh----cCCcccCEEEecCCCeeccCcc
Confidence 9999996655444 6789999999999999988774
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.1e-14 Score=160.32 Aligned_cols=136 Identities=18% Similarity=0.229 Sum_probs=122.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCC-CCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|+.++++.|++++..|..+..+++|+.|+|++|++. +.+|..|..+++|++|+|++|+|++..|..+ +++|+.|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 36889999999999988999999999999999999854 4578899999999999999999998878777 56999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCC-CCCCCCCcceeeeeecC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFP-CSAPADQYHYTLHINCG 140 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p-~~~~~~~~~~~~~~~c~ 140 (626)
|++|+|++..|.++ ..+++|+.|++++|+|++.+|..+..+| ....+.+.+|+|.|+|.
T Consensus 525 Ls~N~l~~l~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 525 MSHNNFFSLDTFPY----KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTSCCCBCCCGGG----TTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCCCChhHH----hCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 99999998877666 7899999999999999999999998885 57778889999999998
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=8.8e-14 Score=150.13 Aligned_cols=115 Identities=17% Similarity=0.216 Sum_probs=84.3
Q ss_pred ccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccccCcccccCCCCCCCCCCCc
Q 006906 21 IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSV 98 (626)
Q Consensus 21 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~ 98 (626)
|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..+ +++|+.|+|++|++++..+..+ ..+
T Consensus 181 ~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~l 254 (440)
T 3zyj_A 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF----DNL 254 (440)
T ss_dssp TTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSS----TTC
T ss_pred hhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhh----cCC
Confidence 444555555555555555 344 35556666666666666665555555 3477777777777776666555 788
Q ss_pred cccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCC
Q 006906 99 NLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 99 ~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~ 141 (626)
++|+.|+|++|+|+...+..+..++....+.+.+|+|+|+|.-
T Consensus 255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 255 QSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred CCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 9999999999999999999999999999999999999999973
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.1e-14 Score=161.36 Aligned_cols=134 Identities=14% Similarity=0.179 Sum_probs=72.3
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCC-CChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG-GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
+|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..+ +++|+.|+|
T Consensus 425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 504 (606)
T 3vq2_A 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504 (606)
T ss_dssp TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence 34555555555555555555555555555555555554 245555555555555555555555444444 335555555
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCC-CCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPC-SAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~-~~~~~~~~~~~~~~c~ 140 (626)
++|++++.+|..+ +.+++|+.|++++|+++ .+|..+..+|. ...+.+.+++|.|+|.
T Consensus 505 s~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 505 SHNNLLFLDSSHY----NQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CSSCCSCEEGGGT----TTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCCCcCHHHc----cCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 5555555544443 45556666666666665 33433555542 5555566666666666
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=132.25 Aligned_cols=113 Identities=18% Similarity=0.162 Sum_probs=96.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+ +++|+.|++
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 479999999999996555678999999999999999997777778999999999999999996555444 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
++|++++..+..+ ..+++|+.|++++|.+.+..|.
T Consensus 132 ~~N~l~~~~~~~~----~~l~~L~~L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 132 YQNQLKSVPDGVF----DRLTSLQYIWLHDNPWDCTCPG 166 (208)
T ss_dssp CSSCCSCCCTTTT----TTCTTCCEEECCSCCBCCCTTT
T ss_pred CCCccceeCHHHh----ccCCCccEEEecCCCeecCCCC
Confidence 9999997655444 7889999999999998877664
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=3.4e-14 Score=156.65 Aligned_cols=140 Identities=14% Similarity=0.097 Sum_probs=100.6
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCC--CChHHhhccCCCCEEeccCccccccCchhh---hhcCCc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKN 75 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~ 75 (626)
++|++|+|++|++++.+|..++++++|++|+|++|+|++ .+|..++++++|++|+|++|++++.+|... +++|+.
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 368888888888888888888888888888888888886 567778888888888888888887677542 235566
Q ss_pred cccccCcccccCCCCC-----------------CCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeee
Q 006906 76 VDISLNNFTWESSDPI-----------------ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHIN 138 (626)
Q Consensus 76 l~ls~N~l~~~~~~~~-----------------~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~ 138 (626)
|++++|++++..|..+ |.....+++|+.|++++|+++...+..+..++....+.+.++++.|+
T Consensus 404 L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp EECCSSCCCGGGGGSCCTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred EECcCCCCCcchhhhhcccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence 6666665554443322 11124667788888888888754444477777777777788888888
Q ss_pred cC
Q 006906 139 CG 140 (626)
Q Consensus 139 c~ 140 (626)
|.
T Consensus 484 c~ 485 (520)
T 2z7x_B 484 CP 485 (520)
T ss_dssp HH
T ss_pred CC
Confidence 76
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=7.1e-14 Score=157.34 Aligned_cols=130 Identities=16% Similarity=0.120 Sum_probs=110.9
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
+++++|+|++|+|++..|.+|.+|++|++|||++|+|++..|..|.+|++|++|+|++|+|++..|..+ +.+|+.|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 368999999999997767889999999999999999998778899999999999999999995444444 459999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCC-CCCcccCCCCCCCCCCCccee
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK-VHPCLRQNFPCSAPADQYHYT 134 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~-~~p~~~~~~p~~~~~~~~~~~ 134 (626)
++|++++..+..+ +.+++|+.|++++|++++ .+|..++.++....+.+..+.
T Consensus 132 s~N~l~~l~~~~~----~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 184 (635)
T 4g8a_A 132 VETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 184 (635)
T ss_dssp TTSCCCCSTTCCC----TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCcCCCCChhhh----hcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence 9999998776666 899999999999999976 578888888877765554443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.2e-14 Score=156.82 Aligned_cols=140 Identities=11% Similarity=0.067 Sum_probs=102.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCC--CChHHhhccCCCCEEeccCccccccCchhh---hhcCCc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKN 75 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~ 75 (626)
++|++|+|++|+|++.+|..++++++|++|+|++|+|++ .+|..|.++++|++|+|++|++++.+|... +++|+.
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 368888888888888888888888888888888888886 345678888888888888888887666543 234444
Q ss_pred cccccCcccccCCCCC-----------------CCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeee
Q 006906 76 VDISLNNFTWESSDPI-----------------ECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHIN 138 (626)
Q Consensus 76 l~ls~N~l~~~~~~~~-----------------~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~ 138 (626)
|++++|++++..|..+ |.....+++|+.|++++|+++...+..+..++....+.+.+|+|.|+
T Consensus 433 L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp EECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred EECCCCCCCcchhhhhcCcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 4444444443332222 12235788899999999999965555588888888888999999999
Q ss_pred cC
Q 006906 139 CG 140 (626)
Q Consensus 139 c~ 140 (626)
|.
T Consensus 513 c~ 514 (562)
T 3a79_B 513 CP 514 (562)
T ss_dssp HH
T ss_pred cc
Confidence 87
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.7e-14 Score=161.49 Aligned_cols=124 Identities=12% Similarity=0.166 Sum_probs=110.0
Q ss_pred CcceEEEeecCceeec-----------------CCcccc--CCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcc-
Q 006906 1 MNLKTLILTKCLIHGE-----------------IPDYIG--DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK- 60 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~- 60 (626)
++|++|+|++|+|+|. +|..++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 4799999999999986 999999 99999999999999999999999999999999999998
Q ss_pred ccc-cCchhh--h------hcCCccccccCcccccCCC--CCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCC
Q 006906 61 LTG-PVPKYI--F------NSNKNVDISLNNFTWESSD--PIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD 129 (626)
Q Consensus 61 l~g-~ip~~~--~------~~l~~l~ls~N~l~~~~~~--~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~ 129 (626)
|+| .+|..+ + ++|+.|++++|+++ .+|. .+ +.+++|+.|++++|+++|.+| .++.++....+.
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l----~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~ 359 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL----QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN 359 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH----TTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh----ccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence 999 899887 3 79999999999999 6665 55 789999999999999999999 666665554443
Q ss_pred C
Q 006906 130 Q 130 (626)
Q Consensus 130 ~ 130 (626)
+
T Consensus 360 L 360 (636)
T 4eco_A 360 L 360 (636)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.8e-13 Score=134.26 Aligned_cols=111 Identities=21% Similarity=0.227 Sum_probs=98.1
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+ +++|+.|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 47999999999998554566899999999999999999877788999999999999999999 889887 459999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
++|++++..+..+ ..+++|+.|++++|.+.+..+
T Consensus 143 ~~N~l~~~~~~~~----~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 143 DQNQLKSIPHGAF----DRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CSSCCCCCCTTTT----TTCTTCCEEECTTSCBCTTBG
T ss_pred CCCcCCccCHHHH----hCCCCCCEEEeeCCCccCCcc
Confidence 9999997665555 789999999999999987655
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.8e-13 Score=137.72 Aligned_cols=124 Identities=15% Similarity=0.155 Sum_probs=94.1
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++ + +.++++++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..+ +++|+.|++
T Consensus 63 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 467888888888885 3 367888888888888888887777778888888888888888885555444 458888888
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
++|++++..+..+ +.+++|+.|++++|++++..|..++.++....+.+
T Consensus 141 ~~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 188 (272)
T 3rfs_A 141 AHNQLQSLPKGVF----DKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188 (272)
T ss_dssp CSSCCCCCCTTTT----TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCccCccCHHHh----ccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence 8888886655444 67788888888888888877777777766554433
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.6e-14 Score=156.28 Aligned_cols=131 Identities=17% Similarity=0.066 Sum_probs=81.7
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhh-ccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE-KLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
+|+.|+|++|+|++..|..++++++|++|+|++|+|++.+|..+. ++++|++|+|++|.|++..+...+++|+.|+|++
T Consensus 121 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~ 200 (487)
T 3oja_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSS 200 (487)
T ss_dssp SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCS
T ss_pred CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCC
Confidence 466666666666666666666677777777777777766666664 5677777777777776543333355677777777
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeee
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHIN 138 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~ 138 (626)
|++++.+|. + +.+++|+.|++++|+|++ +|..+..++....+.+.++++.|.
T Consensus 201 N~l~~~~~~-~----~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 201 NKLAFMGPE-F----QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp SCCCEECGG-G----GGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CCCCCCCHh-H----cCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 777654332 2 566677777777777765 454455555555555555554443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=2.1e-13 Score=127.15 Aligned_cols=107 Identities=16% Similarity=0.106 Sum_probs=92.4
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccccc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISL 80 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~ 80 (626)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ +++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 478999999999 6898774 899999999999999889999999999999999999995444443 55899999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
|+|++..+..+ ..+++|+.|++++|++++..+
T Consensus 88 N~l~~~~~~~~----~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAF----DNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTT----TTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHh----cCCCCCCEEEeCCCCCCCCch
Confidence 99998766555 789999999999999876654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.43 E-value=2e-13 Score=147.79 Aligned_cols=116 Identities=14% Similarity=0.193 Sum_probs=93.4
Q ss_pred cccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccccCcccccCCCCCCCCCCC
Q 006906 20 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGS 97 (626)
Q Consensus 20 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~ 97 (626)
.|.++++|++|+|++|+|++ +| .+..+++|+.|+|++|+|++..|..+ +++|+.|+|++|++++..+..+ ..
T Consensus 191 ~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~----~~ 264 (452)
T 3zyi_A 191 AFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF----DG 264 (452)
T ss_dssp TTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTT----TT
T ss_pred hccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHh----cC
Confidence 35556666666666677663 34 46677778888888888887667666 4588889999999988777666 78
Q ss_pred ccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCC
Q 006906 98 VNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 98 ~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~ 141 (626)
+++|+.|+|++|+|++..+..+..++....+.+.+|+|.|+|.-
T Consensus 265 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 89999999999999999999999999999999999999999983
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.2e-13 Score=153.91 Aligned_cols=137 Identities=13% Similarity=0.157 Sum_probs=122.0
Q ss_pred CcceEEEeecCceeecCC-ccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcccc-ccCchhh--hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT-GPVPKYI--FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~-g~ip~~~--~~~l~~l 76 (626)
++|++|+|++|++++..| ..+.++++|++|+|++|++++.+|..|.++++|++|+|++|+++ +.+|..+ +++|+.|
T Consensus 396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 468888999999887766 46889999999999999999889999999999999999999998 6788776 5699999
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecCC
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~~ 141 (626)
++++|++++..|..+ +.+++|+.|++++|++++.+|..+..++....+.+.++++.|+|..
T Consensus 476 ~l~~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 476 DLSQCQLEQLSPTAF----NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECTTSCCCEECTTTT----TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ECCCCccccCChhhh----hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999998878776 7899999999999999999999999999999999999999999874
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.6e-13 Score=144.09 Aligned_cols=123 Identities=15% Similarity=0.084 Sum_probs=105.0
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhh-ccCCCCEEeccCccccccCchhh--hhcCCcccccc
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE-KLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISL 80 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~ 80 (626)
+.+++++|+|+ .+|..+. +.|+.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..+ +++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57899999999 6898764 5699999999999987777787 99999999999999996655555 56999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcce
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY 133 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~ 133 (626)
|+|+...+..+ ..+++|+.|+|++|++++..|..+..++....+.+..+
T Consensus 98 N~l~~~~~~~~----~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 146 (361)
T 2xot_A 98 NHLHTLDEFLF----SDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146 (361)
T ss_dssp SCCCEECTTTT----TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CcCCcCCHHHh----CCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCC
Confidence 99998766666 78999999999999999998988888887776655444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.4e-13 Score=135.55 Aligned_cols=126 Identities=17% Similarity=0.135 Sum_probs=94.0
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..+ +++|+.|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 57888888888886555678888888888888888885555567888888888888888885333333 4478888888
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY 131 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~ 131 (626)
+|++++..+..+ +.+++|+.|++++|++++..+..++.++....+.+.
T Consensus 118 ~n~l~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 165 (270)
T 2o6q_A 118 RNQLKSLPPRVF----DSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLY 165 (270)
T ss_dssp SSCCCCCCTTTT----TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCccCeeCHHHh----CcCcCCCEEECCCCcCCccCHhHccCCcccceeEec
Confidence 888887665554 677888888888888887777666666666554443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=2.9e-13 Score=137.15 Aligned_cols=127 Identities=12% Similarity=0.001 Sum_probs=91.3
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcc-ccccCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK-LTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~-l~g~ip~~~--~~~l~~l~l 78 (626)
+|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+ ++...|..+ +++|+.|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 57788888888886666677788888888888888877667778888888888888886 664335554 447788888
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYH 132 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~ 132 (626)
++|++++..+..+ ..+++|++|++++|++++..+..++.++....+.+..
T Consensus 113 ~~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 162 (285)
T 1ozn_A 113 DRCGLQELGPGLF----RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162 (285)
T ss_dssp TTSCCCCCCTTTT----TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCcCCEECHhHh----hCCcCCCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence 8888776655554 6677788888888877777766666666665544443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=6.7e-14 Score=157.22 Aligned_cols=135 Identities=14% Similarity=0.178 Sum_probs=78.1
Q ss_pred cceEEEeecCceeecCCcc-ccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcccccc-Cc--hhh--hhcCCc
Q 006906 2 NLKTLILTKCLIHGEIPDY-IGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP-VP--KYI--FNSNKN 75 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~-ip--~~~--~~~l~~ 75 (626)
+|++|+|++|++++..|.. +.++++|++|+|++|.+++..|..|.++++|++|+|++|++++. +| ..+ +++|+.
T Consensus 401 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~ 480 (606)
T 3t6q_A 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480 (606)
T ss_dssp TCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCE
T ss_pred cCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccE
Confidence 4666666666666555443 66666666666666666666666666666666666666666542 11 222 335666
Q ss_pred cccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCC-----------------------CCCCCCCCCcc
Q 006906 76 VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN-----------------------FPCSAPADQYH 132 (626)
Q Consensus 76 l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~-----------------------~p~~~~~~~~~ 132 (626)
|++++|++++..|..+ +.+++|+.|++++|++++.+|..+.. ++....+.+.+
T Consensus 481 L~Ls~n~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 556 (606)
T 3t6q_A 481 LVLSFCDLSSIDQHAF----TSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQ 556 (606)
T ss_dssp EECTTSCCCEECTTTT----TTCTTCCEEECCSSCCCGGGGGGGTTCCSCEEECCSSCCCCCCGGGHHHHHTSSEEECTT
T ss_pred EECCCCccCccChhhh----ccccCCCEEECCCCccCcCChhHhCcccccEEECcCCcccccCHhhcccCCCCCEEeCCC
Confidence 6666666665555444 45555555555555555555544444 44444455566
Q ss_pred eeeeeecC
Q 006906 133 YTLHINCG 140 (626)
Q Consensus 133 ~~~~~~c~ 140 (626)
++|.|+|.
T Consensus 557 N~~~c~c~ 564 (606)
T 3t6q_A 557 NPLDCTCS 564 (606)
T ss_dssp CCEECSGG
T ss_pred CCccccCC
Confidence 66666665
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=4.8e-13 Score=125.26 Aligned_cols=105 Identities=18% Similarity=0.223 Sum_probs=91.2
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccccc
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDISL 80 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~ls~ 80 (626)
+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++ +|... +++|+.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECCC
Confidence 57999999997 8998775 899999999999999889999999999999999999995 55543 46999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
|+|++..+..+ ..+++|+.|++++|++....+
T Consensus 91 N~l~~l~~~~~----~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAF----DNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTT----TTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHh----ccccCCCEEEeCCCCcccccc
Confidence 99997655445 789999999999999875543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=3.2e-13 Score=136.10 Aligned_cols=125 Identities=17% Similarity=0.130 Sum_probs=109.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+ +++|+.|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 68999999999997777789999999999999999998778899999999999999999997666666 5599999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCC-CCCcccCCCCCCCCCCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK-VHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~-~~p~~~~~~p~~~~~~~ 130 (626)
+|++++..+..+ +.+++|+.|++++|++++ .+|..++.++....+.+
T Consensus 109 ~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~L 156 (276)
T 2z62_A 109 ETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156 (276)
T ss_dssp TSCCCCSTTCCC----TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEEC
T ss_pred CCCccccCchhc----ccCCCCCEEECcCCccceecCchhhccCCCCCEEEC
Confidence 999998766555 889999999999999987 46888888877665444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.6e-13 Score=159.04 Aligned_cols=121 Identities=9% Similarity=0.071 Sum_probs=106.9
Q ss_pred CcceEEEeecCceee-----------------cCCcccc--CCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcc-
Q 006906 1 MNLKTLILTKCLIHG-----------------EIPDYIG--DMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK- 60 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g-----------------~~p~~~~--~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~- 60 (626)
++|+.|+|++|+|+| .+|..++ +|++|++|+|++|++.|.+|..|++|++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 479999999999998 4999988 99999999999999999999999999999999999998
Q ss_pred ccc-cCchhh--hh-------cCCccccccCcccccCCC--CCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCC
Q 006906 61 LTG-PVPKYI--FN-------SNKNVDISLNNFTWESSD--PIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPA 128 (626)
Q Consensus 61 l~g-~ip~~~--~~-------~l~~l~ls~N~l~~~~~~--~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~ 128 (626)
|+| .+|..+ +. +|+.|+|++|+++ .+|. .+ +.+++|+.|++++|+++ .+| .++.++....+
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l----~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L 600 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL----QKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL 600 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH----TTCTTCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh----hcCCCCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence 999 899877 33 8999999999999 6665 45 78999999999999999 888 66666655443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.8e-13 Score=145.79 Aligned_cols=134 Identities=12% Similarity=0.093 Sum_probs=100.9
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccccc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISL 80 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~ 80 (626)
|+.|+|++|.+.+.+|..+....+|+.|+|++|+|++..+..|.++++|+.|+|++|++++..+..+ +++|+.|+|++
T Consensus 202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (477)
T 2id5_A 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281 (477)
T ss_dssp CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred cceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence 3333333333333333333333456666666677775445678889999999999999986555544 45889999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
|++++..|..+ ..+++|+.|++++|++++..+..+..++....+.+.+|+|.|+|.
T Consensus 282 n~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 282 GQLAVVEPYAF----RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp SCCSEECTTTB----TTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CccceECHHHh----cCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 99998877766 789999999999999999988888999999999999999999997
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-13 Score=155.98 Aligned_cols=122 Identities=16% Similarity=0.281 Sum_probs=109.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCc-CCC-CChHHhhcc------CCCCEEeccCccccccCch--hh-
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN-LTG-GIPTTFEKL------AKTNFMYLTGNKLTGPVPK--YI- 69 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g-~ip~~~~~l------~~L~~L~ls~N~l~g~ip~--~~- 69 (626)
++|++|+|++|+++|.+|..|+++++|++|+|++|+ |+| .+|..++++ ++|++|+|++|+++ .+|. .+
T Consensus 249 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~ 327 (636)
T 4eco_A 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQ 327 (636)
T ss_dssp TTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHT
T ss_pred CCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhc
Confidence 479999999999999999999999999999999999 999 999999987 99999999999999 8998 66
Q ss_pred -hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCC-CCCCC
Q 006906 70 -FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPC-SAPAD 129 (626)
Q Consensus 70 -~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~-~~~~~ 129 (626)
+++|+.|++++|+++|.+| .+ +.+++|+.|++++|+++ .+|..+..++. ...+.
T Consensus 328 ~l~~L~~L~L~~N~l~g~ip-~~----~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~ 383 (636)
T 4eco_A 328 KMKKLGMLECLYNQLEGKLP-AF----GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLS 383 (636)
T ss_dssp TCTTCCEEECCSCCCEEECC-CC----EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEE
T ss_pred cCCCCCEEeCcCCcCccchh-hh----CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEE
Confidence 5599999999999999988 65 88999999999999999 77877777766 55433
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3.2e-13 Score=150.05 Aligned_cols=108 Identities=16% Similarity=0.191 Sum_probs=98.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
.|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .+ +++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999995 887 999999999999999999 899999999999999999999996 78 55 5699999999
Q ss_pred cCcccccC-CCCCCCCCCCccccceeecCCCccCCCCCcc
Q 006906 80 LNNFTWES-SDPIECPRGSVNLVESYSSPRNKLDKVHPCL 118 (626)
Q Consensus 80 ~N~l~~~~-~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~ 118 (626)
+|++++.. |..+ +.+++|+.|++++|+|++.+|..
T Consensus 517 ~N~l~~~~~p~~l----~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 517 NNRLQQSAAIQPL----VSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp SSCCCSSSTTGGG----GGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCCCcHHH----hcCCCCCEEEecCCcCCCCccHH
Confidence 99999886 6665 89999999999999999887743
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=144.30 Aligned_cols=113 Identities=19% Similarity=0.152 Sum_probs=103.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..+ +++|+.|+|
T Consensus 299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 378 (455)
T 3v47_A 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378 (455)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEEC
Confidence 479999999999999889999999999999999999998889999999999999999999998878877 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
++|++++..+..+ ..+++|+.|++++|++++..|.
T Consensus 379 ~~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 379 DTNQLKSVPDGIF----DRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp CSSCCSCCCTTTT----TTCTTCCEEECCSSCBCCCTTT
T ss_pred CCCccccCCHhHh----ccCCcccEEEccCCCcccCCCc
Confidence 9999997655444 7899999999999999999884
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.38 E-value=6.5e-13 Score=135.07 Aligned_cols=121 Identities=18% Similarity=0.186 Sum_probs=72.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|+.|+|++|+|++..|..|.++++|++|+|++|+|++ +|.. +.+++|++|+|++|+|+ .+|..+ +++|+.|+++
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 56777777777776666677777777777777777763 2322 55666666666666666 455544 3356666666
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD 129 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~ 129 (626)
+|++++..+..+ ..+++|+.|++++|++++..+..+..++....+.
T Consensus 109 ~N~l~~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 109 FNRLTSLPLGAL----RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp SSCCCCCCSSTT----TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCcccCHHHH----cCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 666665444444 5556666666666666655555555554444333
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.2e-13 Score=149.94 Aligned_cols=129 Identities=17% Similarity=0.128 Sum_probs=114.1
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..+ +++|+.|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 368999999999998888899999999999999999998889999999999999999999998778877 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCC-CCCcccCCCCCCCCCCCcce
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK-VHPCLRQNFPCSAPADQYHY 133 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~-~~p~~~~~~p~~~~~~~~~~ 133 (626)
++|++++..+..+ +.+++|++|++++|++++ .+|..++.++....+.+..+
T Consensus 112 ~~n~l~~~~~~~~----~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 112 VETKLASLESFPI----GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp TTSCCCCSSSSCC----TTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred cCCcccccccccc----CCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 9999998776665 899999999999999986 67999998888776655443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.37 E-value=4.6e-13 Score=137.03 Aligned_cols=124 Identities=13% Similarity=0.137 Sum_probs=77.0
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCCh-HHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
+|++|+|++|+++ .+|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|++++..|..+ +++|+.|++
T Consensus 79 ~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 157 (306)
T 2z66_A 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 157 (306)
T ss_dssp CCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred ccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence 5667777777776 456666667777777777776664443 456666667777777766665555544 346666666
Q ss_pred ccCcccc-cCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 79 SLNNFTW-ESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 79 s~N~l~~-~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
++|.+++ ..|..+ ..+++|+.|++++|++++..|..+..++....+.+
T Consensus 158 ~~n~l~~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 206 (306)
T 2z66_A 158 AGNSFQENFLPDIF----TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206 (306)
T ss_dssp TTCEEGGGEECSCC----TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCccccccchhHH----hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence 6666665 334333 55666666666666666666666665555544433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=3.8e-13 Score=153.21 Aligned_cols=135 Identities=21% Similarity=0.260 Sum_probs=91.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCC----h----HHhhccCCCCEEeccCccccccCchhh---h
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI----P----TTFEKLAKTNFMYLTGNKLTGPVPKYI---F 70 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i----p----~~~~~l~~L~~L~ls~N~l~g~ip~~~---~ 70 (626)
+|+.|+|++|+|++..|..|.++++|++|+|++|+|++.. | ..|.++++|++|+|++|+|+ .+|... +
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l 559 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDL 559 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccc
Confidence 4666666666666544555666666666666666665321 1 12566667777777777776 555543 3
Q ss_pred hcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccC-CCCCCCCCCCcceeeeeecCC
Q 006906 71 NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQ-NFPCSAPADQYHYTLHINCGG 141 (626)
Q Consensus 71 ~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~-~~p~~~~~~~~~~~~~~~c~~ 141 (626)
++|+.|+|++|++++..+..+ ..+++|+.|++++|++++..|..+. .++....+.+.+++|.|+|..
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVF----NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTT----TTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCCcCCHhHh----CCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 477777888887775544444 6678888888888888887777665 667777778889999999973
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=6.6e-13 Score=126.86 Aligned_cols=105 Identities=12% Similarity=0.177 Sum_probs=47.2
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|.++ .++.+..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+ +++|+.|+++
T Consensus 67 ~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 67 NIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 3444444444333 12234444555555555555544444444555555555555555554444433 2345555555
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
+|++.+.+| +...+++|+.|++++|++++
T Consensus 145 ~n~~i~~~~-----~l~~l~~L~~L~l~~n~i~~ 173 (197)
T 4ezg_A 145 YNGAITDIM-----PLKTLPELKSLNIQFDGVHD 173 (197)
T ss_dssp SCTBCCCCG-----GGGGCSSCCEEECTTBCCCC
T ss_pred CCCCccccH-----hhcCCCCCCEEECCCCCCcC
Confidence 554211221 12444455555555555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.5e-13 Score=140.02 Aligned_cols=131 Identities=17% Similarity=0.066 Sum_probs=88.0
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhh-ccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE-KLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
+|++|+|++|+|++..|..++.+++|++|+|++|+|++..|..+. .+++|++|+|++|+|++..+...+++|+.|+|++
T Consensus 121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~ 200 (317)
T 3o53_A 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSS 200 (317)
T ss_dssp SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCS
T ss_pred CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCC
Confidence 467777777777765566777777777777777777766666653 6777777777777777432222256777777777
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeee
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHIN 138 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~ 138 (626)
|++++..+. + ..+++|+.|++++|+++. +|..+..++....+.+.++++.|.
T Consensus 201 N~l~~l~~~-~----~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 201 NKLAFMGPE-F----QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp SCCCEECGG-G----GGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CcCCcchhh-h----cccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 777754332 3 567778888888887774 555566666666666666666544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.35 E-value=4.2e-13 Score=153.64 Aligned_cols=111 Identities=22% Similarity=0.178 Sum_probs=82.7
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|+.|+|++|+|+ .+|..+.+|++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..+ +.+|+.|+|+
T Consensus 225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 5777788888877 67777777788888888888887 77777778888888888888877 677766 4477788888
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQ 120 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~ 120 (626)
+|.|+ .+|..+ +.+++|+.|+|++|+|++.+|..+.
T Consensus 302 ~N~l~-~lp~~~----~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (727)
T 4b8c_D 302 DNMVT-TLPWEF----GNLCNLQFLGVEGNPLEKQFLKILT 337 (727)
T ss_dssp SSCCC-CCCSST----TSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred CCCCC-ccChhh----hcCCCccEEeCCCCccCCCChHHHh
Confidence 88775 444444 7777788888888888777776543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.35 E-value=5.2e-13 Score=154.76 Aligned_cols=122 Identities=17% Similarity=0.284 Sum_probs=109.0
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCc-CCC-CChHHhhccC-------CCCEEeccCccccccCch--hh
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN-LTG-GIPTTFEKLA-------KTNFMYLTGNKLTGPVPK--YI 69 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g-~ip~~~~~l~-------~L~~L~ls~N~l~g~ip~--~~ 69 (626)
++|++|+|++|++.|.+|..|++|++|++|+|++|+ |+| .+|..|++++ +|++|+|++|+|+ .+|. .+
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l 569 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence 479999999999999999999999999999999998 999 9999999887 9999999999999 8998 66
Q ss_pred --hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCC-CCCCCC
Q 006906 70 --FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPC-SAPADQ 130 (626)
Q Consensus 70 --~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~-~~~~~~ 130 (626)
+++|+.|+|++|+++ .+| .+ +.+++|+.|++++|+++ .+|..+..++. ...+.+
T Consensus 570 ~~L~~L~~L~Ls~N~l~-~lp-~~----~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~L 626 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVR-HLE-AF----GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGF 626 (876)
T ss_dssp TTCTTCCEEECTTSCCC-BCC-CC----CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEEC
T ss_pred hcCCCCCEEECCCCCcc-cch-hh----cCCCcceEEECcCCccc-cchHHHhhccccCCEEEC
Confidence 559999999999999 666 44 89999999999999999 88887777776 554443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-12 Score=124.48 Aligned_cols=107 Identities=15% Similarity=0.118 Sum_probs=91.2
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDIS 79 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls 79 (626)
++|++|+|++|+|++..|..++.|++|++|+|++|++++..|..++++++|++|+|++|++.+.+|..- +++|+.|+++
T Consensus 88 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167 (197)
T ss_dssp TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECT
T ss_pred CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECC
Confidence 479999999999998889999999999999999999999899999999999999999999444677322 5699999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
+|++++.. ....+++|+.|++++|++.+
T Consensus 168 ~n~i~~~~------~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 168 FDGVHDYR------GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp TBCCCCCT------TGGGCSSCCEEEECBC----
T ss_pred CCCCcChH------HhccCCCCCEEEeeCcccCC
Confidence 99998632 24789999999999999754
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=121.75 Aligned_cols=107 Identities=21% Similarity=0.267 Sum_probs=92.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCc--hhh--hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP--KYI--FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip--~~~--~~~l~~l 76 (626)
++|++|+|++|+|++. ..++.+++|++|+|++|++++.+|..+.++++|++|+|++|+|++ +| ..+ +++|+.|
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEE
Confidence 4799999999999965 789999999999999999998899999999999999999999995 44 445 5699999
Q ss_pred ccccCcccccCC---CCCCCCCCCccccceeecCCCccCCC
Q 006906 77 DISLNNFTWESS---DPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 77 ~ls~N~l~~~~~---~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
++++|.+++..+ ..+ ..+++|+.|++++|.+...
T Consensus 126 ~l~~N~l~~~~~~~~~~~----~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 126 DLFNCEVTNLNDYRESVF----KLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp ECCSSGGGTSTTHHHHHH----TTCSSCCEETTEETTSCBC
T ss_pred EeeCCcCcchHHHHHHHH----HhCccCcEecCCCCChhhc
Confidence 999999986643 233 7889999999999987543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=8.5e-13 Score=143.82 Aligned_cols=125 Identities=18% Similarity=0.139 Sum_probs=107.1
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchh-h--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~-~--~~~l~~l~ 77 (626)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. + +++|+.|+
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEE
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEE
Confidence 36889999999999888889999999999999999999888999999999999999999999 45554 3 45899999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
|++|++.+..+..+ ..+++|+.|++++|++.+..|..+..++....+.+
T Consensus 111 Ls~n~i~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 159 (477)
T 2id5_A 111 ISENKIVILLDYMF----QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTL 159 (477)
T ss_dssp CTTSCCCEECTTTT----TTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEE
T ss_pred CCCCccccCChhHc----cccccCCEEECCCCccceeChhhccCCCCCCEEEC
Confidence 99999998877666 78899999999999999888888887776655433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.7e-13 Score=140.90 Aligned_cols=111 Identities=12% Similarity=0.054 Sum_probs=79.6
Q ss_pred CcceEEEeecCceeecCCccc--cCCCCCCEEEeecCcCCCCChHHhhcc-----CCCCEEeccCccccccCchhh--hh
Q 006906 1 MNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIPTTFEKL-----AKTNFMYLTGNKLTGPVPKYI--FN 71 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~--~~l~~L~~L~Ls~N~l~g~ip~~~~~l-----~~L~~L~ls~N~l~g~ip~~~--~~ 71 (626)
++|++|+|++|+|++.+|..+ +.+++|++|+|++|+|++. |..++++ ++|++|+|++|++++..|..+ ++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 357888888888888888765 7788888888888888866 7777777 788888888888886655665 45
Q ss_pred cCCccccccCcccccCCCCCCCCCCCccccceeecCCCccC
Q 006906 72 SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 72 ~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
+|+.|++++|++.+.++.......+.+++|+.|++++|+++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 78888888888765421100001156777888888888776
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.34 E-value=7.9e-13 Score=135.87 Aligned_cols=112 Identities=17% Similarity=0.129 Sum_probs=67.3
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCC--ChHHh--hccCCCCEEeccCccccc--cCchhhh---hc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG--IPTTF--EKLAKTNFMYLTGNKLTG--PVPKYIF---NS 72 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~--ip~~~--~~l~~L~~L~ls~N~l~g--~ip~~~~---~~ 72 (626)
+|++|+|++|+|++..|..|+++++|++|+|++|++.|. +|..+ .++++|++|+|++|+|++ .++..++ ++
T Consensus 150 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~ 229 (312)
T 1wwl_A 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ 229 (312)
T ss_dssp TCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCC
T ss_pred CCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCC
Confidence 466666666666655556666666666666666666654 23344 666666666666666662 2333332 46
Q ss_pred CCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 73 NKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 73 l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
|+.|+|++|++++.+|.+. ...+++|+.|++++|+++ .+|.
T Consensus 230 L~~L~Ls~N~l~~~~~~~~---~~~l~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 230 LQGLDLSHNSLRDAAGAPS---CDWPSQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp CSEEECTTSCCCSSCCCSC---CCCCTTCCEEECTTSCCS-SCCS
T ss_pred CCEEECCCCcCCcccchhh---hhhcCCCCEEECCCCccC-hhhh
Confidence 6777777777766554322 134566777777777776 4444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-12 Score=133.90 Aligned_cols=117 Identities=17% Similarity=0.150 Sum_probs=101.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|+++ .+|..++++|+.|++++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~L~~L~l~~ 132 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHD 132 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCCTTCCEEECCS
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCccccccCCEEECCC
Confidence 36899999999999777888999999999999999999888999999999999999999999 78888888999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccC--CCCCcccCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLD--KVHPCLRQNF 122 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~--~~~p~~~~~~ 122 (626)
|+++...+..+ ..+++|+.|++++|+++ +..|..+..+
T Consensus 133 n~i~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~~~l 172 (332)
T 2ft3_A 133 NRIRKVPKGVF----SGLRNMNCIEMGGNPLENSGFEPGAFDGL 172 (332)
T ss_dssp SCCCCCCSGGG----SSCSSCCEEECCSCCCBGGGSCTTSSCSC
T ss_pred CccCccCHhHh----CCCccCCEEECCCCccccCCCCcccccCC
Confidence 99986554444 78899999999999995 4666666554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=9.2e-13 Score=136.34 Aligned_cols=123 Identities=17% Similarity=0.149 Sum_probs=105.9
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|+.|+|++|+|++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|+|+ .+|..++++|+.|++++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~~L~~L~l~~ 130 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHE 130 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCS
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhcccccEEECCC
Confidence 36899999999999776778999999999999999999888999999999999999999999 78888888999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccC--CCCCcccCCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLD--KVHPCLRQNFPCSAPA 128 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~--~~~p~~~~~~p~~~~~ 128 (626)
|++++..+..+ ..+++|+.|++++|++. +..+..+..++....+
T Consensus 131 n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L 176 (330)
T 1xku_A 131 NEITKVRKSVF----NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 176 (330)
T ss_dssp SCCCBBCHHHH----TTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred CcccccCHhHh----cCCccccEEECCCCcCCccCcChhhccCCCCcCEE
Confidence 99987655444 77899999999999995 4677777777665543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-12 Score=146.14 Aligned_cols=125 Identities=14% Similarity=0.023 Sum_probs=106.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
++++|+|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+ +++|+.|+++
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 58999999999998888899999999999999999998889999999999999999999998778777 5699999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCC-CCcccCCCCCCCCCCCc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV-HPCLRQNFPCSAPADQY 131 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~-~p~~~~~~p~~~~~~~~ 131 (626)
+|++++..+.++ +.+++|++|++++|++++. +|...+ ++....+.+.
T Consensus 114 ~n~i~~l~~~~~----~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~ 161 (606)
T 3t6q_A 114 QTGISSIDFIPL----HNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQ 161 (606)
T ss_dssp TSCCSCGGGSCC----TTCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECC
T ss_pred ccCcccCCcchh----ccCCcccEEECCCCcccccCcccccC-CcccCEEEcc
Confidence 999998766665 8899999999999999884 455443 5555544443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.8e-12 Score=151.40 Aligned_cols=131 Identities=10% Similarity=0.022 Sum_probs=105.9
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCC-hHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i-p~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|+.|+|++|+|++..|..|+++++|++|||++|.+.+.+ |..|.+|++|++|+|++|+|++..|..+ +.+|+.|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 46889999999999888889999999999999999777777 7889999999999999999998778877 55899999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC-cccCCCCCCCCCCCcce
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP-CLRQNFPCSAPADQYHY 133 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p-~~~~~~p~~~~~~~~~~ 133 (626)
|++|++++.+|... ..+.+++|+.|++++|++++..| ..++.++....+.+..+
T Consensus 104 Ls~n~l~~~~~~~~--~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N 158 (844)
T 3j0a_A 104 LYFCGLSDAVLKDG--YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158 (844)
T ss_dssp CTTCCCSSCCSTTC--CCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESS
T ss_pred CcCCCCCcccccCc--cccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCC
Confidence 99999988665541 13788889999999998887765 46777777666555443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.1e-12 Score=145.68 Aligned_cols=127 Identities=14% Similarity=0.151 Sum_probs=110.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCch-hh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK-YI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~-~~--~~~l~~l~ 77 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|. .+ +.+|+.|+
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELH 103 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEE
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEE
Confidence 36899999999999777778999999999999999999999999999999999999999999 4665 45 55999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcc
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYH 132 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~ 132 (626)
+++|++++..|..+ +.+++|++|++++|++++..|..++.++....+.+..
T Consensus 104 L~~n~l~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 154 (680)
T 1ziw_A 104 LMSNSIQKIKNNPF----VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154 (680)
T ss_dssp CCSSCCCCCCSCTT----TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCS
T ss_pred CCCCccCccChhHc----cccCCCCEEECCCCcccccCchhhcccccCCEEEccC
Confidence 99999987766666 8899999999999999999998888887776655443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.31 E-value=9.4e-13 Score=119.66 Aligned_cols=102 Identities=19% Similarity=0.213 Sum_probs=87.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcccccc-Cchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGP-VPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~-ip~~~--~~~l~~l~ 77 (626)
++|++|+|++|+|++. ..++++++|++|+|++|+|++.+|..+.++++|++|+|++|++++. .|..+ +++|+.|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 4799999999999965 7799999999999999999988999999999999999999999962 33555 55899999
Q ss_pred cccCcccccCC---CCCCCCCCCccccceeecCC
Q 006906 78 ISLNNFTWESS---DPIECPRGSVNLVESYSSPR 108 (626)
Q Consensus 78 ls~N~l~~~~~---~~~~~~~~~~~~l~~l~l~~ 108 (626)
+++|++++..+ ..+ +.+++|+.|++++
T Consensus 120 l~~N~l~~~~~~~~~~~----~~l~~L~~L~l~d 149 (149)
T 2je0_A 120 LFNCEVTNLNDYRENVF----KLLPQLTYLDGYD 149 (149)
T ss_dssp CTTCGGGGSTTHHHHHH----HHCTTCCEETTBC
T ss_pred CcCCcccchHHHHHHHH----HHCCCcccccCCC
Confidence 99999997654 223 6789999998864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.9e-12 Score=142.52 Aligned_cols=113 Identities=17% Similarity=0.168 Sum_probs=95.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccc--cCchhh--hhcCCccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG--PVPKYI--FNSNKNVD 77 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g--~ip~~~--~~~l~~l~ 77 (626)
+|+.|++++|.+.+ ++ .+..+++|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..+ +++|+.|+
T Consensus 303 ~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 303 NIKNFTVSGTRMVH-ML-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CCSEEEEESSCCCC-CC-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred ceeEEEcCCCcccc-cc-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 58999999999873 22 13789999999999999999999999999999999999999996 566666 56999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCccc
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLR 119 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~ 119 (626)
+++|++++.+|... ...+++|+.|++++|++++.+|..+
T Consensus 381 Ls~N~l~~~l~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~l 419 (520)
T 2z7x_B 381 ISQNSVSYDEKKGD---CSWTKSLLSLNMSSNILTDTIFRCL 419 (520)
T ss_dssp CCSSCCBCCGGGCS---CCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred CCCCcCCcccccch---hccCccCCEEECcCCCCCcchhhhh
Confidence 99999998666442 2667889999999999888777654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-12 Score=138.88 Aligned_cols=125 Identities=17% Similarity=0.042 Sum_probs=99.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+ +++|+.|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 368999999999998888999999999999999999998888999999999999999999995444434 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCc-cCCCCCcccCCCCCCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNK-LDKVHPCLRQNFPCSAPAD 129 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~-l~~~~p~~~~~~p~~~~~~ 129 (626)
++|+++...+..+ ..+++|+.|++++|. +....+..+..++....+.
T Consensus 155 ~~N~l~~~~~~~~----~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 202 (452)
T 3zyi_A 155 RNNPIESIPSYAF----NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202 (452)
T ss_dssp CSCCCCEECTTTT----TTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEE
T ss_pred CCCCcceeCHhHH----hcCCcccEEeCCCCCCccccChhhccCCCCCCEEE
Confidence 9999987665555 778888888888844 4433344566665554433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.4e-12 Score=136.26 Aligned_cols=119 Identities=13% Similarity=0.082 Sum_probs=73.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchh-h--hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~-~--~~~l~~l~l 78 (626)
+|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++ +|.. + +++|+.|++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEEC
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEEC
Confidence 56777777777775444567777777777777777776666667777777777777777773 4443 3 346777777
Q ss_pred ccCcccccCC-CCCCCCCCCccccceeecCCC-ccCCCCCcccCCCCCC
Q 006906 79 SLNNFTWESS-DPIECPRGSVNLVESYSSPRN-KLDKVHPCLRQNFPCS 125 (626)
Q Consensus 79 s~N~l~~~~~-~~~~~~~~~~~~l~~l~l~~N-~l~~~~p~~~~~~p~~ 125 (626)
++|+++...+ ..+ ..+++|+.|++++| .+....|..++.++..
T Consensus 132 ~~n~l~~l~~~~~~----~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 176 (353)
T 2z80_A 132 LGNPYKTLGETSLF----SHLTKLQILRVGNMDTFTKIQRKDFAGLTFL 176 (353)
T ss_dssp TTCCCSSSCSSCSC----TTCTTCCEEEEEESSSCCEECTTTTTTCCEE
T ss_pred CCCCCcccCchhhh----ccCCCCcEEECCCCccccccCHHHccCCCCC
Confidence 7777764322 122 55666666666666 3444444455444433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=3.2e-12 Score=142.20 Aligned_cols=127 Identities=17% Similarity=0.122 Sum_probs=111.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+ +.+|+.|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 68999999999998888899999999999999999998888899999999999999999997666666 5699999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCC-CCCcccCCCCCCCCCCCcc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK-VHPCLRQNFPCSAPADQYH 132 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~-~~p~~~~~~p~~~~~~~~~ 132 (626)
+|+++...+.++ +.+++|++|++++|++++ .+|..++.++....+.+..
T Consensus 109 ~n~l~~l~~~~~----~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~ 158 (570)
T 2z63_A 109 ETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (570)
T ss_dssp TSCCCCSTTCSC----TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTT
T ss_pred ccccccCCCccc----cccccccEEecCCCccceecChhhhcccCCCCEEeCcC
Confidence 999997765555 899999999999999987 5798888888777655543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2e-12 Score=133.83 Aligned_cols=121 Identities=16% Similarity=0.198 Sum_probs=67.2
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCC--CCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT--GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls 79 (626)
+|++|+|++|+|++..+..|.++++|++|+|++|++. +..|..|.++++|++|++++|+++ .+|..+.++|+.|+++
T Consensus 122 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~L~~L~l~ 200 (330)
T 1xku_A 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLD 200 (330)
T ss_dssp TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEECT
T ss_pred cccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccccccCCEEECC
Confidence 3445555555555433344555555555555555554 244555555566666666666655 3555555566666666
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAP 127 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~ 127 (626)
+|++++..+..+ ..+++|+.|++++|++++..+..+..++....
T Consensus 201 ~n~l~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 244 (330)
T 1xku_A 201 GNKITKVDAASL----KGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244 (330)
T ss_dssp TSCCCEECTGGG----TTCTTCCEEECCSSCCCEECTTTGGGSTTCCE
T ss_pred CCcCCccCHHHh----cCCCCCCEEECCCCcCceeChhhccCCCCCCE
Confidence 666665544443 55666666666666666665555555554443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1e-11 Score=123.96 Aligned_cols=146 Identities=14% Similarity=0.082 Sum_probs=113.3
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 470 (626)
..-..|.....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456877788888889999999754 6889999987532223346788999888774 667888999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED----------------------------------- 515 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------- 515 (626)
||++|.+|.+.+. +......++.++++++..||+.
T Consensus 90 e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 90 SEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp ECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999876531 1123457888999999999981
Q ss_pred ---------------------CCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 516 ---------------------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 516 ---------------------~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
....++|+|++|.||+++++..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 113489999999999998766667999998764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.2e-12 Score=132.31 Aligned_cols=110 Identities=15% Similarity=0.115 Sum_probs=66.2
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCC--ChH--HhhccCCCCEEeccCccccccCch---hh---hh
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG--IPT--TFEKLAKTNFMYLTGNKLTGPVPK---YI---FN 71 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~--ip~--~~~~l~~L~~L~ls~N~l~g~ip~---~~---~~ 71 (626)
+|++|+|++|+|++..|..|+.+++|++|+|++|++.+. ++. .++++++|++|+|++|+|+ .+|. .+ ++
T Consensus 146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGV 224 (310)
T ss_dssp CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTC
T ss_pred CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCC
Confidence 566666666666655556666666677777777666542 221 2256666666777766665 2332 12 24
Q ss_pred cCCccccccCcccccCCCCCCCCCCCc---cccceeecCCCccCCCCCc
Q 006906 72 SNKNVDISLNNFTWESSDPIECPRGSV---NLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 72 ~l~~l~ls~N~l~~~~~~~~~~~~~~~---~~l~~l~l~~N~l~~~~p~ 117 (626)
+|+.|+|++|++++..|..+ +.+ ++|++|++++|+++ .+|.
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~----~~~~~~~~L~~L~Ls~N~l~-~lp~ 268 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSA----PRCMWSSALNSLNLSFAGLE-QVPK 268 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCC----SSCCCCTTCCCEECCSSCCC-SCCS
T ss_pred CCCEEECCCCCCCccchhhH----HhccCcCcCCEEECCCCCCC-chhh
Confidence 67777777777776655444 333 57777777777776 3444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.6e-12 Score=144.13 Aligned_cols=122 Identities=11% Similarity=0.024 Sum_probs=97.9
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|+++++|++|+|++|++++..|..+ +++|+.|++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 368899999999998888889999999999999999998888889999999999999999997666656 458999999
Q ss_pred ccCccccc-CCCCCCCCCCCccccceeecCCCccCCCCC-cccCCCCCCC
Q 006906 79 SLNNFTWE-SSDPIECPRGSVNLVESYSSPRNKLDKVHP-CLRQNFPCSA 126 (626)
Q Consensus 79 s~N~l~~~-~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p-~~~~~~p~~~ 126 (626)
++|++++. .|..+ +.+++|+.|++++|++.+.+| ..++.++...
T Consensus 106 s~n~l~~~~~~~~~----~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~ 151 (549)
T 2z81_A 106 MGNPYQTLGVTSLF----PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN 151 (549)
T ss_dssp TTCCCSSSCSSCSC----TTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred CCCcccccchhhhh----hccCCccEEECCCCccccccCHhhhhcccccC
Confidence 99998863 33333 788889999999998655555 4555555443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.28 E-value=6.2e-12 Score=141.05 Aligned_cols=109 Identities=17% Similarity=0.232 Sum_probs=75.3
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|+.|+|++|+|++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|+|+ .+|..+ +++|+.|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEe
Confidence 5677777777777666667777777777777777777666666777777777777777777 344433 346777777
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 115 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~ 115 (626)
++|++++..|..+ +.+++|+.|++++|.+++..
T Consensus 155 s~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~ 187 (597)
T 3oja_B 155 SNNNLERIEDDTF----QATTSLQNLQLSSNRLTHVD 187 (597)
T ss_dssp CSSCCCBCCTTTT----TTCTTCCEEECTTSCCSBCC
T ss_pred eCCcCCCCChhhh----hcCCcCcEEECcCCCCCCcC
Confidence 7777776665555 66777777777777776653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.28 E-value=9e-13 Score=144.09 Aligned_cols=111 Identities=19% Similarity=0.100 Sum_probs=80.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|+.|+|++|+|++..|..|+.+++|++|+|++|.|++.+| |+.+++|++|+|++|+|++ +|.. ++|+.|++++|
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~~~--~~L~~L~L~~N 109 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LLVG--PSIETLHAANN 109 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EEEC--TTCCEEECCSS
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CCCC--CCcCEEECcCC
Confidence 79999999999998888899999999999999999998776 9999999999999999985 3322 45666666666
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPC 124 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~ 124 (626)
++++..+. .+++|+.|++++|.+++..|..++.++.
T Consensus 110 ~l~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 145 (487)
T 3oja_A 110 NISRVSCS-------RGQGKKNIYLANNKITMLRDLDEGCRSR 145 (487)
T ss_dssp CCCCEEEC-------CCSSCEEEECCSSCCCSGGGBCGGGGSS
T ss_pred cCCCCCcc-------ccCCCCEEECCCCCCCCCCchhhcCCCC
Confidence 66544321 2344555555555555554444444443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=3.5e-12 Score=141.36 Aligned_cols=121 Identities=18% Similarity=0.168 Sum_probs=106.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccc-cCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG-PVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g-~ip~~~--~~~l~~l~ 77 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|+++++|++|+|++|++++ .+|..+ +++|+.|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 479999999999998888999999999999999999999889889999999999999999996 456655 56999999
Q ss_pred cccCcccccCCC-CCCCCCCCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 78 ISLNNFTWESSD-PIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 78 ls~N~l~~~~~~-~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
+++|++.+.+|. .+ +.+++|+.|++++|++++.+|..++.++..
T Consensus 130 L~~n~~~~~~~~~~~----~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 174 (549)
T 2z81_A 130 IGNVETFSEIRRIDF----AGLTSLNELEIKALSLRNYQSQSLKSIRDI 174 (549)
T ss_dssp EEESSSCCEECTTTT----TTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred CCCCccccccCHhhh----hcccccCeeeccCCcccccChhhhhccccC
Confidence 999996666553 44 789999999999999999999887776543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.27 E-value=2.4e-12 Score=126.76 Aligned_cols=119 Identities=15% Similarity=0.119 Sum_probs=98.7
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCc-CCCCChHHhhccCCCCEEeccC-ccccccCchhh--hhcCCccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN-LTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l~~L~~L~ls~-N~l~g~ip~~~--~~~l~~l~ 77 (626)
+|++|+|++|+|++..+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..+ +++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 68999999999997666789999999999999997 8866667899999999999998 99995444444 56899999
Q ss_pred cccCcccccCCCCCCCCCCCccccc---eeecCCC-ccCCCCCcccCCCCCCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVE---SYSSPRN-KLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~---~l~l~~N-~l~~~~p~~~~~~p~~~ 126 (626)
+++|++++ +|. + +.+++|+ .|++++| ++++..+..+..++...
T Consensus 112 l~~n~l~~-lp~-~----~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~ 158 (239)
T 2xwt_C 112 IFNTGLKM-FPD-L----TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158 (239)
T ss_dssp EEEECCCS-CCC-C----TTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred CCCCCCcc-ccc-c----ccccccccccEEECCCCcchhhcCcccccchhcce
Confidence 99999987 443 3 6677777 9999999 99888777777665544
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.27 E-value=4.2e-12 Score=131.53 Aligned_cols=118 Identities=16% Similarity=0.197 Sum_probs=61.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccc--c---------------
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG--P--------------- 64 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g--~--------------- 64 (626)
+|++|+|++|+|+ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++. .
T Consensus 103 ~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l 179 (332)
T 2ft3_A 103 KLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179 (332)
T ss_dssp TCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBC
T ss_pred CCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEEC
Confidence 4566666666665 4555443 556666666666654444455666666666666665542 2
Q ss_pred -------CchhhhhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCC
Q 006906 65 -------VPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 65 -------ip~~~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~ 126 (626)
+|..+.++|+.|++++|++++..+..+ ..+++|+.|++++|++++..|..+..++...
T Consensus 180 ~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 244 (332)
T 2ft3_A 180 SEAKLTGIPKDLPETLNELHLDHNKIQAIELEDL----LRYSKLYRLGLGHNQIRMIENGSLSFLPTLR 244 (332)
T ss_dssp CSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSS----TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCC
T ss_pred cCCCCCccCccccCCCCEEECCCCcCCccCHHHh----cCCCCCCEEECCCCcCCcCChhHhhCCCCCC
Confidence 333333445555555555544433333 4455555555555555555554444444333
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.8e-12 Score=140.89 Aligned_cols=113 Identities=16% Similarity=0.127 Sum_probs=93.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccc--cCchhh--hhcCCccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTG--PVPKYI--FNSNKNVD 77 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g--~ip~~~--~~~l~~l~ 77 (626)
+|+.|++++|++.. ++ ..+.+++|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..+ +++|+.|+
T Consensus 332 ~L~~L~l~~n~~~~-~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~ 409 (562)
T 3a79_B 332 NIKMLSISDTPFIH-MV-CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409 (562)
T ss_dssp CCSEEEEESSCCCC-CC-CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEE
T ss_pred cceEEEccCCCccc-cc-CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEE
Confidence 58999999999863 22 12789999999999999999999999999999999999999996 334444 56999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCccc
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLR 119 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~ 119 (626)
+++|++++.+|... ...+++|+.|++++|++++.+|..+
T Consensus 410 l~~N~l~~~~~~~~---~~~l~~L~~L~l~~n~l~~~~~~~l 448 (562)
T 3a79_B 410 VSLNSLNSHAYDRT---CAWAESILVLNLSSNMLTGSVFRCL 448 (562)
T ss_dssp CTTSCCBSCCSSCC---CCCCTTCCEEECCSSCCCGGGGSSC
T ss_pred CCCCcCCCccChhh---hcCcccCCEEECCCCCCCcchhhhh
Confidence 99999998666542 2677888899999998887776544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.7e-12 Score=135.33 Aligned_cols=125 Identities=16% Similarity=0.046 Sum_probs=100.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+ +++|+.|+|
T Consensus 64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 143 (440)
T 3zyj_A 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143 (440)
T ss_dssp TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence 368999999999998888899999999999999999998888999999999999999999994433344 468999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCC-CCCcccCCCCCCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK-VHPCLRQNFPCSAPAD 129 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~-~~p~~~~~~p~~~~~~ 129 (626)
++|+++...+..+ ..+++|+.|++++|...+ ..+..+..++....+.
T Consensus 144 ~~N~i~~~~~~~~----~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 144 RNNPIESIPSYAF----NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp CSCCCCEECTTTT----TTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred CCCcccccCHHHh----hhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 9999987766555 788899999999854444 4444566666555433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=131.18 Aligned_cols=107 Identities=17% Similarity=0.225 Sum_probs=50.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|++|+|++|+|++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|..+ +++|+.|++
T Consensus 70 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEEC
Confidence 3445555555554433444555555555555555555444444455555555555555554 333332 234455555
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
++|++++..+..+ +.+++|+.|++++|++++
T Consensus 149 ~~n~l~~~~~~~~----~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 149 SNNNLERIEDDTF----QATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CSSCCCBCCTTTT----SSCTTCCEEECCSSCCSB
T ss_pred CCCccCccChhhc----cCCCCCCEEECCCCcCCc
Confidence 5555544433333 444455555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=2.7e-12 Score=134.11 Aligned_cols=120 Identities=20% Similarity=0.290 Sum_probs=92.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCch--hh--hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK--YI--FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~--~~--~~~l~~l 76 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. .+ +++|+.|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence 46888888888888777778888888888888888888655666888888888888888888 4665 33 4588888
Q ss_pred ccccCc-ccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 77 DISLNN-FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 77 ~ls~N~-l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
++++|+ +....+..+ +.+++|+.|++++|++++..|..++.++..
T Consensus 155 ~l~~n~~~~~~~~~~~----~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 200 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDF----AGLTFLEELEIDASDLQSYEPKSLKSIQNV 200 (353)
T ss_dssp EEEESSSCCEECTTTT----TTCCEEEEEEEEETTCCEECTTTTTTCSEE
T ss_pred ECCCCccccccCHHHc----cCCCCCCEEECCCCCcCccCHHHHhccccC
Confidence 888884 555545444 778888888888888888877776665533
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.24 E-value=6.3e-12 Score=141.00 Aligned_cols=129 Identities=9% Similarity=0.035 Sum_probs=110.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++++.|++++|.++...+..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..|..+ +++|+.|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 367899999999996555568999999999999999998888899999999999999999998666665 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcce
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY 133 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~ 133 (626)
++|++++.++..+ +.+++|+.|++++|.+++..|..++.++....+.+..+
T Consensus 131 ~~n~l~~l~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 181 (597)
T 3oja_B 131 ERNDLSSLPRGIF----HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181 (597)
T ss_dssp CSSCCCCCCTTTT----TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTS
T ss_pred eCCCCCCCCHHHh----ccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCC
Confidence 9999996555444 78999999999999999999998888887776555443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.4e-12 Score=132.13 Aligned_cols=128 Identities=13% Similarity=0.048 Sum_probs=97.1
Q ss_pred CcceEEEeecCceeecCCccc--cCCCCCCEEEeecCcCCCCCh----HHhhccCCCCEEeccCccccccCchhh--hhc
Q 006906 1 MNLKTLILTKCLIHGEIPDYI--GDMTKLKNIDLSFNNLTGGIP----TTFEKLAKTNFMYLTGNKLTGPVPKYI--FNS 72 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~--~~l~~L~~L~Ls~N~l~g~ip----~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~ 72 (626)
++|++|+|++|++++.+|..+ +.+++|++|+|++|++++..| ..+..+++|++|+|++|++++..|..+ +++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 358999999999999999888 899999999999999998665 456789999999999999987666665 568
Q ss_pred CCccccccCccccc--CCCCCCCCCCCccccceeecCCCccCCCCCc---ccCCCCCCCCCCC
Q 006906 73 NKNVDISLNNFTWE--SSDPIECPRGSVNLVESYSSPRNKLDKVHPC---LRQNFPCSAPADQ 130 (626)
Q Consensus 73 l~~l~ls~N~l~~~--~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~---~~~~~p~~~~~~~ 130 (626)
|+.|+|++|++.+. .+... ..+.+++|++|++++|+++...+. .++.++....+.+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~--~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~L 231 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAAL--CPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDL 231 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTS--CTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEEC
T ss_pred CCEEECCCCCCccchhhhHHH--hhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEEC
Confidence 99999999998753 11111 125778899999999988632221 2344555554443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.24 E-value=8.2e-12 Score=116.33 Aligned_cols=86 Identities=22% Similarity=0.214 Sum_probs=76.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+ +++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 468999999999998888999999999999999999998777788999999999999999996444445 569999999
Q ss_pred ccCccccc
Q 006906 79 SLNNFTWE 86 (626)
Q Consensus 79 s~N~l~~~ 86 (626)
++|.+...
T Consensus 110 ~~N~~~c~ 117 (170)
T 3g39_A 110 LNNPWDCA 117 (170)
T ss_dssp CSSCBCTT
T ss_pred CCCCCCCC
Confidence 99999744
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.24 E-value=3.4e-12 Score=119.51 Aligned_cols=120 Identities=17% Similarity=0.180 Sum_probs=93.6
Q ss_pred CcceEEEeecCceeecCCccccCCC-CCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMT-KLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l 76 (626)
++|+.|+|++|+|+ .+|. +..+. +|++|+|++|+|++. ..|.++++|++|+|++|+|++ +|..+ +++|+.|
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTEL 93 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEE
Confidence 36899999999999 5665 55555 999999999999964 589999999999999999995 55433 5699999
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc----ccCCCCCCCCCC
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC----LRQNFPCSAPAD 129 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~----~~~~~p~~~~~~ 129 (626)
++++|+++. +|.. .....+++|+.|++++|+++.. |. .+..+|....+.
T Consensus 94 ~L~~N~i~~-~~~~--~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld 146 (176)
T 1a9n_A 94 ILTNNSLVE-LGDL--DPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLD 146 (176)
T ss_dssp ECCSCCCCC-GGGG--GGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEET
T ss_pred ECCCCcCCc-chhh--HhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeC
Confidence 999999964 3320 0237889999999999999854 44 366666655433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.23 E-value=8.1e-12 Score=130.14 Aligned_cols=102 Identities=12% Similarity=0.098 Sum_probs=87.4
Q ss_pred EEEeecC-ceeecCCccccCCCCCCEEEeec-CcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccccc
Q 006906 5 TLILTKC-LIHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDISL 80 (626)
Q Consensus 5 ~L~L~~N-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~ 80 (626)
.++++++ +|+ .+|. |+.+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..+ +++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4788888 899 6998 99999999999996 99998888899999999999999999998777766 56999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
|+|++..+..+ ..++ |+.|+|.+|+|..
T Consensus 90 N~l~~~~~~~~----~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTV----QGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTT----CSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHc----ccCC-ceEEEeeCCCccC
Confidence 99997655444 3444 9999999998864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.23 E-value=9.6e-12 Score=131.77 Aligned_cols=125 Identities=10% Similarity=0.093 Sum_probs=106.8
Q ss_pred CcceEEEeecCceeecCCc-cccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPD-YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|+.|+|++|.++ .+|. .+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+ +++|+.|+
T Consensus 45 ~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 46899999999999 4565 57999999999999999998888899999999999999999997666665 56999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
+++|+++...+..+ +.+++|++|++++|++++..|..++.++....+.+
T Consensus 124 L~~n~l~~l~~~~~----~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 172 (390)
T 3o6n_A 124 LERNDLSSLPRGIF----HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 172 (390)
T ss_dssp CCSSCCCCCCTTTT----TTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEEC
T ss_pred CCCCccCcCCHHHh----cCCCCCcEEECCCCccCccChhhccCCCCCCEEEC
Confidence 99999985443333 78999999999999999998888888877665444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.2e-11 Score=115.78 Aligned_cols=85 Identities=21% Similarity=0.290 Sum_probs=75.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchh-h--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-I--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~-~--~~~l~~l~ 77 (626)
++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++ +|.. + +++|+.|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce-eCHHHhccccCCCEEE
Confidence 468999999999998889999999999999999999997666678999999999999999995 5554 4 56999999
Q ss_pred cccCccccc
Q 006906 78 ISLNNFTWE 86 (626)
Q Consensus 78 ls~N~l~~~ 86 (626)
|++|.+...
T Consensus 112 L~~N~~~c~ 120 (174)
T 2r9u_A 112 LYNNPWDCE 120 (174)
T ss_dssp CCSSCBCTT
T ss_pred eCCCCcccc
Confidence 999999743
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.21 E-value=2e-12 Score=133.17 Aligned_cols=112 Identities=19% Similarity=0.095 Sum_probs=81.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|++|+|++|+|++..|..|+++++|++|+|++|++++..| |..+++|++|+|++|+|++ +|.. ++|+.|++++|
T Consensus 35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~~~--~~L~~L~l~~n 109 (317)
T 3o53_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LLVG--PSIETLHAANN 109 (317)
T ss_dssp GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EEEC--TTCCEEECCSS
T ss_pred CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-ccCC--CCcCEEECCCC
Confidence 68999999999998777899999999999999999997665 9999999999999999985 3321 46666666666
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
++++..+ ..+++|+.|++++|++++..|..++.++..
T Consensus 110 ~l~~~~~-------~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L 146 (317)
T 3o53_A 110 NISRVSC-------SRGQGKKNIYLANNKITMLRDLDEGCRSRV 146 (317)
T ss_dssp CCSEEEE-------CCCSSCEEEECCSSCCCSGGGBCTGGGSSE
T ss_pred ccCCcCc-------cccCCCCEEECCCCCCCCccchhhhccCCC
Confidence 6654432 223445555555555555555444444433
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.9e-11 Score=125.26 Aligned_cols=104 Identities=15% Similarity=0.271 Sum_probs=60.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|++|+|++|+|++ +| .+..+++|++|+|++|+|++ +|. +.++++|++|+|++|++++..+-.-+++|+.|++++|
T Consensus 86 ~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n 161 (308)
T 1h6u_A 86 KITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA 161 (308)
T ss_dssp SCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSS
T ss_pred CCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCccccCCCCccEEEccCC
Confidence 56777777777663 33 46666777777777777664 332 6666666666666666664333112346666666666
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 115 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~ 115 (626)
++++..+ ...+++|+.|++++|++++..
T Consensus 162 ~l~~~~~------l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 162 QVSDLTP------LANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp CCCCCGG------GTTCTTCCEEECCSSCCCCCG
T ss_pred cCCCChh------hcCCCCCCEEECCCCccCcCh
Confidence 6654322 245555666666666555443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-11 Score=141.76 Aligned_cols=125 Identities=22% Similarity=0.171 Sum_probs=92.7
Q ss_pred ceEEEeecCceee---------cCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hh
Q 006906 3 LKTLILTKCLIHG---------EIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FN 71 (626)
Q Consensus 3 L~~L~L~~N~l~g---------~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~ 71 (626)
|+.++|+.|.|++ ..|..+..+++|+.|+|++|+|. .+|..+.++++|++|+|++|+|+ .+|..+ +.
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 270 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS 270 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence 4455566655554 34778999999999999999998 88988999999999999999999 899887 56
Q ss_pred cCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceee
Q 006906 72 SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTL 135 (626)
Q Consensus 72 ~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~ 135 (626)
+|+.|+|++|+|+ .+|..+ +.+++|++|+|++|.|+ .+|..++.++.+..+.+.+|.+
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~----~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAEL----GSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSG----GGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred CCCEEeCcCCcCC-ccChhh----cCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence 9999999999999 666665 89999999999999997 7787788888887766654443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.5e-11 Score=123.01 Aligned_cols=116 Identities=16% Similarity=0.132 Sum_probs=93.2
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|+.|+|++|+|+ .+| .+..+++|++|+|++|+|++..| +.++++|++|+|++|++++ +|.....+|+.|++++
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~~~L~~L~L~~ 115 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLDN 115 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCCSSCCEEECCS
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccccCcccEEEccC
Confidence 46899999999998 677 78999999999999999996544 9999999999999999995 5543347899999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD 129 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~ 129 (626)
|++++. + ..+.+++|+.|++++|++++. | .++.++....+.
T Consensus 116 N~l~~~-~-----~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~ 156 (263)
T 1xeu_A 116 NELRDT-D-----SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLD 156 (263)
T ss_dssp SCCSBS-G-----GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEE
T ss_pred CccCCC-h-----hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEE
Confidence 999864 1 237889999999999999875 3 355555555433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=5.4e-12 Score=147.36 Aligned_cols=118 Identities=19% Similarity=0.134 Sum_probs=87.2
Q ss_pred CcceEEEeecCceeecC-CccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchh--h--hhcCCc
Q 006906 1 MNLKTLILTKCLIHGEI-PDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY--I--FNSNKN 75 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~--~--~~~l~~ 75 (626)
++|++|+|++|.+.+.+ |..|++|++|++|+|++|+|++..|..|+++++|++|+|++|++++.+|.. + +++|+.
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 36788888888666666 567888888888888888888777888888888888888888888766654 3 457888
Q ss_pred cccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCC
Q 006906 76 VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121 (626)
Q Consensus 76 l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~ 121 (626)
|+|++|++++..+.+ ..+.+++|+.|++++|.+++..|..+..
T Consensus 128 L~Ls~N~l~~~~~~~---~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHP---SFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp EEEESCCCCCCCCCG---GGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred EECCCCcccccccch---hHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 888888887655432 1267778888888888877766655443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.2e-11 Score=121.69 Aligned_cols=110 Identities=15% Similarity=0.147 Sum_probs=86.8
Q ss_pred CcceEEEeecCc-eeecCCccccCCCCCCEEEeec-CcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCC--
Q 006906 1 MNLKTLILTKCL-IHGEIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNK-- 74 (626)
Q Consensus 1 ~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~-- 74 (626)
++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..|..|.++++|++|+|++|++++ +|. + +.+|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 468899999996 8855556788999999999998 99986666788889999999999999885 776 3 44666
Q ss_pred -ccccccC-cccccCCCCCCCCCCCccccc-eeecCCCccCCCCCc
Q 006906 75 -NVDISLN-NFTWESSDPIECPRGSVNLVE-SYSSPRNKLDKVHPC 117 (626)
Q Consensus 75 -~l~ls~N-~l~~~~~~~~~~~~~~~~~l~-~l~l~~N~l~~~~p~ 117 (626)
.|++++| +++...+..+ ..+++|+ .|++++|+++ .+|.
T Consensus 133 ~~L~l~~N~~l~~i~~~~~----~~l~~L~~~L~l~~n~l~-~i~~ 173 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAF----QGLCNETLTLKLYNNGFT-SVQG 173 (239)
T ss_dssp EEEEEESCTTCCEECTTTT----TTTBSSEEEEECCSCCCC-EECT
T ss_pred cEEECCCCcchhhcCcccc----cchhcceeEEEcCCCCCc-ccCH
Confidence 8888888 8876665555 6788888 8888888887 4443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.6e-11 Score=123.23 Aligned_cols=112 Identities=14% Similarity=0.212 Sum_probs=69.2
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls~ 80 (626)
+|++|+|++|+|++ +|. ++++++|++|+|++|+|++ +| .+.++++|++|+|++|++++ ++..- +++|+.|++++
T Consensus 69 ~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~~~l~~l~~L~~L~l~~ 143 (291)
T 1h6t_A 69 NVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGN 143 (291)
T ss_dssp TCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCS
T ss_pred CCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-ChhhcCCCCCCEEEccC
Confidence 56677777777764 333 6667777777777777764 33 36667777777777777764 33211 44677777777
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~ 126 (626)
|++++. . ..+.+++|+.|++++|++++..| +..++...
T Consensus 144 n~l~~~--~----~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~ 181 (291)
T 1h6t_A 144 NKITDI--T----VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181 (291)
T ss_dssp SCCCCC--G----GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred CcCCcc--h----hhccCCCCCEEEccCCccccchh--hcCCCccC
Confidence 776653 1 22566777777777777766555 44454444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.19 E-value=5.9e-12 Score=117.88 Aligned_cols=108 Identities=17% Similarity=0.032 Sum_probs=88.6
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCch--hh--hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK--YI--FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~--~~--~~~l~~l 76 (626)
++|++|+|++|+|++. ..++.+++|++|+|++|+|++..|..|..+++|++|+|++|+|+ .+|. .+ +++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 3799999999999965 67999999999999999999655566799999999999999997 6776 44 4589999
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCCCccC
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
++++|.++.. |..-......+++|+.|+++.|.+.
T Consensus 119 ~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 119 CILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999843 3210001267899999999999874
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.1e-11 Score=120.82 Aligned_cols=122 Identities=19% Similarity=0.178 Sum_probs=96.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDIS 79 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls 79 (626)
++|++|+|++|+|++ +|. ++++++|++|+|++|+|++ +|. +.. ++|++|+|++|++++ +|..- +++|+.|+++
T Consensus 63 ~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TDSLIHLKNLEILSIR 136 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SGGGTTCTTCCEEECT
T ss_pred CCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-ChhhcCcccccEEECC
Confidence 479999999999995 454 9999999999999999995 554 333 899999999999996 55321 5699999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeee
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 136 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~ 136 (626)
+|++++.. ..+.+++|+.|++++|++++. ..+..++....+.+.++.+.
T Consensus 137 ~N~i~~~~------~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 137 NNKLKSIV------MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp TSCCCBCG------GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred CCcCCCCh------HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 99998752 247899999999999999887 55666666665555444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.9e-13 Score=130.71 Aligned_cols=128 Identities=16% Similarity=0.106 Sum_probs=94.2
Q ss_pred cceEEEeecCceeecCCc------cccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcC
Q 006906 2 NLKTLILTKCLIHGEIPD------YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSN 73 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~------~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l 73 (626)
+++.++|+.|.|+|.+|. .++.+++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+ +++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 466677888888888776 78888888888888888885 77 8888888888888888888 677655 4688
Q ss_pred CccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC-cccCCCCCCCCCCCcceeeeee
Q 006906 74 KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP-CLRQNFPCSAPADQYHYTLHIN 138 (626)
Q Consensus 74 ~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p-~~~~~~p~~~~~~~~~~~~~~~ 138 (626)
+.|++++|++++. | . .+.+++|+.|++++|+++...+ ..+..++....+.+..+++.+.
T Consensus 96 ~~L~L~~N~l~~l-~-~----~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 96 EELWISYNQIASL-S-G----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEEEEEEECCCH-H-H----HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CEEECcCCcCCcC-C-c----cccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 8888888888763 2 2 3677888888888888876443 4556666666555544444433
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.16 E-value=4.7e-11 Score=122.36 Aligned_cols=118 Identities=19% Similarity=0.216 Sum_probs=96.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCch-hhhhcCCccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK-YIFNSNKNVDIS 79 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~~l~~l~ls 79 (626)
++|++|+|++|+|++ +|. +..+++|++|+|++|+|++ +| .+.++++|++|+|++|++++ +|. .-+++|+.|+++
T Consensus 63 ~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~ 137 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTPLAGLSNLQVLYLD 137 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGGGTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chhhcCCCCCCEEECC
Confidence 478999999999995 555 9999999999999999985 45 69999999999999999996 554 225699999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQY 131 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~ 131 (626)
+|++++..+ .+.+++|+.|++++|++++..+ +..++....+.+.
T Consensus 138 ~n~l~~~~~------l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~ 181 (308)
T 1h6u_A 138 LNQITNISP------LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181 (308)
T ss_dssp SSCCCCCGG------GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCccCcCcc------ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECC
Confidence 999986543 3788999999999999988655 6666666554443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.16 E-value=5.7e-11 Score=120.71 Aligned_cols=119 Identities=16% Similarity=0.256 Sum_probs=97.9
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|+|++ +| .++.+++|++|+|++|+|++ + ..+.++++|++|+|++|++++. + .+ +++|+.|++
T Consensus 90 ~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L 163 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-T-VLSRLTKLDTLSL 163 (291)
T ss_dssp TTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEEC
T ss_pred CCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-h-hhccCCCCCEEEc
Confidence 479999999999995 55 49999999999999999996 4 4799999999999999999964 3 33 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcce
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHY 133 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~ 133 (626)
++|++++..+ ...+++|+.|++++|++++. |. +..++....+.+..+
T Consensus 164 ~~N~l~~~~~------l~~l~~L~~L~L~~N~i~~l-~~-l~~l~~L~~L~l~~n 210 (291)
T 1h6t_A 164 EDNQISDIVP------LAGLTKLQNLYLSKNHISDL-RA-LAGLKNLDVLELFSQ 210 (291)
T ss_dssp CSSCCCCCGG------GTTCTTCCEEECCSSCCCBC-GG-GTTCTTCSEEEEEEE
T ss_pred cCCccccchh------hcCCCccCEEECCCCcCCCC-hh-hccCCCCCEEECcCC
Confidence 9999987654 37899999999999999875 43 566666665544443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.4e-11 Score=135.01 Aligned_cols=102 Identities=15% Similarity=0.128 Sum_probs=87.3
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccC-chhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPV-PKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~i-p~~~--~~~l~~l~ 77 (626)
++|+.|+|++|+|+ .+|..|++|++|++|+|++|+|++ +| .|++|++|++|+|++|+|++.. |..+ +++|+.|+
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 47999999999999 899999999999999999999996 88 8999999999999999999876 8887 56999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeec
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSS 106 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l 106 (626)
|++|++++.+|... .-...+++|+.|++
T Consensus 540 L~~N~l~~~~~~~~-~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQE-RLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTT-HHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHH-HHHHHCcccCccCC
Confidence 99999998765321 11133678887764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=3.3e-11 Score=119.69 Aligned_cols=138 Identities=16% Similarity=0.109 Sum_probs=100.1
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCc--eeeEEEEEEeCCeEEEEEEec
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~e~~ 473 (626)
++.+..+.+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34333333456669999998777888999997654 2245678888888875544 455888888878899999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------------------------------------- 516 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 516 (626)
++.++. ... . ....++.++++.+..||+..
T Consensus 98 ~G~~l~--~~~--------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 98 PGQDLL--SSH--------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SSEETT--TSC--------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCcccC--cCc--------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 998884 211 1 12356777888888888642
Q ss_pred ------------------CCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 517 ------------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 517 ------------------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
...++|+|++|.||+++.+..+.|+||+.+...
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 122999999999999988766779999998743
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.15 E-value=6.4e-11 Score=128.60 Aligned_cols=118 Identities=18% Similarity=0.192 Sum_probs=55.6
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccCc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNN 82 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N~ 82 (626)
|+.|+|++|++++. |. +..+++|+.|+|++|++++..| ++.+++|+.|+|++|++++..|..-+++|+.|++++|+
T Consensus 267 L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 267 LTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNK 342 (466)
T ss_dssp CSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSC
T ss_pred CCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCc
Confidence 44444444444422 21 4444444444444444443322 44455555555555555544332223455555555555
Q ss_pred ccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcc
Q 006906 83 FTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYH 132 (626)
Q Consensus 83 l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~ 132 (626)
+++.. ..+.+++|+.|++++|++++.+| +..++....+.+..
T Consensus 343 l~~~~------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~ 384 (466)
T 1o6v_A 343 VSDVS------SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 384 (466)
T ss_dssp CCCCG------GGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCC
T ss_pred cCCch------hhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccC
Confidence 54431 12455666666666666666555 44455444433333
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.14 E-value=4.1e-11 Score=133.96 Aligned_cols=113 Identities=14% Similarity=0.206 Sum_probs=69.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls~ 80 (626)
+|+.|+|++|+|++..| ++.|++|+.|+|++|+|++ +| .|..|++|+.|+|++|+|++ +|... +++|+.|+|++
T Consensus 66 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~ 140 (605)
T 1m9s_A 66 NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGN 140 (605)
T ss_dssp TCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCS
T ss_pred CCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCC
Confidence 56677777777764333 6667777777777777664 33 56666777777777777664 33221 44667777777
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAP 127 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~ 127 (626)
|++++. . .++.+++|+.|+|++|+|.+..| +..++.+..
T Consensus 141 N~l~~l--~----~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~ 179 (605)
T 1m9s_A 141 NKITDI--T----VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 179 (605)
T ss_dssp SCCCCC--G----GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred CccCCc--h----hhcccCCCCEEECcCCcCCCchh--hccCCCCCE
Confidence 766643 1 12566667777777777766655 445554443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.13 E-value=4.5e-11 Score=132.38 Aligned_cols=98 Identities=22% Similarity=0.342 Sum_probs=68.6
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+|++
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVRN 169 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCS
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECCC
Confidence 367788888888875 776 655 78888888888875 665 57777778888777775 666 456777777777
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
|+|++ +|. + . ++|+.|++++|+|+ .+|.
T Consensus 170 N~L~~-lp~-l----~--~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 170 NQLTF-LPE-L----P--ESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SCCSC-CCC-C----C--TTCCEEECCSSCCS-SCCC
T ss_pred CCCCC-cch-h----h--CCCCEEECcCCCCC-chhh
Confidence 77776 343 3 2 66777777777776 4443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.1e-10 Score=130.55 Aligned_cols=121 Identities=17% Similarity=0.255 Sum_probs=99.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++ +| .+.+|++|+.|+|++|+|++. + .+ +++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI-T-VLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC-G-GGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc-h-hhcccCCCCEEEC
Confidence 479999999999995 55 79999999999999999996 44 699999999999999999964 3 33 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceee
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTL 135 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~ 135 (626)
++|++++..| + ..+++|+.|+|++|+|++. | .+..++.+..+.+..+.+
T Consensus 161 s~N~l~~~~~--l----~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 161 EDNQISDIVP--L----AGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp CSSCCCCCGG--G----TTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEE
T ss_pred cCCcCCCchh--h----ccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcC
Confidence 9999997655 3 7899999999999999885 3 466677766655554444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-12 Score=125.04 Aligned_cols=110 Identities=15% Similarity=0.084 Sum_probs=94.3
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDIS 79 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls 79 (626)
++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|... +++|+.|+++
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~ 123 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMS 123 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEES
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CCccccCCCCCEEECC
Confidence 479999999999996 88 8999999999999999999 789899999999999999999996 66322 5699999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
+|+++...+.. ....+++|+.|++++|++++.+|.
T Consensus 124 ~N~i~~~~~~~---~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 124 NNKITNWGEID---KLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEECCCHHHHH---HHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCcCCchhHHH---HHhcCCCCCEEEecCCcccccccc
Confidence 99998543211 137889999999999999888775
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.10 E-value=5.9e-11 Score=123.39 Aligned_cols=118 Identities=14% Similarity=0.173 Sum_probs=61.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls~ 80 (626)
+|+.|++++|++++..+ +..+++|++|+|++|++++..+ +..+++|++|+|++|++++ ++..- +++|+.|++++
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~ 274 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGS 274 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCS
T ss_pred ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEccC
Confidence 45566666666653322 5555666666666666653322 5555666666666665553 32211 34555666666
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
|++++. + ....+++|+.|++++|++++..|..++.++....+.+
T Consensus 275 n~l~~~-~-----~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 318 (347)
T 4fmz_A 275 NQISDI-S-----VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318 (347)
T ss_dssp SCCCCC-G-----GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred CccCCC-h-----hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence 655542 1 1244555555555555555555555555554444333
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.6e-11 Score=133.10 Aligned_cols=115 Identities=18% Similarity=0.175 Sum_probs=86.6
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. +.++|+.|+|++|
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~~~L~~L~Ls~N 190 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LPESLEALDVSTN 190 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSS
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hhCCCCEEECcCC
Confidence 68899999999986 777 68899999999999986 775 67889999999999986 777 6678999999999
Q ss_pred cccccCCCCCCCCCCCcccc-------ceeecCCCccCCCCCcccCCCCCCCCCCCcceee
Q 006906 82 NFTWESSDPIECPRGSVNLV-------ESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTL 135 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l-------~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~ 135 (626)
+|+ .+|. ++ . +| +.|++++|+|+. +|..+..++....+.+.+|++
T Consensus 191 ~L~-~lp~-~~----~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 191 LLE-SLPA-VP----V--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL 242 (571)
T ss_dssp CCS-SCCC-CC--------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSC
T ss_pred CCC-chhh-HH----H--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcC
Confidence 888 4444 42 1 55 888888888884 566555577666555544444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.08 E-value=8.3e-11 Score=122.46 Aligned_cols=84 Identities=17% Similarity=0.136 Sum_probs=75.3
Q ss_pred CcceEEEeec-CceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhh--cCCccc
Q 006906 1 MNLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--SNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~--~l~~l~ 77 (626)
++|+.|+|++ |+|++..|..|++|++|++|+|++|+|++..|..|.+|++|++|+|++|+|++ +|..++. .|+.|+
T Consensus 31 ~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L~~l~ 109 (347)
T 2ifg_A 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELV 109 (347)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCEEE
T ss_pred CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcccCCceEEE
Confidence 3699999996 99998777899999999999999999999999999999999999999999995 6655533 599999
Q ss_pred cccCcccc
Q 006906 78 ISLNNFTW 85 (626)
Q Consensus 78 ls~N~l~~ 85 (626)
|++|.|..
T Consensus 110 l~~N~~~c 117 (347)
T 2ifg_A 110 LSGNPLHC 117 (347)
T ss_dssp CCSSCCCC
T ss_pred eeCCCccC
Confidence 99999974
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.04 E-value=3.2e-10 Score=123.11 Aligned_cols=105 Identities=20% Similarity=0.276 Sum_probs=59.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|+.|+|++|++++ ++ .+..+++|++|+|++|++++..| +.++++|+.|+|++|++++..|-.-+++|+.|++++|
T Consensus 222 ~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n 297 (466)
T 1o6v_A 222 NLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 297 (466)
T ss_dssp TCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCccc-ch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcCCC
Confidence 46666666666663 32 45566666666666666665443 5666666666666666664333122445666666666
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
++++..+ .+.+++|+.|++++|++++..|
T Consensus 298 ~l~~~~~------~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 298 QLEDISP------ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp CCSCCGG------GGGCTTCSEEECCSSCCSCCGG
T ss_pred cccCchh------hcCCCCCCEEECcCCcCCCchh
Confidence 6654322 2455566666666666655544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.7e-10 Score=124.90 Aligned_cols=104 Identities=17% Similarity=0.104 Sum_probs=67.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhh---------
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--------- 71 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~--------- 71 (626)
++|+.|+|++|+|++. .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|+|++..+.. ++
T Consensus 191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~-l~~L~~L~l~~ 263 (457)
T 3bz5_A 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVST-LSKLTTLHCIQ 263 (457)
T ss_dssp TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTT-CTTCCEEECTT
T ss_pred CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHH-CCCCCEEeccC
Confidence 3577788888888753 37777888888888888876 56 777788888888888877643322 22
Q ss_pred -cCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 72 -SNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 72 -~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
.|+.|++++|.+.+.+| .+.+++|+.|++++|++.+.+|.
T Consensus 264 n~L~~L~l~~n~~~~~~~------~~~l~~L~~L~Ls~n~~l~~l~~ 304 (457)
T 3bz5_A 264 TDLLEIDLTHNTQLIYFQ------AEGCRKIKELDVTHNTQLYLLDC 304 (457)
T ss_dssp CCCSCCCCTTCTTCCEEE------CTTCTTCCCCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCccc------ccccccCCEEECCCCcccceecc
Confidence 34555556665555443 14556666666666666555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.1e-10 Score=120.54 Aligned_cols=107 Identities=17% Similarity=0.116 Sum_probs=72.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|++|+|++|+..+.+ .++.+++|++|+|++|+|++ +| ++.+++|+.|++++|+|++ ++-.-+++|+.|++++
T Consensus 148 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~~l~~l~~L~~L~Ls~ 221 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK-LDLNQNIQLTFLDCSS 221 (457)
T ss_dssp TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-CCCTTCTTCSEEECCS
T ss_pred CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCe-eccccCCCCCEEECcC
Confidence 35777777777655566 36777777777777777775 45 7777777777777777775 3433355777777777
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQ 120 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~ 120 (626)
|++++ +| + +.+++|+.|++++|++++..+..+.
T Consensus 222 N~l~~-ip--~----~~l~~L~~L~l~~N~l~~~~~~~l~ 254 (457)
T 3bz5_A 222 NKLTE-ID--V----TPLTQLTYFDCSVNPLTELDVSTLS 254 (457)
T ss_dssp SCCSC-CC--C----TTCTTCSEEECCSSCCSCCCCTTCT
T ss_pred Ccccc-cC--c----cccCCCCEEEeeCCcCCCcCHHHCC
Confidence 77776 22 2 5677777777777777776544433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.00 E-value=1.9e-10 Score=124.40 Aligned_cols=64 Identities=14% Similarity=0.122 Sum_probs=35.3
Q ss_pred CCCCEEeccCccccccCchhhhhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCC--CCCcccCCC
Q 006906 49 AKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK--VHPCLRQNF 122 (626)
Q Consensus 49 ~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~--~~p~~~~~~ 122 (626)
++|++|+|++|++++ +|.. +++|+.|++++|+++. +|. .+++|+.|++++|++++ .+|..+..+
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~-~~~L~~L~L~~N~l~~-lp~-------~l~~L~~L~L~~N~l~~l~~ip~~l~~L 382 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL-PPRLERLIASFNHLAE-VPE-------LPQNLKQLHVEYNPLREFPDIPESVEDL 382 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC-CTTCCEEECCSSCCSC-CCC-------CCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred CcCCEEECCCCcccc-cccc-CCcCCEEECCCCcccc-ccc-------hhhhccEEECCCCCCCcCCCChHHHHhh
Confidence 356666666666664 4443 3556666666666652 221 24556666666666666 555544433
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.00 E-value=3.2e-11 Score=124.75 Aligned_cols=121 Identities=16% Similarity=0.207 Sum_probs=69.5
Q ss_pred cceEEEeecCceeec-CCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCc-ccccc-Cchhh--hhcCCcc
Q 006906 2 NLKTLILTKCLIHGE-IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGN-KLTGP-VPKYI--FNSNKNV 76 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N-~l~g~-ip~~~--~~~l~~l 76 (626)
+|++|+|++|++++. +|..+..+++|++|+|++|++++.+|..++++++|++|+|++| .+++. +|..+ +++|+.|
T Consensus 94 ~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L 173 (336)
T 2ast_B 94 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 173 (336)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEE
Confidence 566777777776655 6666666777777777777776666666666777777777776 56542 44433 3466666
Q ss_pred ccccC-ccccc-CCCCCCCCCCCcc-ccceeecCCC--ccC-CCCCcccCCCCCCC
Q 006906 77 DISLN-NFTWE-SSDPIECPRGSVN-LVESYSSPRN--KLD-KVHPCLRQNFPCSA 126 (626)
Q Consensus 77 ~ls~N-~l~~~-~~~~~~~~~~~~~-~l~~l~l~~N--~l~-~~~p~~~~~~p~~~ 126 (626)
++++| ++++. ++..+ ..++ +|+.|++++| .++ +.+|.....+|...
T Consensus 174 ~l~~~~~l~~~~~~~~~----~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~ 225 (336)
T 2ast_B 174 NLSWCFDFTEKHVQVAV----AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225 (336)
T ss_dssp ECCCCTTCCHHHHHHHH----HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS
T ss_pred cCCCCCCcChHHHHHHH----HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCC
Confidence 66666 66542 11111 3445 5555555555 333 33444444444333
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=7.9e-10 Score=115.68 Aligned_cols=142 Identities=15% Similarity=0.241 Sum_probs=105.5
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEec--cCC-hhcHHHHHHHHHHHhcCCC--CceeeEEEEEEeC---CeEEEEEE
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLS--SKS-RQGNREFVNEIGMISAQQH--PNLVKLYGCCVEG---NQLLLVYE 471 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~--~~~-~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~---~~~~lV~e 471 (626)
.+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+.+ ..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999998754 578888775 322 1223567789999888864 4577888888766 34799999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS----------------------------------- 516 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------- 516 (626)
|+++..+.+... ..++..++..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999887754211 24678888999999999999999731
Q ss_pred --------------------CCCeEEeCCCCCCEEEcCCCC--EEEeecCCcccc
Q 006906 517 --------------------RIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLY 549 (626)
Q Consensus 517 --------------------~~~iiH~Dlkp~NILl~~~~~--~kl~DfGla~~~ 549 (626)
...++|+|+++.||+++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999997753 589999998753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.97 E-value=9.6e-10 Score=118.90 Aligned_cols=79 Identities=16% Similarity=0.224 Sum_probs=50.6
Q ss_pred CCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccCcccccCCCCCCCCCCCcccccee
Q 006906 25 TKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESY 104 (626)
Q Consensus 25 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l 104 (626)
++|++|+|++|++++ +| .|+++++|++|++++|++++ +|.. ..+|+.|++++|++++ +| .+ +.+++|+.|
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~-~~~L~~L~L~~n~l~~-l~-~~----~~l~~L~~L 200 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL-PPSLEFIAAGNNQLEE-LP-EL----QNLPFLTAI 200 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC-CTTCCEEECCSSCCSS-CC-CC----TTCTTCCEE
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC-cccccEEECcCCcCCc-Cc-cc----cCCCCCCEE
Confidence 466666666666664 66 46777777777777777764 5543 2467777777777765 23 22 566677777
Q ss_pred ecCCCccCC
Q 006906 105 SSPRNKLDK 113 (626)
Q Consensus 105 ~l~~N~l~~ 113 (626)
++++|++++
T Consensus 201 ~l~~N~l~~ 209 (454)
T 1jl5_A 201 YADNNSLKK 209 (454)
T ss_dssp ECCSSCCSS
T ss_pred ECCCCcCCc
Confidence 777777665
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.97 E-value=4.2e-10 Score=116.91 Aligned_cols=118 Identities=16% Similarity=0.191 Sum_probs=80.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|+.|+|++|++++ ++. +..+++|+.|++++|.+++..+ +..+++|++|+|++|++++..+-.-+++|+.|++++
T Consensus 177 ~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~ 252 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGT 252 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCC
Confidence 367788888888874 443 7778888888888888875544 777888888888888887533322255788888888
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQ 130 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~ 130 (626)
|+++.. . ....+++|+.|++++|++++. | .+..++....+.+
T Consensus 253 n~l~~~--~----~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 253 NQISDI--N----AVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFL 294 (347)
T ss_dssp SCCCCC--G----GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEEC
T ss_pred CccCCC--h----hHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEEC
Confidence 877753 1 136677888888888887765 2 3445555444333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.2e-10 Score=128.31 Aligned_cols=100 Identities=23% Similarity=0.221 Sum_probs=66.0
Q ss_pred CCCCEEEeecCcCCCCChHH---hhc--------------cCCCCEEeccCccccccCchhhhhcCCccccccCcccccC
Q 006906 25 TKLKNIDLSFNNLTGGIPTT---FEK--------------LAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFTWES 87 (626)
Q Consensus 25 ~~L~~L~Ls~N~l~g~ip~~---~~~--------------l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N~l~~~~ 87 (626)
++|+.|+|++|+|++ +|.. +.. +++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+. +
T Consensus 181 ~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp-~~l~~L~~L~Ls~N~L~~-l 256 (622)
T 3g06_A 181 SGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP-VLPSELKELMVSGNRLTS-L 256 (622)
T ss_dssp TTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC-CCCTTCCEEECCSSCCSC-C
T ss_pred CCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC-CCCCcCcEEECCCCCCCc-C
Confidence 666666666666664 3222 222 2667888888888874 66 344678888888888873 2
Q ss_pred CCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeee
Q 006906 88 SDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLH 136 (626)
Q Consensus 88 ~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~ 136 (626)
|. .+++|+.|++++|+|+ .+|..+..++....+.+.+|++.
T Consensus 257 p~-------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 257 PM-------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp CC-------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred Cc-------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCC
Confidence 21 4567888888888888 66777777777766666555543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=3.9e-10 Score=115.18 Aligned_cols=185 Identities=17% Similarity=0.188 Sum_probs=121.0
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCc--eeeEEEEEEeCC---eEEEEEEec
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPN--LVKLYGCCVEGN---QLLLVYEYM 473 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~e~~ 473 (626)
.+.++.|....||+.. ..+++|+.... .....+.+|.+++..+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4679999999999863 45888886532 34567889999998773 332 333444433332 347899999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-------------------------------------- 515 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------- 515 (626)
+|.++.+... ..++..++..++.++++.+..||+.
T Consensus 99 ~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 99 KGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred CCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9988865332 1467777888888888888888861
Q ss_pred -----------------CCCCeEEeCCCCCCEEEcC--CCCEEEeecCCcccccCCCcceecc--------------ccc
Q 006906 516 -----------------SRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYEEDKTHISTR--------------IAG 562 (626)
Q Consensus 516 -----------------~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~--------------~~g 562 (626)
..+.++|+|++|.||++++ +..+.|+||+.+....... ..... ...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHH
Confidence 1234899999999999998 4567899999987543210 00000 000
Q ss_pred CCcccc-hhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 563 TIGYMA-PEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 563 t~~y~a-PE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
..+... |+..... .-..+.|+++.++|++.+|+.++
T Consensus 251 ~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 011111 2222111 11268999999999999998765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.1e-11 Score=126.19 Aligned_cols=127 Identities=9% Similarity=0.081 Sum_probs=99.9
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCC-ChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGG-IPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|+.|+|++|.+++.+|. +..+++|++|+|++|.+++. +|..+.++++|++|+|++|++++.+|..+ +++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 3678999999999976665 66799999999999999876 88889999999999999999988888777 45899999
Q ss_pred cccC-ccccc-CCCCCCCCCCCccccceeecCCC-ccCCC-CCcccCCCC-CCCCCCCcc
Q 006906 78 ISLN-NFTWE-SSDPIECPRGSVNLVESYSSPRN-KLDKV-HPCLRQNFP-CSAPADQYH 132 (626)
Q Consensus 78 ls~N-~l~~~-~~~~~~~~~~~~~~l~~l~l~~N-~l~~~-~p~~~~~~p-~~~~~~~~~ 132 (626)
+++| .+++. ++.. ...+++|+.|++++| .+++. ++..+..+| ....+.+..
T Consensus 149 L~~~~~l~~~~l~~~----~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 149 LSGCSGFSEFALQTL----LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBSCCHHHHHHH----HHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CCCCCCCCHHHHHHH----HhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 9999 67653 2222 257889999999999 88764 566677777 655544433
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.96 E-value=4.7e-11 Score=126.28 Aligned_cols=130 Identities=16% Similarity=0.081 Sum_probs=83.2
Q ss_pred CcceEEEeecC---ceeecCCccc-------cCCCCCCEEEeecCcCCC----CChHHhhccCCCCEEeccCccccccCc
Q 006906 1 MNLKTLILTKC---LIHGEIPDYI-------GDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTGPVP 66 (626)
Q Consensus 1 ~~L~~L~L~~N---~l~g~~p~~~-------~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~ip 66 (626)
++|++|+|++| ++++.+|..+ ..+++|++|+|++|+|++ .+|..+.++++|++|+|++|.|++..+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 46788888874 6666677655 678888888888888887 477788888888888888888875444
Q ss_pred hhhh---------------hcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccC--C---CCCcccCCCCCCC
Q 006906 67 KYIF---------------NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLD--K---VHPCLRQNFPCSA 126 (626)
Q Consensus 67 ~~~~---------------~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~--~---~~p~~~~~~p~~~ 126 (626)
..+. ++|+.|+|++|+++......+...+..+++|+.|++++|+++ | .+|..+..++...
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 3331 578888888888762211110001134566777777777765 2 3343444555444
Q ss_pred CCCC
Q 006906 127 PADQ 130 (626)
Q Consensus 127 ~~~~ 130 (626)
.+.+
T Consensus 220 ~L~L 223 (386)
T 2ca6_A 220 VLDL 223 (386)
T ss_dssp EEEC
T ss_pred EEEC
Confidence 4433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.94 E-value=4.8e-11 Score=125.20 Aligned_cols=112 Identities=17% Similarity=0.146 Sum_probs=80.1
Q ss_pred cceEEEeecCceeecCC----ccccCCC-CCCEEEeecCcCCCCChHHhhcc-----CCCCEEeccCccccccCchhh--
Q 006906 2 NLKTLILTKCLIHGEIP----DYIGDMT-KLKNIDLSFNNLTGGIPTTFEKL-----AKTNFMYLTGNKLTGPVPKYI-- 69 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p----~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l-----~~L~~L~ls~N~l~g~ip~~~-- 69 (626)
+|++|+|++|+|++..+ ..+.+++ +|++|+|++|+|++..+..|..+ ++|++|+|++|++++..+..+
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 48888888888886555 6677777 78888888888887778777776 888888888888887666644
Q ss_pred h-----hcCCccccccCcccccCCCCCCCCCCC-ccccceeecCCCccCC
Q 006906 70 F-----NSNKNVDISLNNFTWESSDPIECPRGS-VNLVESYSSPRNKLDK 113 (626)
Q Consensus 70 ~-----~~l~~l~ls~N~l~~~~~~~~~~~~~~-~~~l~~l~l~~N~l~~ 113 (626)
. ++|+.|+|++|++++..+..+...... ..+|+.|++++|+++.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 1 478888888888876544322101122 2477778888887764
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=2.4e-09 Score=99.75 Aligned_cols=98 Identities=26% Similarity=0.350 Sum_probs=82.6
Q ss_pred cCcHHhhhhhcccCCcceeeeeccCCceeeEEEEEeeeeecCCccccccCceEEEEEecCccccccCCcccccCCcCcce
Q 006906 201 AVDLELYRTARVSPLSLTYYGLCLGNGNYTVRLHFAEIIFKNDSTFNSLGKRIFDIYIQEKLVKKDFNIEDEAGGTGIPI 280 (626)
Q Consensus 201 ~~~~~l~~~~~~~p~~l~~~~~~~~~g~~~~~l~~~~~~~~~~~~~~~l~~~~~~i~~~~~~~~~~~~~~~~~~g~~~~~ 280 (626)
..+.++|.++|..|.+++|...|..+|.|.++|||||+... +.++|+|+|++|+..+.+++++..++++ ..+.
T Consensus 51 ~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrLhF~ei~~~------~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~ 123 (174)
T 2jwp_A 51 PEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVLKFAEVYFA------QSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAH 123 (174)
T ss_dssp HHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEEEEECCSCC------CSSSSCEEEEETTEEEEEEECHHHHHSS-SSCE
T ss_pred CCCchhhhhhccCCCCeEEEEEeCCCeEEEEEEEEeccccC------CCCCeEeEEEECCEEeecCcCHHHhhCC-CeeE
Confidence 45788999999999999999999999999999999998553 3799999999999999999999999977 6788
Q ss_pred eeeeeeeeecCeeEEEEEec-CCcee
Q 006906 281 VKNFPAEVTSHTLKIHLYWA-GRGTT 305 (626)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~-~~~~~ 305 (626)
.+.|.+.++++.+.++..++ +++..
T Consensus 124 ~~~~~~~v~~~~l~i~~~~~~~~g~L 149 (174)
T 2jwp_A 124 DEIIPISIKKGKLSVQGEVSTFTGKL 149 (174)
T ss_dssp EEEEEEEEETTEEEETTEEEECCSEE
T ss_pred EEEEEEEEecCceeeeeeecccCCeE
Confidence 89999988877766654443 33443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.93 E-value=8e-11 Score=124.50 Aligned_cols=130 Identities=16% Similarity=0.166 Sum_probs=98.1
Q ss_pred CcceEEEeecCceeecCC----ccccCCCCCCEEEeecC---cCCCCChHHh-------hccCCCCEEeccCccccc---
Q 006906 1 MNLKTLILTKCLIHGEIP----DYIGDMTKLKNIDLSFN---NLTGGIPTTF-------EKLAKTNFMYLTGNKLTG--- 63 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~Ls~N---~l~g~ip~~~-------~~l~~L~~L~ls~N~l~g--- 63 (626)
++|+.|+|++|+|++..+ ..+..+++|++|+|++| ++++.+|..+ .++++|++|+|++|+|++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 468999999999997644 45789999999999995 6667888776 688999999999999997
Q ss_pred -cCchhh--hhcCCccccccCcccccCCCCCCCCCCCc---------cccceeecCCCccC-CCCCc---ccCCCCCCCC
Q 006906 64 -PVPKYI--FNSNKNVDISLNNFTWESSDPIECPRGSV---------NLVESYSSPRNKLD-KVHPC---LRQNFPCSAP 127 (626)
Q Consensus 64 -~ip~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~~---------~~l~~l~l~~N~l~-~~~p~---~~~~~p~~~~ 127 (626)
.+|..+ +++|+.|+|++|.++...+..++..+..+ ++|+.|++++|+++ +.+|. .+..++....
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 477766 45999999999999755443331111223 89999999999997 56663 3445555444
Q ss_pred CCC
Q 006906 128 ADQ 130 (626)
Q Consensus 128 ~~~ 130 (626)
+.+
T Consensus 192 L~L 194 (386)
T 2ca6_A 192 VKM 194 (386)
T ss_dssp EEC
T ss_pred EEC
Confidence 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.92 E-value=9.8e-10 Score=123.05 Aligned_cols=102 Identities=20% Similarity=0.226 Sum_probs=64.7
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCC--CChHHhhcc--------------CCCCEEeccCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKL--------------AKTNFMYLTGNKLTGPV 65 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l--------------~~L~~L~ls~N~l~g~i 65 (626)
+|+.|+|++|+|+ .+|.. +++|++|+|++|+|++ ..|..+..| ++|+.|+|++|+|++ +
T Consensus 122 ~L~~L~L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l 196 (622)
T 3g06_A 122 GLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-L 196 (622)
T ss_dssp TCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-C
T ss_pred CcCEEECCCCCCC-cCCCC---CCCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-C
Confidence 4666666666666 35543 3667777777777664 222333333 788999999998885 4
Q ss_pred chhh-------------------hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCc
Q 006906 66 PKYI-------------------FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117 (626)
Q Consensus 66 p~~~-------------------~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~ 117 (626)
|..+ +++|+.|+|++|++++ +| ..+++|+.|++++|+|+. +|.
T Consensus 197 ~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp-------~~l~~L~~L~Ls~N~L~~-lp~ 258 (622)
T 3g06_A 197 PTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP-------VLPSELKELMVSGNRLTS-LPM 258 (622)
T ss_dssp CCCCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC-------CCCTTCCEEECCSSCCSC-CCC
T ss_pred CCccchhhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC-------CCCCcCcEEECCCCCCCc-CCc
Confidence 4321 1356677777777764 22 345778888999988874 443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.8e-10 Score=119.32 Aligned_cols=115 Identities=17% Similarity=0.159 Sum_probs=93.1
Q ss_pred EEEeecCceeecCCccccCCCCCCEEEeecCcCCCCCh----HHhhccC-CCCEEeccCccccccCchhh--h-----hc
Q 006906 5 TLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP----TTFEKLA-KTNFMYLTGNKLTGPVPKYI--F-----NS 72 (626)
Q Consensus 5 ~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip----~~~~~l~-~L~~L~ls~N~l~g~ip~~~--~-----~~ 72 (626)
.+.|+.|+++|.+|..+...++|++|||++|+|++..+ ..|.+++ +|++|+|++|+|++..+..+ . ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888888889999999999998777 7888888 89999999999998777666 2 68
Q ss_pred CCccccccCcccccCCCCCCCCCCCc-cccceeecCCCccCCCCCccc
Q 006906 73 NKNVDISLNNFTWESSDPIECPRGSV-NLVESYSSPRNKLDKVHPCLR 119 (626)
Q Consensus 73 l~~l~ls~N~l~~~~~~~~~~~~~~~-~~l~~l~l~~N~l~~~~p~~~ 119 (626)
|+.|+|++|++++..+..+......+ ++|+.|++++|++++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 129 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF 129 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHH
Confidence 99999999999876554331111233 789999999999988776543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.80 E-value=4.1e-09 Score=109.84 Aligned_cols=108 Identities=8% Similarity=0.122 Sum_probs=68.1
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhh---cC-Cccccc
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN---SN-KNVDIS 79 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~---~l-~~l~ls 79 (626)
+.++.++|+|+ .+|..+ .++|+.|+|++|+|+...+..|.+|++|++|+|++|++.+.+|...+. ++ +.+.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 35666777777 667655 356777777777776333345677777777777777776666655433 22 235556
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCL 118 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~ 118 (626)
.|+++...|..+ ..+++|+.|++++|++....+..
T Consensus 89 ~N~l~~l~~~~f----~~l~~L~~L~l~~n~l~~~~~~~ 123 (350)
T 4ay9_X 89 ANNLLYINPEAF----QNLPNLQYLLISNTGIKHLPDVH 123 (350)
T ss_dssp ETTCCEECTTSB----CCCTTCCEEEEEEECCSSCCCCT
T ss_pred CCcccccCchhh----hhccccccccccccccccCCchh
Confidence 677766655554 66677777777777776655443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.78 E-value=4.6e-09 Score=109.48 Aligned_cols=116 Identities=13% Similarity=-0.002 Sum_probs=89.1
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChH-HhhccCCCCE-EeccCccccccCchhh--hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPT-TFEKLAKTNF-MYLTGNKLTGPVPKYI--FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~-L~ls~N~l~g~ip~~~--~~~l~~l 76 (626)
++|++|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.++++|+. +.+++|+|+...|..+ +++|+.|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 3689999999999943345799999999999999999887764 6789998875 6777899996555555 5699999
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCC-CccCCCCCcccC
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPR-NKLDKVHPCLRQ 120 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~-N~l~~~~p~~~~ 120 (626)
++++|++....+..+ ....++..+++.+ |++....+..+.
T Consensus 110 ~l~~n~l~~~~~~~~----~~~~~l~~l~l~~~~~i~~l~~~~f~ 150 (350)
T 4ay9_X 110 LISNTGIKHLPDVHK----IHSLQKVLLDIQDNINIHTIERNSFV 150 (350)
T ss_dssp EEEEECCSSCCCCTT----CCBSSCEEEEEESCTTCCEECTTSST
T ss_pred cccccccccCCchhh----cccchhhhhhhccccccccccccchh
Confidence 999999987665444 4556677888865 556554444433
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.74 E-value=2.4e-10 Score=123.60 Aligned_cols=112 Identities=13% Similarity=0.139 Sum_probs=60.0
Q ss_pred cceEEEeecCceeecC-----CccccCCCCCCEEEeecCcCCCC----ChHHhhccCCCCEEeccCccccccCchhhh--
Q 006906 2 NLKTLILTKCLIHGEI-----PDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTGPVPKYIF-- 70 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~-----p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~-- 70 (626)
+|++|+|++|+|++.- +..+..+++|++|+|++|+|++. +|..+.++++|++|+|++|++++..+..+.
T Consensus 228 ~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 307 (461)
T 1z7x_W 228 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 307 (461)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred CccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH
Confidence 5677777777766432 22233466777777777777643 566666667777777777766543333321
Q ss_pred -----hcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 71 -----NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 71 -----~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
++|+.|++++|.+++.....++.....+++|+.|++++|++++
T Consensus 308 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 355 (461)
T 1z7x_W 308 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355 (461)
T ss_dssp HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccc
Confidence 2555666666655543211111111233455555555555543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.64 E-value=1.6e-09 Score=116.98 Aligned_cols=133 Identities=12% Similarity=0.065 Sum_probs=99.2
Q ss_pred CcceEEEeecCceeec----CCccccCCCCCCEEEeecCcCCCCChHHhhcc-----CCCCEEeccCcccccc----Cch
Q 006906 1 MNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL-----AKTNFMYLTGNKLTGP----VPK 67 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-----~~L~~L~ls~N~l~g~----ip~ 67 (626)
++|++|+|++|+|++. +|..+.++++|++|+|++|.+++..+..+... ++|++|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 4689999999999964 78888889999999999999987666666554 6999999999999875 344
Q ss_pred hh--hhcCCccccccCcccccCCCCCCCCCC-CccccceeecCCCccCC----CCCcccCCCCCCCCCCCcce
Q 006906 68 YI--FNSNKNVDISLNNFTWESSDPIECPRG-SVNLVESYSSPRNKLDK----VHPCLRQNFPCSAPADQYHY 133 (626)
Q Consensus 68 ~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~-~~~~l~~l~l~~N~l~~----~~p~~~~~~p~~~~~~~~~~ 133 (626)
.+ .++|+.|++++|+++...+..+..... ..+.|+.|++++|++++ .+|..+..++....+.+.++
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSS
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCC
Confidence 44 358999999999988664433210001 15689999999999986 77777776776665544433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.51 E-value=5.3e-09 Score=109.92 Aligned_cols=112 Identities=12% Similarity=0.128 Sum_probs=74.2
Q ss_pred cceEEEeecCceeecCCccc-cCCCCCCEEEeecCcCCCCChHHhh-----ccCCCCEEeccCcccccc----Cchhh--
Q 006906 2 NLKTLILTKCLIHGEIPDYI-GDMTKLKNIDLSFNNLTGGIPTTFE-----KLAKTNFMYLTGNKLTGP----VPKYI-- 69 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~ip~~~~-----~l~~L~~L~ls~N~l~g~----ip~~~-- 69 (626)
+|+.|+|++|+|+..-...+ ..+++|+.|+|++|+|+......+. ..++|++|+|++|+|+.. ++..+
T Consensus 102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~ 181 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181 (372)
T ss_dssp CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence 68888888888875433333 3467888888888888755545543 357788888888888742 22322
Q ss_pred hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 70 FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 70 ~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
.++|+.|+|++|.++......+...+..++.|+.|+|++|.++.
T Consensus 182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 33788888888888754322111112445678888888888864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.46 E-value=9.5e-08 Score=94.91 Aligned_cols=100 Identities=13% Similarity=0.089 Sum_probs=68.2
Q ss_pred EEeecCcee---ecCCccccCCCCCCEEEeecCcCCC--CChHHhhccCCCCEEeccCccccccCchhhhh--cCCcccc
Q 006906 6 LILTKCLIH---GEIPDYIGDMTKLKNIDLSFNNLTG--GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--SNKNVDI 78 (626)
Q Consensus 6 L~L~~N~l~---g~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~--~l~~l~l 78 (626)
++++.|+.. +.++....++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++.-.-.-+. .|+.|+|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L 227 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 227 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEEC
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEc
Confidence 567777443 2223223568899999999999997 66788889999999999999998641111133 8889999
Q ss_pred ccCcccccCCCCC---CCCCCCccccceee
Q 006906 79 SLNNFTWESSDPI---ECPRGSVNLVESYS 105 (626)
Q Consensus 79 s~N~l~~~~~~~~---~~~~~~~~~l~~l~ 105 (626)
++|.+++..|..- ..-...+++|+.||
T Consensus 228 ~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 228 DGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred cCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 9999987655210 00124567777765
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.41 E-value=9.7e-09 Score=107.90 Aligned_cols=113 Identities=15% Similarity=0.036 Sum_probs=82.5
Q ss_pred CcceEEEeecCceeecCCccccC-----CCCCCEEEeecCcCCCCChHHh-hccCCCCEEeccCccccccCchhh-----
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGD-----MTKLKNIDLSFNNLTGGIPTTF-EKLAKTNFMYLTGNKLTGPVPKYI----- 69 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~L~ls~N~l~g~ip~~~----- 69 (626)
++|+.|+|++|+|+..-...+.. .++|+.|+|++|.|+......+ ..+++|+.|+|++|+|+..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 36899999999998654444433 3799999999999986544444 456899999999999985443333
Q ss_pred --hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 70 --FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 70 --~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
...|+.|+|++|.++......+...+..++.|++|+|++|.+..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~ 197 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGD 197 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCc
Confidence 14799999999999754322221112457789999999999964
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.8e-06 Score=87.94 Aligned_cols=138 Identities=17% Similarity=0.173 Sum_probs=94.3
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCC---ceeeEEEEEE-eCCeEEEEEEecCC
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP---NLVKLYGCCV-EGNQLLLVYEYMKN 475 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~e~~~~ 475 (626)
.+.++.|....||+. ++.+++|+-.. ......+.+|.+++..+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888998999998 56688888532 33456788999999988653 2455666664 34567899999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED---------------------------------------- 515 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------- 515 (626)
.++.+.... .++...+..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 98 QILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp EECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 888653211 233444445555555555555532
Q ss_pred -----------------CCCCeEEeCCCCCCEEEcC---CCCE-EEeecCCccccc
Q 006906 516 -----------------SRIKIVHRDIKTSNVLLDK---DLNA-KISDFGLAKLYE 550 (626)
Q Consensus 516 -----------------~~~~iiH~Dlkp~NILl~~---~~~~-kl~DfGla~~~~ 550 (626)
..+.++|+|+++.||+++. ++.+ .|+||+.+....
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2234799999999999987 4554 899999887543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.37 E-value=5.4e-08 Score=96.64 Aligned_cols=101 Identities=18% Similarity=0.202 Sum_probs=67.5
Q ss_pred ccCCCCCCE--EEeecCcCC---CCChHHhhccCCCCEEeccCccccc--cCchhh--hhcCCccccccCcccccCCCCC
Q 006906 21 IGDMTKLKN--IDLSFNNLT---GGIPTTFEKLAKTNFMYLTGNKLTG--PVPKYI--FNSNKNVDISLNNFTWESSDPI 91 (626)
Q Consensus 21 ~~~l~~L~~--L~Ls~N~l~---g~ip~~~~~l~~L~~L~ls~N~l~g--~ip~~~--~~~l~~l~ls~N~l~~~~~~~~ 91 (626)
|...+.|+. ++++.|+.. +.++-...++++|+.|+|++|+|++ .+|..+ +++|+.|+|++|++++.. .+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~--~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSER--EL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGG--GG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCch--hh
Confidence 455555665 778888543 2222233567889999999999987 555554 568999999999988651 11
Q ss_pred CCCCCCcc--ccceeecCCCccCCCCCc-------ccCCCCCCCC
Q 006906 92 ECPRGSVN--LVESYSSPRNKLDKVHPC-------LRQNFPCSAP 127 (626)
Q Consensus 92 ~~~~~~~~--~l~~l~l~~N~l~~~~p~-------~~~~~p~~~~ 127 (626)
..+. .|+.|+|++|.+++.+|. .+..+|....
T Consensus 215 ----~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~ 255 (267)
T 3rw6_A 215 ----DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLR 255 (267)
T ss_dssp ----GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCE
T ss_pred ----hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCe
Confidence 2333 888899999998887662 2455555543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2e-06 Score=85.72 Aligned_cols=137 Identities=13% Similarity=0.095 Sum_probs=95.7
Q ss_pred CeeeccCce-EEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeEEEEEEecCCCc
Q 006906 401 NKVGEGGFG-SVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQLLLVYEYMKNNC 477 (626)
Q Consensus 401 ~~IG~G~fG-~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e~~~~gs 477 (626)
+.+..|..| .||+.... ++..+++|+-... ...++.+|.+.|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556665 69998765 4667889986532 3456788988887664 2236678889999999999999999988
Q ss_pred hhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 006906 478 LSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED------------------------------------------ 515 (626)
Q Consensus 478 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 515 (626)
+.+..... ......++.+++..|.-||..
T Consensus 107 ~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 107 AFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp HHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred ccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 76543211 122334555566666666642
Q ss_pred -------------CCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 516 -------------SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 516 -------------~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
..+.++|+|+.+.||+++.++.+-|+||+.+...
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1122899999999999998877779999988753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.34 E-value=2.4e-08 Score=94.03 Aligned_cols=112 Identities=9% Similarity=0.019 Sum_probs=81.3
Q ss_pred CcceEEEeecC-ceeec----CCccccCCCCCCEEEeecCcCCCC----ChHHhhccCCCCEEeccCcccccc----Cch
Q 006906 1 MNLKTLILTKC-LIHGE----IPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTGP----VPK 67 (626)
Q Consensus 1 ~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~----ip~ 67 (626)
++|++|+|++| +|+.. +...+...++|++|+|++|+|... +...+...++|++|+|++|+|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 46899999999 88743 455677788999999999999753 455566678999999999999853 233
Q ss_pred hh--hhcCCcccc--ccCcccccCCCCCCCCCCCccccceeecCCCccC
Q 006906 68 YI--FNSNKNVDI--SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 68 ~~--~~~l~~l~l--s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
.+ ...|+.|+| +.|.++......+...+...+.|+.|++++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 33 237999999 8899875533222111234578999999999874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.23 E-value=8.1e-07 Score=91.44 Aligned_cols=61 Identities=15% Similarity=0.156 Sum_probs=49.6
Q ss_pred CcceEEEeecCcee--e-----------------cCC-ccccC--------CCCCCEEEeecCcCCCCChHHhhccCCCC
Q 006906 1 MNLKTLILTKCLIH--G-----------------EIP-DYIGD--------MTKLKNIDLSFNNLTGGIPTTFEKLAKTN 52 (626)
Q Consensus 1 ~~L~~L~L~~N~l~--g-----------------~~p-~~~~~--------l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 52 (626)
++|+.|||++|+|+ . .|| ..|.+ |++|+.|+|++ +++..-+..|.+|++|+
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~ 127 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLK 127 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCC
T ss_pred ccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccc
Confidence 47999999999998 1 233 35677 99999999999 88855567899999999
Q ss_pred EEeccCcccc
Q 006906 53 FMYLTGNKLT 62 (626)
Q Consensus 53 ~L~ls~N~l~ 62 (626)
.|+|++|.++
T Consensus 128 ~l~l~~n~i~ 137 (329)
T 3sb4_A 128 ICQIRKKTAP 137 (329)
T ss_dssp EEEBCCSSCC
T ss_pred eEEcCCCCcc
Confidence 9999999875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.19 E-value=7e-08 Score=107.57 Aligned_cols=122 Identities=12% Similarity=0.025 Sum_probs=68.0
Q ss_pred cceEEEeecCceeecCCccccC-CCCCCEEEee----cCcCCCC-----ChHHhhccCCCCEEeccC--ccccccCchhh
Q 006906 2 NLKTLILTKCLIHGEIPDYIGD-MTKLKNIDLS----FNNLTGG-----IPTTFEKLAKTNFMYLTG--NKLTGPVPKYI 69 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~-l~~L~~L~Ls----~N~l~g~-----ip~~~~~l~~L~~L~ls~--N~l~g~ip~~~ 69 (626)
+|++|+|+.|++++..+..++. +++|+.|+|+ .|++++. ++..+.++++|+.|+|++ |.+++..+..+
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 4566666666666555555554 6666666664 5566653 444455666666666653 23554444444
Q ss_pred ---hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCC-CCcccCCCCCCC
Q 006906 70 ---FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV-HPCLRQNFPCSA 126 (626)
Q Consensus 70 ---~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~-~p~~~~~~p~~~ 126 (626)
+++|+.|+|++|++++.....+ ...+++|+.|++++|.+++. ++.....+|...
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~~~~~---~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 516 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEGLMEF---SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLR 516 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHHHHHH---HTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCC
T ss_pred HHhCccceEeeccCCCCCHHHHHHH---HhcCcccCeeeccCCCCcHHHHHHHHHhcCccC
Confidence 3367777777777664321111 14567777777777776543 333333444433
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=2.3e-06 Score=89.03 Aligned_cols=81 Identities=6% Similarity=0.009 Sum_probs=54.1
Q ss_pred CCee-eccCceEEEEEEEc-------CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCC---CceeeEEEEEEeC--
Q 006906 400 ANKV-GEGGFGSVYKGILS-------DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQH---PNLVKLYGCCVEG-- 463 (626)
Q Consensus 400 ~~~I-G~G~fG~Vyk~~~~-------~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~~-- 463 (626)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 26678888865432 1012456677777776642 2456677776554
Q ss_pred -CeEEEEEEecCCCchhh
Q 006906 464 -NQLLLVYEYMKNNCLSR 480 (626)
Q Consensus 464 -~~~~lV~e~~~~gsL~~ 480 (626)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.4e-06 Score=97.05 Aligned_cols=82 Identities=12% Similarity=0.142 Sum_probs=37.8
Q ss_pred ceEEEeecCc-eee-cCCccccCCCCCCEEEeecCcCCCC----ChHHhhccCCCCEEeccCccccc----cCchhh--h
Q 006906 3 LKTLILTKCL-IHG-EIPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTG----PVPKYI--F 70 (626)
Q Consensus 3 L~~L~L~~N~-l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g----~ip~~~--~ 70 (626)
|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.++++|+.|+|++|++++ .++..+ +
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 5555555554 111 1222223455555555555555444 33344455555555555555542 122211 2
Q ss_pred hcCCccccccCccc
Q 006906 71 NSNKNVDISLNNFT 84 (626)
Q Consensus 71 ~~l~~l~ls~N~l~ 84 (626)
++|+.|++++|.+.
T Consensus 220 ~~L~~L~L~~~~~~ 233 (592)
T 3ogk_B 220 RSLVSVKVGDFEIL 233 (592)
T ss_dssp TTCCEEECSSCBGG
T ss_pred CCCcEEeccCccHH
Confidence 35555555555544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.9e-06 Score=85.54 Aligned_cols=95 Identities=18% Similarity=0.098 Sum_probs=58.9
Q ss_pred CCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhh---hcCC-ccccccCcccccCCCCCCCCCCCcc
Q 006906 24 MTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNK-NVDISLNNFTWESSDPIECPRGSVN 99 (626)
Q Consensus 24 l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~---~~l~-~l~ls~N~l~~~~~~~~~~~~~~~~ 99 (626)
+++|+.|+|++|+++..-+..|.+|.+|+.|+|++| ++ .|+...+ .+|+ .+++++ +++...+.++ ..++
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF----~~c~ 297 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAF----MGCD 297 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTT----TTCT
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhh----hCCc
Confidence 566777777777766444445667777777777666 55 4555442 2566 666666 5554444555 6667
Q ss_pred ccceeecCCCccCCCCCcccCCCCCC
Q 006906 100 LVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 100 ~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
+|+.++++.|+++...+..+..++..
T Consensus 298 ~L~~l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 298 NLRYVLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp TEEEEEECSSCCCEECTTTTCTTCCC
T ss_pred cCCEEEeCCCccCccchhhhcCCcch
Confidence 77777777777766666666655443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.6e-05 Score=80.12 Aligned_cols=143 Identities=16% Similarity=0.251 Sum_probs=79.7
Q ss_pred CeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcC-----CCCceeeEE-E--EEEeCCeEEEEEEe
Q 006906 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQ-----QHPNLVKLY-G--CCVEGNQLLLVYEY 472 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~-~--~~~~~~~~~lV~e~ 472 (626)
+.|+.|..+.||+....++ .+++|+.... ..++..|.+++..+ ..|.++.-. + +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987655 4889988752 12333344444333 234444310 1 12346778999999
Q ss_pred cCCCchh--------------hhhcCCCccc---------ccCCCHHHH-------------------------------
Q 006906 473 MKNNCLS--------------RAIFGKDTEY---------RLKLDWPTR------------------------------- 498 (626)
Q Consensus 473 ~~~gsL~--------------~~l~~~~~~~---------~~~l~~~~~------------------------------- 498 (626)
++|..+. ..+|...... ...-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1112110000 001123211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 499 KKICIGIARGLAYLHE----------DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 499 ~~i~~~ia~~L~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
..+...+..++++|++ ..+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111224446667763 1234599999999999998888899999998864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.91 E-value=1e-06 Score=98.08 Aligned_cols=110 Identities=13% Similarity=0.102 Sum_probs=70.9
Q ss_pred CcceEEEeecCceeecCCcccc-CCCCCCEEEee--c----CcCCC-----CChHHhhccCCCCEEeccCccccccCchh
Q 006906 1 MNLKTLILTKCLIHGEIPDYIG-DMTKLKNIDLS--F----NNLTG-----GIPTTFEKLAKTNFMYLTGNKLTGPVPKY 68 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls--~----N~l~g-----~ip~~~~~l~~L~~L~ls~N~l~g~ip~~ 68 (626)
++|+.|+++.|++++..+..+. .+++|+.|+|+ + |++++ .++..+.++++|+.|+|++ .+++..+..
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~ 450 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEY 450 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHH
Confidence 3678888888888876666665 47888888888 4 56652 2333466777888888866 566544444
Q ss_pred h---hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 69 I---FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 69 ~---~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
+ +++|+.|+|++|.+++.....+ ...+++|+.|++++|++++.
T Consensus 451 l~~~~~~L~~L~L~~~~i~~~~~~~l---~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 451 IGTYAKKMEMLSVAFAGDSDLGMHHV---LSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp HHHHCTTCCEEEEESCCSSHHHHHHH---HHHCTTCCEEEEESCSCCHH
T ss_pred HHHhchhccEeeccCCCCcHHHHHHH---HhcCCCcCEEECcCCCCcHH
Confidence 4 3467788888877765432221 13467777888888877443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=1.2e-06 Score=91.21 Aligned_cols=109 Identities=12% Similarity=0.019 Sum_probs=71.0
Q ss_pred CcceEEEeecCc-eeecCCccccCCCCCCEEEeecCcCCCCChHHhh--ccCCCCEEeccC--cccccc--C---ch---
Q 006906 1 MNLKTLILTKCL-IHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFE--KLAKTNFMYLTG--NKLTGP--V---PK--- 67 (626)
Q Consensus 1 ~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~--~l~~L~~L~ls~--N~l~g~--i---p~--- 67 (626)
++|+.|+|++|. + .+|. +. +++|+.|+|..|.++......+. .+++|+.|+|+. |...|. + ..
T Consensus 172 P~L~~L~L~g~~~l--~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCcEEEEeCCCCc--eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 468999998883 3 3444 43 78899999988888755555555 688899988853 332221 1 11
Q ss_pred -hhhhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 68 -YIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 68 -~~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
.-+++|+.|+|++|.+...++..+. ..+.+++|+.|+|+.|.+...
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la-~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFL-ESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHH-HCSSGGGCSEEECCSSCCBHH
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHH-hCccCCCCCEEECCCCCCChH
Confidence 1246888888888888654322221 113578888888888888653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=2.8e-05 Score=82.07 Aligned_cols=75 Identities=16% Similarity=0.237 Sum_probs=48.4
Q ss_pred CCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh-------hcHHHHHHHHHHHhcCCC--Ccee-eEEEEEEeCCeEEE
Q 006906 400 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR-------QGNREFVNEIGMISAQQH--PNLV-KLYGCCVEGNQLLL 468 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~nIv-~l~~~~~~~~~~~l 468 (626)
.+.||.|.++.||++... +++.++||....... .....+..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999764 467899998654221 123456778888876632 3333 45543 3455689
Q ss_pred EEEecCCC
Q 006906 469 VYEYMKNN 476 (626)
Q Consensus 469 V~e~~~~g 476 (626)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.80 E-value=9.9e-07 Score=98.18 Aligned_cols=88 Identities=11% Similarity=0.032 Sum_probs=45.0
Q ss_pred CCCCCCEEEeecCcCCCCChHHhh-ccCCCCEEeccCc-ccccc-Cchhh--hhcCCccccccCcccccCCCCCCCCCCC
Q 006906 23 DMTKLKNIDLSFNNLTGGIPTTFE-KLAKTNFMYLTGN-KLTGP-VPKYI--FNSNKNVDISLNNFTWESSDPIECPRGS 97 (626)
Q Consensus 23 ~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~ls~N-~l~g~-ip~~~--~~~l~~l~ls~N~l~~~~~~~~~~~~~~ 97 (626)
.+++|++|+|++|.+++..+..+. ++++|+.|+|++| .++.. ++... +++|+.|+|++|.+++..+..++.-...
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 455666666666666655555554 4566666666665 34322 22222 3356666666666554433222211234
Q ss_pred ccccceeecCCCc
Q 006906 98 VNLVESYSSPRNK 110 (626)
Q Consensus 98 ~~~l~~l~l~~N~ 110 (626)
+++|+.|++++|.
T Consensus 183 ~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 183 YTSLVSLNISCLA 195 (594)
T ss_dssp CCCCCEEECTTCC
T ss_pred CCcCcEEEecccC
Confidence 4555555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.76 E-value=5.2e-06 Score=77.86 Aligned_cols=85 Identities=9% Similarity=0.086 Sum_probs=67.4
Q ss_pred CcceEEEeecCceeec----CCccccCCCCCCEEEeecCcCCCC----ChHHhhccCCCCEEec--cCccccccCchhh-
Q 006906 1 MNLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYL--TGNKLTGPVPKYI- 69 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~l--s~N~l~g~ip~~~- 69 (626)
++|++|+|++|+|+.. +...+...++|++|+|++|.|+.. +...+...++|++|+| ++|.|+..-...+
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4699999999999853 445566678999999999999854 4667778889999999 8899986433223
Q ss_pred -----hhcCCccccccCcccc
Q 006906 70 -----FNSNKNVDISLNNFTW 85 (626)
Q Consensus 70 -----~~~l~~l~ls~N~l~~ 85 (626)
.+.|+.|+|++|.+..
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHHH
T ss_pred HHHHhCCCcCEEeccCCCCCh
Confidence 2389999999999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.72 E-value=5.8e-05 Score=75.83 Aligned_cols=79 Identities=18% Similarity=0.173 Sum_probs=56.6
Q ss_pred CCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCC---ceeeEEEEEEeCCeEEEEEEe
Q 006906 396 NFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP---NLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.....+.+|.|..+.||+.++.||+.|.+|+-..........|..|++.|+.+.-. -+.+++++ .. -++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence 44456789999999999999999999999987655444445678899888876422 23344443 22 3789999
Q ss_pred cCCCch
Q 006906 473 MKNNCL 478 (626)
Q Consensus 473 ~~~gsL 478 (626)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00045 Score=70.15 Aligned_cols=140 Identities=14% Similarity=0.149 Sum_probs=92.2
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC---CCceeeEEEEEEeCCeEEEEEEecCCC
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ---HPNLVKLYGCCVEGNQLLLVYEYMKNN 476 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~e~~~~g 476 (626)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999886 4677888987643 3556788888887763 356778888888888899999999987
Q ss_pred chhh-----------hhcCCCc--ccc---------------cCCCHHHHH---HHHH----------------HHHH-H
Q 006906 477 CLSR-----------AIFGKDT--EYR---------------LKLDWPTRK---KICI----------------GIAR-G 508 (626)
Q Consensus 477 sL~~-----------~l~~~~~--~~~---------------~~l~~~~~~---~i~~----------------~ia~-~ 508 (626)
.+.. .||.... ... ..-+|.... ++.. .++. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 2232211 000 012454321 1111 1111 1
Q ss_pred HHHHHh-CCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 509 LAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 509 L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
.+.|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=7.3e-05 Score=79.55 Aligned_cols=79 Identities=13% Similarity=0.117 Sum_probs=49.2
Q ss_pred CCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcceecccc-cCCcccchhhhccCC---CCChhhHHHHHHHHHH
Q 006906 517 RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIA-GTIGYMAPEYAMRGY---LTSKADVYSFGVVTLE 592 (626)
Q Consensus 517 ~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~---~~~k~Dv~s~Gvil~e 592 (626)
...++|+|++|.|||++.++ ++|+||+.+........ ...... -...|++|+...... .....++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34599999999999998876 99999999875432110 000000 013466666553211 1123556688888888
Q ss_pred HHhCC
Q 006906 593 IVSGK 597 (626)
Q Consensus 593 lltG~ 597 (626)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0001 Score=76.67 Aligned_cols=113 Identities=9% Similarity=0.085 Sum_probs=72.6
Q ss_pred CcceEEEeecCce---------eecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--
Q 006906 1 MNLKTLILTKCLI---------HGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-- 69 (626)
Q Consensus 1 ~~L~~L~L~~N~l---------~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-- 69 (626)
++|+.|.+..+.+ .+.++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..+.++...-..+
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 4789999876643 1235566678899999999988311 3443 3 38899999999888765333333
Q ss_pred --hhcCCcccccc--CcccccCCC-CC--CCCCCCccccceeecCCCccCCCCC
Q 006906 70 --FNSNKNVDISL--NNFTWESSD-PI--ECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 70 --~~~l~~l~ls~--N~l~~~~~~-~~--~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
+++|+.|+|+. |+..+.... .+ ......+++|+.|+|.+|.+....+
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~ 269 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHH
Confidence 35899999864 232222100 00 0111457899999999998865443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00042 Score=73.12 Aligned_cols=112 Identities=10% Similarity=0.021 Sum_probs=70.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCC-----CCChHHhhccCCCCEEeccCccccccCchhhh---hcC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLT-----GGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSN 73 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-----g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~---~~l 73 (626)
+|+.|.| .|.++..-+..|.+|++|+.++|.+|.+. ..-+..|.+|++|+.++|.+ .++ .|+...+ .+|
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L 325 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKV 325 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCc
Confidence 4666666 34455333456778888888888877765 23345677888888888874 466 5655442 477
Q ss_pred CccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCC
Q 006906 74 KNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNF 122 (626)
Q Consensus 74 ~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~ 122 (626)
+.++|..| ++.....++ ..+ +|+.+++++|.+....+..+..+
T Consensus 326 ~~l~lp~~-l~~I~~~aF----~~~-~L~~l~l~~n~~~~l~~~~F~~~ 368 (401)
T 4fdw_A 326 TQLTIPAN-VTQINFSAF----NNT-GIKEVKVEGTTPPQVFEKVWYGF 368 (401)
T ss_dssp CEEEECTT-CCEECTTSS----SSS-CCCEEEECCSSCCBCCCSSCCCS
T ss_pred cEEEECcc-ccEEcHHhC----CCC-CCCEEEEcCCCCcccccccccCC
Confidence 77877544 554444455 566 78888888887655544444433
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0017 Score=66.10 Aligned_cols=161 Identities=12% Similarity=0.030 Sum_probs=87.8
Q ss_pred ccHHHHHHHhcCCCC-----CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCC--ceeeEE
Q 006906 385 YTLRQIKAATNNFDP-----ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHP--NLVKLY 457 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~-----~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~ 457 (626)
.+.+++...-+.|.. .+.++ |....||+....+|+.+++|...... .....+..|.+++..+... .+.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344444444444432 23566 78889999887777789999986431 2344566677766655321 133333
Q ss_pred EE-----EEeCCeEEEEEEecCCCchhh--------------hhcC----CCcccccCCCHHHH----HH----------
Q 006906 458 GC-----CVEGNQLLLVYEYMKNNCLSR--------------AIFG----KDTEYRLKLDWPTR----KK---------- 500 (626)
Q Consensus 458 ~~-----~~~~~~~~lV~e~~~~gsL~~--------------~l~~----~~~~~~~~l~~~~~----~~---------- 500 (626)
.. ....+..++||||+++..+.. .+|. ........+++... ..
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 223556788999998765421 0111 00000011222111 00
Q ss_pred -----HHHHHHHHHHHHHhC----CCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 501 -----ICIGIARGLAYLHED----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 501 -----i~~~ia~~L~yLH~~----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
+...+...++.+... .+..++|+|+++.||+++ + .+.|+||+.+...
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 111111223333221 234488999999999999 5 8999999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0054 Score=62.18 Aligned_cols=161 Identities=12% Similarity=0.143 Sum_probs=87.0
Q ss_pred ccHHHHHHHhcCCCCC-----CeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCc--eeeEE
Q 006906 385 YTLRQIKAATNNFDPA-----NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN--LVKLY 457 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~-----~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~ 457 (626)
++.+++...-..|... +.|+.|....+|+....++ .+++|+..... ...++..|++++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 4555666666667652 3466788899999987666 57889876521 1223445666555442111 22222
Q ss_pred E------EEEeCCeEEEEEEecCCCchhh--------------hhcCCCccccc----C---CCHHHHHH----------
Q 006906 458 G------CCVEGNQLLLVYEYMKNNCLSR--------------AIFGKDTEYRL----K---LDWPTRKK---------- 500 (626)
Q Consensus 458 ~------~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~~~~~~----~---l~~~~~~~---------- 500 (626)
. +....+..+++|+|++|..+.. .+|........ . ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 1 1123466789999999865421 01211000000 0 11322110
Q ss_pred --HHHHHHHHHHHHHhC----CCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 501 --ICIGIARGLAYLHED----SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 501 --i~~~ia~~L~yLH~~----~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
+...+...++++++. .+..++|+|+++.||+++.+..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244455666532 223589999999999999876568999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00071 Score=72.03 Aligned_cols=73 Identities=18% Similarity=0.229 Sum_probs=48.8
Q ss_pred CCeeeccCceEEEEEEEcC--------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeEEEEE
Q 006906 400 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 470 (626)
.+.|+.|-...+|+....+ ++.+++|+.... .....+..|..++..+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3568888889999998753 478899988542 112455678888776643333 45666543 2 2899
Q ss_pred EecCCCch
Q 006906 471 EYMKNNCL 478 (626)
Q Consensus 471 e~~~~gsL 478 (626)
||+++.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.001 Score=67.12 Aligned_cols=141 Identities=12% Similarity=0.155 Sum_probs=74.0
Q ss_pred CCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeEEEEEEec-CCCc
Q 006906 400 ANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYEYM-KNNC 477 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e~~-~~gs 477 (626)
.+.|+.|....+|+. +.+++|+....... .....+|.+++..+....+ .+++++ ..+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 45888887653211 1122356666655432222 344443 343457899999 5544
Q ss_pred hhh------------------hhcCCCcccccCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCC
Q 006906 478 LSR------------------AIFGKDTEYRLKLD-WPTRKKICI--------------GIARGL----AYLHE-DSRIK 519 (626)
Q Consensus 478 L~~------------------~l~~~~~~~~~~l~-~~~~~~i~~--------------~ia~~L----~yLH~-~~~~~ 519 (626)
+.. .+|..........+ +........ .+...+ +.+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 431 11221110000011 111111100 011111 12211 22344
Q ss_pred eEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 520 iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
++|+|+.+.||+ ..++.+.++||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 66678899999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0023 Score=65.46 Aligned_cols=34 Identities=32% Similarity=0.411 Sum_probs=28.5
Q ss_pred CCCeEEeCCCCCCEEEcCC----CCEEEeecCCccccc
Q 006906 517 RIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLYE 550 (626)
Q Consensus 517 ~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~~~ 550 (626)
...++|||+.+.||+++.+ ..+.|+||+.+....
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 3459999999999999875 678999999987543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0015 Score=68.96 Aligned_cols=54 Identities=20% Similarity=0.185 Sum_probs=29.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEecc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 57 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls 57 (626)
+|+.|.|.+ .++..-+..|.+|++|+.++|++|+++..-...|. +.+|+.+.|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 356666664 45533345666677777777776666522222232 3555555554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0017 Score=67.72 Aligned_cols=145 Identities=19% Similarity=0.239 Sum_probs=83.2
Q ss_pred CCeeeccCceEEEEEEEcC--------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCc-eeeEEEEEEeCCeEEEEE
Q 006906 400 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN-LVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~ 470 (626)
.+.+..|-...+|+....+ ++.+++|+.... ......+.+|.++++.+.-.. ..++++++. + .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEE
Confidence 3567778888999998752 478899986432 223455668888887664222 245565543 2 2899
Q ss_pred EecCCCchhhh-----------------hcCCCcccccCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 006906 471 EYMKNNCLSRA-----------------IFGKDTEYRLKLD--WPTRKKICIGIAR-------------------GLAYL 512 (626)
Q Consensus 471 e~~~~gsL~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia~-------------------~L~yL 512 (626)
||+++.+|..- +|........... |.++.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 1222111111122 4455555443321 23333
Q ss_pred ----HhC-CCCCeEEeCCCCCCEEEcCC----CCEEEeecCCcccc
Q 006906 513 ----HED-SRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLY 549 (626)
Q Consensus 513 ----H~~-~~~~iiH~Dlkp~NILl~~~----~~~kl~DfGla~~~ 549 (626)
... ....++|+|+.+.||+++.+ +.+.|+||..+...
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 222 22358999999999999876 78999999988753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00036 Score=64.29 Aligned_cols=90 Identities=13% Similarity=-0.013 Sum_probs=57.2
Q ss_pred CCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcc-ccccCchhh------hhcCCccccccC-cccccCC
Q 006906 17 IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK-LTGPVPKYI------FNSNKNVDISLN-NFTWESS 88 (626)
Q Consensus 17 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~-l~g~ip~~~------~~~l~~l~ls~N-~l~~~~~ 88 (626)
+|...-.--+|+.||||++.++..--..+.+|++|+.|+|+++. ++..-=..+ .++|+.|+|+++ +++...-
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 45433233468888888888776555567778888888888874 553211112 135888888876 4664433
Q ss_pred CCCCCCCCCccccceeecCCCc
Q 006906 89 DPIECPRGSVNLVESYSSPRNK 110 (626)
Q Consensus 89 ~~~~~~~~~~~~l~~l~l~~N~ 110 (626)
..+ ..+++|++|++++..
T Consensus 133 ~~L----~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 133 IAL----HHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHG----GGCTTCCEEEEESCT
T ss_pred HHH----hcCCCCCEEECCCCC
Confidence 333 567888888888874
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00098 Score=58.30 Aligned_cols=57 Identities=18% Similarity=0.131 Sum_probs=43.1
Q ss_pred eEEEeecCcee-ecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCcccc
Q 006906 4 KTLILTKCLIH-GEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLT 62 (626)
Q Consensus 4 ~~L~L~~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~ 62 (626)
+.++.++++|+ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 35778888886 45775542 46888999999998555667788888898888888765
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.00067 Score=59.39 Aligned_cols=53 Identities=13% Similarity=0.101 Sum_probs=24.2
Q ss_pred EEeccCcccc-ccCchhhhhcCCccccccCcccccCCCCCCCCCCCccccceeecCCC
Q 006906 53 FMYLTGNKLT-GPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRN 109 (626)
Q Consensus 53 ~L~ls~N~l~-g~ip~~~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N 109 (626)
.++.+++.|+ ..+|..+..+|+.|+|++|+|+...+..+ ..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f----~~l~~L~~L~L~~N 65 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLL----DALPALRTAHLGAN 65 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTG----GGCTTCCEEECCSS
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhh----hhccccCEEEecCC
Confidence 3444444443 23444444444555555555543322222 34455555555555
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00011 Score=68.99 Aligned_cols=110 Identities=9% Similarity=0.069 Sum_probs=64.6
Q ss_pred cceEEEeecC-ceeec----CCccccCCCCCCEEEeecCcCCC----CChHHhhccCCCCEEeccCccccccCchhhh--
Q 006906 2 NLKTLILTKC-LIHGE----IPDYIGDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF-- 70 (626)
Q Consensus 2 ~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~-- 70 (626)
.|++|+|++| +|... +-..+..=+.|+.|+|++|+|.. .|-+.+..-+.|+.|+|++|+|+..--..+.
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~a 121 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 121 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHH
Confidence 5788888875 76532 34455666778888888888863 3344555667888888888888753222221
Q ss_pred ----hcCCccccccCcc---cccCCCCCCCCCCCccccceeecCCCcc
Q 006906 71 ----NSNKNVDISLNNF---TWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 71 ----~~l~~l~ls~N~l---~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
..|+.|+|++|.. .......+...+..-+.|..|+++.|..
T Consensus 122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 2678888876532 2111101100012235677777766643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00031 Score=64.67 Aligned_cols=81 Identities=15% Similarity=0.062 Sum_probs=61.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCc-CCCCChHHhhcc----CCCCEEeccCcc-ccccCchhh--hhcC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNN-LTGGIPTTFEKL----AKTNFMYLTGNK-LTGPVPKYI--FNSN 73 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l----~~L~~L~ls~N~-l~g~ip~~~--~~~l 73 (626)
+|+.|||+++.|+..-=..+.+|++|+.|+|+++. |++.-=..++.+ ++|++|+|+++. +|..-=..+ +++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 58999999999986544568899999999999995 876555566664 479999999974 774211222 4689
Q ss_pred CccccccCc
Q 006906 74 KNVDISLNN 82 (626)
Q Consensus 74 ~~l~ls~N~ 82 (626)
+.|+|++..
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0043 Score=66.39 Aligned_cols=74 Identities=15% Similarity=0.068 Sum_probs=46.8
Q ss_pred CCeeeccCceEEEEEEEcC-CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeEEEEEEecCCCc
Q 006906 400 ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVYEYMKNNC 477 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e~~~~gs 477 (626)
.+.|+.|-...+|+....+ ++.+++|+....... .-+..+|..++..+...++ .++++++ .+ .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 3568888889999998865 477888887543211 1112478888877765555 4566665 23 25999998765
Q ss_pred h
Q 006906 478 L 478 (626)
Q Consensus 478 L 478 (626)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0057 Score=63.44 Aligned_cols=73 Identities=10% Similarity=0.119 Sum_probs=41.9
Q ss_pred CeeeccCceEEEEEEEcC---------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCce-eeEEEEEEeCCeEEEEE
Q 006906 401 NKVGEGGFGSVYKGILSD---------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-VKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~---------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 470 (626)
+.|+.|....+|+....+ ++.+++|+....... ..+...|.+++..+....+ .++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 467778888999998754 267888887543211 1123466666666543333 3555443 22 6899
Q ss_pred EecCCCch
Q 006906 471 EYMKNNCL 478 (626)
Q Consensus 471 e~~~~gsL 478 (626)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.20 E-value=0.018 Score=58.99 Aligned_cols=32 Identities=28% Similarity=0.385 Sum_probs=28.2
Q ss_pred CCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 518 IKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 518 ~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 45999999999999998888999999887654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0017 Score=60.93 Aligned_cols=88 Identities=11% Similarity=0.081 Sum_probs=62.0
Q ss_pred cCCCCCCEEEeecC-cCCCC----ChHHhhccCCCCEEeccCccccccCc----hhh--hhcCCccccccCcccccCCCC
Q 006906 22 GDMTKLKNIDLSFN-NLTGG----IPTTFEKLAKTNFMYLTGNKLTGPVP----KYI--FNSNKNVDISLNNFTWESSDP 90 (626)
Q Consensus 22 ~~l~~L~~L~Ls~N-~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~ip----~~~--~~~l~~l~ls~N~l~~~~~~~ 90 (626)
.+-+.|+.|+|++| +|... +-+.+..-..|+.|+|++|+|...-- ..+ -+.|+.|+|+.|++...+...
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 44578999999986 88632 44556667899999999999984322 222 128999999999998664433
Q ss_pred CCCCCCCccccceeecCCC
Q 006906 91 IECPRGSVNLVESYSSPRN 109 (626)
Q Consensus 91 ~~~~~~~~~~l~~l~l~~N 109 (626)
+...+..-..|+.|+|++|
T Consensus 118 la~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHTTTTCCCSEEECCCC
T ss_pred HHHHHhhCCceeEEECCCC
Confidence 3222234566899999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.02 Score=60.44 Aligned_cols=144 Identities=10% Similarity=0.089 Sum_probs=82.2
Q ss_pred CCeeeccCceEEEEEEEcC--------CcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCc-eeeEEEEEEeCCeEEEEE
Q 006906 400 ANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPN-LVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lV~ 470 (626)
.+.+..|-...+|+....+ ++.+++|+...... ..-+..+|.++++.+.-.. ..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3567778888999998763 57889998654321 1112345666666553222 33455432 22 6899
Q ss_pred EecCCCchhhh-----------------hcCCCc-----c---cccCCCHHHHHHHHHHH-------------------H
Q 006906 471 EYMKNNCLSRA-----------------IFGKDT-----E---YRLKLDWPTRKKICIGI-------------------A 506 (626)
Q Consensus 471 e~~~~gsL~~~-----------------l~~~~~-----~---~~~~l~~~~~~~i~~~i-------------------a 506 (626)
||+++.+|..- +|.... . ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998764310 111110 0 00111244444333222 2
Q ss_pred HHHHHHHh---------------------CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 507 RGLAYLHE---------------------DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 507 ~~L~yLH~---------------------~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
..+++|.+ ..+..++|+|+.+.||+ +.++.+.|+||..+...
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 22333321 11234899999999999 88889999999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.077 Score=54.87 Aligned_cols=115 Identities=14% Similarity=0.097 Sum_probs=59.6
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++..-...|.++.+|+.+.+.++ ++ .++... +.+|+.+++
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEE
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccc
Confidence 3455555443 23222345666677777777655 44233445666666666666543 33 344433 236666666
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
.+|.++......+ ..+.+|+.+.+..+ ++-.-..++.....+
T Consensus 294 ~~~~i~~I~~~aF----~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 294 DNSAIETLEPRVF----MDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp CCTTCCEECTTTT----TTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred cccccceehhhhh----cCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 6666654444444 55666666666544 333333344444333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.39 E-value=0.092 Score=54.73 Aligned_cols=98 Identities=15% Similarity=0.190 Sum_probs=47.5
Q ss_pred ccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhh---hcCCccccccCcccccCCCCCCCCC
Q 006906 19 DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDISLNNFTWESSDPIECPR 95 (626)
Q Consensus 19 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~---~~l~~l~ls~N~l~~~~~~~~~~~~ 95 (626)
..|.++++|+.+.+.++..+ .-...|.++.+|+.+.+. +.++ .|+...+ .+|+.++|..| ++-....++
T Consensus 259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF---- 330 (394)
T 4gt6_A 259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAF---- 330 (394)
T ss_dssp TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTT----
T ss_pred ceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHh----
Confidence 34566666666666554432 233455566666666664 2333 3444432 25566665533 333333333
Q ss_pred CCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 96 GSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 96 ~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
..+.+|+.+.+..+ ++-.-...+..+..+
T Consensus 331 ~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L 359 (394)
T 4gt6_A 331 AGCEQLERIAIPSS-VTKIPESAFSNCTAL 359 (394)
T ss_dssp TTCTTCCEEEECTT-CCBCCGGGGTTCTTC
T ss_pred hCCCCCCEEEECcc-cCEEhHhHhhCCCCC
Confidence 45556666665543 333333444444333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.90 E-value=0.094 Score=54.66 Aligned_cols=101 Identities=9% Similarity=0.104 Sum_probs=66.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|+.+.+.++..+ .-...|.++++|+.+.+. +.++..-...|.++.+|+.++|.+| ++ .|.+.. +.+|+.+.|
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEE
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEE
Confidence 5677777766543 334567888888888886 4555344457888888888888765 55 455544 347888888
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCcc
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
..+ ++-....++ ..+.+|+.+++.+|..
T Consensus 342 p~s-v~~I~~~aF----~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 342 PSS-VTKIPESAF----SNCTALNNIEYSGSRS 369 (394)
T ss_dssp CTT-CCBCCGGGG----TTCTTCCEEEESSCHH
T ss_pred Ccc-cCEEhHhHh----hCCCCCCEEEECCcee
Confidence 644 543333344 6778888888887754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.32 E-value=0.43 Score=49.85 Aligned_cols=30 Identities=23% Similarity=0.424 Sum_probs=25.4
Q ss_pred eEEeCCCCCCEEE------cCCCCEEEeecCCcccc
Q 006906 520 IVHRDIKTSNVLL------DKDLNAKISDFGLAKLY 549 (626)
Q Consensus 520 iiH~Dlkp~NILl------~~~~~~kl~DfGla~~~ 549 (626)
++|+|+.+.|||+ +++..++++||..|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 5799999999999 44667999999988753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=91.94 E-value=0.18 Score=52.52 Aligned_cols=112 Identities=11% Similarity=0.031 Sum_probs=59.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|+.+.+..+..+ .-...|..+..|+.+.+..+.+. ...|..+.+|+.+.+.+| ++ .|++.. +.+|+.++|
T Consensus 254 ~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 254 DLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp SCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECC
T ss_pred cceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cc-eechhhhcCCCCCCEEEe
Confidence 4667777766544 33445666667776666655432 124556666666666544 33 344433 235666666
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
..+ ++-....++ ..+.+|+.+.+..| ++-.-...+..++.+
T Consensus 328 p~~-v~~I~~~aF----~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 328 PYL-VEEIGKRSF----RGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp CTT-CCEECTTTT----TTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred CCc-ccEEhHHhc----cCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 533 443333344 55666666666555 443334444444433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=91.12 E-value=0.6 Score=47.98 Aligned_cols=58 Identities=9% Similarity=0.110 Sum_probs=25.7
Q ss_pred cccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhh---hcCCccccc
Q 006906 20 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIF---NSNKNVDIS 79 (626)
Q Consensus 20 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~---~~l~~l~ls 79 (626)
.|.++.+|+.+.+..+ +...-...|.++.+|+.+.+.+|.++ .|++..+ .+|+.++|.
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcC
Confidence 4444555555555432 32122234455555555555555444 3433321 245555544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.03 E-value=0.48 Score=44.71 Aligned_cols=99 Identities=11% Similarity=0.101 Sum_probs=63.7
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
-+|.+.|...+ .++++++++.++.|.+.+|.-+-.+.. + ..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence 47888885443 489999999999999999877622111 1 1233457899999999988763 1111
Q ss_pred eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh
Q 006906 556 ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595 (626)
Q Consensus 556 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt 595 (626)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122366888653 344678999999999999774
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=88.31 E-value=1.2 Score=46.08 Aligned_cols=113 Identities=12% Similarity=0.089 Sum_probs=68.9
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|+.+.+.++. +..-...+.++.+|+.+.+..|..+ .....|.++..|+.+.+..+.+ +... ..+|+.+.+
T Consensus 231 ~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i----~~~~F~~~~~L~~i~l 304 (394)
T 4fs7_A 231 GVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV----PEKTFYGCSSLTEVKL 304 (394)
T ss_dssp CCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE----CTTTTTTCTTCCEEEE
T ss_pred CCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee----cccccccccccccccc
Confidence 46666665443 3223456778888888888877554 4455677888888888776643 3332 347777777
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~ 126 (626)
..| +......++ ..+.+|+.+++..+ ++-.-..++..+..+.
T Consensus 305 ~~~-i~~I~~~aF----~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~ 346 (394)
T 4fs7_A 305 LDS-VKFIGEEAF----ESCTSLVSIDLPYL-VEEIGKRSFRGCTSLS 346 (394)
T ss_dssp CTT-CCEECTTTT----TTCTTCCEECCCTT-CCEECTTTTTTCTTCC
T ss_pred ccc-cceechhhh----cCCCCCCEEEeCCc-ccEEhHHhccCCCCCC
Confidence 654 544444444 66778888888654 4433344455444433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.32 E-value=2.5 Score=39.65 Aligned_cols=116 Identities=9% Similarity=0.065 Sum_probs=77.3
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 006906 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 527 (626)
Q Consensus 448 l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp 527 (626)
..||+++.. ..-.+++.+.+.|+.-+.+.=...+ ..++...+++++.+|+...++++.+ +|--+.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEec
Confidence 468888866 4566677777666654422111112 2577889999999999988777654 6889999
Q ss_pred CCEEEcCCCCEEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCC
Q 006906 528 SNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNT 600 (626)
Q Consensus 528 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~ 600 (626)
.||+++.++.+++.-.|+-..+.+. ..+...=.-.+=+++..+++++..|
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~P~-----------------------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVDPL-----------------------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBSCC-----------------------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred ceEEEcCCCCEEEEEccCccCCCCC-----------------------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999999999877764433211 1111222335667777778887665
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.16 E-value=3.3 Score=38.96 Aligned_cols=86 Identities=13% Similarity=0.111 Sum_probs=62.0
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEeCCC
Q 006906 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA-YLHEDSRIKIVHRDIK 526 (626)
Q Consensus 448 l~H~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~iiH~Dlk 526 (626)
..||++ -...-.+++.+.+.|+--+++.=...+ ..++...+++.+.+|+...+ +++. -+|--+.
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~ 111 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVC 111 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCC
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEe
Confidence 367887 334446778887777765443222222 25678899999999888777 6654 4688999
Q ss_pred CCCEEEcCCCCEEEeecCCccc
Q 006906 527 TSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 527 p~NILl~~~~~~kl~DfGla~~ 548 (626)
|.||++|.++.+++.-.|+-..
T Consensus 112 P~NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp GGGEEECTTCCEEESCCEETTT
T ss_pred CceEEEeCCCcEEEEEcCCccc
Confidence 9999999999999998776443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 626 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.004 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 5e-64
Identities = 49/207 (23%), Positives = 97/207 (46%), Gaps = 12/207 (5%)
Query: 393 ATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQH 450
++F+ +++G G G V+K G V+A K + + + R + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
P +V YG ++ + E+M L + + ++ K+ I + +GL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLT 118
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YL + KI+HRD+K SN+L++ K+ DFG++ + GT YM+PE
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPE 173
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ + ++D++S G+ +E+ G+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-63
Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
++G G FG+VYKG + + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
G QL +V ++ + + L + +T K + I A+G+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 122
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE-DKTHISTRIAGTIGYMAPEYAM 573
I+HRD+K++N+ L +DL KI DFGLA + +H +++G+I +MAPE
Sbjct: 123 K---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 574 ---RGYLTSKADVYSFGVVTLEIVSGK 597
+ + ++DVY+FG+V E+++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-61
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 9/229 (3%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
++G G FG V+ G + T +AVK L + F+ E ++ QH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+LY + + ++ EYM+N L + +KL + IA G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
+HRD++ +N+L+ L+ KI+DFGLA+L E+++ I + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 575 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 622
G T K+DV+SFG++ EIV+ G+ N + + L+ Y + +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-60
Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 9/231 (3%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
+ ++G G FG V+ G + +A+K + + +F+ E ++ HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+LYG C+E + LV+E+M++ CLS + + + T +C+ + G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEE 119
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
++HRD+ N L+ ++ K+SDFG+ + +D+ ST + + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 575 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEIY 624
+SK+DV+SFGV+ E+ S GK R N + V + + L + +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-59
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 9/231 (3%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
+ ++G G FG V G +A+K + + EF+ E ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+LYG C + + ++ EYM N CL + R + ++C + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
+ +HRD+ N L++ K+SDFGL++ +D+ S + + PE M
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 575 GYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEEIY 624
+SK+D+++FGV+ EI S GK N + + L +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-58
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 8/203 (3%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
+ K+G+G FG V+ G + T +A+K L F+ E ++ +H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
+LY + +V EYM L + G+ +Y P + IA G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVE- 130
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
R+ VHRD++ +N+L+ ++L K++DFGLA+L E+++ I + APE A+
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
G T K+DV+SFG++ E+ +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKG 211
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-56
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 9/209 (4%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 452
+++ +G G +G K SDG ++ K+L S + + V+E+ ++ +HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 453 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
+V+ Y ++ L +V EY + L+ I K T+ R LD ++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 511 YLHE--DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMA 568
H D ++HRD+K +NV LD N K+ DFGLA++ D T + GT YM+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182
Query: 569 PEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
PE R K+D++S G + E+ +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-56
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 12/221 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHPN 452
++D +GEG +G V + +AVK + K E EI + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+VK YG EGN L EY L I + + P ++ + G+ YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYL 119
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED-KTHISTRIAGTIGYMAPEY 571
H I I HRDIK N+LLD+ N KISDFGLA ++ + + + ++ GT+ Y+APE
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 572 AMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 611
R + DV+S G+V +++G+ + + Y
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 4e-56
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 20/237 (8%)
Query: 397 FDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN---REFVNEIGMISAQQHPN 452
F ++G G FG+VY + + V+A+K++S +Q N ++ + E+ + +HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
++ GC + + LV EY + K L + G +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYL 131
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H ++HRD+K N+LL + K+ DFG A + + + GT +MAPE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 183
Query: 573 M---RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEIYWS 626
+ G K DV+S G+ +E+ K +Y + + +WS
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-56
Identities = 58/219 (26%), Positives = 114/219 (52%), Gaps = 17/219 (7%)
Query: 386 TLRQIKAATNNFDPA------NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREF 438
L ++++ + DP K+G+G G+VY + ++ G +A++Q++ + +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI 64
Query: 439 VNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTR 498
+NEI ++ ++PN+V + G++L +V EY+ L+ D +D
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT------DVVTETCMDEGQI 118
Query: 499 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558
+C + L +LH + +++HRDIK+ N+LL D + K++DFG +++ ST
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ GT +MAPE R K D++S G++ +E++ G+
Sbjct: 176 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (475), Expect = 4e-55
Identities = 66/257 (25%), Positives = 115/257 (44%), Gaps = 26/257 (10%)
Query: 385 YTLRQIKAATNNFDPA---------NKVGEGGFGSVYKGIL----SDGTVIAVKQL-SSK 430
+T A F +G G FG V G L +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 431 SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYR 490
+ + R+F++E ++ HPN++ L G + ++++ E+M+N L + D ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 491 LKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550
+ GIA G+ YL + VHRD+ N+L++ +L K+SDFGL++ E
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 551 EDKTHISTR----IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPN 605
+D + + I + APE TS +DV+S+G+V E++S G+ N
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 606 EDFVYLLDWAYVLQEEE 622
+D + ++ Y L
Sbjct: 240 QDVINAIEQDYRLPPPM 256
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGC 459
++G+G FG VYK + A K + +KS + +++ EI ++++ HPN+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIK 519
N L ++ E+ + + E L + +C L YLH+ K
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD---NK 130
Query: 520 IVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM-----R 574
I+HRD+K N+L D + K++DFG++ + I GT +MAPE M
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKD 189
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
KADV+S G+ +E+ +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIE 212
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 1e-54
Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 8/217 (3%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
+ +K+G G +G VY+G+ +AVK L + + EF+ E ++ +HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
V+L G C ++ E+M L + + R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE 132
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
+ +HRD+ N L+ ++ K++DFGL++L D I + APE
Sbjct: 133 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 574 RGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
+ K+DV++FGV+ EI + + + VY
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-54
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 15/230 (6%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
+G+G FG V G G +AVK + + + + F+ E +++ +H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 455 KLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+L G VE L +V EYM L + + R L K + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAM 573
+ VHRD+ NVL+ +D AK+SDFGL K + + + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALR 173
Query: 574 RGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQEEE 622
++K+DV+SFG++ EI S G+ P +D V ++ Y + +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 9e-54
Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 16/240 (6%)
Query: 388 RQIKAATNNFDPAN-KVGEGGFGSVYKGIL---SDGTVIAVKQLSSKSRQGNRE-FVNEI 442
+++ +N A+ ++G G FGSV +G+ +A+K L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 443 GMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKIC 502
++ +P +V+L G C + L+LV E L + + GK R ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELL 115
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--I 560
++ G+ YL E VHRD+ NVLL AKISDFGL+K D ++ + R
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 561 AGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVLQ 619
+ + APE +S++DV+S+GV E +S G+ + + ++ ++
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 1e-53
Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 30/251 (11%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNR-EFV 439
L ++ NN + +GEG FG V++ T++AVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 440 NEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKD------------- 486
E +++ +PN+VKL G C G + L++EYM L+ +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 487 ------TEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540
+ L + I +A G+AYL E K VHRD+ T N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 541 SDFGLAK-LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSN 599
+DFGL++ +Y D A I +M PE T+++DV+++GVV EI S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 600 TNYRPNEDFVY 610
Y + V
Sbjct: 242 PYYGMAHEEVI 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 401 NKVGEGGFGSVYKGILSD-GTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLY 457
++G G F +VYKG+ ++ +A +L + ++ + F E M+ QHPN+V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 458 GCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
++LV E M + L + + + C I +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 514 EDSRIKIVHRDIKTSNVLL-DKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
+ I+HRD+K N+ + + KI D GLA L + GT +MAPE
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185
Query: 573 MRGYLTSKADVYSFGVVTLEIVSGK 597
Y DVY+FG+ LE+ + +
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSE 209
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-53
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 26/241 (10%)
Query: 402 KVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCV 461
+G+G FG V++G G +AVK SS+ + + EI +H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 462 EGN----QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-- 515
+ N QL LV +Y ++ L + R + K+ + A GLA+LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 516 ---SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS---TRIAGTIGYMAP 569
+ I HRD+K+ N+L+ K+ I+D GLA ++ I GT YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 570 EY------AMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 623
E +AD+Y+ G+V EI S + Y EE+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 624 Y 624
Sbjct: 242 R 242
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-53
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 450
+F+ +G+G FG+VY ++A+K L + E+ + S +H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
PN+++LYG + ++ L+ EY + R + K D +A L+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
Y H +++HRDIK N+LL KI+DFG + + + GT+ Y+ PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPE 174
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
K D++S GV+ E + GK
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-52
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 401 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHPNLVK 455
++G G FG+V KG +AVK L +++ E + E ++ +P +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 456 LYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED 515
+ G C E +LV E + L++ + + ++ ++ G+ YL E
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126
Query: 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTR--IAGTIGYMAPEYAM 573
VHRD+ NVLL AKISDFGL+K D+ + + + + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 574 RGYLTSKADVYSFGVVTLEIVS 595
+SK+DV+SFGV+ E S
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-52
Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 30/230 (13%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD------GTVIAVKQLSSKSRQGNRE-FVNEIGMISA 447
N + +G G FG V +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 448 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK------------------DTE 488
H N+V L G C + L++EY L + K + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 489 YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK- 547
L + +A+G+ +L VHRD+ NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ + + + +MAPE G T K+DV+S+G++ EI S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 15/224 (6%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGT-----VIAVKQLSSKSRQGNR-EFVNEIGMISAQ 448
+ +G G FG VYKG+L + +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 449 QHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
H N+++L G + ++++ EYM+N L + + KD + + GIA G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAG 122
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED--KTHISTRIAGTIGY 566
+ YL + VHRD+ N+L++ +L K+SDFGL+++ E+D T+ ++ I +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
APE TS +DV+SFG+V E+++ + + V
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 25/235 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLSSKSRQGNRE-FVNEIGMISA 447
N +G G FG V + +AVK L + RE ++E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 448 -QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGK-------------DTEYRLKL 493
H N+V L G C G L++ EY L + K + L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 494 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEED 552
D +A+G+A+L +HRD+ N+LL KI DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 553 KTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607
+ + +MAPE T ++DV+S+G+ E+ S S+ D
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 4e-51
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
+++D ++G G FG V++ + G A K + + EI +S +HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
V L+ + N+++++YE+M L + + K+ + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 514 EDSRIKIVHRDIKTSNVLLDKDLN--AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
E VH D+K N++ + K+ DFGL + ++ T GT + APE
Sbjct: 142 E---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEV 196
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGK 597
A + D++S GV++ ++SG
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-51
Identities = 68/246 (27%), Positives = 121/246 (49%), Gaps = 18/246 (7%)
Query: 387 LRQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTV----IAVKQLS-SKSRQGNREFVN 440
LR +K F +G G FG+VYKG+ + +G +A+K+L + S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 441 EIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKK 500
E ++++ +P++ +L G C+ + L+ + M CL +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNI----GSQYLLN 115
Query: 501 ICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTR 559
C+ IA+G+ YL ++VHRD+ NVL+ + KI+DFGLAK L E+K + +
Sbjct: 116 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 560 IAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWAYVL 618
I +MA E + T ++DV+S+GV E+++ G + P + +L+ L
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232
Query: 619 QEEEIY 624
+ I
Sbjct: 233 PQPPIC 238
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 7e-51
Identities = 70/239 (29%), Positives = 109/239 (45%), Gaps = 20/239 (8%)
Query: 396 NFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGN-REFVNEIGMISAQQH 450
+F+ +G G FG VY G L D AVK L+ + G +F+ E ++ H
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 451 PNLVKLYGCCVEG-NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
PN++ L G C+ L+V YMK+ L I + + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGM 143
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY---EEDKTHISTRIAGTIGY 566
+L K VHRD+ N +LD+ K++DFGLA+ E D H T + +
Sbjct: 144 KFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 567 MAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS--NTNYRPNEDFVYLLDWAYVLQEEEI 623
MA E T+K+DV+SFGV+ E+++ + + + VYLL +LQ E
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-50
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDG---TVIAVKQLS-SKSRQGNREFVNEIGMISA-QQ 449
N+ + +GEG FG V K + A+K++ S+ +R+F E+ ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKLDWPTR 498
HPN++ L G C L L EY + L + F L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 499 KKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIST 558
+ARG+ YL + + +HRD+ N+L+ ++ AKI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 559 RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ +MA E T+ +DV+S+GV+ EIVS
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (444), Expect = 5e-50
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
+ +D ++G G FG V++ + + G V K +++ NEI +++ HP L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 454 VKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLH 513
+ L+ + +++L+ E++ L I +D K+ GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMH 144
Query: 514 EDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
E IVH DIK N++ + K + KI DFGLA D+ T T + APE
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEI 199
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGK 597
R + D+++ GV+ ++SG
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-49
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 13/221 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQ 449
+ +GEG FG V++GI +A+K + + RE F+ E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
HP++VKL G E N + ++ E L + + LD + ++ L
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTAL 121
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
AYL + VHRDI NVL+ + K+ DFGL++ E+ + +++ I +MAP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
E TS +DV+ FGV EI+ + V
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 13/212 (6%)
Query: 391 KAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMIS 446
K +F +GEG F +V L+ A+K L + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 447 AQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
HP VKLY + +L Y KN L + I D + I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIV 118
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY-EEDKTHISTRIAGTIG 565
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ E K + GT
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y++PE +D+++ G + ++V+G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-48
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL----SDGTVIAVKQLSSK---SRQGNREFVNEIGMISA 447
+ K+G+G FG V +G +AVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
H NL++LYG + + +V E L + +++ T + + +A
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH--ISTRIAGTIG 565
G+ YL + +HRD+ N+LL KI DFGL + ++ H +
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVS 595
+ APE + +D + FGV E+ +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (432), Expect = 3e-48
Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 19/230 (8%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK---SRQGNREFVNEIGMISAQQ- 449
N+F +G GGFG VY +D G + A+K L K +QG +NE M+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 450 --HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
P +V + ++L + + M L + + I
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIIL 118
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
GL ++H +V+RD+K +N+LLD+ + +ISD GLA + + K H S GT GYM
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 172
Query: 568 APEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAY 616
APE +G S AD +S G + +++ G S +D +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-46
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 16/229 (6%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL------SDGTVIAVKQLS-SKSRQGNREFVNEIGMISA 447
+ ++G+G FG VY+G+ T +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----FGKDTEYRLKLDWPTRKKIC 502
++V+L G +G L++ E M L + + ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 503 IGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK-LYEEDKTHISTRIA 561
IA G+AYL+ + K VHRD+ N ++ +D KI DFG+ + +YE D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVY 610
+ +M+PE G T+ +DV+SFGVV EI + + + V
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-45
Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 24/238 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI------LSDGTVIAVKQLSSKSRQG-NREFVNEIGMISA 447
+ +G G FG V + + +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 448 QQH-PNLVKLYGCCVE-GNQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLD 494
H N+V L G C + G L+++ E+ K LS + K E Y+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 495 WPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554
+A+G+ +L K +HRD+ N+LL + KI DFGLA+ +D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 555 HI-STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYL 611
++ + +MAPE T ++DV+SFGV+ EI S ++ D +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 8e-45
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 9/212 (4%)
Query: 388 RQIKAATNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMI 445
+Q + + +D + +G G F V ++A+K ++ K+ +G NEI ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 446 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 505
+HPN+V L G L L+ + + L I K ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQV 116
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
+ YLH+ + + LD+D ISDFGL+K+ ED + + GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPG 174
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y+APE + + D +S GV+ ++ G
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 9e-45
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 16/208 (7%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 450
+F +G G FG V+ +G A+K L + + +E M+S H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
P +++++G + Q+ ++ +Y++ L + + P K + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALE 118
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH I++RD+K N+LLDK+ + KI+DFG AK + + GT Y+APE
Sbjct: 119 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPE 171
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGKS 598
D +SFG++ E+++G +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-44
Identities = 64/251 (25%), Positives = 105/251 (41%), Gaps = 26/251 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGIL--------SDGTVIAVKQLSSKSRQGN-REFVNEIGMI 445
+ +GEG FG V + T +AVK L S + + + + ++E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 446 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAI-----------FGKDTEYRLKL 493
+H N++ L G C + L ++ EY L + + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 494 DWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553
+ARG+ YL K +HRD+ NVL+ +D KI+DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 554 THIST-RIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYL 611
+ T + +MAPE T ++DV+SFGV+ EI + G S P E+ L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 612 LDWAYVLQEEE 622
L + + +
Sbjct: 250 LKEGHRMDKPS 260
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-44
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 10/209 (4%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE-FVNEIGMISAQQHP 451
+ + +GEG +G V + +A+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
N++ + + Y+ + + ++ L I RGL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHIS--TRIAGTIGYMAP 569
+H ++HRD+K SN+LL+ + KI DFGLA++ + D H T T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 570 EYAMRG-YLTSKADVYSFGVVTLEIVSGK 597
E + T D++S G + E++S +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (394), Expect = 1e-43
Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 452
+ K+GEG +G VYK + G A+K++ + + EI ++ +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+VKLY +L+LV+E++ + + L+ T K + + G+AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYC 116
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H+ +++HRD+K N+L++++ KI+DFGLA+ + + I
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 573 MRGYLTSKADVYSFGVVTLEIVSGK 597
++ D++S G + E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 10/205 (4%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHPN 452
NF K+GEG +G VYK G V+A+K++ +++ + EI ++ HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+VKL N+L LV+E++ + D + P K + +GLA+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYA 572
H +++HRD+K N+L++ + K++DFGLA+ + + +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 573 MRGYLTSKADVYSFGVVTLEIVSGK 597
Y ++ D++S G + E+V+ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 39/199 (19%), Positives = 79/199 (39%), Gaps = 13/199 (6%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
+G G FG V++ + S K + K EI +++ +H N++ L+
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520
+L++++E++ + I +L+ + L +LH I
Sbjct: 71 ESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 521 VHRDIKTSNVLLDKDLNA--KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLT 578
H DI+ N++ ++ KI +FG A+ + Y APE ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVS 181
Query: 579 SKADVYSFGVVTLEIVSGK 597
+ D++S G + ++SG
Sbjct: 182 TATDMWSLGTLVYVLLSGI 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 14/209 (6%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQ-Q 449
+F +G+G FG V+ A+K L + + + E ++S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 450 HPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGL 509
HP L ++ L V EY+ L I K D I GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
+LH IV+RD+K N+LLDKD + KI+DFG+ K +T GT Y+AP
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 172
Query: 570 EYAMRGYLTSKADVYSFGVVTLEIVSGKS 598
E + D +SFGV+ E++ G+S
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (391), Expect = 2e-43
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 396 NFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---------SKSRQGNREFVNEIGMI 445
N++P +G G V + I AVK + + ++ + E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 446 SA-QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIG 504
HPN+++L LV++ MK L + K L +KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
+ + LH+ + IVHRD+K N+LLD D+N K++DFG + + + + GT
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
Query: 565 GYMAPEYAM------RGYLTSKADVYSFGVVTLEIVSGK 597
Y+APE + D++S GV+ +++G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-43
Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 393 ATNNFDPANKVGEGGFGSVYKG--ILSDGTVIAVKQLSSKSRQGNRE-----FVNEIGMI 445
A ++ ++GEG +G V+K + + G +A+K++ ++ + V + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 446 SAQQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFG-KDTEYRLKLDWPTRKKICIG 504
+HPN+V+L+ C + + + + D + T K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 505 IARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTI 564
+ RGL +LH ++VHRD+K N+L+ K++DFGLA++Y T + T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 565 GYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y APE ++ + D++S G + E+ K
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 3e-42
Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS---SKSRQGNREFVNEIGMISAQQ 449
++ ++ +G GG V+ L +AVK L ++ F E +A
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 450 HPNLVKLYGCCVE----GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 505
HP +V +Y G +V EY+ L + + + ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADA 120
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHI--STRIAGT 563
+ L + H+ I+HRD+K +N+++ K+ DFG+A+ + + + + GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y++PE A + +++DVYS G V E+++G+
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-42
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 401 NKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQG-----NREFVNEIGMISAQQHPNLV 454
+ +GEG F +VYK + ++A+K++ R NR + EI ++ HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 455 KLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE 514
L + + LV+++M+ + + L L K + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVI-----IKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 515 DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
I+HRD+K +N+LLD++ K++DFGLAK + T T Y APE
Sbjct: 119 H---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174
Query: 575 -GYLTSKADVYSFGVVTLEIVSGK 597
D+++ G + E++
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 396 NFDPANKVGEGGFGSVYKGIL-SDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV 454
++ +G G FG VY+ L G ++A+K++ R NRE + ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 455 KLYGCCVEGNQ------LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARG 508
+L + L LV +Y+ A + L K + R
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL--PVIYVKLYMYQLFRS 134
Query: 509 LAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYM 567
LAY+H I HRDIK N+LLD D K+ DFG AK + ++ + I
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRA 190
Query: 568 APEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
TS DV+S G V E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 6e-40
Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 21/231 (9%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL 453
N + K+G G FG +Y G ++ G +A+K K++ + E + Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 454 VKLYG-CCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+ C EG+ ++V E + + F K T + + + Y+
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYI 119
Query: 513 HEDSRIKIVHRDIKTSNVL---LDKDLNAKISDFGLAKLYEEDKTHI------STRIAGT 563
H +HRD+K N L K I DFGLAK Y + +TH + + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDW 614
Y + + + + D+ S G V + G +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-40
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 21/214 (9%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNR------EFVNEIGMISA 447
+ +D ++G G F V K S G A K + + + +R + E+ ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 448 QQHPNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIAR 507
QHPN++ L+ ++L+ E + L + K+ L + I
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILN 124
Query: 508 GLAYLHEDSRIKIVHRDIKTSNVLLDKD----LNAKISDFGLAKLYEEDKTHISTRIAGT 563
G+ YLH +I H D+K N++L KI DFGLA + I GT
Sbjct: 125 GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGT 179
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
++APE L +AD++S GV+T ++SG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE------FVNEIGMISA--QQHPN 452
+G GGFGSVY GI +SD +A+K + E E+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+++L + +L+ E + + R L + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC 126
Query: 513 HEDSRIKIVHRDIKTSNVLLDKD-LNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
H ++HRDIK N+L+D + K+ DFG L ++ T GT Y PE+
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEW 180
Query: 572 AM-RGYLTSKADVYSFGVVTLEIVSGKS 598
Y A V+S G++ ++V G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 2e-39
Identities = 41/226 (18%), Positives = 81/226 (35%), Gaps = 23/226 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPN 452
++ ++GEG FG +++G L + +A+K +S + +E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 453 LVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYL 512
+ +Y EG +LV + + + K T + + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 513 HEDSRIKIVHRDIKTSNVLLDKDLN-----AKISDFGLAKLYEEDKTHI------STRIA 561
HE +V+RDIK N L+ + + + DFG+ K Y + T ++
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 562 GTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607
GT YM+ + + + D+ + G V + + G
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-39
Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGN--REFVNEIGMISAQQHP 451
+ ++ K+G+G FG V+K G +A+K++ ++ + + EI ++ +H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 452 NLVKLYGCCVEG--------NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICI 503
N+V L C + LV+++ +++ G + +K K++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-----GLLSNVLVKFTLSEIKRVMQ 124
Query: 504 GIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT---HISTRI 560
+ GL Y+H + KI+HRD+K +NVL+ +D K++DFGLA+ + K + T
Sbjct: 125 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 561 AGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGK 597
T+ Y PE + D++ G + E+ +
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 9e-39
Identities = 58/207 (28%), Positives = 85/207 (41%), Gaps = 13/207 (6%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQH 450
N+FD +G+G FG V + G A+K L + ++ V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
P L L ++L V EY L + + + I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH +V+RDIK N++LDKD + KI+DFGL K D GT Y+APE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPE 175
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
D + GVV E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 49/203 (24%), Positives = 77/203 (37%), Gaps = 20/203 (9%)
Query: 403 VGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC- 460
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 461 ---VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR 517
LL+V E + L I + + +I I + YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHS--- 129
Query: 518 IKIVHRDIKTSNVLLDK---DLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMR 574
I I HRD+K N+L + K++DFG AK + + T Y+APE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187
Query: 575 GYLTSKADVYSFGVVTLEIVSGK 597
D++S GV+ ++ G
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 1e-37
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNRE---FVNEIGMISAQQH 450
+ FD +G G FG V G A+K L + ++ +NE ++ A
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
P LVKL + + L +V EY+ + + + P + I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
YLH + +++RD+K N+L+D+ +++DFG AK + + GT +APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPE 208
Query: 571 YAMRGYLTSKADVYSFGVVTLEIVSGK 597
+ D ++ GV+ E+ +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 39/207 (18%), Positives = 85/207 (41%), Gaps = 11/207 (5%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNREFVNEIGMISAQQHP 451
++ K+GEG +G+V+K ++A+K++ + EI ++ +H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 452 NLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAY 511
N+V+L+ +L LV+E+ + K + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGF 116
Query: 512 LHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEY 571
H ++HRD+K N+L++++ K+++FGLA+ + S +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 572 AMRGYLTSKADVYSFGVVTLEIVSGKS 598
++ D++S G + E+ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 5e-35
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 28/227 (12%)
Query: 385 YTLRQIKAAT----NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQL--SSKSRQGNRE 437
+ +++ + VG G +G+V + G +A+K+L +S +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 438 FVNEIGMISAQQHPNLVKLYGCCVEGNQL------LLVYEYMKNNCLSRAIFGKDTEYRL 491
E+ ++ +H N++ L L LV +M +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------- 116
Query: 492 KLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551
KL + + + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ +
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 552 DKTHISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGK 597
+ T T Y APE + T D++S G + E+++GK
Sbjct: 174 EMTG----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 22/212 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQHP 451
+ +G G G V +A+K+LS +++ + E+ ++ H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 452 NLVKLYGCCV------EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGI 505
N++ L E + LV E M N +++LD + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV--------IQMELDHERMSYLLYQM 128
Query: 506 ARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIG 565
G+ +LH I HRD+K SN+++ D KI DFGLA+ T T
Sbjct: 129 LCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 183
Query: 566 YMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK 597
Y APE + D++S G + E+V K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (318), Expect = 8e-33
Identities = 41/210 (19%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 395 NNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIG-MISAQQHPN 452
+++ K+G G + V++ I +++ + VK L ++ + EI + + + PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 453 LVKLYGCCVE--GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
++ L + LV+E++ N + L + I + L
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFK--------QLYQTLTDYDIRFYMYEILKALD 143
Query: 511 YLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAP 569
Y H + I+HRD+K NV++D + ++ D+GLA+ Y + + + + P
Sbjct: 144 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
Query: 570 EYAMR-GYLTSKADVYSFGVVTLEIVSGKS 598
E + D++S G + ++ K
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-32
Identities = 58/240 (24%), Positives = 103/240 (42%), Gaps = 24/240 (10%)
Query: 369 VSADKELRGLDLQTGLYTLRQIKAATNNFDPANKVGEGGFGSVYKGIL----SDGTVIAV 424
++ ELR +L T K NF+ +G G +G V+ G + A+
Sbjct: 3 LTVKHELRTANL-----TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 57
Query: 425 KQLS----SKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYEYMKNNCLS 479
K L + + E ++ + P LV L+ +L L+ +Y+ L
Sbjct: 58 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 480 RAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAK 539
+ ++ T ++ I + + L ++ I++RDIK N+LLD + +
Sbjct: 118 THLSQRE--------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 540 ISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGK 597
++DFGL+K + D+T + GTI YMAP+ G D +S GV+ E+++G
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 394 TNNFDPANKVGEGGFGSVYKGI-LSDGTVIAVKQLS--SKSRQGNREFVNEIGMISAQQH 450
+ + VG G +GSV G +AVK+LS +S + E+ ++ +H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLA 510
N++ L L + L A + + KL + + I RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLK 135
Query: 511 YLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTHISTRIAGTIGYMAPE 570
Y+H I+HRD+K SN+ +++D KI DFGLA+ +++ T T Y APE
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 188
Query: 571 YAMR-GYLTSKADVYSFGVVTLEIVSGK 597
+ + D++S G + E+++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 1e-26
Identities = 51/240 (21%), Positives = 94/240 (39%), Gaps = 27/240 (11%)
Query: 402 KVGEGGFGSVYKGI-LSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCC 460
K+G G F +V+ + + T +A+K + + +EI ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 461 VEG-NQLLLVYEYMKNNCLSRAIFGKDTEY----------RLKLDWPTRKKICIGIARGL 509
+LL + + N + + + + K+I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 510 AYLHEDSRIKIVHRDIKTSNVLLDKD------LNAKISDFGLAKLYEEDKTHISTRIAGT 563
Y+H I+H DIK NVL++ + KI+D G A Y+E T+ T
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QT 192
Query: 564 IGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNEDFVYLLDWAYVLQEEEI 623
Y +PE + AD++S + E+++G + P+E Y D ++ Q E+
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDF--LFEPDEGHSYTKDDDHIAQIIEL 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.1 bits (220), Expect = 5e-21
Identities = 28/161 (17%), Positives = 45/161 (27%), Gaps = 30/161 (18%)
Query: 401 NKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR----------QGNREFVNEIGMISAQQH 450
+GEG +V+ VK G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 451 PNLVKLYGCCV----EGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIA 506
L KL G V ++ E + L R ++ I
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113
Query: 507 RGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547
+A + IVH D+ NVL+ + I DF +
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 18/58 (31%), Positives = 28/58 (48%), Gaps = 2/58 (3%)
Query: 8 LTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK-LTGP 64
L I+G +P + + L ++++SFNNL G IP L + + NK L G
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.8 bits (99), Expect = 6e-05
Identities = 12/56 (21%), Positives = 22/56 (39%)
Query: 11 CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP 66
+G L +DL N + G +P +L + + ++ N L G +P
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 37.4 bits (85), Expect = 0.004
Identities = 10/41 (24%), Positives = 18/41 (43%), Gaps = 1/41 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP 42
L +L ++ + GEIP G++ + + N G P
Sbjct: 269 FLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 14/81 (17%), Positives = 31/81 (38%), Gaps = 4/81 (4%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNK 60
NL L L I P + +TKL+ + + N ++ ++ L N++ N+
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 61 LTGPVPKYIFNSNKNVDISLN 81
++ P + ++
Sbjct: 363 ISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 17/104 (16%), Positives = 29/104 (27%), Gaps = 22/104 (21%)
Query: 1 MNLKTLILTKCLIHGEIP--------------------DYIGDMTKLKNIDLSFNNLTGG 40
L L L I P I ++ L + L FNN++
Sbjct: 263 TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI 322
Query: 41 IPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLNNFT 84
P L K ++ NK++ + + N +
Sbjct: 323 SP--VSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQIS 364
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 23/120 (19%), Positives = 41/120 (34%), Gaps = 3/120 (2%)
Query: 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKL 61
NL TLIL I P + KL+ + LS N L +P K + ++ N++
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVH--ENEI 112
Query: 62 TGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQN 121
T N+ + + L +SS + + + + L +
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS 172
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 13/142 (9%), Positives = 29/142 (20%), Gaps = 4/142 (2%)
Query: 2 NLKTLILTKCLIHGE----IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLT 57
+ + L C + I + L ++L N L + +T +
Sbjct: 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
Query: 58 GNKLTGPVPKYIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPC 117
L + + E + + +
Sbjct: 88 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ 147
Query: 118 LRQNFPCSAPADQYHYTLHINC 139
L +A + L
Sbjct: 148 LEYCSLSAASCEPLASVLRAKP 169
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 11/78 (14%), Positives = 22/78 (28%), Gaps = 9/78 (11%)
Query: 1 MNLKTLILTKCLIHGEIPDYIGDM----TKLKNIDLSFNNLTGGIPTTFEKLAKTN---- 52
L+ L L C + + L+ +DLS N L + +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 53 -FMYLTGNKLTGPVPKYI 69
+ L + + +
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 8/85 (9%), Positives = 27/85 (31%), Gaps = 5/85 (5%)
Query: 1 MNLKTLILTKCLI-HGEIPDYIGDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMY 55
+++++L + + + + + + + + L LT I + +
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 56 LTGNKLTGPVPKYIFNSNKNVDISL 80
L N+L + + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKI 86
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 626 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.55 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.5 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.47 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.46 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.45 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.26 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.23 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.19 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.13 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.07 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.0 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.0 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.99 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.98 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.93 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.9 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.89 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.86 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.81 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.79 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.67 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.54 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.52 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.48 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.47 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.39 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.25 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.02 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.01 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.92 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.91 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.62 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.57 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.54 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.03 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.84 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.8 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.19 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.79 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.39 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=370.07 Aligned_cols=202 Identities=31% Similarity=0.479 Sum_probs=176.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+++.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56889999999999999999986 68999999987653 23346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999996542 6999999999999999999999997 999999999999999999999999999976543
Q ss_pred C-cceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 553 K-THISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 553 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
. .......+||+.|||||++.+..+ +.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 2 223345679999999999988765 678999999999999999999997654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=369.36 Aligned_cols=198 Identities=26% Similarity=0.525 Sum_probs=179.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999975 69999999998765566778999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+++... .+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999887543 5899999999999999999999997 9999999999999999999999999999775433
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 2 23446799999999999999999999999999999999999999964
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=366.36 Aligned_cols=199 Identities=30% Similarity=0.539 Sum_probs=166.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467888999999999999999998999999999764 3456789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+|+|.+++.... ..++|..+..++.|||.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999987653 36899999999999999999999997 99999999999999999999999999987765444
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTN 601 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG-~~p~~ 601 (626)
.......||+.|+|||++....++.++|||||||++|||+|+ ++|+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 444446789999999999999999999999999999999995 54443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=362.73 Aligned_cols=198 Identities=28% Similarity=0.476 Sum_probs=177.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+|+.+ +++.||||++... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999986 6889999998653 2334567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999998643 26999999999999999999999997 9999999999999999999999999998665
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 432 23457999999999999999999999999999999999999999653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=365.38 Aligned_cols=200 Identities=31% Similarity=0.521 Sum_probs=176.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4568888999999999999999988899999999764 3456789999999999999999999998754 5679999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+++..... ..++|..+++|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999998765432 36999999999999999999999987 9999999999999999999999999999876555
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
........||+.|+|||++....++.++|||||||++|||+||..|+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 444455678999999999999999999999999999999999665543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=366.24 Aligned_cols=207 Identities=27% Similarity=0.445 Sum_probs=166.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--CCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVE--GNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 469 (626)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ ++.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999975 68999999987653 3345678999999999999999999999864 4568999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSR--IKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~--~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||+++. .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999885431 223469999999999999999999998642 359999999999999999999999999999
Q ss_pred cccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 7754332 234467999999999999999999999999999999999999999653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=363.78 Aligned_cols=201 Identities=31% Similarity=0.533 Sum_probs=169.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|.+.+.||+|+||+||+|+++ ..||||+++.. .....++|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999864 35999998754 34456789999999999999999999998754 56899999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+++|+|.++++... ..+++..+..++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999997653 26999999999999999999999987 99999999999999999999999999987654
Q ss_pred CC-cceecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 552 DK-THISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 552 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
.. ........||+.|||||++.. ..++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 32 223345679999999999864 358999999999999999999999997543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=367.30 Aligned_cols=201 Identities=27% Similarity=0.465 Sum_probs=177.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
+.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788999999999999999976 68999999998776666788999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999875432 36999999999999999999999997 9999999999999999999999999998654321
Q ss_pred cceecccccCCcccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAM-----RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. ......||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 165 ~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 165 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp H-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred c-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 1 223467999999999984 456899999999999999999999999754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=357.69 Aligned_cols=201 Identities=27% Similarity=0.485 Sum_probs=182.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6789999999999999999999989999999998653 456789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+|+|.+++.... ..+++..+.+++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999876553 36899999999999999999999987 99999999999999999999999999987765544
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
.......||+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 44444678999999999999999999999999999999998 89999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-45 Score=369.94 Aligned_cols=204 Identities=25% Similarity=0.435 Sum_probs=181.3
Q ss_pred HHhcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 392 AATNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 392 ~~t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
...++|++.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888999999999999999986 5889999998764 345678999999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++..... ..+++..++.++.|||.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 93 E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999865422 37899999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
...........|++.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 6555445556689999999999999999999999999999999998777643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=373.90 Aligned_cols=200 Identities=24% Similarity=0.432 Sum_probs=177.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+++.+|+.++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 568999999999999999999975 68999999997653 3335678999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999998643 2689999999999999999999975 5 9999999999999999999999999999764
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 157 ~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 157 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 322 234679999999999999999999999999999999999999997643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=364.48 Aligned_cols=201 Identities=26% Similarity=0.408 Sum_probs=176.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999985 68999999987532 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999987643 26999999999999999999999997 9999999999999999999999999999775
Q ss_pred CCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 432 22334467999999999999999999999999999999999999999753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-44 Score=368.14 Aligned_cols=212 Identities=29% Similarity=0.498 Sum_probs=169.5
Q ss_pred ccHHHHHHHhcC---------CCCCCeeeccCceEEEEEEEcC-C---cEEEEEEeccC-ChhcHHHHHHHHHHHhcCCC
Q 006906 385 YTLRQIKAATNN---------FDPANKVGEGGFGSVYKGILSD-G---TVIAVKQLSSK-SRQGNREFVNEIGMISAQQH 450 (626)
Q Consensus 385 ~~~~~l~~~t~~---------f~~~~~IG~G~fG~Vyk~~~~~-g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H 450 (626)
+++++...++.+ |++.++||+|+||+||+|+++. + ..||||++... .....++|.+|++++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 455565555543 4556799999999999999752 2 36899998764 34455789999999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 006906 451 PNLVKLYGCCVEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNV 530 (626)
Q Consensus 451 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI 530 (626)
||||+++++|.+++..++||||+++|+|.+++.... ..++|.++.+++.|||+||+|||+++ |+||||||+||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NI 159 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNI 159 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceE
Confidence 999999999999999999999999999999887643 26899999999999999999999987 99999999999
Q ss_pred EEcCCCCEEEeecCCcccccCCCcce----ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 531 LLDKDLNAKISDFGLAKLYEEDKTHI----STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 531 Ll~~~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
|++.++.+||+|||+++......... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 99999999999999999765432211 112457899999999999999999999999999999998 89998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=356.56 Aligned_cols=202 Identities=30% Similarity=0.474 Sum_probs=173.2
Q ss_pred cCCCCCC-eeeccCceEEEEEEEc---CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPAN-KVGEGGFGSVYKGILS---DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~-~IG~G~fG~Vyk~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|.+.+ +||+|+||+||+|+++ ++..||||+++... ....++|.+|++++++++|||||+++++|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455566 4999999999999864 35579999997653 4456789999999999999999999999865 568999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++.... ..+++..+.+++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 mE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999886543 26899999999999999999999987 999999999999999999999999999977
Q ss_pred cCCCcce--ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 550 EEDKTHI--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 550 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
....... .....||+.|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 5433222 233568999999999999999999999999999999998 999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=351.68 Aligned_cols=196 Identities=28% Similarity=0.468 Sum_probs=168.7
Q ss_pred CCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe----CCeEEEEE
Q 006906 398 DPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE----GNQLLLVY 470 (626)
Q Consensus 398 ~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 470 (626)
+..++||+|+||+||+|+.. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999986 5889999998654 33445678999999999999999999999875 35689999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCCEEEeecCCcccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD-KDLNAKISDFGLAKLY 549 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~~kl~DfGla~~~ 549 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999998643 36899999999999999999999985 4599999999999996 5789999999999865
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... .....||+.|||||++.+ .++.++|||||||++|||+||+.||...
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 4322 234679999999998865 6899999999999999999999999643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7e-43 Score=363.56 Aligned_cols=201 Identities=25% Similarity=0.407 Sum_probs=180.6
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
-++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 6899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--CCCEEEeecCCccccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK--DLNAKISDFGLAKLYE 550 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~~kl~DfGla~~~~ 550 (626)
|++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 105 ~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999986542 26899999999999999999999997 999999999999964 6789999999999775
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... .....||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 4332 33467999999999999999999999999999999999999999643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=363.31 Aligned_cols=200 Identities=29% Similarity=0.371 Sum_probs=179.4
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+|+.+ +++.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57899999999999999999975 7999999999754 2334577899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999988654 26899999999999999999999997 9999999999999999999999999998664
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 3322 234467999999999999999999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-43 Score=359.55 Aligned_cols=197 Identities=27% Similarity=0.448 Sum_probs=177.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999985 6899999998753 2334578899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+++|+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec
Confidence 9999999998886543 5789999999999999999999997 9999999999999999999999999999765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ...+||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 432 3467999999999999999999999999999999999999999653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-42 Score=362.12 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=180.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 56899999999999999999975 69999999998776666678899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCCCEEEeecCCcccccC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD--KDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~~kl~DfGla~~~~~ 551 (626)
++|+|.+.+.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 109 ~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 109 SGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999988775543 36899999999999999999999997 99999999999998 578999999999998765
Q ss_pred CCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 432 33457999999999999999999999999999999999999999653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-43 Score=358.98 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=161.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
.+.|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466889999999999999999986 68999999997653 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCCEEEeecCCccc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKL 548 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~ 548 (626)
|+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++.
T Consensus 88 ~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999997542 6999999999999999999999997 99999999999994 578999999999986
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
..... .....+||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 160 EDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 64332 23346799999999999999999999999999999999999999964
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-43 Score=358.12 Aligned_cols=195 Identities=29% Similarity=0.495 Sum_probs=172.2
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---hcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---QGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
+.|+..+.||+|+||+||+|+.. +++.||||++..... ...+++.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34888999999999999999975 688999999876532 33467899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
|||++|+|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999997765433 36999999999999999999999997 9999999999999999999999999998654
Q ss_pred CCCcceecccccCCcccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMR---GYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 32 23569999999999864 4689999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-43 Score=352.36 Aligned_cols=194 Identities=30% Similarity=0.438 Sum_probs=165.9
Q ss_pred CeeeccCceEEEEEEEcC---CcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecCC
Q 006906 401 NKVGEGGFGSVYKGILSD---GTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMKN 475 (626)
Q Consensus 401 ~~IG~G~fG~Vyk~~~~~---g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~~ 475 (626)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 4689999997542 2335689999999999999999999999865 457899999999
Q ss_pred CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCcc
Q 006906 476 NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKTH 555 (626)
Q Consensus 476 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~ 555 (626)
|+|.++++.. ..++|..+.+++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999998654 26999999999999999999999987 999999999999999999999999999976544332
Q ss_pred e--ecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCC
Q 006906 556 I--STRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYR 603 (626)
Q Consensus 556 ~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~ 603 (626)
. .....||+.|+|||.+....++.++|||||||++|||+| |+.||...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 2 233568999999999999999999999999999999998 89999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=355.59 Aligned_cols=200 Identities=30% Similarity=0.503 Sum_probs=169.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEecC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYMK 474 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~~ 474 (626)
++|++.+.||+|+||.||+|++++++.||||++... ....++|.+|+.++++++|||||+++++|. ++..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 568889999999999999999998889999999754 445678999999999999999999999985 456899999999
Q ss_pred CCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCCc
Q 006906 475 NNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDKT 554 (626)
Q Consensus 475 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~ 554 (626)
+|+|..++..... ..++|.+++.++.|||.||+|||+++ |+||||||+|||+|.++++||+|||+++.......
T Consensus 95 ~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 95 KGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999988865322 36999999999999999999999997 99999999999999999999999999987755444
Q ss_pred ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 555 HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 555 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.......||+.|+|||++....++.++|||||||++|||+||..|+..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 444446789999999999999999999999999999999997666543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-43 Score=353.19 Aligned_cols=200 Identities=30% Similarity=0.512 Sum_probs=166.0
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCC-----cEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDG-----TVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
+.|+..++||+|+||+||+|++++. ..||||++.... .....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999997642 479999997643 3445679999999999999999999999999999999
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+.++++.+.+.... ..++|.++.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999998875443 36999999999999999999999987 99999999999999999999999999997
Q ss_pred ccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 006906 549 YEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTN 601 (626)
Q Consensus 549 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~ 601 (626)
....... ......||+.|+|||++....++.++|||||||++|||+||..|+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 6543222 2233568999999999999999999999999999999999766654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=350.31 Aligned_cols=200 Identities=27% Similarity=0.358 Sum_probs=177.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC------hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS------RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367899999999999999999985 68999999986532 22357899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----CEEEee
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL----NAKISD 542 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~~kl~D 542 (626)
++|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 9999999999999998643 26999999999999999999999997 99999999999998876 499999
Q ss_pred cCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 543 FGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 543 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 161 fG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 161 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp CTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 99998765432 233456899999999999999999999999999999999999999753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=358.98 Aligned_cols=208 Identities=29% Similarity=0.447 Sum_probs=175.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC-C-----cEEEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD-G-----TVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~-g-----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
.++|++.+.||+|+||+||+|++.. + ..||||.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999999753 2 36999998654 334456789999999987 89999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTE------------------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKT 527 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp 527 (626)
.++||||+++|+|.++++..... ....++|..++.++.||+.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 99999999999999999765321 1235899999999999999999999987 99999999
Q ss_pred CCEEEcCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 528 SNVLLDKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 528 ~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876544332 2344568999999999999999999999999999999998 899997643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-42 Score=357.74 Aligned_cols=196 Identities=25% Similarity=0.356 Sum_probs=176.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 470 (626)
++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47899999999999999999985 69999999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYE 550 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~ 550 (626)
||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999988644 26899999999999999999999997 9999999999999999999999999999765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ....||+.|||||++.+..++.++|||||||++|||+||+.||..
T Consensus 193 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 422 335799999999999999999999999999999999999999964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.3e-42 Score=357.94 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=172.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHH---HHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFV---NEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+. +|+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999976 68999999986431 12223333 4467778889999999999999999999
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999998643 36889999999999999999999997 9999999999999999999999999999
Q ss_pred cccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
.+.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.....
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 765432 234579999999999975 5689999999999999999999999976543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=350.34 Aligned_cols=200 Identities=30% Similarity=0.436 Sum_probs=175.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHh-cCCCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMIS-AQQHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999986 68999999997532 233456677777665 68999999999999999999999
Q ss_pred EEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccc
Q 006906 470 YEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLY 549 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~ 549 (626)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999998643 26899999999999999999999997 999999999999999999999999999866
Q ss_pred cCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 154 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 54322 234467999999999999999999999999999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=343.37 Aligned_cols=203 Identities=28% Similarity=0.399 Sum_probs=163.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC----CcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD----GTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
.++|++.+.||+|+||.||+|++.. +..||||.++... ....+.|.+|++++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999998753 3568999987543 334567999999999999999999999985 567899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
||||+++|+|.+++.... ..+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999998875443 36899999999999999999999997 99999999999999999999999999997
Q ss_pred ccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 549 YEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 549 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
.............||+.|+|||.+....++.++|||||||++|||+| |+.|+....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 76544444455678999999999999999999999999999999998 899987543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-42 Score=350.50 Aligned_cols=213 Identities=30% Similarity=0.457 Sum_probs=179.1
Q ss_pred HHHHHHHhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCCh-hcHHHHHHHHHHHhcCCCCceeeEEEE
Q 006906 387 LRQIKAATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKSR-QGNREFVNEIGMISAQQHPNLVKLYGC 459 (626)
Q Consensus 387 ~~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~ 459 (626)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||++..... ...++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445556788999999999999999999974 357899999976533 345679999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhhhhcCCCc-------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006906 460 CVEGNQLLLVYEYMKNNCLSRAIFGKDT-------------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKI 520 (626)
Q Consensus 460 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 520 (626)
|...+..++||||+++|+|.++++.... .....+++..++.|+.|++.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 9999999999999999999999864321 11235899999999999999999999987 9
Q ss_pred EEeCCCCCCEEEcCCCCEEEeecCCcccccCCC-cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCC-
Q 006906 521 VHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK-THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS- 598 (626)
Q Consensus 521 iH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~- 598 (626)
+||||||+|||+|.++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998664432 223344678999999999999999999999999999999999964
Q ss_pred CCCC
Q 006906 599 NTNY 602 (626)
Q Consensus 599 p~~~ 602 (626)
|+..
T Consensus 242 p~~~ 245 (301)
T d1lufa_ 242 PYYG 245 (301)
T ss_dssp TTTT
T ss_pred CCCC
Confidence 5654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-41 Score=341.55 Aligned_cols=202 Identities=23% Similarity=0.368 Sum_probs=168.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC---hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC----e
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS---RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----Q 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 465 (626)
.++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.|.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 79999999997643 233467899999999999999999999988654 3
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.|+||||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence 79999999999999887543 26999999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCC--cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDK--THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 87654322 12234467999999999999999999999999999999999999999643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-41 Score=339.29 Aligned_cols=199 Identities=27% Similarity=0.417 Sum_probs=174.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh---------hcHHHHHHHHHHHhcCC-CCceeeEEEEEEeC
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR---------QGNREFVNEIGMISAQQ-HPNLVKLYGCCVEG 463 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 463 (626)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|++++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999975 789999999876421 11245889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
+..|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999643 36999999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMR------GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++...... ......||+.|+|||.+.. ..++.++||||+||++|||+||+.||...
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 9999765432 2244679999999999863 35788999999999999999999999754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=348.36 Aligned_cols=202 Identities=30% Similarity=0.551 Sum_probs=169.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGT----VIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 468 (626)
++|++.++||+|+||+||+|++. +|+ .||+|++... .....++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46889999999999999999975 343 5899988654 344567899999999999999999999999865 5678
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
++||+.+|+|.+.+.... ..+++..+++++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 899999999998876543 36999999999999999999999987 99999999999999999999999999997
Q ss_pred ccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC
Q 006906 549 YEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRP 604 (626)
Q Consensus 549 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~ 604 (626)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||+...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 7543332 2233568999999999999999999999999999999998 788887543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=344.99 Aligned_cols=200 Identities=20% Similarity=0.311 Sum_probs=177.3
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
.++|.+.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467889999999999999999986 68899999997653 3345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC--CCEEEeecCCccccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD--LNAKISDFGLAKLYE 550 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~~kl~DfGla~~~~ 550 (626)
|++|+|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++...
T Consensus 83 ~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 83 ISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999996543 25899999999999999999999997 9999999999999854 579999999998765
Q ss_pred CCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 551 EDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 551 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......+|+.|+|||...+..++.++||||+||++|||++|+.||...
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 433 233456899999999999999999999999999999999999999753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=338.93 Aligned_cols=205 Identities=29% Similarity=0.454 Sum_probs=167.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeEEEEEEec
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM 473 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~ 473 (626)
++|++.+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++|||||+++|+|.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45778899999999999999985 788999999754 345789999999999999999999999865 45689999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.++++... ...++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 84 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999996532 135899999999999999999999986 9999999999999999999999999998654322
Q ss_pred cceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCCCChhhHHHHH
Q 006906 554 THISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNYRPNEDFVYLLDWA 615 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~~~~~~~~~l~~w~ 615 (626)
....+|..|+|||++.+..++.++|||||||++|||+| |+.|+... ...++..++
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i 213 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRV 213 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHH
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHH
Confidence 22457899999999999999999999999999999998 67777643 233444444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=341.50 Aligned_cols=195 Identities=28% Similarity=0.406 Sum_probs=166.1
Q ss_pred CCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhc-----HHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEec
Q 006906 400 ANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQG-----NREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEYM 473 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~~ 473 (626)
.++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 68999999987543221 346889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
.++++..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 998877665433 36899999999999999999999997 9999999999999999999999999998765433
Q ss_pred cceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 554 THISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 554 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
. .....+||+.|+|||++... .++.++|||||||++|||+||+.||...
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 2 22335799999999998754 6799999999999999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=338.13 Aligned_cols=200 Identities=25% Similarity=0.438 Sum_probs=162.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC--C--cEEEEEEeccC---ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD--G--TVIAVKQLSSK---SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLL 467 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~--g--~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 467 (626)
++|++.+.||+|+||.||+|++.. + ..||||++... .....++|.+|++++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 468889999999999999998642 2 36899998754 23345689999999999999999999999965 4678
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
+||||+++|++.+++.... ..+++..+++++.|||.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 9999999999998875432 36999999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCcc--eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 548 LYEEDKTH--ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 548 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
........ ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 77544322 2233457889999999999999999999999999999998 8999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=344.96 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=169.2
Q ss_pred hcCCCCCC-eeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHh-cCCCCceeeEEEEEEe----CCeE
Q 006906 394 TNNFDPAN-KVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMIS-AQQHPNLVKLYGCCVE----GNQL 466 (626)
Q Consensus 394 t~~f~~~~-~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~----~~~~ 466 (626)
.++|.+.+ .||+|+||+||+|+.. +++.||||+++.. ..+.+|++++. ..+|||||++++++.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35787764 6999999999999974 6899999998643 45678998865 4589999999999875 4568
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCCEEEeec
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK---DLNAKISDF 543 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~~kl~Df 543 (626)
|+|||||++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence 999999999999999975432 36899999999999999999999997 999999999999985 567999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+|+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 99987654332 23467999999999999999999999999999999999999999643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=337.20 Aligned_cols=201 Identities=28% Similarity=0.459 Sum_probs=170.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57899999999999999999975 68999999996543 2335788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
|+.++.+........ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEEHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCchhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC
Confidence 998765544433322 36999999999999999999999997 99999999999999999999999999987654
Q ss_pred CCcceecccccCCcccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred Ccc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 332 233457999999999887654 588999999999999999999999753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=338.17 Aligned_cols=198 Identities=29% Similarity=0.415 Sum_probs=162.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHH--HHHhcCCCCceeeEEEEEEeCC----eEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEI--GMISAQQHPNLVKLYGCCVEGN----QLLL 468 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~--~~l~~l~H~nIv~l~~~~~~~~----~~~l 468 (626)
++|...+.||+|+||.||+|++ +|+.||||+++... .+++..|. ..+..++|||||+++++|.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3466778999999999999997 68899999996542 33444444 4556789999999999998654 6899
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHED-----SRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
||||+++|+|.++++.. .++|..+.+++.|+|.||+|||+. +..+|+||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999653 589999999999999999999974 1235999999999999999999999999
Q ss_pred CCcccccCCCcc---eecccccCCcccchhhhccCC------CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 544 GLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRGY------LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|+++........ ......||++|+|||++.... ++.++|||||||+||||+||..|+..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 999977543322 223467999999999987542 57799999999999999999887643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-40 Score=335.45 Aligned_cols=196 Identities=29% Similarity=0.449 Sum_probs=169.2
Q ss_pred CCeeeccCceEEEEEEEcCC----cEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe-CCeEEEEEEec
Q 006906 400 ANKVGEGGFGSVYKGILSDG----TVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE-GNQLLLVYEYM 473 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~e~~ 473 (626)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++|||||+++|+|.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 36899999753 44556789999999999999999999999876 46899999999
Q ss_pred CCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCCC
Q 006906 474 KNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEEDK 553 (626)
Q Consensus 474 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~~ 553 (626)
++|+|.++++... ..+++..+.+++.|+|.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999987653 35788999999999999999999987 9999999999999999999999999998765432
Q ss_pred cc---eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 554 TH---ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 554 ~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
.. ......||+.|+|||.+....++.++||||||+++|||+||+.|+..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 21 22335689999999999999999999999999999999998887754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=337.57 Aligned_cols=208 Identities=28% Similarity=0.408 Sum_probs=165.2
Q ss_pred HhcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC-
Q 006906 393 ATNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG- 463 (626)
Q Consensus 393 ~t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~- 463 (626)
..++|++.+.||+|+||.||+|++. +++.||||+++.. .....+++.+|.+.+.++ +|+|||++++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3467889999999999999999864 2468999999754 334456788888877766 789999999998764
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.++++..... ....+++.++..++.||++||+|||+++ |+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 4689999999999999999654321 1235899999999999999999999987 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCC-CCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK-SNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~-~p~~~~ 603 (626)
+.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999876543322 233467999999999999999999999999999999999975 566543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=337.04 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=169.7
Q ss_pred cCCCCCCeeeccCceEEEEEEEcC-Cc--EEEEEEeccC-ChhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCeEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSD-GT--VIAVKQLSSK-SRQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQLLLV 469 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~-g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 469 (626)
++|++.++||+|+||+||+|++++ +. .||||++... .....++|.+|+++++++ +|||||+++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567888999999999999999863 44 5788887654 334556899999999998 799999999999999999999
Q ss_pred EEecCCCchhhhhcCCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCE
Q 006906 470 YEYMKNNCLSRAIFGKDT-----------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNA 538 (626)
Q Consensus 470 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~ 538 (626)
|||+++|+|.++++.... .....++|..+.+++.|||.||+|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 999999999999976521 12347999999999999999999999997 9999999999999999999
Q ss_pred EEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCC-CCCC
Q 006906 539 KISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKS-NTNY 602 (626)
Q Consensus 539 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~-p~~~ 602 (626)
||+|||+++....... .....||..|+|||.+....++.++|||||||++|||++|.. |+..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 9999999986543222 223458999999999999999999999999999999999765 5643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-40 Score=332.86 Aligned_cols=200 Identities=28% Similarity=0.436 Sum_probs=172.5
Q ss_pred cCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||+||+|+.++++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999999999999997653 23357899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccCC
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEED 552 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~~ 552 (626)
+.++.+..+.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9988777766443 36999999999999999999999987 999999999999999999999999999876543
Q ss_pred CcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 553 KTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 553 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
.. ......+++.|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 32 2233468999999999875 45799999999999999999999999754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=334.38 Aligned_cols=206 Identities=29% Similarity=0.432 Sum_probs=171.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEcC--------CcEEEEEEeccCCh-hcHHHHHHHHHHHhcC-CCCceeeEEEEEEeC
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILSD--------GTVIAVKQLSSKSR-QGNREFVNEIGMISAQ-QHPNLVKLYGCCVEG 463 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~~--------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 463 (626)
.++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3567888999999999999998632 34799999976543 4457888999988887 899999999999999
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTE-----------YRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
+..++||||+++|+|.+++...... ....+++.++++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 9999999999999999999655321 1246899999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVS-GKSNTNY 602 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~ellt-G~~p~~~ 602 (626)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+| |+.||..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999999999999997754332 23344678999999999999999999999999999999998 6888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=334.78 Aligned_cols=207 Identities=28% Similarity=0.418 Sum_probs=176.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcC-CCCceeeEEEEEEeCCe
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQ-QHPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 465 (626)
.++|++.+.||+|+||.||+|++. +++.||||+++... .....+|.+|+++++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 457888899999999999999862 45789999997653 34456789999999998 69999999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCc-------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDT-------------EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLL 532 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl 532 (626)
.++||||+++|+|.++++.... .....+++..+.+++.||++||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999865421 12246999999999999999999999997 9999999999999
Q ss_pred cCCCCEEEeecCCcccccCCCc-ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCCCC
Q 006906 533 DKDLNAKISDFGLAKLYEEDKT-HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSG-KSNTNYR 603 (626)
Q Consensus 533 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG-~~p~~~~ 603 (626)
+.++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+ ++|+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997764433 233446789999999999999999999999999999999995 5555443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-40 Score=335.38 Aligned_cols=206 Identities=27% Similarity=0.420 Sum_probs=175.8
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc------CCcEEEEEEeccC-ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS------DGTVIAVKQLSSK-SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~------~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 466 (626)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++|||||+++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999874 3578999999754 334445789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhhhcCCCc-----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 467 LLVYEYMKNNCLSRAIFGKDT-----EYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
++||||+++|+|.++++.... .....+++..+.+++.|+|+||+|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 999999999999998864321 11235799999999999999999999986 9999999999999999999999
Q ss_pred ecCCcccccCCCcc-eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCC-CCCCC
Q 006906 542 DFGLAKLYEEDKTH-ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGK-SNTNY 602 (626)
Q Consensus 542 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~-~p~~~ 602 (626)
|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||+ .|+..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 99999976543332 223356899999999999999999999999999999999985 56643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=331.48 Aligned_cols=197 Identities=23% Similarity=0.376 Sum_probs=167.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCCh------hcHHHHHHHHHHHhcCC--CCceeeEEEEEEeCCe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSR------QGNREFVNEIGMISAQQ--HPNLVKLYGCCVEGNQ 465 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~ 465 (626)
++|++.+.||+|+||+||+|+.. +++.||||++..... ...+++.+|++++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999975 689999999865321 11234678999999886 8999999999999999
Q ss_pred EEEEEEecCC-CchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CCEEEeec
Q 006906 466 LLLVYEYMKN-NCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKD-LNAKISDF 543 (626)
Q Consensus 466 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~~kl~Df 543 (626)
.++||||+.+ +++.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 9999999976 5677766432 36999999999999999999999997 9999999999999854 78999999
Q ss_pred CCcccccCCCcceecccccCCcccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 544 GLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYL-TSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 544 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
|+++..... ......||+.|+|||++....+ +.++|||||||++|||+||+.||..
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 999865433 2334679999999999987665 6679999999999999999999964
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=332.36 Aligned_cols=202 Identities=26% Similarity=0.459 Sum_probs=167.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-C-CcEEEEEEeccCC--hhcHHHHHHHHHHHh---cCCCCceeeEEEEEEe----
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-D-GTVIAVKQLSSKS--RQGNREFVNEIGMIS---AQQHPNLVKLYGCCVE---- 462 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~-g~~vAvK~l~~~~--~~~~~~~~~E~~~l~---~l~H~nIv~l~~~~~~---- 462 (626)
.++|++.+.||+|+||+||+|+.. + ++.||||++.... ......+.+|+++++ ..+||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 6779999986532 222334556666655 4589999999999863
Q ss_pred -CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEe
Q 006906 463 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKIS 541 (626)
Q Consensus 463 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~ 541 (626)
....+++|||+.++.+........ ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence 346899999999987765543332 36899999999999999999999997 9999999999999999999999
Q ss_pred ecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 542 DFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 542 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 999998654332 2344679999999999999999999999999999999999999997543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-38 Score=320.46 Aligned_cols=204 Identities=21% Similarity=0.296 Sum_probs=173.9
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCC-CceeeEEEEEEeCCeEEEEEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 471 (626)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ...++.+|++.++.++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 467899999999999999999976 68999999986542 23456788888888866 899999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----CCCEEEeecCCc
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDK-----DLNAKISDFGLA 546 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~~kl~DfGla 546 (626)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccccee
Confidence 99 689988876543 36899999999999999999999997 999999999999974 578999999999
Q ss_pred ccccCCCc------ceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 006906 547 KLYEEDKT------HISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPNED 607 (626)
Q Consensus 547 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~~~ 607 (626)
+.+..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 97654321 12234679999999999999999999999999999999999999998655443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=327.11 Aligned_cols=201 Identities=24% Similarity=0.403 Sum_probs=167.8
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe--------C
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE--------G 463 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 463 (626)
++|++.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67889999999999999999975 7999999998654 23345778999999999999999999999865 3
Q ss_pred CeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeec
Q 006906 464 NQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDF 543 (626)
Q Consensus 464 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~Df 543 (626)
+..++||||++++.+....... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 4689999999988776554333 36889999999999999999999997 999999999999999999999999
Q ss_pred CCcccccCCCcc---eecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 544 GLAKLYEEDKTH---ISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 544 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
|+++.+...... ......||+.|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 999876533211 22335699999999998765 6899999999999999999999999754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-38 Score=328.35 Aligned_cols=201 Identities=24% Similarity=0.369 Sum_probs=167.4
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC-hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC----eEE
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS-RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN----QLL 467 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~ 467 (626)
+++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 456889999999999999999974 79999999997543 344567899999999999999999999987543 234
Q ss_pred EEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcc
Q 006906 468 LVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAK 547 (626)
Q Consensus 468 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~ 547 (626)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 555667799999998543 5899999999999999999999997 9999999999999999999999999998
Q ss_pred cccCCCcc--eecccccCCcccchhhhc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 548 LYEEDKTH--ISTRIAGTIGYMAPEYAM-RGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 548 ~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
........ ......||+.|+|||++. ...++.++||||+||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 76543221 223466999999999985 456789999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=327.75 Aligned_cols=202 Identities=27% Similarity=0.390 Sum_probs=174.6
Q ss_pred cCCCCCCeeeccCceEEEEEEEc----CCcEEEEEEeccCC----hhcHHHHHHHHHHHhcCCC-CceeeEEEEEEeCCe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS----DGTVIAVKQLSSKS----RQGNREFVNEIGMISAQQH-PNLVKLYGCCVEGNQ 465 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~----~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 465 (626)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 47899999986532 2334678899999999977 899999999999999
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.++||||+.+|+|.+++.... .+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999986542 5788899999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG--YLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
++.+............|++.|+|||.+... .++.++|||||||+||||+||+.||....
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 987765444444556799999999999754 47889999999999999999999997653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-38 Score=327.42 Aligned_cols=198 Identities=29% Similarity=0.380 Sum_probs=163.8
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC------CeEEE
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVKLYGCCVEG------NQLLL 468 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 468 (626)
+|+..++||+|+||+||+|+.. +++.||||++...... +.+|++++++++|+|||++++++... ..+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4667889999999999999986 6899999999765322 34699999999999999999998643 34789
Q ss_pred EEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcc
Q 006906 469 VYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAK 547 (626)
Q Consensus 469 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~ 547 (626)
||||++++.+..+.+.. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 99999877544433211 11246999999999999999999999987 99999999999999775 89999999998
Q ss_pred cccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 548 LYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 548 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 7654332 233579999999998875 578999999999999999999999997543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-38 Score=327.40 Aligned_cols=196 Identities=26% Similarity=0.420 Sum_probs=164.2
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCC------
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVEGN------ 464 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 464 (626)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999975 6999999999754 3344567899999999999999999999998654
Q ss_pred eEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecC
Q 006906 465 QLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFG 544 (626)
Q Consensus 465 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfG 544 (626)
..++||||+ +.+|..+.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 579999999 5567776643 25999999999999999999999997 9999999999999999999999999
Q ss_pred CcccccCCCcceecccccCCcccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 545 LAKLYEEDKTHISTRIAGTIGYMAPEYAMR-GYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 545 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+++...... +...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 167 LARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp TCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 998765432 34568999999999876 45789999999999999999999999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=313.86 Aligned_cols=199 Identities=22% Similarity=0.372 Sum_probs=174.1
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeCCeEEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEGNQLLLVYE 471 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 471 (626)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999975 78899999986543 3345788999999999999999999999999999999999
Q ss_pred ecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCCcccccC
Q 006906 472 YMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKLYEE 551 (626)
Q Consensus 472 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~~~~ 551 (626)
++.++++..++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999998877654 26889999999999999999999997 99999999999999999999999999997654
Q ss_pred CCcceecccccCCcccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCC
Q 006906 552 DKTHISTRIAGTIGYMAPEYAMRGY-LTSKADVYSFGVVTLEIVSGKSNTNY 602 (626)
Q Consensus 552 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~s~Gvil~elltG~~p~~~ 602 (626)
... ......++..|+|||.+.... ++.++|||||||++|||++|+.|+..
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 332 223345778999999987654 68999999999999999999999754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-37 Score=313.80 Aligned_cols=201 Identities=24% Similarity=0.335 Sum_probs=165.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCceee-EEEEEEeCCeEEEEEEe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLVK-LYGCCVEGNQLLLVYEY 472 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~e~ 472 (626)
++|++.+.||+|+||+||+|+.. +++.||||++..... ..++..|+++++.++|+|++. +.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 56889999999999999999975 689999999876432 345788999999998776555 55566788889999999
Q ss_pred cCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCCEEEeecCCcccc
Q 006906 473 MKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLD---KDLNAKISDFGLAKLY 549 (626)
Q Consensus 473 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~~kl~DfGla~~~ 549 (626)
+. +++.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+
T Consensus 85 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred cC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 95 45555543322 36899999999999999999999997 99999999999985 4567999999999987
Q ss_pred cCCCcc------eecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCC
Q 006906 550 EEDKTH------ISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYRPN 605 (626)
Q Consensus 550 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~~~ 605 (626)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 543321 22346799999999999999999999999999999999999999976543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-36 Score=314.89 Aligned_cols=194 Identities=21% Similarity=0.355 Sum_probs=167.9
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEe--CCeEEEEE
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVE--GNQLLLVY 470 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV~ 470 (626)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999975 6899999999754 3467889999999985 9999999999984 45689999
Q ss_pred EecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-CEEEeecCCcccc
Q 006906 471 EYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDL-NAKISDFGLAKLY 549 (626)
Q Consensus 471 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~~kl~DfGla~~~ 549 (626)
||+.+++|..+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999997653 25899999999999999999999997 99999999999998655 5899999999876
Q ss_pred cCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 006906 550 EEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYRP 604 (626)
Q Consensus 550 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~~ 604 (626)
..... .....+|+.|+|||.+... .++.++||||+||++|||++|+.||....
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 54332 2345689999999998765 47999999999999999999999997543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=317.22 Aligned_cols=197 Identities=26% Similarity=0.393 Sum_probs=166.5
Q ss_pred hcCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCC--hhcHHHHHHHHHHHhcCCCCceeeEEEEEEeC-----Ce
Q 006906 394 TNNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKS--RQGNREFVNEIGMISAQQHPNLVKLYGCCVEG-----NQ 465 (626)
Q Consensus 394 t~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 465 (626)
+++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++++.++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 567999999999999999999975 79999999997543 34456788999999999999999999998643 34
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.+++++|+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence 56778888999999998543 5899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRG-YLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
+...... .....||+.|+|||...+. .++.++|||||||++|||++|+.||...
T Consensus 168 a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 168 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp --CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 9865432 2335689999999987765 5689999999999999999999999754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-36 Score=314.75 Aligned_cols=196 Identities=26% Similarity=0.344 Sum_probs=160.3
Q ss_pred cCCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccC--ChhcHHHHHHHHHHHhcCCCCceeeEEEEEEe------CCe
Q 006906 395 NNFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSK--SRQGNREFVNEIGMISAQQHPNLVKLYGCCVE------GNQ 465 (626)
Q Consensus 395 ~~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 465 (626)
++|++.++||+|+||+||+|++. +|+.||||++... .....+++.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999976 6999999999754 23445678899999999999999999999963 368
Q ss_pred EEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEEeecCC
Q 006906 466 LLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKISDFGL 545 (626)
Q Consensus 466 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGl 545 (626)
.|+||||+.++.+.. ++ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchHHHHh-hh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 899999998765544 32 25889999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 546 AKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 546 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++...... ......+|+.|+|||.+.+..+++++||||+||+++||++|+.||...
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 88654322 234457899999999999999999999999999999999999999643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.3e-31 Score=280.27 Aligned_cols=198 Identities=23% Similarity=0.269 Sum_probs=158.2
Q ss_pred CCCCCCeeeccCceEEEEEEEc-CCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-----------CCceeeEEEEEEe-
Q 006906 396 NFDPANKVGEGGFGSVYKGILS-DGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----------HPNLVKLYGCCVE- 462 (626)
Q Consensus 396 ~f~~~~~IG~G~fG~Vyk~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~- 462 (626)
+|++.++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888999999999999999975 79999999997643 33456778888887765 5789999988764
Q ss_pred -CCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEEcCCCC---
Q 006906 463 -GNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLN--- 537 (626)
Q Consensus 463 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~--- 537 (626)
....+++|+++..+........ ......+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred cccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 4567778887765543322211 1112468899999999999999999998 54 999999999999987653
Q ss_pred ---EEEeecCCcccccCCCcceecccccCCcccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Q 006906 538 ---AKISDFGLAKLYEEDKTHISTRIAGTIGYMAPEYAMRGYLTSKADVYSFGVVTLEIVSGKSNTNYR 603 (626)
Q Consensus 538 ---~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~s~Gvil~elltG~~p~~~~ 603 (626)
++++|||.+....... ....||+.|+|||.+....++.++||||+||+++||++|+.||...
T Consensus 168 ~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 8999999998654322 3456999999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.8e-23 Score=196.31 Aligned_cols=162 Identities=19% Similarity=0.140 Sum_probs=120.2
Q ss_pred CCCeeeccCceEEEEEEEcCCcEEEEEEeccCCh------------------hcHHHHHHHHHHHhcCCCCceeeEEEEE
Q 006906 399 PANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSR------------------QGNREFVNEIGMISAQQHPNLVKLYGCC 460 (626)
Q Consensus 399 ~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 460 (626)
+.++||+|+||+||+|+..+|+.||||+++.... .....+..|...+.+++|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 5689999999999999998999999998753210 1123455688899999999999887653
Q ss_pred EeCCeEEEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCCEEE
Q 006906 461 VEGNQLLLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDSRIKIVHRDIKTSNVLLDKDLNAKI 540 (626)
Q Consensus 461 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~~kl 540 (626)
. .+++|||+++..+. .+++....+++.|++++++|||+.+ |+||||||+|||+++++ ++|
T Consensus 84 --~--~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 84 --G--NAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp --T--TEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred --C--CEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence 2 37899999876543 2445567789999999999999997 99999999999999764 899
Q ss_pred eecCCcccccCCCcceecccccCCcccc------hhhhccCCCCChhhHHHHHHHH
Q 006906 541 SDFGLAKLYEEDKTHISTRIAGTIGYMA------PEYAMRGYLTSKADVYSFGVVT 590 (626)
Q Consensus 541 ~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~k~Dv~s~Gvil 590 (626)
+|||+|......... .|.. .|.+ ...|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999865432211 1111 1222 34567889999986444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.55 E-value=3e-15 Score=140.42 Aligned_cols=131 Identities=18% Similarity=0.145 Sum_probs=116.3
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCC-hHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGI-PTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i-p~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
.+.++.++|+|+ .+|..+. ++|++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..+ +..|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 457899999999 8998774 78999999999998755 5678999999999999999997766666 4599999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
+|+++...+..+ ..+++|+.|+|++|+|++..|..+..++....+.+.+++|.|+|.
T Consensus 87 ~N~l~~l~~~~F----~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 87 ENKIKEISNKMF----LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSS----TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cccccccCHHHH----hCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 999998877776 889999999999999999999999999999999999999999886
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.7e-14 Score=142.44 Aligned_cols=132 Identities=21% Similarity=0.188 Sum_probs=90.7
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|++|+|++|+|+ .+|..+.++++|++|++++|.+.+..+..+..+.+|++|++++|.++ .+|... ++.++.+++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc-eeccccccccccchhccc
Confidence 3444444444444 23344444555555555555554444444555555555666666666 344433 347889999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++|++++..+..+ ..+++|++|+|++|+|+ .+|..+..++....+.+.+|+|.|+|.
T Consensus 156 ~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 156 ANNNLTELPAGLL----NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp TTSCCSCCCTTTT----TTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ccccccccCcccc----ccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 9999998776666 78999999999999999 778777788888889999999999997
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.50 E-value=5.6e-15 Score=149.53 Aligned_cols=120 Identities=21% Similarity=0.361 Sum_probs=109.5
Q ss_pred cceEEEeecCceee--cCCccccCCCCCCEEEeec-CcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcc
Q 006906 2 NLKTLILTKCLIHG--EIPDYIGDMTKLKNIDLSF-NNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNV 76 (626)
Q Consensus 2 ~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l 76 (626)
+++.|+|++|+++| .+|+++++|++|++|+|++ |+|+|.+|..|++|++|++|+|++|+|++..|..+ ...|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 58999999999998 5899999999999999996 99999999999999999999999999998888766 4489999
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
+++.|++.+.+|..+ +.++.++.+++++|++.|.+|..+..++..
T Consensus 131 ~l~~N~~~~~~p~~l----~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l 175 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSI----SSLPNLVGITFDGNRISGAIPDSYGSFSKL 175 (313)
T ss_dssp ECCSSEEESCCCGGG----GGCTTCCEEECCSSCCEEECCGGGGCCCTT
T ss_pred ccccccccccCchhh----ccCcccceeecccccccccccccccccccc
Confidence 999999999888776 899999999999999999999988776654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=2.7e-14 Score=142.31 Aligned_cols=136 Identities=15% Similarity=0.178 Sum_probs=123.5
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..+ +++|+.+++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 479999999999987667788999999999999999997778889999999999999999996555555 458999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCCCcceeeeeecC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPADQYHYTLHINCG 140 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~~~~~~~~~~c~ 140 (626)
++|++++..|..+ ..+++|+.|++++|++.+..|..++.++....+.+.+|+|+|+|.
T Consensus 185 ~~N~l~~i~~~~f----~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 185 HQNRVAHVHPHAF----RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CSSCCCEECTTTT----TTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhccccccChhHh----hhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 9999999888777 889999999999999999999999999999999999999999997
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.46 E-value=3.8e-14 Score=132.73 Aligned_cols=112 Identities=19% Similarity=0.236 Sum_probs=98.8
Q ss_pred CcceEEEeecCceeecCC-ccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTKCLIHGEIP-DYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
+++++|+|++|+|++.++ ..|.++++|+.|+|++|++.+..+..|..+++|++|+|++|+|+...|..+ +++|+.|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 368999999999987664 568999999999999999999999999999999999999999996555555 55999999
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
|++|+|++..+..+ ..+++|++|+|++|.+....+
T Consensus 109 L~~N~l~~i~~~~f----~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 109 LYDNQISCVMPGSF----EHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSSCCCEECTTSS----TTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccccccCHHHh----cCCcccccccccccccccccc
Confidence 99999998888777 789999999999999976544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.45 E-value=1.7e-14 Score=145.96 Aligned_cols=120 Identities=23% Similarity=0.312 Sum_probs=108.1
Q ss_pred CcceEEEeec-CceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccc
Q 006906 1 MNLKTLILTK-CLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ 77 (626)
++|++|+|++ |+|+|.+|++|++|++|++|+|++|+|.+..|..+.++.+|+++++++|++.+.+|..+ ++.++.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 4799999996 89999999999999999999999999999999999999999999999999999999988 45899999
Q ss_pred cccCcccccCCCCCCCCCCCcccc-ceeecCCCccCCCCCcccCCCCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLV-ESYSSPRNKLDKVHPCLRQNFPC 124 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l-~~l~l~~N~l~~~~p~~~~~~p~ 124 (626)
+++|.+.|.+|..+ ..+..+ +.++++.|++++..|..+..+..
T Consensus 156 l~~n~l~~~ip~~~----~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~ 199 (313)
T d1ogqa_ 156 FDGNRISGAIPDSY----GSFSKLFTSMTISRNRLTGKIPPTFANLNL 199 (313)
T ss_dssp CCSSCCEEECCGGG----GCCCTTCCEEECCSSEEEEECCGGGGGCCC
T ss_pred cccccccccccccc----cccccccccccccccccccccccccccccc
Confidence 99999999988765 555554 88999999999999988776543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=6.9e-14 Score=121.10 Aligned_cols=104 Identities=16% Similarity=0.161 Sum_probs=88.3
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCccccccCc
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISLNN 82 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls~N~ 82 (626)
|.|+|++|+|+ .+| .+.++++|++|||++|+|+ .+|..|+.+++|++|++++|+|+ .+|... +++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGGGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCccccccccCeEECCCCc
Confidence 58999999999 666 4899999999999999998 78889999999999999999999 566522 5699999999999
Q ss_pred ccccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 83 FTWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 83 l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
++...... ..+.+++|+.|++++|+++..
T Consensus 77 i~~~~~~~---~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 77 LQQSAAIQ---PLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCSSSTTG---GGGGCTTCCEEECTTSGGGGS
T ss_pred cCCCCCch---hhcCCCCCCEEECCCCcCCcC
Confidence 98543211 237889999999999999643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=1.6e-12 Score=117.84 Aligned_cols=106 Identities=15% Similarity=0.165 Sum_probs=88.1
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCcccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDI 78 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~l 78 (626)
+|++|+|++|+|+ .+|..+..+++|++||||+|+|+ .++ .|..+++|++|+|++|+++. +|..+ +++|+.|++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELIL 94 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEEC
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccC-CCcccccccccccccee
Confidence 6899999999999 67877788999999999999998 564 58999999999999999994 55543 569999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
++|+++..... .....+++|++|++++|.++..
T Consensus 95 ~~N~i~~~~~l---~~l~~l~~L~~L~l~~N~i~~~ 127 (162)
T d1a9na_ 95 TNNSLVELGDL---DPLASLKSLTYLCILRNPVTNK 127 (162)
T ss_dssp CSCCCCCGGGG---GGGGGCTTCCEEECCSSGGGGS
T ss_pred ccccccccccc---cccccccccchhhcCCCccccc
Confidence 99999753211 1237889999999999998654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=4.6e-12 Score=124.63 Aligned_cols=117 Identities=19% Similarity=0.183 Sum_probs=65.4
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+|++ +|..+ ++.|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccccccc-ccccccccccccccccc
Confidence 4566666666666444455666666666666666665 344 24556666666666666663 33333 3356666666
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCS 125 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~ 125 (626)
+|.+....+..+ ..+.+++.|++++|.++...+..+..++..
T Consensus 109 ~~~~~~~~~~~~----~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l 150 (266)
T d1p9ag_ 109 FNRLTSLPLGAL----RGLGELQELYLKGNELKTLPPGLLTPTPKL 150 (266)
T ss_dssp SSCCCCCCSSTT----TTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccceeecccc----ccccccccccccccccceeccccccccccc
Confidence 666654433333 455566666666666665555554444433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=4.5e-12 Score=125.91 Aligned_cols=112 Identities=14% Similarity=0.134 Sum_probs=99.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|++++|++++..|..+ +++|+.||+
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 368999999999996666789999999999999999998888999999999999999999998878877 469999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
++|++.+..+..+ +.+++|++|++++|++.+.-+
T Consensus 209 ~~N~i~~~~~~~~----~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 209 FANNLSALPTEAL----APLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CSSCCSCCCHHHH----TTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccc----ccccccCEEEecCCCCCCCcc
Confidence 9999998776555 788999999999999986533
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.13 E-value=2.5e-11 Score=104.61 Aligned_cols=82 Identities=16% Similarity=0.197 Sum_probs=71.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCch--hh--hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK--YI--FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~--~~--~~~l~~l 76 (626)
++|++|+|++|+|+ .+|+.++.+++|++|++++|+|+ .+| .+.++++|++|++++|+|+. +|. .+ +++|+.|
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLL 95 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCS-SSTTGGGGGCTTCCEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCC-CCCchhhcCCCCCCEE
Confidence 47999999999999 78989999999999999999999 566 59999999999999999994 443 33 4589999
Q ss_pred ccccCccccc
Q 006906 77 DISLNNFTWE 86 (626)
Q Consensus 77 ~ls~N~l~~~ 86 (626)
++++|.++..
T Consensus 96 ~l~~N~i~~~ 105 (124)
T d1dcea3 96 NLQGNSLCQE 105 (124)
T ss_dssp ECTTSGGGGS
T ss_pred ECCCCcCCcC
Confidence 9999999854
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.07 E-value=1.1e-10 Score=116.69 Aligned_cols=103 Identities=13% Similarity=0.151 Sum_probs=48.5
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
+|+.|++++|+++ .+|..+ +++|+.|++++|.+++..|..|.+++.+++|++++|++++..|..+ +++|+.|+|+
T Consensus 151 ~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~ 227 (305)
T d1xkua_ 151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227 (305)
T ss_dssp TCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred ccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence 3445555555554 344322 3455555555555554445555555555555555555553333333 2345555555
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
+|+|+ .+|..+ ..+++|++|++++|+|+
T Consensus 228 ~N~L~-~lp~~l----~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 228 NNKLV-KVPGGL----ADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp SSCCS-SCCTTT----TTCSSCCEEECCSSCCC
T ss_pred ccccc-cccccc----ccccCCCEEECCCCccC
Confidence 55554 222222 44455555555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.00 E-value=4e-12 Score=119.24 Aligned_cols=106 Identities=16% Similarity=0.117 Sum_probs=54.3
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls~ 80 (626)
+|++|+|++|+|+ .++ .+..|++|++|+|++|+|+ .+|..+..+++|++|++++|+++ .++... +++|+.|++++
T Consensus 49 ~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~~~~l~~L~~L~L~~ 124 (198)
T d1m9la_ 49 ACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSN 124 (198)
T ss_dssp TCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHHHHHHHHSSEEEESE
T ss_pred ccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cccccccccccccccccc
Confidence 4556666666655 343 3555566666666666655 44444444455666666666655 233211 44566666666
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKV 114 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~ 114 (626)
|+++...... ....+++|+.|++++|++...
T Consensus 125 N~i~~~~~~~---~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 125 NKITNWGEID---KLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp EECCCHHHHH---HHTTTTTCSEEEECSSHHHHH
T ss_pred chhccccccc---cccCCCccceeecCCCccccC
Confidence 6554321100 124555566666666655433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=2.7e-10 Score=102.11 Aligned_cols=103 Identities=12% Similarity=0.018 Sum_probs=79.1
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecC-cCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCccccc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFN-NLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDIS 79 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls 79 (626)
.+.+++++++++ .+|..+..+++|+.|+|++| .|+..-+..|.++++|+.|+|++|+|+..-|..+ .++|+.|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 456888888888 67888999999999999766 4886556789999999999999999995445544 4488999999
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCcc
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
+|+|+...+..+ ....|+.|+|++|++
T Consensus 89 ~N~l~~l~~~~~-----~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 89 FNALESLSWKTV-----QGLSLQELVLSGNPL 115 (156)
T ss_dssp SSCCSCCCSTTT-----CSCCCCEEECCSSCC
T ss_pred CCCCcccChhhh-----ccccccccccCCCcc
Confidence 999984433332 233688888888865
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=1.8e-10 Score=103.41 Aligned_cols=83 Identities=17% Similarity=0.141 Sum_probs=72.8
Q ss_pred CcceEEEeecC-ceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhh--cCCccc
Q 006906 1 MNLKTLILTKC-LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFN--SNKNVD 77 (626)
Q Consensus 1 ~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~--~l~~l~ 77 (626)
++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|..++. .|+.|+
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~ 109 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELV 109 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEE
T ss_pred cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccc
Confidence 47899999876 588555578999999999999999999777889999999999999999999 77777644 789999
Q ss_pred cccCccc
Q 006906 78 ISLNNFT 84 (626)
Q Consensus 78 ls~N~l~ 84 (626)
|++|.+.
T Consensus 110 L~~Np~~ 116 (156)
T d2ifga3 110 LSGNPLH 116 (156)
T ss_dssp CCSSCCC
T ss_pred cCCCccc
Confidence 9999885
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.99 E-value=3.5e-10 Score=112.97 Aligned_cols=111 Identities=19% Similarity=0.121 Sum_probs=94.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++|+.|+|++|.+++..|..|.+++.+++|++++|.+++..|..|.++++|++|+|++|+|+ .+|..+ +++|+.|+|
T Consensus 171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L 249 (305)
T d1xkua_ 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249 (305)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence 46899999999999999999999999999999999999888999999999999999999999 788877 469999999
Q ss_pred ccCcccccCCCCCCC--CCCCccccceeecCCCccC
Q 006906 79 SLNNFTWESSDPIEC--PRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 79 s~N~l~~~~~~~~~~--~~~~~~~l~~l~l~~N~l~ 112 (626)
++|+++......+.. ....+.+|+.|++++|+++
T Consensus 250 s~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 999998654333311 1245678999999999885
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.98 E-value=4.4e-10 Score=105.03 Aligned_cols=100 Identities=18% Similarity=0.217 Sum_probs=54.7
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCch-hhhhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPK-YIFNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~~l~~l~ls~ 80 (626)
+|+.|++++|.|+ .++ .+..|++|++|+|++|+|++..| ++++++|++|++++|.+. .+|. .-++.|+.|++++
T Consensus 41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFN 115 (199)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGGGTTCTTCSEEECCS
T ss_pred CCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-cccccccccccccccccc
Confidence 4566666666665 343 35566666666666666664322 666666666666666665 3332 1134555666665
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
|.+.... +...+++|+.|++++|++.
T Consensus 116 ~~~~~~~------~~~~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 116 NQITDID------PLKNLTNLNRLELSSNTIS 141 (199)
T ss_dssp SCCCCCG------GGTTCTTCSEEECCSSCCC
T ss_pred ccccccc------ccchhhhhHHhhhhhhhhc
Confidence 5554321 1244555555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.93 E-value=8.9e-10 Score=103.88 Aligned_cols=112 Identities=14% Similarity=0.207 Sum_probs=54.6
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh-hhcCCcccccc
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI-FNSNKNVDISL 80 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls~ 80 (626)
+|++|+|++|+|++ ++ .+++|++|++|++++|+|+ .+| .+.++++|+.|++++|.++ .++... ++.++.++++.
T Consensus 69 ~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~~l~~l~~l~~l~~~~ 143 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGN 143 (210)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCGGGGGCTTCCEEECCS
T ss_pred CCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cccccccccccccccccc
Confidence 45555555555553 22 2344555555555555554 233 3445555555555555544 222211 23455555555
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~ 126 (626)
|.++... ....+++|+.+++++|++++..| ++.++...
T Consensus 144 n~l~~~~------~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~ 181 (210)
T d1h6ta2 144 NKITDIT------VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181 (210)
T ss_dssp SCCCCCG------GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred ccccccc------ccccccccccccccccccccccc--ccCCCCCC
Confidence 5544211 12456677777777777765432 44454443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.90 E-value=2.1e-10 Score=103.51 Aligned_cols=107 Identities=8% Similarity=0.021 Sum_probs=83.5
Q ss_pred cccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchh-hhhcCCccccccCcccccCCCCCCCCCCCc
Q 006906 20 YIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKY-IFNSNKNVDISLNNFTWESSDPIECPRGSV 98 (626)
Q Consensus 20 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~ 98 (626)
.+.++.+|+.|||++|+|+ .+|..+..+++|+.|+|++|+|+ .++.. -+++|+.|++++|+++...+..+ ..+
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~l~~~~~----~~l 86 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLD----QAL 86 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCEECSCHH----HHC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCCcccCcchhhhhcccccccCCCcccc----ccc
Confidence 4778899999999999998 67877788999999999999999 56532 25699999999999986544322 568
Q ss_pred cccceeecCCCccCCCCC-cccCCCCCCCCCCCcc
Q 006906 99 NLVESYSSPRNKLDKVHP-CLRQNFPCSAPADQYH 132 (626)
Q Consensus 99 ~~l~~l~l~~N~l~~~~p-~~~~~~p~~~~~~~~~ 132 (626)
++|+.|++++|+++.... ..+..+|....+.+.+
T Consensus 87 ~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~ 121 (162)
T d1a9na_ 87 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121 (162)
T ss_dssp TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCS
T ss_pred cccccceeccccccccccccccccccccchhhcCC
Confidence 999999999999975432 3456666666544433
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.89 E-value=1.6e-09 Score=102.15 Aligned_cols=114 Identities=18% Similarity=0.248 Sum_probs=93.2
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|++|+|++|+|+ .+| .+.++++|+.|++++|.+. .++ .+.++++|+.+++++|++++..+..-+++|+.+++++
T Consensus 90 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~ 165 (210)
T d1h6ta2 90 KNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLED 165 (210)
T ss_dssp TTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCS
T ss_pred cccccccccccccc-ccc-ccccccccccccccccccc-ccc-ccccccccccccccccccccccccccccccccccccc
Confidence 47999999999999 466 5899999999999999997 444 6899999999999999999644444467999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~ 126 (626)
|++++.. +...+++|+.|++++|+++. +|. +..++...
T Consensus 166 n~l~~i~------~l~~l~~L~~L~Ls~N~i~~-l~~-l~~l~~L~ 203 (210)
T d1h6ta2 166 NQISDIV------PLAGLTKLQNLYLSKNHISD-LRA-LAGLKNLD 203 (210)
T ss_dssp SCCCCCG------GGTTCTTCCEEECCSSCCCB-CGG-GTTCTTCS
T ss_pred ccccccc------cccCCCCCCEEECCCCCCCC-Chh-hcCCCCCC
Confidence 9998532 23789999999999999975 453 55555544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.86 E-value=1.8e-09 Score=110.75 Aligned_cols=114 Identities=20% Similarity=0.228 Sum_probs=57.0
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCc---------------
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP--------------- 66 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip--------------- 66 (626)
+|+.|++++|+++. +| .+..+++|+.|++++|++++..| ++.+++|++|++++|++++..|
T Consensus 220 ~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n 295 (384)
T d2omza2 220 NLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295 (384)
T ss_dssp TCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence 45555555555552 22 34555555555555555553322 4455555555555555443211
Q ss_pred ------h-hhhhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCC
Q 006906 67 ------K-YIFNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAP 127 (626)
Q Consensus 67 ------~-~~~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~ 127 (626)
. ..+..++.|++++|++++..+ ...+++|+.|++++|+++. +| .++.+|....
T Consensus 296 ~l~~~~~~~~~~~l~~L~ls~n~l~~l~~------l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~ 355 (384)
T d2omza2 296 QLEDISPISNLKNLTYLTLYFNNISDISP------VSSLTKLQRLFFANNKVSD-VS-SLANLTNINW 355 (384)
T ss_dssp CCSCCGGGGGCTTCSEEECCSSCCSCCGG------GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCE
T ss_pred ccccccccchhcccCeEECCCCCCCCCcc------cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCE
Confidence 0 112355666666666664321 2456666666666666654 22 2444554443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.81 E-value=3.8e-09 Score=98.49 Aligned_cols=114 Identities=18% Similarity=0.244 Sum_probs=88.3
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|++|+|++|+|++ +++ ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+....+-.-+++|+.|++++
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~ 137 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 137 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccccccccccccccchhhhhHHhhhhh
Confidence 478999999999985 443 899999999999999987 455 4889999999999999988543333367899999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSA 126 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~ 126 (626)
|++... + ....+++|+.|++++|++++..| ++.++...
T Consensus 138 n~l~~~-~-----~l~~~~~L~~L~l~~n~l~~l~~--l~~l~~L~ 175 (199)
T d2omxa2 138 NTISDI-S-----ALSGLTSLQQLNFSSNQVTDLKP--LANLTTLE 175 (199)
T ss_dssp SCCCCC-G-----GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hhhccc-c-----cccccccccccccccccccCCcc--ccCCCCCC
Confidence 988642 1 23678899999999999887533 44555443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.79 E-value=6e-11 Score=111.05 Aligned_cols=122 Identities=13% Similarity=0.066 Sum_probs=94.0
Q ss_pred ceEEEeecC--ceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh--hhcCCcccc
Q 006906 3 LKTLILTKC--LIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI--FNSNKNVDI 78 (626)
Q Consensus 3 L~~L~L~~N--~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~l 78 (626)
++.++|+.+ .++ .+|.+++.|++|++|+|++|+|+ .++ .|.+|++|++|+|++|+|+ .+|... .+.|+.|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 445566554 344 56678999999999999999998 565 5999999999999999998 677544 458999999
Q ss_pred ccCcccccCCCCCCCCCCCccccceeecCCCccCCCCC-cccCCCCCCCCCCCccee
Q 006906 79 SLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP-CLRQNFPCSAPADQYHYT 134 (626)
Q Consensus 79 s~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p-~~~~~~p~~~~~~~~~~~ 134 (626)
++|+++.. + +...+++|+.|++++|+++.... ..++.+|....+.+.+++
T Consensus 101 ~~N~i~~l-~-----~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~ 151 (198)
T d1m9la_ 101 SYNQIASL-S-----GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp SEEECCCH-H-----HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred cccccccc-c-----cccccccccccccccchhccccccccccCCCccceeecCCCc
Confidence 99999853 1 23678999999999999976432 346777777665554444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.67 E-value=1.3e-08 Score=104.15 Aligned_cols=116 Identities=18% Similarity=0.214 Sum_probs=93.7
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|+.|++++|++++. + .+..+..++.+++++|++++ ++ .+..+.+|+.|+|++|++++..|-.-+++|+.|++++
T Consensus 263 ~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~~-~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~ 338 (384)
T d2omza2 263 TKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLED-IS-PISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFAN 338 (384)
T ss_dssp TTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC-CG-GGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCS
T ss_pred ccCCEeeccCcccCCC-C-cccccccccccccccccccc-cc-ccchhcccCeEECCCCCCCCCcccccCCCCCEEECCC
Confidence 4789999999999954 3 37889999999999999986 33 5889999999999999999754434477999999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPA 128 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~ 128 (626)
|+++.. + . ++.+++|++|++++|++++.+| +..++....+
T Consensus 339 n~l~~l-~-~----l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L 378 (384)
T d2omza2 339 NKVSDV-S-S----LANLTNINWLSAGHNQISDLTP--LANLTRITQL 378 (384)
T ss_dssp SCCCCC-G-G----GGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEE
T ss_pred CCCCCC-h-h----HcCCCCCCEEECCCCcCCCChh--hccCCCCCEe
Confidence 999853 2 2 3788999999999999998776 5666655443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.54 E-value=5e-08 Score=98.18 Aligned_cols=99 Identities=16% Similarity=0.212 Sum_probs=81.8
Q ss_pred cceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCccccccC
Q 006906 2 NLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISLN 81 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~N 81 (626)
+|+.|+|++|.|+ .+|+. +++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++. +.+.|+.|++++|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-lp~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-LPPLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-CCTTCCEEECCSS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-hcccccccccccc
Confidence 5889999999998 78964 478999999999999 88865 468999999999998 6664 4568999999999
Q ss_pred cccccCCCCCCCCCCCccccceeecCCCccCCCCC
Q 006906 82 NFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHP 116 (626)
Q Consensus 82 ~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p 116 (626)
.+... |. .+.++.|+.|++++|.+....+
T Consensus 109 ~l~~l-p~-----~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 109 QLEKL-PE-----LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp CCSSC-CC-----CTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccc-cc-----hhhhccceeecccccccccccc
Confidence 99743 32 2678999999999999865443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=5.3e-08 Score=93.11 Aligned_cols=103 Identities=9% Similarity=0.174 Sum_probs=56.1
Q ss_pred eEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhh---hhcCCccccc-
Q 006906 4 KTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYI---FNSNKNVDIS- 79 (626)
Q Consensus 4 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~---~~~l~~l~ls- 79 (626)
+.++.+++.++ .+|..+- +++++|||++|+|+...+..|.++++|++|+|++|.+...+|... ...++.++++
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 34556666666 5665442 456666666666653333356666666666666666655444433 2344555543
Q ss_pred cCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 80 LNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 80 ~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
.|++....+..+ ..+++|+.+++++|++..
T Consensus 88 ~n~l~~~~~~~~----~~l~~L~~l~l~~~~l~~ 117 (242)
T d1xwdc1 88 ANNLLYINPEAF----QNLPNLQYLLISNTGIKH 117 (242)
T ss_dssp CTTCCEECTTSE----ECCTTCCEEEEESCCCCS
T ss_pred cccccccccccc----cccccccccccchhhhcc
Confidence 345544443333 455666666666666543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=3.2e-07 Score=88.57 Aligned_cols=150 Identities=14% Similarity=0.103 Sum_probs=99.5
Q ss_pred HHHHHHhcCCCCCCeeeccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-CCceeeEEEEEEeCCeE
Q 006906 388 RQIKAATNNFDPANKVGEGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-HPNLVKLYGCCVEGNQL 466 (626)
Q Consensus 388 ~~l~~~t~~f~~~~~IG~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 466 (626)
.++...-..|...+..+-++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 34555556666555444444578999875 45667888876654444455677887776553 33356678888888999
Q ss_pred EEEEEecCCCchhhhhcCCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 006906 467 LLVYEYMKNNCLSRAIFGKDTEYRLKLDWPTRKKICIGIARGLAYLHEDS------------------------------ 516 (626)
Q Consensus 467 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------ 516 (626)
++||+++++.++.+..... .....++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEEeccccccccccccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999998775543211 122334455555555555421
Q ss_pred --------------------------CCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 517 --------------------------RIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 517 --------------------------~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999877677999998874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.48 E-value=7.4e-08 Score=91.35 Aligned_cols=115 Identities=17% Similarity=0.185 Sum_probs=87.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|+.|++++|++.+. ..+...+.++.+.++++.+.... .+.++++|+.|++++|++++..+-.-+++|+.|+|++
T Consensus 107 ~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~ 182 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182 (227)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCS
T ss_pred cccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccchhhcccccceecccCC
Confidence 4688999999998753 34677889999999999997554 3778899999999999988544423367899999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAP 127 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~ 127 (626)
|++++.. +.+.+++|++|++++|+++...| ++.++....
T Consensus 183 n~l~~l~------~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~ 221 (227)
T d1h6ua2 183 NKISDIS------PLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221 (227)
T ss_dssp SCCCCCG------GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCE
T ss_pred CccCCCh------hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCE
Confidence 9987532 23788999999999999986544 456655443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.47 E-value=1.3e-07 Score=89.68 Aligned_cols=117 Identities=15% Similarity=0.223 Sum_probs=92.8
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCchhhhhcCCcccccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVPKYIFNSNKNVDISL 80 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~~~l~~l~ls~ 80 (626)
++|++|++++|.++ .++ .+..+++|+.|++++|...+.. .+...+.++.+.++++.+....+-.-.+.|+.|++++
T Consensus 85 ~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~ 160 (227)
T d1h6ua2 85 TKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160 (227)
T ss_dssp CSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccc-ccc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchhhhhccccccccccccc
Confidence 46899999999998 555 5889999999999999998654 4778899999999999998655544466899999999
Q ss_pred CcccccCCCCCCCCCCCccccceeecCCCccCCCCCcccCCCCCCCCCC
Q 006906 81 NNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLRQNFPCSAPAD 129 (626)
Q Consensus 81 N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~~~~p~~~~~~ 129 (626)
|.+....+ .+.+++|+.|++++|++++. |. ++.+|....+.
T Consensus 161 n~~~~~~~------l~~l~~L~~L~Ls~n~l~~l-~~-l~~l~~L~~L~ 201 (227)
T d1h6ua2 161 AQVSDLTP------LANLSKLTTLKADDNKISDI-SP-LASLPNLIEVH 201 (227)
T ss_dssp SCCCCCGG------GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEE
T ss_pred cccccchh------hcccccceecccCCCccCCC-hh-hcCCCCCCEEE
Confidence 99875432 37889999999999999874 33 55666655443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=1.1e-07 Score=90.77 Aligned_cols=116 Identities=15% Similarity=0.054 Sum_probs=88.1
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCCh-HHhhccCCCCEEecc-CccccccCchhh--hhcCCcc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIP-TTFEKLAKTNFMYLT-GNKLTGPVPKYI--FNSNKNV 76 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~ls-~N~l~g~ip~~~--~~~l~~l 76 (626)
+++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|.++++++.|.+. .|+++...+..+ +++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 368999999999995444579999999999999999987664 468899999999986 477886555555 5699999
Q ss_pred ccccCcccccCCCCCCCCCCCccccceeecCCCccCCCCCccc
Q 006906 77 DISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVHPCLR 119 (626)
Q Consensus 77 ~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~p~~~ 119 (626)
++++|++....+... ...+..+..+..+++.+....+..+
T Consensus 109 ~l~~~~l~~~~~~~~---~~~l~~l~~~~~~n~~l~~i~~~~~ 148 (242)
T d1xwdc1 109 LISNTGIKHLPDVHK---IHSLQKVLLDIQDNINIHTIERNSF 148 (242)
T ss_dssp EEESCCCCSCCCCTT---TCBSSCEEEEEESCTTCCEECTTSS
T ss_pred ccchhhhcccccccc---ccccccccccccccccccccccccc
Confidence 999999975433222 2456667777777777765544443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.25 E-value=5.3e-08 Score=101.54 Aligned_cols=112 Identities=11% Similarity=0.079 Sum_probs=84.6
Q ss_pred cceEEEeecCceeecC-CccccCCCCCCEEEeecCcCCC----CChHHhhccCCCCEEeccCcccccc----Cchhh---
Q 006906 2 NLKTLILTKCLIHGEI-PDYIGDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTGP----VPKYI--- 69 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g~----ip~~~--- 69 (626)
+|+.|||+.|+|++.- ..-+..+++|++|+|++|.|+. .++..+..+++|++|||++|+|+.. +...+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 7999999999998532 3446678999999999999983 4566788999999999999998731 22222
Q ss_pred hhcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccCC
Q 006906 70 FNSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDK 113 (626)
Q Consensus 70 ~~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~ 113 (626)
...|+.|+|++|+++...-..++.....++.|++|++++|++..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 12799999999999765322221123578899999999999854
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.05 E-value=4.2e-06 Score=83.54 Aligned_cols=76 Identities=21% Similarity=0.322 Sum_probs=62.4
Q ss_pred CcceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhcc-CCCCEEeccCccccccCchhh-hhcCCcccc
Q 006906 1 MNLKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKL-AKTNFMYLTGNKLTGPVPKYI-FNSNKNVDI 78 (626)
Q Consensus 1 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~l 78 (626)
++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++ .+ +.|++|+|++|+++ .+|... +..|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~----~lp~~L~~L~L~~n~l~-~lp~~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALS----DLPPLLEYLGVSNNQLE-KLPELQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCC----SCCTTCCEEECCSSCCS-SCCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhh----hhccccccccccccccc-cccchhhhccceeecc
Confidence 47899999999999 889764 58899999999998 444 23 46999999999999 677543 569999999
Q ss_pred ccCccccc
Q 006906 79 SLNNFTWE 86 (626)
Q Consensus 79 s~N~l~~~ 86 (626)
++|.+...
T Consensus 128 ~~~~~~~~ 135 (353)
T d1jl5a_ 128 DNNSLKKL 135 (353)
T ss_dssp CSSCCSCC
T ss_pred cccccccc
Confidence 99988754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=1.2e-05 Score=76.80 Aligned_cols=143 Identities=16% Similarity=0.132 Sum_probs=84.5
Q ss_pred eeeccCc-eEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCC--CceeeEEEEEEeCCeEEEEEEecCCCch
Q 006906 402 KVGEGGF-GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQH--PNLVKLYGCCVEGNQLLLVYEYMKNNCL 478 (626)
Q Consensus 402 ~IG~G~f-G~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~e~~~~gsL 478 (626)
.+..|.. +.||+...+++..+++|....... ..+..|++.++.+.. -.+.++++++.+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 679999988888889998765432 245566666655432 3356678888888889999999988765
Q ss_pred hhh-----------------hcCCCcccccCCC--HHHHHHHH--------------------HHHHHHHHHHHhC----
Q 006906 479 SRA-----------------IFGKDTEYRLKLD--WPTRKKIC--------------------IGIARGLAYLHED---- 515 (626)
Q Consensus 479 ~~~-----------------l~~~~~~~~~~l~--~~~~~~i~--------------------~~ia~~L~yLH~~---- 515 (626)
.+. ||..... ...+. +.....-. ......+..+...
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPA-TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGG-GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred ccccccHHHHHHHHHHHHHHHccCChh-hCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence 431 1111000 00000 00000000 0011122333322
Q ss_pred CCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 516 SRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 516 ~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112379999999999999876678999998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.02 E-value=1.4e-07 Score=84.52 Aligned_cols=103 Identities=14% Similarity=0.003 Sum_probs=50.8
Q ss_pred ceEEEeecCceeecCCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccCccccccCc---hhh--hhcCCccc
Q 006906 3 LKTLILTKCLIHGEIPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTGNKLTGPVP---KYI--FNSNKNVD 77 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip---~~~--~~~l~~l~ 77 (626)
.+.|+|+++... | .+..+..+..|++.+|... .++..+.++++|++|+|++|+|+. ++ ..+ +++|+.|+
T Consensus 24 ~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~-l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 24 QQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYR-LDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCC-CSGGGTHHHHSTTCCCCC
T ss_pred hCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccC-CchhHHHHhhCCcccccc
Confidence 345666555422 2 2344444444444444332 344444556666666666666663 22 222 34666666
Q ss_pred cccCcccccCCCCCCCCCCCccccceeecCCCccCCCC
Q 006906 78 ISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLDKVH 115 (626)
Q Consensus 78 ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~~~~ 115 (626)
|++|+++...+... .....|+.|++++|.++...
T Consensus 98 Ls~N~i~~l~~l~~----l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 98 LSGNELKSERELDK----IKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp CTTSCCCCGGGHHH----HTTCCCSSCCCTTSTTSSSS
T ss_pred cccCccccchhhhh----hhccccceeecCCCCcCcCc
Confidence 66666653221111 12234666666666665543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.01 E-value=2.2e-07 Score=93.84 Aligned_cols=111 Identities=13% Similarity=0.102 Sum_probs=52.5
Q ss_pred cceEEEeecCceeec-----CCccccCCCCCCEEEeecCcCCCC----ChHHhhccCCCCEEeccCccccccCchhhh--
Q 006906 2 NLKTLILTKCLIHGE-----IPDYIGDMTKLKNIDLSFNNLTGG----IPTTFEKLAKTNFMYLTGNKLTGPVPKYIF-- 70 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~-----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~-- 70 (626)
.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...+..+++|++|+|++|.|++.-...+.
T Consensus 187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~ 266 (344)
T d2ca6a1 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 266 (344)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHH
Confidence 355666666665421 223345555666666666665422 233445556666666666665542112220
Q ss_pred ------hcCCccccccCcccccCCCCCCCCC-CCccccceeecCCCccC
Q 006906 71 ------NSNKNVDISLNNFTWESSDPIECPR-GSVNLVESYSSPRNKLD 112 (626)
Q Consensus 71 ------~~l~~l~ls~N~l~~~~~~~~~~~~-~~~~~l~~l~l~~N~l~ 112 (626)
..|+.|++++|+++......+...+ ..++.|+.|++++|++.
T Consensus 267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 1455666666655432111110000 12345566666666553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.92 E-value=7.2e-07 Score=79.67 Aligned_cols=89 Identities=15% Similarity=0.128 Sum_probs=64.9
Q ss_pred cCCccccCCCCCCEEEeecCcCCCC--ChHHhhccCCCCEEeccCccccccCchh-hh--hcCCccccccCcccccCCCC
Q 006906 16 EIPDYIGDMTKLKNIDLSFNNLTGG--IPTTFEKLAKTNFMYLTGNKLTGPVPKY-IF--NSNKNVDISLNNFTWESSDP 90 (626)
Q Consensus 16 ~~p~~~~~l~~L~~L~Ls~N~l~g~--ip~~~~~l~~L~~L~ls~N~l~g~ip~~-~~--~~l~~l~ls~N~l~~~~~~~ 90 (626)
.++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+++ .+++. .. ..|+.|++++|.++......
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~ 134 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQ 134 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSH
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccc
Confidence 4444456789999999999999853 4567889999999999999999 56552 22 37899999999997653321
Q ss_pred C---CCCCCCccccceee
Q 006906 91 I---ECPRGSVNLVESYS 105 (626)
Q Consensus 91 ~---~~~~~~~~~l~~l~ 105 (626)
. ..-...+|+|+.||
T Consensus 135 ~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 135 STYISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHHHHTTSTTCCEET
T ss_pred hhHHHHHHHHCCCCCEEC
Confidence 0 00014578888776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.91 E-value=1.6e-06 Score=84.98 Aligned_cols=127 Identities=14% Similarity=0.118 Sum_probs=66.9
Q ss_pred cceEEEeecCceeec-CCccccCCCCCCEEEeecCcCCCCChHHhhccCCCCEEeccC-cccccc-Cchhh--hhcCCcc
Q 006906 2 NLKTLILTKCLIHGE-IPDYIGDMTKLKNIDLSFNNLTGGIPTTFEKLAKTNFMYLTG-NKLTGP-VPKYI--FNSNKNV 76 (626)
Q Consensus 2 ~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~-ip~~~--~~~l~~l 76 (626)
+|++|+|++|.+++. ++.-+.++++|++|+|+++.+++..+..++++++|++|+|++ +.++.. +..-. +++|+.|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 466666666666533 333456666666666666666666666666666666666666 344421 11111 2355666
Q ss_pred ccccC-ccccc--------CCCCCC--------CC---------CCCccccceeecCCC-ccCCCCCcccCCCCCCCCC
Q 006906 77 DISLN-NFTWE--------SSDPIE--------CP---------RGSVNLVESYSSPRN-KLDKVHPCLRQNFPCSAPA 128 (626)
Q Consensus 77 ~ls~N-~l~~~--------~~~~~~--------~~---------~~~~~~l~~l~l~~N-~l~~~~p~~~~~~p~~~~~ 128 (626)
+++++ +++.. .+..+. .. ...+++|+.|++++| .+++.....+..+|....+
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 66552 22111 000000 00 023577888888875 4666666666666655443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=3.1e-05 Score=75.37 Aligned_cols=113 Identities=11% Similarity=0.049 Sum_probs=78.6
Q ss_pred CcceEEEeecC--ceeec-CCccccCCCCCCEEEeecC-cCCCCChHHhhccCCCCEEeccC-ccccccCchhh--hhcC
Q 006906 1 MNLKTLILTKC--LIHGE-IPDYIGDMTKLKNIDLSFN-NLTGGIPTTFEKLAKTNFMYLTG-NKLTGPVPKYI--FNSN 73 (626)
Q Consensus 1 ~~L~~L~L~~N--~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~ls~-N~l~g~ip~~~--~~~l 73 (626)
++|+.|+|+++ .++.. +..-+.++++|++|+|++| .+++..+..+.++++|++|+|++ +.++......+ .++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 36899999865 44432 3334467899999999985 58888888999999999999999 57776555555 4589
Q ss_pred CccccccCcccccCCCCCCCCCCC-ccccceeecCCCccCCCCCcccCC
Q 006906 74 KNVDISLNNFTWESSDPIECPRGS-VNLVESYSSPRNKLDKVHPCLRQN 121 (626)
Q Consensus 74 ~~l~ls~N~l~~~~~~~~~~~~~~-~~~l~~l~l~~N~l~~~~p~~~~~ 121 (626)
+.|+++++ ++.. .+ .. ...+..|.+..++++...+...+.
T Consensus 228 ~~L~l~~~-~~d~---~l----~~l~~~lp~L~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 228 KTLQVFGI-VPDG---TL----QLLKEALPHLQINCSHFTTIARPTIGN 268 (284)
T ss_dssp CEEECTTS-SCTT---CH----HHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CEEeeeCC-CCHH---HH----HHHHHhCccccccCccCCCCCCCccCc
Confidence 99999876 3211 11 11 134555677888888776666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.57 E-value=1.9e-06 Score=86.66 Aligned_cols=41 Identities=12% Similarity=0.156 Sum_probs=18.9
Q ss_pred cCCCCCCEEEeecCcCCCC-----ChHHhhccCCCCEEeccCcccc
Q 006906 22 GDMTKLKNIDLSFNNLTGG-----IPTTFEKLAKTNFMYLTGNKLT 62 (626)
Q Consensus 22 ~~l~~L~~L~Ls~N~l~g~-----ip~~~~~l~~L~~L~ls~N~l~ 62 (626)
..++.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 3444555555555555421 1122344455555555555544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.54 E-value=2.7e-06 Score=88.18 Aligned_cols=110 Identities=11% Similarity=0.022 Sum_probs=55.0
Q ss_pred ceEEEeecCceeecCCccc-----cCCCCCCEEEeecCcCCCCChHH----hhccCCCCEEeccCcccccc----Cchhh
Q 006906 3 LKTLILTKCLIHGEIPDYI-----GDMTKLKNIDLSFNNLTGGIPTT----FEKLAKTNFMYLTGNKLTGP----VPKYI 69 (626)
Q Consensus 3 L~~L~L~~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~g~ip~~----~~~l~~L~~L~ls~N~l~g~----ip~~~ 69 (626)
++.+++++|.++......+ .....|+.+++++|.++..-... +....+|++|+|++|+|+.. ++..+
T Consensus 285 l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l 364 (460)
T d1z7xw1 285 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 364 (460)
T ss_dssp CCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHH
T ss_pred ccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhh
Confidence 4555555555543211111 12345666666666666443222 33445677777777766542 22222
Q ss_pred h---hcCCccccccCcccccCCCCCCCCCCCccccceeecCCCccC
Q 006906 70 F---NSNKNVDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 70 ~---~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
. ..|+.|+|++|+++......+...+..+++|++|++++|+++
T Consensus 365 ~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 1 246667777776654322111111133466777777777664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00021 Score=72.75 Aligned_cols=77 Identities=13% Similarity=0.143 Sum_probs=46.7
Q ss_pred CCeeeccCceEEEEEEEcC-CcEEEEEEeccC-------ChhcHHHHHHHHHHHhcCC-C--CceeeEEEEEEeCCeEEE
Q 006906 400 ANKVGEGGFGSVYKGILSD-GTVIAVKQLSSK-------SRQGNREFVNEIGMISAQQ-H--PNLVKLYGCCVEGNQLLL 468 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~-g~~vAvK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~l 468 (626)
.+.||.|....||+....+ ++.|+||.-... ..........|.+.|..+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998754 678889864321 1112233455777766542 2 234445544 4555688
Q ss_pred EEEecCCCch
Q 006906 469 VYEYMKNNCL 478 (626)
Q Consensus 469 V~e~~~~gsL 478 (626)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.03 E-value=0.00015 Score=64.44 Aligned_cols=62 Identities=15% Similarity=0.235 Sum_probs=31.7
Q ss_pred cceEEEeecC-ceeec----CCccccCCCCCCEEEeecCcCCC----CChHHhhccCCCCEEeccCccccc
Q 006906 2 NLKTLILTKC-LIHGE----IPDYIGDMTKLKNIDLSFNNLTG----GIPTTFEKLAKTNFMYLTGNKLTG 63 (626)
Q Consensus 2 ~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~ls~N~l~g 63 (626)
+|++|+|+++ .++.. +-..+...+.|+.|+|++|.|.. .+...+...+.|+.|+|++|.|+.
T Consensus 16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence 4566666653 34321 22234455556666666666642 222334445566666666666553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.84 E-value=0.0017 Score=63.91 Aligned_cols=137 Identities=13% Similarity=0.072 Sum_probs=78.0
Q ss_pred eEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCCCCce-----eeEE--EEEEeCCeEEEEEEecCCCchh--
Q 006906 409 GSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNL-----VKLY--GCCVEGNQLLLVYEYMKNNCLS-- 479 (626)
Q Consensus 409 G~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-----v~l~--~~~~~~~~~~lV~e~~~~gsL~-- 479 (626)
-.||+++.++|+.|++|+.+.. ....+++..|.+.+..+....+ +..- ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5899999999999999998754 2345667778777665532211 1111 1234567788999999875432
Q ss_pred ----------------hhhcCCCcccccCCCH-------------------HHHHHHHHHHHHHHHHHHh----CCCCCe
Q 006906 480 ----------------RAIFGKDTEYRLKLDW-------------------PTRKKICIGIARGLAYLHE----DSRIKI 520 (626)
Q Consensus 480 ----------------~~l~~~~~~~~~~l~~-------------------~~~~~i~~~ia~~L~yLH~----~~~~~i 520 (626)
..............++ ..+..+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1111111000111111 1111222223333333332 223458
Q ss_pred EEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 521 VHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 521 iH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 56899998874
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.80 E-value=9.8e-05 Score=65.60 Aligned_cols=91 Identities=11% Similarity=0.089 Sum_probs=65.2
Q ss_pred cCCCCCCEEEeecC-cCCCC----ChHHhhccCCCCEEeccCccccccCch----hh--hhcCCccccccCcccccCCCC
Q 006906 22 GDMTKLKNIDLSFN-NLTGG----IPTTFEKLAKTNFMYLTGNKLTGPVPK----YI--FNSNKNVDISLNNFTWESSDP 90 (626)
Q Consensus 22 ~~l~~L~~L~Ls~N-~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~ip~----~~--~~~l~~l~ls~N~l~~~~~~~ 90 (626)
.+.++|+.|+|+++ .++.. +-..+...+.|+.|+|++|.++..-.. .+ .+.|+.|+|++|.++..+...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45689999999974 57633 334566778999999999998742222 22 237999999999998664333
Q ss_pred CCCCCCCccccceeecCCCccC
Q 006906 91 IECPRGSVNLVESYSSPRNKLD 112 (626)
Q Consensus 91 ~~~~~~~~~~l~~l~l~~N~l~ 112 (626)
+...+...+.|++|++++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 3223356688999999999653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.44 E-value=0.00011 Score=65.10 Aligned_cols=111 Identities=9% Similarity=0.000 Sum_probs=70.1
Q ss_pred CcceEEEeec-Cceeec----CCccccCCCCCCEEEeecCcCCCCC----hHHhhccCCCCEEeccCccccccCchhhh-
Q 006906 1 MNLKTLILTK-CLIHGE----IPDYIGDMTKLKNIDLSFNNLTGGI----PTTFEKLAKTNFMYLTGNKLTGPVPKYIF- 70 (626)
Q Consensus 1 ~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~i----p~~~~~l~~L~~L~ls~N~l~g~ip~~~~- 70 (626)
++|++|+|++ |.|+.. +-..+...++|+.|+|++|.++... -..+...++|+.|++++|.++..--..++
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4688999987 567532 2344567888999999999887542 34456678999999999988754322222
Q ss_pred -----hcCCc--cccccCcccccCCCCCCCCCCCccccceeecCCCcc
Q 006906 71 -----NSNKN--VDISLNNFTWESSDPIECPRGSVNLVESYSSPRNKL 111 (626)
Q Consensus 71 -----~~l~~--l~ls~N~l~~~~~~~~~~~~~~~~~l~~l~l~~N~l 111 (626)
+.|+. |+++.|.+.......+...+...+.|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 25665 444566665332212211123567788888877654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.19 E-value=0.0056 Score=61.70 Aligned_cols=74 Identities=19% Similarity=0.216 Sum_probs=48.1
Q ss_pred CCeeeccCceEEEEEEEcCC--------cEEEEEEeccCChhcHHHHHHHHHHHhcCCCCcee-eEEEEEEeCCeEEEEE
Q 006906 400 ANKVGEGGFGSVYKGILSDG--------TVIAVKQLSSKSRQGNREFVNEIGMISAQQHPNLV-KLYGCCVEGNQLLLVY 470 (626)
Q Consensus 400 ~~~IG~G~fG~Vyk~~~~~g--------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ 470 (626)
.+.|+.|-.-.+|++..+++ +.|.+++.... .......+|..+++.+.-.+++ ++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688888899999987543 45667766532 2234455788877766433444 56666532 5799
Q ss_pred EecCCCchh
Q 006906 471 EYMKNNCLS 479 (626)
Q Consensus 471 e~~~~gsL~ 479 (626)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.79 E-value=0.039 Score=53.13 Aligned_cols=161 Identities=12% Similarity=0.063 Sum_probs=83.6
Q ss_pred ccHHHHHHHhcCCCCCCeee-----ccCceEEEEEEEcCCcEEEEEEeccCChhcHHHHHHHHHHHhcCC-----CCcee
Q 006906 385 YTLRQIKAATNNFDPANKVG-----EGGFGSVYKGILSDGTVIAVKQLSSKSRQGNREFVNEIGMISAQQ-----HPNLV 454 (626)
Q Consensus 385 ~~~~~l~~~t~~f~~~~~IG-----~G~fG~Vyk~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv 454 (626)
.+.++++....+|.+.+... .|---+.|+.+..+|+ +++|+...... .+++..|++++..+. -|..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 45678888888898866543 4555788999887665 89998865322 233344555544432 22222
Q ss_pred eEE---EEEEeCCeEEEEEEecCCCchhhh--------------hc----CC--Ccccc----------------cCCCH
Q 006906 455 KLY---GCCVEGNQLLLVYEYMKNNCLSRA--------------IF----GK--DTEYR----------------LKLDW 495 (626)
Q Consensus 455 ~l~---~~~~~~~~~~lV~e~~~~gsL~~~--------------l~----~~--~~~~~----------------~~l~~ 495 (626)
... .+.........++.++.+...... ++ .. ..... .....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 211 012234566777777766433210 00 00 00000 00011
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCEEEcCCCCEEEeecCCccc
Q 006906 496 PTRKKICIGIARGLAYLHE-DSRIKIVHRDIKTSNVLLDKDLNAKISDFGLAKL 548 (626)
Q Consensus 496 ~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~~kl~DfGla~~ 548 (626)
......+..+...+.-.+. .-+..+||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111222222222222221 1223499999999999999887778999999874
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.39 E-value=0.0034 Score=54.98 Aligned_cols=94 Identities=12% Similarity=0.090 Sum_probs=63.1
Q ss_pred CccccCCCCCCEEEeec-CcCCCC----ChHHhhccCCCCEEeccCccccccCchhh------hhcCCccccccCccccc
Q 006906 18 PDYIGDMTKLKNIDLSF-NNLTGG----IPTTFEKLAKTNFMYLTGNKLTGPVPKYI------FNSNKNVDISLNNFTWE 86 (626)
Q Consensus 18 p~~~~~l~~L~~L~Ls~-N~l~g~----ip~~~~~l~~L~~L~ls~N~l~g~ip~~~------~~~l~~l~ls~N~l~~~ 86 (626)
.....+.++|+.|+|++ |.++.. +-..+...+.|+.|+|++|.++..--..+ .+.++.++++.|.++..
T Consensus 10 ~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~ 89 (166)
T d1io0a_ 10 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 89 (166)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccch
Confidence 33446779999999998 568633 23445578899999999999885433333 23889999999998755
Q ss_pred CCCCCCCCCCCccccceee--cCCCcc
Q 006906 87 SSDPIECPRGSVNLVESYS--SPRNKL 111 (626)
Q Consensus 87 ~~~~~~~~~~~~~~l~~l~--l~~N~l 111 (626)
.-..+.......+.|+.++ +++|.+
T Consensus 90 g~~~l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 90 GILALVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HHHHHHHGGGGCSSCCEEECCCCSSCC
T ss_pred hHHHHHHHHHhCccccEEeeccCCCcC
Confidence 4333322235567777644 456665
|